"pdb","title","DOI","resolution","Mean_B_Factor","oligo","oligo_sequence","residue_links","oligo_mean_B_Factor","comments","warnings","errors"
"1A7C","HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE","10.1016/S0969-2126(98)00064-1 ",1.95,33.17,"1a7c_oligo1","DGlcpNAcb1-4[DArapb1-6]DGlcpNAcb1-ASN","RIP(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",47.6844,"","",""
"1ABR","CRYSTAL STRUCTURE OF ABRIN-A","10.1006/JMBI.1995.0382 ",2.14,30.1,"1abr_oligo2","DManpb1-3[DManpa1-6]DGlcpa1-4LGlcpNAca1-4DGlcpNAcx1-","MAN(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NGZ(2_C_)-NDG(1_C_)",51.1106,"","",""
"1ABR","CRYSTAL STRUCTURE OF ABRIN-A","10.1006/JMBI.1995.0382 ",2.14,30.1,"1abr_oligo1","DManpb1-3[DManpa1-6]DGlcpb1-4LManpNAca1-4DGlcpNAcx1-","MAN(5_D_)-[BMA(4_D_)]-BGC(3_D_)-NDG(2_D_)-NDG(1_D_)",60.705,"","",""
"1AGM","REFINED STRUCTURE FOR THE COMPLEX OF ACARBOSE WITH GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100 TO 2.4 ANGSTROMS RESOLUTION","",2.3,0,"1agm_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",25.2255,"","",""
"1AH1","CTLA-4, NMR, 20 STRUCTURES","10.1038/NSB0797-527 ","2.95026e-39","1.15243e-41","1ah1_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(78_A_)",0,"","",""
"1AU1","HUMAN INTERFERON-BETA CRYSTAL STRUCTURE","10.1073/PNAS.94.22.11813 ",2.2,0,"1au1_oligo2","DGlcpb1-4DGlcpb1-2DGlcpb1-3DGlcpb1-4DGlcpb1-4[DQuipa1-6]DGlcpb1-ASN","G6D(7_C_)-[BGC(6_C_)-BGC(5_C_)-BGC(4_C_)-BGC(3_C_)-BGC(2_C_)]-BGC(1_C_)-ASN(80_A_)",73.0399,"","",""
"1AU1","HUMAN INTERFERON-BETA CRYSTAL STRUCTURE","10.1073/PNAS.94.22.11813 ",2.2,0,"1au1_oligo1","DQuipa1-6DGlcpb1-ASN","G6D(2_D_)-BGC(1_D_)-ASN(80_B_)",59.0432,"","",""
"1AX0","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACTYLGALACTOSAMINE","10.1006/JMBI.1998.1664 ",1.9,25.1,"1ax0_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",33.6915,"","",""
"1AX1","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH LACTOSE","10.1006/JMBI.1998.1664 ",1.95,32.4,"1ax1_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",39.5702,"","",""
"1AX2","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACETYLLACTOSAMINE","10.1006/JMBI.1998.1664 ",1.95,27.5,"1ax2_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",36.984,"","",""
"1AXY","ERYTHRINA CORALLODENDRON LECTIN","10.1006/JMBI.1998.1664 ",1.95,27.4,"1axy_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",33.4228,"","",""
"1AXZ","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH D-GALACTOSE","10.1006/JMBI.1998.1664 ",1.95,23.2,"1axz_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",29.3988,"","",""
"1B0F","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146","10.1021/JM970812E ",3,21,"1b0f_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",52.1676,"","",""
"1B0F","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146","10.1021/JM970812E ",3,21,"1b0f_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(159_A_)",52.5397,"","",""
"1B37","A 30 ANGSTROM U-SHAPED CATALYTIC TUNNEL IN THE CRYSTAL STRUCTURE OF POLYAMINE OXIDASE","10.1016/S0969-2126(99)80037-9 ",1.9,0,"1b37_oligo7","DManpa1-6DManpa1-4DGlcpNAcx1-","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)",38.1639,"","",""
"1B41","HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II, GLYCOSYLATED PROTEIN","10.1107/S0907444900010659 ",2.76,49.9,"1b41_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",90.9942,"","",""
"1B5F","NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.","10.1074/JBC.274.39.27694 ",1.72,0,"1b5f_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUC(6_G_)]-NAG(1_G_)-ASN(67_C_)",55.8461,"","",""
"1B5Q","A 30 ANGSTROM U-SHAPED CATALYTIC TUNNEL IN THE CRYSTAL STRUCTURE OF POLYAMINE OXIDASE","10.1016/S0969-2126(99)80037-9 ",1.9,0,"1b5q_oligo10","DManpa1-6DManpx1-","MAN(4_F_)-MAN(3_F_)",42.9098,"","",""
"1BHG","HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION","10.1038/NSB0496-375 ",2.53,0,"1bhg_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(173_B_)",19.3783,"","",""
"1BHG","HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION","10.1038/NSB0496-375 ",2.53,0,"1bhg_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(173_A_)",15.4829,"","",""
"1BLF","STRUCTURE OF DIFERRIC BOVINE LACTOFERRIN AT 2.8 ANGSTROMS RESOLUTION","10.1006/JMBI.1997.1386 ",2.8,0,"1blf_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(545_A_)",68.3311,"","",""
"1BRR","X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX","10.1073/PNAS.95.20.11673 ",2.9,58.2,"1brr_oligo3","DGalp[3S]b1-6DManpa1-2DGlcpa1-C43O3","SGA(3_E_)-MAN(2_E_)-GLC(1_E_)",73.2818,"","",""
"1BRR","X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX","10.1073/PNAS.95.20.11673 ",2.9,58.2,"1brr_oligo2","DGalp[3S]b1-6DManpa1-2DGlcpa1-C43O3","SGA(3_D_)-MAN(2_D_)-GLC(1_D_)",77.7748,"","",""
"1BZB","GLYCOSYLATED EEL CALCITONIN","10.1021/BI983018J ","2.95026e-39",0,"1bzb_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(3_A_)",0,"","",""
"1C1Z","CRYSTAL STRUCTURE OF HUMAN BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H)","10.1093/EMBOJ/18.22.6228 ",2.87,55.3,"1c1z_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(174_A_)",118.151,"","",""
"1CDR","STRUCTURE OF A SOLUBLE, GLYCOSYLATED FORM OF THE HUMAN COMPLEMENT REGULATORY PROTEIN CD59","10.1016/S0969-2126(00)00020-4 ","2.95026e-39",0,"1cdr_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(18_A_)",0,"","",""
"1CF5","BETA-MOMORCHARIN STRUCTURE AT 2.55 A","10.1107/S0907444999003297 ",2.55,0,"1cf5_oligo1","DXylpb1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LAltp[6H]b1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-FUC(6_C_)]-NAG(1_C_)-ASN(51_A_)",92.5848,"","",""
"1CF5","BETA-MOMORCHARIN STRUCTURE AT 2.55 A","10.1107/S0907444999003297 ",2.55,0,"1cf5_oligo2","DXylpb1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LAltp[6H]b1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-FUC(6_D_)]-NAG(1_D_)-ASN(51_B_)",87.2672,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-[MAN(7_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(80_E_)",132.307,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(80_D_)",126.692,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo14","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(49_F_)",126.858,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(80_F_)",126.788,"","",""
"1CPO","CHLOROPEROXIDASE","10.1016/S0969-2126(01)00274-X ",1.9,0,"1cpo_oligo1","DManpa1-3DLyxpa1-6[DLyxpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-XYS(4_B_)-[XYS(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(93_A_)",37.9158,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(4062_D_)",98.7493,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(2188_B_)",98.0675,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(1188_A_)",95.1556,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo4","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(2301_B_)",90.0091,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo2","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_F_)-[MAN(2_F_)]-MAN(1_F_)",26.2806,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_H_)-[MAN(2_H_)]-MAN(1_H_)",16.8776,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_E_)-[MAN(2_E_)]-MAN(1_E_)",15.0533,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_G_)-[MAN(2_G_)]-MAN(1_G_)",22.8291,"","",""
"1CVU","CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2","10.1038/35011103 ",2.4,0,"1cvu_oligo2","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(144_A_)",54.027,"","",""
"1CVU","CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2","10.1038/35011103 ",2.4,0,"1cvu_oligo4","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(2144_B_)",58.2795,"","",""
"1CXP","CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C","10.1074/JBC.275.16.11964 ",1.8,0,"1cxp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",14.6659,"","",""
"1CXP","CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C","10.1074/JBC.275.16.11964 ",1.8,0,"1cxp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",13.8448,"","",""
"1D2V","CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1074/JBC.275.16.11964 ",1.75,0,"1d2v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",14.0189,"","",""
"1D2V","CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1074/JBC.275.16.11964 ",1.75,0,"1d2v_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",13.4588,"","",""
"1D5L","CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1021/BI0111808 ",1.9,0,"1d5l_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",13.0735,"","",""
"1D5L","CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1021/BI0111808 ",1.9,0,"1d5l_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",12.6232,"","",""
"1D7W","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH CYANIDE AND BROMIDE AT PH 4.0","10.1021/BI0111808 ",1.9,0,"1d7w_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",15.8158,"","",""
"1D7W","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH CYANIDE AND BROMIDE AT PH 4.0","10.1021/BI0111808 ",1.9,0,"1d7w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",15.8056,"","",""
"1DEO","RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.55 A RESOLUTION WITH SO4 IN THE ACTIVE SITE","10.1016/S0969-2126(00)00118-0 ",1.55,0,"1deo_oligo1","DManpa1-3[DManpa1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(182_A_)",33.3305,"","",""
"1DEX","RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.9 A RESOLUTION","10.1016/S0969-2126(00)00118-0 ",1.9,0,"1dex_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(182_A_)",34.9688,"","",""
"1DGL","LECTIN FROM DIOCLEA GRANDIFLORA COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.273.49.32818 ",2.4,0,"1dgl_oligo1","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_D_)-[MAN(2_D_)]-MMA(1_D_)",34.3364,"","",""
"1DGL","LECTIN FROM DIOCLEA GRANDIFLORA COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.273.49.32818 ",2.4,0,"1dgl_oligo2","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_C_)-[MAN(2_C_)]-MMA(1_C_)",36.9403,"","",""
"1DIY","CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE ACTIVE SITE OF PGHS-1","10.1126/SCIENCE.289.5486.1933 ",3,0,"1diy_oligo6","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",64.1649,"","",""
"1DL2","CRYSTAL STRUCTURE OF CLASS I ALPHA-1,2-MANNOSIDASE FROM SACCHAROMYCES CEREVISIAE AT 1.54 ANGSTROM RESOLUTION","10.1093/EMBOJ/19.4.581 ",1.54,26.1,"1dl2_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NDG(2_B_)-NAG(1_B_)",27.4757,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"1DNU","STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.85,0,"1dnu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",15.8106,"","",""
"1DNU","STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.85,0,"1dnu_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",15.5174,"","",""
"1DNW","HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.9,0,"1dnw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",14.932,"","",""
"1DNW","HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.9,0,"1dnw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",15.428,"","",""
"1DOG","REFINED STRUCTURE FOR THE COMPLEX OF 1-DEOXYNOJIRIMYCIN WITH GLUCOAMYLASE FROM (ASPERGILLUS AWAMORI) VAR. X100 TO 2.4 ANGSTROMS RESOLUTION","10.1021/BI00057A028 ",2.3,0,"1dog_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",26.1206,"","",""
"1DP5","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR","10.1038/72378 ",2.2,0,"1dp5_oligo1","DManpb1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(9_C_)-MAN(8_C_)-[MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",41.1271,"","",""
"1DPJ","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR","10.1038/72378 ",1.8,0,"1dpj_oligo1","DManpb1-2DManpa1-2[DManpa1-2DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-[MAN(8_C_)-MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",30.7005,"","",""
"1DWA","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 1: STRUCTURE PRIOR TO IRRADIATION","10.1107/S0907444999016261 ",2,18,"1dwa_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",28.6489,"","",""
"1DWF","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 2: STRUCTURE AFTER IRRADIATION WITH 9.1*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,19.4,"1dwf_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",30.6889,"","",""
"1DWG","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL: PART 3 STRUCTURE AFTER IRRADIATION WITH 18.2*10E15 PHOTONS/MM2.","10.1107/S0907444999016261 ",2,22.3,"1dwg_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",33.6089,"","",""
"1DWH","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 4: STRUCTURE AFTER IRRADIATION WITH 27.2*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,25.7,"1dwh_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",36.9989,"","",""
"1DWI","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 5: STRUCTURE AFTER IRRADIATION WITH 54.0*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,40.1,"1dwi_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",51.4189,"","",""
"1DWJ","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. REFINED PART 6: STRUCTURE AFTER A RADIATION DOSE OF 54*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2.4,42.6,"1dwj_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",53.8593,"","",""
"1DZE","STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN TRAPPED AT 100K","10.1016/J.JMB.2004.06.080 ",2.5,36,"1dze_oligo1","DGalpb1-6DManpa1-2DGlcpa1-C40O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",83.6209,"","",""
"1E04","PLASMA BETA ANTITHROMBIN-III","10.1016/S0022-2836(02)01382-7 ",2.6,53,"1e04_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_L_)",129.508,"","",""
"1E05","PLASMA ALPHA ANTITHROMBIN-III","10.1016/S0022-2836(02)01382-7 ",2.62,53,"1e05_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[BMA(8_D_)-MAN(7_D_)]-GUP(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_L_)",119.17,"","",""
"1E4K","CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX","10.1038/35018508 ",3.2,95.1,"1e4k_oligo1","DGalpa1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GLA(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",99.2311,"","",""
"1E4K","CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX","10.1038/35018508 ",3.2,95.1,"1e4k_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",73.1865,"","",""
"1E6Q","MYROSINASE FROM SINAPIS ALBA WITH THE BOUND TRANSITION STATE ANALOGUE GLUCO-TETRAZOLE","10.1074/JBC.M006796200 ",1.35,16.2,"1e6q_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",28.8593,"","",""
"1E6S","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE","10.1074/JBC.M006796200 ",1.35,17.2,"1e6s_oligo4","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",27.5871,"","",""
"1EOM","CRYSTAL STRUCTURE OF THE COMPLEX OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 WITH A BIANTENNARY COMPLEX OCTASACCHARIDE","10.1021/BI0001731 ",2.1,20.6,"1eom_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_B_)-NAG(7_B_)-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-MAN(2_B_)-NAG(1_B_)",38.3739,"","",""
"1ETH","TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX","10.1074/JBC.271.30.18007 ",2.8,19.73,"1eth_oligo2","DManpa1-3[DManpa1-6]DManpb1-","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)",48.5009,"","",""
"1ETH","TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX","10.1074/JBC.271.30.18007 ",2.8,19.73,"1eth_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",45.3998,"","",""
"1EX1","BETA-D-GLUCAN EXOHYDROLASE FROM BARLEY","10.1016/S0969-2126(99)80024-0 ",2.2,0,"1ex1_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-[FCA(6_B_)]-NAG(1_B_)-ASN(498_A_)",62.2608,"","",""
"1F6A","STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)","10.1038/35018500 ",3.5,89.2,"1f6a_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(166_A_)",163.89,"","",""
"1F6A","STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)","10.1038/35018500 ",3.5,89.2,"1f6a_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(42_A_)",88.8044,"","",""
"1F6A","STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)","10.1038/35018500 ",3.5,89.2,"1f6a_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_B_)",123.404,"","",""
"1F6A","STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)","10.1038/35018500 ",3.5,89.2,"1f6a_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(21_A_)",160.324,"","",""
"1F8B","NATIVE INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH NEU5AC2EN","10.1110/PS.41801 ",1.8,0,"1f8b_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",26.7296,"","",""
"1F8C","NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4-AMINO-2-DEOXY-2,3- DEHYDRO-N-NEURAMINIC ACID","10.1110/PS.41801 ",1.7,0,"1f8c_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",19.9523,"","",""
"1F8D","NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 9-AMINO-2-DEOXY-2,3- DEHYDRO-N-NEURAMINIC ACID","10.1110/PS.41801 ",1.4,0,"1f8d_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",18.1599,"","",""
"1F8E","NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4,9-DIAMINO-2-DEOXY-2, 3-DEHYDRO-N-ACETYL-NEURAMINIC ACID","10.1110/PS.41801 ",1.4,0,"1f8e_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",18.2405,"","",""
"1F8R","CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE","10.1093/EMBOJ/19.16.4204 ",2,24.5,"1f8r_oligo6","DGlcpNAcb1-4[LAllp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(172_B_)",59.6267,"","",""
"1F8R","CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE","10.1093/EMBOJ/19.16.4204 ",2,24.5,"1f8r_oligo8","DGlcpNAcb1-4[LAllp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(172_D_)",47.3997,"","",""
"1F8R","CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE","10.1093/EMBOJ/19.16.4204 ",2,24.5,"1f8r_oligo5","DGlcpNAcb1-4[LAllp[6H]a1-6]DGlcpNAca1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(172_A_)",50.8782,"","",""
"1FC1","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.9,0,"1fc1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",30.6905,"","",""
"1FC1","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.9,0,"1fc1_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",23.2549,"","",""
"1FC2","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.8,0,"1fc2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[NAG(8_A_)-MAN(7_A_)]-MAN(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_D_)",22.9883,"","",""
"1FE2","CRYSTAL STRUCTURE OF DIHOMO-GAMMA-LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M009378200 ",3,0,"1fe2_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",62.8149,"","",""
"1FE8","CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING","10.1074/JBC.M006548200 ",2.03,0,"1fe8_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(56_I_)",54.6382,"","",""
"1FE8","CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING","10.1074/JBC.M006548200 ",2.03,0,"1fe8_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(56_H_)",53.2927,"","",""
"1FE8","CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING","10.1074/JBC.M006548200 ",2.03,0,"1fe8_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(56_J_)",58.8777,"","",""
"1FI1","FHUA IN COMPLEX WITH LIPOPOLYSACCHARIDE AND RIFAMYCIN CGP4832","10.1016/S0969-2126(01)00631-1 ",2.9,68.4,"1fi1_oligo1","DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GMH(10_B_)-[GLA(9_B_)-[GLC(8_B_)-GLC(7_B_)]-GLC(6_B_)]-GMH(5_B_)-GMH(4_B_)-[KDO(11_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",87.83,"","",""
"1FRT","CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC","10.1038/372379A0 ",4.5,199,"1frt_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(225_A_)",175.059,"","",""
"1FRT","CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC","10.1038/372379A0 ",4.5,199,"1frt_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_C_)",515.103,"","",""
"1FUJ","PR3 (MYELOBLASTIN)","10.1006/JMBI.1996.0458 ",2.2,0,"1fuj_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(159_A_)",64.3186,"","",""
"1FUJ","PR3 (MYELOBLASTIN)","10.1006/JMBI.1996.0458 ",2.2,0,"1fuj_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(159_C_)",85.2359,"","",""
"1FUJ","PR3 (MYELOBLASTIN)","10.1006/JMBI.1996.0458 ",2.2,0,"1fuj_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(159_B_)",65.3386,"","",""
"1FUJ","PR3 (MYELOBLASTIN)","10.1006/JMBI.1996.0458 ",2.2,0,"1fuj_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(159_D_)",71.1614,"","",""
"1FX5","CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I","10.1006/JMBI.2000.4214 ",2.2,0,"1fx5_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYL(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(23_A_)",57.5082,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo2","DGlcpNAcb1-2DManpa1-6[DRhapa1-3]DManpb1-4DGlcpNAca1-C6N1O4","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-MAN(3_J_)-NDG(2_J_)-NAG(1_J_)",55.3113,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo4","DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpa1-4DGlcpNAcb1-4NAG1-ASN","NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(667_D_)",48.1047,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_I_)-MAN(4_I_)-[MAN(6_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(667_A_)",48.8518,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo3","DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_K_)-MAN(4_K_)-[MAN(6_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(667_C_)",48.0854,"","",""
"1G0V","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV","10.1074/JBC.M008520200 ",2,20.6,"1g0v_oligo1","DManpb1-2DManpa1-2[DManpa1-2DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",31.4385,"","",""
"1G6I","CRYSTAL STRUCTURE OF THE YEAST ALPHA-1,2-MANNOSIDASE WITH BOUND 1- DEOXYMANNOJIRIMYCIN AT 1.59 A RESOLUTION","",1.59,27.8,"1g6i_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(224_A_)",48.1344,"","",""
"1G6I","CRYSTAL STRUCTURE OF THE YEAST ALPHA-1,2-MANNOSIDASE WITH BOUND 1- DEOXYMANNOJIRIMYCIN AT 1.59 A RESOLUTION","",1.59,27.8,"1g6i_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NDG(2_B_)-NAG(1_B_)-ASN(96_A_)",33.063,"","",""
"1G7P","CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE","10.1016/S0022-2836(02)00198-5 ",1.5,25.4,"1g7p_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",54.1691,"","",""
"1G7Q","CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA","10.1016/S0022-2836(02)00196-1 ",1.6,28.6,"1g7q_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",61.9,"","",""
"1G82","STRUCTURE OF FIBROBLAST GROWTH FACTOR 9","10.1107/S0907444900020813 ",2.6,51.97,"1g82_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(79_A_)",69.7088,"","",""
"1G82","STRUCTURE OF FIBROBLAST GROWTH FACTOR 9","10.1107/S0907444900020813 ",2.6,51.97,"1g82_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(79_D_)",75.4651,"","",""
"1G82","STRUCTURE OF FIBROBLAST GROWTH FACTOR 9","10.1107/S0907444900020813 ",2.6,51.97,"1g82_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(79_C_)",73.997,"","",""
"1G9M","HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B","10.1016/S0969-2126(00)00547-5 ",2.2,31.5,"1g9m_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(463_G_)",123.394,"","",""
"1G9M","HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B","10.1016/S0969-2126(00)00547-5 ",2.2,31.5,"1g9m_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(295_G_)",57.2264,"","",""
"1GAH","GLUCOAMYLASE-471 COMPLEXED WITH ACARBOSE","10.1021/BI960321G ",2,14.3,"1gah_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-[MAN(8_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",33.145,"","",""
"1GAI","GLUCOAMYLASE-471 COMPLEXED WITH D-GLUCO-DIHYDROACARBOSE","10.1021/BI960321G ",1.7,14.7,"1gai_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-[MAN(8_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",29.4852,"","",""
"1GC1","HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY","10.1038/31405 ",2.5,21,"1gc1_oligo3","LFucpa1-6DGlcpNAca1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(234_G_)",50.8736,"","",""
"1GC1","HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY","10.1038/31405 ",2.5,21,"1gc1_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(392_G_)",49.7255,"","",""
"1GC1","HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY","10.1038/31405 ",2.5,21,"1gc1_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(448_G_)",46.0545,"","",""
"1GC1","HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY","10.1038/31405 ",2.5,21,"1gc1_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(295_G_)",37.0755,"","",""
"1GH7","CRYSTAL STRUCTURE OF THE COMPLETE EXTRACELLULAR DOMAIN OF THE BETA- COMMON RECEPTOR OF IL-3, IL-5, AND GM-CSF","10.1016/S0092-8674(01)00213-6 ",3,0,"1gh7_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(167_A_)",106.11,"","",""
"1GH7","CRYSTAL STRUCTURE OF THE COMPLETE EXTRACELLULAR DOMAIN OF THE BETA- COMMON RECEPTOR OF IL-3, IL-5, AND GM-CSF","10.1016/S0092-8674(01)00213-6 ",3,0,"1gh7_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(167_B_)",106.397,"","",""
"1GLM","REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100","10.1006/JMBI.1994.1316 ",2.4,0,"1glm_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",29.2817,"","",""
"1GPZ","THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R","10.1093/EMBOJ/21.3.231 ",2.9,59.4,"1gpz_oligo2","DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(564_A_)",121.934,"","",""
"1GPZ","THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R","10.1093/EMBOJ/21.3.231 ",2.9,59.4,"1gpz_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(497_B_)",90.0675,"","",""
"1GQH","QUERCETIN 2,3-DIOXYGENASE IN COMPLEX WITH THE INHIBITOR KOJIC ACID","10.1021/BI0159736 ",2.15,0,"1gqh_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(191_C_)",34.8734,"","",""
"1GW0","CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM","10.1038/NSB823 ",2.4,24.6,"1gw0_oligo2","DManpa1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",60.3469,"","",""
"1GW0","CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM","10.1038/NSB823 ",2.4,24.6,"1gw0_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(88_B_)",65.432,"","",""
"1GYA","N-GLYCAN AND POLYPEPTIDE NMR SOLUTION STRUCTURES OF THE ADHESION DOMAIN OF HUMAN CD2","","2.95026e-39",0,"1gya_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(65_A_)",0,"","",""
"1H1B","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151)","10.1021/JM020881F ",2,41.4,"1h1b_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(109_A_)",58.5941,"","",""
"1H1B","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151)","10.1021/JM020881F ",2,41.4,"1h1b_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(159_A_)",48.8095,"","",""
"1H1B","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151)","10.1021/JM020881F ",2,41.4,"1h1b_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(109_B_)",61.4027,"","",""
"1H1B","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151)","10.1021/JM020881F ",2,41.4,"1h1b_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(159_B_)",67.0332,"","",""
"1H1M","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE KAEMPFEROL","10.1073/PNAS.262506299 ",1.9,12.83,"1h1m_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(191_A_)",46.5247,"","",""
"1H1M","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE KAEMPFEROL","10.1073/PNAS.262506299 ",1.9,12.83,"1h1m_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(191_C_)",33.533,"","",""
"1H1M","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE KAEMPFEROL","10.1073/PNAS.262506299 ",1.9,12.83,"1h1m_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(191_B_)",42.2489,"","",""
"1H3U","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2","10.1016/S0022-2836(02)01250-0 ",2.4,0,"1h3u_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.5065,"","",""
"1H3U","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2","10.1016/S0022-2836(02)01250-0 ",2.4,0,"1h3u_oligo1","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",91.4576,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",48.3753,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",79.6368,"","",""
"1H3W","STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY","10.1016/S0022-2836(02)01250-0 ",2.85,0,"1h3w_oligo1","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[NAG(5_A_)-BMA(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_M_)",94.8221,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",90.2742,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",58.5281,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo1","DGalpa1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GLA(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",36.1271,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo2","DGalpa1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GLA(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9137,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo1","DManpb1-2DManpa1-3[DManpa1-2DManpb1-6]DManpa1-6[DManpb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-BMA(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(10_C_)-BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",83.5686,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(325_A_)",89.9071,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo3","DManpb1-2DManpb1-3[DManpb1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_E_)-[BMA(7_E_)]-BMA(6_E_)-[BMA(5_E_)-BMA(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_B_)",80.0983,"","",""
"1H81","STRUCTURE OF POLYAMINE OXIDASE IN THE REDUCED STATE","10.1021/BI002751J ",2.1,0,"1h81_oligo9","DManpa1-6DManpa1-4DGlcpNAcx1-","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)",46.5447,"","",""
"1H82","STRUCTURE OF POLYAMINE OXIDASE IN COMPLEX WITH GUAZATINE","10.1021/BI002751J ",1.9,0,"1h82_oligo9","DManpa1-6DManpb1-4DGlcpNAcx1-","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)",48.2623,"","",""
"1H83","STRUCTURE OF POLYAMINE OXIDASE IN COMPLEX WITH 1,8-DIAMINOOCTANE","10.1021/BI002751J ",1.9,0,"1h83_oligo9","DManpa1-6DManpb1-4DGlcpNAcx1-","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)",35.4967,"","",""
"1H84","COVALENT ADDUCT BETWEEN POLYAMINE OXIDASE AND N1ETHYLN11((CYCLOHEPTYL)METHYL)4,8DIAZAUNDECANE AT PH 4.6","10.1021/BI002751J ",2,0,"1h84_oligo9","DManpa1-6DManpb1-4DGlcpNAcx1-","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)",40.2129,"","",""
"1H86","COVALENT ADDUCT BETWEEN POLYAMINE OXIDASE AND N1ETHYLN11((CYCLOHEPTYL)METHYL)4,8DIAZAUNDECANE AT PH 7.0","10.1021/BI002751J ",2,0,"1h86_oligo7","DManpa1-6DManpb1-4DGlcpNAcx1-","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)",38.7454,"","",""
"1HD4","SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [MODELED WITH DIANTENNARY GLYCAN AT ASN78]","10.1021/BI992786N ","2.95026e-39",0,"1hd4_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(78_A_)",0,"","",""
"1HWM","EBULIN,ORTHORHOMBIC CRYSTAL FORM MODEL","10.1002/PROT.1043 ",2.8,0,"1hwm_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(186_B_)",19.4704,"","",""
"1HZH","CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN","10.1126/SCIENCE.1061692 ",2.7,90.1,"1hzh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(9_A_)-NAG(8_A_)-MAN(7_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",160.95,"","",""
"1HZH","CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN","10.1126/SCIENCE.1061692 ",2.7,90.1,"1hzh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)",117.935,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_D_)",199.986,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",121.533,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",100.324,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.0807,"","",""
"1IAU","HUMAN GRANZYME B IN COMPLEX WITH AC-IEPD-CHO","10.1016/S1074-5521(01)00018-7 ",2,42.9,"1iau_oligo1","DGlcpNAcb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[BMA(5_C_)-[NAG(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(98_A_)",87.9146,"","",""
"1IEQ","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1","10.1016/S0969-2126(01)00673-6 ",2.7,0,"1ieq_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(498_A_)",72.3941,"","",""
"1IEW","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 2-DEOXY-2-FLUORO-ALPHA-D-GLUCOSIDE","10.1016/S0969-2126(01)00673-6 ",2.55,0,"1iew_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUL(6_C_)]-NAG(1_C_)-ASN(498_A_)",67.8349,"","",""
"1IEX","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4I,4III,4V-S-TRITHIOCELLOHEXAOSE","10.1016/S0969-2126(01)00673-6 ",2.2,0,"1iex_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(6_B_)]-NAG(1_B_)-ASN(498_A_)",87.07,"","",""
"1IGR","TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (DOMAINS 1-3)","10.1038/28668 ",2.6,52.3,"1igr_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(105_A_)",66.7439,"","",""
"1IGR","TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (DOMAINS 1-3)","10.1038/28668 ",2.6,52.3,"1igr_oligo2","DManpa1-3DManpb1-4DGlcpNb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(284_A_)",55.4538,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(314_B_)",67.7962,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(314_D_)",142.475,"","",""
"1IGX","CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M105982200 ",3.1,0,"1igx_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",64.8125,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(314_B_)",79.4591,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NDG(2_F_)]-NAG(1_F_)-ASN(314_D_)",77.3494,"","",""
"1IGZ","CRYSTAL STRUCTURE OF LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M105982200 ",2.9,0,"1igz_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",69.8235,"","",""
"1ING","INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR","10.1021/JM00017A005 ",2.4,0,"1ing_oligo8","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[DManpa1-6]DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(200_B_)",37.2152,"","",""
"1INW","A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES","10.1006/JMBI.1994.0051 ",2.4,12.79,"1inw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",34.2862,"","",""
"1INX","A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES","10.1006/JMBI.1994.0051 ",2.4,9.28,"1inx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",28.9496,"","",""
"1INY","A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES","10.1006/JMBI.1994.0051 ",2.4,12.79,"1iny_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-C8N1O5","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)",33.9415,"","",""
"1IVF","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivf_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[DManpa1-6]DGlcp[2<R1>]b1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)--ASN(200_A_)",36.5564,"","",""
"1IVF","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivf_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[DManpa1-6]DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(200_B_)",36.5564,"","",""
"1IW6","CRYSTAL STRUCTURE OF THE GROUND STATE OF BACTERIORHODOPSIN","10.1016/S0022-2836(02)01110-5 ",2.3,56.4,"1iw6_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C43O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",101.678,"","",""
"1IW9","CRYSTAL STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN","10.1016/J.JMB.2004.06.080 ",2.5,47,"1iw9_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C43O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",73.3915,"","",""
"1IXF","CRYSTAL STRUCTURE OF THE K INTERMEDIATE OF BACTERIORHODOPSIN","10.1016/S0022-2836(02)01110-5 ",2.6,60.49,"1ixf_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C38O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",101.318,"","",""
"1J06","CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE IN THE APO FORM","10.1093/EMBOJ/CDG005 ",2.35,0,"1j06_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",86.1486,"","",""
"1J07","CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-DECIDIUM COMPLEX","10.1093/EMBOJ/CDG005 ",2.35,52.1,"1j07_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",93.17,"","",""
"1J0I","CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE","10.1016/S0022-2836(02)01402-X ",2.4,0,"1j0i_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",42.8224,"","",""
"1J0I","CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE","10.1016/S0022-2836(02)01402-X ",2.4,0,"1j0i_oligo2","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",48.1333,"","",""
"1J0K","CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE","10.1016/S0022-2836(02)01402-X ",3.2,0,"1j0k_oligo1","DGlcpa1-4DGlcpa1-6DGlcpa1-ROH","GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",11.68,"","",""
"1J0K","CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE","10.1016/S0022-2836(02)01402-X ",3.2,0,"1j0k_oligo2","DGlcpa1-4DGlcpa1-6DGlcpa1-ROH","GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",15.0152,"","",""
"1J86","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), MONOCLINIC CRYSTAL FORM 2","10.1006/JMBI.2001.4929 ",3.2,67.5,"1j86_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(42_A_)",66.4336,"","",""
"1J86","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), MONOCLINIC CRYSTAL FORM 2","10.1006/JMBI.2001.4929 ",3.2,67.5,"1j86_oligo5","DGlcpNAcb1-4[DFucpa1-6]DGlcpNAcb1-ASN","FCA(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(135_B_)",85.6173,"","",""
"1J87","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), HEXAGONAL CRYSTAL FORM 1","10.1006/JMBI.2001.4929 ",3.2,96,"1j87_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",112.179,"","",""
"1J87","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), HEXAGONAL CRYSTAL FORM 1","10.1006/JMBI.2001.4929 ",3.2,96,"1j87_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(140_A_)",105.009,"","",""
"1J88","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), TETRAGONAL CRYSTAL FORM 1","10.1006/JMBI.2001.4929 ",3.2,126.8,"1j88_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(42_E_)",185.862,"","",""
"1J8V","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4'-NITROPHENYL 3I-THIOLAMINARITRIOSIDE","10.1105/TPC.010442 ",2.4,0,"1j8v_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(498_A_)",61.3233,"","",""
"1JDN","CRYSTAL STRUCTURE OF HORMONE RECEPTOR","10.1126/SCIENCE.1062246 ",2.9,65.8,"1jdn_oligo2","DManpb1-4DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(4_C_)-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(349_A_)",84.5889,"","",""
"1JDN","CRYSTAL STRUCTURE OF HORMONE RECEPTOR","10.1126/SCIENCE.1062246 ",2.9,65.8,"1jdn_oligo1","DManpb1-4DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NDG(2_B_)-NAG(1_B_)-ASN(248_A_)",86.0976,"","",""
"1JPC","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE- ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE","10.1016/S0969-2126(96)00141-4 ",2,33.5,"1jpc_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_B_)-[MAN(2_B_)]-MAN(1_B_)",27.9779,"","",""
"1JPC","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE- ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE","10.1016/S0969-2126(96)00141-4 ",2,33.5,"1jpc_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_D_)-[MAN(2_D_)]-MAN(1_D_)",39.1379,"","",""
"1JPC","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE- ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE","10.1016/S0969-2126(96)00141-4 ",2,33.5,"1jpc_oligo2","DManpa1-6DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",15.7959,"","",""
"1JS8","STRUCTURE OF A FUNCTIONAL UNIT FROM OCTOPUS HEMOCYANIN","10.1006/JMBI.1998.1647 ",2.3,0,"1js8_oligo3","DManpa1-3[DManpb1-6]DManpx1-","BMA(3_E_)-[MAN(2_E_)]-MAN(1_E_)",49.2162,"","",""
"1JS8","STRUCTURE OF A FUNCTIONAL UNIT FROM OCTOPUS HEMOCYANIN","10.1006/JMBI.1998.1647 ",2.3,0,"1js8_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)-NDG(1_C_)-ASN(2553_A_)",31.9926,"","",""
"1JU2","CRYSTAL STRUCTURE OF THE HYDROXYNITRILE LYASE FROM ALMOND","10.1016/S0969-2126(01)00639-6 ",1.47,16.7,"1ju2_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-[FUC(5_G_)]-NAG(1_G_)-ASN(135_B_)",34.9513,"","",""
"1JU2","CRYSTAL STRUCTURE OF THE HYDROXYNITRILE LYASE FROM ALMOND","10.1016/S0969-2126(01)00639-6 ",1.47,16.7,"1ju2_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(135_A_)",33.6445,"","",""
"1JUH","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE","10.1016/S0969-2126(02)00704-9 ",1.6,20.88,"1juh_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(191_C_)",34.4789,"","",""
"1JUH","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE","10.1016/S0969-2126(02)00704-9 ",1.6,20.88,"1juh_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(191_A_)",37.8903,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo3","DGalpb1-6DGlcpb1-ROH","GAL(2_G_)-BGC(1_G_)",47.4105,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo4","DGalpb1-6DGlcpb1-ROH","GAL(2_H_)-BGC(1_H_)",49.9195,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo1","DGalpb1-6DGlcpb1-ROH","GAL(2_E_)-BGC(1_E_)",51.1227,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo2","DGalpb1-6DManpb1-ROH","GAL(2_F_)-BGC(1_F_)",32.7595,"","",""
"1K7C","RHAMNOGALACTURONAN ACETYLESTERASE WITH SEVEN N-LINKED CARBOHYDRATE RESIDUES DISTRIBUTED AT TWO N-GLYCOSYLATION SITES REFINED AT 1.12 A RESOLUTION","10.1107/S0907444901018479 ",1.12,0,"1k7c_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DManp[2H]b1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(182_A_)",22.691,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_K_)-MAN(4_K_)-[NAG(3_K_)-MAN(2_K_)]-MAN(1_K_)",57.0844,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_M_)-MAN(4_M_)-[NAG(3_M_)-MAN(2_M_)]-MAN(1_M_)",34.8735,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_N_)-MAN(4_N_)-[NAG(3_N_)-MAN(2_N_)]-MAN(1_N_)",41.1196,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_L_)-MAN(4_L_)-[NAG(3_L_)-MAN(2_L_)]-MAN(1_L_)",45.066,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_O_)-MAN(4_O_)-[NAG(3_O_)-MAN(2_O_)]-MAN(1_O_)",41.8747,"","",""
"1K9J","COMPLEX OF DC-SIGNR AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",1.9,26.1,"1k9j_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_C_)-MAN(4_C_)-[NAG(3_C_)-MAN(2_C_)]-MAN(1_C_)",34.5642,"","",""
"1KBG","MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2","10.1016/S1074-7613(00)80006-0 ",2.2,30.8,"1kbg_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(176_H_)",56.1827,"","",""
"1KJ2","MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX","10.1016/S1074-7613(02)00288-1 ",2.71,45.65,"1kj2_oligo1","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(8_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(21_A_)",94.329,"","",""
"1KKT","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kkt_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(366_A_)",39.4729,"","",""
"1KKT","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kkt_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(366_B_)",59.0089,"","",""
"1KPU","HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/VSV8","",1.5,17.19,"1kpu_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",37.6382,"","",""
"1KPV","HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/SEV9","",1.71,21.2,"1kpv_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",53.3345,"","",""
"1KRE","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kre_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(366_A_)",36.67,"","",""
"1KRE","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kre_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(366_B_)",55.8665,"","",""
"1KRF","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1krf_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(366_B_)",56.2936,"","",""
"1KRF","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1krf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(366_A_)",41.0025,"","",""
"1KX1","RAT MANNOSE PROTEIN A COMPLEXED WITH MAN6-GLCNAC2-ASN","10.1074/JBC.M200493200 ",2.8,38.4,"1kx1_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-ROH","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-[MAN(3_G_)-MAN(2_G_)]-MAN(1_G_)",59.5029,"","",""
"1KX1","RAT MANNOSE PROTEIN A COMPLEXED WITH MAN6-GLCNAC2-ASN","10.1074/JBC.M200493200 ",2.8,38.4,"1kx1_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-ROH","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(3_H_)-MAN(2_H_)]-MAN(1_H_)",59.547,"","",""
"1L6X","FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C","",1.65,24.8,"1l6x_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",34.0833,"","",""
"1L7F","CRYSTAL STRUCTURE OF INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812","10.1021/JM010528U ",1.8,0,"1l7f_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",23.1586,"","",""
"1L7G","CRYSTAL STRUCTURE OF E119G MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812","10.1021/JM010528U ",1.85,0,"1l7g_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",28.4565,"","",""
"1L7H","CRYSTAL STRUCTURE OF R292K MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812","10.1021/JM010528U ",1.85,0,"1l7h_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",23.8791,"","",""
"1LCS","RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS","10.1128/JVI.77.4.2717-2729.2003 ",2.5,0,"1lcs_oligo1","DGlcpNAca1-2DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NDG(5_F_)-BMA(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(24_B_)",88.2067,"","",""
"1LEG","CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE","10.1084/JEM.20011644 ",1.75,0,"1leg_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",49.9876,"","",""
"1LEK","CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8","10.1084/JEM.20011644 ",2.15,0,"1lek_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)",80.765,"","",""
"1LFG","STRUCTURE OF DIFERRIC HUMAN LACTOFERRIN","10.1107/S0907444994013521 ",2.2,0,"1lfg_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(137_A_)",92.1554,"","",""
"1LGB","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",3.3,0,"1lgb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(137_C_)",54.3261,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_K_)-[MAN(8_K_)-[SIA(7_K_)-GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(512_I_)",57.2812,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_G_)-[NAG(9_G_)-MAN(8_G_)-[GAL(7_G_)-[FUC(6_G_)]-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(512_H_)",52.396,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_L_)-[MAN(8_L_)-[SIA(7_L_)-GAL(6_L_)-NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(512_J_)",59.1371,"","",""
"1LK2","1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE","",1.35,9.96,"1lk2_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(176_A_)",29.0591,"","",""
"1LOF","X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION","",2.3,0,"1lof_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",77.3305,"","",""
"1LQ2","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1074/JBC.M307188200 ",2.7,0,"1lq2_oligo2","DGlcpNAcb1-2DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-[FUC(6_B_)]-NAG(1_B_)-ASN(498_A_)",75.7435,"","",""
"1LQ8","CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR","10.1016/S0969-2126(02)00944-9 ",2.4,0,"1lq8_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_L_)-[MAN(2_L_)]-MAN(1_L_)",151.655,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(95_D_)",26.8577,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(95_B_)",11.1053,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(95_A_)",11.0156,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(95_C_)",26.3032,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo4","DManpb1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(95_D_)",28.0773,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(95_B_)",12.8217,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(95_C_)",24.4688,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(95_A_)",14.0645,"","",""
"1LTE","STRUCTURE OF A LEGUME LECTIN WITH AN ORDERED N-LINKED CARBOHYDRATE IN COMPLEX WITH LACTOSE","",2,0,"1lte_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYL(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",31.3476,"","",""
"1LTJ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGANDS GLY-PRO-ARG-PRO-AMIDE AND GLY-HIS-ARG-PRO-AMIDE","10.1021/BI0261894 ",2.8,45,"1ltj_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(364_B_)",100.273,"","",""
"1LTJ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGANDS GLY-PRO-ARG-PRO-AMIDE AND GLY-HIS-ARG-PRO-AMIDE","10.1021/BI0261894 ",2.8,45,"1ltj_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(364_E_)",74.8967,"","",""
"1LX5","CRYSTAL STRUCTURE OF THE BMP7/ACTRII EXTRACELLULAR DOMAIN COMPLEX","10.1016/S1097-2765(03)00094-7 ",3.3,69.6,"1lx5_oligo1","DManpa1-3[DManpb1-4][DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[BMA(5_C_)]-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(80_A_)",127.69,"","",""
"1LYA","CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN","10.1073/PNAS.90.14.6796 ",2.5,0,"1lya_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(70_C_)",86.7305,"","",""
"1LYA","CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN","10.1073/PNAS.90.14.6796 ",2.5,0,"1lya_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(70_A_)",84.4491,"","",""
"1LYB","CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN","10.1073/PNAS.90.14.6796 ",2.5,0,"1lyb_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(70_A_)",92.8259,"","",""
"1LYB","CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN","10.1073/PNAS.90.14.6796 ",2.5,0,"1lyb_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(70_C_)",90.3841,"","",""
"1M4W","THERMOPHILIC B-1,4-XYLANASE FROM NONOMURAEA FLEXUOSA","10.1046/J.1432-1033.2003.03496.X ",2.1,0,"1m4w_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(7_A_)",43.155,"","",""
"1MCO","THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION","10.1073/PNAS.90.9.4271 ",3.2,0,"1mco_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_A_)-[NAG(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(282_H_)",15,"","",""
"1MHL","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C","10.1006/ABBI.1995.1086 ",2.25,20.3,"1mhl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",26.4176,"","",""
"1MHL","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C","10.1006/ABBI.1995.1086 ",2.25,20.3,"1mhl_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",27.063,"","",""
"1MOX","CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA","10.1016/S0092-8674(02)00940-6 ",2.5,0,"1mox_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(32_B_)",104.913,"","",""
"1MOX","CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA","10.1016/S0092-8674(02)00940-6 ",2.5,0,"1mox_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(32_A_)",106.448,"","",""
"1MWE","THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH SIALIC ACID AT 4 DEGREES C REVEALING A SECOND SIALIC ACID BINDING SITE","10.1073/PNAS.94.22.11808 ",1.7,0,"1mwe_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManp[3<R1>]a1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.8249,"","",""
"1MYR","MYROSINASE FROM SINAPIS ALBA","10.1016/S0969-2126(97)00221-9 ",1.64,16.7,"1myr_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(7_D_)]-NAG(1_D_)-ASN(292_A_)",30.7501,"","",""
"1N1M","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR","10.1038/NSB882 ",2.5,34.4,"1n1m_oligo3","DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NDG(2_C_)]-NAG(1_C_)-ASN(85_A_)",63.7482,"","",""
"1N1M","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR","10.1038/NSB882 ",2.5,34.4,"1n1m_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(150_A_)",77.7036,"","",""
"1N1M","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR","10.1038/NSB882 ",2.5,34.4,"1n1m_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(85_B_)",71.4923,"","",""
"1N26","CRYSTAL STRUCTURE OF THE EXTRA-CELLULAR DOMAINS OF HUMAN INTERLEUKIN-6 RECEPTOR ALPHA CHAIN","10.1073/PNAS.232432399 ",2.4,0,"1n26_oligo2","DGlcpNAca1-4DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NDG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(226_A_)",91.6938,"","",""
"1N5M","CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-GALLAMINE COMPLEX","10.1093/EMBOJ/CDG005 ",2.2,46.4,"1n5m_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",89.8936,"","",""
"1N5R","CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-PROPIDIUM COMPLEX","10.1093/EMBOJ/CDG005 ",2.25,49.4,"1n5r_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",90.4336,"","",""
"1N7D","EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR","10.1126/SCIENCE.1078124 ",3.7,124.7,"1n7d_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",124.7,"","",""
"1N7D","EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR","10.1126/SCIENCE.1078124 ",3.7,124.7,"1n7d_oligo2","DRhapa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",124.7,"","",""
"1NHC","STRUCTURAL INSIGHTS INTO THE PROCESSIVITY OF ENDOPOLYGALACTURONASE I FROM ASPERGILLUS NIGER","10.1016/S0014-5793(03)01221-3 ",1.7,25,"1nhc_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(246_B_)",53.813,"","",""
"1NMB","THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY","10.1016/S0969-2126(00)00074-5 ",2.2,0,"1nmb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DGlcpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",9.05912,"","",""
"1NN2","THREE-DIMENSIONAL STRUCTURE OF THE NEURAMINIDASE OF INFLUENZA VIRUS A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION","10.1016/0022-2836(91)80068-6 ",2.2,0,"1nn2_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",47.1244,"","",""
"1NXC","STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA REVEALS THE MOLECULAR BASIS FOR SUBSTRATE SPECIFICITY AMONG CLASS I ENZYMES (FAMILY 47 GLYCOSIDASES)","10.1074/JBC.M403065200 ",1.51,8.55,"1nxc_oligo1","DManpa1-6DManpx1-","MAN(5_B_)-MAN(4_B_)",23.4402,"","",""
"1NXC","STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA REVEALS THE MOLECULAR BASIS FOR SUBSTRATE SPECIFICITY AMONG CLASS I ENZYMES (FAMILY 47 GLYCOSIDASES)","10.1074/JBC.M403065200 ",1.51,8.55,"1nxc_oligo2","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(6_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(515_A_)",9.58018,"","",""
"1O0V","THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION","10.1038/NI811 ",2.6,46,"1o0v_oligo1","DManpa1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",76.5565,"","",""
"1O0V","THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION","10.1038/NI811 ",2.6,46,"1o0v_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",95.6934,"","",""
"1O75","TP47, THE 47-KILODALTON LIPOPROTEIN OF TREPONEMA PALLIDUM","10.1074/JBC.M207402200 ",1.95,43.4,"1o75_oligo1","DGlcp[2<R1>,3<R2>]a1-6DGlcp[2<R3>,3<R4>]a1-ROH","PDX(2_C_)-PDX(1_C_)",55.3104,"","",""
"1O7D","THE STRUCTURE OF THE BOVINE LYSOSOMAL A-MANNOSIDASE SUGGESTS A NOVEL MECHANISM FOR LOW PH ACTIVATION","10.1016/S0022-2836(03)00172-4 ",2.7,38.8,"1o7d_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(497_C_)",39.3178,"","",""
"1O7V","HIGH RESOLUTION STRUCTURE OF SIGLEC-7","10.1074/JBC.M210602200 ",1.9,34.09,"1o7v_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(105_A_)",52.8605,"","",""
"1OGO","DEX49A FROM PENICILLIUM MINIOLUTEUM COMPLEX WITH ISOMALTOSE","10.1016/S0969-2126(03)00147-3 ",1.65,19.21,"1ogo_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_A_)-BGC(1_A_)",25.8805,"","",""
"1OH4","STRUCTURAL AND THERMODYNAMIC DISSECTION OF SPECIFIC MANNAN RECOGNITION BY A CARBOHYDRATE-BINDING MODULE","10.1016/S0969-2126(03)00100-X ",1.35,11.94,"1oh4_oligo1","DManpb1-4[DGalpa1-6]DManpb1-4DManpb1-4DManpb1-4DManpb1-ROH","GLA(6_B_)-[BMA(5_B_)]-BMA(4_B_)-BMA(3_B_)-BMA(2_B_)-BMA(1_B_)",21.7314,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo1","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_G_)-[MAN(2_G_)]-MMA(1_G_)",16.4364,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo2","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_F_)-[MAN(2_F_)]-MMA(1_F_)",23.5794,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo3","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_E_)-[MAN(2_E_)]-MMA(1_E_)",30.12,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo4","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_H_)-[MAN(2_H_)]-MMA(1_H_)",38.4997,"","",""
"1ONQ","CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE","10.1038/NI948 ",2.15,13.91,"1onq_oligo6","LFucpa1-6DGlcpNAca1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(20_A_)",29.5482,"","",""
"1OOK","CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND HUMAN ALPHA-THROMBIN","10.1126/SCIENCE.1084183 ",2.3,0,"1ook_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(60_B_)",83.9736,"","",""
"1OP0","CRYSTAL STRUCTURE OF AAV-SP-I, A GLYCOSYLATED SNAKE VENOM SERINE PROTEINASE FROM AGKISTRODON ACUTUS","10.1074/JBC.M412900200 ",2,25.1,"1op0_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(35_A_)",48.1612,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",68.4325,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NDG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",55.5502,"","",""
"1OQX","G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C","",2.6,55.8,"1oqx_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",81.8391,"","",""
"1OQX","G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C","",2.6,55.8,"1oqx_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[BMA(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",83.1185,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo3","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-BMA(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)",186.95,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(58_C_)",184.379,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo2","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUC(8_F_)-[SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-BMA(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",186.95,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo6","DManpb1-4DManpb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_L_)-BMA(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(156_D_)",170.465,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo8","DManpb1-4DManpb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_I_)-BMA(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_C_)",170.465,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo4","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(58_D_)",184.379,"","",""
"1OYH","CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN","10.1074/JBC.M311644200 ",2.62,0,"1oyh_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_L_)",129.564,"","",""
"1OZN","1.5A CRYSTAL STRUCTURE OF THE NOGO RECEPTOR LIGAND BINDING DOMAIN REVEALS A CONVERGENT RECOGNITION SCAFFOLD MEDIATING INHIBITION OF MYELINATION","10.1016/S0896-6273(03)00232-0 ",1.52,19.5,"1ozn_oligo2","DManpa1-6DManpa1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(4_B_)-MAN(3_B_)-NDG(2_B_)-NAG(1_B_)-ASN(82_A_)",64.2836,"","",""
"1P0I","CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE","10.1074/JBC.M210241200 ",2,36.5,"1p0i_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",51.8809,"","",""
"1P0I","CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE","10.1074/JBC.M210241200 ",2,36.5,"1p0i_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",59.247,"","",""
"1P0M","CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH A CHOLINE MOLECULE","10.1074/JBC.M210241200 ",2.38,49.2,"1p0m_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",74.087,"","",""
"1P0M","CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH A CHOLINE MOLECULE","10.1074/JBC.M210241200 ",2.38,49.2,"1p0m_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",65.1451,"","",""
"1P0P","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH THE SUBSTRATE ANALOG BUTYRYLTHIOCHOLINE","10.1074/JBC.M210241200 ",2.3,35.1,"1p0p_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",53.9109,"","",""
"1P0P","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH THE SUBSTRATE ANALOG BUTYRYLTHIOCHOLINE","10.1074/JBC.M210241200 ",2.3,35.1,"1p0p_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",65.583,"","",""
"1P0Q","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE","10.1074/JBC.M210241200 ",2.43,38.3,"1p0q_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",65.5149,"","",""
"1P0Q","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE","10.1074/JBC.M210241200 ",2.43,38.3,"1p0q_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",56.1421,"","",""
"1P8J","CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN","10.1038/NSB941 ",2.6,21.3,"1p8j_oligo1","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(11_I_)-[NAG(10_I_)-MAN(9_I_)-[GAL(8_I_)-NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(440_A_)",52.6426,"","",""
"1PPF","X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR","",1.8,0,"1ppf_oligo2","DAllpa1-4LTalpNAca1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GLC(6_B_)-NAG(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_E_)",14.9883,"","",""
"1PPF","X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR","",1.8,0,"1ppf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(159_E_)",12.708,"","",""
"1PPG","THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR","10.1016/0014-5793(88)80118-2 ",2.3,0,"1ppg_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(159_E_)",8.11784,"","",""
"1PPG","THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR","10.1016/0014-5793(88)80118-2 ",2.3,0,"1ppg_oligo2","DAllpa1-4DAllpNAca1-2DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GLC(6_B_)-NDG(5_B_)-BMA(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_E_)",9.54705,"","",""
"1Q25","CRYSTAL STRUCTURE OF N-TERMINAL 3 DOMAINS OF CI-MPR","10.1038/SJ.EMBOJ.7600215 ",1.8,34.19,"1q25_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(76_A_)",31.1918,"","",""
"1Q4G","2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID","10.1016/J.JMB.2003.10.073 ",2,44.1,"1q4g_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(410_A_)",73.1811,"","",""
"1Q4G","2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID","10.1016/J.JMB.2003.10.073 ",2,44.1,"1q4g_oligo2","DManpb1-6DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(5_H_)-BMA(4_H_)-BMA(3_H_)-NDG(2_H_)-NAG(1_H_)-ASN(144_B_)",69.3798,"","",""
"1Q4G","2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID","10.1016/J.JMB.2003.10.073 ",2,44.1,"1q4g_oligo3","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(410_B_)",64.1464,"","",""
"1Q4G","2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID","10.1016/J.JMB.2003.10.073 ",2,44.1,"1q4g_oligo5","DManpa1-6DManpa1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NDG(2_E_)-NAG(1_E_)-ASN(144_A_)",70.3671,"","",""
"1Q83","CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-TZ2PA6 SYN COMPLEX","10.1073/PNAS.0308206100 ",2.65,34.49,"1q83_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(350_A_)",66.2345,"","",""
"1Q8S","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN","10.1016/J.JMB.2003.11.043 ",2.05,0,"1q8s_oligo4","DManpa1-6DManpa1-OME","MAN(2_D_)-MMA(1_D_)",47.2232,"","",""
"1Q8S","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN","10.1016/J.JMB.2003.11.043 ",2.05,0,"1q8s_oligo1","DManpa1-6DManpa1-OME","MAN(2_C_)-MMA(1_C_)",46.3973,"","",""
"1Q8V","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE TRIMANNOSIDE [MAN(ALPHA1-3)]MAN(ALPHA1-6)MAN","10.1016/J.JMB.2003.11.043 ",1.85,0,"1q8v_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_D_)-[MAN(2_D_)]-MAN(1_D_)",36.2103,"","",""
"1QDC","MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2,25,"1qdc_oligo2","DManpa1-6DManpa1-OME","MAN(2_E_)-MMA(1_E_)",18.885,"","",""
"1QDC","MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2,25,"1qdc_oligo1","DManpa1-6DManpa1-OME","MAN(2_F_)-MMA(1_F_)",34.8009,"","",""
"1QDC","MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2,25,"1qdc_oligo3","DManpa1-6DManpa1-OME","MAN(2_G_)-MMA(1_G_)",38.4609,"","",""
"1QDC","MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2,25,"1qdc_oligo4","DManpa1-6DManpa1-OME","MAN(2_H_)-MMA(1_H_)",30.7491,"","",""
"1QFG","E. COLI FERRIC HYDROXAMATE RECEPTOR (FHUA)","10.1016/S0969-2126(00)00143-X ",2.5,65.4,"1qfg_oligo1","DGlcpa1-3[DGalpa1-6]DGlcpa1-3GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]a1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GLA(8_B_)-[GLC(7_B_)]-GLC(6_B_)-GMH(5_B_)-GMH(4_B_)-[KDO(9_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",72.7149,"","",""
"1QFX","PH 2.5 ACID PHOSPHATASE FROM ASPERGILLUS NIGER","10.1006/JMBI.1999.2736 ",2.4,25.6,"1qfx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(172_A_)",48.3257,"","",""
"1QFX","PH 2.5 ACID PHOSPHATASE FROM ASPERGILLUS NIGER","10.1006/JMBI.1999.2736 ",2.4,25.6,"1qfx_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(172_B_)",44.4504,"","",""
"1QKC","ESCHERICHIA COLI FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) IN COMPLEX DELTA TWO-ALBOMYCIN","10.1110/PS.9.5.956 ",3.1,82.4,"1qkc_oligo2","DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DAltp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GMH(10_B_)-[GLA(9_B_)-[GLC(8_B_)-GLC(7_B_)]-GLC(6_B_)]-GMH(5_B_)-GMH(4_B_)-[KDO(11_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",93.3385,"","",""
"1QM8","STRUCTURE OF BACTERIORHODOPSIN AT 100 K","10.1006/JMBI.1998.2103 ",2.5,0,"1qm8_oligo1","DGalpb1-6DManpa1-2DGlcpa1-C40O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",78.5394,"","",""
"1R46","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.25,64.4,"1r46_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(139_B_)",137.761,"","",""
"1R46","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.25,64.4,"1r46_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",105.814,"","",""
"1R47","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.45,56.7,"1r47_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(192_B_)",119.562,"","",""
"1R47","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.45,56.7,"1r47_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(139_B_)",172.644,"","",""
"1R47","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.45,56.7,"1r47_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_A_)",127.796,"","",""
"1R55","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM 33","10.1016/J.JMB.2003.10.037 ",1.58,0,"1r55_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(276_A_)",32.1833,"","",""
"1RD3","2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K","10.1074/JBC.M402364200 ",2.5,41.6,"1rd3_oligo1","DManpa1-6DManpb1-4DGlcpNAca1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(60_B_)",100.135,"","",""
"1RD3","2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K","10.1074/JBC.M402364200 ",2.5,41.6,"1rd3_oligo2","DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NDG(2_F_)]-NAG(1_F_)-ASN(60_D_)",109.662,"","",""
"1RER","CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS.","10.1038/NATURE02239 ",3.2,0,"1rer_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(141_B_)",134.96,"","",""
"1RF1","CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE","10.1021/BI0359978 ",2.53,38.5,"1rf1_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(364_E_)",62.4409,"","",""
"1RF1","CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE","10.1021/BI0359978 ",2.53,38.5,"1rf1_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(364_B_)",89.763,"","",""
"1RJ6","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE CARBONIC ANHYDRASE XIV IN COMPLEX WITH ACETAZOLAMIDE","10.1074/JBC.M310809200 ",2.9,53.7,"1rj6_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(195_B_)",75.0427,"","",""
"1RMG","RHAMNOGALACTURONASE A FROM ASPERGILLUS ACULEATUS","10.1016/S0969-2126(97)00209-8 ",2,20.3,"1rmg_oligo8","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(32_A_)",53.0109,"","",""
"1RZJ","HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B","10.1073/PNAS.0308527100 ",2.2,31,"1rzj_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(295_G_)",58.1505,"","",""
"1RZJ","HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B","10.1073/PNAS.0308527100 ",2.2,31,"1rzj_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(463_G_)",123.37,"","",""
"1S4N","CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P","10.1074/JBC.M312720200 ",2.01,22.8,"1s4n_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(197_A_)",44.157,"","",""
"1S4O","CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P: BINARY COMPLEX WITH GDP/MN","10.1074/JBC.M312720200 ",2.01,24.6,"1s4o_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(197_A_)",35.1659,"","",""
"1S4P","CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P: TERNARY COMPLEX WITH GDP/MN AND METHYL-ALPHA-MANNOSIDE ACCEPTOR","10.1074/JBC.M312720200 ",2.01,25.9,"1s4p_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(197_A_)",34.584,"","",""
"1SL4","CRYSTAL STRUCTURE OF DC-SIGN CARBOHYDRATE RECOGNITION DOMAIN COMPLEXED WITH MAN4","10.1038/NSMB784 ",1.55,24.1,"1sl4_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-MAN(1_B_)",43.8945,"","",""
"1SLA","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.45,0,"1sla_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_C_)-NAG(7_C_)-MAN(6_C_)-[GAL(5_C_)-NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",62.7982,"","",""
"1SLB","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.3,0,"1slb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",32.335,"","",""
"1SLB","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.3,0,"1slb_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-ROH","GAL(7_F_)-NAG(6_F_)-MAN(5_F_)-[GAL(4_F_)-NAG(3_F_)-MAN(2_F_)]-MAN(1_F_)",43.4294,"","",""
"1SLC","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.15,0,"1slc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-ROH","GAL(8_F_)-NAG(7_F_)-MAN(6_F_)-[GAL(5_F_)-NAG(4_F_)-MAN(3_F_)]-BMA(2_F_)-NDG(1_F_)",32.2076,"","",""
"1SLC","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.15,0,"1slc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",32.7994,"","",""
"1SZN","THE STRUCTURE OF ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.03.062 ",1.54,22.95,"1szn_oligo1","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(157_A_)",38.4571,"","",""
"1SZN","THE STRUCTURE OF ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.03.062 ",1.54,22.95,"1szn_oligo3","DManpb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(215_A_)",51.4533,"","",""
"1T0O","THE STRUCTURE OF ALPHA-GALACTOSIDASE FROM TRICHODERMA REESEI COMPLEXED WITH BETA-D-GALACTOSE","10.1016/J.JMB.2004.03.062 ",1.96,25.21,"1t0o_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(157_A_)",33.1266,"","",""
"1T83","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)","10.1074/JBC.M100350200 ",3,0,"1t83_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",100.864,"","",""
"1T83","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)","10.1074/JBC.M100350200 ",3,0,"1t83_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",112.121,"","",""
"1T89","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)","10.1074/JBC.M100350200 ",3.5,0,"1t89_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",72.4128,"","",""
"1T89","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)","10.1074/JBC.M100350200 ",3.5,0,"1t89_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",91.035,"","",""
"1TB6","2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX","10.1038/NSMB811 ",2.5,0,"1tb6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(155_I_)",90.4258,"","",""
"1TB6","2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX","10.1038/NSMB811 ",2.5,0,"1tb6_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(60_H_)",85.1391,"","",""
"1TCR","MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE","10.1126/SCIENCE.274.5285.209 ",2.5,35.8,"1tcr_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(185_A_)",80.0989,"","",""
"1TCR","MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE","10.1126/SCIENCE.274.5285.209 ",2.5,35.8,"1tcr_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(70_A_)",72.3382,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_K_)-MAN(4_K_)-[NAG(3_K_)-MAN(2_K_)]-MAN(1_K_)",35.3765,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_J_)-MAN(4_J_)-[NAG(3_J_)-MAN(2_J_)]-MAN(1_J_)",37.2491,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_L_)-MAN(4_L_)-[NAG(3_L_)-MAN(2_L_)]-MAN(1_L_)",35.266,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo6","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_N_)-MAN(4_N_)-[NAG(3_N_)-MAN(2_N_)]-MAN(1_N_)",38.9276,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo8","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_P_)-MAN(4_P_)-[NAG(3_P_)-MAN(2_P_)]-MAN(1_P_)",49.7678,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_M_)-MAN(4_M_)-[NAG(3_M_)-MAN(2_M_)]-MAN(1_M_)",27.3398,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_I_)-MAN(4_I_)-[NAG(3_I_)-MAN(2_I_)]-MAN(1_I_)",21.8505,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo7","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_O_)-MAN(4_O_)-[NAG(3_O_)-MAN(2_O_)]-MAN(1_O_)",40.0495,"","",""
"1TG7","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP.","10.1016/J.JMB.2004.09.012 ",1.9,0,"1tg7_oligo4","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(780_A_)",40.7991,"","",""
"1TG7","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP.","10.1016/J.JMB.2004.09.012 ",1.9,0,"1tg7_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(917_A_)",24.2317,"","",""
"1TG7","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP.","10.1016/J.JMB.2004.09.012 ",1.9,0,"1tg7_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(625_A_)",28.7491,"","",""
"1TK3","CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/CD26","10.1074/JBC.M405400200 ",2,27.6,"1tk3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(150_A_)",70.653,"","",""
"1TK3","CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/CD26","10.1074/JBC.M405400200 ",2,27.6,"1tk3_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(85_A_)",56.5658,"","",""
"1TK3","CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/CD26","10.1074/JBC.M405400200 ",2,27.6,"1tk3_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(85_B_)",64.9691,"","",""
"1TKR","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITH DIISOPROPYL FLUOROPHOSPHATE","10.1074/JBC.M405400200 ",2.7,27.6,"1tkr_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(85_B_)",71.4864,"","",""
"1TKR","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITH DIISOPROPYL FLUOROPHOSPHATE","10.1074/JBC.M405400200 ",2.7,27.6,"1tkr_oligo1","DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NDG(2_C_)]-NAG(1_C_)-ASN(85_A_)",65.6203,"","",""
"1TKR","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITH DIISOPROPYL FLUOROPHOSPHATE","10.1074/JBC.M405400200 ",2.7,27.6,"1tkr_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(150_A_)",78.6491,"","",""
"1TYE","STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN","10.1038/NATURE02976 ",2.9,63,"1tye_oligo2","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[BMA(4_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(320_D_)",96.2518,"","",""
"1U67","CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO A MUTANT OF PROSTAGLADIN H SYNTHASE-1 THAT FORMS PREDOMINANTLY 11-HPETE.","10.1074/JBC.M403013200 ",3.1,41.1,"1u67_oligo7","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",76.9502,"","",""
"1U8E","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F","10.1074/JBC.M405400200 ",2.2,29.7,"1u8e_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(85_B_)",77.2876,"","",""
"1U8E","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F","10.1074/JBC.M405400200 ",2.2,29.7,"1u8e_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(150_A_)",78.4136,"","",""
"1U8E","HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F","10.1074/JBC.M405400200 ",2.2,29.7,"1u8e_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(85_A_)",74.8379,"","",""
"1UCQ","CRYSTAL STRUCTURE OF THE L INTERMEDIATE OF BACTERIORHODOPSIN","10.1016/J.JMB.2003.10.068 ",2.4,66.47,"1ucq_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C38O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",105.885,"","",""
"1UGY","CRYSTAL STRUCTURE OF JACALIN- MELLIBIOSE (GAL-ALPHA(1-6)-GLC) COMPLEX","10.1016/S0022-2836(03)00901-X ",2.4,35.1,"1ugy_oligo1","DGalpa1-6DGlcpb1-ROH","GLA(2_K_)-BGC(1_K_)",47.7409,"","",""
"1UGY","CRYSTAL STRUCTURE OF JACALIN- MELLIBIOSE (GAL-ALPHA(1-6)-GLC) COMPLEX","10.1016/S0022-2836(03)00901-X ",2.4,35.1,"1ugy_oligo4","DGalpa1-6DGlcpa1-ROH","GLA(2_J_)-GLC(1_J_)",47.6123,"","",""
"1UGY","CRYSTAL STRUCTURE OF JACALIN- MELLIBIOSE (GAL-ALPHA(1-6)-GLC) COMPLEX","10.1016/S0022-2836(03)00901-X ",2.4,35.1,"1ugy_oligo2","DGalpa1-6DGlcpb1-ROH","GLA(2_L_)-BGC(1_L_)",60.3823,"","",""
"1UGY","CRYSTAL STRUCTURE OF JACALIN- MELLIBIOSE (GAL-ALPHA(1-6)-GLC) COMPLEX","10.1016/S0022-2836(03)00901-X ",2.4,35.1,"1ugy_oligo3","DGalpa1-6DGlcpb1-ROH","GLA(2_I_)-GLC(1_I_)",45.4655,"","",""
"1UMZ","XYLOGLUCAN ENDOTRANSGLYCOSYLASE IN COMPLEX WITH THE XYLOGLUCAN NONASACCHARIDE XLLG.","10.1105/TPC.020065 ",1.8,27.91,"1umz_oligo3","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpx1-","GAL(6_F_)-XYS(5_F_)-[XYS(4_F_)-BGC(3_F_)]-BGC(2_F_)-BGC(1_F_)",35.0648,"","",""
"1UMZ","XYLOGLUCAN ENDOTRANSGLYCOSYLASE IN COMPLEX WITH THE XYLOGLUCAN NONASACCHARIDE XLLG.","10.1105/TPC.020065 ",1.8,27.91,"1umz_oligo2","DXylpa1-6DGlcpb1-4DGlcpb1-4DGlcpx1-","XYS(4_D_)-BGC(3_D_)-BGC(2_D_)-BGC(1_D_)",43.983,"","",""
"1UVQ","CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE","10.1073/PNAS.0308458100 ",1.8,0,"1uvq_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(19_B_)",25.5777,"","",""
"1V0Z","STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6","",1.84,15.07,"1v0z_oligo4","DManpa1-6DManpb1-4DGlcpNAcx1-","MAN(3_H_)-BMA(2_H_)-NAG(1_H_)",36.0783,"","",""
"1V0Z","STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6","",1.84,15.07,"1v0z_oligo6","DManpa1-6DManpx1-","MAN(2_J_)-BMA(1_J_)",41.6296,"","",""
"1V0Z","STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6","",1.84,15.07,"1v0z_oligo3","DManpAa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(207_A_)",25.4802,"","",""
"1V0Z","STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6","",1.84,15.07,"1v0z_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(4_F_)-[MAN(3_F_)]-BMA(2_F_)-NAG(1_F_)",30.3318,"","",""
"1V2I","STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III","10.1016/J.JMB.2003.11.032 ",2.2,34.2,"1v2i_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",56.7611,"","",""
"1VB9","CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT","10.1111/J.1432-1033.2004.04183.X ",2.2,31.8,"1vb9_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-4[DGlcpa1-6]DGlcpa1-4DGlcpa1-ROH","GLC(6_C_)-[GLC(5_C_)-GLC(4_C_)-GLC(3_C_)]-GLC(2_C_)-GLC(1_C_)",36.8112,"","",""
"1VB9","CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT","10.1111/J.1432-1033.2004.04183.X ",2.2,31.8,"1vb9_oligo2","DGlcpa1-6DGlcpa1-4DGlcpa1-4[DGlcpa1-6]DGlcpa1-4DGlcpa1-ROH","GLC(6_D_)-[GLC(5_D_)-GLC(4_D_)-GLC(3_D_)]-GLC(2_D_)-GLC(1_D_)",42.94,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo3","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_K_)-[MAN(2_K_)]-MAN(1_K_)",40.8682,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo5","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_M_)-[MAN(2_M_)]-MAN(1_M_)",63.2139,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo6","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_N_)-[MAN(2_N_)]-MAN(1_N_)",42.1367,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_L_)-[MAN(2_L_)]-MAN(1_L_)",67.7452,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo1","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_I_)-[MAN(2_I_)]-MAN(1_I_)",61.5027,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo2","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_J_)-[MAN(2_J_)]-MAN(1_J_)",87.2861,"","",""
"1VBP","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOPENTOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",3.5,49.7,"1vbp_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(3_C_)-MAN(2_C_)-[MAN(4_C_)]-MAN(1_C_)",90.6914,"","",""
"1VBP","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOPENTOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",3.5,49.7,"1vbp_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_D_)-[MAN(2_D_)]-MAN(1_D_)",92.2867,"","",""
"1W2T","BETA-FRUCTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH RAFFINOSE","10.1042/BJ20051936 ",1.87,15.8,"1w2t_oligo4","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_J_)-GLC(1_J_)-FRU(2_J_)",23.1912,"","",""
"1W2T","BETA-FRUCTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH RAFFINOSE","10.1042/BJ20051936 ",1.87,15.8,"1w2t_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_G_)-GLC(1_G_)-FRU(2_G_)",24.5129,"","",""
"1W2T","BETA-FRUCTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH RAFFINOSE","10.1042/BJ20051936 ",1.87,15.8,"1w2t_oligo3","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_I_)-GLC(1_I_)-FRU(2_I_)",35.7063,"","",""
"1W2T","BETA-FRUCTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH RAFFINOSE","10.1042/BJ20051936 ",1.87,15.8,"1w2t_oligo5","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_K_)-GLC(1_K_)-FRU(2_K_)",29.4558,"","",""
"1W2T","BETA-FRUCTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH RAFFINOSE","10.1042/BJ20051936 ",1.87,15.8,"1w2t_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_H_)-GLC(1_H_)-FRU(2_H_)",34.0755,"","",""
"1W2T","BETA-FRUCTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH RAFFINOSE","10.1042/BJ20051936 ",1.87,15.8,"1w2t_oligo6","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_L_)-GLC(1_L_)-FRU(2_L_)",26.2841,"","",""
"1W9B","S. ALBA MYROSINASE IN COMPLEX WITH CARBA-GLUCOTROPAEOLIN","10.1039/B502990B ",1.7,19.4,"1w9b_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",39.8715,"","",""
"1W9D","S. ALBA MYROSINASE IN COMPLEX WITH S-ETHYL PHENYLACETOTHIOHYDROXIMATE- O-SULFATE","10.1039/B502990B ",1.6,18.46,"1w9d_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",39.6415,"","",""
"1WCY","CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH DIPROTIN A","10.1515/BC.2004.068 ",2.2,28.8,"1wcy_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(85_B_)",54.3627,"","",""
"1WCY","CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH DIPROTIN A","10.1515/BC.2004.068 ",2.2,28.8,"1wcy_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(85_A_)",56.1936,"","",""
"1X0K","CRYSTAL STRUCTURE OF BACTERIORHODOPSIN AT PH 10","10.1016/J.JMB.2005.06.026 ",2.6,53.93,"1x0k_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C38O3","GAL(3_A_)-MAN(2_A_)-GLC(1_A_)-L2P(270_1_)",78.7379,"","",""
"1X0S","CRYSTAL STRUCTURE OF THE 13-CIS ISOMER OF BACTERIORHODOPSIN","10.1016/J.JMB.2005.07.021 ",2.5,66.47,"1x0s_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C37O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",107.533,"","",""
"1X38","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.7,38.79,"1x38_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",57.8196,"","",""
"1X39","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.8,32.56,"1x39_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",50.8142,"","",""
"1XC6","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE","10.1016/J.JMB.2004.09.012 ",2.1,22.63,"1xc6_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(625_A_)",27.4606,"","",""
"1XC6","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE","10.1016/J.JMB.2004.09.012 ",2.1,22.63,"1xc6_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(780_A_)",42.9416,"","",""
"1XC6","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE","10.1016/J.JMB.2004.09.012 ",2.1,22.63,"1xc6_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(917_A_)",25.6114,"","",""
"1XCX","ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS","10.1021/BI048334E ",1.9,0,"1xcx_oligo2","DQuip[4N]a1-4DGlcpa1-6DGlcpb1-ROH","AC1(3_B_)-GLC(2_B_)-BGC(1_B_)",33.43,"","",""
"1XMN","CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN","10.1074/JBC.M411606200 ",1.85,0,"1xmn_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(60_H_)",95.342,"","",""
"1XZ0","CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE","10.1016/J.IMMUNI.2004.12.009 ",2.8,52.26,"1xz0_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(57_A_)",54.2827,"","",""
"1XZ0","CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE","10.1016/J.IMMUNI.2004.12.009 ",2.8,52.26,"1xz0_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(57_C_)",56.3918,"","",""
"1Y4J","CRYSTAL STRUCTURE OF THE PARALOGUE OF THE HUMAN FORMYLGLYCINE GENERATING ENZYME","10.1074/JBC.M414317200 ",1.86,28.3,"1y4j_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(191_A_)",50.7694,"","",""
"1Y9M","CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI IN SPACEGROUP P212121","10.1016/J.JMB.2004.09.024 ",1.89,24.91,"1y9m_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",41.4309,"","",""
"1YAE","STRUCTURE OF THE KAINATE RECEPTOR SUBUNIT GLUR6 AGONIST BINDING DOMAIN COMPLEXED WITH DOMOIC ACID","10.1073/PNAS.0409573102 ",3.11,59.26,"1yae_oligo3","LFucpa1-6DGlcpNAca1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(423_A_)",80.5073,"","",""
"1YKB","CRYSTAL STRUCTURE OF INSECT CELL EXPRESSED IL-22","10.1107/S0907444905009601 ",2.6,60.32,"1ykb_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(54_A_)",85.0042,"","",""
"1YKB","CRYSTAL STRUCTURE OF INSECT CELL EXPRESSED IL-22","10.1107/S0907444905009601 ",2.6,60.32,"1ykb_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(54_D_)",86.4325,"","",""
"1YM0","CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT B: A NOVEL, GLYCOSYLATED TWO-CHAINED TRYPSIN","10.1016/J.JMB.2005.02.055 ",2.06,23.3,"1ym0_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(4_C_)-MAN(3_C_)-NAG(2_C_)]-[FUC(5_C_)]-NAG(1_C_)-ASN(161_A_)",37.5012,"","",""
"1YPZ","IMMUNE RECEPTOR","10.1126/SCIENCE.1106885 ",3.4,103.7,"1ypz_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ROH","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)",153.964,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo14","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_d_)-NAG(1_d_)-ASN(52_M_)",63.5886,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(162_M_)",50.2425,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo12","DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(52_K_)",77.1839,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo11","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_a_)-NAG(1_a_)-ASN(233_I_)",81.1395,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo8","DAltp[6H]a1-6DGlcpNAca1-ASN","FUC(2_X_)-NAG(1_X_)-ASN(233_G_)",89.395,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo1","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_U_)-NAG(1_U_)-ASN(172_E_)",81.955,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo6","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_V_)-NAG(1_V_)-ASN(52_G_)",66.5786,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo3","DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(52_A_)",80.0685,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(162_O_)",70.29,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo2","DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(233_C_)",95.9124,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(162_I_)",66.4147,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo4","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(52_C_)",68.1314,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo5","DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(52_E_)",84.9891,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo9","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_Y_)-NAG(1_Y_)-ASN(52_I_)",68.8418,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(162_K_)",52.0098,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo17","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_g_)-NAG(1_g_)-ASN(52_O_)",69.0309,"","",""
"1YY9","STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225","10.1016/J.CCR.2005.03.003 ",2.61,33.7,"1yy9_oligo1","DRhapa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(328_A_)",33.1901,"","",""
"1ZAG","HUMAN ZINC-ALPHA-2-GLYCOPROTEIN","10.1126/SCIENCE.283.5409.1914 ",2.8,54.3,"1zag_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(239_A_)",48.8521,"","",""
"1ZAG","HUMAN ZINC-ALPHA-2-GLYCOPROTEIN","10.1126/SCIENCE.283.5409.1914 ",2.8,54.3,"1zag_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(239_B_)",63.8662,"","",""
"1ZHN","CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE","",2.8,25.72,"1zhn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",51.7318,"","",""
"1ZHN","CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE","",2.8,25.72,"1zhn_oligo1","LFucpa1-6DGlcpNAca1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(20_A_)",53.295,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",20.68,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",22.6273,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",23.8518,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",32.3629,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",21.5691,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",38.1807,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",19.6678,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",21.7853,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",36.1844,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",21.9527,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",30.698,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",19.0782,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",17.1165,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",27.6162,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",23.5135,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",22.9218,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo25","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(198_E_)",83.2005,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(194_E_)",81.9753,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(194_A_)",81.47,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(198_C_)",79.4632,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(77_B_)",73.8033,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(77_E_)",75.8482,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(194_B_)",83.2687,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(194_C_)",85.916,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(198_A_)",82.0095,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo30","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-MAN(4_j_)-[MAN(6_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(198_F_)",80.6418,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(77_F_)",68.9776,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-[MAN(6_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(198_D_)",70.0315,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo17","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(198_B_)",81.2404,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(194_F_)",76.9169,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(194_D_)",74.9596,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(77_C_)",82.1195,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(77_A_)",75.8404,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(77_D_)",77.5516,"","",""
"2A0Z","THE MOLECULAR STRUCTURE OF TOLL-LIKE RECEPTOR 3 LIGAND BINDING DOMAIN","10.1073/PNAS.0505077102 ",2.4,45.4,"2a0z_oligo7","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(413_A_)",77.0195,"","",""
"2A0Z","THE MOLECULAR STRUCTURE OF TOLL-LIKE RECEPTOR 3 LIGAND BINDING DOMAIN","10.1073/PNAS.0505077102 ",2.4,45.4,"2a0z_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAc[3S]b1-ASN","FUC(3_H_)-[NAG(2_H_)--ASN(398_A_)",84.9291,"","",""
"2A0Z","THE MOLECULAR STRUCTURE OF TOLL-LIKE RECEPTOR 3 LIGAND BINDING DOMAIN","10.1073/PNAS.0505077102 ",2.4,45.4,"2a0z_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(507_A_)",68.6633,"","",""
"2AAI","CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS","10.1002/PROT.340100308 ",2.5,0,"2aai_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(95_B_)",42.6235,"","",""
"2AAI","CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS","10.1002/PROT.340100308 ",2.5,0,"2aai_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(135_B_)",43.948,"","",""
"2AC1","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE FROM ARABIDOPSIS THALIANA","10.1107/S0907444906044489 ",2.15,30.9,"2ac1_oligo1","DManpa1-2DManpa1-3[DManpb1-3DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",58.7278,"","",""
"2AE7","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1016/J.JMB.2005.07.050 ",2,32.2,"2ae7_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_E_)-MAN(2_E_)-MAN(1_E_)",43.3058,"","",""
"2AEC","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,6-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,31.4,"2aec_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_D_)-MAN(2_D_)-BMA(1_D_)",43.1009,"","",""
"2AEC","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,6-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,31.4,"2aec_oligo7","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_F_)-MAN(2_F_)-BMA(1_F_)",57.327,"","",""
"2AEC","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,6-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,31.4,"2aec_oligo6","DGlcpNAcb1-2DManpa1-6DManpb1-ROH","NAG(3_E_)-MAN(2_E_)-BMA(1_E_)",39.6597,"","",""
"2AEP","AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.","10.1016/J.JMB.2005.11.061 ",2.1,32.91,"2aep_oligo1","DManpa1-6DManpx1-","MAN(7_B_)-MAN(6_B_)",58.474,"","",""
"2AR6","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE PENTASACCHARIDE M592","10.1111/J.1742-4658.2006.05248.X ",1.8,0,"2ar6_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_D_)-MAN(4_D_)-[NAG(3_D_)-MAN(2_D_)]-MAN(1_D_)",31.9809,"","",""
"2ARX","PTEROCARPUS ANGOLENSIS SEED LECTIN IN COMPLEX WITH THE DECASACCHARIDE NA2F","10.1111/J.1742-4658.2006.05248.X ",2,0,"2arx_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-ROH","NAG(7_D_)-MAN(6_D_)-[GAL(5_D_)-NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NDG(1_D_)",41.1288,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo1","DManpb1-6DManpa1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(144_A_)",60.4125,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(410_A_)",63.5411,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo2","DManpb1-6DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1144_B_)",58.3144,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo3","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1410_B_)",56.6864,"","",""
"2B4C","CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY","10.1126/SCIENCE.1118398 ",3.3,126.2,"2b4c_oligo4","LFucpa1-6DGlcpNAca1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(276_G_)",140.774,"","",""
"2B5T","2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES","10.1074/JBC.M607204200 ",2.1,43.3,"2b5t_oligo1","DManp[2H]a1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(96_I_)",102.935,"","",""
"2B5T","2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES","10.1074/JBC.M607204200 ",2.1,43.3,"2b5t_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(60_B_)",84.5368,"","",""
"2B5T","2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES","10.1074/JBC.M607204200 ",2.1,43.3,"2b5t_oligo4","LFucpa1-6DGlcpNAca1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(60_D_)",75.5309,"","",""
"2B65","CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH MALTOSE AT 1.5A RESOLUTION","",1.5,21.56,"2b65_oligo2","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",52.4458,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-[MAN(8_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(201_D_)",25.7044,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-[MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(201_C_)",28.5894,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-[MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(201_A_)",24.7213,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(201_B_)",33.5904,"","",""
"2B9L","CRYSTAL STRUCTURE OF PROPHENOLOXIDASE ACTIVATING FACTOR-II FROM THE BEETLE HOLOTRICHIA DIOMPHALIA","10.1038/SJ.EMBOJ.7600891 ",2,32,"2b9l_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(32_A_)",49.8027,"","",""
"2BAT","THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID, THE VIRAL RECEPTOR","10.1002/PROT.340140302 ",2,0,"2bat_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",40.3709,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(475_A_)",180.899,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(478_A_)",159.538,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(459_A_)",139.332,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(277_A_)",123.823,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(243_A_)",115.522,"","",""
"2C10","THE STRUCTURE OF A TRUNCATED, SOLUBLE VERSION OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.5,37.62,"2c10_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",71.0982,"","",""
"2CL2","ENDO-1,3(4)-BETA-GLUCANASE FROM PHANEROCHAETE CHRYSOSPORIUM, SOLVED USING NATIVE SULFUR SAD, EXHIBITING INTACT HEPTASACCHARIDE GLYCOSYLATION","10.1107/S0907444906036407 ",1.35,8,"2cl2_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(43_A_)",24.49,"","",""
"2CML","STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR, CRYSTAL SOAKED FOR 3 HOURS AT 291 K.","",2.15,13.81,"2cml_oligo2","DManpa1-6DManpb1-4DGlcpNAcx1-","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)",28.1432,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_C_)-XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-GLC(1_C_)",15.0176,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo4","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_F_)-XYS(7_F_)-[XYS(6_F_)-[XYS(5_F_)-BGC(4_F_)]-BGC(3_F_)]-BGC(2_F_)-GLC(1_F_)",19.1898,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo3","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_E_)-XYS(7_E_)-[XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-GLC(1_E_)",16.4964,"","",""
"2CN3","CRYSTAL STRUCTURES OF CLOSTRIDIUM THERMOCELLUM XYLOGLUCANASE","10.1074/JBC.M603583200 ",1.95,15.64,"2cn3_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_D_)-XYS(8_D_)-[GAL(7_D_)-XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-GLC(1_D_)",19.0238,"","",""
"2D0F","CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 (TVAI) MUTANT D356N COMPLEXED WITH P2, A PULLULAN MODEL OLIGOSACCHARIDE","10.1111/J.1742-4658.2005.05013.X ",2.08,0,"2d0f_oligo1","DGlcpa1-4DGlcpa1-4DGlcpa1-6DGlcpa1-4DGlcpb1-ROH","GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-BGC(1_B_)",26.7925,"","",""
"2D0G","CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P5, A PULLULAN MODEL OLIGOSACCHARIDE","10.1111/J.1742-4658.2005.05013.X ",2.6,0,"2d0g_oligo1","DGlcpb1-4DGlcpa1-6DGlcpb1-4DGlcpb1-4DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","BGC(10_B_)-GLC(9_B_)-BGC(8_B_)-BGC(7_B_)-GLC(6_B_)-GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",31.806,"","",""
"2D0H","CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P2, A PULLULAN MODEL OLIGOSACCHARIDE","10.1111/J.1742-4658.2005.05013.X ",2.1,0,"2d0h_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(6_B_)-GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",37.3105,"","",""
"2D80","CRYSTAL STRUCTURE OF PHB DEPOLYMERASE FROM PENICILLIUM FUNICULOSUM","10.1016/J.JMB.2005.12.028 ",1.7,18.3,"2d80_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(144_A_)",48.6967,"","",""
"2DOJ","CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH ADENOSINE AT 2.4 A RESOLUTION","",2.4,29.55,"2doj_oligo4","DManpb1-6DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(4_C_)-MAN(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(476_A_)",66.6218,"","",""
"2DP8","CARBOHYDRATE RECOGNITION BY LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH TRISACCHARIDE AT 2.5 A RESOLUTION","",2.5,37.17,"2dp8_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(476_A_)",92.7018,"","",""
"2DQV","STRUCTURE OF THE C-TERMINAL LOBE OF BOVINE LACTOFERRIN IN COMPLEX WITH GALACTOSE AT 2.7 A RESOLUTION","",2.7,33.9,"2dqv_oligo1","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(476_A_)",90.7338,"","",""
"2DSZ","THREE DIMENSIONAL STRUCTURE OF A GOAT SIGNALLING PROTEIN SECRETED DURING INVOLUTION","10.1107/S0907444907001631 ",2.35,39.4,"2dsz_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",52.5705,"","",""
"2DTS","CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2007.02.034 ",2.2,37.02,"2dts_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",31.8688,"","",""
"2DTS","CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2007.02.034 ",2.2,37.02,"2dts_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",37.4082,"","",""
"2DVB","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,6-GALNAC COMPLEX","10.1107/S0907444906035712 ",2.25,33.3,"2dvb_oligo1","DGalpb1-6DGalpNAca1-ROH","GAL(2_E_)-NGA(1_E_)",51.6732,"","",""
"2DVC","STRUCTURE OF THE BOVINE LACTOFERRIN C-LOBE COMPLEX WITH SUCROSE AT 3.0 A RESOLUTION","",3,32.7,"2dvc_oligo3","DManpb1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",47.5247,"","",""
"2DVG","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-ALPHA-1,6-GLC COMPLEX","10.1107/S0907444906035712 ",2.78,32.7,"2dvg_oligo1","DGalpa1-6DGlcpb1-ROH","GLA(2_E_)-BGC(1_E_)",58.6545,"","",""
"2DW0","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-1 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.15,0,"2dw0_oligo2","DManpa1-3[DGlcpNAcb1-4][DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)]-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",53.4933,"","",""
"2DW1","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-2 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.5,0,"2dw1_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(371_B_)",69.1418,"","",""
"2DW2","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.7,0,"2dw2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(8_C_)]-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(371_A_)",35.7425,"","",""
"2DW2","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.7,0,"2dw2_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(8_D_)]-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(371_B_)",38.0175,"","",""
"2DWA","STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-TERMINAL HALF WITH FUCOSE AT 2.07 A RESOLUTION","",2.07,34.49,"2dwa_oligo2","DManpb1-4[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[BMA(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",60.8813,"","",""
"2DWI","CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN C-TERMINAL HALF OF BOVINE LACTOFERRIN AND CELLOBIOSE AT 2.2 A RESOLUTION","",2.2,30.25,"2dwi_oligo4","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",67.6991,"","",""
"2DWJ","STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH RAFFINOSE AT 2.3 A RESOLUTION","",2.3,39.2,"2dwj_oligo1","DGalpb1-6DGlcpa1-","GAL(3_B_)-GLC(2_B_)-FRU(1_B_)",78.3359,"","",""
"2DXR","CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN C-TERMINAL HALF OF BOVINE LACTOFERRIN AND SORBITOL AT 2.85 A RESOLUTION","",2.85,28.31,"2dxr_oligo3","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",65.1382,"","",""
"2DYX","STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-LOBE WITH MELIBIOSE AT 2.0 A RESOLUTION","",2,34.84,"2dyx_oligo4","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",67.2367,"","",""
"2DYX","STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-LOBE WITH MELIBIOSE AT 2.0 A RESOLUTION","",2,34.84,"2dyx_oligo3","DGalpb1-6DGlcpa1-ROH","GAL(2_E_)-BGC(1_E_)",35.2082,"","",""
"2E0S","CARBOHYDRATE RECOGNITION OF C-TERMINAL HALF OF LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE WITH RHAMNOSE AT 2.15 A RESOLUTION","",2.15,27.09,"2e0s_oligo3","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",52.0555,"","",""
"2E1S","CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL HALF OF BOVINE LACTOFERRIN AND ARABINOSE AT 2.7 A RESOLUTION","",2.7,19.16,"2e1s_oligo1","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",50.7555,"","",""
"2E33","STRUCTURAL BASIS FOR SELECTION OF GLYCOSYLATED SUBSTRATE BY SCFFBS1 UBIQUITIN LIGASE","10.1073/PNAS.0610312104 ",2.7,54.8,"2e33_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",70.4113,"","",""
"2E3X","CRYSTAL STRUCTURE OF RUSSELL'S VIPER VENOM METALLOPROTEINASE","10.1016/J.FEBSLET.2007.11.062 ",2.91,0,"2e3x_oligo3","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(24_C_)",118.321,"","",""
"2EBS","CRYSTAL STRUCTURE ANAALYSIS OF OLIGOXYLOGLUCAN REDUCING-END-SPECIFIC CELLOBIOHYDROLASE (OXG-RCBH) D465N MUTANT COMPLEXED WITH A XYLOGLUCAN HEPTASACCHARIDE","10.1016/J.JMB.2007.04.035 ",2.4,22.13,"2ebs_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-BGC(1_D_)",21.2363,"","",""
"2EBS","CRYSTAL STRUCTURE ANAALYSIS OF OLIGOXYLOGLUCAN REDUCING-END-SPECIFIC CELLOBIOHYDROLASE (OXG-RCBH) D465N MUTANT COMPLEXED WITH A XYLOGLUCAN HEPTASACCHARIDE","10.1016/J.JMB.2007.04.035 ",2.4,22.13,"2ebs_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",23.4341,"","",""
"2ERJ","CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2","10.1073/PNAS.0511161103 ",3,91.91,"2erj_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(45_B_)",96.2441,"","",""
"2ERJ","CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2","10.1073/PNAS.0511161103 ",3,91.91,"2erj_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(17_F_)",89.2961,"","",""
"2ERJ","CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2","10.1073/PNAS.0511161103 ",3,91.91,"2erj_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(17_B_)",95.7859,"","",""
"2ERJ","CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2","10.1073/PNAS.0511161103 ",3,91.91,"2erj_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(45_F_)",104.088,"","",""
"2ESC","CRYSTAL STRUCTURE OF A 40 KDA PROTECTIVE SIGNALLING PROTEIN FROM BOVINE (SPC-40) AT 2.1 A RESOLUTION","10.1107/S0907444906020427 ",2.1,36.15,"2esc_oligo1","DManpb1-4DManpb1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",46.9409,"","",""
"2F9N","CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT K192Q/D216G IN COMPLEX WITH LEUPEPTIN","10.1016/J.JMB.2005.12.037 ",1.6,23.6,"2f9n_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[NAG(3_I_)]-[FUC(2_I_)]-NAG(1_I_)-ASN(113_B_)",54.2086,"","",""
"2F9N","CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT K192Q/D216G IN COMPLEX WITH LEUPEPTIN","10.1016/J.JMB.2005.12.037 ",1.6,23.6,"2f9n_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[NAG(3_J_)]-[FUC(2_J_)]-NAG(1_J_)-ASN(113_D_)",55.2086,"","",""
"2FA7","CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE LACTOFERRIN C-LOBE WITH A PENTASACCHARIDE AT 2.38 A RESOLUTION","",2.38,33.51,"2fa7_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(476_A_)",77.4207,"","",""
"2FBJ","REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION","",1.95,0,"2fbj_oligo2","DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(156_H_)",64.0545,"","",""
"2FCP","FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) FROM E.COLI","10.1126/SCIENCE.282.5397.2215 ",2.5,67.4,"2fcp_oligo1","DGalpa1-3[DGalpa1-6]DGlcpa1-3GPH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]a1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GLA(8_B_)-[GLA(7_B_)]-GLC(6_B_)-GPH(5_B_)-GMH(4_B_)-[KDO(9_B_)]-KDO(3_B_)-GP4(2_B_)-GP1(1_B_)",78.6068,"","",""
"2FFD","FIBRINOGEN FRAGMENT D WITH ""A"" KNOB PEPTIDE MIMIC GPRVVE","10.1111/J.1538-7836.2006.01902.X ",2.89,36.57,"2ffd_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(364_B_)",95.2958,"","",""
"2FFD","FIBRINOGEN FRAGMENT D WITH ""A"" KNOB PEPTIDE MIMIC GPRVVE","10.1111/J.1538-7836.2006.01902.X ",2.89,36.57,"2ffd_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(364_E_)",69.3797,"","",""
"2FH8","CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA PNEUMONIAE PULLULANASE COMPLEXED WITH ISOMALTOSE","10.1016/J.JMB.2006.03.058 ",1.9,28.7,"2fh8_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_B_)-BGC(1_B_)",43.1673,"","",""
"2FO4","ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE","10.1111/J.1365-2567.2006.02434.X ",2.7,37.5,"2fo4_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(176_A_)",76.8377,"","",""
"2G8Z","CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF SIGNALLING PROTEIN FROM SHEEP (SPS-40) WITH TRIMER AND DESIGNED PEPTIDE AT 2.5A RESOLUTION","",2.5,36.2,"2g8z_oligo2","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",49.6591,"","",""
"2G93","LIGAND RECOGNITION SITE IN C-LOBE OF LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH METHYL ALPHA-D- MANNOPYRANOSIDE AT 1.9 A RESOLUTION","",1.9,36.02,"2g93_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)",75.4602,"","",""
"2GAZ","MYCOBACTERIAL LIPOGLYCAN PRESENTATION BY CD1D","",2.61,46.13,"2gaz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",63.2202,"","",""
"2GD4","CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX","10.1038/SJ.EMBOJ.7601089 ",3.3,36.57,"2gd4_oligo1","DManp[2H]a1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(155_I_)",127.786,"","",""
"2GH0","GROWTH FACTOR/RECEPTOR COMPLEX","10.1016/J.STR.2006.05.010 ",1.92,37.51,"2gh0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(309_A_)",37.2489,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"2GN7","METAL-FREE (APO) P. ANGOLENSIS SEED LECTIN IN COMPLEX WITH MAN- ALPHA(1-3)MAN-ALPHA(1-6)MAN","10.1016/J.JMB.2006.06.006 ",2.9,0,"2gn7_oligo3","DManpb1-3[DManpa1-6]DManpa1-ROH","MAN(3_C_)-[BMA(2_C_)]-MAN(1_C_)",68.93,"","",""
"2GYW","CRYSTAL STRUCTURE OF MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH OBIDOXIME","10.1016/J.BCP.2006.05.027 ",2.4,43.65,"2gyw_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",87.4468,"","",""
"2H4I","CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEOLYTICALLY PRODUCED C- TERMINAL HALF OF BOVINE LACTOFERRIN WITH LACTOSE AT 2.55 A RESOLUTION","",2.55,35.9,"2h4i_oligo3","DManpb1-4[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[BMA(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",61.9042,"","",""
"2H5U","CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION","10.1107/S1744309106036578 ",1.9,12.23,"2h5u_oligo4","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)",15.2067,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo18","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-MAN(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo45","DManpa1-6DManpb1-3DGlcpNAca1-4DGlcpNAcx1-","MAN(7_f_)-MAN(3_f_)-NDG(2_f_)-NAG(1_f_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo41","DManpb1-6DManpa1-6DManpx1-","MAN(8_d_)-MAN(6_d_)-MAN(3_d_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo13","DManpb1-3[DManpb1-6]DManpx1-","MAN(7_J_)-[MAN(5_J_)]-MAN(4_J_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo29","DManpb1-3[DManpb1-6]DManpx1-","MAN(11_U_)-[MAN(10_U_)]-BMA(9_U_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo15","DManpb1-3DManpb1-6DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(10_M_)-MAN(9_M_)-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(195_A_)",128.191,"","",""
"2HA0","CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH 4- KETOAMYLTRIMETHYLAMMONIUM","10.1074/JBC.M603018200 ",2.2,45.35,"2ha0_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",88.3091,"","",""
"2HA3","CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH CHOLINE","10.1074/JBC.M603018200 ",2.25,42.04,"2ha3_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",89.405,"","",""
"2HA5","CRYSTAL STRUCTURE OF MUTANT S203A OF ACETYLCHOLINESTERASE COMPLEXED WITH ACETYLTHIOCHOLINE","10.1074/JBC.M603018200 ",2.15,43.96,"2ha5_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",95.9113,"","",""
"2HCA","CRYSTAL STRUCTURE OF BOVINE LACTOFERRIN C-LOBE LIGANDED WITH GLUCOSE AT 2.8 A RESOLUTION","",2.8,30.29,"2hca_oligo3","DManpb1-4[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[BMA(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",47.5971,"","",""
"2HCZ","CRYSTAL STRUCTURE OF EXPB1 (ZEA M 1), A BETA-EXPANSIN AND GROUP-1 POLLEN ALLERGEN FROM MAIZE","10.1073/PNAS.0605979103 ",2.75,56.87,"2hcz_oligo1","DXylpa1-2[DManpa1-3][DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-[XYS(4_A_)]-MAN(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(10_X_)",62.9004,"","",""
"2HPA","STRUCTURAL ORIGINS OF L(+)-TARTRATE INHIBITION OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1074/JBC.273.46.30406 ",2.9,17.5,"2hpa_oligo1","DManpa1-6DManpb1-4DGlcpNAcx1-","MAN(3_E_)-BMA(2_E_)-NAG(1_E_)",100.218,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(418_A_)",110.862,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(215_B_)",83.081,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(255_B_)",80.987,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(111_A_)",74.367,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(337_B_)",82.4194,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(255_A_)",61.9973,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(111_B_)",85.6456,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(337_A_)",106.896,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(418_B_)",91.6261,"","",""
"2HRG","CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE","10.1016/J.ICA.2008.03.091 ",1.58,19.7,"2hrg_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",27.707,"","",""
"2HYQ","CRYSTAL STRUCTURE OF A COMPLEX OF GRIFFITHSIN WITH 6ALPHA-MANNOBIOSE","10.1002/PROT.21336 ",2,46.33,"2hyq_oligo6","DManpa1-6DManpa1-ROH","MAN(2_H_)-MAN(1_H_)",61.3314,"","",""
"2HYQ","CRYSTAL STRUCTURE OF A COMPLEX OF GRIFFITHSIN WITH 6ALPHA-MANNOBIOSE","10.1002/PROT.21336 ",2,46.33,"2hyq_oligo3","DManpa1-6DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",73.355,"","",""
"2HYQ","CRYSTAL STRUCTURE OF A COMPLEX OF GRIFFITHSIN WITH 6ALPHA-MANNOBIOSE","10.1002/PROT.21336 ",2,46.33,"2hyq_oligo5","DManpa1-6DManpa1-ROH","MAN(2_G_)-MAN(1_G_)",67.8268,"","",""
"2HYQ","CRYSTAL STRUCTURE OF A COMPLEX OF GRIFFITHSIN WITH 6ALPHA-MANNOBIOSE","10.1002/PROT.21336 ",2,46.33,"2hyq_oligo4","DManpa1-6DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",74.6118,"","",""
"2HYQ","CRYSTAL STRUCTURE OF A COMPLEX OF GRIFFITHSIN WITH 6ALPHA-MANNOBIOSE","10.1002/PROT.21336 ",2,46.33,"2hyq_oligo1","DManpa1-6DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",78.69,"","",""
"2HYQ","CRYSTAL STRUCTURE OF A COMPLEX OF GRIFFITHSIN WITH 6ALPHA-MANNOBIOSE","10.1002/PROT.21336 ",2,46.33,"2hyq_oligo2","DManpa1-6DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",62.3977,"","",""
"2I58","CRYSTAL STRUCTURE OF RAFE FROM STREPTOCOCCUS PNEUMONIAE COMPLEXED WITH RAFFINOSE","",2.8,47.86,"2i58_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(1_D_)-GLC(2_D_)-FRU(3_D_)",42.9263,"","",""
"2I58","CRYSTAL STRUCTURE OF RAFE FROM STREPTOCOCCUS PNEUMONIAE COMPLEXED WITH RAFFINOSE","",2.8,47.86,"2i58_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(1_C_)-GLC(2_C_)-FRU(3_C_)",48.2798,"","",""
"2I6Q","COMPLEMENT COMPONENT C2A","10.1016/J.STR.2006.08.008 ",2.1,22.51,"2i6q_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(313_A_)",50.5309,"","",""
"2I74","CRYSTAL STRUCTURE OF MOUSE PEPTIDE N-GLYCANASE C-TERMINAL DOMAIN IN COMPLEX WITH MANNOPENTAOSE","10.1073/PNAS.0602954103 ",1.75,13.84,"2i74_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-MAN(1_C_)",36.7716,"","",""
"2I74","CRYSTAL STRUCTURE OF MOUSE PEPTIDE N-GLYCANASE C-TERMINAL DOMAIN IN COMPLEX WITH MANNOPENTAOSE","10.1073/PNAS.0602954103 ",1.75,13.84,"2i74_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-MAN(1_D_)",21.7252,"","",""
"2I9B","CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX","10.1016/J.JMB.2006.08.063 ",2.8,67.3,"2i9b_oligo1","DManpb1-6DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(52_E_)",116.827,"","",""
"2I9B","CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX","10.1016/J.JMB.2006.08.063 ",2.8,67.3,"2i9b_oligo2","DManpb1-6DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(52_F_)",110.606,"","",""
"2ID5","CRYSTAL STRUCTURE OF THE LINGO-1 ECTODOMAIN","10.1074/JBC.M607314200 ",2.7,78.95,"2id5_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-MAN(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(254_D_)",82.952,"","",""
"2IH8","A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE","10.1016/J.BBRC.2006.09.144 ",2,19.26,"2ih8_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(88_B_)",41.7955,"","",""
"2IH8","A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE","10.1016/J.BBRC.2006.09.144 ",2,19.26,"2ih8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",45.4684,"","",""
"2IID","STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA IN COMPLEX WITH L-PHENYLALANINE","10.1016/J.JMB.2006.09.032 ",1.8,19.36,"2iid_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(172_C_)",43.2605,"","",""
"2IID","STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA IN COMPLEX WITH L-PHENYLALANINE","10.1016/J.JMB.2006.09.032 ",1.8,19.36,"2iid_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(172_D_)",35.0714,"","",""
"2IID","STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA IN COMPLEX WITH L-PHENYLALANINE","10.1016/J.JMB.2006.09.032 ",1.8,19.36,"2iid_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(172_A_)",40.7236,"","",""
"2IQ7","CRYSTAL STRUCTURE OF THE POLYGALACTURONASE FROM COLLETOTRICHUM LUPINI AND ITS IMPLICATIONS FOR THE INTERACTION WITH POLYGALACTURONASE- INHIBITING PROTEINS","10.1002/PROT.21610 ",1.94,14.12,"2iq7_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(209_A_)",20.1782,"","",""
"2IUL","HUMAN TACE G13 MUTANT","10.1021/BI061146Z ",2.01,19.59,"2iul_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",51.8058,"","",""
"2IWG","COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC","10.1073/PNAS.0609174104 ",2.35,71.56,"2iwg_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_D_)",88.8714,"","",""
"2IWG","COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC","10.1073/PNAS.0609174104 ",2.35,71.56,"2iwg_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",88.8714,"","",""
"2J0G","L-FICOLIN COMPLEXED TO N-ACETYL-MANNOSAMINE","10.1038/SJ.EMBOJ.7601500 ",2.85,40.37,"2j0g_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[MAN(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(215_E_)",63.5886,"","",""
"2J0G","L-FICOLIN COMPLEXED TO N-ACETYL-MANNOSAMINE","10.1038/SJ.EMBOJ.7601500 ",2.85,40.37,"2j0g_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(215_B_)",62.4489,"","",""
"2J1G","L-FICOLIN COMPLEXED TO N-ACETYL-CYSTEIN","10.1038/SJ.EMBOJ.7601500 ",1.95,38.77,"2j1g_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(215_B_)",40.008,"","",""
"2J3F","L-FICOLIN COMPLEXED TO N-ACETYL-D-GALACTOSAMINE","10.1038/SJ.EMBOJ.7601500 ",2.8,41.92,"2j3f_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(215_B_)",42.0347,"","",""
"2J3G","L-FICOLIN","10.1038/SJ.EMBOJ.7601500 ",2.5,35.88,"2j3g_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(215_B_)",41.8655,"","",""
"2J4C","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 10MM HGCL2","10.1111/J.1742-4658.2007.05732.X ",2.75,56.9,"2j4c_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",91.1491,"","",""
"2J4C","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 10MM HGCL2","10.1111/J.1742-4658.2007.05732.X ",2.75,56.9,"2j4c_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",112.109,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",116.527,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",54.9007,"","",""
"2J73","ALPHA-GLUCAN RCOGNITION BY A FAMILY 41 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA PULLULANASE PULA","10.1016/J.JMB.2006.10.018 ",1.4,15.32,"2j73_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",24.0984,"","",""
"2JEN","FAMILY 12 XYLOGLUCANASE FROM BACILLUS LICHENIFORMIS IN COMPLEX WITH LIGAND","10.1074/JBC.M700224200 ",1.4,12.06,"2jen_oligo4","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(4_C_)-[XYS(3_C_)-GLC(2_C_)]-GLC(1_C_)",22.8195,"","",""
"2JEN","FAMILY 12 XYLOGLUCANASE FROM BACILLUS LICHENIFORMIS IN COMPLEX WITH LIGAND","10.1074/JBC.M700224200 ",1.4,12.06,"2jen_oligo2","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(6_B_)-[XYS(5_B_)-[BGC(4_B_)]-BGC(3_B_)]-GLC(2_B_)-GLC(1_B_)",28.0618,"","",""
"2JEQ","FAMILY 5 XYLOGLUCANASE FROM PAENIBACILLUS PABULI IN COMPLEX WITH LIGAND","10.1074/JBC.M700224200 ",1.94,21.02,"2jeq_oligo1","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_B_)-XYS(6_B_)-[XYS(5_B_)-[BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",31.6102,"","",""
"2MSB","STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN COMPLEXED WITH AN OLIGOSACCHARIDE","10.1038/360127A0 ",1.7,0,"2msb_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManp[6Me]a1-6]DManpb1-OME","MAN(6_C_)-MAN(5_C_)-[MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",35.0245,"","",""
"2NYK","CRYSTAL STRUCTURE OF M157 FROM MOUSE CYTOMEGALOVIRUS","10.1073/PNAS.0703735104 ",2.1,36.9,"2nyk_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(178_A_)",60.7291,"","",""
"2O9O","CRYSTAL STRUCTURE OF THE BUFFALO SECRETORY SIGNALLING GLYCOPROTEIN AT 2.8 A RESOLUTION","10.1107/S1744309107010445 ",2.8,34.29,"2o9o_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",54.8635,"","",""
"2OBD","CRYSTAL STRUCTURE OF CHOLESTERYL ESTER TRANSFER PROTEIN","10.1038/NSMB1197 ",2.1,44.54,"2obd_oligo1","DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(396_A_)",65.8682,"","",""
"2OK5","HUMAN COMPLEMENT FACTOR B","10.1038/NSMB1210 ",2.3,33.68,"2ok5_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(97_A_)",43.3179,"","",""
"2OXE","STRUCTURE OF THE HUMAN PANCREATIC LIPASE-RELATED PROTEIN 2","10.1021/BI8005576 ",2.8,39.62,"2oxe_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_B_)",103.257,"","",""
"2OXE","STRUCTURE OF THE HUMAN PANCREATIC LIPASE-RELATED PROTEIN 2","10.1021/BI8005576 ",2.8,39.62,"2oxe_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(353_A_)",96.6098,"","",""
"2OYE","INDOMETHACIN-(R)-ALPHA-ETHYL-ETHANOLAMIDE BOUND TO CYCLOOXYGENASE-1","10.1074/JBC.M701335200 ",2.85,62.96,"2oye_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(144_P_)",76.5657,"","",""
"2OYH","CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAD298,301A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE","10.1021/BI602607A ",2.4,46.9,"2oyh_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(364_B_)",101.715,"","",""
"2OYH","CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAD298,301A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE","10.1021/BI602607A ",2.4,46.9,"2oyh_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(364_E_)",74.4818,"","",""
"2OYI","CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAD298,301A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-PRO-ARG-PRO-AMIDE","10.1021/BI602607A ",2.7,41.6,"2oyi_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(364_E_)",64.6503,"","",""
"2OYI","CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAD298,301A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-PRO-ARG-PRO-AMIDE","10.1021/BI602607A ",2.7,41.6,"2oyi_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(364_B_)",101.634,"","",""
"2OZ4","STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION","10.1073/PNAS.0707406104 ",2.7,63.34,"2oz4_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(240_A_)",80.96,"","",""
"2PE4","STRUCTURE OF HUMAN HYALURONIDASE 1, A HYALURONAN HYDROLYZING ENZYME INVOLVED IN TUMOR GROWTH AND ANGIOGENESIS","10.1021/BI700382G ",2,37.02,"2pe4_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(350_A_)",60.3311,"","",""
"2PGZ","CRYSTAL STRUCTURE OF COCAINE BOUND TO AN ACH-BINDING PROTEIN","10.1016/J.JMB.2007.03.067 ",1.76,29.49,"2pgz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(74_C_)",43.9247,"","",""
"2PHF","PTEROCARPUS ANGOLENSIS LECTIN COMPLEXED WITH MAN-6","10.1104/PP.107.100867 ",2.1,0,"2phf_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-BMA(1_D_)",41.767,"","",""
"2PHR","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-7D1","10.1104/PP.107.100867 ",1.9,0,"2phr_oligo4","DRhapa1-3[DManpa1-6]DManpa1-OME","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-BMA(1_D_)",39.2294,"","",""
"2PHT","PTEROCARPUS ANGOLENSIS LECTIN (P L) IN COMPLEX WITH MAN-7D3","10.1104/PP.107.100867 ",2.1,0,"2pht_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-ROH","MAN(4_D_)-MAN(3_D_)-[MAN(5_D_)]-MAN(2_D_)-BMA(1_D_)",39.5825,"","",""
"2PHU","PTEROCARPUS ANGOLENSIS LECTIN IN COMPLEX WITH MAN-8D1D3","10.1104/PP.107.100867 ",2.2,0,"2phu_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-ROH","MAN(4_C_)-MAN(3_C_)-[MAN(5_C_)]-MAN(2_C_)-BMA(1_C_)",45.0575,"","",""
"2PHW","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-9","10.1104/PP.107.100867 ",1.8,0,"2phw_oligo2","DManpa1-2DManpa1-6[DManp[2Me]a1-3]DManpa1-6DManpb1-ROH","MAN(7_D_)-MAN(6_D_)-MAN(4_D_)]-MAN(3_D_)-BMA(2_D_)-MAN(1_D_)",37.9593,"","",""
"2PHX","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-5","10.1104/PP.107.100867 ",1.8,0,"2phx_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-MAN(1_D_)",33.8918,"","",""
"2PI6","CRYSTAL STRUCTURE OF THE SHEEP SIGNALLING GLYCOPROTEIN (SPS-40) COMPLEX WITH 2-METHYL-2-4-PENTANEDIOL AT 1.65A RESOLUTION REVEALS SPECIFIC BINDING CHARACTERISTICS OF SPS-40","10.1107/S0907444909002327 ",1.65,24.22,"2pi6_oligo1","DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",65.4515,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(342_C_)",130.849,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(342_A_)",110.884,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(218_C_)",102.328,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(218_A_)",102.238,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[MAN(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(397_A_)",61.5918,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_R_)-[MAN(4_R_)-MAN(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(397_C_)",76.5838,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(121_A_)",73.927,"","",""
"2Q7Y","STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D","10.1016/J.JMB.2008.01.061 ",1.95,32.36,"2q7y_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",52.6042,"","",""
"2Q86","STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14","10.1016/J.JMB.2008.01.061 ",1.85,35.32,"2q86_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(23_A_)",43.7442,"","",""
"2Q86","STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14","10.1016/J.JMB.2008.01.061 ",1.85,35.32,"2q86_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(23_C_)",44.3239,"","",""
"2QC1","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE NICOTINIC ACETYLCHOLINE RECEPTOR 1 SUBUNIT BOUND TO ALPHA-BUNGAROTOXIN AT 1.9 A RESOLUTION","10.1038/NN1942 ",1.94,30.8,"2qc1_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(141_B_)",32.8527,"","",""
"2QJR","DIPEPDYL PEPTIDASE IV IN COMPLEX WITH INHIBITOR PZF","10.1016/J.BMCL.2007.07.081 ",2.2,53.31,"2qjr_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","LGU(803_A_)-[MAN(4_D_)]-LGU(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(229_A_)",83.0264,"","",""
"2QL1","STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT","10.1016/J.MOLIMM.2007.10.042 ",2.53,36.25,"2ql1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",74.3521,"","",""
"2QQM","CRYSTAL STRUCTURE OF THE A2B1B2 DOMAINS FROM HUMAN NEUROPILIN-1","10.1038/SJ.EMBOJ.7601906 ",2,36.27,"2qqm_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(261_A_)",45.5705,"","",""
"2QQU","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (D239A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE","10.1016/J.JMB.2007.12.074 ",2.84,39.24,"2qqu_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",50.4211,"","",""
"2QQV","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (E203A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE","10.1016/J.JMB.2007.12.074 ",3.01,41.04,"2qqv_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",48.5604,"","",""
"2QQW","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (D23A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE","10.1016/J.JMB.2007.12.074 ",2.8,45.5,"2qqw_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",58.2229,"","",""
"2QT6","CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS","10.1186/1472-6807-7-60 ",1.5,26.09,"2qt6_oligo1","DManpb1-6DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-[BMA(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",33.07,"","",""
"2QT6","CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS","10.1186/1472-6807-7-60 ",1.5,26.09,"2qt6_oligo2","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(54_B_)",37.8806,"","",""
"2QWA","THE X-RAY STRUCTURE OF A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.7,0,"2qwa_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",18.3477,"","",""
"2QWB","THE X-RAY STRUCTURE OF A COMPLEX OF SIALIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",22.3252,"","",""
"2QWC","THE X-RAY STRUCTURE OF A COMPLEX OF NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.6,0,"2qwc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.9408,"","",""
"2QWD","THE X-RAY STRUCTURE OF A COMPLEX OF 4-AMINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwd_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.9605,"","",""
"2QWE","THE X-RAY STRUCTURE OF A COMPLEX OF 4-GUANIDINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwe_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",21.8071,"","",""
"2QWF","THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.9,0,"2qwf_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.9622,"","",""
"2QWG","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.8,0,"2qwg_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.9679,"","",""
"2QWH","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.8,0,"2qwh_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",23.1039,"","",""
"2QWJ","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",26.1005,"","",""
"2QWK","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.8,0,"2qwk_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",27.2731,"","",""
"2R71","CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE C-LOBE WITH INOSITOL AT 2.1A RESOLUTION","",2.07,33.84,"2r71_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",62.22,"","",""
"2R7E","CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII","10.1182/BLOOD-2007-08-109918 ",3.7,168.5,"2r7e_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(239_A_)",148.949,"","",""
"2R7E","CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII","10.1182/BLOOD-2007-08-109918 ",3.7,168.5,"2r7e_oligo3","DManpa1-2DManpb1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2118_B_)",170.793,"","",""
"2RG3","COVALENT COMPLEX STRUCTURE OF ELASTASE","10.1021/JM700966P ",1.8,0,"2rg3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)",20.4153,"","",""
"2RGS","FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS","10.1111/J.1365-2567.2008.02904.X ",2.13,25.87,"2rgs_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",27.267,"","",""
"2RGS","FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS","10.1111/J.1365-2567.2008.02904.X ",2.13,25.87,"2rgs_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",27.747,"","",""
"2RI8","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE COMPLEX WITH GLYCEROL","10.1107/S0907444907065572 ",2.16,28,"2ri8_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(1366_A_)",32.8576,"","",""
"2RI8","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE COMPLEX WITH GLYCEROL","10.1107/S0907444907065572 ",2.16,28,"2ri8_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(2366_B_)",43.04,"","",""
"2RI9","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH A SUBSTRATE ANALOG","10.1107/S0907444907065572 ",1.95,28.3,"2ri9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NDG(2_D_)-NAG(1_D_)-ASN(1366_A_)",29.9751,"","",""
"2RI9","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH A SUBSTRATE ANALOG","10.1107/S0907444907065572 ",1.95,28.3,"2ri9_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-MAN(3_H_)-NDG(2_H_)-NAG(1_H_)-ASN(2366_B_)",54.9084,"","",""
"2RIP","STRUCTURE OF DPPIV IN COMPLEX WITH AN INHIBITOR","10.1016/J.BMCL.2007.10.063 ",2.9,38.89,"2rip_oligo4","DManpa1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(85_A_)",71.7118,"","",""
"2VC2","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758","10.1083/JCB.200801146 ",3.1,3.21,"2vc2_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",28.0539,"","",""
"2VC2","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758","10.1083/JCB.200801146 ",3.1,3.21,"2vc2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",33.6633,"","",""
"2VCO","CRYSTAL STRUCTURE OF THE FIMBRIAL ADHESIN FIMH IN COMPLEX WITH ITS HIGH-MANNOSE EPITOPE","10.1371/JOURNAL.PONE.0002040 ",2.1,27.63,"2vco_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)",49.7153,"","",""
"2VCO","CRYSTAL STRUCTURE OF THE FIMBRIAL ADHESIN FIMH IN COMPLEX WITH ITS HIGH-MANNOSE EPITOPE","10.1371/JOURNAL.PONE.0002040 ",2.1,27.63,"2vco_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)",50.3495,"","",""
"2VDK","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.8,17.09,"2vdk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",55.9564,"","",""
"2VDK","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.8,17.09,"2vdk_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",47.5294,"","",""
"2VDL","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.75,36.91,"2vdl_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",77.0405,"","",""
"2VDL","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.75,36.91,"2vdl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",83.6053,"","",""
"2VDM","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN","10.1083/JCB.200801146 ",2.9,42.7,"2vdm_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",82.5252,"","",""
"2VDM","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN","10.1083/JCB.200801146 ",2.9,42.7,"2vdm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",88.0869,"","",""
"2VDN","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE","10.1083/JCB.200801146 ",2.9,44.6,"2vdn_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",89.2851,"","",""
"2VDN","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE","10.1083/JCB.200801146 ",2.9,44.6,"2vdn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",97.6993,"","",""
"2VDO","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV","10.1083/JCB.200801146 ",2.51,51.55,"2vdo_oligo2","DManpb1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",91.3655,"","",""
"2VDO","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV","10.1083/JCB.200801146 ",2.51,51.55,"2vdo_oligo1","DManpb1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",108.462,"","",""
"2VDP","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE,LGGAKQAGDV","10.1083/JCB.200801146 ",2.8,48.02,"2vdp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",99.3907,"","",""
"2VDP","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE,LGGAKQAGDV","10.1083/JCB.200801146 ",2.8,48.02,"2vdp_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",90.0051,"","",""
"2VDQ","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV","10.1083/JCB.200801146 ",2.59,41.15,"2vdq_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",85.0145,"","",""
"2VDQ","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV","10.1083/JCB.200801146 ",2.59,41.15,"2vdq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",95.672,"","",""
"2VDR","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV","10.1083/JCB.200801146 ",2.4,43.58,"2vdr_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",83.9629,"","",""
"2VDR","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV","10.1083/JCB.200801146 ",2.4,43.58,"2vdr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",94.0078,"","",""
"2VH9","CRYSTAL STRUCTURE OF NXG1-DELTAYNIIG IN COMPLEX WITH XLLG, A XYLOGLUCAN DERIVED OLIGOSACCHARIDE","10.1002/PROT.22291 ",2.1,14.71,"2vh9_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpx1-","GAL(3_C_)-XYS(2_C_)-[GAL(3_D_)-XYS(2_D_)-[XYS(2_E_)-BGC(1_E_)]-BGC(1_D_)]-BGC(1_C_)-BGC(303_A_)",18.2104,"","",""
"2VH9","CRYSTAL STRUCTURE OF NXG1-DELTAYNIIG IN COMPLEX WITH XLLG, A XYLOGLUCAN DERIVED OLIGOSACCHARIDE","10.1002/PROT.22291 ",2.1,14.71,"2vh9_oligo1","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpx1-","GAL(3_F_)-XYS(2_F_)-[GAL(3_G_)-XYS(2_G_)-[XYS(2_H_)-BGC(1_H_)]-BGC(1_G_)]-BGC(1_F_)",18.4704,"","",""
"2VJJ","TAILSPIKE PROTEIN OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1111/J.1365-2958.2008.06311.X ",1.59,8.74,"2vjj_oligo2","LRhapa1-6DGlcpa1-ROH","RAM(4_B_)-GLC(3_B_)-GAL(2_B_)",10.875,"","",""
"2VUO","CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT","10.1042/BJ20081355 ",1.95,26.63,"2vuo_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",40.3597,"","",""
"2VUO","CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT","10.1042/BJ20081355 ",1.95,26.63,"2vuo_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",42.0043,"","",""
"2VUZ","CRYSTAL STRUCTURE OF CODAKINE IN COMPLEX WITH BIANTENNARY NONASACCHARIDE AT 1.7A RESOLUTION","10.1074/JBC.M804353200 ",1.7,18.48,"2vuz_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",34.3566,"","",""
"2VX6","CELLVIBRIO JAPONICUS MANNANASE CJMAN26C GAL1MAN4-BOUND FORM","10.1074/JBC.M804053200 ",1.57,9.17,"2vx6_oligo1","DManpb1-4[DGalpa1-6]DManpb1-4DManpb1-4DManpb1-ROH","GLA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-BMA(2_B_)-BMA(1_B_)",25.782,"","",""
"2W52","2 BETA-GLUCANS (6-O-GLUCOSYL-LAMINARITRIOSE) IN BOTH DONOR AND ACCEPTOR SITES OF GH16 LAMINARINASE 16A FROM PHANEROCHAETE CHRYSOSPORIUM.","10.1111/J.1742-4658.2009.07099.X ",1.56,12.69,"2w52_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(43_A_)",32.4496,"","",""
"2WAH","CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)","10.1016/J.JMB.2009.02.033 ",2.51,19.57,"2wah_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",73.1347,"","",""
"2WBJ","TCR COMPLEX","10.1016/J.IMMUNI.2009.01.009 ",3,64.11,"2wbj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(118_E_)",84.2891,"","",""
"2WFZ","NON-AGED CONJUGATE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE WITH SOMAN","10.1021/JM900433T ",1.95,31.37,"2wfz_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(59_A_)",69.8659,"","",""
"2WG1","TERNARY COMPLEX OF THE AGED CONJUGATE OF TORPEDO CALIFORNICA ACEYLCHOLINESTERASE WITH SOMAN AND 2-PAM","10.1021/JM900433T ",2.2,31.19,"2wg1_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",75.31,"","",""
"2WG2","NON-AGED CONJUGATE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE WITH SOMAN (ALTERNATIVE REFINEMENT)","10.1021/JM900433T ",1.95,31.37,"2wg2_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",69.8964,"","",""
"2WII","COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4","10.1038/NI.1755 ",2.7,68.2,"2wii_oligo1","DManpb1-6DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(63_A_)",134.842,"","",""
"2WIL","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","10.1042/BJ20090091 ",3.1,73.73,"2wil_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(341_B_)",103.564,"","",""
"2WIL","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","10.1042/BJ20090091 ",3.1,73.73,"2wil_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(241_B_)",117.873,"","",""
"2WIL","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","10.1042/BJ20090091 ",3.1,73.73,"2wil_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",104.068,"","",""
"2WIL","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","10.1042/BJ20090091 ",3.1,73.73,"2wil_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",118.812,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo12","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_b_)-[MAN(4_b_)]-MAN(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(260_K_)",223.247,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo3","DManpb1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_S_)-BMA(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(63_C_)",216.238,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo8","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(917_H_)",224.788,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo6","DManpb1-3[DManpb1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(6_V_)-[BMA(5_V_)]-BMA(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(917_F_)",219.747,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(63_E_)",217.541,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(917_D_)",206.402,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo7","DManpb1-6DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_W_)-BMA(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(63_G_)",225.702,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo2","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","BMA(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(917_B_)",210.553,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo1","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(63_A_)",205.398,"","",""
"2WKK","IDENTIFICATION OF THE GLYCAN TARGET OF THE NEMATOTOXIC FUNGAL GALECTIN CGL2 IN CAENORHABDITIS ELEGANS","10.1371/JOURNAL.PPAT.1000717 ",1.5,20.91,"2wkk_oligo1","DGalpb1-4LFucpa1-6DManp[2H]x1-","GAL(3_F_)-FUC(2_F_)-NAG(1_F_)",35.8135,"","",""
"2WKK","IDENTIFICATION OF THE GLYCAN TARGET OF THE NEMATOTOXIC FUNGAL GALECTIN CGL2 IN CAENORHABDITIS ELEGANS","10.1371/JOURNAL.PPAT.1000717 ",1.5,20.91,"2wkk_oligo3","DGalpb1-4LFucpa1-6DManp[2H]x1-","GAL(3_G_)-FUC(2_G_)-NAG(1_G_)",43.2321,"","",""
"2WLQ","NUCLEOPHILE-DISABLED LAM16A MUTANT HOLDS LAMINARIHEPTAOSE (L7) IN A CYCLICAL CONFORMATION","10.1021/JA909129B ",1.4,13,"2wlq_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(43_A_)",26.7853,"","",""
"2WN9","CRYSTAL STRUCTURE OF APLYSIA ACHBP IN COMPLEX WITH 4-0H-DMXBA","10.1038/EMBOJ.2009.227 ",1.75,32.43,"2wn9_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(74_A_)",47.5731,"","",""
"2WNE","MUTANT LAMINARINASE 16A CYCLIZES LAMINARIHEPTAOSE","10.1021/JA909129B ",2.12,13.02,"2wne_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(43_A_)",36.013,"","",""
"2WQR","THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC","10.1038/NSMB.2044 ",1.9,47.98,"2wqr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",104.66,"","",""
"2WQR","THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC","10.1038/NSMB.2044 ",1.9,47.98,"2wqr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",70.128,"","",""
"2WRA","BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA COMPLEXED WITH AMAN1(AMAN1- 6)-3MAN TRISACCHARIDE","10.1093/GLYCOB/CWP151 ",1.1,10.22,"2wra_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_B_)-[MAN(2_B_)]-MAN(1_B_)",11.7848,"","",""
"2WSL","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4","10.1042/BJ20090091 ",2,27.9,"2wsl_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",58.8558,"","",""
"2WSL","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4","10.1042/BJ20090091 ",2,27.9,"2wsl_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(106_A_)",33.1536,"","",""
"2WXD","A MICROMOLAR O-SULFATED THIOHYDROXIMATE INHIBITOR BOUND TO PLANT MYROSINASE","10.1107/S1744309109052865 ",1.6,12.44,"2wxd_oligo6","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_D_)-[MAN(5_D_)]-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(7_D_)]-NAG(1_D_)",31.0797,"","",""
"2X6W","TAILSPIKE PROTEIN MUTANT E372Q OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1093/GLYCOB/CWS126 ",1.35,10.63,"2x6w_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(4_B_)-[RAM(6_B_)-GLC(5_B_)-[NAG(7_B_)]-GLA(2_B_)]-NDG(1_B_)",13.0438,"","",""
"2X6X","TAILSPIKE PROTEIN MUTANT D339N OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1093/GLYCOB/CWS126 ",1.48,17.49,"2x6x_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-ROH","RAM(3_B_)-GLC(2_B_)-[NAG(4_B_)]-GLA(1_B_)",24.0114,"","",""
"2X6Y","TAILSPIKE PROTEIN MUTANT D339A OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1093/GLYCOB/CWS126 ",1.35,13.8,"2x6y_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAcb1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NAG(1_B_)",12.2433,"","",""
"2X72","CRYSTAL STRUCTURE OF THE CONSTITUTIVELY ACTIVE E113Q,D2C,D282C RHODOPSIN MUTANT WITH BOUND GALPHACT PEPTIDE.","10.1038/NATURE09795 ",3,80.4,"2x72_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",83.7405,"","",""
"2X85","TAILSPIKE PROTEIN OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1093/GLYCOB/CWS126 ",1.5,14.9,"2x85_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAcb1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NAG(1_B_)",15.8244,"","",""
"2X8Y","CRYSTAL STRUCTURE OF ANCE","10.1016/J.JMB.2010.05.024 ",1.9,34.91,"2x8y_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",55.2003,"","",""
"2X8Z","CRYSTAL STRUCTURE OF ANCE-CAPTOPRIL COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,30.9,"2x8z_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",50.0815,"","",""
"2X90","CRYSTAL STRUCTURE OF ANCE-ENALAPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,27.66,"2x90_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.6505,"","",""
"2X91","CRYSTAL STRUCTURE OF ANCE-LISINOPRIL COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,29.73,"2x91_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.837,"","",""
"2X92","CRYSTAL STRUCTURE OF ANCE-RAMIPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",2.11,22.46,"2x92_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",37.793,"","",""
"2X93","CRYSTAL STRUCTURE OF ANCE-TRANDOLAPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,25.7,"2x93_oligo3","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",45.6244,"","",""
"2X94","CRYSTAL STRUCTURE OF ANCE-PERINDOPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.88,29.53,"2x94_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",46.5421,"","",""
"2X95","CRYSTAL STRUCTURE OF ANCE-LISINOPRIL-TRYPTOPHAN ANALOGUE, LISW-S COMPLEX","10.1016/J.JMB.2010.05.024 ",1.96,28.5,"2x95_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",48.0124,"","",""
"2X96","CRYSTAL STRUCTURE OF ANCE-RXPA380 COMPLEX","10.1016/J.JMB.2010.05.024 ",1.85,29.84,"2x96_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",50.0386,"","",""
"2X97","CRYSTAL STRUCTURE OF ANCE-RXP407 COMPLEX","10.1016/J.JMB.2010.05.024 ",1.85,28.46,"2x97_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.8682,"","",""
"2XHM","CRYSTAL STRUCTURE OF ANCE-K26 COMPLEX","10.1016/J.BBRC.2010.06.113 ",1.96,32.74,"2xhm_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.447,"","",""
"2XJR","X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF THE FLOCCULIN FLO5 FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH CALCIUM AND MAN5(D2-D3)","10.1073/PNAS.1013210108 ",1.25,10.39,"2xjr_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(4_B_)-[MAN(3_B_)-MAN(2_B_)]-MAN(1_B_)",22.6868,"","",""
"2XMD","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ECHOTHIOPHATE","10.1042/BJ20101648 ",2.3,40.08,"2xmd_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",63.9164,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo9","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(299_C_)",36.2789,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo11","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(299_E_)",42.0606,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo13","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(299_G_)",34.5776,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo15","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(299_I_)",32.8621,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo7","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(299_A_)",32.0432,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo17","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(299_K_)",35.6364,"","",""
"2XUI","CRYSTAL STRUCTURE OF MACHE-Y337A-TZ2PA6 SYN COMPLEX (1 WK)","10.1021/JA106820E ",2.6,58.94,"2xui_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",91.7268,"","",""
"2XWT","CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY","10.1530/JME-10-0127 ",1.9,16.89,"2xwt_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(198_C_)",46.79,"","",""
"2XXL","CRYSTAL STRUCTURE OF DROSOPHILA GRASS CLIP SERINE PROTEASE OF TOLL PATHWAY","10.1074/JBC.M110.182741 ",1.8,20.2,"2xxl_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(230_A_)",25.1973,"","",""
"2XXL","CRYSTAL STRUCTURE OF DROSOPHILA GRASS CLIP SERINE PROTEASE OF TOLL PATHWAY","10.1074/JBC.M110.182741 ",1.8,20.2,"2xxl_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(270_B_)",45.7802,"","",""
"2XXL","CRYSTAL STRUCTURE OF DROSOPHILA GRASS CLIP SERINE PROTEASE OF TOLL PATHWAY","10.1074/JBC.M110.182741 ",1.8,20.2,"2xxl_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(230_B_)",25.1609,"","",""
"2XY9","HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE","10.1042/BJ20102123 ",1.97,21.94,"2xy9_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",48.6943,"","",""
"2XYB","CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS","",1.75,32.75,"2xyb_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",51.8725,"","",""
"2XYD","HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE","10.1042/BJ20102123 ",2.15,36.88,"2xyd_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",56.9577,"","",""
"2XYD","HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE","10.1042/BJ20102123 ",2.15,36.88,"2xyd_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(416_A_)",60.3984,"","",""
"2XYD","HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE","10.1042/BJ20102123 ",2.15,36.88,"2xyd_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_B_)",59.9059,"","",""
"2Y1K","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT","10.1021/TX100447K ",2.5,61.36,"2y1k_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(341_A_)",69.3236,"","",""
"2YB7","CBM62 IN COMPLEX WITH 6-ALPHA-D-GALACTOSYL-MANNOTRIOSE","10.1074/JBC.M110.217372 ",1.7,19.91,"2yb7_oligo1","DGalpa1-6DManpb1-ROH","GLA(2_C_)-BMA(1_C_)",41.0905,"","",""
"2YB7","CBM62 IN COMPLEX WITH 6-ALPHA-D-GALACTOSYL-MANNOTRIOSE","10.1074/JBC.M110.217372 ",1.7,19.91,"2yb7_oligo2","DGalpa1-6DManpb1-ROH","GLA(2_D_)-BMA(1_D_)",40.0527,"","",""
"2YFZ","CBM62 FROM CLOSTRIDIUM THERMOCELLUM XYL5A","10.1074/JBC.M110.217372 ",1.8,14.91,"2yfz_oligo1","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-4DGlcpb1-ROH","GAL(4_B_)-XYS(3_B_)-[BGC(5_B_)]-BGC(2_B_)-BGC(1_B_)",36.6665,"","",""
"2YG0","CBM62 FROM CLOSTRIDIUM THERMOCELLUM XYL5A","10.1074/JBC.M110.217372 ",1.8,17.72,"2yg0_oligo1","DGalpa1-6DManpb1-ROH","GLA(2_B_)-BMA(1_B_)",36.3127,"","",""
"2YIH","STRUCTURE OF A PAENIBACILLUS POLYMYXA XYLOGLUCANASE FROM GH FAMILY 44 WITH XYLOGLUCAN","10.1074/JBC.M111.262345 ",1.7,14.14,"2yih_oligo1","[DXylpa1-6]DGlcpb1-4DGlcpb1-4DGlcpb1-4DGlcpb1-ROH","XYS(6_B_)-BGC(5_B_)]-BGC(4_B_)-BGC(3_B_)-BGC(2_B_)-BGC(1_B_)",29.0525,"","",""
"2YOR","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.19,23.29,"2yor_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_B_)",45.1475,"","",""
"2YOR","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.19,23.29,"2yor_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(161_A_)",66.012,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo9","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(161_A_)",59.1098,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo8","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-[MAN(7_M_)]-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(286_B_)",38.5319,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_A_)",54.2694,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-[MAN(7_H_)]-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(286_A_)",52.0392,"","",""
"2YPJ","NON-CATALYTIC CARBOHYDRATE BINDING MODULE CBM65B","10.1074/JBC.M112.432781 ",2.35,49.06,"2ypj_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",47.424,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo1","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_C_)-MAN(2_C_)-GLC(1_C_)-L2P(280_A_)",109.437,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo4","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_H_)-MAN(2_H_)-GLC(1_H_)-L2P(280_E_)",108.897,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo2","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_F_)-MAN(2_F_)-GLC(1_F_)-L2P(280_B_)",106.962,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo3","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_G_)-MAN(2_G_)-GLC(1_G_)-L2P(280_D_)",107.053,"","",""
"2Z7F","CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN NEUTROPHIL ELASTASE WITH 1/2SLPI","10.1107/S0909049507060670 ",1.7,20.88,"2z7f_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(109_E_)",26.0523,"","",""
"2Z7F","CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN NEUTROPHIL ELASTASE WITH 1/2SLPI","10.1107/S0909049507060670 ",1.7,20.88,"2z7f_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(159_E_)",23.8077,"","",""
"2Z8G","ASPERGILLUS NIGER ATCC9642 ISOPULLULANASE COMPLEXED WITH ISOPANOSE","10.1016/J.JMB.2007.11.098 ",1.7,21.1,"2z8g_oligo1","DGlcpa1-4DGlcpa1-6DGlcpb1-ROH","GLC(3_C_)-GLC(2_C_)-BGC(1_C_)",22.2312,"","",""
"2Z8G","ASPERGILLUS NIGER ATCC9642 ISOPULLULANASE COMPLEXED WITH ISOPANOSE","10.1016/J.JMB.2007.11.098 ",1.7,21.1,"2z8g_oligo2","DGlcpa1-4DGlcpa1-6DGlcpb1-ROH","GLC(3_D_)-GLC(2_D_)-BGC(1_D_)",26.8836,"","",""
"2ZFE","CRYSTAL STRUCTURE OF BACTERIORHODOPSIN-XENON COMPLEX","10.1016/J.JMB.2008.09.075 ",2.5,53.6,"2zfe_oligo1","DGalp[3S]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",98.7785,"","",""
"2ZID","CRYSTAL STRUCTURE OF DEXTRAN GLUCOSIDASE E236Q COMPLEX WITH ISOMALTOTRIOSE","10.1016/J.JMB.2008.03.016 ",2.2,13.9,"2zid_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",23.2433,"","",""
"2ZMB","CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH PARECOXIB AT 2.9 A RESOLUTION","",2.9,46.9,"2zmb_oligo1","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BGC(5_B_)-[MAN(4_B_)]-BGC(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",77.5238,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo1","DGalpa1-6DGlcpb1-ROH","GLA(2_M_)-BGC(1_M_)",53.2809,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo4","DGalpa1-6DGlcpb1-ROH","GLA(2_J_)-BGC(1_J_)",32.6032,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo3","DGalpa1-6DGlcpb1-ROH","GLA(2_G_)-BGC(1_G_)",51.5595,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo5","DGalpa1-6DGlcpb1-ROH","GLA(2_O_)-BGC(1_O_)",61.0577,"","",""
"2ZX3","RHAMNOSE-BINDING LECTIN CSL3","10.1016/J.JMB.2009.06.027 ",2.1,17.66,"2zx3_oligo1","DGalpa1-6DGlcpb1-ROH","GLA(2_F_)-BGC(1_F_)",30.4927,"","",""
"2ZX3","RHAMNOSE-BINDING LECTIN CSL3","10.1016/J.JMB.2009.06.027 ",2.1,17.66,"2zx3_oligo2","DGalpa1-6DGlcpb1-ROH","GLA(2_E_)-BGC(1_E_)",25.8991,"","",""
"2ZX3","RHAMNOSE-BINDING LECTIN CSL3","10.1016/J.JMB.2009.06.027 ",2.1,17.66,"2zx3_oligo3","DGalpa1-6DGlcpb1-ROH","GLA(2_D_)-BGC(1_D_)",26.0232,"","",""
"2ZX3","RHAMNOSE-BINDING LECTIN CSL3","10.1016/J.JMB.2009.06.027 ",2.1,17.66,"2zx3_oligo4","DGalpa1-6DGlcpb1-ROH","GLA(2_C_)-BGC(1_C_)",22.67,"","",""
"2ZZL","STRUCTURE OF BACTERIORHODOPSIN'S M INTERMEDIATE AT PH 7","10.1016/J.JMB.2009.08.047 ",2.03,41.47,"2zzl_oligo1","DGalp[3<R1>]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",52.4455,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo10","DGalpa1-6DGalpb1-C39O5","DGD(1056_C_)-DGD(1056_C_)",175.53,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo7","DGalpa1-6DGalpb1-C39O5","DGD(6056_c_)-DGD(6056_c_)",180.31,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo13","DGalpa1-6DGalpb1-C39O5","DGD(6058_h_)-DGD(6058_h_)",159.235,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo5","DGalpa1-6DGalpb1-C39O5","DGD(1055_C_)-DGD(1055_C_)",142.706,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(6055_c_)-DGD(6055_c_)",159.393,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo11","DGalpa1-6DGalpb1-C39O5","DGD(1057_C_)-DGD(1057_C_)",131.189,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo4","DGalpa1-6DGalpb1-C39O5","DGD(1058_H_)-DGD(1058_H_)",160.2,"","",""
"3A0B","CRYSTAL STRUCTURE OF BR-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",3.7,167.2,"3a0b_oligo8","DGalpa1-6DGalpb1-C39O5","DGD(6057_c_)-DGD(6057_c_)",133.017,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo12","DGalpa1-6DGalpb1-C39O5","DGD(6057_c_)-DGD(6057_c_)",182.259,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo7","DGalpa1-6DGalpb1-C39O5","DGD(1058_B_)-DGD(1058_B_)",192.733,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo9","DGalpa1-6DGalpb1-C39O5","DGD(6056_c_)-DGD(6056_c_)",206.456,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo15","DGalpa1-6DGalpb1-C39O5","DGD(1056_C_)-DGD(1056_C_)",206.456,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo11","DGalpa1-6DGalpb1-C39O5","DGD(6058_b_)-DGD(6058_b_)",192.733,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo16","DGalpa1-6DGalpb1-C39O5","DGD(1055_C_)-DGD(1055_C_)",191.513,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo5","DGalpa1-6DGalpb1-C39O5","DGD(1057_C_)-DGD(1057_C_)",182.259,"","",""
"3A0H","CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX","10.1073/PNAS.0812797106 ",4,164.4,"3a0h_oligo4","DGalpa1-6DGalpb1-C39O5","DGD(6055_c_)-DGD(6055_c_)",191.513,"","",""
"3A5V","CRYSTAL STRUCTURE OF ALPHA-GALACTOSIDASE I FROM MORTIERELLA VINACEA","10.1271/BBB.90604 ",2,18.99,"3a5v_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(155_A_)",45.0086,"","",""
"3ABG","X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL","10.1107/S1744309110018828 ",2.3,41.28,"3abg_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(472_B_)",54.8151,"","",""
"3AGV","CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX","10.1093/NAR/GKQ615 ",2.15,54.6,"3agv_oligo12","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ROH","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)",80.3653,"","",""
"3AGV","CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX","10.1093/NAR/GKQ615 ",2.15,54.6,"3agv_oligo11","DGalpa1-4DGlcpNAca1-2DManpa1-6DManpa1-ROH","GLA(4_C_)-NDG(3_C_)-MAN(2_C_)-MAN(1_C_)",110.018,"","",""
"3AIH","HUMAN OS-9 MRH DOMAIN COMPLEXED WITH ALPHA3,ALPHA6-MAN5","10.1016/J.MOLCEL.2010.11.017 ",2.1,31.26,"3aih_oligo1","DManpa1-6DManpa1-6DManpb1-ROH","MAN(3_C_)-MAN(2_C_)-BMA(1_C_)",54.5236,"","",""
"3AIH","HUMAN OS-9 MRH DOMAIN COMPLEXED WITH ALPHA3,ALPHA6-MAN5","10.1016/J.MOLCEL.2010.11.017 ",2.1,31.26,"3aih_oligo2","DManpa1-6DManpa1-6DManpb1-ROH","MAN(3_D_)-MAN(2_D_)-BMA(1_D_)",54.8748,"","",""
"3AL8","PLEXIN A2 / SEMAPHORIN 6A COMPLEX","10.1038/NATURE09473 ",3.6,99.66,"3al8_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(327_B_)",106.743,"","",""
"3ALA","CRYSTAL STRUCTURE OF VASCULAR ADHESION PROTEIN-1 IN SPACE GROUP C2","10.1107/S1744309110041515 ",2.9,40.04,"3ala_oligo20","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_a_)-NAG(1_a_)-ASN(592_G_)",71.625,"","",""
"3ALA","CRYSTAL STRUCTURE OF VASCULAR ADHESION PROTEIN-1 IN SPACE GROUP C2","10.1107/S1744309110041515 ",2.9,40.04,"3ala_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUL(2_O_)-NAG(1_O_)-ASN(592_C_)",35.0223,"","",""
"3ALT","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH MELIBIOSE","10.1074/JBC.M110.200576 ",2.5,34.88,"3alt_oligo3","DGalpa1-6DGlcpa1-ROH","GLA(2_G_)-GLC(1_G_)",43.2691,"","",""
"3ALT","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH MELIBIOSE","10.1074/JBC.M110.200576 ",2.5,34.88,"3alt_oligo4","DGalpa1-6DGlcpa1-ROH","GLA(2_H_)-GLC(1_H_)",43.0841,"","",""
"3ALT","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH MELIBIOSE","10.1074/JBC.M110.200576 ",2.5,34.88,"3alt_oligo2","DGalpa1-6DGlcpa1-ROH","GLA(2_E_)-GLC(1_E_)",43.1368,"","",""
"3ALT","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH MELIBIOSE","10.1074/JBC.M110.200576 ",2.5,34.88,"3alt_oligo1","DGalpa1-6DGlcpa1-ROH","GLA(2_F_)-GLC(1_F_)",43.0518,"","",""
"3ALU","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE","10.1074/JBC.M110.200576 ",1.65,20.38,"3alu_oligo3","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_G_)-GLC(2_G_)-FRU(1_G_)",19.3959,"","",""
"3ALU","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE","10.1074/JBC.M110.200576 ",1.65,20.38,"3alu_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_E_)-GLC(2_E_)-FRU(1_E_)",35.4607,"","",""
"3ALU","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE","10.1074/JBC.M110.200576 ",1.65,20.38,"3alu_oligo4","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_H_)-GLC(2_H_)-FRU(1_H_)",29.5109,"","",""
"3ALU","CRYSTAL STRUCTURE OF CEL-IV COMPLEXED WITH RAFFINOSE","10.1074/JBC.M110.200576 ",1.65,20.38,"3alu_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_F_)-GLC(2_F_)-FRU(1_F_)",18.8138,"","",""
"3AU1","CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3","10.1016/J.IMMUNI.2011.01.013 ",2.5,54.64,"3au1_oligo3","DManpa1-3[DManpb1-6]DGlcpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[BMA(5_D_)-[MAN(4_D_)]-GLC(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",33.8345,"","",""
"3AVE","CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2011.03.031 ",2,41.11,"3ave_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",69.476,"","",""
"3AVE","CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2011.03.031 ",2,41.11,"3ave_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",50.4686,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",48.3941,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",49.5257,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(162_C_)",75.4793,"","",""
"3B2D","CRYSTAL STRUCTURE OF HUMAN RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",2.8,47.5,"3b2d_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(402_A_)",38.3844,"","",""
"3B2D","CRYSTAL STRUCTURE OF HUMAN RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",2.8,47.5,"3b2d_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-[MAN(7_G_)]-MAN(4_G_)-[MAN(8_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(402_B_)",31.7182,"","",""
"3B9F","1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX","10.1073/PNAS.0711055105 ",1.6,30.2,"3b9f_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(60_H_)",60.9018,"","",""
"3BKK","TESIS ACE CO-CRYSTAL STRUCTURE WITH KETONE ACE INHIBITOR KAF","10.1021/BI8002605 ",2.17,22.8,"3bkk_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",42.3358,"","",""
"3BKL","TESTIS ACE CO-CRYSTAL STRUCTURE WITH KETONE ACE INHIBITOR KAW","10.1021/BI8002605 ",2.18,21.6,"3bkl_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",48.8182,"","",""
"3BL8","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF NEUROLIGIN 2A FROM MOUSE","10.1073/PNAS.0711701105 ",3.3,126.2,"3bl8_oligo2","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(98_B_)",100.434,"","",""
"3BPL","CRYSTAL STRUCTURE OF THE IL4-IL4R-COMMON GAMMA TERNARY COMPLEX","10.1016/J.CELL.2007.12.030 ",2.93,38.19,"3bpl_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(184_B_)",78.5248,"","",""
"3BVH","CRYSTAL STRUCTURE OF RECOMBINANT GAMMAD364A FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGAND GLY-PRO-ARG-PRO-AMIDE","10.1021/BI8000769 ",2.6,37.3,"3bvh_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(364_B_)",61.0127,"","",""
"3BVU","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL(ALPHA-D-MANNOPYRANOSYL)-(1->3)-S-[(ALPHA-D-MANNOPYRANOSYL)-(1- >6)]-ALPHA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.12,"1.15243e-41","3bvu_oligo1","DManpa1-3[DManpa1-6]DManp[3<R1>]a1-OME","MAN(3_B_)-[MAN(2_B_)-",14.4573,"","",""
"3BVV","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL ALPHA-D-MANNOPYRANOSYL-(1->3)-[6-THIO-ALPHA-D-MANNOPYRANOSYL- (1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.3,16.37,"3bvv_oligo1","DManpa1-3[DLyxpa1-6]DManpb1-OME","Z4Y(3_B_)-[MAN(2_B_)]-YZ0(1_B_)",15.8924,"","",""
"3BVW","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL (2-DEOXY-2-ACETAMIDO-BETA-D-GLUCOPYRANOSYL)-(1->2)-ALPHA-D- MANNOPYRANOSYL- (1->3)-[ALPHA-D-MANNOPYRANOSYL-(1->6)-6-THIO-ALPHA-D- MANNOPYRANOSYL- (1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.2,"1.15243e-41","3bvw_oligo1","DGlcpNAcb1-2DManpa1-3[DLyxpa1-6]DManpb1-OME","Z4Y(4_B_)-[NAG(3_B_)-MAN(2_B_)]-YZ0(1_B_)",38.1853,"","",""
"3BVX","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL (2-DEOXY-2-ACETAMIDO-BETA-D-GLUCOPYRANOSYL)-(1->2)-(ALPHA-D- MANNOPYRANOSYL)- (1->3)-[(ALPHA-D-MANNOPYRANOSYL)-(1->6)-(ALPHA-D- MANNOPYRANOSYL)-(1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.1,0,"3bvx_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-OME","MAN(5_B_)-MAN(4_B_)-[NAG(3_B_)-MAN(2_B_)]-YZ0(1_B_)",31.9624,"","",""
"3BWH","ATOMIC RESOLUTION STRUCTURE OF CUCURMOSIN, A NOVEL TYPE 1 RIP FROM THE SARCOCARP OF CUCURBITA MOSCHATA","10.1016/J.JSB.2008.06.011 ",1,9.72,"3bwh_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",49.1578,"","",""
"3BYN","CRYSTAL STRUCTURE OF B. SUBTILIS LEVANSUCRASE MUTANT E342A BOUND TO RAFFINOSE","",2.1,15.24,"3byn_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_B_)-GLC(2_B_)-FRU(1_B_)",13.8835,"","",""
"3C2S","STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS","10.1107/S0907444908007877 ",2.3,43.32,"3c2s_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",71.3893,"","",""
"3C5X","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN- ENVELOPE PROTEIN HETERODIMER FROM THE DENGUE 2 VIRUS AT LOW PH","10.1126/SCIENCE.1153263 ",2.2,0,"3c5x_oligo2","DManpa1-3[DManpb1-6]DAltpa1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_D_)-[BMA(4_D_)]-SHD(3_D_)-NAG(2_D_)-NAG(1_D_)",115.248,"","",""
"3CA0","SAMBUCUS NIGRA AGGLUTININ II (SNA-II), HEXAGONAL CRYSTAL FORM","10.1002/PROT.22222 ",1.95,41.66,"3ca0_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(63_A_)",53.8283,"","",""
"3CDZ","CRYSTAL STRUCTURE OF HUMAN FACTOR VIII","10.1016/J.STR.2008.03.001 ",3.98,199.2,"3cdz_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcx1-","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-NAG(1_D_)",258.64,"","",""
"3CFW","L-SELECTIN LECTIN AND EGF DOMAINS","10.1074/JBC.M116.767186 ",2.2,34.9,"3cfw_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(66_A_)",38.8387,"","",""
"3CIG","CRYSTAL STRUCTURE OF MOUSE TLR3 ECTODOMAIN","10.1126/SCIENCE.1155406 ",2.66,64.69,"3cig_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(5_F_)-[BMA(4_F_)]-MAN(3_F_)-NDG(2_F_)-NAG(1_F_)-ASN(413_A_)",100.949,"","",""
"3CIY","MOUSE TOLL-LIKE RECEPTOR 3 ECTODOMAIN COMPLEXED WITH DOUBLE-STRANDED RNA","10.1126/SCIENCE.1155406 ",3.41,154.3,"3ciy_oligo109","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(413_A_)",173.161,"","",""
"3CIY","MOUSE TOLL-LIKE RECEPTOR 3 ECTODOMAIN COMPLEXED WITH DOUBLE-STRANDED RNA","10.1126/SCIENCE.1155406 ",3.41,154.3,"3ciy_oligo78","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(5_P_)-[MAN(4_P_)]-MAN(3_P_)-NDG(2_P_)-NAG(1_P_)-ASN(413_B_)",174.139,"","",""
"3CIY","MOUSE TOLL-LIKE RECEPTOR 3 ECTODOMAIN COMPLEXED WITH DOUBLE-STRANDED RNA","10.1126/SCIENCE.1155406 ",3.41,154.3,"3ciy_oligo107","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(291_A_)",181.578,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",129.284,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",125.824,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_T_)-[NAG(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",138.302,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_X_)-[NAG(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",142.661,"","",""
"3CV5","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH 3ALPHA,6ALPHA-MANNOPENTAOSE","10.1073/PNAS.0802206105 ",1.6,16.8,"3cv5_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-[MAN(5_B_)]-BMA(1_B_)",29.4238,"","",""
"3CY4","CRYSTAL STRUCTURE CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR AT PH 7.4","10.1074/JBC.M708994200 ",1.51,14.03,"3cy4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(81_B_)",25.1838,"","",""
"3CY4","CRYSTAL STRUCTURE CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR AT PH 7.4","10.1074/JBC.M708994200 ",1.51,14.03,"3cy4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(81_A_)",13.6535,"","",""
"3CZN","GOLGI ALPHA-MANNOSIDASE II (D204A NUCLEOPHILE MUTANT) IN COMPLEX WITH GNMAN5GN","10.1073/PNAS.0802206105 ",1.4,17.67,"3czn_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAca1-ROH","MAN(7_B_)-[MAN(6_B_)]-MAN(5_B_)-[NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NDG(1_B_)",18.7778,"","",""
"3D11","CRYSTAL STRUCTURES OF THE NIPAH G ATTACHMENT GLYCOPROTEIN","10.1073/PNAS.0804797105 ",2.31,42.51,"3d11_oligo1","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(306_A_)",46.7891,"","",""
"3D12","CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3","10.1073/PNAS.0804797105 ",3.01,69.13,"3d12_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(306_A_)",78.3029,"","",""
"3D12","CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3","10.1073/PNAS.0804797105 ",3.01,69.13,"3d12_oligo1","DGlcpb1-3[LGlcpa1-6]DGulpa1-4LGalpNAcb1-4[LGlcpa1-6][LIdopa1-3]DIdopNAca1-ASN","GLC(7_F_)-[GLC(5_F_)-[BGC(4_F_)]-GL0(3_F_)-NGA(2_F_)]-[BGC(6_F_)]-LXZ(1_F_)-ASN(529_A_)",86.7593,"","",""
"3D12","CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3","10.1073/PNAS.0804797105 ",3.01,69.13,"3d12_oligo3","DGlcpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[BGC(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(306_D_)",105.676,"","",""
"3D12","CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3","10.1073/PNAS.0804797105 ",3.01,69.13,"3d12_oligo4","DGlcpb1-3[LGlcpa1-6]DGulpa1-4LGlcpNAcb1-4[LGlcpa1-6][LIdopa1-3]DGulpNAcb1-ASN","GXL(7_I_)-[GLC(5_I_)-[BGC(4_I_)]-GL0(3_I_)-NGZ(2_I_)]-[BGC(6_I_)]-LXB(1_I_)-ASN(529_D_)",96.8656,"","",""
"3D6G","FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.","10.1021/JP909405B ",2.3,72.42,"3d6g_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",68.4889,"","",""
"3D6G","FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.","10.1021/JP909405B ",2.3,72.42,"3d6g_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",71.969,"","",""
"3DGC","STRUCTURE OF IL-22/IL-22R1","10.1016/J.STR.2008.06.005 ",2.5,0,"3dgc_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_A_)-[MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(172_R_)",84.6366,"","",""
"3DKH","L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE","10.1111/J.1742-4658.2009.07336.X ",2.4,21.12,"3dkh_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",33.855,"","",""
"3DNI","CRYSTALLOGRAPHIC REFINEMENT AND STRUCTURE OF DNASE I AT 2 ANGSTROMS RESOLUTION","10.1016/0022-2836(86)90280-9 ",2,0,"3dni_oligo1","DGalpa1-6DManpb1-3[DManpb1-6DAltpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_B_)-MAN(6_B_)-[GLA(5_B_)-BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(18_A_)",57.589,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",74.4228,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.7868,"","",""
"3E0G","STRUCTURE OF THE LEUKEMIA INHIBITORY FACTOR RECEPTOR (LIF-R) DOMAINS D1-D5","10.1016/J.MOLCEL.2008.08.011 ",3.1,94.34,"3e0g_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(252_A_)",100.541,"","",""
"3EQA","CATALYTIC DOMAIN OF GLUCOAMYLASE FROM ASPERGILLUS NIGER COMPLEXED WITH TRIS AND GLYCEROL","10.1107/S1744309110049390 ",1.9,17.86,"3eqa_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(419_A_)",38.7802,"","",""
"3EVJ","INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE","",3,64.2,"3evj_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_L_)",79.4464,"","",""
"3F9P","CRYSTAL STRUCTURE OF MYELOPEROXIDASE FROM HUMAN LEUKOCYTES","10.1074/JBC.M109.002154 ",2.93,67.16,"3f9p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",66.6189,"","",""
"3F9P","CRYSTAL STRUCTURE OF MYELOPEROXIDASE FROM HUMAN LEUKOCYTES","10.1074/JBC.M109.002154 ",2.93,67.16,"3f9p_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",65.6962,"","",""
"3FBY","THE CRYSTAL STRUCTURE OF THE SIGNATURE DOMAIN OF CARTILAGE OLIGOMERIC MATRIX PROTEIN.","10.1096/FJ.08-128090 ",3.15,55.48,"3fby_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(742_A_)",86.69,"","",""
"3FBY","THE CRYSTAL STRUCTURE OF THE SIGNATURE DOMAIN OF CARTILAGE OLIGOMERIC MATRIX PROTEIN.","10.1096/FJ.08-128090 ",3.15,55.48,"3fby_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(742_C_)",85.288,"","",""
"3FCU","STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION","10.1016/J.MOLCEL.2008.11.018 ",2.9,60.2,"3fcu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",109.916,"","",""
"3FCU","STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION","10.1016/J.MOLCEL.2008.11.018 ",2.9,60.2,"3fcu_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(320_F_)",109.861,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo3","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_G_)-[MAN(2_G_)]-BMA(1_G_)-NGT(625_D_)",20,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo4","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_H_)-[MAN(2_H_)]-BMA(1_H_)-NGT(625_F_)",20,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo1","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_C_)-[MAN(2_C_)]-BMA(1_C_)-NGT(625_A_)",20,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo2","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_E_)-[MAN(2_E_)]-BMA(1_E_)-NGT(625_B_)",20,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.0298,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",107.811,"","",""
"3FPX","NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA","",1.8,31.28,"3fpx_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",41.1664,"","",""
"3FRU","NEONATAL FC RECEPTOR, PH 6.5","10.1016/S0969-2126(98)00008-2 ",2.2,51.6,"3fru_oligo2","DGalpb1-4DGlcpNAca1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_H_)-[GAL(6_H_)-NDG(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(225_C_)",85.2953,"","",""
"3FRU","NEONATAL FC RECEPTOR, PH 6.5","10.1016/S0969-2126(98)00008-2 ",2.2,51.6,"3fru_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NDG(2_G_)]-NAG(1_G_)-ASN(225_A_)",75.6945,"","",""
"3FU7","MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 2,6- DIMETHOXYPHENOL","10.1016/J.JMB.2009.06.053 ",1.67,17.02,"3fu7_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(88_B_)",27.9309,"","",""
"3FU7","MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 2,6- DIMETHOXYPHENOL","10.1016/J.JMB.2009.06.053 ",1.67,17.02,"3fu7_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)",24.8039,"","",""
"3FU8","MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 2,6- DIMETHOXYPHENOL","10.1016/J.JMB.2009.06.053 ",1.8,19.71,"3fu8_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_H_)-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)",30.1233,"","",""
"3FU8","MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 2,6- DIMETHOXYPHENOL","10.1016/J.JMB.2009.06.053 ",1.8,19.71,"3fu8_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)",24.9825,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(475_A_)",180.282,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(243_A_)",122.215,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(277_A_)",128.633,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo3","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_H_)-[MAN(5_H_)-BMA(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(376_A_)",160.923,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo4","DManpb1-2DManpa1-2DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[BMA(6_I_)-MAN(5_I_)-BMA(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(459_A_)",134.506,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(478_A_)",150.871,"","",""
"3GDN","ALMOND HYDROXYNITRILE LYASE IN COMPLEX WITH BENZALDEHYDE","10.1021/BI802162S ",1.67,16.55,"3gdn_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(135_B_)",39.0134,"","",""
"3GDP","HYDROXYNITRILE LYASE FROM ALMOND, MONOCLINIC CRYSTAL FORM","10.1021/BI802162S ",1.57,15.64,"3gdp_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(135_B_)",36.2214,"","",""
"3GDP","HYDROXYNITRILE LYASE FROM ALMOND, MONOCLINIC CRYSTAL FORM","10.1021/BI802162S ",1.57,15.64,"3gdp_oligo3","DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-[FUL(5_C_)]-NAG(1_C_)-ASN(135_A_)",39.0736,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(364_H_)",101.151,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo2","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","SIA(11_V_)-GAL(10_V_)-NAG(9_V_)-MAN(8_V_)-[SIA(7_V_)-GAL(6_V_)-NAG(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(364_E_)",107.051,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo1","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","SIA(11_U_)-GAL(10_U_)-NAG(9_U_)-MAN(8_U_)-[SIA(7_U_)-GAL(6_U_)-NAG(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",105.172,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo4","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","SIA(11_X_)-GAL(10_X_)-NAG(9_X_)-MAN(8_X_)-[SIA(7_X_)-GAL(6_X_)-NAG(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",106.19,"","",""
"3GLY","REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100","10.1006/JMBI.1994.1316 ",2.2,0,"3gly_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",30.4481,"","",""
"3GML","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH","10.1016/J.JMB.2009.08.061 ",1.7,24.06,"3gml_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",40.6138,"","",""
"3GMM","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH","10.1016/J.JMB.2009.08.061 ",1.8,25.62,"3gmm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",44.478,"","",""
"3GMN","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH","10.1016/J.JMB.2009.08.061 ",1.7,27.15,"3gmn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",42.1379,"","",""
"3GMO","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF","10.1016/J.JMB.2009.08.061 ",1.6,22.25,"3gmo_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",36.1602,"","",""
"3GMP","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25","10.1016/J.JMB.2009.08.061 ",1.7,23.57,"3gmp_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",36.8029,"","",""
"3GMQ","STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED","10.1016/J.JMB.2009.08.061 ",1.8,29.23,"3gmq_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",49.5811,"","",""
"3GMR","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP","10.1016/J.JMB.2009.08.061 ",1.9,16.69,"3gmr_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",47.5094,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo1","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_G_)-MAN(11_G_)-[MAN(10_G_)-MAN(9_G_)]-MAN(8_G_)-[GLC(7_G_)-MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(196_A_)",58.8424,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo11","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_Q_)-MAN(11_Q_)-[MAN(10_Q_)-MAN(9_Q_)]-MAN(8_Q_)-[GLC(7_Q_)-MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(196_F_)",56.6375,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo3","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_I_)-MAN(11_I_)-[MAN(10_I_)-MAN(9_I_)]-MAN(8_I_)-[GLC(7_I_)-MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(196_B_)",58.4268,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo7","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_M_)-MAN(11_M_)-[MAN(10_M_)-MAN(9_M_)]-MAN(8_M_)-[GLC(7_M_)-MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(196_D_)",58.6183,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo9","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_O_)-MAN(11_O_)-[MAN(10_O_)-MAN(9_O_)]-MAN(8_O_)-[GLC(7_O_)-MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(196_E_)",58.6251,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo5","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_K_)-MAN(11_K_)-[MAN(10_K_)-MAN(9_K_)]-MAN(8_K_)-[GLC(7_K_)-MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(196_C_)",57.2404,"","",""
"3GXZ","CRYSTAL STRUCTURE OF CYANOVIRIN-N COMPLEXED TO OLIGOMANNOSE-9 (MAN-9)","10.1074/JBC.M205909200 ",2.5,66.73,"3gxz_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",104.599,"","",""
"3H32","CRYSTAL STRUCTURE OF D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH GLY-HIS- ARG-PRO-TYR-AMIDE","10.1021/BI900647G ",3.6,0,"3h32_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(364_B_)",110.818,"","",""
"3H32","CRYSTAL STRUCTURE OF D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH GLY-HIS- ARG-PRO-TYR-AMIDE","10.1021/BI900647G ",3.6,0,"3h32_oligo2","DNeup5Acb2-6DGalpb1-4DGlcpNAca1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(8_H_)-[SIA(7_H_)-GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(364_E_)",111.526,"","",""
"3H53","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1016/J.JMB.2009.08.021 ",2.01,29.36,"3h53_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(124_B_)",84.2524,"","",""
"3H53","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1016/J.JMB.2009.08.021 ",2.01,29.36,"3h53_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",70.3025,"","",""
"3H53","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1016/J.JMB.2009.08.021 ",2.01,29.36,"3h53_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(124_A_)",94.2864,"","",""
"3H53","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1016/J.JMB.2009.08.021 ",2.01,29.36,"3h53_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",60.8011,"","",""
"3H54","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE,COMPLEX WITH GALNAC","10.1016/J.JMB.2009.08.021 ",2.2,36.6,"3h54_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(124_B_)",105.144,"","",""
"3H54","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE,COMPLEX WITH GALNAC","10.1016/J.JMB.2009.08.021 ",2.2,36.6,"3h54_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",86.9193,"","",""
"3H54","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE,COMPLEX WITH GALNAC","10.1016/J.JMB.2009.08.021 ",2.2,36.6,"3h54_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(124_A_)",108.491,"","",""
"3H54","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE,COMPLEX WITH GALNAC","10.1016/J.JMB.2009.08.021 ",2.2,36.6,"3h54_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",77.492,"","",""
"3H55","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COMPLEX WITH GALACTOSE","10.1016/J.JMB.2009.08.021 ",1.91,24.91,"3h55_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",49.5211,"","",""
"3H55","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COMPLEX WITH GALACTOSE","10.1016/J.JMB.2009.08.021 ",1.91,24.91,"3h55_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(124_A_)",85.4459,"","",""
"3H55","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COMPLEX WITH GALACTOSE","10.1016/J.JMB.2009.08.021 ",1.91,24.91,"3h55_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(124_B_)",74.7385,"","",""
"3H55","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COMPLEX WITH GALACTOSE","10.1016/J.JMB.2009.08.021 ",1.91,24.91,"3h55_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",61.5936,"","",""
"3H9Y","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.23,37.9,"3h9y_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",87.0977,"","",""
"3H9Y","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.23,37.9,"3h9y_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_E_)",76.3102,"","",""
"3H9Y","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.23,37.9,"3h9y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",77.8044,"","",""
"3H9Z","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.45,31.78,"3h9z_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_B_)",67.1174,"","",""
"3H9Z","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.45,31.78,"3h9z_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_C_)",64.6785,"","",""
"3H9Z","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.45,31.78,"3h9z_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_D_)",68.784,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(394_B_)",97.9304,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_D_)",102.173,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(394_F_)",104.417,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_A_)",87.2578,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_E_)",110.381,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_C_)",97.2445,"","",""
"3HG2","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 1. EMPTY ACTIVE SITE","10.1074/JBC.M109.060145 ",2.3,36.47,"3hg2_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(139_A_)",68.5664,"","",""
"3HG3","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 2. SUBSTRATE BOUND","10.1074/JBC.M109.060145 ",1.9,23.34,"3hg3_oligo5","DGalpa1-6DGlcpa1-ROH","GLA(2_G_)-GLC(1_G_)",48.3927,"","",""
"3HG3","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 2. SUBSTRATE BOUND","10.1074/JBC.M109.060145 ",1.9,23.34,"3hg3_oligo3","DGalpa1-6DGlcpa1-ROH","GLA(2_E_)-GLC(1_E_)",47.5418,"","",""
"3HG4","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 3. COVALENT INTERMEDIATE","10.1074/JBC.M109.060145 ",2.3,49.85,"3hg4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_A_)",79.5715,"","",""
"3HG4","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 3. COVALENT INTERMEDIATE","10.1074/JBC.M109.060145 ",2.3,49.85,"3hg4_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(139_B_)",85.7894,"","",""
"3HG4","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 3. COVALENT INTERMEDIATE","10.1074/JBC.M109.060145 ",2.3,49.85,"3hg4_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(139_A_)",81.0097,"","",""
"3HG4","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 3. COVALENT INTERMEDIATE","10.1074/JBC.M109.060145 ",2.3,49.85,"3hg4_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(192_B_)",82.9909,"","",""
"3HMX","CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX","10.1016/J.JMB.2010.07.046 ",3,100.8,"3hmx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",117.851,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)]-MAN(4_G_)-[MAN(10_G_)-MAN(9_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(173_D_)",25.8059,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[BMA(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(173_B_)",23.925,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(173_E_)",13.0892,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[LGulpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[GUP(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(173_A_)",22.492,"","",""
"3HUS","CRYSTAL STRUCTURE OF RECOMBINANT GAMMA N308K FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGAND GLY-PRO-ARG-PRO-AMIDE","10.1021/BI900239B ",3.04,61.95,"3hus_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(364_B_)",97.8403,"","",""
"3HUS","CRYSTAL STRUCTURE OF RECOMBINANT GAMMA N308K FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGAND GLY-PRO-ARG-PRO-AMIDE","10.1021/BI900239B ",3.04,61.95,"3hus_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)",135.297,"","",""
"3I26","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE","10.1073/PNAS.0904266106 ",1.8,19.7,"3i26_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(343_A_)",56.8405,"","",""
"3I26","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE","10.1073/PNAS.0904266106 ",1.8,19.7,"3i26_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(313_D_)",51.5091,"","",""
"3I26","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE","10.1073/PNAS.0904266106 ",1.8,19.7,"3i26_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(313_A_)",51.0541,"","",""
"3I27","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE IN COMPLEX WITH RECEPTOR","10.1073/PNAS.0904266106 ",2,15.26,"3i27_oligo9","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(313_D_)",46.9005,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(213_A_)",58.9535,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(213_C_)",59.7176,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(213_B_)",60.9495,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(213_D_)",59.1924,"","",""
"3IAZ","STRUCTURAL BASIS OF THE PREVENTION OF NSAID-INDUCED DAMAGE OF THE GASTROINTESTINAL TRACT BY C-TERMINAL HALF (C-LOBE) OF BOVINE COLOSTRUM PROTEIN LACTOFERRIN: BINDING AND STRUCTURAL STUDIES OF THE C-LOBE COMPLEX WITH ASPIRIN","10.1016/J.BPJ.2009.09.030 ",2,33.65,"3iaz_oligo3","DManpb1-4[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(476_A_)",83.8916,"","",""
"3IB0","STRUCTURAL BASIS OF THE PREVENTION OF NSAID-INDUCED DAMAGE OF THE GASTROINTESTINAL TRACT BY C-TERMINAL HALF (C-LOBE) OF BOVINE COLOSTRUM PROTEIN LACTOFERRIN: BINDING AND STRUCTURAL STUDIES OF C- LOBE COMPLEX WITH DICLOFENAC","10.1016/J.BPJ.2009.09.030 ",1.4,23.61,"3ib0_oligo2","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(476_A_)",53.0767,"","",""
"3IGU","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COVALENT INTERMEDIATE","10.1016/J.JMB.2009.08.021 ",2.15,28.73,"3igu_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(124_B_)",105.081,"","",""
"3IGU","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COVALENT INTERMEDIATE","10.1016/J.JMB.2009.08.021 ",2.15,28.73,"3igu_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",86.5465,"","",""
"3IGU","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COVALENT INTERMEDIATE","10.1016/J.JMB.2009.08.021 ",2.15,28.73,"3igu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",61.3198,"","",""
"3IJE","CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT","10.1083/JCB.200905085 ",2.9,45.77,"3ije_oligo7","DManpa1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",83.8674,"","",""
"3IJE","CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT","10.1083/JCB.200905085 ",2.9,45.77,"3ije_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(44_A_)",92.0582,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(342_A_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(37_B_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(598_A_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo14","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_P_)-NAG(1_P_)-ASN(598_B_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(37_A_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo12","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(422_B_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(422_A_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(245_B_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(342_B_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(245_A_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(595_A_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(595_B_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(46_B_)",50,"","",""
"3J0A","HOMOLOGY MODEL OF HUMAN TOLL-LIKE RECEPTOR 5 FITTED INTO AN ELECTRON MICROSCOPY SINGLE PARTICLE RECONSTRUCTION","10.1016/J.JSB.2011.12.002 ",26,0,"3j0a_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(46_A_)",50,"","",""
"3J2Q","MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS","10.1002/BIP.22199 ",15,0,"3j2q_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcx1-","BMA(4_D_)-[MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",258.64,"","",""
"3J8F","CRYO-EM RECONSTRUCTION OF POLIOVIRUS-RECEPTOR COMPLEX","10.1128/JVI.03101-14 ",3.7,"2.68029e-09","3j8f_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(307_7_)",300,"","",""
"3J8F","CRYO-EM RECONSTRUCTION OF POLIOVIRUS-RECEPTOR COMPLEX","10.1128/JVI.03101-14 ",3.7,"2.68029e-09","3j8f_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(120_7_)",295.455,"","",""
"3J9F","POLIOVIRUS COMPLEXED WITH SOLUBLE, DEGLYCOSYLATED POLIOVIRUS RECEPTOR (PVR) AT 4 DEGREES C","10.1128/JVI.03101-14 ",9,"1.35632e-19","3j9f_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(307_9_)",50,"","",""
"3J9F","POLIOVIRUS COMPLEXED WITH SOLUBLE, DEGLYCOSYLATED POLIOVIRUS RECEPTOR (PVR) AT 4 DEGREES C","10.1128/JVI.03101-14 ",9,"1.35632e-19","3j9f_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(120_7_)",50,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo21","DGalpa1-6DGalpb1-C28O5","DGD(518_C_)-DGD(518_C_)",67.2064,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",154.315,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",89.345,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo3","DGalpa1-6DGalpb1-C28O5","DGD(518_c_)-DGD(518_c_)",67.2064,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",131.352,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(520_C_)-DGD(520_C_)",131.352,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",89.345,"","",""
"3JCU","CRYO-EM STRUCTURE OF SPINACH PSII-LHCII SUPERCOMPLEX AT 3.2 ANGSTROM RESOLUTION","10.1038/NATURE18020 ",3.2,"1.35632e-19","3jcu_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",154.315,"","",""
"3JD8","CRYO-EM STRUCTURE OF THE FULL-LENGTH HUMAN NPC1 AT 4.4 ANGSTROM","",4.43,0,"3jd8_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",253.125,"","",""
"3K24","CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT IN COMPLEX WITH GLN-LEU-ALA PEPTIDE","10.1038/NCOMMS1204 ",2.5,34.81,"3k24_oligo1","DGlcpNAca1-6DManpb1-6[DManpa1-2]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","NDG(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-NDG(2_E_)-NAG(1_E_)-ASN(108_B_)",99.7732,"","",""
"3K36","CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE","10.1021/JM100621S ",2.2,17.37,"3k36_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(284_A_)",59.6962,"","",""
"3K36","CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE","10.1021/JM100621S ",2.2,17.37,"3k36_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(284_B_)",63.4823,"","",""
"3K41","CRYSTAL STRUCTURE OF SCD-MPR MUTANT E19Q/K137M BOUND TO MAN-6-P","10.1021/BI901725X ",1.9,27.31,"3k41_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(81_A_)",53.9848,"","",""
"3K6S","STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN","10.1038/EMBOJ.2009.367 ",3.5,0,"3k6s_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(373_A_)",254.105,"","",""
"3K71","STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN","10.1038/EMBOJ.2009.367 ",3.95,0,"3k71_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-MAN(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(373_G_)",309.087,"","",""
"3K72","STRUCTURE OF INTEGRIN ALPHAX BETA2","10.1038/EMBOJ.2009.367 ",3.7,0,"3k72_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(373_A_)",319.833,"","",""
"3K72","STRUCTURE OF INTEGRIN ALPHAX BETA2","10.1038/EMBOJ.2009.367 ",3.7,0,"3k72_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(373_C_)",320.744,"","",""
"3K7N","STRUCTURES OF TWO ELAPID SNAKE VENOM METALLOPROTEASES WITH DISTINCT ACTIVITIES HIGHLIGHT THE DISULFIDE PATTERNS IN THE D DOMAIN OF ADAMALYSIN FAMILY PROTEINS","10.1016/J.JSB.2009.11.009 ",2.3,0,"3k7n_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(319_A_)",111.082,"","",""
"3KAS","MACHUPO VIRUS GP1 BOUND TO HUMAN TRANSFERRIN RECEPTOR 1","10.1038/NSMB.1772 ",2.4,54.78,"3kas_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(178_B_)",106.782,"","",""
"3KAS","MACHUPO VIRUS GP1 BOUND TO HUMAN TRANSFERRIN RECEPTOR 1","10.1038/NSMB.1772 ",2.4,54.78,"3kas_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(166_B_)",109.883,"","",""
"3KCG","CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX","10.1073/PNAS.0910144107 ",1.7,33.3,"3kcg_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(96_I_)",70.7727,"","",""
"3KCG","CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX","10.1073/PNAS.0910144107 ",1.7,33.3,"3kcg_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(192_I_)",71.7732,"","",""
"3KK6","CRYSTAL STRUCTURE OF CYCLOOXYGENASE-1 IN COMPLEX WITH CELECOXIB","10.1073/PNAS.0909765106 ",2.75,70.52,"3kk6_oligo5","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)",130.793,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(1092_D_)",173.559,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(413_A_)",131.803,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(413_E_)",135.71,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(413_C_)",135.954,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1092_F_)",175.146,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1092_B_)",173.623,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo3","DGalpa1-6DGalpb1-C39O5","DGD(493_C_)-DGD(493_C_)",162.757,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo20","DGalpa1-6DGalpb1-C25O5","DGD(375_A_)-DGD(375_A_)",180,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo24","DGalpa1-6DGalpb1-C39O5","DGD(533_B_)-DGD(533_B_)",180,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo5","DGalpa1-6DGalpb1-C31O5","DGD(528_B_)-DGD(528_B_)",164.183,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo1","DGalpa1-6DGalpb1-C26O5","DGD(491_C_)-DGD(491_C_)",158.874,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(492_C_)-DGD(492_C_)",168.277,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo19","DGalpa1-6DGalpb1-C29O5","DGD(474_C_)-DGD(474_C_)",180,"","",""
"3KZI","CRYSTAL STRUCTURE OF MONOMERIC FORM OF CYANOBACTERIAL PHOTOSYSTEM II","10.1074/JBC.M110.127589 ",3.6,162.6,"3kzi_oligo4","DGalpa1-6DGalpb1-C36O5","DGD(362_D_)-DGD(362_D_)",180,"","",""
"3L2L","X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PIG PANCREATIC ALPHA-AMYLASE WITH LIMIT DEXTRIN AND OLIGOSACCHARIDE","10.1021/BI902183W ",2.11,19.7,"3l2l_oligo3","DGlcpa1-4DGlcpa1-4[DGlcpa1-6]DGlcpa1-4DGlcpa1-4DGlcpb1-ROH","GLC(6_C_)-[GLC(5_C_)-GLC(4_C_)]-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",38.3088,"","",""
"3L3N","TESTIS ACE CO-CRYSTAL STRUCTURE WITH NOVEL INHIBITOR LISW","10.1042/BJ20100056 ",2.3,27.68,"3l3n_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",44.4048,"","",""
"3L5H","CRYSTAL STRUCTURE OF THE FULL ECTODOMAIN OF HUMAN GP130: NEW INSIGHTS INTO THE MOLECULAR ASSEMBLY OF RECEPTOR COMPLEXES","10.1074/JBC.C110.129502 ",3.6,93.97,"3l5h_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(357_A_)",128.028,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_K_)-[BMA(3_K_)-NAG(2_K_)]-[FUC(4_K_)]-NAG(1_K_)-ASN(57_E_)",47.1975,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_J_)-[BMA(3_J_)-NAG(2_J_)]-[FUC(4_J_)]-NAG(1_J_)-ASN(57_C_)",51.0529,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-[FUC(5_I_)]-NAG(1_I_)-ASN(57_A_)",59.2968,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_L_)-[BMA(3_L_)-NAG(2_L_)]-[FUC(4_L_)]-NAG(1_L_)-ASN(57_G_)",49.9053,"","",""
"3LIH","CRYSTAL STRUCTURE OF FRUCTOSYLTRANSFERASE (D191A) FROM A. JAPONICUS IN COMPLEX WITH RAFFINOSE","10.1074/JBC.M110.113027 ",2.2,0,"3lih_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_B_)-GLC(2_B_)-FRU(1_B_)",35.5881,"","",""
"3LIZ","CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3","10.1371/JOURNAL.PONE.0022223 ",1.8,36.02,"3liz_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(268_A_)",54.243,"","",""
"3LL2","MONOMERIC GRIFFITHSIN IN COMPLEX WITH A HIGH-MANNOSE BRANCHED CARBOHYDRATE","10.1016/J.STR.2010.05.016 ",0.97,15.23,"3ll2_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-ROH","MAN(8_B_)-[MAN(7_B_)-MAN(6_B_)]-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-MAN(1_B_)",17.9215,"","",""
"3LPO","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SUCRASE-ISOMALTASE","10.1074/JBC.M109.078980 ",3.2,48.2,"3lpo_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",72.2636,"","",""
"3LPO","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SUCRASE-ISOMALTASE","10.1074/JBC.M109.078980 ",3.2,48.2,"3lpo_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(822_A_)",61.9931,"","",""
"3LRL","STRUCTURE OF ALFA-GALACTOSIDASE (MEL1) FROM SACCHAROMYCES CEREVISIAE WITH MELIBIOSE","10.1074/JBC.M110.144584 ",2.4,26.25,"3lrl_oligo2","DGalpa1-6DGlcpb1-ROH","GLA(2_D_)-GLC(1_D_)",49.3373,"","",""
"3LRM","STRUCTURE OF ALFA-GALACTOSIDASE FROM SACCHAROMYCES CEREVISIAE WITH RAFFINOSE","10.1074/JBC.M110.144584 ",2.7,40.55,"3lrm_oligo7","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_K_)-GLC(1_K_)-FRU(2_K_)",76.2752,"","",""
"3LRM","STRUCTURE OF ALFA-GALACTOSIDASE FROM SACCHAROMYCES CEREVISIAE WITH RAFFINOSE","10.1074/JBC.M110.144584 ",2.7,40.55,"3lrm_oligo9","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_M_)-GLC(1_M_)-FRU(2_M_)",85.1108,"","",""
"3LRM","STRUCTURE OF ALFA-GALACTOSIDASE FROM SACCHAROMYCES CEREVISIAE WITH RAFFINOSE","10.1074/JBC.M110.144584 ",2.7,40.55,"3lrm_oligo8","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_L_)-GLC(1_L_)-FRU(2_L_)",82.8301,"","",""
"3LRM","STRUCTURE OF ALFA-GALACTOSIDASE FROM SACCHAROMYCES CEREVISIAE WITH RAFFINOSE","10.1074/JBC.M110.144584 ",2.7,40.55,"3lrm_oligo10","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_N_)-GLC(1_N_)-FRU(2_N_)",99.253,"","",""
"3LTF","CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN IN COMPLEX WITH SPITZ","10.1016/J.CELL.2010.07.015 ",3.2,80.2,"3ltf_oligo1","DManpb1-4DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(470_A_)",84.5435,"","",""
"3LZG","CRYSTAL STRUCTURE OF A 2009 H1N1 INFLUENZA VIRUS HEMAGGLUTININ","10.1126/SCIENCE.1186430 ",2.6,65.71,"3lzg_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(94_I_)",79.3449,"","",""
"3MDJ","ER AMINOPEPTIDASE, ERAP1, BOUND TO THE ZINC AMINOPEPTIDASE INHIBITOR, BESTATIN","10.1038/NSMB.2021 ",2.95,0,"3mdj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(70_A_)",112.23,"","",""
"3MDJ","ER AMINOPEPTIDASE, ERAP1, BOUND TO THE ZINC AMINOPEPTIDASE INHIBITOR, BESTATIN","10.1038/NSMB.2021 ",2.95,0,"3mdj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(70_C_)",118.939,"","",""
"3MJ6","CRYSTAL STRUCTURE OF THE GAMMADELTA T CELL COSTIMULATORY RECEPTOR JUNCTIONAL ADHESION MOLECULE-LIKE PROTEIN, JAML","10.1126/SCIENCE.1187996 ",2.19,37.61,"3mj6_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(105_A_)",84.8591,"","",""
"3MJ7","CRYSTAL STRUCTURE OF THE COMPLEX OF JAML AND COXSACKIE AND ADENOVIRUS RECEPTOR, CAR","10.1126/SCIENCE.1187996 ",2.8,68.21,"3mj7_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(69_A_)",98.2709,"","",""
"3MJ9","CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10","10.1016/J.STR.2010.10.007 ",2.95,77.24,"3mj9_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(105_A_)",91.5379,"","",""
"3MKK","THE CRYSTAL STRUCTURE OF THE D307A MUTANT OF GLYCOSIDE HYDROLASE (FAMILY 31) FROM RUMINOCOCCUS OBEUM ATCC 29174 IN COMPLEX WITH ISOMALTOSE","10.1096/FJ.10-156257 ",1.91,9.61,"3mkk_oligo2","DGlcpa1-6DGlcpb1-ROH","GLC(801_A_)-BGC(802_A_)",33.7395,"","",""
"3MKK","THE CRYSTAL STRUCTURE OF THE D307A MUTANT OF GLYCOSIDE HYDROLASE (FAMILY 31) FROM RUMINOCOCCUS OBEUM ATCC 29174 IN COMPLEX WITH ISOMALTOSE","10.1096/FJ.10-156257 ",1.91,9.61,"3mkk_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_C_)-BGC(1_C_)",30.5714,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",206.141,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",193.789,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",213.046,"","",""
"3MW2","CRYSTAL STRUCTURE OF BETA-NEUREXIN 1 WITH THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2.69,35.84,"3mw2_oligo2","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(184_A_)",49.0579,"","",""
"3MW2","CRYSTAL STRUCTURE OF BETA-NEUREXIN 1 WITH THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2.69,35.84,"3mw2_oligo1","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(184_B_)",49.6894,"","",""
"3MW3","CRYSTAL STRUCTURE OF BETA-NEUREXIN 2 WITH THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2.33,34.77,"3mw3_oligo1","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcx1-","BMA(3_B_)-[NAG(2_B_)]-NAG(1_B_)",44.989,"","",""
"3MW4","CRYSTAL STRUCTURE OF BETA-NEUREXIN 3 WITHOUT THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2,30.56,"3mw4_oligo2","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(182_B_)",42.4048,"","",""
"3MW4","CRYSTAL STRUCTURE OF BETA-NEUREXIN 3 WITHOUT THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2,30.56,"3mw4_oligo1","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(182_A_)",41.5673,"","",""
"3MW4","CRYSTAL STRUCTURE OF BETA-NEUREXIN 3 WITHOUT THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2,30.56,"3mw4_oligo3","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(182_C_)",54.063,"","",""
"3N85","CRYSTALLOGRAPHIC TRIMER OF HER2 EXTRACELLULAR REGIONS IN COMPLEX WITH TRYPTOPHAN-RICH ANTIBODY FRAGMENT","10.1016/J.JMB.2010.07.027 ",3.2,71.72,"3n85_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(165_A_)",120.898,"","",""
"3N8V","CRYSTAL STRUCTURE OF UNOCCUPIED CYCLOOXYGENASE-1","10.1021/BI1003298 ",3.05,68.31,"3n8v_oligo6","DManpa1-6DManpa1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NDG(2_E_)-NAG(1_E_)-ASN(144_A_)",57.5456,"","",""
"3N8V","CRYSTAL STRUCTURE OF UNOCCUPIED CYCLOOXYGENASE-1","10.1021/BI1003298 ",3.05,68.31,"3n8v_oligo2","DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NDG(2_H_)-NAG(1_H_)-ASN(144_B_)",57.5445,"","",""
"3N8W","CRYSTAL STRUCTURE OF R120Q/NATIVE CYCLOOXYGENASE-1 HETERODIMER MUTANT IN COMPLEX WITH FLURBIPROFEN","10.1021/BI1003298 ",2.75,56.78,"3n8w_oligo4","DManpa1-6DManpa1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NDG(2_E_)-NAG(1_E_)-ASN(144_A_)",77.0804,"","",""
"3N8X","CRYSTAL STRUCTURE OF CYCLOOXYGENASE-1 IN COMPLEX WITH NIMESULIDE","10.1021/BI1003298 ",2.75,56,"3n8x_oligo7","DManpb1-6DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(144_A_)",73.8171,"","",""
"3N8Y","STRUCTURE OF ASPIRIN ACETYLATED CYCLOOXYGENASE-1 IN COMPLEX WITH DICLOFENAC","10.1021/BI1003298 ",2.6,47.01,"3n8y_oligo7","DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","BMA(4_G_)-BMA(3_G_)-NDG(2_G_)-NAG(1_G_)",74.1731,"","",""
"3N8Y","STRUCTURE OF ASPIRIN ACETYLATED CYCLOOXYGENASE-1 IN COMPLEX WITH DICLOFENAC","10.1021/BI1003298 ",2.6,47.01,"3n8y_oligo6","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",88.169,"","",""
"3N8Y","STRUCTURE OF ASPIRIN ACETYLATED CYCLOOXYGENASE-1 IN COMPLEX WITH DICLOFENAC","10.1021/BI1003298 ",2.6,47.01,"3n8y_oligo1","DManpa1-6DManpa1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NDG(2_D_)-NAG(1_D_)-ASN(144_A_)",66.0862,"","",""
"3N8Y","STRUCTURE OF ASPIRIN ACETYLATED CYCLOOXYGENASE-1 IN COMPLEX WITH DICLOFENAC","10.1021/BI1003298 ",2.6,47.01,"3n8y_oligo9","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(410_A_)",73.4098,"","",""
"3NGB","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120","10.1126/SCIENCE.1192819 ",2.68,57.3,"3ngb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(72_C_)",185.104,"","",""
"3NGB","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120","10.1126/SCIENCE.1192819 ",2.68,57.3,"3ngb_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(72_K_)",208.257,"","",""
"3NGB","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120","10.1126/SCIENCE.1192819 ",2.68,57.3,"3ngb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(72_L_)",196.789,"","",""
"3NID","THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING","10.1182/BLOOD-2010-04-281154 ",2.3,51.82,"3nid_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",74.2518,"","",""
"3NKM","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN","10.1038/NSMB.1998 ",2,25.43,"3nkm_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",31.4235,"","",""
"3NKN","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 14:0-LPA","10.1038/NSMB.1998 ",1.8,32.38,"3nkn_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",32.6077,"","",""
"3NKO","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 16:0-LPA","10.1038/NSMB.1998 ",1.75,33.53,"3nko_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",33.8101,"","",""
"3NKP","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 18:1-LPA","10.1038/NSMB.1998 ",1.75,32.74,"3nkp_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",34.7789,"","",""
"3NKQ","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 18:3-LPA","10.1038/NSMB.1998 ",1.7,31.14,"3nkq_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",33.2638,"","",""
"3NKR","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 22:6-LPA","10.1038/NSMB.1998 ",1.7,32.24,"3nkr_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",33.5603,"","",""
"3NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"3nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.5727,"","",""
"3NXQ","ANGIOTENSIN CONVERTING ENZYME N DOMAIN GLYCSOYLATION MUTANT (NDOM389) IN COMPLEX WITH RXP407","10.1074/JBC.M110.167866 ",1.99,32.81,"3nxq_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(416_B_)",62.853,"","",""
"3NXQ","ANGIOTENSIN CONVERTING ENZYME N DOMAIN GLYCSOYLATION MUTANT (NDOM389) IN COMPLEX WITH RXP407","10.1074/JBC.M110.167866 ",1.99,32.81,"3nxq_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",51.0232,"","",""
"3NXQ","ANGIOTENSIN CONVERTING ENZYME N DOMAIN GLYCSOYLATION MUTANT (NDOM389) IN COMPLEX WITH RXP407","10.1074/JBC.M110.167866 ",1.99,32.81,"3nxq_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(416_A_)",55.2725,"","",""
"3NXQ","ANGIOTENSIN CONVERTING ENZYME N DOMAIN GLYCSOYLATION MUTANT (NDOM389) IN COMPLEX WITH RXP407","10.1074/JBC.M110.167866 ",1.99,32.81,"3nxq_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_B_)",52.4855,"","",""
"3O8X","RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR","10.1084/JEM.20101335 ",2.74,41.07,"3o8x_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",56.1888,"","",""
"3O9W","RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR","10.1084/JEM.20101335 ",2.8,47.45,"3o9w_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",68.843,"","",""
"3OG2","NATIVE CRYSTAL STRUCTURE OF TRICHODERMA REESEI BETA-GALACTOSIDASE","10.1016/J.JSB.2010.11.024 ",1.2,"1.15243e-41","3og2_oligo2","DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_C_)-MAN(10_C_)-[MAN(12_C_)]-MAN(9_C_)-[GLC(8_C_)-GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",34.8781,"","",""
"3OG2","NATIVE CRYSTAL STRUCTURE OF TRICHODERMA REESEI BETA-GALACTOSIDASE","10.1016/J.JSB.2010.11.024 ",1.2,"1.15243e-41","3og2_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",15.5471,"","",""
"3OGR","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH GALACTOSE","10.1016/J.JSB.2010.11.024 ",1.5,13.87,"3ogr_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",13.9286,"","",""
"3OGR","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH GALACTOSE","10.1016/J.JSB.2010.11.024 ",1.5,13.87,"3ogr_oligo2","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_C_)-[MAN(9_C_)]-MAN(8_C_)-[GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",25.3371,"","",""
"3OGS","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH IPTG","10.1016/J.JSB.2010.11.024 ",1.75,20.71,"3ogs_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",20.2988,"","",""
"3OGS","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH IPTG","10.1016/J.JSB.2010.11.024 ",1.75,20.71,"3ogs_oligo2","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",32.3339,"","",""
"3OGV","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH PETG","10.1016/J.JSB.2010.11.024 ",1.4,15.63,"3ogv_oligo3","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",17.4128,"","",""
"3OGV","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH PETG","10.1016/J.JSB.2010.11.024 ",1.4,15.63,"3ogv_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",14.6147,"","",""
"3OJA","CRYSTAL STRUCTURE OF LRIM1/APL1C COMPLEX","10.1073/PNAS.1010575107 ",2.7,37.56,"3oja_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_B_)",44.1445,"","",""
"3OKW","MOUSE SEMAPHORIN 6A, EXTRACELLULAR DOMAINS 1-2","10.1038/NATURE09468 ",2.3,0,"3okw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(461_B_)",138.404,"","",""
"3OTK","STRUCTURE AND MECHANISIM OF CORE 2 BETA1,6-N- ACETYLGLUCOSAMINYLTRANSFERASE: A METAL-ION INDEPENDENT GT-A GLYCOSYLTRANSFERASE","10.1016/J.JMB.2011.10.039 ",2.3,43.77,"3otk_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(95_C_)",71.5797,"","",""
"3OTK","STRUCTURE AND MECHANISIM OF CORE 2 BETA1,6-N- ACETYLGLUCOSAMINYLTRANSFERASE: A METAL-ION INDEPENDENT GT-A GLYCOSYLTRANSFERASE","10.1016/J.JMB.2011.10.039 ",2.3,43.77,"3otk_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(95_A_)",67.703,"","",""
"3PMH","MECHANISM OF SULFOTYROSINE-MEDIATED GLYCOPROTEIN IB INTERACTION WITH TWO DISTINCT ALPHA-THROMBIN SITES","10.1073/PNAS.1017042108 ",3.2,0,"3pmh_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(60_B_)",109.447,"","",""
"3PPS","CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA","10.1111/J.1742-4658.2011.08146.X ",2.5,0,"3pps_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(202_A_)",24.1999,"","",""
"3PXL","TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA","",1.2,17.36,"3pxl_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",25.8564,"","",""
"3Q76","STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (UNCOMPLEXED)","10.1016/J.JMB.2011.04.047 ",1.86,0,"3q76_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(159_B_)",20.5982,"","",""
"3Q76","STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (UNCOMPLEXED)","10.1016/J.JMB.2011.04.047 ",1.86,0,"3q76_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(159_A_)",29.1997,"","",""
"3Q77","STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1016/J.JMB.2011.04.047 ",2,0,"3q77_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(159_A_)",28.8979,"","",""
"3QEL","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH IFENPRODIL","10.1038/NATURE10180 ",2.6,0,"3qel_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(389_A_)",61.7232,"","",""
"3QEM","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH RO 25-6981","10.1038/NATURE10180 ",3,0,"3qem_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",67.8358,"","",""
"3QNF","CRYSTAL STRUCTURE OF THE OPEN STATE OF HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 ERAP1","10.1073/PNAS.1101262108 ",3,34.25,"3qnf_oligo1","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(70_A_)",52.5209,"","",""
"3QSP","ANALYSIS OF A NEW FAMILY OF WIDELY DISTRIBUTED METAL-INDEPENDENT ALPHA MANNOSIDASES PROVIDES UNIQUE INSIGHT INTO THE PROCESSING OF N-LINKED GLYCANS, STREPTOCOCCUS PNEUMONIAE SP_2144 NON-PRODUCTIVE SUBSTRATE COMPLEX WITH ALPHA-1,6-MANNOBIOSE","10.1074/JBC.M111.223172 ",2.1,14.53,"3qsp_oligo2","DManpa1-6DManpb1-ROH","MAN(2_D_)-BMA(1_D_)",20.1582,"","",""
"3QSP","ANALYSIS OF A NEW FAMILY OF WIDELY DISTRIBUTED METAL-INDEPENDENT ALPHA MANNOSIDASES PROVIDES UNIQUE INSIGHT INTO THE PROCESSING OF N-LINKED GLYCANS, STREPTOCOCCUS PNEUMONIAE SP_2144 NON-PRODUCTIVE SUBSTRATE COMPLEX WITH ALPHA-1,6-MANNOBIOSE","10.1074/JBC.M111.223172 ",2.1,14.53,"3qsp_oligo1","DManpa1-6DManpb1-ROH","MAN(2_C_)-BMA(1_C_)",15.0759,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo3","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6DManpa1-3[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6DManp[2<R1>]a1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(15_G_)-[SIA(14_G_)-GAL(13_G_)-NAG(12_G_)-MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(61_Q_)",122.697,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo2","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-4DManpa1-3[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(15_E_)-[SIA(14_E_)-GAL(13_E_)-NAG(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)]-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(61_P_)",112.455,"","",""
"3QUX","STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX","10.1038/EMBOJ.2011.145 ",2.91,46.58,"3qux_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",65.9073,"","",""
"3QUY","STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX","10.1038/EMBOJ.2011.145 ",2.25,40.57,"3quy_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",54.5506,"","",""
"3QUZ","STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX","10.1038/EMBOJ.2011.145 ",2.3,42.68,"3quz_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",50.027,"","",""
"3QW9","CRYSTAL STRUCTURE OF BETAGLYCAN ZP-C DOMAIN","10.1073/PNAS.1010689108 ",2,39.45,"3qw9_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(3_C_)-NAG(2_C_)]-[FUC(4_C_)]-NAG(1_C_)-ASN(14_A_)",43.6036,"","",""
"3QW9","CRYSTAL STRUCTURE OF BETAGLYCAN ZP-C DOMAIN","10.1073/PNAS.1010689108 ",2,39.45,"3qw9_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-[FUC(6_D_)]-NAG(1_D_)-ASN(14_B_)",58.0687,"","",""
"3QWQ","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH AN ADNECTIN","10.1016/J.STR.2011.11.016 ",2.75,64.63,"3qwq_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(504_A_)",97.8162,"","",""
"3QWQ","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH AN ADNECTIN","10.1016/J.STR.2011.11.016 ",2.75,64.63,"3qwq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(32_A_)",88.1097,"","",""
"3R4L","HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1","10.3892/IJMM.2011.798 ",2.7,68.8,"3r4l_oligo1","DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(288_A_)",84.5155,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(402_A_)",48.696,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo16","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-MAN(5_f_)-[MAN(7_f_)]-MAN(4_f_)-[MAN(8_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(402_N_)",48.5487,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo14","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-MAN(5_d_)-[MAN(7_d_)]-MAN(4_d_)-[MAN(8_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(402_J_)",49.0244,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-MAN(5_X_)-[MAN(7_X_)]-MAN(4_X_)-[MAN(8_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(402_M_)",48.731,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-MAN(5_T_)-[MAN(7_T_)]-MAN(4_T_)-[MAN(8_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(402_E_)",49.0734,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-MAN(5_V_)-[MAN(7_V_)]-MAN(4_V_)-[MAN(8_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(402_I_)",49.3895,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo10","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-MAN(5_Z_)-[MAN(7_Z_)]-MAN(4_Z_)-[MAN(8_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(402_B_)",48.4424,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo12","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-MAN(5_b_)-[MAN(7_b_)]-MAN(4_b_)-[MAN(8_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(402_F_)",48.9718,"","",""
"3RJD","CRYSTAL STRUCTURE OF FC RI AND ITS IMPLICATION TO HIGH AFFINITY IMMUNOGLOBULIN G BINDING","10.1074/JBC.M111.257550 ",2.65,84.3,"3rjd_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(152_A_)",128.557,"","",""
"3RUM","NEW STRATEGY TO ANALYZE STRUCTURES OF GLYCOPEPTIDE ANTIBIOTIC-TARGET COMPLEXES","10.1021/JA208755J ",1.85,0,"3rum_oligo3","DArafa1-2DManpa1-2[LRhapa1-6]DGlcpb1-C60N7O19","RAM(4_E_)-[BXY(3_E_)-MAN(2_E_)]-BGC(1_E_)-GHP(4_C_)",32.225,"","",""
"3RUM","NEW STRATEGY TO ANALYZE STRUCTURES OF GLYCOPEPTIDE ANTIBIOTIC-TARGET COMPLEXES","10.1021/JA208755J ",1.85,0,"3rum_oligo1","DArafa1-2DManpa1-2[LRhapa1-6]DGlcpb1-C60N7O19","RAM(4_D_)-[BXY(3_D_)-MAN(2_D_)]-BGC(1_D_)-GHP(4_B_)",29.5767,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo3","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(6_F_)-[MAN(5_F_)-[BMA(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NDG(1_F_)-ASN(145_C_)",65.053,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",58.4448,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(10_D_)-[NAG(9_D_)-MAN(8_D_)-[SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)-ASN(297_A_)",60.0921,"","",""
"3S2K","STRUCTURAL BASIS OF WNT SIGNALING INHIBITION BY DICKKOPF BINDING TO LRP5/6.","10.1016/J.DEVCEL.2011.09.003 ",2.8,0,"3s2k_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(692_B_)",111.063,"","",""
"3S2K","STRUCTURAL BASIS OF WNT SIGNALING INHIBITION BY DICKKOPF BINDING TO LRP5/6.","10.1016/J.DEVCEL.2011.09.003 ",2.8,0,"3s2k_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(692_A_)",128.75,"","",""
"3S5X","STRUCTURE OF THE CYANOBACTERIAL OSCILLATORIA AGARDHII AGGLUTININ (OAA) IN COMPLEX WITH A3,A6 MANNOPENTAOSE","10.1016/J.STR.2011.05.010 ",1.65,18.37,"3s5x_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(3_B_)-MAN(2_B_)-[MAN(4_B_)]-BMA(1_B_)",14.5595,"","",""
"3S5X","STRUCTURE OF THE CYANOBACTERIAL OSCILLATORIA AGARDHII AGGLUTININ (OAA) IN COMPLEX WITH A3,A6 MANNOPENTAOSE","10.1016/J.STR.2011.05.010 ",1.65,18.37,"3s5x_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(3_C_)-MAN(2_C_)-[MAN(4_C_)]-BMA(1_C_)",18.9239,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(139_A_)",100.866,"","",""
"3S5Z","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2,33.72,"3s5z_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(192_A_)",78.3548,"","",""
"3SAJ","CRYSTAL STRUCTURE OF GLUTAMATE RECEPTOR GLUA1 AMINO TERMINAL DOMAIN","10.1042/BJ20110801 ",2.5,70.83,"3saj_oligo9","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-MAN(5_M_)-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(345_C_)",186.472,"","",""
"3SDY","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ","10.1126/SCIENCE.1204839 ",2.85,0,"3sdy_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(81_A_)",132.243,"","",""
"3SDY","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ","10.1126/SCIENCE.1204839 ",2.85,0,"3sdy_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(154_B_)",156.094,"","",""
"3SDY","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ","10.1126/SCIENCE.1204839 ",2.85,0,"3sdy_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",183.283,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",49.3643,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_C_)",77.6204,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo3","DGlcpNAcb1-2DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",42.0992,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(8_D_)]-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",47.0327,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo1","DManpa1-2DManpb1-3[DManpb1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_C_)",56.5764,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo3","DGlcpNAcb1-2DManpb1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(8_E_)]-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",61.4043,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-[MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(74_B_)",82.9218,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo21","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(74_G_)",84.5226,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(110_E_)",79.812,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(110_J_)",87.2856,"","",""
"3SNG","X-RAY STRUCTURE OF FULLY GLYCOSYLATED BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)","10.1107/S0907444912043697 ",2.16,31.64,"3sng_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(137_A_)",52.1211,"","",""
"3SQR","CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION","10.1107/S1399004714020380 ",1.67,22.46,"3sqr_oligo1","DManpa1-2DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(194_A_)",42.075,"","",""
"3T3M","A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS","10.1126/SCITRANSLMED.3003576 ",2.6,0,"3t3m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",100.032,"","",""
"3T3P","A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS","10.1126/SCITRANSLMED.3003576 ",2.2,0,"3t3p_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",70.8718,"","",""
"3T6Q","CRYSTAL STRUCTURE OF MOUSE RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",1.9,34.67,"3t6q_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(402_B_)",32.4485,"","",""
"3T6Q","CRYSTAL STRUCTURE OF MOUSE RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",1.9,34.67,"3t6q_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(402_A_)",29.1212,"","",""
"3T8X","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER","",1.9,38.89,"3t8x_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(20_C_)",70.9505,"","",""
"3T8X","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER","",1.9,38.89,"3t8x_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(57_C_)",53.0636,"","",""
"3T8X","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER","",1.9,38.89,"3t8x_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(57_A_)",60.4698,"","",""
"3T8X","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER","",1.9,38.89,"3t8x_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(20_A_)",65.46,"","",""
"3TA3","STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX","10.1371/JOURNAL.PBIO.1001189 ",2.7,37.08,"3ta3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",56.9142,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo6","DManpa1-6DManpa1-6DManpa1-6DManpx1-","MAN(6_T_)-MAN(5_T_)-MAN(4_T_)-BMA(3_T_)",135.657,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo15","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(6_X_)-[MAN(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)",108.188,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo11","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_V_)-MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",106.12,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo14","DManpa1-6DManpa1-6DManpx1-","MAN(5_W_)-MAN(4_W_)-BMA(3_W_)",126.352,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_W_)-[NAG(2_W_)]-NAG(1_W_)",74.5113,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo4","DManpa1-6DManpa1-6DManpa1-6DManpx1-","MAN(6_R_)-MAN(5_R_)-MAN(4_R_)-BMA(3_R_)",135.657,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo10","DManpa1-6DManpa1-6DManpa1-6DManpx1-","MAN(6_U_)-MAN(5_U_)-MAN(4_U_)-BMA(3_U_)",135.657,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo2","DManpa1-6DManpa1-6DManpa1-6DManpx1-","MAN(6_S_)-MAN(5_S_)-MAN(4_S_)-BMA(3_S_)",135.657,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo3","DManpa1-6DManpa1-6DManpa1-6DManpx1-","MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)-BMA(3_Q_)",135.657,"","",""
"3THM","CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01","10.1038/CDD.2011.208 ",2.1,0,"3thm_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(25_L_)",52.2703,"","",""
"3TV3","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9","10.1126/SCIENCE.1213256 ",1.29,20.6,"3tv3_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]MAN1-C1","MAN(7_A_)-MAN(6_A_)-[MAN(8_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)--AML(300_H_)",25.1499,"","",""
"3TVM","STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX","10.1016/J.CHEMBIOL.2011.10.015 ",2.8,52.28,"3tvm_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(165_E_)",76.113,"","",""
"3TVM","STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX","10.1016/J.CHEMBIOL.2011.10.015 ",2.8,52.28,"3tvm_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(165_A_)",54.11,"","",""
"3TWC","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9","10.1126/SCIENCE.1213256 ",1.65,29,"3twc_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]MAN1-C1","MAN(7_A_)-MAN(6_A_)-[MAN(8_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)--AML(300_H_)",36.8832,"","",""
"3TYG","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3)","10.1126/SCIENCE.1213256 ",3.25,117.5,"3tyg_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(104_A_)",76.0156,"","",""
"3TYG","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3)","10.1126/SCIENCE.1213256 ",3.25,117.5,"3tyg_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(121_A_)",72.8814,"","",""
"3TZV","CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE","10.1038/EMBOJ.2012.54 ",3.06,0,"3tzv_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(20_C_)",92.2559,"","",""
"3U0P","CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE","10.1038/EMBOJ.2012.54 ",2.8,0,"3u0p_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(20_A_)",121.871,"","",""
"3U0P","CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE","10.1038/EMBOJ.2012.54 ",2.8,0,"3u0p_oligo2","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(20_C_)",127.993,"","",""
"3U0P","CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE","10.1038/EMBOJ.2012.54 ",2.8,0,"3u0p_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(20_E_)",140.211,"","",""
"3U2S","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NATURE10696 ",1.8,0,"3u2s_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(160_G_)",34.9742,"","",""
"3U2S","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NATURE10696 ",1.8,0,"3u2s_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(160_C_)",40.1351,"","",""
"3U4E","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45","10.1038/NATURE10696 ",2.19,0,"3u4e_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(156_G_)",109.907,"","",""
"3U4E","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45","10.1038/NATURE10696 ",2.19,0,"3u4e_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(160_G_)",51.7638,"","",""
"3U4E","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45","10.1038/NATURE10696 ",2.19,0,"3u4e_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(160_J_)",52.296,"","",""
"3U7B","A NEW CRYSTAL STRUCTURE OF A FUSARIUM OXYSPORUM GH10 XYLANASE REVEALS THE PRESENCE OF AN EXTENDED LOOP ON TOP OF THE CATALYTIC CLEFT","10.1107/S0907444912007044 ",1.94,16.34,"3u7b_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(101_D_)",30.4061,"","",""
"3U7B","A NEW CRYSTAL STRUCTURE OF A FUSARIUM OXYSPORUM GH10 XYLANASE REVEALS THE PRESENCE OF AN EXTENDED LOOP ON TOP OF THE CATALYTIC CLEFT","10.1107/S0907444912007044 ",1.94,16.34,"3u7b_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(101_E_)",30.4211,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-[FUC(5_I_)]-NAG(1_I_)-ASN(178_B_)",28.7258,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-[FUC(5_H_)]-NAG(1_H_)-ASN(178_B_)",39.7075,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-[FUC(5_I_)]-NAG(1_I_)-ASN(400_B_)",54.0902,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo3","DXylpa1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-[XYS(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(7_E_)]-NAG(1_E_)-ASN(400_A_)",55.6746,"","",""
"3UJI","CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE","10.1371/JOURNAL.PONE.0027780 ",1.6,21.42,"3uji_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(60_H_)",19.6079,"","",""
"3ULU","STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)","10.1016/J.JMB.2012.05.006 ",3.52,0,"3ulu_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(413_A_)",147.514,"","",""
"3ULV","STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)","10.1016/J.JMB.2012.05.006 ",3.52,0,"3ulv_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(413_A_)",75.5945,"","",""
"3UUE","CRYSTAL STRUCTURE OF MONO- AND DIACYLGLYCEROL LIPASE FROM MALASSEZIA GLOBOSA","10.1016/J.JSB.2012.03.006 ",1.45,9.39,"3uue_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(253_A_)",14.3267,"","",""
"3UYV","CRYSTAL STRUCTURE OF A GLYCOSYLATED ICE-BINDING PROTEIN (LEIBP) FROM ARCTIC YEAST","10.1074/JBC.M111.331835 ",2.43,23.6,"3uyv_oligo1","DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(185_A_)",49.7052,"","",""
"3V0W","CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS","10.1073/PNAS.1209253109 ",1.73,25.01,"3v0w_oligo1","DGlcpNa1-2DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GM01-3GM01-5[DKdopa2-4]DKdopa2-ROH","GMH(9_A_)-[GLA(8_A_)-[PA1(7_A_)-GLC(6_A_)-GLC(5_A_)]-GLC(4_A_)]-GM0(3_A_)-GM0(2_A_)-[KDO(10_A_)]-KDO(1_A_)",23.9209,"","",""
"3V3C","CRYSTAL STRUCTURE OF CHLOROPLAST ATP SYNTHASE C-RING FROM PISUM SATIVUM","10.1371/JOURNAL.PONE.0043045 ",3.4,92.76,"3v3c_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(82_A_)-DGD(82_A_)",144.579,"","",""
"3V7M","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+","",2.02,47.93,"3v7m_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",70.5152,"","",""
"3V8X","THE CRYSTAL STRUCTURE OF TRANSFERRIN BINDING PROTEIN A (TBPA) FROM NEISSERIAL MENINGITIDIS SEROGROUP B IN COMPLEX WITH FULL LENGTH HUMAN TRANSFERRIN","10.1038/NATURE10823 ",2.6,0,"3v8x_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-4DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(10_C_)-NAG(9_C_)-MAN(8_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(413_B_)",110.842,"","",""
"3V8X","THE CRYSTAL STRUCTURE OF TRANSFERRIN BINDING PROTEIN A (TBPA) FROM NEISSERIAL MENINGITIDIS SEROGROUP B IN COMPLEX WITH FULL LENGTH HUMAN TRANSFERRIN","10.1038/NATURE10823 ",2.6,0,"3v8x_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-4DManpa1-6[DGlcpNAcb1-4DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(611_B_)",147.147,"","",""
"3V95","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA","",2.7,39.73,"3v95_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",38.9226,"","",""
"3V95","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA","",2.7,39.73,"3v95_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",67.4025,"","",""
"3V9C","TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION","",2,26.62,"3v9c_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",37.4868,"","",""
"3VG0","ANTIBODY FAB FRAGMENT","10.1016/J.STR.2012.01.019 ",2.27,36.9,"3vg0_oligo1","DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(22_L_)",89.9509,"","",""
"3VHZ","CRYSTAL STRUCTURE OF THE TRANS ISOMER OF THE L93A MUTANT OF BACTERIORHODOPSIN","10.1002/PROT.24124 ",2.3,47.29,"3vhz_oligo2","DGalp[3<R1>]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",93.2833,"","",""
"3VI0","CRYSTAL STRUCTURE OF THE O INTERMEDIATE OF THE L93A MUTANT OF BACTERIORHODOPSIN","10.1002/PROT.24124 ",2.3,39.58,"3vi0_oligo1","DGalp[3S]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(303_A_)",79.7203,"","",""
"3VI3","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)","10.1083/JCB.201111077 ",2.9,71.74,"3vi3_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(275_A_)",82.1147,"","",""
"3VI3","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)","10.1083/JCB.201111077 ",2.9,71.74,"3vi3_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(275_C_)",73.7908,"","",""
"3VI4","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE","10.1083/JCB.201111077 ",2.9,69.94,"3vi4_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(275_C_)",76.1756,"","",""
"3VI4","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE","10.1083/JCB.201111077 ",2.9,69.94,"3vi4_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(275_A_)",78.6789,"","",""
"3VL9","CRYSTAL STRUCTURE OF XEG-XYLOGLUCAN","10.1074/JBC.M112.350520 ",1.2,10.3,"3vl9_oligo2","DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-4DGlcpb1-ROH","XYS(5_D_)-[BGC(4_D_)]-BGC(3_D_)-BGC(2_D_)-BGC(1_D_)",15.0799,"","",""
"3VL9","CRYSTAL STRUCTURE OF XEG-XYLOGLUCAN","10.1074/JBC.M112.350520 ",1.2,10.3,"3vl9_oligo1","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(6_C_)-[XYS(5_C_)-[BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",11.8814,"","",""
"3VMO","CRYSTAL STRUCTURE OF DEXTRANASE FROM STREPTOCOCCUS MUTANS IN COMPLEX WITH ISOMALTOTRIOSE","10.1074/JBC.M112.342444 ",1.9,35.12,"3vmo_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",43.4982,"","",""
"3VMO","CRYSTAL STRUCTURE OF DEXTRANASE FROM STREPTOCOCCUS MUTANS IN COMPLEX WITH ISOMALTOTRIOSE","10.1074/JBC.M112.342444 ",1.9,35.12,"3vmo_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-BGC(1_B_)",54.7559,"","",""
"3VTA","CRYSTAL STRUCTURE OF CUCUMISIN, A SUBTILISIN-LIKE ENDOPROTEASE FROM CUCUMIS MELO L","10.1016/J.JMB.2012.07.013 ",2.75,49.3,"3vta_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(466_B_)",63.5513,"","",""
"3VTA","CRYSTAL STRUCTURE OF CUCUMISIN, A SUBTILISIN-LIKE ENDOPROTEASE FROM CUCUMIS MELO L","10.1016/J.JMB.2012.07.013 ",2.75,49.3,"3vta_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(466_A_)",55.7076,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)-[NAG(8_M_)-MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(81_E_)",91.0734,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_E_)",120.22,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(81_C_)",87.8973,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(285_C_)",117.05,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(285_A_)",119.297,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(81_A_)",90.6585,"","",""
"3VYK","CRYSTAL STRUCTURE OF C-TYPE LECTIN DOMAIN OF MURINE DENDRITIC CELL INHIBITORY RECEPTOR 2 IN COMPLEX WITH N-GLYCAN","10.1074/JBC.M113.513572 ",1.5,19.15,"3vyk_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_B_)-MAN(4_B_)-[NAG(6_B_)]-[NAG(3_B_)-MAN(2_B_)]-MMA(1_B_)",20.6395,"","",""
"3W09","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 2,3-DIF GUANIDINO-NEU5AC2EN INHIBITOR","10.1126/SCIENCE.1232552 ",2,34.89,"3w09_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",48.5631,"","",""
"3W3D","CRYSTAL STRUCTURE OF SMOOTH MUSCLE G ACTIN DNASE I COMPLEX","",1.8,31.09,"3w3d_oligo2","DManpa1-6DManpb1-3[DManpb1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_C_)-MAN(6_C_)-[MAN(5_C_)-BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_B_)",61.1696,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",59.2047,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",66.1249,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",65.6862,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",63.7425,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(590_D_)",50.9695,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(590_B_)",50.4325,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(590_C_)",47.6475,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(293_D_)",56.6027,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(293_A_)",38.4331,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(293_C_)",53.3511,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(590_A_)",47.9751,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(293_B_)",36.3069,"","",""
"3W3M","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 2","10.1126/SCIENCE.1229159 ",2.7,57.04,"3w3m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(590_A_)",61.2389,"","",""
"3W3M","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 2","10.1126/SCIENCE.1229159 ",2.7,57.04,"3w3m_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",52.8213,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",40.1222,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",57.1625,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",49.6907,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",50.4042,"","",""
"3W7X","CRYSTAL STRUCTURE OF E. COLI YGJK D324N COMPLEXED WITH MELIBIOSE","10.1111/FEBS.12424 ",2.7,25.07,"3w7x_oligo1","DGalpa1-6DGlcpa1-ROH","GLA(2_C_)-GLC(1_C_)",33.2759,"","",""
"3W7X","CRYSTAL STRUCTURE OF E. COLI YGJK D324N COMPLEXED WITH MELIBIOSE","10.1111/FEBS.12424 ",2.7,25.07,"3w7x_oligo2","DGalpa1-6DGlcpa1-ROH","GLA(2_D_)-GLC(1_D_)",39.7809,"","",""
"3W81","HUMAN ALPHA-L-IDURONIDASE","10.1073/PNAS.1306939110 ",2.3,34.51,"3w81_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(190_B_)",105.573,"","",""
"3W81","HUMAN ALPHA-L-IDURONIDASE","10.1073/PNAS.1306939110 ",2.3,34.51,"3w81_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(372_B_)",54.5497,"","",""
"3W81","HUMAN ALPHA-L-IDURONIDASE","10.1073/PNAS.1306939110 ",2.3,34.51,"3w81_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(372_A_)",46.1867,"","",""
"3W82","HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID","10.1073/PNAS.1306939110 ",2.76,28.14,"3w82_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(372_B_)",50.6829,"","",""
"3W82","HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID","10.1073/PNAS.1306939110 ",2.76,28.14,"3w82_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(190_B_)",80.5005,"","",""
"3W82","HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID","10.1073/PNAS.1306939110 ",2.76,28.14,"3w82_oligo7","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(372_A_)",29.6338,"","",""
"3WAV","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH COMPOUND 10","10.1021/CB400150C ",1.8,35.45,"3wav_oligo3","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",37.3873,"","",""
"3WAW","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 2BOA","10.1021/CB400150C ",1.95,38.54,"3waw_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",48.2187,"","",""
"3WAX","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 3BOA","10.1021/CB400150C ",1.9,35.71,"3wax_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",47.38,"","",""
"3WAY","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 4BOA","10.1021/CB400150C ",1.75,30.21,"3way_oligo4","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",32.962,"","",""
"3WCT","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: OXYGENATED FORM","10.1107/S1399004714008475 ",2.4,48.1,"3wct_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",137.269,"","",""
"3WCT","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: OXYGENATED FORM","10.1107/S1399004714008475 ",2.4,48.1,"3wct_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",138.051,"","",""
"3WCU","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: DEOXYGENATED FORM","10.1107/S1399004714008475 ",2.9,70.75,"3wcu_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",184.658,"","",""
"3WCU","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: DEOXYGENATED FORM","10.1107/S1399004714008475 ",2.9,70.75,"3wcu_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",184.658,"","",""
"3WCV","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: CA BOUND FORM","10.1107/S1399004714008475 ",2.6,61.72,"3wcv_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",146.525,"","",""
"3WCV","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: CA BOUND FORM","10.1107/S1399004714008475 ",2.6,61.72,"3wcv_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",143.834,"","",""
"3WCW","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: MG BOUND FORM","10.1107/S1399004714008475 ",2.5,42.04,"3wcw_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",126.94,"","",""
"3WCW","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: MG BOUND FORM","10.1107/S1399004714008475 ",2.5,42.04,"3wcw_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",104.769,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",81.7589,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",80.7042,"","",""
"3WJL","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.86,65.55,"3wjl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",119.817,"","",""
"3WJL","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.86,65.55,"3wjl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",64.4536,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo6","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(208_D_)",83.3209,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo7","DManpb1-3DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[BMA(5_K_)-BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(211_E_)",70.4524,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(211_A_)",57.6647,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo5","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(208_C_)",81.06,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_S_)-[GAL(6_S_)-NAG(5_S_)-MAN(4_S_)-[NAG(8_S_)-MAN(7_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(297_A_)",62.0332,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_W_)-[GAL(6_W_)-NAG(5_W_)-MAN(4_W_)-[NAG(8_W_)-MAN(7_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(297_M_)",69.9621,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_R_)-[GAL(6_R_)-NAG(5_R_)-MAN(4_R_)-[NAG(8_R_)-MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(297_B_)",83.8199,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_V_)-[GAL(6_V_)-NAG(5_V_)-MAN(4_V_)-[NAG(8_V_)-MAN(7_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(297_J_)",83.2386,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_X_)-[GAL(6_X_)-NAG(5_X_)-MAN(4_X_)-[NAG(8_X_)-MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(297_N_)",89.819,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_Q_)-[GAL(6_Q_)-NAG(5_Q_)-MAN(4_Q_)-[NAG(8_Q_)-MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(297_C_)",77.8989,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_T_)-[GAL(6_T_)-NAG(5_T_)-MAN(4_T_)-[NAG(8_T_)-MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(297_D_)",59.0888,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_U_)-[GAL(6_U_)-NAG(5_U_)-MAN(4_U_)-[NAG(8_U_)-MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(297_I_)",66.7113,"","",""
"3WLH","CRYSTAL STRUCTURE ANALYSIS OF PLANT EXOHYDROLASE","10.1038/S41467-019-09691-Z ",1.65,26.49,"3wlh_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUL(6_C_)]-NAG(1_C_)-ASN(498_A_)",56.9233,"","",""
"3WLJ","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 3-DEOXY-GLUCOSE","10.1038/S41467-019-09691-Z ",1.67,26.37,"3wlj_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUL(6_C_)]-NAG(1_C_)-ASN(498_A_)",64.0915,"","",""
"3WLK","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4-DEOXY-GLUCOSE","10.1038/S41467-019-09691-Z ",1.8,29.96,"3wlk_oligo3","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(498_X_)",67.0644,"","",""
"3WLL","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH PEG400","10.1038/S41467-019-09691-Z ",1.8,30.34,"3wll_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",54.6636,"","",""
"3WLN","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH OCTYL-S-GLUCOSIDE","10.1038/S41467-019-09691-Z ",2,32.21,"3wln_oligo2","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(498_A_)",81.3987,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_K_)-[NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(297_D_)",57.258,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",54.1912,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(159_C_)",70.6342,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)-[NAG(8_L_)-MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_E_)",70.6244,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",67.0639,"","",""
"3WNL","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOHEXAOSE","10.1074/JBC.M114.547992 ",2.6,69.16,"3wnl_oligo3","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",124.541,"","",""
"3WNL","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOHEXAOSE","10.1074/JBC.M114.547992 ",2.6,69.16,"3wnl_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-BGC(1_B_)",63.6945,"","",""
"3WNM","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOHEPTAOSE","10.1074/JBC.M114.547992 ",2.25,42.52,"3wnm_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(7_B_)-GLC(6_B_)-GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-BGC(1_B_)",44.2125,"","",""
"3WNM","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOHEPTAOSE","10.1074/JBC.M114.547992 ",2.25,42.52,"3wnm_oligo3","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",73.6364,"","",""
"3WNN","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOOCTAOSE","10.1074/JBC.M114.547992 ",2.25,48.54,"3wnn_oligo5","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_D_)-GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",74.4041,"","",""
"3WNN","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOOCTAOSE","10.1074/JBC.M114.547992 ",2.25,48.54,"3wnn_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(8_E_)-GLC(7_E_)-GLC(6_E_)-GLC(5_E_)-GLC(4_E_)-GLC(3_E_)-GLC(2_E_)-BGC(1_E_)",39.9185,"","",""
"3WNN","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOOCTAOSE","10.1074/JBC.M114.547992 ",2.25,48.54,"3wnn_oligo3","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(8_C_)-GLC(7_C_)-GLC(6_C_)-GLC(5_C_)-GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-BGC(1_C_)",49.0448,"","",""
"3WNN","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOOCTAOSE","10.1074/JBC.M114.547992 ",2.25,48.54,"3wnn_oligo6","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(5_F_)-GLC(4_F_)-GLC(3_F_)-GLC(2_F_)-GLC(1_F_)",70.2533,"","",""
"3WNO","D308A MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH CYCLOISOMALTOOCTAOSE","10.1074/JBC.M114.547992 ",1.9,28.4,"3wno_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_G_)-GLC(3_G_)-GLC(2_G_)-GLC(1_G_)",41.548,"","",""
"3WNP","D308A, F268V, D469Y, A513V, AND Y515S QUINTUPLE MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOUNDECAOSE","10.1042/BJ20140860 ",2.8,66.99,"3wnp_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-BGC(1_C_)",55.4982,"","",""
"3WNP","D308A, F268V, D469Y, A513V, AND Y515S QUINTUPLE MUTANT OF BACILLUS CIRCULANS T-3040 CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH ISOMALTOUNDECAOSE","10.1042/BJ20140860 ",2.8,66.99,"3wnp_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(4_D_)-GLC(3_D_)-GLC(2_D_)-BGC(1_D_)",57.4155,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(197_F_)",134.905,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo9","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(197_B_)",136.092,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo22","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_h_)-[NAG(2_h_)]-NAG(1_h_)-ASN(297_J_)",114.031,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(197_D_)",117.753,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_Z_)-[MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(297_F_)",106.165,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo12","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(150_D_)",129.953,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo18","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_d_)-[BMA(3_d_)-NAG(2_d_)]-NAG(1_d_)-ASN(297_H_)",97.1027,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(236_F_)",128.081,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(197_H_)",141.877,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(297_B_)",88.5076,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(150_B_)",159.317,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo26","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_l_)-[BMA(3_l_)-NAG(2_l_)]-NAG(1_l_)-ASN(297_L_)",147.641,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(297_D_)",107.662,"","",""
"3WO4","CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX","10.1038/NCOMMS6340 ",3.1,77.81,"3wo4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(197_B_)",156.914,"","",""
"3WO4","CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX","10.1038/NCOMMS6340 ",3.1,77.81,"3wo4_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",108.799,"","",""
"3WO4","CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX","10.1038/NCOMMS6340 ",3.1,77.81,"3wo4_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(150_B_)",145.649,"","",""
"3WQ6","BETA-PRIMEVEROSIDASE IN COMPLEX WITH DISACCHARIDE SUBSTRATE-ANALOG N- BETA-PRIMEVEROSYLAMIDINE, ARTIFICIAL AGLYCONE DERIVATIVE","10.1074/JBC.M114.553271 ",1.8,0,"3wq6_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(35_A_)",34.0516,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",26.7068,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo18","DGalpa1-6DGalpb1-C35O5","DGD(919_c_)-DGD(919_c_)",27.9373,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",35.8564,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",31.1341,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",25.17,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",25.4968,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(917_c_)-DGD(917_c_)",27.3755,"","",""
"3WU2","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1038/NATURE09913 ",1.9,35.3,"3wu2_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(918_c_)-DGD(918_c_)",31.4359,"","",""
"3WWG","CRYSTAL STRUCTURE OF THE N-GLYCAN-DEFICIENT VARIANT N448A OF ISOPULLULANASE COMPLEXED WITH ISOPANOSE","10.1093/JB/MVU065 ",2.2,29.86,"3wwg_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_E_)-BGC(1_E_)",67.32,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(75_A_)",30.1538,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(75_B_)",53.1377,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(458_A_)",48.6839,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(458_B_)",66.8857,"","",""
"3ZDX","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.45,59.8,"3zdx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",87.558,"","",""
"3ZDZ","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.75,91.9,"3zdz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",94.4518,"","",""
"3ZE2","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.35,66.4,"3ze2_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",61.6473,"","",""
"3ZMR","BACTEROIDES OVATUS GH5 XYLOGLUCANASE IN COMPLEX WITH A XXXG HEPTASACCHARIDE","10.1038/NATURE12907 ",1.43,22.61,"3zmr_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpx1-","XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-GLC(1519_A_)",31.6896,"","",""
"3ZMR","BACTEROIDES OVATUS GH5 XYLOGLUCANASE IN COMPLEX WITH A XXXG HEPTASACCHARIDE","10.1038/NATURE12907 ",1.43,22.61,"3zmr_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-C6O6","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-GLO(1_D_)",42.0001,"","",""
"3ZO0","MOUSE IGG2A IN COMPLEX WITH MOUSE TRIM21 PRYSPRY","10.1073/PNAS.0800159105 ",1.99,36.52,"3zo0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",32.8146,"","",""
"3ZQZ","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH A SELENIUM ANALOGUE OF CAPTOPRIL","10.1111/J.1742-4658.2011.08276.X ",2.35,57,"3zqz_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",90.8656,"","",""
"3ZS0","HUMAN MYELOPEROXIDASE INACTIVATED BY TX2","10.1074/JBC.M111.266981 ",2.3,20.63,"3zs0_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",30.2049,"","",""
"3ZS0","HUMAN MYELOPEROXIDASE INACTIVATED BY TX2","10.1074/JBC.M111.266981 ",2.3,20.63,"3zs0_oligo1","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",30.3838,"","",""
"3ZS1","HUMAN MYELOPEROXIDASE INACTIVATED BY TX5","10.1074/JBC.M111.266981 ",2.6,13.62,"3zs1_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",24.1614,"","",""
"3ZVX","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH A TRIMANNOSIDE","10.1074/JBC.M112.375816 ",2.1,24.05,"3zvx_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_C_)-[MAN(2_C_)]-MAN(1_C_)",22.723,"","",""
"3ZYR","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH HEPTASACCHARIDE","10.1074/JBC.M112.375816 ",1.65,11.04,"3zyr_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",15.7529,"","",""
"3ZYR","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH HEPTASACCHARIDE","10.1074/JBC.M112.375816 ",1.65,11.04,"3zyr_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(299_A_)",13.1886,"","",""
"4A5S","CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A NOVAL HETEROCYCLIC DPP4 INHIBITOR","10.1016/J.BMCL.2011.11.054 ",1.62,25.12,"4a5s_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",29.2645,"","",""
"4AA1","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH ANGIOTENSIN-II","10.1111/FEBS.12038 ",1.99,35.55,"4aa1_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.5591,"","",""
"4AA2","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ POTENTIATING PEPTIDE B","10.1111/FEBS.12038 ",1.99,37.56,"4aa2_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",57.2048,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo8","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-MAN(4_f_)-[MAN(6_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(95_N_)",223.533,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(6_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(95_A_)",241.915,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(95_M_)",239.43,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(95_D_)",241.949,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(95_F_)",254.849,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(95_B_)",243.121,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-[MAN(7_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(95_R_)",252.145,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo10","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-[MAN(6_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(95_P_)",251.851,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)]-MAN(4_a_)-[MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(95_C_)",283.17,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)]-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(95_Q_)",252.18,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(95_E_)",268.379,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(95_O_)",218.91,"","",""
"4AGT","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUC1-6GLCNAC.","10.1107/S1399004714026595 ",2,13.67,"4agt_oligo2","LFucpa1-6DGlcpNAcb1-ROH","FUC(2_D_)-NAG(1_D_)",20.7036,"","",""
"4AGT","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUC1-6GLCNAC.","10.1107/S1399004714026595 ",2,13.67,"4agt_oligo1","LFucpa1-6DGlcpNAca1-ROH","FUC(2_C_)-NDG(1_C_)",23.0641,"","",""
"4AL9","CRYSTAL STRUCTURE OF THE LECTIN PA-IL FROM PSEUDOMONAS AERUGINOAS IN COMPLEX WITH MELIBIOSE","10.1002/PROT.24430 ",1.75,17.25,"4al9_oligo2","DGalpa1-6DGlcpa1-ROH","GLA(2_J_)-GLC(1_J_)",18.3923,"","",""
"4AL9","CRYSTAL STRUCTURE OF THE LECTIN PA-IL FROM PSEUDOMONAS AERUGINOAS IN COMPLEX WITH MELIBIOSE","10.1002/PROT.24430 ",1.75,17.25,"4al9_oligo1","DGalpa1-6DGlcpa1-ROH","GLA(2_I_)-GLC(1_I_)",16.0573,"","",""
"4AMT","CRYSTAL STRUCTURE AT 2.6A OF HUMAN PRORENIN","",2.6,80.37,"4amt_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(118_A_)",77.0859,"","",""
"4AQB","MBL-FICOLIN ASSOCIATED PROTEIN-1, MAP-1 AKA MAP44","10.1074/JBC.M112.386680 ",4.2,145.5,"4aqb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(49_A_)",268.584,"","",""
"4ARN","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF DROSOPHILA TOLL RECEPTOR","10.1016/J.STR.2012.11.003 ",2.41,66.68,"4arn_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(140_C_)",97.6677,"","",""
"4ARN","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF DROSOPHILA TOLL RECEPTOR","10.1016/J.STR.2012.11.003 ",2.41,66.68,"4arn_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(140_A_)",111.605,"","",""
"4ASQ","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ","10.1111/FEBS.12038 ",1.99,29.32,"4asq_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.4294,"","",""
"4ASR","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH THR6-BRADYKININ","10.1111/FEBS.12038 ",1.9,26.7,"4asr_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",40.9314,"","",""
"4AVV","STRUCTURE OF CPHPC BOUND TO SERUM AMYLOID P COMPONENT","10.1107/S1399004714013455 ",1.6,18.9,"4avv_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_G_)-MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(32_D_)",33.5094,"","",""
"4B1Q","NMR STRUCTURE OF THE GLYCOSYLATED CONOTOXIN CCTX FROM CONUS CONSORS","10.1002/CHEM.201202713 ","2.95026e-39",0,"4b1q_oligo1","LGalpa1-2DGalpb1-3[LGalpa1-4DGlcpNAca1-6]DGalpNAcx1-","GXL(5_A_)-NDG(4_A_)-[GXL(3_A_)-GAL(2_A_)]-A2G(1_A_)",36.6727,"","",""
"4B56","STRUCTURE OF ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (NPP1)","10.1016/J.STR.2012.09.001 ",3,116.1,"4b56_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(567_B_)",152.127,"","",""
"4B56","STRUCTURE OF ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (NPP1)","10.1016/J.STR.2012.09.001 ",3,116.1,"4b56_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",130.868,"","",""
"4B7I","CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS","10.1021/JA306068G ",2.36,43.41,"4b7i_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",85.9662,"","",""
"4BDV","CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII","10.1515/HSZ-2012-0298 ",3.98,160.4,"4bdv_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(2118_B_)",232.889,"","",""
"4BFN","CRYSTAL STRUCTURE OF THE STARCH-BINDING DOMAIN FROM RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH ISOMALTOTETRAOSE","10.1002/PROT.24446 ",1.32,14.06,"4bfn_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",33.3425,"","",""
"4BFO","CRYSTAL STRUCTURE OF THE STARCH-BINDING DOMAIN FROM RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH ISOMALTOTRIOSE","10.1002/PROT.24446 ",1.18,10.24,"4bfo_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",24.9618,"","",""
"4BH2","CRYSTAL STRUCTURE OF THE HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS","10.1038/NATURE12144 ",2.12,45.5,"4bh2_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",66.8815,"","",""
"4BH3","HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE 6'-SLN","10.1038/NATURE12144 ",2,38.24,"4bh3_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",47.2706,"","",""
"4BH4","HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'-SLN","10.1038/NATURE12144 ",1.9,38.74,"4bh4_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",45.6453,"","",""
"4BJ0","XYLOGLUCAN BINDING MODULE (CBM4-2 X2-L110F) IN COMPLEX WITH BRANCHED XYLOSES","10.1002/PROT.24700 ",1,14.1,"4bj0_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",12.165,"","",""
"4BM7","CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION","10.1021/JA4014375 ",1.95,45.81,"4bm7_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9148,"","",""
"4BOE","JAPANIN FROM RHIPICEPHALUS APPENDICULATUS BOUND TO CHOLESTEROL: TETRAGONAL CRYSTAL FORM","10.1038/S41598-017-16413-2 ",2.24,46.31,"4boe_oligo5","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(131_A_)",70.6423,"","",""
"4BOJ","CRYSTAL STRUCTURE OF BACILLUS CIRCULANS TN-31 AMAN6 IN COMPLEX WITH MANNOBIOSE","",1.38,0,"4boj_oligo3","DManpa1-6DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",15.575,"","",""
"4BOJ","CRYSTAL STRUCTURE OF BACILLUS CIRCULANS TN-31 AMAN6 IN COMPLEX WITH MANNOBIOSE","",1.38,0,"4boj_oligo1","DManpa1-6DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",12.1755,"","",""
"4BOJ","CRYSTAL STRUCTURE OF BACILLUS CIRCULANS TN-31 AMAN6 IN COMPLEX WITH MANNOBIOSE","",1.38,0,"4boj_oligo2","DManpa1-6DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",10.9705,"","",""
"4BQU","JAPANIN FROM RHIPICEPHALUS APPENDICULATUS BOUND TO CHOLESTEROL: ORTHORHOMBIC CRYSTAL FORM","10.1038/S41598-017-16413-2 ",2.36,56.46,"4bqu_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(131_A_)",97.6827,"","",""
"4BQU","JAPANIN FROM RHIPICEPHALUS APPENDICULATUS BOUND TO CHOLESTEROL: ORTHORHOMBIC CRYSTAL FORM","10.1038/S41598-017-16413-2 ",2.36,56.46,"4bqu_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(131_B_)",87.8,"","",""
"4BQU","JAPANIN FROM RHIPICEPHALUS APPENDICULATUS BOUND TO CHOLESTEROL: ORTHORHOMBIC CRYSTAL FORM","10.1038/S41598-017-16413-2 ",2.36,56.46,"4bqu_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(35_B_)",102.181,"","",""
"4BSV","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1","10.4161/MABS.25632 ",1.75,25.78,"4bsv_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",73.5696,"","",""
"4BSV","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1","10.4161/MABS.25632 ",1.75,25.78,"4bsv_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(297_A_)",46.4595,"","",""
"4BSV","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1","10.4161/MABS.25632 ",1.75,25.78,"4bsv_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcx1-","GAL(5_D_)-NAG(4_D_)-MAN(3_D_)-BMA(2_D_)-NAG(1_D_)",37.9626,"","",""
"4BSW","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","10.4161/MABS.25632 ",2.15,45.51,"4bsw_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",73.5148,"","",""
"4BSW","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","10.4161/MABS.25632 ",2.15,45.51,"4bsw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.1684,"","",""
"4BTW","CRYSTAL STRUCTURE OF HUMAN VASCULAR ADHESION PROTEIN-1 IN COMPLEX WITH PYRIDAZINONE INHIBITORS","10.1021/JM401372D ",2.8,0,"4btw_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",111.674,"","",""
"4BV4","STRUCTURE AND ALLOSTERY IN TOLL-SPATZLE RECOGNITION","10.1073/PNAS.1317002110 ",2.35,59.74,"4bv4_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_A_)-[MAN(7_A_)]-BMA(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(346_R_)",68.4011,"","",""
"4BXK","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DOMAIN-SPECIFIC INHIBITOR","10.1042/CS20130403 ",2.2,28.23,"4bxk_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",46.0105,"","",""
"4BXK","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DOMAIN-SPECIFIC INHIBITOR","10.1042/CS20130403 ",2.2,28.23,"4bxk_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(416_A_)",47.3102,"","",""
"4BXS","CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS","10.1182/BLOOD-2013-06-511733 ",3.32,117.5,"4bxs_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(212_V_)",148.042,"","",""
"4BYH","CRYSTAL STRUCTURE OF SIALYLATED IGG FC","10.1073/PNAS.1310657110 ",2.3,66.11,"4byh_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.0439,"","",""
"4BYH","CRYSTAL STRUCTURE OF SIALYLATED IGG FC","10.1073/PNAS.1310657110 ",2.3,66.11,"4byh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_D_)-[GAL(9_D_)-NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",61.7989,"","",""
"4BZR","HUMAN TESTIS ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH K-26","10.1021/ML4004588 ",1.84,23.37,"4bzr_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",46.218,"","",""
"4BZS","HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH K-26","10.1021/ML4004588 ",2.1,40.64,"4bzs_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_B_)",57.4241,"","",""
"4BZS","HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH K-26","10.1021/ML4004588 ",2.1,40.64,"4bzs_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",61.8132,"","",""
"4C1M","MYELOPEROXIDASE IN COMPLEX WITH THE REVESIBLE INHIBITOR HX1","10.1074/JBC.M113.507756 ",2,0,"4c1m_oligo1","DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",22.2062,"","",""
"4C1M","MYELOPEROXIDASE IN COMPLEX WITH THE REVESIBLE INHIBITOR HX1","10.1074/JBC.M113.507756 ",2,0,"4c1m_oligo3","DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",24.5333,"","",""
"4C2O","CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT D465T","10.1074/JBC.M113.512335 ",1.8,19.78,"4c2o_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",39.2116,"","",""
"4C2P","CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522K IN COMPLEX WITH CAPTOPRIL","10.1074/JBC.M113.512335 ",1.99,23.74,"4c2p_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)",53.2163,"","",""
"4C2Q","CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522K","10.1074/JBC.M113.512335 ",2.4,31.44,"4c2q_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",57.7186,"","",""
"4C53","CRYSTAL STRUCTURE OF GUANARITO VIRUS GP2 IN THE POST-FUSION CONFORMATION","10.1128/JVI.02298-13 ",4.14,222.8,"4c53_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(381_C_)",295.647,"","",""
"4C53","CRYSTAL STRUCTURE OF GUANARITO VIRUS GP2 IN THE POST-FUSION CONFORMATION","10.1128/JVI.02298-13 ",4.14,222.8,"4c53_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(351_B_)",294.068,"","",""
"4C53","CRYSTAL STRUCTURE OF GUANARITO VIRUS GP2 IN THE POST-FUSION CONFORMATION","10.1128/JVI.02298-13 ",4.14,222.8,"4c53_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(314_C_)",295.576,"","",""
"4C54","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",1.9,0,"4c54_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",59.663,"","",""
"4C54","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",1.9,0,"4c54_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",44.019,"","",""
"4C55","CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",2.35,0,"4c55_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",82.7285,"","",""
"4C55","CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",2.35,0,"4c55_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[NAG1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",52.4188,"","",""
"4C7L","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ- ESTERASE","10.1371/JOURNAL.PPAT.1002492 ",2.1,45.72,"4c7l_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(374_B_)",48.7514,"","",""
"4C7W","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ- ESTERASE IN COMPLEX WITH 4-O-ACETYLATED SIALIC ACID","10.1371/JOURNAL.PPAT.1002492 ",2.5,45.02,"4c7w_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(374_B_)",41.7751,"","",""
"4C9F","STRUCTURE OF SIGN-R1 IN COMPLEX WITH SULFODEXTRAN","10.1016/J.STR.2014.09.001 ",2.6,34.52,"4c9f_oligo4","DGlcpa1-6DGlcp[4S]a1-ROH","GLC(2_E_)-GQ1(1_E_)",92.5027,"","",""
"4C9F","STRUCTURE OF SIGN-R1 IN COMPLEX WITH SULFODEXTRAN","10.1016/J.STR.2014.09.001 ",2.6,34.52,"4c9f_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcp[4S]a1-ROH","GLC(4_G_)-GLC(3_G_)-GLC(2_G_)-GQ1(1_G_)",99.585,"","",""
"4C9F","STRUCTURE OF SIGN-R1 IN COMPLEX WITH SULFODEXTRAN","10.1016/J.STR.2014.09.001 ",2.6,34.52,"4c9f_oligo6","DGlcpa1-6DGlcpa1-ROH","GLC(2_F_)-GQ1(1_F_)",74.6073,"","",""
"4CA5","HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI","10.1111/FEBS.12660 ",1.85,18.48,"4ca5_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",36.8982,"","",""
"4CA6","HUMAN ANGIOTENSIN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI","10.1111/FEBS.12660 ",1.91,29.76,"4ca6_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(416_A_)",50.551,"","",""
"4CA6","HUMAN ANGIOTENSIN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI","10.1111/FEBS.12660 ",1.91,29.76,"4ca6_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",54.7755,"","",""
"4CA6","HUMAN ANGIOTENSIN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI","10.1111/FEBS.12660 ",1.91,29.76,"4ca6_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_B_)",53.0623,"","",""
"4CA7","DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI","10.1111/FEBS.12660 ",1.82,28.86,"4ca7_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",52.1352,"","",""
"4CA8","DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FII","10.1111/FEBS.12660 ",1.99,30,"4ca8_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",56.2638,"","",""
"4CDH","CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC- FRAGMENT","10.1016/J.STR.2014.09.001 ",2.3,43.12,"4cdh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(78_B_)",68.154,"","",""
"4CDH","CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC- FRAGMENT","10.1016/J.STR.2014.09.001 ",2.3,43.12,"4cdh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(78_A_)",55.2306,"","",""
"4CPM","STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH OSELTAMIVIR","10.1093/INFDIS/JIU244 ",2.75,46.6,"4cpm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(283_A_)",101.562,"","",""
"4CPN","STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH ZANAMIVIR","10.1093/INFDIS/JIU244 ",2.4,0,"4cpn_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(283_A_)",93.6668,"","",""
"4CQP","CRYSTAL STRUCTURE OF H5 (VN1194) SER227ASN/GLN196ARG MUTANT HAEMAGGLUTININ","10.1016/J.VIROL.2014.03.008 ",2.65,101.6,"4cqp_oligo3","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",195.055,"","",""
"4CQQ","H5 (VN1194) SER227ASN/GLN196ARG MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'SLN","10.1016/J.VIROL.2014.03.008 ",2.55,87.51,"4cqq_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",153.499,"","",""
"4CQR","H5 (VN1194) SER227ASN/GLN196ARG MUTANT HAEMAGGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE 6'SLN","10.1016/J.VIROL.2014.03.008 ",2.45,88.76,"4cqr_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",155.548,"","",""
"4CQS","H5 (VN1194) ASN186LYS MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'SLN","10.1016/J.VIROL.2014.03.008 ",2.55,78.98,"4cqs_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",144.656,"","",""
"4CQU","H5 (VN1194) ASN186LYS MUTANT HAEMAGGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE 6'SLN","10.1016/J.VIROL.2014.03.008 ",2.48,85.13,"4cqu_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",151.433,"","",""
"4CUO","BANYAN PEROXIDASE WITH GLYCOSYLATION","10.1111/FEBS.12900 ",1.67,41.56,"4cuo_oligo4","DXylpa1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",51.3664,"","",""
"4CVU","STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",1.9,46.08,"4cvu_oligo2","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(86_A_)",57.4459,"","",""
"4CVU","STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",1.9,46.08,"4cvu_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(255_A_)",50.1096,"","",""
"4CWM","HIGH-GLYCOSYLATION CRYSTAL STRUCTURE OF THE BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA","10.1371/JOURNAL.PONE.0105821 ",2.09,27.39,"4cwm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(91_A_)",36.4491,"","",""
"4CWM","HIGH-GLYCOSYLATION CRYSTAL STRUCTURE OF THE BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA","10.1371/JOURNAL.PONE.0105821 ",2.09,27.39,"4cwm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(91_B_)",44.0424,"","",""
"4CXO","BIFUNCTIONAL ENDONUCLEASE IN COMPLEX WITH SSDNA","10.1371/JOURNAL.PONE.0105821 ",1.67,27.7,"4cxo_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(91_A_)",42.6776,"","",""
"4CXP","STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SULFATE","10.1371/JOURNAL.PONE.0105821 ",1.22,16.19,"4cxp_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(91_A_)",22.3191,"","",""
"4CXV","STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) IN COMPLEX WITH PHOSPHATE.","10.1371/JOURNAL.PONE.0105821 ",2,28.36,"4cxv_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(91_B_)",42.2477,"","",""
"4CYV","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ","10.1038/NATURE13443 ",2.3,57.08,"4cyv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(82_D_)",73.5427,"","",""
"4CYV","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ","10.1038/NATURE13443 ",2.3,57.08,"4cyv_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(82_F_)",96.4684,"","",""
"4CYV","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ","10.1038/NATURE13443 ",2.3,57.08,"4cyv_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]x1-","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",67.3417,"","",""
"4CYW","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOG 6-SLN","10.1038/NATURE13443 ",2.6,60.89,"4cyw_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(82_D_)",89.8085,"","",""
"4CYW","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOG 6-SLN","10.1038/NATURE13443 ",2.6,60.89,"4cyw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(82_B_)",97.7984,"","",""
"4CYZ","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG LSTA","10.1038/NATURE13443 ",2.4,47.62,"4cyz_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(82_D_)",77.4642,"","",""
"4CYZ","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG LSTA","10.1038/NATURE13443 ",2.4,47.62,"4cyz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(82_B_)",69.9162,"","",""
"4CZ0","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG SU-3SLN","10.1038/NATURE13443 ",3.2,97.39,"4cz0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(82_D_)",122.121,"","",""
"4CZ0","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG SU-3SLN","10.1038/NATURE13443 ",3.2,97.39,"4cz0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(82_B_)",112.866,"","",""
"4CZ0","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG SU-3SLN","10.1038/NATURE13443 ",3.2,97.39,"4cz0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(82_F_)",132.055,"","",""
"4D6W","CRYSTAL STRUCTURE OF THE LOW PH CONFORMATION OF CHANDIPURA VIRUS GLYCOPROTEIN G ECTODOMAIN","10.1371/JOURNAL.PPAT.1004756 ",3.6,0,"4d6w_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(323_B_)",144.116,"","",""
"4DAG","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE","10.1038/NSMB.2250 ",3.39,0,"4dag_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(353_A_)",135.588,"","",""
"4DAG","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE","10.1038/NSMB.2250 ",3.39,0,"4dag_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(57_A_)",170.121,"","",""
"4DBM","APLYSIA CALIFORNICA-ACHBP IN COMPLEX WITH TRIAZOLE 18","10.1021/JA3001858 ",2.3,36.15,"4dbm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(74_E_)",74.8498,"","",""
"4DGR","INFLUENZA SUBTYPE 9 NEURAMINIDASE BENZOIC ACID INHIBITOR COMPLEX","10.1186/1472-6807-12-7 ",1.55,0,"4dgr_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",22.4599,"","",""
"4DJ4","X-RAY STRUCTURE OF MUTANT N211D OF BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)","10.1107/S0907444912043697 ",2.35,40.61,"4dj4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(137_B_)",77.544,"","",""
"4DJ4","X-RAY STRUCTURE OF MUTANT N211D OF BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)","10.1107/S0907444912043697 ",2.35,40.61,"4dj4_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(137_A_)",61.9916,"","",""
"4DKE","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1","10.1016/J.STR.2012.02.010 ",3,67.84,"4dke_oligo2","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(76_B_)",106.069,"","",""
"4DKE","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1","10.1016/J.STR.2012.02.010 ",3,67.84,"4dke_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",100.573,"","",""
"4DKF","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2","10.1016/J.STR.2012.02.010 ",2.61,63.75,"4dkf_oligo2","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(76_B_)",96.8184,"","",""
"4DKF","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2","10.1016/J.STR.2012.02.010 ",2.61,63.75,"4dkf_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",83.5982,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_V_)-[MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(317_L_)",28.3247,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_X_)-[MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(317_P_)",34.2679,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_T_)-[MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(317_H_)",31.9327,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_W_)-[MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(317_O_)",38.8638,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(189_P_)",37.6947,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(317_G_)",40.9082,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Q_)-[MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(317_C_)",30.2408,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_R_)-[MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(317_D_)",27.3439,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_U_)-[MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(317_K_)",31.3267,"","",""
"4DO4","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.4,31.11,"4do4_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",72.9245,"","",""
"4DO4","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.4,31.11,"4do4_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(124_B_)",99.2379,"","",""
"4DO4","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.4,31.11,"4do4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",65.2056,"","",""
"4DO5","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.51,29.56,"4do5_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",67.6104,"","",""
"4DO5","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.51,29.56,"4do5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",57.1147,"","",""
"4DO6","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.6,30.99,"4do6_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(124_B_)",99.3391,"","",""
"4DO6","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.6,30.99,"4do6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",59.6395,"","",""
"4DO6","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.6,30.99,"4do6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",67.1178,"","",""
"4DQO","CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NSMB.2600 ",2.44,0,"4dqo_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_B_)-[MAN(9_B_)]-MAN(8_B_)-[SIA(7_B_)-GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(173_C_)",69.023,"","",""
"4DQO","CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NSMB.2600 ",2.44,0,"4dqo_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(160_C_)",60.5177,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo4","DGalpb1-6DGlcpb1-ROH","GAL(2_H_)-BGC(1_H_)",51.1918,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo1","DGalpb1-6DGlcpb1-ROH","GAL(2_E_)-BGC(1_E_)",55.8186,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo3","DGalpb1-6DGlcpb1-ROH","GAL(2_G_)-BGC(1_G_)",47.8818,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo2","DGalpb1-6DGlcpb1-ROH","GAL(2_F_)-BGC(1_F_)",46.4468,"","",""
"4DVK","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 STRAIN NCP-7","10.1016/J.STR.2012.03.018 ",2.21,42.29,"4dvk_oligo3","DManpb1-6DManpb1-3[DManpa1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[BMA(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",54.4716,"","",""
"4DVK","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 STRAIN NCP-7","10.1016/J.STR.2012.03.018 ",2.21,42.29,"4dvk_oligo1","DManpa1-4DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[BMA(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",51.8759,"","",""
"4DVL","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP","10.1016/J.STR.2012.03.018 ",2.75,62.41,"4dvl_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",64.992,"","",""
"4DVL","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP","10.1016/J.STR.2012.03.018 ",2.75,62.41,"4dvl_oligo2","DManpb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[BMA(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",63.0053,"","",""
"4DVN","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP","10.1016/J.STR.2012.03.018 ",2.38,33.59,"4dvn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",42.4427,"","",""
"4DVN","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP","10.1016/J.STR.2012.03.018 ",2.38,33.59,"4dvn_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",43.696,"","",""
"4DVN","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP","10.1016/J.STR.2012.03.018 ",2.38,33.59,"4dvn_oligo9","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(13_A_)",51.3482,"","",""
"4DW1","CRYSTAL STRUCTURE OF THE ATP-GATED P2X4 ION CHANNEL IN THE ATP-BOUND, OPEN STATE AT 2.8 ANGSTROMS","10.1038/NATURE11010 ",2.8,0,"4dw1_oligo3","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(213_A_)",96.7509,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo7","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(13_A_)",49.4885,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",44.0882,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",45.8547,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo11","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(4_B_)",37.4459,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",39.7051,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo8","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(13_A_)",35.8104,"","",""
"4DW5","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A NON-CLEAVABLE CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",2.21,49.18,"4dw5_oligo8","DManpb1-6DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[BMA(5_C_)-BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",53.6144,"","",""
"4DW5","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A NON-CLEAVABLE CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",2.21,49.18,"4dw5_oligo3","DManpb1-6DManpb1-3[DManpb1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_F_)-MAN(6_F_)-[BMA(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",56.4982,"","",""
"4DW7","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.08,79.18,"4dw7_oligo5","DManpb1-6DManpb1-3[DManpa1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[BMA(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",112.431,"","",""
"4DW7","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.08,79.18,"4dw7_oligo6","DManpb1-6DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",86.0696,"","",""
"4DWA","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPUPC TRINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.01,47.86,"4dwa_oligo4","DManpb1-6DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[BMA(5_G_)-BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(4_B_)",66.3174,"","",""
"4DWA","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPUPC TRINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.01,47.86,"4dwa_oligo12","DManpb1-6DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",56.0309,"","",""
"4DWC","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH ZN IONS","10.1016/J.STR.2012.03.018 ",2.89,52.74,"4dwc_oligo4","DManpa1-6DManpb1-3[DManpb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_F_)-MAN(6_F_)-[MAN(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",63.0664,"","",""
"4DWC","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH ZN IONS","10.1016/J.STR.2012.03.018 ",2.89,52.74,"4dwc_oligo1","DManpa1-6DManpb1-3[DManpb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_C_)-MAN(6_C_)-[MAN(5_C_)-BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",71.7091,"","",""
"4DWC","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH ZN IONS","10.1016/J.STR.2012.03.018 ",2.89,52.74,"4dwc_oligo5","DGlcpNAcb1-4[DFucpa1-6]DGlcpNAcb1-ASN","FCA(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(67_B_)",122.815,"","",""
"4DZ8","HUMAN IGG1 FC FRAGMENT HETERODIMER","10.1016/J.JMB.2012.04.020 ",1.91,32.06,"4dz8_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",34.3539,"","",""
"4DZ8","HUMAN IGG1 FC FRAGMENT HETERODIMER","10.1016/J.JMB.2012.04.020 ",1.91,32.06,"4dz8_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",59.2558,"","",""
"4EBZ","CRYSTAL STRUCTURE OF THE ECTODOMAIN OF A RECEPTOR LIKE KINASE","10.1126/SCIENCE.1218867 ",1.79,0,"4ebz_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(102_A_)",57.1115,"","",""
"4ELM","CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX","10.1038/NI.2371 ",3.48,74.93,"4elm_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(165_C_)",86.7645,"","",""
"4EWS","CRYSTAL STRUCTURE OF CHOLESTERYL ESTER TRANSFER PROTEIN IN COMPLEX WITH INHIBITORS","10.1074/JBC.M112.380063 ",2.59,82.43,"4ews_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(396_A_)",145.59,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(76_B_)",125.708,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo7","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_K_)-[BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(76_F_)",126.989,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(76_E_)",137.419,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo4","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",104.646,"","",""
"4EY4","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN THE APO STATE","10.1021/JM300871X ",2.16,0,"4ey4_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",89.4203,"","",""
"4EY4","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN THE APO STATE","10.1021/JM300871X ",2.16,0,"4ey4_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",95.5788,"","",""
"4EY5","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH (-)-HUPERZINE A","10.1021/JM300871X ",2.3,0,"4ey5_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",84.8485,"","",""
"4EY5","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH (-)-HUPERZINE A","10.1021/JM300871X ",2.3,0,"4ey5_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",78.44,"","",""
"4EY6","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH (-)-GALANTAMINE","10.1021/JM300871X ",2.4,0,"4ey6_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",86.4621,"","",""
"4EY6","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH (-)-GALANTAMINE","10.1021/JM300871X ",2.4,0,"4ey6_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",80.2318,"","",""
"4EY7","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DONEPEZIL","10.1021/JM300871X ",2.35,0,"4ey7_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",66.8727,"","",""
"4EY7","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DONEPEZIL","10.1021/JM300871X ",2.35,0,"4ey7_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",63.2179,"","",""
"4EY8","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH FASCICULIN-2","10.1021/JM300871X ",2.6,0,"4ey8_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",122.376,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",147.718,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",151.795,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",130.967,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",148.886,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",151.017,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",148.671,"","",""
"4F0A","CRYSTAL STRUCTURE OF XWNT8 IN COMPLEX WITH THE CYSTEINE-RICH DOMAIN OF FRIZZLED 8","10.1126/SCIENCE.1222879 ",3.25,0,"4f0a_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(263_B_)",126.479,"","",""
"4F12","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR GBR2","10.1038/NN.3133 ",3.02,62.02,"4f12_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(404_A_)",73.8415,"","",""
"4F2A","CRYSTAL STRUCTURE OF CHOLESTRYL ESTERS TRANSFER PROTEIN IN COMPLEX WITH INHIBITORS","10.1074/JBC.M112.380063 ",3.11,102,"4f2a_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(396_A_)",169.891,"","",""
"4F4O","STRUCTURE OF THE HAPTOGLOBIN-HAEMOGLOBIN COMPLEX","10.1038/NATURE11369 ",2.9,0,"4f4o_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_P_)-NAG(1_P_)-ASN(232_F_)",138.947,"","",""
"4F4O","STRUCTURE OF THE HAPTOGLOBIN-HAEMOGLOBIN COMPLEX","10.1038/NATURE11369 ",2.9,0,"4f4o_oligo12","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(232_C_)",134.846,"","",""
"4F4O","STRUCTURE OF THE HAPTOGLOBIN-HAEMOGLOBIN COMPLEX","10.1038/NATURE11369 ",2.9,0,"4f4o_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_S_)-NAG(1_S_)-ASN(232_L_)",198.907,"","",""
"4F4O","STRUCTURE OF THE HAPTOGLOBIN-HAEMOGLOBIN COMPLEX","10.1038/NATURE11369 ",2.9,0,"4f4o_oligo14","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(232_I_)",141.718,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[NAG(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(412_E_)",97.8735,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo19","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(412_B_)",124.786,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(412_F_)",96.1684,"","",""
"4F9U","STRUCTURE OF GLYCOSYLATED GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER","10.1021/BI300687G ",1.8,17.77,"4f9u_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(42_B_)",40.3517,"","",""
"4F9V","STRUCTURE OF C113A/C136A MUTANT VARIANT OF GLYCOSYLATED GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER","10.1021/BI300687G ",2.1,21.13,"4f9v_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",63.6726,"","",""
"4FBV","CRYSTAL STRUCTURE OF THE MYXOCOCCUS XANTHUS HEMAGGLUTININ IN COMPLEX WITH A3,A6-MANNOPENTAOSE","10.1074/JBC.M112.388579 ",1.76,24.26,"4fbv_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-BMA(1_B_)",35.3327,"","",""
"4FBV","CRYSTAL STRUCTURE OF THE MYXOCOCCUS XANTHUS HEMAGGLUTININ IN COMPLEX WITH A3,A6-MANNOPENTAOSE","10.1074/JBC.M112.388579 ",1.76,24.26,"4fbv_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-[MAN(5_C_)]-BMA(1_C_)",21.8129,"","",""
"4FMK","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2","10.1038/NSMB.2366 ",2.56,88.03,"4fmk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(138_A_)",154.553,"","",""
"4FMK","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2","10.1038/NSMB.2366 ",2.56,88.03,"4fmk_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(128_A_)",146.853,"","",""
"4FN0","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2, 2ND CRYSTAL FORM","10.1038/NSMB.2366 ",3.35,135,"4fn0_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(128_A_)",159.413,"","",""
"4FN0","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2, 2ND CRYSTAL FORM","10.1038/NSMB.2366 ",3.35,135,"4fn0_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(138_A_)",146.326,"","",""
"4FN0","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2, 2ND CRYSTAL FORM","10.1038/NSMB.2366 ",3.35,135,"4fn0_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(138_B_)",189.179,"","",""
"4FN0","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2, 2ND CRYSTAL FORM","10.1038/NSMB.2366 ",3.35,135,"4fn0_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(128_B_)",158.479,"","",""
"4FN0","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2, 2ND CRYSTAL FORM","10.1038/NSMB.2366 ",3.35,135,"4fn0_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(128_C_)",155.367,"","",""
"4FNK","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/NATURE11414 ",1.9,0,"4fnk_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",59.8676,"","",""
"4FNK","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/NATURE11414 ",1.9,0,"4fnk_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",59.277,"","",""
"4FNT","CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D548N FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH RAFFINOSE","10.1074/JBC.M112.394114 ",2.6,0,"4fnt_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_F_)-GLC(2_F_)-FRU(1_F_)",90.5755,"","",""
"4FNT","CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D548N FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH RAFFINOSE","10.1074/JBC.M112.394114 ",2.6,0,"4fnt_oligo3","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_G_)-GLC(2_G_)-FRU(1_G_)",79.571,"","",""
"4FNT","CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D548N FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH RAFFINOSE","10.1074/JBC.M112.394114 ",2.6,0,"4fnt_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_E_)-GLC(2_E_)-FRU(1_E_)",96.9461,"","",""
"4FNU","CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D478A FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH STACHYOSE","10.1074/JBC.M112.394114 ",3.6,0,"4fnu_oligo3","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(1_G_)-GLA(2_G_)-GLC(3_G_)-FRU(4_G_)",126.345,"","",""
"4FNU","CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D478A FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH STACHYOSE","10.1074/JBC.M112.394114 ",3.6,0,"4fnu_oligo4","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(1_H_)-GLA(2_H_)-GLC(3_H_)-FRU(4_H_)",114.988,"","",""
"4FNU","CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D478A FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH STACHYOSE","10.1074/JBC.M112.394114 ",3.6,0,"4fnu_oligo2","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(1_F_)-GLA(2_F_)-GLC(3_F_)-FRU(4_F_)",120.421,"","",""
"4FNU","CRYSTAL STRUCTURE OF GH36 ALPHA-GALACTOSIDASE AGAA A355E D478A FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH STACHYOSE","10.1074/JBC.M112.394114 ",3.6,0,"4fnu_oligo1","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(1_E_)-GLA(2_E_)-GLC(3_E_)-FRU(4_E_)",130.941,"","",""
"4FOM","CRYSTAL STRUCTURE OF HUMAN NECTIN-3 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.93,170.5,"4fom_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(222_A_)",133.415,"","",""
"4FOM","CRYSTAL STRUCTURE OF HUMAN NECTIN-3 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.93,170.5,"4fom_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(73_A_)",206.898,"","",""
"4FOM","CRYSTAL STRUCTURE OF HUMAN NECTIN-3 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.93,170.5,"4fom_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",166.612,"","",""
"4FQC","CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N- GLYCAN","10.1073/PNAS.1217207109 ",2.4,32.26,"4fqc_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_A_)-[NAG(9_A_)-MAN(8_A_)-[SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(105_H_)",38.303,"","",""
"4FQP","CRYSTAL STRUCTURE OF HUMAN NECTIN-LIKE 5 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.6,116.4,"4fqp_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(307_A_)",167.318,"","",""
"4FQP","CRYSTAL STRUCTURE OF HUMAN NECTIN-LIKE 5 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.6,116.4,"4fqp_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(120_A_)",141.572,"","",""
"4FS0","CRYSTAL STRUCTURE OF MUTANT F136D OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2","10.1038/NSMB.2366 ",3.25,52.84,"4fs0_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)",57.9182,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-MAN(4_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",151.434,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(654_B_)",165.889,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(44_A_)",142.879,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(371_B_)",152.682,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(844_A_)",198.364,"","",""
"4G1M","RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE","10.1021/BI300734N ",2.9,0,"4g1m_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",118.856,"","",""
"4G1M","RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE","10.1021/BI300734N ",2.9,0,"4g1m_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(44_A_)",151.33,"","",""
"4GC2","CRYSTAL STRUCTURE OF THE BACTERIOCIN LLPA FROM PSEUDOMONAS SP. IN COMPLEX WITH GLCNAC BETA(1-2)MAN ALPHA(1-3)[GLCNAC BETA(1-2)MAN ALPHA(1-6)]MAN","10.1371/JOURNAL.PPAT.1003199 ",2.12,0,"4gc2_oligo1","DGlcpNAcb1-2DRhapa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_C_)-MAN(4_C_)-[NAG(3_C_)-MAN(2_C_)]-MAN(1_C_)",60.7284,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo7","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[NAG(3_M_)]-[FUL(2_M_)]-NAG(1_M_)-ASN(269_F_)",51.335,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-[FUL(5_H_)]-NAG(1_H_)-ASN(269_B_)",75.5186,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo5","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUL(2_K_)]-NAG(1_K_)-ASN(269_E_)",61.5386,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(269_D_)",67.5633,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo3","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[NAG(3_I_)]-[FUL(2_I_)]-NAG(1_I_)-ASN(269_C_)",86.1489,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(5_G_)-[BMA(3_G_)-NAG(2_G_)]-[FUL(4_G_)]-NAG(1_G_)-ASN(269_A_)",66.8293,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(248_E_)",74.9459,"","",""
"4GDJ","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010","10.1073/PNAS.1212579109 ",2,0,"4gdj_oligo1","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUL(2_E_)]-NAG(1_E_)-ASN(269_A_)",45.0114,"","",""
"4GDJ","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010","10.1073/PNAS.1212579109 ",2,0,"4gdj_oligo4","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[NAG(3_H_)]-[FUL(2_H_)]-NAG(1_H_)-ASN(269_D_)",52.355,"","",""
"4GDJ","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010","10.1073/PNAS.1212579109 ",2,0,"4gdj_oligo2","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[NAG(3_F_)]-[FUL(2_F_)]-NAG(1_F_)-ASN(269_B_)",46.5984,"","",""
"4GDJ","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010","10.1073/PNAS.1212579109 ",2,0,"4gdj_oligo3","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUL(2_G_)]-NAG(1_G_)-ASN(269_C_)",44.2993,"","",""
"4GEZ","STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",2.5,0,"4gez_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(260_E_)",53.4368,"","",""
"4GEZ","STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",2.5,0,"4gez_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(260_I_)",68.1736,"","",""
"4GEZ","STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",2.5,0,"4gez_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(260_A_)",47.8568,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-[MAN(5_B_)]-BMA(1_B_)",34.1764,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-[MAN(5_C_)]-BMA(1_C_)",41.2527,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_E_)-[MAN(3_E_)]-MAN(2_E_)-[MAN(5_E_)]-BMA(1_E_)",42.3096,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-[MAN(5_D_)]-BMA(1_D_)",33.3205,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",162.098,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",150.779,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",153.008,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",172.228,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",138.07,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",203.398,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_A_)",151.305,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",147.973,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(165_E_)",134.161,"","",""
"4GOS","CRYSTAL STRUCTURE OF HUMAN B7-H4 IGV-LIKE DOMAIN","10.1016/J.CELREP.2014.09.053 ",1.59,15.87,"4gos_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(112_A_)",13.3144,"","",""
"4GRW","STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)","10.3389/FIMMU.2017.00884 ",2.55,50.5,"4grw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",78.7338,"","",""
"4GRW","STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)","10.3389/FIMMU.2017.00884 ",2.55,50.5,"4grw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",86.3782,"","",""
"4GT7","AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION","10.1074/JBC.M112.407502 ",2.61,0,"4gt7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",92.7842,"","",""
"4GT7","AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION","10.1074/JBC.M112.407502 ",2.61,0,"4gt7_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_C_)",95.4333,"","",""
"4GT7","AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION","10.1074/JBC.M112.407502 ",2.61,0,"4gt7_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(394_D_)",83.5189,"","",""
"4GT7","AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION","10.1074/JBC.M112.407502 ",2.61,0,"4gt7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",84.6169,"","",""
"4GTW","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH AMP","10.1073/PNAS.1208017109 ",2.7,48.3,"4gtw_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",61.7561,"","",""
"4GTX","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH TMP","10.1073/PNAS.1208017109 ",3.2,81.4,"4gtx_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",92.6433,"","",""
"4GTY","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH GMP","10.1073/PNAS.1208017109 ",3.19,92.83,"4gty_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",87.8226,"","",""
"4GTZ","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH CMP","10.1073/PNAS.1208017109 ",3.19,98.12,"4gtz_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",112.192,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-[FUC(5_I_)]-NAG(1_I_)-ASN(370_B_)",74.617,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo8","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[NAG(3_J_)]-[FUC(2_J_)]-NAG(1_J_)-ASN(445_B_)",52.712,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-[FUC(6_D_)]-NAG(1_D_)-ASN(370_A_)",66.696,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo9","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)]-MAN(4_K_)-[MAN(9_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(547_B_)",61.5964,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(547_A_)",73.6989,"","",""
"4GWN","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA","10.1073/PNAS.1211076109 ",3,113.2,"4gwn_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)]-MAN(4_D_)-[MAN(10_D_)-MAN(9_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(547_A_)",131.164,"","",""
"4GWN","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA","10.1073/PNAS.1211076109 ",3,113.2,"4gwn_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(436_A_)",171.233,"","",""
"4GWN","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA","10.1073/PNAS.1211076109 ",3,113.2,"4gwn_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(370_A_)",146.371,"","",""
"4GXX","CRYSTAL STRUCTURE OF THE ""AVIANIZED"" 1918 INFLUENZA VIRUS HEMAGGLUTININ","10.1371/JOURNAL.PPAT.1003067 ",1.8,51.52,"4gxx_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(95_C_)",71.4038,"","",""
"4GZ8","MOUSE SEMAPHORIN 3A, DOMAINS SEMA-PSI-IG","10.1038/NSMB.2416 ",3.3,55.9,"4gz8_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(53_B_)",73.9689,"","",""
"4GZO","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.6,46.32,"4gzo_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",71.7114,"","",""
"4GZP","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.3,38.82,"4gzp_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",52.3113,"","",""
"4GZQ","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH SIALIC ACID","10.1128/JVI.01426-12 ",2.2,33.43,"4gzq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",46.262,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",42.7075,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",42.322,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(146_C_)",60.62,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_C_)",42.9418,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_D_)",44.9502,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(146_A_)",64.8259,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(146_B_)",67.1345,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",44.2975,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(146_C_)",66.6595,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo7","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(146_D_)",65.0284,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",43.2925,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_H_)-[BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_C_)",42.7575,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo5","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_D_)",44.9751,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(200_D_)",42.0722,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_C_)",40.5615,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",38.4856,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(146_D_)",55.9779,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_D_)",42.4858,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_B_)",40.5431,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_C_)",42.3964,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",41.1193,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(146_C_)",65.5006,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",12.8038,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_D_)",11.7938,"","",""
"4HAF","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)","10.1016/J.MOLIMM.2013.03.018 ",2.04,35.1,"4haf_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.2141,"","",""
"4HAG","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (CENTERED CRYSTAL FORM)","10.1016/J.MOLIMM.2013.03.018 ",3.4,193.5,"4hag_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",227.074,"","",""
"4HF5","CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ","10.1038/NSMB.2500 ",3,98.23,"4hf5_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(169_A_)",126.888,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo6","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1035_A_)",71.3325,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1035_C_)",97.1602,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo9","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_H_)-[BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1035_D_)",62.8318,"","",""
"4HPO","CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 IN COMPLEX WITH V2 PEPTIDE","10.1016/J.IMMUNI.2012.11.011 ",1.69,0,"4hpo_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(93_L_)",62.5868,"","",""
"4HQ1","CRYSTAL STRUCTURE OF AN LRR PROTEIN WITH TWO SOLENOIDS","10.1038/CR.2012.159 ",1.55,20.68,"4hq1_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(158_A_)",28.7464,"","",""
"4HSA","STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR","10.1038/NCOMMS2880 ",3.15,106.3,"4hsa_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(194_C_)",180.885,"","",""
"4HSA","STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR","10.1038/NCOMMS2880 ",3.15,106.3,"4hsa_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(18_C_)",165.135,"","",""
"4HSA","STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR","10.1038/NCOMMS2880 ",3.15,106.3,"4hsa_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_J_)-[MAN(4_J_)-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(194_F_)",212.222,"","",""
"4HSA","STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR","10.1038/NCOMMS2880 ",3.15,106.3,"4hsa_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(23_C_)",160.021,"","",""
"4HZV","THE CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3","10.1128/JVI.01129-13 ",1.8,0,"4hzv_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(307_A_)",37.9418,"","",""
"4HZV","THE CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3","10.1128/JVI.01129-13 ",1.8,0,"4hzv_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",39.2861,"","",""
"4HZW","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH LANINAMIVIR","10.1128/JVI.01129-13 ",1.7,0,"4hzw_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(307_A_)",29.5951,"","",""
"4HZW","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH LANINAMIVIR","10.1128/JVI.01129-13 ",1.7,0,"4hzw_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",33.2936,"","",""
"4HZX","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH OSELTAMIVIR","10.1128/JVI.01129-13 ",2.2,0,"4hzx_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(307_A_)",28.5777,"","",""
"4HZX","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH OSELTAMIVIR","10.1128/JVI.01129-13 ",2.2,0,"4hzx_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",40.2976,"","",""
"4HZY","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y","10.1128/JVI.01129-13 ",1.6,0,"4hzy_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(307_A_)",22.4294,"","",""
"4HZY","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y","10.1128/JVI.01129-13 ",1.6,0,"4hzy_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",30.0852,"","",""
"4HZZ","CRYSTAL STRUCTURE OF INFLUENZA NEURAMINIDASE N3-H274Y COMPLEXED WITH OSELTAMIVIR","10.1128/JVI.01129-13 ",1.6,0,"4hzz_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",25.4291,"","",""
"4HZZ","CRYSTAL STRUCTURE OF INFLUENZA NEURAMINIDASE N3-H274Y COMPLEXED WITH OSELTAMIVIR","10.1128/JVI.01129-13 ",1.6,0,"4hzz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(307_A_)",25.6751,"","",""
"4I00","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y COMPLEXED WITH ZANAMIVIR","10.1128/JVI.01129-13 ",1.6,0,"4i00_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(307_A_)",39.0818,"","",""
"4I00","CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y COMPLEXED WITH ZANAMIVIR","10.1128/JVI.01129-13 ",1.6,0,"4i00_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",42.66,"","",""
"4I0K","CRYSTAL STRUCTURE OF MURINE B7-H3 EXTRACELLULAR DOMAIN","10.1016/J.STR.2013.03.003 ",2.97,72.27,"4i0k_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(104_A_)",92.8816,"","",""
"4I78","CRYSTAL STRUCTURE OF A SUBTYPE H17 HEMAGGLUTININ HOMOLOGUE FROM A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010 (H17N10)","10.1073/PNAS.1218509110 ",3.18,64.65,"4i78_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(117_A_)",124.497,"","",""
"4I8D","CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI","10.1074/JBC.M114.587766 ",2.48,48.42,"4i8d_oligo3","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(208_A_)",82.5772,"","",""
"4I8D","CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI","10.1074/JBC.M114.587766 ",2.48,48.42,"4i8d_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-[MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(208_B_)",67.0916,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",20.0062,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",27.5032,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",25.467,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo5","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",23.8221,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_L_)-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)]-MAN(4_L_)-[MAN(10_L_)-MAN(9_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(322_B_)",14.1725,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",17.7161,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",30.0343,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_N_)-MAN(5_N_)-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",25.4592,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo14","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_O_)-MAN(4_O_)-[MAN(6_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",28.6177,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",36.5064,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo15","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",31.201,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo13","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",20.0635,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",40.5639,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo5","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",24.5409,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",35.1986,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo7","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",29.9751,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",24.0031,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",43.2304,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",30.195,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",51.3945,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",46.8316,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",36.81,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",41.997,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo13","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",24.709,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",30.6323,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo15","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",38.5771,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo7","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",37.3352,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",43.7843,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",49.642,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",29.4585,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",38.8048,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",39.3431,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",22.0026,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo6","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",31.9227,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",32.3396,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",27.0173,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo7","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",42.9252,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",30.0085,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo5","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",41.1492,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",43.8439,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",50.9044,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",48.4102,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",35.1524,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",36.1693,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",46.5373,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo17","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",39.8387,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo9","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",38.4318,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",32.6139,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo13","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",59.2486,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo15","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",27.0105,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",44.4231,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo7","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",29.7901,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",50.9671,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",47.0197,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",18.6712,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",29.3738,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",31.2708,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",18.8849,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",44.1347,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",35.8414,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",14.876,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo5","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",30.5023,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",29.8397,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo56","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",32.3618,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo54","DGalpa1-6DGalpb1-C35O5","DGD(515_c_)-DGD(515_c_)",31.1191,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo53","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",33.9441,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo57","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",39.0991,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo55","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",38.5514,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",26.8123,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",31.2327,"","",""
"4IL6","STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II","10.1073/PNAS.1219922110 ",2.1,37.68,"4il6_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",29.1691,"","",""
"4IRJ","STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX","10.4049/JIMMUNOL.1203134 ",3,41.88,"4irj_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",55.6006,"","",""
"4IUG","CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH GALACTOSE","10.1016/J.IJBIOMAC.2013.05.003 ",2.6,0,"4iug_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",35.3595,"","",""
"4IUG","CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH GALACTOSE","10.1016/J.IJBIOMAC.2013.05.003 ",2.6,0,"4iug_oligo8","DManpa1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_F_)-[MAN(9_F_)]-MAN(8_F_)-[MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(914_A_)",36.2238,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo21","DGalpa1-6DGalpb1-C36O5","DGD(408_d_)-DGD(408_d_)",167.899,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo44","DGalpa1-6DGalpb1-C39O5","DGD(518_C_)-DGD(518_C_)",67.8055,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",86.3382,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo39","DGalpa1-6DGalpb1-C29O5","DGD(411_A_)-DGD(411_A_)",123.298,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo40","DGalpa1-6DGalpb1-C31O5","DGD(621_B_)-DGD(621_B_)",81.9709,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo15","DGalpa1-6DGalpb1-C29O5","DGD(413_a_)-DGD(413_a_)",123.655,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo16","DGalpa1-6DGalpb1-C25O5","DGD(602_b_)-DGD(602_b_)",145.449,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo18","DGalpa1-6DGalpb1-C26O5","DGD(517_c_)-DGD(517_c_)",82.5332,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo42","DGalpa1-6DGalpb1-C26O5","DGD(516_C_)-DGD(516_C_)",82.2077,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo17","DGalpa1-6DGalpb1-C31O5","DGD(622_b_)-DGD(622_b_)",82.6259,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo20","DGalpa1-6DGalpb1-C39O5","DGD(519_c_)-DGD(519_c_)",68.6664,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo43","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",84.1114,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo41","DGalpa1-6DGalpb1-C25O5","DGD(626_B_)-DGD(626_B_)",149.706,"","",""
"4IXQ","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, DARK STATE","10.1126/SCIENCE.1234273 ",5.7,0,"4ixq_oligo14","DGalpa1-6DGalpb1-C36O5","DGD(410_D_)-DGD(410_D_)",166.474,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo42","DGalpa1-6DGalpb1-C36O5","DGD(409_D_)-DGD(409_D_)",167.666,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo47","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",85.1873,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo48","DGalpa1-6DGalpb1-C39O5","DGD(518_c_)-DGD(518_c_)",69.0045,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo49","DGalpa1-6DGalpb1-C36O5","DGD(409_d_)-DGD(409_d_)",167.83,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo56","DGalpa1-6DGalpb1-C31O5","DGD(621_B_)-DGD(621_B_)",84.1609,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo46","DGalpa1-6DGalpb1-C26O5","DGD(516_c_)-DGD(516_c_)",81.3627,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo57","DGalpa1-6DGalpb1-C25O5","DGD(627_B_)-DGD(627_B_)",147.522,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo59","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",82.0432,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo44","DGalpa1-6DGalpb1-C25O5","DGD(602_b_)-DGD(602_b_)",147.792,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo43","DGalpa1-6DGalpb1-C29O5","DGD(413_a_)-DGD(413_a_)",125.885,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo58","DGalpa1-6DGalpb1-C26O5","DGD(517_C_)-DGD(517_C_)",84.8982,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo45","DGalpa1-6DGalpb1-C31O5","DGD(623_b_)-DGD(623_b_)",84.9141,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo55","DGalpa1-6DGalpb1-C29O5","DGD(411_A_)-DGD(411_A_)",124.64,"","",""
"4IXR","RT FS X-RAY DIFFRACTION OF PHOTOSYSTEM II, FIRST ILLUMINATED STATE","10.1126/SCIENCE.1234273 ",5.9,0,"4ixr_oligo60","DGalpa1-6DGalpb1-C39O5","DGD(519_C_)-DGD(519_C_)",68.1782,"","",""
"4J0M","CRYSTAL STRUCTURE OF BRL1 (LRR) IN COMPLEX WITH BRASSINOLIDE","10.1007/S13238-013-3027-8 ",2.5,25.82,"4j0m_oligo7","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(257_B_)",24.37,"","",""
"4J0M","CRYSTAL STRUCTURE OF BRL1 (LRR) IN COMPLEX WITH BRASSINOLIDE","10.1007/S13238-013-3027-8 ",2.5,25.82,"4j0m_oligo1","DManpa1-2DRhapa1-3DManpa1-6DManpb1-4DGlcpNb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(257_A_)",24.6055,"","",""
"4J12","MONOMERIC FC","10.1074/JBC.M113.457689 ",1.9,49.35,"4j12_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",95.8401,"","",""
"4J3W","CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE (E510A MUTANT) IN COMPLEX WITH A BRANCHED MALTOHEXASACCHARIDE","10.1016/J.JMB.2014.12.019 ",1.67,16.02,"4j3w_oligo1","DGlcpa1-4DGlcpa1-4DGlcpa1-6[DGlcpa1-4]DGlcpa1-4DGlcpa1-ROH","GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-[GLC(6_B_)]-GLC(2_B_)-GLC(1_B_)",15.3756,"","",""
"4J3X","CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE (E510A MUTANT) IN COMPLEX WITH A BRANCHED MALTOHEPTASACCHARIDE","10.1016/J.JMB.2014.12.019 ",1.75,18.34,"4j3x_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(7_B_)-GLC(6_B_)-GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",24.6656,"","",""
"4J4P","THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS","10.1038/NSMB.2795 ",2.91,104.7,"4j4p_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",103.719,"","",""
"4J4P","THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS","10.1038/NSMB.2795 ",2.91,104.7,"4j4p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",114.223,"","",""
"4JDG","STRUCTURE OF TOMATO BIFUNCTIONAL NUCLEASE TBN1, VARIANT N211D","10.1107/S2053230X15018324 ",2.74,66.59,"4jdg_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(137_A_)",83.0355,"","",""
"4JHV","T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA","10.1107/S1399004715001595 ",1.6,17.89,"4jhv_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",30.9898,"","",""
"4JKP","RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES","10.1084/JEM.20130221 ",2.82,0,"4jkp_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(276_G_)",146.906,"","",""
"4JKP","RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES","10.1084/JEM.20130221 ",2.82,0,"4jkp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(262_G_)",102.461,"","",""
"4JM2","CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB","10.1038/NSMB.2594 ",3.1,0,"4jm2_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(332_E_)",104.132,"","",""
"4JM2","CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB","10.1038/NSMB.2594 ",3.1,0,"4jm2_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(392_E_)",101.841,"","",""
"4JS1","CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDE ALPHA-2,6- SIALYLTRANSFERASE 1 IN COMPLEX WITH CYTIDINE AND PHOSPHATE","10.1107/S0907444913015412 ",2.09,0,"4js1_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(149_A_)",99.1286,"","",""
"4JS2","CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDE ALPHA-2,6- SIALYLTRANSFERASE 1 IN COMPLEX WITH CMP","10.1107/S0907444913015412 ",2.3,0,"4js2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(149_A_)",96.6658,"","",""
"4JY4","CRYSTAL STRUCTURE OF HUMAN FAB PGT121, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY","10.1371/JOURNAL.PPAT.1003342 ",2.8,0,"4jy4_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[MAN(8_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(103_B_)",73.8247,"","",""
"4JYW","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH CTT1057","",1.73,22.91,"4jyw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",27.1751,"","",""
"4JYW","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH CTT1057","",1.73,22.91,"4jyw_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(140_A_)",33.0273,"","",""
"4JZJ","CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX","10.1016/J.CELREP.2014.06.038 ",2.8,50.31,"4jzj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcx1-","FUL(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUL(6_E_)]-NAG(1_E_)",83.4233,"","",""
"4K1H","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.8,24.68,"4k1h_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_B_)",32.8284,"","",""
"4K1H","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.8,24.68,"4k1h_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",31.1129,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-[FUL(6_K_)]-NAG(1_K_)-ASN(242_C_)",76.5977,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo8","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[NAG(3_N_)]-[FUL(2_N_)]-NAG(1_N_)-ASN(264_E_)",89.8645,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-[FUL(6_H_)]-NAG(1_H_)-ASN(21_A_)",87.7256,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUL(6_G_)]-NAG(1_G_)-ASN(242_A_)",65.6516,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo6","DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(5_L_)-[BMA(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(264_C_)",81.5867,"","",""
"4K3Y","CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.68,0,"4k3y_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(401_C_)",125.798,"","",""
"4KGJ","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO- ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.99,39.85,"4kgj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",61.7836,"","",""
"4KGJ","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO- ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.99,39.85,"4kgj_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",68.9756,"","",""
"4KGL","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R,3R,4R, 5S]-2-CARBOXY-3,4,5-TRIHYDROXY-PIPERIDINE","10.1038/NCHEMBIO.1357 ",2.7,53.22,"4kgl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",77.252,"","",""
"4KGL","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R,3R,4R, 5S]-2-CARBOXY-3,4,5-TRIHYDROXY-PIPERIDINE","10.1038/NCHEMBIO.1357 ",2.7,53.22,"4kgl_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",73.9774,"","",""
"4KH2","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 2-DEOXY-2- FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.36,37.32,"4kh2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",64.8293,"","",""
"4KH2","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 2-DEOXY-2- FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.36,37.32,"4kh2_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",50.6132,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_B_)",98.6207,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_C_)",95.5311,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(394_D_)",109.352,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_A_)",98.8144,"","",""
"4KMX","HUMAN FOLATE RECEPTOR ALPHA (FOLR1) AT ACIDIC PH, HEXAGONAL FORM","10.1073/PNAS.1308827110 ",2.2,0,"4kmx_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(161_A_)",55.2258,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4316,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",63.871,"","",""
"4KW1","STRUCTURE OF A/EGYPT/N03072/2010 H5 HA","10.1371/JOURNAL.PONE.0075209 ",2.5,57.84,"4kw1_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(164_A_)",87.8578,"","",""
"4KW1","STRUCTURE OF A/EGYPT/N03072/2010 H5 HA","10.1371/JOURNAL.PONE.0075209 ",2.5,57.84,"4kw1_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(164_C_)",79.7711,"","",""
"4KZN","CRYSTAL STRUCTURE OF HUMAN VEGF-A RECEPTOR BINDING DOMAIN","",1.71,5.52,"4kzn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(75_A_)",46.0808,"","",""
"4L37","SP2-SP3 - A COMPLEX OF TWO STORAGE PROTEINS FROM BOMBYX MORI HEMOLYMPH","10.1107/S0907444913021823 ",2.9,51.41,"4l37_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(195_B_)",85.1016,"","",""
"4L37","SP2-SP3 - A COMPLEX OF TWO STORAGE PROTEINS FROM BOMBYX MORI HEMOLYMPH","10.1107/S0907444913021823 ",2.9,51.41,"4l37_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",82.6987,"","",""
"4L4J","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY","10.1016/J.YMETH.2013.06.035 ",1.92,39.9,"4l4j_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",89.4141,"","",""
"4L4J","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY","10.1016/J.YMETH.2013.06.035 ",1.92,39.9,"4l4j_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",43.027,"","",""
"4LIQ","STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CSF-1 RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF RG7155","10.1016/J.CCR.2014.05.016 ",2.6,57.82,"4liq_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_A_)-[BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(335_E_)",76.7575,"","",""
"4LIQ","STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CSF-1 RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF RG7155","10.1016/J.CCR.2014.05.016 ",2.6,57.82,"4liq_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(428_E_)",64.6836,"","",""
"4LN6","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013)","10.1128/JVI.01854-13 ",2.12,38.69,"4ln6_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(12_E_)",91.6616,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(12_A_)",115.862,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(12_E_)",120.216,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(12_C_)",118.672,"","",""
"4LQG","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR CTT1056","10.1021/ACS.JMEDCHEM.5B01850 ",1.77,23.43,"4lqg_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(140_A_)",49.6867,"","",""
"4LQG","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR CTT1056","10.1021/ACS.JMEDCHEM.5B01850 ",1.77,23.43,"4lqg_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",38.1018,"","",""
"4LQG","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR CTT1056","10.1021/ACS.JMEDCHEM.5B01850 ",1.77,23.43,"4lqg_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(121_A_)",57.353,"","",""
"4LSC","ISOLATED SERK1 CO-RECEPTOR ECTODOMAIN AT HIGH RESOLUTION","10.1126/SCIENCE.1242468 ",1.53,0,"4lsc_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(104_A_)",47.5457,"","",""
"4LU3","THE CRYSTAL STRUCTURE OF THE HUMAN CARBONIC ANHYDRASE XIV","10.1002/BIP.22456 ",2,0,"4lu3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(195_A_)",38.5315,"","",""
"4M0E","STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DIHYDROTANSHINONE I","10.1021/ML400304W ",2,28.61,"4m0e_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",68.8439,"","",""
"4M0E","STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DIHYDROTANSHINONE I","10.1021/ML400304W ",2,28.61,"4m0e_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",66.3221,"","",""
"4M0F","STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH TERRITREM B","10.1021/ML400304W ",2.3,47.33,"4m0f_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",80.6485,"","",""
"4M0F","STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH TERRITREM B","10.1021/ML400304W ",2.3,47.33,"4m0f_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",84.3682,"","",""
"4MA1","UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB","10.1074/JBC.M113.528224 ",2.32,48.25,"4ma1_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(9_G_)-NAG(1_G_)-ASN(85_H_)",69.0636,"","",""
"4MA1","UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB","10.1074/JBC.M113.528224 ",2.32,48.25,"4ma1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(85_E_)",100.281,"","",""
"4MA1","UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB","10.1074/JBC.M113.528224 ",2.32,48.25,"4ma1_oligo4","DGalpa1-3DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(8_G_)-[GLA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)",94.7876,"","",""
"4MA1","UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB","10.1074/JBC.M113.528224 ",2.32,48.25,"4ma1_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_A_)-[MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(85_B_)",95.3316,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUL(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(240_B_)",73.7017,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUL(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUC(6_E_)]-NAG(1_E_)-ASN(240_A_)",67.153,"","",""
"4MHH","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.01577-13 ",3.56,0,"4mhh_oligo12","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(169_E_)",204.921,"","",""
"4MHH","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.01577-13 ",3.56,0,"4mhh_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(169_A_)",217.835,"","",""
"4MHH","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.01577-13 ",3.56,0,"4mhh_oligo7","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-MAN(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(169_C_)",216.499,"","",""
"4MHJ","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)","10.1128/JVI.01577-13 ",6.98,89.86,"4mhj_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Z_)-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)]-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(33_C_)",90,"","",""
"4MJ2","CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM","10.1038/NCHEMBIO.1357 ",2.1,36.06,"4mj2_oligo4","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",55.0188,"","",""
"4MJ2","CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM","10.1038/NCHEMBIO.1357 ",2.1,36.06,"4mj2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",62.7431,"","",""
"4MJ4","HUMAN IDURONIDASE APO STRUCTURE P21 FORM","10.1038/NCHEMBIO.1357 ",2.17,37.71,"4mj4_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(372_A_)",60.0711,"","",""
"4MMX","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.32,0,"4mmx_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",95.9556,"","",""
"4MMY","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF","10.1038/NSMB.2797 ",3.18,0,"4mmy_oligo3","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",133.258,"","",""
"4MMZ","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.1,0,"4mmz_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",123.124,"","",""
"4MQE","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR IN THE APO FORM","10.1038/NATURE12725 ",2.35,69.77,"4mqe_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(404_B_)",91.9809,"","",""
"4MQE","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR IN THE APO FORM","10.1038/NATURE12725 ",2.35,69.77,"4mqe_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",91.8908,"","",""
"4MQF","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST 2-HYDROXYSACLOFEN","10.1038/NATURE12725 ",2.22,38.88,"4mqf_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",79.8459,"","",""
"4MQF","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST 2-HYDROXYSACLOFEN","10.1038/NATURE12725 ",2.22,38.88,"4mqf_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(404_B_)",75.948,"","",""
"4MR7","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP54626","10.1038/NATURE12725 ",2.15,39.04,"4mr7_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(404_B_)",67.0609,"","",""
"4MR7","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP54626","10.1038/NATURE12725 ",2.15,39.04,"4mr7_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",70.5114,"","",""
"4MR8","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP35348","10.1038/NATURE12725 ",2.15,53.26,"4mr8_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",90.4054,"","",""
"4MR8","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP35348","10.1038/NATURE12725 ",2.15,53.26,"4mr8_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(404_B_)",78.8727,"","",""
"4MS1","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP46381","10.1038/NATURE12725 ",2.25,63.49,"4ms1_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(404_B_)",84.3045,"","",""
"4MSL","CRYSTAL STRUCTURE OF THE VPS10P DOMAIN OF HUMAN SORTILIN/NTS3 IN COMPLEX WITH AF40431","10.1107/S1399004713030149 ",2.7,0,"4msl_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",102.277,"","",""
"4MWF","STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C","10.1126/SCIENCE.1243876 ",2.65,0,"4mwf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(430_C_)",92.2426,"","",""
"4MWJ","ANHUI N9","10.1038/CR.2013.144 ",1.8,15.17,"4mwj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",20.6165,"","",""
"4MWL","SHANGHAI N9","10.1038/CR.2013.144 ",1.8,12.64,"4mwl_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",17.6664,"","",""
"4MWQ","ANHUI N9-OSELTAMIVIR CARBOXYLATE","10.1038/CR.2013.144 ",2,19.03,"4mwq_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",28.8249,"","",""
"4MWR","ANHUI N9-ZANAMIVIR","10.1038/CR.2013.144 ",1.8,20.21,"4mwr_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",26.4366,"","",""
"4MWU","ANHUI N9-LANINAMIVIR","10.1038/CR.2013.144 ",1.8,13.9,"4mwu_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",19.8616,"","",""
"4MWV","ANHUI N9-PERAMIVIR","10.1038/CR.2013.144 ",2,19.09,"4mwv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",26.6057,"","",""
"4MWW","SHANGHAI N9-OSELTAMIVIR CARBOXYLATE","10.1038/CR.2013.144 ",1.9,17.02,"4mww_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",23.3598,"","",""
"4MWX","SHANGHAI N9-ZANAMIVIR","10.1038/CR.2013.144 ",1.8,16.13,"4mwx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",22.7272,"","",""
"4MWY","SHANGHAI N9-LANINAMIVIR","10.1038/CR.2013.144 ",1.8,14.29,"4mwy_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",19.4712,"","",""
"4MX0","SHANGHAI N9-PERAMIVIR","10.1038/CR.2013.144 ",2.1,24.44,"4mx0_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",36.1485,"","",""
"4MZA","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE","10.1128/MBIO.00803-13 ",1.65,31.02,"4mza_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(308_B_)",56.602,"","",""
"4MZA","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE","10.1128/MBIO.00803-13 ",1.65,31.02,"4mza_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",53.9457,"","",""
"4MZE","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE, H552Q/Q559R MUTANT","10.1128/MBIO.00803-13 ",1.8,29.87,"4mze_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(308_B_)",46.9233,"","",""
"4MZE","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE, H552Q/Q559R MUTANT","10.1128/MBIO.00803-13 ",1.8,29.87,"4mze_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",65.6023,"","",""
"4N0U","TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR, SERUM ALBUMIN AND FC","10.1074/JBC.M113.537563 ",3.8,143.8,"4n0u_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_E_)",124.464,"","",""
"4N8D","DPP4 COMPLEXED WITH SYN-7AA","10.1016/J.BMCL.2013.12.118 ",1.65,28.15,"4n8d_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",36.1689,"","",""
"4N8E","DPP4 COMPLEXED WITH COMPOUND 12A","10.1016/J.BMCL.2013.12.118 ",2.3,25.67,"4n8e_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",41.8364,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)]-MAN(4_a_)-[MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_I_)",393.501,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-MAN(8_Q_)-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(332_A_)",365.319,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)]-MAN(4_V_)-[MAN(7_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(301_E_)",405.684,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)]-MAN(4_S_)-[MAN(7_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(137_E_)",522.187,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-MAN(8_c_)-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(332_I_)",372.38,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo14","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(137_A_)",457.677,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_E_)",410.657,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_A_)",429.176,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_W_)-MAN(8_W_)-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_E_)",406.521,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(156_E_)",415.661,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo15","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_A_)",437.974,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(156_I_)",447.876,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[MAN(5_Y_)]-MAN(4_Y_)-[MAN(7_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(137_I_)",490.109,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(301_A_)",394.297,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)]-MAN(4_b_)-[MAN(7_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(301_I_)",409.167,"","",""
"4NE9","PCSK9 IN COMPLEX WITH LDLR PEPTIDE","10.1016/J.CHEMBIOL.2013.11.014 ",2.6,70.49,"4ne9_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(533_A_)",140.305,"","",""
"4NEH","AN INTERNAL LIGAND-BOUND, METASTABLE STATE OF A LEUKOCYTE INTEGRIN, AXB2","10.1083/JCB.201308083 ",2.75,0,"4neh_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(373_A_)",130.365,"","",""
"4NEN","AN INTERNAL LIGAND-BOUND, METASTABLE STATE OF A LEUKOCYTE INTEGRIN, AXB2","10.1083/JCB.201308083 ",2.9,0,"4nen_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(373_A_)",120.544,"","",""
"4NGM","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",1.84,27.4,"4ngm_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",45.4364,"","",""
"4NGP","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",1.63,24.12,"4ngp_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",39.9125,"","",""
"4NGQ","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",2.08,25.61,"4ngq_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",43.1056,"","",""
"4NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"4nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",26.333,"","",""
"4NYT","L-FICOLIN COMPLEXED TO PHOSPHOCHOLINE","10.4049/JIMMUNOL.1400127 ",2.25,60.17,"4nyt_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(215_C_)",38.3693,"","",""
"4NZD","INTERLEUKIN 21 RECEPTOR","",2.75,0,"4nzd_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(54_B_)",58.7867,"","",""
"4NZD","INTERLEUKIN 21 RECEPTOR","",2.75,0,"4nzd_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(54_A_)",72.1351,"","",""
"4NZD","INTERLEUKIN 21 RECEPTOR","",2.75,0,"4nzd_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(54_C_)",68.4449,"","",""
"4O02","ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.","10.1074/JBC.M113.546929 ",3.61,0,"4o02_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",134.084,"","",""
"4O02","ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.","10.1074/JBC.M113.546929 ",3.61,0,"4o02_oligo1","DManpb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(44_A_)",165.455,"","",""
"4O58","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",2.75,0,"4o58_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",85.7227,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(165_E_)",157.439,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(165_A_)",151.281,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(165_C_)",145.323,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(38_E_)",192.001,"","",""
"4O6D","WEST NILE VIRUS NON-STRUCTURAL PROTEIN 1 (NS1) FORM 1 CRYSTAL","10.1126/SCIENCE.1247749 ",2.59,98.18,"4o6d_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(207_B_)",151.467,"","",""
"4OBR","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L- IDURONIC ACID","",2.46,39.55,"4obr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",62.8695,"","",""
"4OBR","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L- IDURONIC ACID","",2.46,39.55,"4obr_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",64.4858,"","",""
"4OBS","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE IN THE P212121 FORM","",2.26,17.69,"4obs_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(372_A_)",37.0609,"","",""
"4OC2","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CEIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXYBUT- 3-YN-1-YL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.65,32.03,"4oc2_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(140_A_)",50.4615,"","",""
"4OC2","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CEIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXYBUT- 3-YN-1-YL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.65,32.03,"4oc2_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(121_A_)",56.1754,"","",""
"4OC3","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CFIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXY-2- (FURAN-2-YL)ETHYL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.79,29.2,"4oc3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(140_A_)",54.3282,"","",""
"4OC6","STRUCTURE OF CATHEPSIN D WITH INHIBITOR 2-BROMO-N-[(2S,3S)-4-{[2-(2,4- DICHLOROPHENYL)ETHYL][3-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL) PROPANOYL]AMINO}-3-HYDROXY-1-(3-PHENOXYPHENYL)BUTAN-2-YL]-4,5- DIMETHOXYBENZAMIDE","10.1016/J.BMCL.2014.07.054 ",2.64,87.11,"4oc6_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(70_A_)",127.339,"","",""
"4OF3","CRYSTAL STRUCTURE OF SYG-1 D1-D2, GLYCOSYLATED","10.1016/J.CELL.2014.01.004 ",2.5,0,"4of3_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[NAG(3_D_)]-[FUC(2_D_)]-NAG(1_D_)-ASN(206_A_)",112.161,"","",""
"4OF3","CRYSTAL STRUCTURE OF SYG-1 D1-D2, GLYCOSYLATED","10.1016/J.CELL.2014.01.004 ",2.5,0,"4of3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(93_A_)",133.441,"","",""
"4OF6","CRYSTAL STRUCTURE OF SYG-1 D1, CRYSTAL FORM 1","10.1016/J.CELL.2014.01.004 ",1.7,0,"4of6_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(93_B_)",67.5168,"","",""
"4OGA","INSULIN IN COMPLEX WITH SITE 1 OF THE HUMAN INSULIN RECEPTOR","10.1073/PNAS.1412897111 ",3.5,238.4,"4oga_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(255_E_)",287.958,"","",""
"4OIB","CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT, SPACE GROUP R3","10.1107/S1399004714009468 ",3.5,0,"4oib_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(43_A_)",312.327,"","",""
"4OVE","X-RAY CRYSTAL STRUCTURE OF MOUSE NETRIN-1","10.1016/J.CCELL.2016.01.001 ",2.64,64.55,"4ove_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(95_A_)",132.773,"","",""
"4P2O","CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH 2A/I-EK","10.1016/J.CELL.2014.03.047 ",2.6,0,"4p2o_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(19_B_)",96.2232,"","",""
"4P45","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR JRB-4-73","10.1111/FEBS.13557 ",1.87,27.13,"4p45_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(140_A_)",56.1015,"","",""
"4P45","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR JRB-4-73","10.1111/FEBS.13557 ",1.87,27.13,"4p45_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(121_A_)",65.5942,"","",""
"4P4E","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR MP1D","10.1111/FEBS.13557 ",1.67,31.83,"4p4e_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(140_A_)",58.9212,"","",""
"4P4E","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR MP1D","10.1111/FEBS.13557 ",1.67,31.83,"4p4e_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(121_A_)",66.3873,"","",""
"4P9H","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2","10.1016/J.CELREP.2014.04.001 ",3,66.79,"4p9h_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(386_G_)",111.833,"","",""
"4P9H","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2","10.1016/J.CELREP.2014.04.001 ",3,66.79,"4p9h_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(276_G_)",85.8438,"","",""
"4P9H","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2","10.1016/J.CELREP.2014.04.001 ",3,66.79,"4p9h_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(234_G_)",70.6277,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(101_j_)-DGD(101_j_)",28.2745,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(916_c_)-DGD(916_c_)",27.5786,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",35.6591,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",25.2541,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",26.7355,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(406_D_)-DGD(406_D_)",100.167,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",25.6314,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(917_c_)-DGD(917_c_)",31.7168,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",31.3905,"","",""
"4PBU","SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE","10.1038/NATURE13453 ",5,33.75,"4pbu_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(406_d_)-DGD(406_d_)",102.41,"","",""
"4PE5","CRYSTAL STRUCTURE OF GLUN1A/GLUN2B NMDA RECEPTOR ION CHANNEL","10.1126/SCIENCE.1251915 ",3.96,0,"4pe5_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(688_D_)",340.225,"","",""
"4PE5","CRYSTAL STRUCTURE OF GLUN1A/GLUN2B NMDA RECEPTOR ION CHANNEL","10.1126/SCIENCE.1251915 ",3.96,0,"4pe5_oligo5","DManpa1-6DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(688_B_)",349.103,"","",""
"4PE5","CRYSTAL STRUCTURE OF GLUN1A/GLUN2B NMDA RECEPTOR ION CHANNEL","10.1126/SCIENCE.1251915 ",3.96,0,"4pe5_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(440_C_)",348.362,"","",""
"4PE5","CRYSTAL STRUCTURE OF GLUN1A/GLUN2B NMDA RECEPTOR ION CHANNEL","10.1126/SCIENCE.1251915 ",3.96,0,"4pe5_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(203_A_)",354.378,"","",""
"4PE5","CRYSTAL STRUCTURE OF GLUN1A/GLUN2B NMDA RECEPTOR ION CHANNEL","10.1126/SCIENCE.1251915 ",3.96,0,"4pe5_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(368_A_)",343.697,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",31.8759,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",47.4368,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",44.0673,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",41.1523,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(515_c_)-DGD(515_c_)",33.0814,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",39.7091,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",44.1827,"","",""
"4PJ0","STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING","10.1016/J.STR.2014.09.007 ",2.44,0,"4pj0_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",45.2877,"","",""
"4PSP","CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM","10.1074/JBC.M114.583286 ",1.56,19.74,"4psp_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(280_A_)",27.1403,"","",""
"4PSR","CRYSTAL STRUCTURE OF ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM IN COMPLEX WITH L-FUCOSE","10.1074/JBC.M114.583286 ",1.38,19.34,"4psr_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(280_A_)",26.1953,"","",""
"4Q4B","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2221)","10.1038/NCOMMS5321 ",2.82,63.81,"4q4b_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_A_)",79.6334,"","",""
"4Q4B","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2221)","10.1038/NCOMMS5321 ",2.82,63.81,"4q4b_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(412_A_)",73.4855,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(412_A_)",83.5969,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo3","DManp[6P]b1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","M6D(6_F_)-MAN(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_A_)",93.016,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(206_A_)",103.01,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",77.2996,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",63.3129,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpx1-","GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-BMA(3_G_)",81.3295,"","",""
"4Q6Y","CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)","10.1016/J.JMB.2014.07.006 ",3,0,"4q6y_oligo6","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcx1-","NAG(7_E_)-MAN(6_E_)-BMA(3_E_)-NAG(2_E_)",90.6542,"","",""
"4Q74","F241A FC","10.1016/J.JMB.2014.07.006 ",2.19,0,"4q74_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(7_C_)-[NAG(2_C_)]-NAG(1_C_)",47.2556,"","",""
"4Q7D","WILD TYPE FC (WTFC)","10.1016/J.JMB.2014.07.006 ",2.35,0,"4q7d_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",69.09,"","",""
"4Q7D","WILD TYPE FC (WTFC)","10.1016/J.JMB.2014.07.006 ",2.35,0,"4q7d_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",52.2443,"","",""
"4Q7X","NEUTROPHIL SERINE PROTEASE 4 (PRSS57) APO FORM 1","10.1016/J.STR.2014.07.008 ",2.55,53.8,"4q7x_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(169_A_)",61.3423,"","",""
"4Q7X","NEUTROPHIL SERINE PROTEASE 4 (PRSS57) APO FORM 1","10.1016/J.STR.2014.07.008 ",2.55,53.8,"4q7x_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(169_B_)",60.2182,"","",""
"4Q7Y","NEUTROPHIL SERINE PROTEASE 4 (PRSS57) APO FORM 2","10.1016/J.STR.2014.07.008 ",2.7,33.15,"4q7y_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(169_A_)",41.2241,"","",""
"4Q7Z","NEUTROPHIL SERINE PROTEASE 4 (PRSS57) WITH PHE-PHE-ARG- CHLOROMETHYLKETONE (FFR-CMK)","10.1016/J.STR.2014.07.008 ",1.4,19.68,"4q7z_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(169_A_)",38.5573,"","",""
"4QGT","THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON","10.1021/ACSCHEMBIO.5B01035 ",2.99,0,"4qgt_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",245.651,"","",""
"4QGT","THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON","10.1021/ACSCHEMBIO.5B01035 ",2.99,0,"4qgt_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",101.025,"","",""
"4QN4","CRYSTAL STRUCTURE OF NEURAMINIDASE N6","10.1128/JVI.00805-14 ",1.8,13.41,"4qn4_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(122_B_)",22.267,"","",""
"4QN4","CRYSTAL STRUCTURE OF NEURAMINIDASE N6","10.1128/JVI.00805-14 ",1.8,13.41,"4qn4_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(122_A_)",19.9985,"","",""
"4QN6","CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR","10.1128/JVI.00805-14 ",1.95,22.08,"4qn6_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(122_A_)",31.2268,"","",""
"4QN6","CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR","10.1128/JVI.00805-14 ",1.95,22.08,"4qn6_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(122_B_)",28.6067,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(453_B_)",74.0353,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(453_A_)",64.7571,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_A_)",87.1011,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(343_B_)",79.0986,"","",""
"4R07","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH ORN06","10.1038/NSMB.2943 ",2,41.97,"4r07_oligo15","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(293_C_)",48.2314,"","",""
"4R09","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH ORN06S","10.1038/NSMB.2943 ",2.62,63.34,"4r09_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(293_A_)",52.0724,"","",""
"4R09","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH ORN06S","10.1038/NSMB.2943 ",2.62,63.34,"4r09_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(293_C_)",58.8509,"","",""
"4R0L","ANTI-CANINE CD28 ANTIBODY, 1C6, BOUND CANINE CD28","10.1097/TXD.0000000000000516 ",3.3,84.56,"4r0l_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(74_D_)",116.265,"","",""
"4R0L","ANTI-CANINE CD28 ANTIBODY, 1C6, BOUND CANINE CD28","10.1097/TXD.0000000000000516 ",3.3,84.56,"4r0l_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(74_C_)",113.101,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(332_E_)",44.2849,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",49.5149,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-MAN(8_V_)-[MAN(10_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",54.2975,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_R_)-MAN(8_R_)-[MAN(10_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",54.3256,"","",""
"4R6A","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH HYBRID-2","",2.1,38.48,"4r6a_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",37.9564,"","",""
"4RBP","CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE","10.1093/GLYCOB/CWU123 ",1.85,0,"4rbp_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpa1-5DKdopa2-ROH","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)-MAN(3_B_)]-MAN(2_B_)-KDO(1_B_)",39.7385,"","",""
"4RBP","CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE","10.1093/GLYCOB/CWU123 ",1.85,0,"4rbp_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpa1-5DKdopa2-ROH","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)-MAN(3_A_)]-MAN(2_A_)-KDO(1_A_)",42.7628,"","",""
"4RGA","PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME","10.1111/MMI.12978 ",2.1,47.57,"4rga_oligo1","DGlcpNAcb1-2DGalfb1-6DGlcpa1-OME","NAG(3_C_)-GZL(2_C_)-GYP(1_C_)",58.1023,"","",""
"4RGA","PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME","10.1111/MMI.12978 ",2.1,47.57,"4rga_oligo2","DGlcpNAcb1-2DGalfb1-6DGlcpa1-OME","NAG(3_D_)-GZL(2_D_)-GYP(1_D_)",61.1312,"","",""
"4RK9","CRYSTAL STRUCTURE OF SUGAR TRANSPORTER BL01359 FROM BACILLUS LICHENIFORMIS, TARGET EFI-510856, IN COMPLEX WITH STACHYOSE","",2.15,61.93,"4rk9_oligo2","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(3_D_)-GLA(2_D_)-GLC(1_D_)-FRU(4_D_)",44.289,"","",""
"4RK9","CRYSTAL STRUCTURE OF SUGAR TRANSPORTER BL01359 FROM BACILLUS LICHENIFORMIS, TARGET EFI-510856, IN COMPLEX WITH STACHYOSE","",2.15,61.93,"4rk9_oligo1","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(3_C_)-GLA(2_C_)-GLC(1_C_)-FRU(4_C_)",36.9915,"","",""
"4RKU","CRYSTAL STRUCTURE OF PLANT PHOTOSYSTEM I AT 3 ANGSTROM RESOLUTION","",3,0,"4rku_oligo3","DGalpa1-6DGalpb1-C34O5","DGD(7101_B_)-DGD(7101_B_)",83.9023,"","",""
"4RQS","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB","10.1002/PROT.24747 ",4.49,0,"4rqs_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_A_)-[MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",172.279,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",26.7355,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",25.6314,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",31.3905,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",31.3905,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",25.6314,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",26.7355,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(410_d_)-DGD(410_d_)",100.167,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(410_D_)-DGD(410_D_)",100.167,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",25.2541,"","",""
"4RVY","SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)","10.1038/NATURE13453 ",5.5,0,"4rvy_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",25.2541,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo6","DGalpa1-6DGalpb1-C39O5","DGD(517_c_)-DGD(517_c_)",206.68,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo12","DGalpa1-6DGalpb1-C26O5","DGD(515_C_)-DGD(515_C_)",206.329,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo11","DGalpa1-6DGalpb1-C25O5","DGD(625_B_)-DGD(625_B_)",209.491,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo15","DGalpa1-6DGalpb1-C36O5","DGD(409_D_)-DGD(409_D_)",208.808,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo3","DGalpa1-6DGalpb1-C31O5","DGD(624_b_)-DGD(624_b_)",206.374,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo1","DGalpa1-6DGalpb1-C29O5","DGD(411_a_)-DGD(411_a_)",207.889,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",207.058,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",207.102,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo7","DGalpa1-6DGalpb1-C36O5","DGD(409_d_)-DGD(409_d_)",209.955,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo14","DGalpa1-6DGalpb1-C39O5","DGD(517_C_)-DGD(517_C_)",206.835,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo2","DGalpa1-6DGalpb1-C25O5","DGD(601_b_)-DGD(601_b_)",208.504,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo4","DGalpa1-6DGalpb1-C26O5","DGD(515_c_)-DGD(515_c_)",207.32,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo9","DGalpa1-6DGalpb1-C29O5","DGD(408_A_)-DGD(408_A_)",207.942,"","",""
"4TNH","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 4.9 A RESOLUTION","10.1038/NCOMMS5371 ",4.9,206.8,"4tnh_oligo10","DGalpa1-6DGalpb1-C31O5","DGD(620_B_)-DGD(620_B_)",207.188,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo28","DGalpa1-6DGalpb1-C29O5","DGD(410_a_)-DGD(410_a_)",180.915,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo30","DGalpa1-6DGalpb1-C31O5","DGD(624_b_)-DGD(624_b_)",179.3,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",179.647,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo27","DGalpa1-6DGalpb1-C36O5","DGD(410_D_)-DGD(410_D_)",181.502,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo33","DGalpa1-6DGalpb1-C39O5","DGD(517_c_)-DGD(517_c_)",179.857,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo22","DGalpa1-6DGalpb1-C31O5","DGD(620_B_)-DGD(620_B_)",179.634,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo31","DGalpa1-6DGalpb1-C26O5","DGD(515_c_)-DGD(515_c_)",179.681,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo23","DGalpa1-6DGalpb1-C25O5","DGD(625_B_)-DGD(625_B_)",181.613,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo32","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",179.247,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo21","DGalpa1-6DGalpb1-C29O5","DGD(408_A_)-DGD(408_A_)",180.333,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo29","DGalpa1-6DGalpb1-C25O5","DGD(601_b_)-DGD(601_b_)",181.107,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo53","DGalpa1-6DGalpb1-C36O5","DGD(410_d_)-DGD(410_d_)",182.341,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo26","DGalpa1-6DGalpb1-C39O5","DGD(517_C_)-DGD(517_C_)",179.124,"","",""
"4TNI","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE THIRD ILLUMINATION AT 4.6 A RESOLUTION","10.1038/NCOMMS5371 ",4.6,179.4,"4tni_oligo24","DGalpa1-6DGalpb1-C26O5","DGD(515_C_)-DGD(515_C_)",179.138,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo22","DGalpa1-6DGalpb1-C31O5","DGD(624_b_)-DGD(624_b_)",173.878,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo59","DGalpa1-6DGalpb1-C26O5","DGD(515_C_)-DGD(515_C_)",173.788,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo25","DGalpa1-6DGalpb1-C39O5","DGD(517_c_)-DGD(517_c_)",174.069,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo19","DGalpa1-6DGalpb1-C36O5","DGD(409_D_)-DGD(409_D_)",175.68,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",173.752,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo23","DGalpa1-6DGalpb1-C26O5","DGD(515_c_)-DGD(515_c_)",174.267,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo58","DGalpa1-6DGalpb1-C25O5","DGD(625_B_)-DGD(625_B_)",176.15,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo20","DGalpa1-6DGalpb1-C29O5","DGD(411_a_)-DGD(411_a_)",175.425,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo18","DGalpa1-6DGalpb1-C39O5","DGD(517_C_)-DGD(517_C_)",173.779,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo26","DGalpa1-6DGalpb1-C36O5","DGD(408_d_)-DGD(408_d_)",176.663,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo57","DGalpa1-6DGalpb1-C31O5","DGD(620_B_)-DGD(620_B_)",174.08,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo21","DGalpa1-6DGalpb1-C25O5","DGD(601_b_)-DGD(601_b_)",175.808,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo60","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",174.186,"","",""
"4TNJ","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 4.5 A RESOLUTION","10.1038/NCOMMS5371 ",4.5,174,"4tnj_oligo56","DGalpa1-6DGalpb1-C29O5","DGD(408_A_)-DGD(408_A_)",174.788,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo35","DGalpa1-6DGalpb1-C29O5","DGD(409_A_)-DGD(409_A_)",209.092,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo23","DGalpa1-6DGalpb1-C29O5","DGD(408_a_)-DGD(408_a_)",209.112,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo28","DGalpa1-6DGalpb1-C39O5","DGD(517_c_)-DGD(517_c_)",207.409,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo36","DGalpa1-6DGalpb1-C31O5","DGD(620_B_)-DGD(620_B_)",207.878,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",208.113,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo26","DGalpa1-6DGalpb1-C26O5","DGD(515_c_)-DGD(515_c_)",207.473,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo22","DGalpa1-6DGalpb1-C36O5","DGD(407_D_)-DGD(407_D_)",209.165,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo38","DGalpa1-6DGalpb1-C26O5","DGD(514_C_)-DGD(514_C_)",206.976,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo24","DGalpa1-6DGalpb1-C25O5","DGD(601_b_)-DGD(601_b_)",208.805,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo25","DGalpa1-6DGalpb1-C31O5","DGD(625_b_)-DGD(625_b_)",207.255,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo40","DGalpa1-6DGalpb1-C39O5","DGD(516_C_)-DGD(516_C_)",207.475,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo29","DGalpa1-6DGalpb1-C36O5","DGD(410_d_)-DGD(410_d_)",209.597,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo37","DGalpa1-6DGalpb1-C25O5","DGD(626_B_)-DGD(626_B_)",209.413,"","",""
"4TNK","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSEC AFTER THE THIRD ILLUMINATION AT 5.2 A RESOLUTION","10.1038/NCOMMS5371 ",5.2,207.6,"4tnk_oligo39","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",208.28,"","",""
"4TPK","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-(2,3-DIHYDRO-1H- INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)-2-NAPHTHAMIDE","10.1021/JM501195E ",2.7,0,"4tpk_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(241_A_)",111.665,"","",""
"4TPK","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-(2,3-DIHYDRO-1H- INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)-2-NAPHTHAMIDE","10.1021/JM501195E ",2.7,0,"4tpk_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(341_A_)",100.656,"","",""
"4TPL","WEST NILE VIRUS NON-STRUCTURAL PROTEIN 1 (NS1) FORM 1 CRYSTAL","10.1107/S1399004714017556 ",2.9,100.3,"4tpl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(207_B_)",151.528,"","",""
"4TTU","N-TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E FROM LEUCONOSTOC MESENTEROIDES NRRL B-1299 IN COMPLEX WITH ISOMALTOTRIOSE","10.1074/JBC.M115.688796 ",2.18,27.88,"4ttu_oligo1","DGlcpa1-6DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",63.9664,"","",""
"4TVC","N-TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E FROM LEUCONOSTOC MESENTEROIDES NRRL B-1299 IN COMPLEX WITH GLUCO-OLIGOSACCHARIDES","10.1074/JBC.M115.688796 ",1.85,29.44,"4tvc_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",70.4561,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_G_)",102.019,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",88.2486,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_G_)",119.641,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",114.15,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)]-MAN(4_K_)-[MAN(10_K_)-MAN(9_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(325_B_)",82.3019,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(412_A_)",58.8758,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo8","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_A_)",75.3942,"","",""
"4TW2","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",2.89,53.32,"4tw2_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(325_A_)",59.3755,"","",""
"4TW2","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",2.89,53.32,"4tw2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(68_A_)",59.4471,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(918_c_)-DGD(918_c_)",28.3273,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(406_d_)-DGD(406_d_)",114.793,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",22.7159,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(405_D_)-DGD(405_D_)",99.9955,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(917_c_)-DGD(917_c_)",30.0682,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",34.6114,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo55","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",23.2309,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo56","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",25.4568,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(916_c_)-DGD(916_c_)",27.3973,"","",""
"4UB6","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub6_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",33.5582,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",29.3905,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(407_d_)-DGD(407_d_)",110.32,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(407_D_)-DGD(407_D_)",105.154,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo18","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",27.8227,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",24.3391,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",34.5886,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",27.9423,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo31","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",26.1736,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",32.5041,"","",""
"4UB8","NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER","10.1038/NATURE13991 ",1.95,0,"4ub8_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",41.0273,"","",""
"4UFA","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AC-SD","10.1038/SREP13742 ",1.8,28.59,"4ufa_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",50.0834,"","",""
"4UFA","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AC-SD","10.1038/SREP13742 ",1.8,28.59,"4ufa_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_B_)",54.6186,"","",""
"4UFB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH LYS-PRO","10.1038/SREP13742 ",1.8,29.21,"4ufb_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(416_D_)",48.1795,"","",""
"4UFB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH LYS-PRO","10.1038/SREP13742 ",1.8,29.21,"4ufb_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(416_C_)",46.8189,"","",""
"4UFB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH LYS-PRO","10.1038/SREP13742 ",1.8,29.21,"4ufb_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(480_C_)",55.9409,"","",""
"4UFB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH LYS-PRO","10.1038/SREP13742 ",1.8,29.21,"4ufb_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(480_D_)",49.6364,"","",""
"4UFB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH LYS-PRO","10.1038/SREP13742 ",1.8,29.21,"4ufb_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_A_)",64.6677,"","",""
"4UFB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH LYS-PRO","10.1038/SREP13742 ",1.8,29.21,"4ufb_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(480_B_)",54.0232,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(260_A_)",145.249,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(266_A_)",106.841,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(266_C_)",129.504,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo3","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(524_A_)",137.846,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(524_C_)",138.646,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(370_D_)",165.366,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(44_A_)",126.625,"","",""
"4UM9","CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE","10.1038/NSMB.2905 ",2.5,74.31,"4um9_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(266_C_)",115.868,"","",""
"4UM9","CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE","10.1038/NSMB.2905 ",2.5,74.31,"4um9_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",120.063,"","",""
"4UM9","CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE","10.1038/NSMB.2905 ",2.5,74.31,"4um9_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(260_A_)",115.738,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(285_A_)",98.0962,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(165_A_)",118.949,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(165_E_)",126.265,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",111.649,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_C_)",119.677,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo13","DGlcpNAca1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(285_E_)",119.569,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",95.9628,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",137.896,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",125.234,"","",""
"4UNY","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",2.9,67.81,"4uny_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_C_)",143.448,"","",""
"4UNY","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",2.9,67.81,"4uny_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(22_C_)",93.4209,"","",""
"4UNY","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",2.9,67.81,"4uny_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",118.178,"","",""
"4UNY","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",2.9,67.81,"4uny_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(165_E_)",134.985,"","",""
"4UNZ","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,73.96,"4unz_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",127.126,"","",""
"4UNZ","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,73.96,"4unz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(22_C_)",105.096,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(165_E_)",63.8605,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(63_C_)",80.234,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_A_)",66.5993,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",63.2887,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(22_C_)",52.1642,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(165_C_)",101.585,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_E_)",119.96,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(165_A_)",134.572,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(165_E_)",91.2593,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",104.758,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(165_C_)",89.2498,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(165_A_)",80.106,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(22_C_)",73.6771,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(8_A_)",93.0268,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo6","DAltp[6H]a1-6DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(154_D_)",104.558,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_C_)",94.9764,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(38_C_)",100.583,"","",""
"4UO4","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,74.11,"4uo4_oligo3","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",111.328,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_A_)",124.8,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",114.852,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(165_E_)",121.944,"","",""
"4UO6","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,88.61,"4uo6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",133.157,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(165_E_)",101.609,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",97.3336,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_A_)",94.6709,"","",""
"4UO8","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",3,83.04,"4uo8_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",131.378,"","",""
"4UOA","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ MET29ILE MUTANT","10.1073/PNAS.1406606111 ",2.5,60.45,"4uoa_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",101.787,"","",""
"4UOA","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ MET29ILE MUTANT","10.1073/PNAS.1406606111 ",2.5,60.45,"4uoa_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(285_A_)",116.314,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(86_B_)",63.0052,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo9","DManpa1-2DManpa1-2DManpb1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(255_B_)",49.5038,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo6","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(8_G_)-MAN(7_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(86_A_)",61.8599,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo2","DManpa1-2DManpa1-2DManpb1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(255_A_)",51.9064,"","",""
"4UT6","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 B7","10.1038/NATURE14130 ",3.2,92.81,"4ut6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",91.8967,"","",""
"4UT6","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 B7","10.1038/NATURE14130 ",3.2,92.81,"4ut6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",107.364,"","",""
"4UTA","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8","10.1038/NATURE14130 ",3,88.63,"4uta_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(67_B_)",113.708,"","",""
"4UTA","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8","10.1038/NATURE14130 ",3,88.63,"4uta_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(67_A_)",117.269,"","",""
"4UTB","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NATURE14130 ",3.85,129.3,"4utb_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(153_B_)",132.016,"","",""
"4UTB","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NATURE14130 ",3.85,129.3,"4utb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",130.293,"","",""
"4UTC","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN","10.1038/NATURE14130 ",3.08,85.62,"4utc_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(153_B_)",88.3062,"","",""
"4UTC","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN","10.1038/NATURE14130 ",3.08,85.62,"4utc_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",138.703,"","",""
"4W4N","CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A","10.1038/NCOMMS7866 ",1.8,43.23,"4w4n_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",31.415,"","",""
"4W4N","CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A","10.1038/NCOMMS7866 ",1.8,43.23,"4w4n_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",61.1245,"","",""
"4W4O","HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI","10.1038/NCOMMS7866 ",1.8,42.26,"4w4o_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",54.0719,"","",""
"4W4O","HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI","10.1038/NCOMMS7866 ",1.8,42.26,"4w4o_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",47.3679,"","",""
"4W87","CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4- GLUCANASE FROM METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE","10.1021/ACS.BIOCHEM.5B00011 ",2.15,30.89,"4w87_oligo2","DXylpa1-6DGlcpb1-4DGlcpb1-4DGlcpb1-ROH","XYS(4_C_)-BGC(3_C_)-BGC(2_C_)-BGC(1_C_)",58.0939,"","",""
"4W87","CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4- GLUCANASE FROM METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE","10.1021/ACS.BIOCHEM.5B00011 ",2.15,30.89,"4w87_oligo1","DXylpa1-6DGlcpb1-4DGlcpb1-4DGlcpb1-ROH","XYS(4_D_)-BGC(3_D_)-BGC(2_D_)-BGC(1_D_)",56.5206,"","",""
"4W88","CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4- GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE AND TRIS","10.1021/ACS.BIOCHEM.5B00011 ",1.58,24.74,"4w88_oligo1","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-ROH","GAL(3_C_)-XYS(2_C_)-[BGC(4_C_)]-BGC(1_C_)",41.3732,"","",""
"4W88","CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4- GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE AND TRIS","10.1021/ACS.BIOCHEM.5B00011 ",1.58,24.74,"4w88_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(6_D_)-XYS(5_D_)-[XYS(4_D_)-BGC(3_D_)]-BGC(2_D_)-BGC(1_D_)",44.1751,"","",""
"4W8B","CRYSTAL STRUCTURE OF XEG5B, A GH5 XYLOGLUCAN-SPECIFIC BETA-1,4- GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH XXLG","10.1021/ACS.BIOCHEM.5B00011 ",1.15,9.96,"4w8b_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DXylpa1-ROH","GAL(8_B_)-XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-GLC(1_B_)",14.0792,"","",""
"4W8B","CRYSTAL STRUCTURE OF XEG5B, A GH5 XYLOGLUCAN-SPECIFIC BETA-1,4- GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH XXLG","10.1021/ACS.BIOCHEM.5B00011 ",1.15,9.96,"4w8b_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(5_C_)-[XYS(4_C_)-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",23.5817,"","",""
"4WA4","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.02723-14 ",1.95,17.45,"4wa4_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(144_A_)",48.4591,"","",""
"4WA5","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH ZANAMIVIR","10.1128/JVI.02723-14 ",1.95,16.23,"4wa5_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(144_A_)",43.6227,"","",""
"4WE4","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM 1968 H3N2 INFLUENZA VIRUS","10.1016/J.VIROL.2014.12.024 ",2.35,0,"4we4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",72.7062,"","",""
"4WE4","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM 1968 H3N2 INFLUENZA VIRUS","10.1016/J.VIROL.2014.12.024 ",2.35,0,"4we4_oligo3","DGlcpNAca1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",80.6393,"","",""
"4WEF","STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID","10.1016/J.ANTIVIRAL.2015.08.014 ",2.5,36.06,"4wef_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(523_B_)",67.8215,"","",""
"4WEF","STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID","10.1016/J.ANTIVIRAL.2015.08.014 ",2.5,36.06,"4wef_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(523_A_)",99.2433,"","",""
"4WEG","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX 2,3-DIFLUOROSIALIC ACID","10.1016/J.ANTIVIRAL.2015.08.014 ",2.1,32.49,"4weg_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",42.4535,"","",""
"4WI2","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)","",1.9,0,"4wi2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",92.3777,"","",""
"4WI2","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)","",1.9,0,"4wi2_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.86,"","",""
"4WI3","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A","",2.7,0,"4wi3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",160.251,"","",""
"4WI3","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A","",2.7,0,"4wi3_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",161.436,"","",""
"4WI4","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A","",2.8,0,"4wi4_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",134.939,"","",""
"4WI4","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A","",2.8,0,"4wi4_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",150.74,"","",""
"4WI5","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A","",2.8,0,"4wi5_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",178.87,"","",""
"4WI5","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A","",2.8,0,"4wi5_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",182.481,"","",""
"4WI6","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A","",2.2,0,"4wi6_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",72.1728,"","",""
"4WI6","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A","",2.2,0,"4wi6_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",102.249,"","",""
"4WI7","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A","",1.9,0,"4wi7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",57.2102,"","",""
"4WI7","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A","",1.9,0,"4wi7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",69.8317,"","",""
"4WI8","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A","",2.8,0,"4wi8_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_D_)-[NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",144.051,"","",""
"4WI8","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A","",2.8,0,"4wi8_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",87.8138,"","",""
"4WI9","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A","",2.65,0,"4wi9_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(297_A_)",154.198,"","",""
"4WI9","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A","",2.65,0,"4wi9_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",131.71,"","",""
"4WI9","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A","",2.65,0,"4wi9_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcx1-","NAG(6_D_)-MAN(5_D_)-[NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",125.241,"","",""
"4WJK","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",1.85,60.35,"4wjk_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(275_A_)",96.9492,"","",""
"4WJK","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",1.85,60.35,"4wjk_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(43_A_)",77.9331,"","",""
"4WK0","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",1.78,50.29,"4wk0_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(275_A_)",70.8288,"","",""
"4WK2","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,99.46,"4wk2_oligo2","DManpa1-3[DManpa1-6]DManpx1-","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)",130.003,"","",""
"4WK2","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,99.46,"4wk2_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(43_A_)",127.841,"","",""
"4WK4","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,104,"4wk4_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(141_A_)",152.975,"","",""
"4WK4","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,104,"4wk4_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(275_A_)",138.434,"","",""
"4WO4","THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.","10.1084/JEM.20141764 ",2.5,41.39,"4wo4_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(20_A_)",70.9193,"","",""
"4WO4","THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.","10.1084/JEM.20141764 ",2.5,41.39,"4wo4_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(163_A_)",73.5876,"","",""
"4WRL","STRUCTURE OF THE HUMAN CSF-1:CSF-1R COMPLEX","10.1016/J.STR.2015.06.019 ",2.8,0,"4wrl_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[SIA(3_E_)-GAL(2_E_)]-NAG(1_E_)-ASN(73_A_)",146.155,"","",""
"4WRL","STRUCTURE OF THE HUMAN CSF-1:CSF-1R COMPLEX","10.1016/J.STR.2015.06.019 ",2.8,0,"4wrl_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[SIA(3_H_)-GAL(2_H_)]-NAG(1_H_)-ASN(73_C_)",146.249,"","",""
"4WVP","CRYSTAL STRUCTURE OF AN ACTIVITY-BASED PROBE HNE COMPLEX","10.1021/CB500909N ",1.63,18.13,"4wvp_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_A_)-[BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(159_E_)",24.4557,"","",""
"4WVP","CRYSTAL STRUCTURE OF AN ACTIVITY-BASED PROBE HNE COMPLEX","10.1021/CB500909N ",1.63,18.13,"4wvp_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(109_E_)",50.2085,"","",""
"4X0L","HUMAN HAPTOGLOBIN-HAEMOGLOBIN COMPLEX","10.7554/ELIFE.05553 ",2.05,24.45,"4x0l_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(241_C_)",28.5595,"","",""
"4X4K","STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT","10.1107/S2053230X1502052X ",2.3,39.24,"4x4k_oligo1","DManpb1-2DManpb1-6DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(194_A_)",70.1142,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_J_)-MAN(5_J_)-[NAG(4_J_)-MAN(3_J_)]-BMA(2_J_)-NAG(1_J_)-NAG(1001_D_)-ASN(297_D_)",186.422,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",122.935,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_C_)",145.232,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",152.959,"","",""
"4X6D","CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR","10.1038/NI.3098 ",2.98,0,"4x6d_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(57_A_)",129.093,"","",""
"4X6D","CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR","10.1038/NI.3098 ",2.98,0,"4x6d_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(57_C_)",132.734,"","",""
"4X8X","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.5,0,"4x8x_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(18_B_)",142.833,"","",""
"4X98","IMMUNOGLOBULIN FC HETERODIMER VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x98_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.6668,"","",""
"4X98","IMMUNOGLOBULIN FC HETERODIMER VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x98_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.2932,"","",""
"4X99","IMMUNOGLOBULIN FC HETERODIMERS VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x99_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",105.177,"","",""
"4X99","IMMUNOGLOBULIN FC HETERODIMERS VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x99_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",62.246,"","",""
"4X9B","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 4.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.2,0,"4x9b_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",41.2198,"","",""
"4X9F","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.35,0,"4x9f_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(291_B_)",91.1329,"","",""
"4X9F","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.35,0,"4x9f_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",70.6225,"","",""
"4X9G","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",3.4,0,"4x9g_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(291_B_)",119.556,"","",""
"4X9G","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",3.4,0,"4x9g_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(291_A_)",128.585,"","",""
"4X9G","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",3.4,0,"4x9g_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",83.9731,"","",""
"4XB8","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 9.44, N-TERMINAL FOUR IG DOMAINS (WITH ZINC)","10.1126/SCIADV.1501118 ",3.2,0,"4xb8_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",71.392,"","",""
"4XHJ","GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.","10.1073/PNAS.1501176112 ",3.16,0,"4xhj_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(66_F_)",125.264,"","",""
"4XHJ","GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.","10.1073/PNAS.1501176112 ",3.16,0,"4xhj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(66_B_)",160.804,"","",""
"4XHQ","RE-REFINEMENT THE CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.34, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",1.95,0,"4xhq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(290_A_)",68.6631,"","",""
"4XK8","CRYSTAL STRUCTURE OF PLANT PHOTOSYSTEM I-LHCI SUPER-COMPLEX AT 2.8 ANGSTROM RESOLUTION","10.1126/SCIENCE.AAB0214 ",2.8,0,"4xk8_oligo5","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",82.2168,"","",""
"4XK8","CRYSTAL STRUCTURE OF PLANT PHOTOSYSTEM I-LHCI SUPER-COMPLEX AT 2.8 ANGSTROM RESOLUTION","10.1126/SCIENCE.AAB0214 ",2.8,0,"4xk8_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(849_b_)-DGD(849_b_)",83.8868,"","",""
"4XKW","TAILSPIKE PROTEIN MUTANT D339N OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.45,15.13,"4xkw_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",15.5498,"","",""
"4XLA","TAILSPIKE PROTEIN MUTANT D339A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.47,16.4,"4xla_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAcb1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NAG(1_B_)",16.4418,"","",""
"4XLE","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.45,14.36,"4xle_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",13.7458,"","",""
"4XLF","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.75,14.86,"4xlf_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",13.9275,"","",""
"4XM3","TAILSPIKE PROTEIN MUTANT E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.27,12.76,"4xm3_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",12.5916,"","",""
"4XMY","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.45,14.57,"4xmy_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",14.0305,"","",""
"4XN3","TAILSPIKE PROTEIN MUTANT E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.65,14.94,"4xn3_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",13.7791,"","",""
"4XNM","ANTIBODY INFLUENZA H5 COMPLEX","10.1073/PNAS.1502762112 ",2.51,0,"4xnm_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(18_L_)",104.88,"","",""
"4XNQ","ANTIBODY HEMAGGLUTININ COMPLEXES","10.1073/PNAS.1502762112 ",2,0,"4xnq_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(18_L_)",85.9555,"","",""
"4XNZ","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120","10.1016/J.CELL.2015.03.004 ",3.39,144.9,"4xnz_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(102_L_)",145.698,"","",""
"4XNZ","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120","10.1016/J.CELL.2015.03.004 ",3.39,144.9,"4xnz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(102_C_)",159.419,"","",""
"4XNZ","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120","10.1016/J.CELL.2015.03.004 ",3.39,144.9,"4xnz_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(102_F_)",189.562,"","",""
"4XOP","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.59,15.57,"4xop_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",13.4732,"","",""
"4XOR","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.5,15.11,"4xor_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",14.4802,"","",""
"4XOT","TAILSPIKE PROTEIN MUTANT E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.06,11.58,"4xot_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",9.92636,"","",""
"4XR6","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.78,17.61,"4xr6_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",17.1306,"","",""
"4XRC","ANTIBODY HEMAGGLUTININ COMPLEXES","10.1073/PNAS.1502762112 ",2.74,0,"4xrc_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(18_L_)",102.427,"","",""
"4XSS","INSULIN-LIKE GROWTH FACTOR I IN COMPLEX WITH SITE 1 OF A HYBRID INSULIN RECEPTOR / TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR","10.1016/J.STR.2015.04.016 ",3,129.7,"4xss_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_A_)-[BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(25_E_)",217.955,"","",""
"4XSS","INSULIN-LIKE GROWTH FACTOR I IN COMPLEX WITH SITE 1 OF A HYBRID INSULIN RECEPTOR / TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR","10.1016/J.STR.2015.04.016 ",3,129.7,"4xss_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(255_E_)",166.815,"","",""
"4XST","STRUCTURE OF THE ENDOGLYCOSIDASE-H TREATED L1-CR DOMAINS OF THE HUMAN INSULIN RECEPTOR IN COMPLEX WITH RESIDUES 697-719 OF THE HUMAN INSULIN RECEPTOR (A-ISOFORM)","10.1016/J.STR.2015.04.016 ",3,113.7,"4xst_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(255_E_)",168.454,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)]-MAN(4_D_)-[MAN(9_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(91_A_)",40.9033,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo3","DManpa1-4DManpa1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(54_B_)",50.9794,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",34.8257,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(91_B_)",33.1431,"","",""
"4Y19","IMMUNE COMPLEX","10.1038/NI.3271 ",2.5,34.62,"4y19_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(78_A_)",52.3916,"","",""
"4Y28","THE STRUCTURE OF PLANT PHOTOSYSTEM I SUPER-COMPLEX AT 2.8 ANGSTROM RESOLUTION.","10.7554/ELIFE.07433 ",2.8,98.19,"4y28_oligo8","DGalpa1-6DGalpb1-C34O5","DGD(7101_B_)-DGD(7101_B_)",88.1332,"","",""
"4Y4K","CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX","",2.9,37.57,"4y4k_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",49.4349,"","",""
"4YAQ","CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT","10.1172/JCI80693 ",2.3,0,"4yaq_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(24_B_)",94.0012,"","",""
"4YAQ","CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT","10.1172/JCI80693 ",2.3,0,"4yaq_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(24_L_)",87.6012,"","",""
"4YEJ","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.4,13.79,"4yej_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",13.3558,"","",""
"4YEL","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.72,16.16,"4yel_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",15.0444,"","",""
"4YH6","CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN","10.1038/NCOMMS7926 ",3,0,"4yh6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(213_B_)",101.162,"","",""
"4YH6","CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN","10.1038/NCOMMS7926 ",3,0,"4yh6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(213_A_)",113.037,"","",""
"4YH6","CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN","10.1038/NCOMMS7926 ",3,0,"4yh6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(264_A_)",119.287,"","",""
"4YH7","CRYSTAL STRUCTURE OF PTPDELTA ECTODOMAIN IN COMPLEX WITH IL1RAPL1","10.1038/NCOMMS7926 ",4.4,0,"4yh7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_B_)",163.819,"","",""
"4YN3","CRYSTAL STRUCTURE OF CUCUMISIN COMPLEX WITH PRO-PEPTIDE","10.1093/JB/MVW053 ",1.95,41.3,"4yn3_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(466_A_)",44.7035,"","",""
"4YQX","MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT","10.1016/J.IMMUNI.2015.04.015 ",2.83,63.58,"4yqx_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(31_H_)",114.323,"","",""
"4Z7N","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE","10.1074/JBC.M115.705624 ",2.6,0,"4z7n_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(320_B_)",82.1713,"","",""
"4Z7O","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE","10.1074/JBC.M115.705624 ",2.85,0,"4z7o_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_B_)",113.191,"","",""
"4Z7Q","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE","10.1074/JBC.M115.705624 ",2.7,0,"4z7q_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_B_)",106.219,"","",""
"4Z7U","S13 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.7,67.59,"4z7u_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(19_B_)",121.575,"","",""
"4Z7U","S13 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.7,67.59,"4z7u_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[NAG(3_L_)]-[FUC(2_L_)]-NAG(1_L_)-ASN(19_D_)",108.29,"","",""
"4Z7V","L3-12 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.65,61.71,"4z7v_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[NAG(3_L_)]-[FUC(2_L_)]-NAG(1_L_)-ASN(19_D_)",108.408,"","",""
"4Z7V","L3-12 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.65,61.71,"4z7v_oligo1","DManpa1-4DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(4_K_)-MAN(3_K_)-NAG(2_K_)]-[FUC(5_K_)]-NAG(1_K_)-ASN(19_B_)",134.342,"","",""
"4Z7W","T316 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.89,59.64,"4z7w_oligo1","DManpa1-6DManpa1-3DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(4_K_)-MAN(3_K_)-NAG(2_K_)]-[FUC(5_K_)]-NAG(1_K_)-ASN(78_A_)",60.7742,"","",""
"4Z7W","T316 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.89,59.64,"4z7w_oligo2","DManpa1-6DManpa1-3DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(4_L_)-MAN(3_L_)-NAG(2_L_)]-[FUC(5_L_)]-NAG(1_L_)-ASN(78_C_)",70.8189,"","",""
"4ZEL","HUMAN DOPAMINE BETA-HYDROXYLASE","10.1126/SCIADV.1500980 ",2.9,75.18,"4zel_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(344_B_)",89.6332,"","",""
"4ZLP","CRYSTAL STRUCTURE OF NOTCH3 NEGATIVE REGULATORY REGION","10.1016/J.STR.2015.05.001 ",2.48,0,"4zlp_oligo2","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1438_A_)",82.3264,"","",""
"4ZMJ","CRYSTAL STRUCTURE OF LIGAND-FREE BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1038/NSMB.3051 ",3.31,0,"4zmj_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",119.188,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_J_)",72.298,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_E_)",63.5537,"","",""
"4ZPL","CRYSTAL STRUCTURE OF PROTOCADHERIN BETA 1 EC1-3","10.1016/J.CELL.2015.09.026 ",3.3,0,"4zpl_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(141_A_)",142.602,"","",""
"4ZPL","CRYSTAL STRUCTURE OF PROTOCADHERIN BETA 1 EC1-3","10.1016/J.CELL.2015.09.026 ",3.3,0,"4zpl_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(181_A_)",124.843,"","",""
"4ZPL","CRYSTAL STRUCTURE OF PROTOCADHERIN BETA 1 EC1-3","10.1016/J.CELL.2015.09.026 ",3.3,0,"4zpl_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(229_A_)",138.531,"","",""
"4ZPN","CRYSTAL STRUCTURE OF PROTOCADHERIN GAMMA C5 EC1-3 WITH EXTENDED N- TERMINUS","10.1016/J.CELL.2015.09.026 ",3.3,0,"4zpn_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(241_B_)",136.214,"","",""
"4ZPN","CRYSTAL STRUCTURE OF PROTOCADHERIN GAMMA C5 EC1-3 WITH EXTENDED N- TERMINUS","10.1016/J.CELL.2015.09.026 ",3.3,0,"4zpn_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",90.1821,"","",""
"4ZPO","CRYSTAL STRUCTURE OF PROTOCADHERIN GAMMA C5 EC1-3","10.1016/J.CELL.2015.09.026 ",2.9,0,"4zpo_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(236_A_)",129.768,"","",""
"4ZPQ","CRYSTAL STRUCTURE OF PROTOCADHERIN GAMMA C5 EC1-3","10.1016/J.CELL.2015.09.026 ",3.1,0,"4zpq_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(236_C_)",124.591,"","",""
"4ZPQ","CRYSTAL STRUCTURE OF PROTOCADHERIN GAMMA C5 EC1-3","10.1016/J.CELL.2015.09.026 ",3.1,0,"4zpq_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(236_B_)",115.791,"","",""
"4ZPQ","CRYSTAL STRUCTURE OF PROTOCADHERIN GAMMA C5 EC1-3","10.1016/J.CELL.2015.09.026 ",3.1,0,"4zpq_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(236_A_)",116.705,"","",""
"4ZRD","CRYSTAL STRUCTURE OF SMG1 F278N MUTANT","10.1111/FEBS.13513 ",2.3,21.78,"4zrd_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(253_A_)",27.9005,"","",""
"4ZS9","RAFFINOSE AND PANOSE BINDING PROTEIN FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04, BOUND WITH RAFFINOSE","10.1074/JBC.M116.746529 ",1.37,19.17,"4zs9_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_D_)-GLC(2_D_)-FRU(1_D_)",8.31936,"","",""
"4ZS9","RAFFINOSE AND PANOSE BINDING PROTEIN FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04, BOUND WITH RAFFINOSE","10.1074/JBC.M116.746529 ",1.37,19.17,"4zs9_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_C_)-GLC(2_C_)-FRU(1_C_)",10.3284,"","",""
"4ZSO","CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY","",2.5,43.45,"4zso_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(43_F_)",78.2585,"","",""
"4ZSO","CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY","",2.5,43.45,"4zso_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(43_E_)",75.3523,"","",""
"4ZXB","STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES","10.1016/J.STR.2015.12.014 ",3.3,134.1,"4zxb_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(418_E_)",187.711,"","",""
"4ZXB","STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES","10.1016/J.STR.2015.12.014 ",3.3,134.1,"4zxb_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(606_E_)",188.48,"","",""
"4ZXB","STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES","10.1016/J.STR.2015.12.014 ",3.3,134.1,"4zxb_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(881_E_)",180.311,"","",""
"4ZXB","STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES","10.1016/J.STR.2015.12.014 ",3.3,134.1,"4zxb_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[NAG(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(397_E_)",181.128,"","",""
"4ZXB","STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES","10.1016/J.STR.2015.12.014 ",3.3,134.1,"4zxb_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(25_E_)",192.023,"","",""
"4ZXB","STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES","10.1016/J.STR.2015.12.014 ",3.3,134.1,"4zxb_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(255_E_)",158.569,"","",""
"4ZZA","RAFFINOSE AND PANOSE BINDING PROTEIN FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04, BOUND WITH RAFFINOSE, SELENOMETHIONINE DERIVATIVE","10.1074/JBC.M116.746529 ",2.02,15.02,"4zza_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_D_)-GLC(2_D_)-FRU(1_D_)",7.92021,"","",""
"4ZZA","RAFFINOSE AND PANOSE BINDING PROTEIN FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04, BOUND WITH RAFFINOSE, SELENOMETHIONINE DERIVATIVE","10.1074/JBC.M116.746529 ",2.02,15.02,"4zza_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_C_)-GLC(2_C_)-FRU(1_C_)",9.3647,"","",""
"4ZZE","RAFFINOSE AND PANOSE BINDING PROTEIN FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04, BOUND WITH PANOSE","10.1074/JBC.M116.746529 ",1.76,21.23,"4zze_oligo2","DGlcpa1-6DGlcpa1-4DGlcpb1-ROH","GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",12.39,"","",""
"4ZZE","RAFFINOSE AND PANOSE BINDING PROTEIN FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04, BOUND WITH PANOSE","10.1074/JBC.M116.746529 ",1.76,21.23,"4zze_oligo1","DGlcpa1-6DGlcpa1-4DGlcpb1-ROH","GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",13.347,"","",""
"5A09","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",1.81,25.87,"5a09_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(109_A_)",54.4832,"","",""
"5A09","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",1.81,25.87,"5a09_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(159_A_)",23.0795,"","",""
"5A0A","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",1.78,30.91,"5a0a_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(159_E_)",29.8595,"","",""
"5A0A","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",1.78,30.91,"5a0a_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(109_E_)",59.8005,"","",""
"5A0B","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",2.23,24.27,"5a0b_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(109_A_)",35.8191,"","",""
"5A0B","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",2.23,24.27,"5a0b_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(159_A_)",29.7886,"","",""
"5A0C","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",2.1,27.22,"5a0c_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(113_B_)",59.5005,"","",""
"5A0C","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",2.1,27.22,"5a0c_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(113_A_)",58.7009,"","",""
"5A0C","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",2.1,27.22,"5a0c_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(163_A_)",36.7912,"","",""
"5A0C","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500131 ",2.1,27.22,"5a0c_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(163_B_)",35.2997,"","",""
"5A63","CRYO-EM STRUCTURE OF THE HUMAN GAMMA-SECRETASE COMPLEX AT 3.4 ANGSTROM RESOLUTION.","10.1038/NATURE14892 ",3.4,"1.35632e-19","5a63_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",390.712,"","",""
"5A7M","THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1)","",1.8,15.48,"5a7m_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(123_A_)",23.9825,"","",""
"5A8X","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500269 ",2.23,17.44,"5a8x_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(159_A_)",17.9286,"","",""
"5A8X","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500269 ",2.23,17.44,"5a8x_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(109_A_)",46.1132,"","",""
"5A8Y","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500269 ",1.9,18.75,"5a8y_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(3_B_)-NAG(1_B_)-ASN(159_A_)",17.9627,"","",""
"5A8Y","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500269 ",1.9,18.75,"5a8y_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(109_A_)",42.8036,"","",""
"5A8Z","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500269 ",2,22.7,"5a8z_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(109_A_)",53.1109,"","",""
"5A8Z","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR","10.1002/CMDC.201500269 ",2,22.7,"5a8z_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(159_A_)",23.9895,"","",""
"5AB0","CRYSTAL STRUCTURE OF AMINOPEPTIDASE ERAP2 WITH LIGAND","10.1074/JBC.M115.685909 ",2.5,56.3,"5ab0_oligo6","DManpb1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[BMA(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(85_C_)",64.6682,"","",""
"5AB2","CRYSTAL STRUCTURE OF AMINOPEPTIDASE ERAP2 WITH LIGAND","10.1074/JBC.M115.685909 ",2.73,82.4,"5ab2_oligo8","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(85_B_)",85.775,"","",""
"5ABW","NEUTROPHIL ELASTASE INHIBITORS FOR THE TREATMENT OF (CARDIO)PULMONARY DISEASES","10.1016/J.BMCL.2015.08.049 ",1.6,15.55,"5abw_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(159_A_)",15.2648,"","",""
"5AFE","MEDIUM RESOLUTION STRUCTURE OF THE C-TERMINAL FAMILY 65 CARBOHYDRATE BINDING MODULE (CBM65B) OF ENDOGLUCANASE CEL5A FROM EUBACTERIUM CELLULOSOLVENS WITH A BOUND XYLOGLUCAN HEPTASACCHARIDE (XXXG)","",2.6,71.47,"5afe_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",73.7371,"","",""
"5AGD","AN INACTIVE (D125N) VARIANT OF THE CATALYTIC DOMAIN, BCGH76, OF BACILLUS CIRCULANS AMAN6 IN COMPLEX WITH ALPHA-1,6-MANNOPENTAOSE","10.1002/ANIE.201410502 ",1.2,22.04,"5agd_oligo2","DManpa1-6DManpa1-6DManpa1-6DManpa1-6DManpa1-ROH","MAN(5_D_)-MAN(4_D_)-MAN(3_D_)-MAN(2_D_)-MAN(500_B_)",19.8085,"","",""
"5AGD","AN INACTIVE (D125N) VARIANT OF THE CATALYTIC DOMAIN, BCGH76, OF BACILLUS CIRCULANS AMAN6 IN COMPLEX WITH ALPHA-1,6-MANNOPENTAOSE","10.1002/ANIE.201410502 ",1.2,22.04,"5agd_oligo1","DManpa1-6DManpa1-6DManpa1-6DManpa1-6DManpa1-ROH","MAN(5_C_)-MAN(4_C_)-MAN(3_C_)-MAN(2_C_)-MAN(500_A_)",16.9809,"","",""
"5AJM","H5 (VN1194) ASN186LYS MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'SLN","10.1016/J.VIROL.2014.03.008 ",2.45,78.35,"5ajm_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",146.112,"","",""
"5AM8","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 4-10","10.1111/FEBS.13647 ",1.9,25.01,"5am8_oligo9","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[MAN(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(416_D_)",44.0093,"","",""
"5AM8","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 4-10","10.1111/FEBS.13647 ",1.9,25.01,"5am8_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_B_)",43.5986,"","",""
"5AM8","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 4-10","10.1111/FEBS.13647 ",1.9,25.01,"5am8_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(480_C_)",49.2291,"","",""
"5AM9","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 10-16","10.1111/FEBS.13647 ",1.8,27.35,"5am9_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(480_B_)",51.605,"","",""
"5AM9","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 10-16","10.1111/FEBS.13647 ",1.8,27.35,"5am9_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(416_C_)",41.6784,"","",""
"5AM9","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 10-16","10.1111/FEBS.13647 ",1.8,27.35,"5am9_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(480_D_)",52.1227,"","",""
"5AM9","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 10-16","10.1111/FEBS.13647 ",1.8,27.35,"5am9_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(416_D_)",51.302,"","",""
"5AM9","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 10-16","10.1111/FEBS.13647 ",1.8,27.35,"5am9_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(480_C_)",52.6745,"","",""
"5AMA","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 1-16","10.1111/FEBS.13647 ",1.8,23.81,"5ama_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(480_C_)",47.2209,"","",""
"5AMA","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 1-16","10.1111/FEBS.13647 ",1.8,23.81,"5ama_oligo10","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[MAN(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(416_D_)",46.6334,"","",""
"5AMA","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 1-16","10.1111/FEBS.13647 ",1.8,23.81,"5ama_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_B_)",39.3791,"","",""
"5AMA","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 1-16","10.1111/FEBS.13647 ",1.8,23.81,"5ama_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(480_D_)",44.2177,"","",""
"5AMB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 35-42","10.1111/FEBS.13647 ",1.55,0,"5amb_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_B_)",63.7991,"","",""
"5AMB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 35-42","10.1111/FEBS.13647 ",1.55,0,"5amb_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",59.0736,"","",""
"5AMB","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 35-42","10.1111/FEBS.13647 ",1.55,0,"5amb_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(416_A_)",55.0032,"","",""
"5AMC","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA FLUOROGENIC FRAGMENT 4-10","10.1111/FEBS.13647 ",1.65,30.14,"5amc_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(416_A_)",48.295,"","",""
"5AMC","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA FLUOROGENIC FRAGMENT 4-10","10.1111/FEBS.13647 ",1.65,30.14,"5amc_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",51.7314,"","",""
"5AMC","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA FLUOROGENIC FRAGMENT 4-10","10.1111/FEBS.13647 ",1.65,30.14,"5amc_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_B_)",56.0395,"","",""
"5ANM","CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY","10.4161/MABS.28394 ",2.85,68.61,"5anm_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_F_)",79.6876,"","",""
"5ANM","CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY","10.4161/MABS.28394 ",2.85,68.61,"5anm_oligo3","DManpa1-3DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[BMA(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_G_)",71.3477,"","",""
"5ANM","CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY","10.4161/MABS.28394 ",2.85,68.61,"5anm_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_E_)",94.5333,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo31","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",40.9809,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo25","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",36.3092,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo29","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",28.0687,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",30.41,"","",""
"5AV7","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",1.85,23.1,"5av7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_E_)-MAN(4_E_)-[NAG(6_E_)]-[NAG(3_E_)-MAN(2_E_)]-MMA(1_E_)",27.2962,"","",""
"5AV7","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",1.85,23.1,"5av7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_F_)-MAN(4_F_)-[NAG(6_F_)]-[NAG(3_F_)-MAN(2_F_)]-MMA(1_F_)",26.8536,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_J_)-NAG(4_J_)-MAN(3_J_)-[NAG(8_J_)]-[NAG(7_J_)-MAN(6_J_)]-BMA(2_J_)-NAG(1_J_)",44.5369,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_K_)-NAG(4_K_)-MAN(3_K_)-[NAG(8_K_)]-[NAG(7_K_)-MAN(6_K_)]-BMA(2_K_)-NAG(1_K_)",56.6309,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_I_)-NAG(4_I_)-MAN(3_I_)-[NAG(8_I_)]-[NAG(7_I_)-MAN(6_I_)]-BMA(2_I_)-NAG(1_I_)",45.0045,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_P_)-NAG(4_P_)-MAN(3_P_)-[NAG(8_P_)]-[NAG(7_P_)-MAN(6_P_)]-BMA(2_P_)-NAG(1_P_)",79.072,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_M_)-NAG(4_M_)-MAN(3_M_)-[NAG(8_M_)]-[NAG(7_M_)-MAN(6_M_)]-BMA(2_M_)-NAG(1_M_)",54.1475,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_O_)-NAG(4_O_)-MAN(3_O_)-[NAG(8_O_)]-[NAG(7_O_)-MAN(6_O_)]-BMA(2_O_)-NAG(1_O_)",67.8809,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_L_)-NAG(4_L_)-MAN(3_L_)-[NAG(8_L_)]-[NAG(7_L_)-MAN(6_L_)]-BMA(2_L_)-NAG(1_L_)",56.638,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_N_)-NAG(4_N_)-MAN(3_N_)-[NAG(8_N_)]-[NAG(7_N_)-MAN(6_N_)]-BMA(2_N_)-NAG(1_N_)",65.7048,"","",""
"5AWA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH MB-568","",2.2,57.74,"5awa_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",64.5118,"","",""
"5AWD","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH N1-4-AMINOMETHYLBENZYL (IMDQ)","10.1021/ACS.JMEDCHEM.5B01087 ",2.05,38.44,"5awd_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",43.9944,"","",""
"5AWP","ARTHROBACTER GLOBIFORMIS T6 ISOMALTO-DEXTRANASE COMPLEXED WITH ISOMALTOSE","10.1074/JBC.M115.680942 ",2,18.84,"5awp_oligo2","DGlcpa1-6DGlcpb1-ROH","GLC(2_C_)-BGC(1_C_)",27.3441,"","",""
"5AWP","ARTHROBACTER GLOBIFORMIS T6 ISOMALTO-DEXTRANASE COMPLEXED WITH ISOMALTOSE","10.1074/JBC.M115.680942 ",2,18.84,"5awp_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_B_)-BGC(1_B_)",14.4909,"","",""
"5AWQ","ARTHROBACTER GLOBIFORMIS T6 ISOMALTO-DEXTRANSE COMPLEXED WITH PANOSE","10.1074/JBC.M115.680942 ",1.48,16.76,"5awq_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",13.5494,"","",""
"5AWQ","ARTHROBACTER GLOBIFORMIS T6 ISOMALTO-DEXTRANSE COMPLEXED WITH PANOSE","10.1074/JBC.M115.680942 ",1.48,16.76,"5awq_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",25.9268,"","",""
"5AXH","CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS, D312G MUTANT IN COMPLEX WITH ISOMALTOHEXAOSE","10.1093/JB/MVV104 ",2.2,34.67,"5axh_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(6_D_)-GLC(5_D_)-GLC(4_D_)-GLC(3_D_)-GLC(2_D_)-BGC(1_D_)",46.9653,"","",""
"5AXH","CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS, D312G MUTANT IN COMPLEX WITH ISOMALTOHEXAOSE","10.1093/JB/MVV104 ",2.2,34.67,"5axh_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",40.4693,"","",""
"5AZ5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH MB-343","",2.4,61.96,"5az5_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(590_C_)",60.008,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",24.8359,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(919_c_)-DGD(919_c_)",24.1623,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",27.5582,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",31.5332,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",24.1195,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",33.2332,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(917_c_)-DGD(917_c_)",24.7227,"","",""
"5B5E","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.87,33.64,"5b5e_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(918_c_)-DGD(918_c_)",29.0418,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo37","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",25.9364,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo57","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",26.1473,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo62","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",26.19,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo38","DGalpa1-6DGalpb1-C28O5","DGD(517_C_)-DGD(517_C_)",30.0968,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo59","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",33.8,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo61","DGalpa1-6DGalpb1-C30O5","DGD(516_c_)-DGD(516_c_)",31.18,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo60","DGalpa1-6DGalpb1-C35O5","DGD(515_c_)-DGD(515_c_)",26.85,"","",""
"5B66","CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX","10.1021/JACS.6B09666 ",1.85,35.29,"5b66_oligo64","DGalpa1-6DGalpb1-C35O5","DGD(101_h_)-DGD(101_h_)",34.6986,"","",""
"5BK3","CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY","10.1016/J.IMMUNI.2017.11.007 ",2.8,0,"5bk3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(29_F_)",71.0411,"","",""
"5BK3","CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY","10.1016/J.IMMUNI.2017.11.007 ",2.8,0,"5bk3_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(29_D_)",98.5859,"","",""
"5BK3","CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY","10.1016/J.IMMUNI.2017.11.007 ",2.8,0,"5bk3_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(29_L_)",61.5012,"","",""
"5BK3","CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY","10.1016/J.IMMUNI.2017.11.007 ",2.8,0,"5bk3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(29_B_)",107.603,"","",""
"5BO6","STRUCTURE OF HUMAN SIALYLTRANSFERASE ST8SIAIII IN COMPLEX WITH CDP","10.1038/NSMB.3060 ",2.07,39.93,"5bo6_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(160_A_)",43.1861,"","",""
"5BO7","STRUCTURE OF HUMAN SIALYLTRANSFERASE ST8SIAIII IN COMPLEX WITH CTP","10.1038/NSMB.3060 ",1.85,35.9,"5bo7_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(160_A_)",37.4503,"","",""
"5BO8","STRUCTURE OF HUMAN SIALYLTRANSFERASE ST8SIAIII","10.1038/NSMB.3060 ",2.7,59.97,"5bo8_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(160_B_)",84.4754,"","",""
"5BO8","STRUCTURE OF HUMAN SIALYLTRANSFERASE ST8SIAIII","10.1038/NSMB.3060 ",2.7,59.97,"5bo8_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(113_A_)",92.8548,"","",""
"5BO9","STRUCTURE OF HUMAN SIALYLTRANSFERASE ST8SIAIII IN COMPLEX WITH CMP- 3FNEU5AC AND SIA-6S-LACNAC","10.1038/NSMB.3060 ",2.3,43.94,"5bo9_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(160_A_)",51.6406,"","",""
"5BR0","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1)","10.1371/JOURNAL.PONE.0134576 ",2.39,38.05,"5br0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(154_B_)",89.88,"","",""
"5BR0","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1)","10.1371/JOURNAL.PONE.0134576 ",2.39,38.05,"5br0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(154_D_)",91.5727,"","",""
"5BR3","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTA","10.1371/JOURNAL.PONE.0134576 ",2.55,39.84,"5br3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-[FUC(6_H_)]-NAG(1_H_)-ASN(154_D_)",61.5486,"","",""
"5BR3","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTA","10.1371/JOURNAL.PONE.0134576 ",2.55,39.84,"5br3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(154_B_)",80.7542,"","",""
"5BR6","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTC","10.1371/JOURNAL.PONE.0134576 ",2.43,37.54,"5br6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(154_B_)",49.5821,"","",""
"5BR6","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTC","10.1371/JOURNAL.PONE.0134576 ",2.43,37.54,"5br6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-[FUC(6_H_)]-NAG(1_H_)-ASN(154_D_)",48.8662,"","",""
"5BV7","CRYSTAL STRUCTURE OF HUMAN LCAT (L4F, N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY","10.1074/JBC.M115.672790 ",2.45,53.13,"5bv7_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(272_A_)",59.6548,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(162_C_)",93.4722,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",72.0614,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",77.391,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(301_C_)",193.467,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-MAN(8_L_)-[MAN(10_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(332_C_)",182.839,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-[MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(276_C_)",177.149,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_T_)-MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(234_C_)",149.229,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)]-MAN(4_S_)-[MAN(8_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(637_D_)",174.899,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_C_)",186.752,"","",""
"5CD5","CRYSTAL STRUCTURE OF AN IMMATURE VRC01-CLASS ANTIBODY DRVIA7 FROM A CHINESE DONOR BOUND TO CLADE A/E HIV-1 GP120 CORE","10.1016/J.IMMUNI.2016.03.006 ",3.4,0,"5cd5_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(289_A_)",167.64,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_G_)",215.609,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-MAN(8_Q_)-[MAN(301_H_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(332_G_)",115.06,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",178.833,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(301_D_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(88_G_)",109.625,"","",""
"5CJF","THE CRYSTAL STRUCTURE OF THE HUMAN CARBONIC ANHYDRASE XIV IN COMPLEX WITH A 1,1'-BIPHENYL-4-SULFONAMIDE INHIBITOR.","10.1021/ACS.JMEDCHEM.5B01144 ",1.83,20.99,"5cjf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(195_A_)",35.2364,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(637_B_)",127.056,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_K_)",108.82,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_K_)",168.826,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(276_Y_)",170.571,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-MAN(8_N_)-[MAN(10_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(234_G_)",122.847,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Z_)-MAN(8_Z_)-[MAN(10_Z_)]-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(234_Y_)",118.244,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_G_)",162.803,"","",""
"5CXF","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF GLYCOPROTEIN B FROM HUMAN CYTOMEGALOVIRUS","10.1371/JOURNAL.PPAT.1005227 ",3.6,0,"5cxf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(208_C_)",116.602,"","",""
"5CXY","STRUCTURE OF A GLYCOSYLTRANSFERASE IN COMPLEX WITH INHIBITOR","",2.15,38.14,"5cxy_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(160_A_)",49.1518,"","",""
"5D4K","CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN","10.7554/ELIFE.10640 ",2.6,69.22,"5d4k_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(72_B_)",82.1823,"","",""
"5D4K","CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN","10.7554/ELIFE.10640 ",2.6,69.22,"5d4k_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(72_A_)",86.0905,"","",""
"5D4Q","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC","10.1016/J.JSB.2016.02.001 ",2.39,0,"5d4q_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",72.2706,"","",""
"5D4Q","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC","10.1016/J.JSB.2016.02.001 ",2.39,0,"5d4q_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",99.5748,"","",""
"5D6D","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA","10.1016/J.JSB.2016.02.001 ",3.13,0,"5d6d_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",49.7178,"","",""
"5D6D","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA","10.1016/J.JSB.2016.02.001 ",3.13,0,"5d6d_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",56.2964,"","",""
"5D9M","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 ENZYME FROM PREVOTELLA BRYANTII B14, E280A MUTANT IN COMPLEX WITH THE XYLOGLUCAN TETRADECASACCHARIDE XXXGXXXG","10.1074/JBC.M115.691659 ",1.9,0,"5d9m_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpa1-ROH","XYS(14_D_)-[XYS(13_D_)-[XYS(12_D_)-[XYS(11_D_)-[XYS(10_D_)-[XYS(9_D_)-BGC(8_D_)]-BGC(7_D_)]-BGC(6_D_)-BGC(5_D_)]-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-GLC(1_D_)",25.3549,"","",""
"5D9M","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 ENZYME FROM PREVOTELLA BRYANTII B14, E280A MUTANT IN COMPLEX WITH THE XYLOGLUCAN TETRADECASACCHARIDE XXXGXXXG","10.1074/JBC.M115.691659 ",1.9,0,"5d9m_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpa1-ROH","XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-GLC(1_C_)",29.4015,"","",""
"5D9N","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 MEMBER FROM PREVOTELLA BRYANTII B14, IN COMPLEX WITH THE XYLOGLUCAN HEPTASACCHARIDE XXXG","10.1074/JBC.M115.691659 ",1.86,0,"5d9n_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",47.3254,"","",""
"5D9N","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 MEMBER FROM PREVOTELLA BRYANTII B14, IN COMPLEX WITH THE XYLOGLUCAN HEPTASACCHARIDE XXXG","10.1074/JBC.M115.691659 ",1.86,0,"5d9n_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-BGC(1_D_)",49.3623,"","",""
"5D9P","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 ENZYME FROM PREVOTELLA BRYANTII B14, IN COMPLEX WITH AN INHIBITORY N- BROMOACETYLGLYCOSYLAMINE DERIVATIVE OF XXXG","10.1074/JBC.M115.691659 ",1.8,0,"5d9p_oligo4","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-C2N1O1","XYS(7_F_)-[XYS(6_F_)-[XYS(5_F_)-BGC(4_F_)]-BGC(3_F_)]-BGC(2_F_)-NBG(1_F_)",34.6055,"","",""
"5D9P","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 ENZYME FROM PREVOTELLA BRYANTII B14, IN COMPLEX WITH AN INHIBITORY N- BROMOACETYLGLYCOSYLAMINE DERIVATIVE OF XXXG","10.1074/JBC.M115.691659 ",1.8,0,"5d9p_oligo3","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-C2N1O1","XYS(7_E_)-[XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-NBG(1_E_)",26.2315,"","",""
"5D9P","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 ENZYME FROM PREVOTELLA BRYANTII B14, IN COMPLEX WITH AN INHIBITORY N- BROMOACETYLGLYCOSYLAMINE DERIVATIVE OF XXXG","10.1074/JBC.M115.691659 ",1.8,0,"5d9p_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-C2N1O1","XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-NBG(1_C_)",24.2154,"","",""
"5D9P","CRYSTAL STRUCTURE OF PBGH5A, A GLYCOSIDE HYDROLASE FAMILY 5 ENZYME FROM PREVOTELLA BRYANTII B14, IN COMPLEX WITH AN INHIBITORY N- BROMOACETYLGLYCOSYLAMINE DERIVATIVE OF XXXG","10.1074/JBC.M115.691659 ",1.8,0,"5d9p_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-C2N1O1","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-NBG(1_D_)",38.5604,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(88_G_)",261.824,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(197_G_)",260.434,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo21","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)]-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(301_G_)",260.061,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_G_)",261.033,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(156_G_)",303.776,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo36","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_v_)-[MAN(5_v_)]-MAN(4_v_)-[MAN(7_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(197_J_)",260.395,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo22","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(332_G_)",287.755,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo40","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_z_)-[MAN(5_z_)]-MAN(4_z_)-[MAN(7_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(301_J_)",260.369,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_w_)-MAN(10_w_)-[MAN(9_w_)-MAN(8_w_)]-MAN(7_w_)-[MAN(6_w_)-MAN(5_w_)-MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(234_J_)",260.645,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo41","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_0_)-[MAN(9_0_)-MAN(8_0_)]-MAN(7_0_)-[MAN(6_0_)-MAN(5_0_)-MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)-ASN(332_J_)",287.524,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-[MAN(5_h_)]-MAN(4_h_)-[MAN(7_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(197_A_)",260.643,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_t_)-[MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(156_J_)",304.145,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_m_)-[MAN(9_m_)-MAN(8_m_)]-MAN(7_m_)-[MAN(6_m_)-MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(332_A_)",287.337,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_i_)-MAN(10_i_)-[MAN(9_i_)-MAN(8_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_A_)",260.955,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_x_)-[MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(262_J_)",260.621,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo14","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_l_)-[MAN(5_l_)]-MAN(4_l_)-[MAN(7_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(301_A_)",259.994,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(88_J_)",261.595,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(156_A_)",303.609,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(88_A_)",261.176,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_A_)",261.173,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_U_)-MAN(10_U_)-[MAN(9_U_)-MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(234_G_)",260.58,"","",""
"5DI8","FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V","10.1016/J.STR.2016.02.013 ",1.9,32.81,"5di8_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",42.6784,"","",""
"5DI8","FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V","10.1016/J.STR.2016.02.013 ",1.9,32.81,"5di8_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",48.1348,"","",""
"5DJ0","FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q","10.1016/J.STR.2016.02.013 ",2.28,35.83,"5dj0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",52.1898,"","",""
"5DJ0","FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q","10.1016/J.STR.2016.02.013 ",2.28,35.83,"5dj0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",56.1274,"","",""
"5DJ2","FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",2.56,33.38,"5dj2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",49.7502,"","",""
"5DJ2","FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",2.56,33.38,"5dj2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",53.9367,"","",""
"5DJ6","FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M","10.1016/J.STR.2016.02.013 ",2,33.23,"5dj6_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",48.6548,"","",""
"5DJ6","FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M","10.1016/J.STR.2016.02.013 ",2,33.23,"5dj6_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",44.8356,"","",""
"5DJ8","FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I","10.1016/J.STR.2016.02.013 ",2.4,35.3,"5dj8_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",49.2726,"","",""
"5DJ8","FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I","10.1016/J.STR.2016.02.013 ",2.4,35.3,"5dj8_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",53.3258,"","",""
"5DJA","FC HETERODIMER DESIGN 9.1 Y407M + T366I","10.1016/J.STR.2016.02.013 ",2.9,36.93,"5dja_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",55.4084,"","",""
"5DJA","FC HETERODIMER DESIGN 9.1 Y407M + T366I","10.1016/J.STR.2016.02.013 ",2.9,36.93,"5dja_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",51.2286,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",66.0385,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",49.1042,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",65.4632,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",47.2822,"","",""
"5DJD","FC HETERODIMER DESIGN 5.1 T366V + Y407F","10.1016/J.STR.2016.02.013 ",2.3,37.32,"5djd_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",54.7122,"","",""
"5DJD","FC HETERODIMER DESIGN 5.1 T366V + Y407F","10.1016/J.STR.2016.02.013 ",2.3,37.32,"5djd_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",59.0298,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",59.0361,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",50.4009,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",37.675,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",41.2795,"","",""
"5DJY","FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.15,36.44,"5djy_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",47.1226,"","",""
"5DJY","FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.15,36.44,"5djy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",51.116,"","",""
"5DJZ","FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",1.9,35.23,"5djz_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",44.7762,"","",""
"5DK0","FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.3,46.09,"5dk0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",55.3636,"","",""
"5DK0","FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.3,46.09,"5dk0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",65.5225,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_B_)",51.3615,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(297_E_)",97.8827,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_A_)",54.0703,"","",""
"5DK3","CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY","10.1038/NSMB.3129 ",2.28,64.17,"5dk3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",101.243,"","",""
"5DK3","CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY","10.1038/NSMB.3129 ",2.28,64.17,"5dk3_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_G_)",88.2457,"","",""
"5DLP","ACETYLCHOLINESTERASE METHYLENE BLUE NO PEG","10.1002/PRO.2923 ",2.7,52.02,"5dlp_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",67.5364,"","",""
"5DLV","CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) WITH TAUROURSODEOXYCHOLIC ACID (TUDCA)","10.1038/NCOMMS11248 ",2,35.51,"5dlv_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",38.1012,"","",""
"5DLV","CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) WITH TAUROURSODEOXYCHOLIC ACID (TUDCA)","10.1038/NCOMMS11248 ",2,35.51,"5dlv_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_B_)",50.1538,"","",""
"5DLW","CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) WITH TAUROURSODEOXYCHOLIC ACID (TUDCA) AND LYSOPHOSPHATIDIC ACID (LPA)","10.1038/NCOMMS11248 ",1.8,32.91,"5dlw_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",46.9844,"","",""
"5DPN","ENGINEERED CBM X-2 L110F IN COMPLEX WITH BRANCHED CARBOHYDRATE XXXG.","10.1021/ACS.BIOCHEM.5B01058 ",1.6,0,"5dpn_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-","XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",35.0874,"","",""
"5DYS","CRYSTAL STRUCTURE OF T94I RHODOPSIN MUTANT","10.15252/EMBR.201642671 ",2.3,66.09,"5dys_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",81.56,"","",""
"5DYT","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-METHYLNAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.55,0,"5dyt_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)",110.365,"","",""
"5DYT","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-METHYLNAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.55,0,"5dyt_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(455_B_)",120.255,"","",""
"5DYT","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-METHYLNAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.55,0,"5dyt_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(241_A_)",119.973,"","",""
"5DYW","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2- SULFONAMIDE","10.1038/SREP39495 ",2.5,0,"5dyw_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(57_A_)",84.4997,"","",""
"5DYW","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2- SULFONAMIDE","10.1038/SREP39495 ",2.5,0,"5dyw_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(241_A_)",91.0848,"","",""
"5DYY","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)NAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.65,0,"5dyy_oligo11","LFucpa1-6DGlcpNAcx1-","FUC(2_C_)-NAG(1_C_)",99.965,"","",""
"5DZG","CRYSTAL STRUCTURE OF THE CATALYTIC NUCLEOPHILE MUTANT OF VVEG16 IN COMPLEX WITH A XYLOGLUCAN TETRADECASACCHARIDE","10.1111/TPJ.13421 ",1.79,21.7,"5dzg_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpa1-ROH","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-GLC(1_D_)",24.4521,"","",""
"5DZG","CRYSTAL STRUCTURE OF THE CATALYTIC NUCLEOPHILE MUTANT OF VVEG16 IN COMPLEX WITH A XYLOGLUCAN TETRADECASACCHARIDE","10.1111/TPJ.13421 ",1.79,21.7,"5dzg_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpa1-ROH","XYS(14_C_)-[XYS(13_C_)-[XYS(12_C_)-[XYS(11_C_)-[XYS(10_C_)-[XYS(9_C_)-BGC(8_C_)]-BGC(7_C_)]-BGC(6_C_)-BGC(5_C_)]-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-GLC(1_C_)",28.5647,"","",""
"5DZV","PROTOCADHERIN ALPHA 7 EXTRACELLULAR CADHERIN DOMAINS 1-5","10.1016/J.NEURON.2016.04.004 ",3.6,0,"5dzv_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(228_A_)",208.07,"","",""
"5DZV","PROTOCADHERIN ALPHA 7 EXTRACELLULAR CADHERIN DOMAINS 1-5","10.1016/J.NEURON.2016.04.004 ",3.6,0,"5dzv_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(236_A_)",201,"","",""
"5DZV","PROTOCADHERIN ALPHA 7 EXTRACELLULAR CADHERIN DOMAINS 1-5","10.1016/J.NEURON.2016.04.004 ",3.6,0,"5dzv_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(228_B_)",175.41,"","",""
"5DZX","PROTOCADHERIN BETA 6 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.88,0,"5dzx_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(141_A_)",130.67,"","",""
"5DZX","PROTOCADHERIN BETA 6 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.88,0,"5dzx_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(389_A_)",112.1,"","",""
"5DZY","PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.9,0,"5dzy_oligo1","DGalpb1-4DGlcpNAcb1-4DManpa1-3[DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_I_)-[NAG(8_I_)-MAN(7_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(389_B_)",139.324,"","",""
"5DZY","PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.9,0,"5dzy_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(141_D_)",144.721,"","",""
"5DZY","PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.9,0,"5dzy_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(141_A_)",142.769,"","",""
"5DZY","PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.9,0,"5dzy_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(389_A_)",140.946,"","",""
"5DZY","PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.9,0,"5dzy_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(389_E_)",141.137,"","",""
"5E2Y","CRYSTAL STRUCTURE OF H5 HEMAGGLUTININ Q226L MUTANT FROM THE INFLUENZA VIRUS A/DUCK/EGYPT/10185SS/2010 (H5N1)","10.1016/J.CELREP.2015.10.027 ",2.6,0,"5e2y_oligo2","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[NAG(3_H_)]-[FUL(2_H_)]-NAG(1_H_)-ASN(169_C_)",78.7664,"","",""
"5E2Z","CRYSTAL STRUCTURE OF H5 HEMAGGLUTININ Q226L MUTANT FROM THE INFLUENZA VIRUS A/DUCK/EGYPT/10185SS/2010 (H5N1) WITH LSTA","10.1016/J.CELREP.2015.10.027 ",2.62,0,"5e2z_oligo3","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[NAG(3_I_)]-[FUL(2_I_)]-NAG(1_I_)-ASN(169_A_)",78.155,"","",""
"5E30","CRYSTAL STRUCTURE OF H5 HEMAGGLUTININ Q226L MUTANT FROM THE INFLUENZA VIRUS A/DUCK/EGYPT/10185SS/2010 (H5N1) WITH LSTC","10.1016/J.CELREP.2015.10.027 ",2.7,0,"5e30_oligo1","LFucpb1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUL(2_G_)]-NAG(1_G_)-ASN(169_C_)",64.5841,"","",""
"5E4T","ACETYLCHOLINESTERASE METHYLENE BLUE WITH PEG","10.1002/PRO.2923 ",2.43,47.6,"5e4t_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",70.6918,"","",""
"5E5W","HEMAGGLUTININ-ESTERASE-FUSION MUTANT STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e5w_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",34.363,"","",""
"5E5W","HEMAGGLUTININ-ESTERASE-FUSION MUTANT STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e5w_oligo5","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(130_C_)",42.4927,"","",""
"5E5W","HEMAGGLUTININ-ESTERASE-FUSION MUTANT STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e5w_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",41.9086,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(130_C_)",38.377,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",39.2076,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",45.38,"","",""
"5E64","HEMAGGLUTININ-ESTERASE-FUSION PROTEIN STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e64_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",24.4382,"","",""
"5E64","HEMAGGLUTININ-ESTERASE-FUSION PROTEIN STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e64_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",37.6208,"","",""
"5E64","HEMAGGLUTININ-ESTERASE-FUSION PROTEIN STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e64_oligo5","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(130_C_)",31.6962,"","",""
"5E65","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-O-AC-3'SLN (TR322)","10.1371/JOURNAL.PPAT.1005411 ",2.2,0,"5e65_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",34.5509,"","",""
"5E65","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-O-AC-3'SLN (TR322)","10.1371/JOURNAL.PPAT.1005411 ",2.2,0,"5e65_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(130_C_)",34.2953,"","",""
"5E65","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-O-AC-3'SLN (TR322)","10.1371/JOURNAL.PPAT.1005411 ",2.2,0,"5e65_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",41.6989,"","",""
"5E66","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-N-AC-SIA","10.1371/JOURNAL.PPAT.1005411 ",3.1,0,"5e66_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(130_A_)",98.3601,"","",""
"5E76","CRYSTAL STRUCTURE OF BACOVA_02651 WITH XYLOGLUCO-OLIGOSACCHARIDE","10.1128/MBIO.02134-15 ",2.3,0,"5e76_oligo1","DGlcpb1-4DGlcpb1-4DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-4DGlcpb1-ROH","XYS(9_B_)-[XYS(8_B_)-[BGC(7_B_)-BGC(6_B_)-BGC(5_B_)]-BGC(4_B_)]-BGC(3_B_)-BGC(2_B_)-BGC(1_B_)",70.1152,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",87.0414,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",88.1455,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",66.3914,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(405_d_)-DGD(405_d_)",161.577,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",86.6641,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",67.4955,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",72.1505,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(101_E_)-DGD(101_E_)",140.927,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",66.0141,"","",""
"5E79","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS","10.1038/NATURE16949 ",3.5,0,"5e79_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",92.8005,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",66.0141,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",92.8005,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",87.0414,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",88.1455,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(405_d_)-DGD(405_d_)",161.577,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",67.4955,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",72.1505,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",86.6641,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo18","DGalpa1-6DGalpb1-C35O5","DGD(406_D_)-DGD(406_D_)",140.927,"","",""
"5E7C","MACROMOLECULAR DIFFRACTIVE IMAGING USING IMPERFECT CRYSTALS - BRAGG DATA","10.1038/NATURE16949 ",4.5,0,"5e7c_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",66.3914,"","",""
"5E7G","CRYSTAL STRUCTURE OF BACOVA_02650 WITH XYLOGLUCO-OLIGOSACCHARIDE","10.1128/MBIO.02134-15 ",2.37,57.81,"5e7g_oligo1","DGlcpb1-4DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(9_B_)-[XYS(8_B_)-[XYS(7_B_)-[BGC(6_B_)-BGC(5_B_)]-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",69.6951,"","",""
"5E8E","CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB","10.1111/JTH.13171 ",1.9,35.11,"5e8e_oligo4","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(373_H_)",72.9396,"","",""
"5E8M","CRYSTAL STRUCTURE OF HUMAN HEPARANASE","10.1038/NSMB.3136 ",1.75,37.36,"5e8m_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(459_A_)",65.38,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo2","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_M_)-GLC(2_M_)-5LS(1_M_)",442.273,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo8","DGlcp[2S]a1-6DGlcpa1-6DGlcp[2S]a1-6DGlcp[3S]a1-6DGlcp[2S,3<R1>]a1-6DGlcp[3S]a1-6DGlcp[2S,4S]a1-ROH","5TH(7_T_)-5TK(6_T_)-Z4K(5_T_)-5TJ(4_T_)-5TM(3_T_)-5TJ(2_T_)-5LS(1_T_)",531.803,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo15","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_a_)-GLC(2_a_)-5LS(1_a_)",410.296,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo25","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_k_)-GLC(2_k_)-5LS(1_k_)",466.278,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo9","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_U_)-GLC(2_U_)-5LS(1_U_)",456.664,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo12","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_X_)-GLC(2_X_)-5LS(1_X_)",431.638,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo5","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_Q_)-GLC(2_Q_)-5LS(1_Q_)",443.577,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo13","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_Y_)-GLC(2_Y_)-5LS(1_Y_)",381.672,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo10","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_V_)-GLC(2_V_)-5LS(1_V_)",433.115,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo4","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_P_)-GLC(2_P_)-5LS(1_P_)",434.364,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo24","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_j_)-GLC(2_j_)-5LS(1_j_)",401.886,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo17","DGlcp[2S]a1-6DGlcpa1-6DGlcp[2S]a1-6DGlcp[3S]a1-6DGlcp[2S,3<R1>]a1-6DGlcp[3S]a1-6DGlcp[2S,4S]a1-ROH","5TH(7_c_)-5TK(6_c_)-Z4K(5_c_)-5TJ(4_c_)-5TM(3_c_)-5TJ(2_c_)-5LS(1_c_)",520.52,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo28","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_n_)-GLC(2_n_)-5LS(1_n_)",440.486,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo22","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_h_)-GLC(2_h_)-5LS(1_h_)",385.821,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo19","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_e_)-GLC(2_e_)-5LS(1_e_)",476.768,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo21","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_g_)-GLC(2_g_)-5LS(1_g_)",406.648,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo11","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_W_)-GLC(2_W_)-5LS(1_W_)",430.384,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo6","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_R_)-GLC(2_R_)-5LS(1_R_)",430.472,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo18","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_d_)-GLC(2_d_)-5LS(1_d_)",387.897,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo3","DGlcp[2S]a1-6DGlcpa1-6DGlcp[2S]a1-6DGlcp[3S]a1-6DGlcp[2S,3<R1>]a1-6DGlcp[3S]a1-6DGlcp[2S,4S]a1-ROH","5TH(7_O_)-5TK(6_O_)-Z4K(5_O_)-5TJ(4_O_)-5TM(3_O_)-5TJ(2_O_)-5LS(1_O_)",515.324,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo16","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_b_)-GLC(2_b_)-5LS(1_b_)",369.585,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo20","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_f_)-GLC(2_f_)-5LS(1_f_)",443.504,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo27","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_m_)-GLC(2_m_)-5LS(1_m_)",416.69,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo23","DGlcp[2S]a1-6DGlcpa1-6DGlcp[2S]a1-6DGlcp[3S]a1-6DGlcp[2S,3<R1>]a1-6DGlcp[3S]a1-6DGlcp[2S,4S]a1-ROH","5TH(7_i_)-5TK(6_i_)-Z4K(5_i_)-5TJ(4_i_)-5TM(3_i_)-5TJ(2_i_)-5LS(1_i_)",515.104,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo14","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_Z_)-GLC(2_Z_)-5LS(1_Z_)",436.784,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo1","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_N_)-GLC(2_N_)-5LS(1_N_)",395.142,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo26","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_l_)-GLC(2_l_)-5LS(1_l_)",432.127,"","",""
"5EBZ","CRYSTAL STRUCTURE OF HUMAN IKK1","10.1016/J.CELREP.2016.10.067 ",4.5,267.7,"5ebz_oligo7","DGlcp[2S,3S]a1-6DGlcpa1-6DGlcp[2S,4S]a1-ROH","PDX(3_S_)-GLC(2_S_)-5LS(1_S_)",423.301,"","",""
"5EFI","CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH THE P99P LIPOPEPTIDE","10.1074/JBC.M115.702118 ",1.8,34.97,"5efi_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",55.0388,"","",""
"5EHQ","MACHE-ANTI TZ2PA5 COMPLEX","10.1021/JACS.5B11384 ",2.5,67.58,"5ehq_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",121.143,"","",""
"5EHQ","MACHE-ANTI TZ2PA5 COMPLEX","10.1021/JACS.5B11384 ",2.5,67.58,"5ehq_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",135.085,"","",""
"5EIE","MACHE-TZ2 COMPLEX","10.1021/JACS.5B11384 ",2.1,50.43,"5eie_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",96.733,"","",""
"5EN2","MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES","10.1016/J.CHOM.2015.11.005 ",1.82,25.51,"5en2_oligo1","DManpa1-3[DManp[2H]a1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(178_C_)",52.7025,"","",""
"5EOK","HUMAN PLASMA COAGULATION FACTOR XI IN COMPLEX WITH PEPTIDE P39","10.1182/BLOOD-2015-10-676122 ",2.8,71.56,"5eok_oligo1","DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(108_A_)",101.333,"","",""
"5ERD","CRYSTAL STRUCTURE OF HUMAN DESMOGLEIN-2 ECTODOMAIN","10.1073/PNAS.1606272113 ",2.9,0,"5erd_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(465_A_)",108.574,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo8","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(716_C_)",270.583,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(880_E_)",277.153,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(70_G_)",289.133,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(716_E_)",272.799,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo10","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(70_E_)",266.359,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(716_G_)",289.925,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(716_A_)",269.296,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(880_C_)",273.395,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo7","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(373_C_)",314.399,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo2","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_A_)",273.693,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo15","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_W_)-MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(373_G_)",317.799,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo1","DManpa1-6DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-[MAN(10_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(373_A_)",291.692,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(130_G_)",119.419,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(160_F_)",109.805,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(160_G_)",76.956,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(139_G_)",106.868,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(139_F_)",74.3506,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(160_E_)",59.5684,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(130_E_)",109.508,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(139_E_)",90.8969,"","",""
"5ESZ","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244","10.1038/NSMB.3144 ",4.19,0,"5esz_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(160_C_)",68.825,"","",""
"5ESZ","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244","10.1038/NSMB.3144 ",4.19,0,"5esz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",61.7344,"","",""
"5ESZ","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244","10.1038/NSMB.3144 ",4.19,0,"5esz_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(160_G_)",63.4745,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo10","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-MAN(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(414_D_)",173.031,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(464_B_)",180.794,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo18","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(414_F_)",177.385,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo4","DManpa1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(414_A_)",172.518,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo7","DManpa1-2[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(414_C_)",178.317,"","",""
"5EWJ","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH IFENPRODIL","10.1124/MOL.115.103036 ",2.77,75.14,"5ewj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",67.4113,"","",""
"5EWL","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH MK-22","10.1124/MOL.115.103036 ",2.98,72.87,"5ewl_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",72.8169,"","",""
"5EWM","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH EVT-101","10.1124/MOL.115.103036 ",2.76,77.45,"5ewm_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",70.3275,"","",""
"5EZI","CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM","10.7554/ELIFE.20383 ",1.61,0,"5ezi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_A_)-[NAG(8_A_)-MAN(7_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(33_H_)",63.5516,"","",""
"5EZJ","CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM","10.7554/ELIFE.20383 ",1.95,0,"5ezj_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(33_A_)",92.8205,"","",""
"5EZO","CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.","10.7554/ELIFE.20383 ",3.63,70.8,"5ezo_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(37_H_)",110.926,"","",""
"5F7R","ROK REPRESSOR LMO0178 FROM LISTERIA MONOCYTOGENES BOUND TO INDUCER","10.1038/NMICROBIOL.2016.202 ",1.85,32.37,"5f7r_oligo1","DGlcpa1-6DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",17.8677,"","",""
"5F7R","ROK REPRESSOR LMO0178 FROM LISTERIA MONOCYTOGENES BOUND TO INDUCER","10.1038/NMICROBIOL.2016.202 ",1.85,32.37,"5f7r_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",16.4559,"","",""
"5F7U","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PENTASACCHARIDE SUBSTRATE","10.1038/NMICROBIOL.2016.202 ",1.7,22.33,"5f7u_oligo5","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_F_)-GLC(2_F_)-GLC(1_F_)",28.1227,"","",""
"5F7U","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PENTASACCHARIDE SUBSTRATE","10.1038/NMICROBIOL.2016.202 ",1.7,22.33,"5f7u_oligo1","DGlcpa1-6DGlcpa1-3[DGlcpa1-6]DGlcpa1-ROH","GLC(4_B_)-[GLC(3_B_)-GLC(2_B_)]-GLC(1_B_)",31.7161,"","",""
"5F7U","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PENTASACCHARIDE SUBSTRATE","10.1038/NMICROBIOL.2016.202 ",1.7,22.33,"5f7u_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",41.2541,"","",""
"5F7U","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PENTASACCHARIDE SUBSTRATE","10.1038/NMICROBIOL.2016.202 ",1.7,22.33,"5f7u_oligo3","DGlcpa1-6DGlcpa1-ROH","GLC(2_D_)-GLC(1_D_)",35.5427,"","",""
"5FA2","CRYSTAL STRUCTURE OF 426C.TM4DELTAV1-3 P120","10.7554/ELIFE.13783 ",2,48.66,"5fa2_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(262_A_)",77.1645,"","",""
"5FC1","MURINE SMPDL3A IN COMPLEX WITH SULFATE","10.1074/JBC.M115.711085 ",1.39,0,"5fc1_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(66_A_)",68.3542,"","",""
"5FC1","MURINE SMPDL3A IN COMPLEX WITH SULFATE","10.1074/JBC.M115.711085 ",1.39,0,"5fc1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",60.8862,"","",""
"5FC1","MURINE SMPDL3A IN COMPLEX WITH SULFATE","10.1074/JBC.M115.711085 ",1.39,0,"5fc1_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(235_A_)",85.9597,"","",""
"5FC5","MURINE SMPDL3A IN COMPLEX WITH PHOSPHOCHOLINE","10.1074/JBC.M115.711085 ",1.68,0,"5fc5_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(66_A_)",92.2924,"","",""
"5FC5","MURINE SMPDL3A IN COMPLEX WITH PHOSPHOCHOLINE","10.1074/JBC.M115.711085 ",1.68,0,"5fc5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",83.8298,"","",""
"5FC5","MURINE SMPDL3A IN COMPLEX WITH PHOSPHOCHOLINE","10.1074/JBC.M115.711085 ",1.68,0,"5fc5_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(235_A_)",99.7967,"","",""
"5FC6","MURINE SMPDL3A IN COMPLEX WITH ADP ANALOG AMPCP","10.1074/JBC.M115.711085 ",1.66,0,"5fc6_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(66_A_)",82.6745,"","",""
"5FC6","MURINE SMPDL3A IN COMPLEX WITH ADP ANALOG AMPCP","10.1074/JBC.M115.711085 ",1.66,0,"5fc6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",74.9669,"","",""
"5FC6","MURINE SMPDL3A IN COMPLEX WITH ADP ANALOG AMPCP","10.1074/JBC.M115.711085 ",1.66,0,"5fc6_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(235_A_)",95.3197,"","",""
"5FC7","MURINE SMPDL3A IN COMPLEX WITH SULFATE (TETRAGONAL)","10.1074/JBC.M115.711085 ",1.46,0,"5fc7_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(235_A_)",69.2239,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(235_B_)",109.816,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(235_A_)",101.714,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(353_A_)",107.68,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(66_B_)",114.273,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(66_A_)",99.0843,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(353_B_)",92.9222,"","",""
"5FCB","MURINE SMPDL3A IN COMPLEX WITH AMP","10.1074/JBC.M115.711085 ",1.55,0,"5fcb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",71.2053,"","",""
"5FCB","MURINE SMPDL3A IN COMPLEX WITH AMP","10.1074/JBC.M115.711085 ",1.55,0,"5fcb_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(235_A_)",84.6159,"","",""
"5FCB","MURINE SMPDL3A IN COMPLEX WITH AMP","10.1074/JBC.M115.711085 ",1.55,0,"5fcb_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(128_A_)",76.2961,"","",""
"5FCB","MURINE SMPDL3A IN COMPLEX WITH AMP","10.1074/JBC.M115.711085 ",1.55,0,"5fcb_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(66_A_)",80.6788,"","",""
"5FEC","CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120","10.7554/ELIFE.13783 ",3.17,0,"5fec_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",75.7517,"","",""
"5FFG","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD","10.1038/NATURE21035 ",2.25,0,"5ffg_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(525_A_)",106.944,"","",""
"5FFG","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD","10.1038/NATURE21035 ",2.25,0,"5ffg_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",73.4533,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(459_E_)",298.415,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(266_A_)",215.247,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(459_A_)",285.521,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo9","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(260_E_)",258.779,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(53_H_)",253.66,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-[MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(266_E_)",224.999,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(260_A_)",265.001,"","",""
"5FI9","CLOSED FORM OF MURINE ACID SPHINGOMYELINASE IN COMPLEX WITH BISPHOSPHONATE INHIBITOR ABPA","10.1038/NCOMMS12196 ",2.54,0,"5fi9_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(84_A_)",60.0767,"","",""
"5FI9","CLOSED FORM OF MURINE ACID SPHINGOMYELINASE IN COMPLEX WITH BISPHOSPHONATE INHIBITOR ABPA","10.1038/NCOMMS12196 ",2.54,0,"5fi9_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(393_B_)",63.3227,"","",""
"5FI9","CLOSED FORM OF MURINE ACID SPHINGOMYELINASE IN COMPLEX WITH BISPHOSPHONATE INHIBITOR ABPA","10.1038/NCOMMS12196 ",2.54,0,"5fi9_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(84_B_)",68.8182,"","",""
"5FI9","CLOSED FORM OF MURINE ACID SPHINGOMYELINASE IN COMPLEX WITH BISPHOSPHONATE INHIBITOR ABPA","10.1038/NCOMMS12196 ",2.54,0,"5fi9_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(333_B_)",66.2941,"","",""
"5FI9","CLOSED FORM OF MURINE ACID SPHINGOMYELINASE IN COMPLEX WITH BISPHOSPHONATE INHIBITOR ABPA","10.1038/NCOMMS12196 ",2.54,0,"5fi9_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(393_A_)",66.8255,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(333_A_)",77.9588,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_J_)-[MAN(4_J_)-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(84_B_)",125.399,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(84_A_)",127.013,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(518_B_)",107.394,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(173_A_)",150.998,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(393_B_)",58.8897,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(393_A_)",97.1917,"","",""
"5FIC","OPEN FORM OF MURINE ACID SPHINGOMYELINASE IN PRESENCE OF LIPID","10.1038/NCOMMS12196 ",2.8,0,"5fic_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(393_D_)",83.2579,"","",""
"5FIC","OPEN FORM OF MURINE ACID SPHINGOMYELINASE IN PRESENCE OF LIPID","10.1038/NCOMMS12196 ",2.8,0,"5fic_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(393_A_)",90.3848,"","",""
"5FIW","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE AT 1.7 ANGSTROMS RESOLUTION","",1.7,23.24,"5fiw_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",19.457,"","",""
"5FIW","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE AT 1.7 ANGSTROMS RESOLUTION","",1.7,23.24,"5fiw_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",19.7136,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo33","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",52.2549,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",43.7795,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",56.495,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",45.2536,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo11","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",38.7421,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo18","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_M_)-MAN(10_M_)-[MAN(9_M_)-MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(323_B_)",36.5474,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(323_A_)",29.3727,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo20","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(9_O_)-MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(524_B_)",36.854,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo15","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",36.1621,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo13","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(524_A_)",35.6111,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo4","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(565_A_)",45.6044,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo11","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(524_B_)",48.1373,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_P_)-MAN(10_P_)-[MAN(9_P_)-MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(323_B_)",37.0198,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo23","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-[MAN(7_a_)]-MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(565_C_)",47.1865,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(253_B_)",45.3868,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo2","DManpa1-2DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(524_A_)",46.1129,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(62_B_)",34.3334,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(316_B_)",34.5157,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)]-MAN(4_X_)-[MAN(9_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(323_C_)",31.0926,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_H_)-MAN(10_H_)-[MAN(9_H_)-MAN(8_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(323_A_)",43.7348,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(253_A_)",44.5368,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo17","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(62_C_)",36.1255,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo30","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-MAN(5_h_)-[MAN(7_h_)]-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(524_D_)",41.0305,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo22","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-MAN(5_Z_)-[MAN(7_Z_)]-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(524_C_)",45.2118,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo31","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-MAN(5_i_)-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(565_D_)",40.1617,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo12","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(565_B_)",40.6624,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo28","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_f_)-MAN(7_f_)-[MAN(6_f_)-MAN(5_f_)]-MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(323_D_)",41.2128,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo34","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-[MAN(7_I_)]-MAN(4_I_)-[MAN(9_I_)-MAN(8_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(107_B_)",43.532,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(58_B_)",53.0939,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo30","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(107_A_)",41.3349,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo29","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(58_A_)",42.9641,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo35","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(107_B_)",41.3224,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo30","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(58_A_)",45.4607,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo34","DManpa1-3DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(58_B_)",47.6364,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(107_A_)",38.1225,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",34.7685,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo31","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",44.4392,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(58_B_)",48.7968,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(107_B_)",37.6797,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo34","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(58_B_)",46.765,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo24","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_J_)-GLC(2_J_)-FRU(1_J_)",23.0557,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",34.068,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo33","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_F_)-GLC(2_F_)-FRU(1_F_)",16.8959,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo35","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(107_B_)",36.7635,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo30","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",37.5336,"","",""
"5FKP","CRYSTAL STRUCTURE OF THE MOUSE CD1D IN COMPLEX WITH THE P99 PEPTIDE","10.1074/JBC.M115.702118 ",1.8,0,"5fkp_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",51.7058,"","",""
"5FKS","UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE","10.1111/FEBS.13696 ",1.99,0,"5fks_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_C_)-XYS(8_C_)-[GAL(7_C_)-XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",27.5899,"","",""
"5FKS","UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE","10.1111/FEBS.13696 ",1.99,0,"5fks_oligo1","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_B_)-XYS(6_B_)-[XYS(5_B_)-[BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",21.2905,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",52.7911,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo33","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[BMA(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",48.5129,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",37.0936,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",39.3928,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo36","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",38.6798,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo33","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",36.8668,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo35","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",46.5648,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo30","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",45.3161,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo38","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",42.9545,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo36","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",36.3393,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",38.1226,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo35","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[BMA(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",43.8558,"","",""
"5FOB","CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH SMALLPOX INHIBITOR OF COMPLEMENT (SPICE)","10.15252/EMBJ.201593673 ",2.6,80,"5fob_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(85_A_)",135.082,"","",""
"5FQL","INSIGHTS INTO HUNTER SYNDROME FROM THE STRUCTURE OF IDURONATE-2- SULFATASE","10.1038/NCOMMS15786 ",2.3,0,"5fql_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(115_A_)",154.964,"","",""
"5FQL","INSIGHTS INTO HUNTER SYNDROME FROM THE STRUCTURE OF IDURONATE-2- SULFATASE","10.1038/NCOMMS15786 ",2.3,0,"5fql_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(144_A_)",148.217,"","",""
"5FQL","INSIGHTS INTO HUNTER SYNDROME FROM THE STRUCTURE OF IDURONATE-2- SULFATASE","10.1038/NCOMMS15786 ",2.3,0,"5fql_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(513_A_)",132.625,"","",""
"5FUK","CRYSTALLIZATION OF A DIMERIC HEME PEROXYGENASE FROM THE FUNGUS MARASMIUS ROTULA","",1.55,23.48,"5fuk_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(122_B_)",46.5739,"","",""
"5FUK","CRYSTALLIZATION OF A DIMERIC HEME PEROXYGENASE FROM THE FUNGUS MARASMIUS ROTULA","",1.55,23.48,"5fuk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(122_A_)",39.2327,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo19","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_a_)-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)]-MAN(4_a_)-[MAN(9_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(386_G_)",168.417,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo14","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-MAN(5_T_)-[MAN(7_T_)]-MAN(4_T_)-[MAN(9_T_)-MAN(8_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(293_G_)",166.95,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo17","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)-[MAN(7_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(344_G_)",178.651,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(241_G_)",151.474,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo24","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-MAN(4_f_)-[MAN(6_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(72_V_)",206.778,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_N_)-[MAN(9_N_)-MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(188_G_)",186.881,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo21","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(442_G_)",184.853,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(234_G_)",172.485,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-[MAN(7_J_)]-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_G_)",99.6225,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",105.178,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(276_G_)",133.007,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo15","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(301_G_)",149.828,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(156_G_)",174.865,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo16","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_X_)-[MAN(9_X_)-MAN(8_X_)]-MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(332_G_)",118.047,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_M_)-[MAN(9_M_)-MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(160_G_)",194.512,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo23","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(23_H_)",185.879,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_b_)-MAN(7_b_)-[MAN(6_b_)-MAN(5_b_)]-MAN(4_b_)-[MAN(10_b_)-MAN(9_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(413_G_)",165.571,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo13","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(355_G_)",214.982,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo12","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(339_G_)",209.694,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(295_G_)",190.332,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",125.012,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo15","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-MAN(5_W_)-[MAN(7_W_)]-MAN(4_W_)-[MAN(8_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(386_G_)",210.642,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo20","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-MAN(4_b_)-[MAN(6_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(72_V_)",252.938,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo10","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-[MAN(8_P_)-MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(301_G_)",201.351,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo18","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(448_G_)",178.435,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo16","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-[MAN(6_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(392_G_)",198.407,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-[MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",194.613,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_Q_)-[MAN(9_Q_)-MAN(8_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(332_G_)",135.796,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",153.131,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-[MAN(7_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(187_G_)",233.019,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(160_G_)",209.568,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_G_)",172.965,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(386_G_)",149.172,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(234_G_)",158.146,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-[MAN(7_J_)]-MAN(4_J_)-[MAN(9_J_)-MAN(8_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(156_G_)",154.604,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(295_G_)",154.935,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(160_G_)",169.419,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo17","DManpa1-2DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-MAN(5_W_)-MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(448_G_)",166.805,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_S_)-[MAN(9_S_)-MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_G_)",102.294,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_R_)-[MAN(7_R_)]-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",171.064,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(137_G_)",161.521,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo11","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",167.726,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",118.272,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(276_G_)",179.967,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(392_G_)",169.107,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo13","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(8_O_)-MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",135.994,"","",""
"5G64","THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS","10.1074/JBC.M117.776476 ",3.72,0,"5g64_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",160.04,"","",""
"5G64","THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS","10.1074/JBC.M117.776476 ",3.72,0,"5g64_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",142.165,"","",""
"5GIJ","CRYSTAL STRUCTURE OF TDR-TDIF COMPLEX","10.1038/NCOMMS12383 ",3,76.11,"5gij_oligo2","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(471_B_)",113.505,"","",""
"5GIJ","CRYSTAL STRUCTURE OF TDR-TDIF COMPLEX","10.1038/NCOMMS12383 ",3,76.11,"5gij_oligo3","DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_H_)-[MAN(4_H_)-MAN(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(525_B_)",75.1127,"","",""
"5GJE","THREE-DIMENSIONAL RECONSTRUCTION OF HUMAN LRP6 ECTODOMAIN COMPLEXED WITH DKK1","10.1016/J.CELREP.2016.12.017 ",21,"1.39094e+10","5gje_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(692_B_)",111.063,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo4","DGlcpNAcb1-3DManpa1-6DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","NAG(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(297_D_)",74.8084,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(8_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(297_C_)",33.4821,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",34.3694,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",29.2103,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",39.7945,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",39.8273,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",49.2868,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",43.3832,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",31.4209,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",36.0664,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo31","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",44.5809,"","",""
"5GTH","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)","10.1038/NATURE21400 ",2.5,0,"5gth_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",43.9114,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",49.1618,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo52","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",34.2973,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",53.1923,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",38.66,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",44.8682,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",49.1536,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",45.9014,"","",""
"5GTI","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)","10.1038/NATURE21400 ",2.5,0,"5gti_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",41.8359,"","",""
"5GZ4","CRYSTAL STRUCTURE OF SNAKE VENOM PHOSPHODIESTERASE (PDE) FROM TAIWAN COBRA (NAJA ATRA ATRA)","",2.55,0,"5gz4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(512_A_)",52.4624,"","",""
"5GZ4","CRYSTAL STRUCTURE OF SNAKE VENOM PHOSPHODIESTERASE (PDE) FROM TAIWAN COBRA (NAJA ATRA ATRA)","",2.55,0,"5gz4_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(746_A_)",57.4303,"","",""
"5GZ5","CRYSTAL STRUCTURE OF SNAKE VENOM PHOSPHODIESTERASE (PDE) FROM TAIWAN COBRA (NAJA ATRA ATRA) IN COMPLEX WITH AMP","",2.09,0,"5gz5_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(765_A_)",56.2432,"","",""
"5GZ5","CRYSTAL STRUCTURE OF SNAKE VENOM PHOSPHODIESTERASE (PDE) FROM TAIWAN COBRA (NAJA ATRA ATRA) IN COMPLEX WITH AMP","",2.09,0,"5gz5_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(746_A_)",72.523,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",34.3232,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",45.9591,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",29.5077,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",40.6809,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",30.21,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(917_c_)-DGD(917_c_)",32.84,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(919_c_)-DGD(919_c_)",35.0514,"","",""
"5H2F","CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II","10.1039/C6FD00213G ",2.2,42.03,"5h2f_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(918_c_)-DGD(918_c_)",40.8841,"","",""
"5HBT","COMPLEX STRUCTURE OF FAB35 AND HUMAN NACHR ALPHA1","10.7554/ELIFE.23043 ",2.61,56.34,"5hbt_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-[MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",83.4052,"","",""
"5HBV","COMPLEX STRUCTURE OF FAB35 AND MOUSE NACHR ALPHA1","10.7554/ELIFE.23043 ",2.7,67.87,"5hbv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-[MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",79.6292,"","",""
"5HDB","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054","10.1074/JBC.M115.705624 ",2.7,0,"5hdb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",117.188,"","",""
"5HDH","CRYSTAL STRUCTURE OF HUMAN TLR8 WITH AN UNCLEAVED Z-LOOP","10.1073/PNAS.1516000113 ",2.6,80.14,"5hdh_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(590_A_)",84.6678,"","",""
"5HDH","CRYSTAL STRUCTURE OF HUMAN TLR8 WITH AN UNCLEAVED Z-LOOP","10.1073/PNAS.1516000113 ",2.6,80.14,"5hdh_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",83.3291,"","",""
"5HF5","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON IN THE UNAGED STATE (PREDOMINANT ACYL LOOP CONFORMATION)","10.1002/PROT.25073 ",2.15,42.32,"5hf5_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",76.8933,"","",""
"5HF5","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON IN THE UNAGED STATE (PREDOMINANT ACYL LOOP CONFORMATION)","10.1002/PROT.25073 ",2.15,42.32,"5hf5_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",77.8509,"","",""
"5HF6","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON IN THE AGED STATE","10.1002/PROT.25073 ",2.3,54.73,"5hf6_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",95.7488,"","",""
"5HF6","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON IN THE AGED STATE","10.1002/PROT.25073 ",2.3,54.73,"5hf6_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",98.6012,"","",""
"5HF8","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON (ALTERNATIVE ACYL LOOP CONFORMATION)","10.1002/PROT.25073 ",2.8,48.47,"5hf8_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",91.7424,"","",""
"5HF8","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON (ALTERNATIVE ACYL LOOP CONFORMATION)","10.1002/PROT.25073 ",2.8,48.47,"5hf8_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",97.6861,"","",""
"5HF9","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON AND HI6","10.1002/PROT.25073 ",2.2,48.15,"5hf9_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",80.7261,"","",""
"5HF9","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON AND HI6","10.1002/PROT.25073 ",2.2,48.15,"5hf9_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",84.3312,"","",""
"5HFA","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON AND 2-PAM","10.1002/PROT.25073 ",2.2,47.26,"5hfa_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",81.1567,"","",""
"5HFA","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH PARAOXON AND 2-PAM","10.1002/PROT.25073 ",2.2,47.26,"5hfa_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",80.1842,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo3","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(563_L_)",201.54,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo1","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(563_D_)",200.743,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo4","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_T_)-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(563_P_)",201.012,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo2","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_H_)",201.356,"","",""
"5HJR","MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND COVALENT INTERMEDIATE","10.1073/PNAS.1604463113 ",2.4,59.28,"5hjr_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(97_C_)",95.2473,"","",""
"5HNS","STRUCTURE OF GLYCOSYLATED NPC1 LUMINAL DOMAIN C","10.1002/1873-3468.12089 ",2.45,73.01,"5hns_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(557_A_)",102.957,"","",""
"5HNS","STRUCTURE OF GLYCOSYLATED NPC1 LUMINAL DOMAIN C","10.1002/1873-3468.12089 ",2.45,73.01,"5hns_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(557_B_)",113.04,"","",""
"5HQB","A GLYCOSIDE HYDROLASE FAMILY 97 ENZYME (E480Q) IN COMPLEX WITH PANOSE FROM PSEUDOALTEROMONAS SP. STRAIN K8","10.1016/J.JSB.2016.09.009 ",1.8,24.11,"5hqb_oligo1","DGlcpa1-6DGlcpa1-4DGlcpx1-","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",31.9573,"","",""
"5HQN","CATALYTIC DOMAIN OF MURINE ACID SPHINGOMYELINASE (ASMASE, ASM, SMPD1)","10.1038/NCOMMS12196 ",2.6,0,"5hqn_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(333_B_)",121.453,"","",""
"5HQN","CATALYTIC DOMAIN OF MURINE ACID SPHINGOMYELINASE (ASMASE, ASM, SMPD1)","10.1038/NCOMMS12196 ",2.6,0,"5hqn_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(393_A_)",82.6718,"","",""
"5HQN","CATALYTIC DOMAIN OF MURINE ACID SPHINGOMYELINASE (ASMASE, ASM, SMPD1)","10.1038/NCOMMS12196 ",2.6,0,"5hqn_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(393_B_)",78.9942,"","",""
"5HRT","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH A DNA APTAMER","10.1038/NSMB.3200 ",2,0,"5hrt_oligo12","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",54.101,"","",""
"5HU8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/SICHUAN/26221/2014 (H5N6) INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,58.4,"5hu8_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(165_A_)",93.9927,"","",""
"5HU8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/SICHUAN/26221/2014 (H5N6) INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,58.4,"5hu8_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(165_E_)",100.694,"","",""
"5HU8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/SICHUAN/26221/2014 (H5N6) INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,58.4,"5hu8_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(23_C_)",140.645,"","",""
"5HU8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/SICHUAN/26221/2014 (H5N6) INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,58.4,"5hu8_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(165_C_)",110.178,"","",""
"5HU8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/SICHUAN/26221/2014 (H5N6) INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,58.4,"5hu8_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(23_E_)",129.795,"","",""
"5HU8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/SICHUAN/26221/2014 (H5N6) INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,58.4,"5hu8_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(23_A_)",108.635,"","",""
"5HUG","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/AMERICAN GREEN-WINGED TEAL/WASHINGTON/195750/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",1.85,21.29,"5hug_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(88_A_)",45.0697,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_B_)",88.1809,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_A_)",60.9379,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(200_D_)",66.1547,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_C_)",70.9693,"","",""
"5HVG","CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH AN INHIBITORY NANOBODY (VHH-A204)","10.1111/JTH.13381 ",3.05,85.02,"5hvg_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(22_A_)",152.841,"","",""
"5HVW","MONOMERIC IGG4 FC","10.1371/JOURNAL.PONE.0160345 ",1.95,66.13,"5hvw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",103.175,"","",""
"5HXM","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PANOSE","10.1016/J.STR.2016.12.007 ",1.9,44.39,"5hxm_oligo1","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",44.0177,"","",""
"5HY9","GLYCOSYLATED, DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.7,92.03,"5hy9_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",47.8242,"","",""
"5HY9","GLYCOSYLATED, DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.7,92.03,"5hy9_oligo2","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.4974,"","",""
"5HYE","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)","10.1093/PROTEIN/GZX041 ",1.89,62.68,"5hye_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-BMA(4_B_)-[NAG(8_B_)-BMA(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",49.8034,"","",""
"5HYE","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)","10.1093/PROTEIN/GZX041 ",1.89,62.68,"5hye_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_C_)",109.557,"","",""
"5HYF","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P6122)","10.1093/PROTEIN/GZX041 ",1.8,39.51,"5hyf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-BMA(4_B_)-[NAG(8_B_)-BMA(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",54.3523,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",115.86,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",132.336,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",134.99,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_D_)",118.569,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(394_K_)",107.903,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(394_G_)",96.3784,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(394_I_)",105.043,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(394_J_)",108.731,"","",""
"5I0D","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN","10.1016/J.STR.2016.12.007 ",1.77,20.2,"5i0d_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",19.2732,"","",""
"5I0D","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN","10.1016/J.STR.2016.12.007 ",1.77,20.2,"5i0d_oligo1","DGlcpa1-6DGlcpa1-ROH","GLC(2_E_)-GLC(1_E_)",26.3918,"","",""
"5I0D","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN","10.1016/J.STR.2016.12.007 ",1.77,20.2,"5i0d_oligo3","DGlcpa1-3DGlcpa1-6DGlcpa1-ROH","GLC(3_G_)-GLC(2_G_)-GLC(1_G_)",32.6876,"","",""
"5I0D","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN","10.1016/J.STR.2016.12.007 ",1.77,20.2,"5i0d_oligo5","DGlcpa1-6DGlcpa1-ROH","GLC(2_J_)-GLC(1_J_)",19.1636,"","",""
"5I0D","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN","10.1016/J.STR.2016.12.007 ",1.77,20.2,"5i0d_oligo4","DGlcpa1-6DGlcpa1-ROH","GLC(2_I_)-GLC(1_I_)",31.3014,"","",""
"5I0E","CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH ISOMALTOSE","10.1016/J.STR.2016.12.007 ",2.3,43.32,"5i0e_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_A_)-GLC(1_A_)",28.6841,"","",""
"5I0F","CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH COVALENT INTERMEDIATE","10.1016/J.STR.2016.12.007 ",1.85,27.27,"5i0f_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_A_)-GLC(1_A_)",29.0373,"","",""
"5I0F","CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH COVALENT INTERMEDIATE","10.1016/J.STR.2016.12.007 ",1.85,27.27,"5i0f_oligo1","DGlcpa1-6DGlcpb1-ASP","GLC(2_C_)-BGC(1_C_)-ASP(467_B_)",19.7445,"","",""
"5I4F","SCFV 2D10 COMPLEXED WITH ALPHA 1,6 MANNOBIOSE","10.1002/SLCT.201600945 ",1.55,0,"5i4f_oligo2","DManpa1-6DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",29.1245,"","",""
"5I4F","SCFV 2D10 COMPLEXED WITH ALPHA 1,6 MANNOBIOSE","10.1002/SLCT.201600945 ",1.55,0,"5i4f_oligo1","DManpa1-6DManpa1-ROH","MAN(2_B_)-MAN(1_B_)",25.055,"","",""
"5I81","ASMASE WITH ZINC","10.1038/NCOMMS13082 ",2.25,0,"5i81_oligo4","DManpb1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(2_D_)-MAN(1_D_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",96.4687,"","",""
"5I85","ASMASE WITH ZINC AND PHOSPHOCHOLINE","10.1038/NCOMMS13082 ",2.5,0,"5i85_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",83.4347,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(88_C_)",206.227,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_U_)-[MAN(9_U_)-MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_A_)",215.123,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_A_)",206.958,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(156_C_)",240.049,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",218.41,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo22","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_h_)-[MAN(9_h_)-MAN(8_h_)]-MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_C_)",217.212,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_A_)",248.067,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_C_)",234.518,"","",""
"5I9Q","CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120","10.7554/ELIFE.13783 ",3,0,"5i9q_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",58.856,"","",""
"5IFP","STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER","10.1111/FEBS.14083 ",1.71,12.62,"5ifp_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",21.0531,"","",""
"5IFP","STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER","10.1111/FEBS.14083 ",1.71,12.62,"5ifp_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",24.8777,"","",""
"5IFT","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 3-B-GALACTOPYRANOSYL GLUCOSE","10.1111/FEBS.14083 ",2.45,21.24,"5ift_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",40.2291,"","",""
"5IHR","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH ALLOLACTOSE","10.1111/FEBS.14083 ",2.4,21.7,"5ihr_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",43.0142,"","",""
"5IHR","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH ALLOLACTOSE","10.1111/FEBS.14083 ",2.4,21.7,"5ihr_oligo4","DGalpb1-6DGlcpa1-ROH","GAL(2_E_)-GLC(1_E_)",56.1705,"","",""
"5IHR","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH ALLOLACTOSE","10.1111/FEBS.14083 ",2.4,21.7,"5ihr_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",31.1824,"","",""
"5IKQ","THE STRUCTURE OF MECLOFENAMIC ACID BOUND TO HUMAN CYCLOOXYGENASE-2","10.1074/JBC.M116.725713 ",2.41,0,"5ikq_oligo1","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",68.7682,"","",""
"5IKQ","THE STRUCTURE OF MECLOFENAMIC ACID BOUND TO HUMAN CYCLOOXYGENASE-2","10.1074/JBC.M116.725713 ",2.41,0,"5ikq_oligo2","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(145_B_)",60.8159,"","",""
"5IW3","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.05,26.87,"5iw3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(320_A_)",41.8844,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo2","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",98.8407,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_A_)",85.8538,"","",""
"5J3H","HUMAN INSULIN RECEPTOR DOMAINS L1-CR IN COMPLEX WITH PEPTIDE S519C16 AND 83-7 FV","10.1074/JBC.M116.732180 ",3.27,122.8,"5j3h_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(25_E_)",177.514,"","",""
"5J3H","HUMAN INSULIN RECEPTOR DOMAINS L1-CR IN COMPLEX WITH PEPTIDE S519C16 AND 83-7 FV","10.1074/JBC.M116.732180 ",3.27,122.8,"5j3h_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(255_E_)",118.412,"","",""
"5J5J","CRYSTAL STRUCTURE OF A CHIMERA OF HUMAN DESMOCOLLIN-2 EC1 AND HUMAN DESMOGLEIN-2 EC2-EC5","10.1073/PNAS.1606272113 ",3.29,0,"5j5j_oligo1","DGalpb1-4DGlcpNAcb1-3DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(31_A_)",205.562,"","",""
"5J5J","CRYSTAL STRUCTURE OF A CHIMERA OF HUMAN DESMOCOLLIN-2 EC1 AND HUMAN DESMOGLEIN-2 EC2-EC5","10.1073/PNAS.1606272113 ",3.29,0,"5j5j_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(463_A_)",196.697,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo2","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(10_E_)-MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(732_A_)",129.625,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo4","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)]-MAN(4_H_)-[MAN(10_H_)-MAN(9_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(732_D_)",131.109,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo1","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)]-MAN(4_G_)-[MAN(10_G_)-MAN(9_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(732_C_)",116.384,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo3","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(732_B_)",134.432,"","",""
"5J68","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",5.22,0,"5j68_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(10_B_)-MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(732_A_)",346.214,"","",""
"5J6S","CRYSTAL STRUCTURE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 (ERAP2) IN COMPLEX WITH A HYDROXAMIC DERIVATIVE LIGAND","10.1021/ACSMEDCHEMLETT.6B00505 ",2.8,0,"5j6s_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(85_B_)",86.7636,"","",""
"5JBE","4,6-ALPHA-GLUCANOTRANSFERASE GTFB FROM LACTOBACILLUS REUTERI 121 COMPLEXED WITH AN ISOMALTO-MALTOPENTASACCHARIDE","10.1016/J.STR.2016.11.023 ",2.1,39.02,"5jbe_oligo2","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(5_C_)-GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",50.6778,"","",""
"5JBE","4,6-ALPHA-GLUCANOTRANSFERASE GTFB FROM LACTOBACILLUS REUTERI 121 COMPLEXED WITH AN ISOMALTO-MALTOPENTASACCHARIDE","10.1016/J.STR.2016.11.023 ",2.1,39.02,"5jbe_oligo3","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(5_D_)-GLC(4_D_)-GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",55.9607,"","",""
"5JIF","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN DVIM HEMAGGLUTININ- ESTERASE","10.1073/PNAS.1519881113 ",2,51.65,"5jif_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(309_A_)",56.3314,"","",""
"5JIF","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN DVIM HEMAGGLUTININ- ESTERASE","10.1073/PNAS.1519881113 ",2,51.65,"5jif_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(324_A_)",80.5802,"","",""
"5JIH","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)","10.1016/J.STR.2017.04.014 ",1.66,0,"5jih_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",97.3946,"","",""
"5JIH","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)","10.1016/J.STR.2017.04.014 ",1.66,0,"5jih_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",70.2827,"","",""
"5JII","CRYSTAL STRUCTURE OF HUMAN IGG1-FC","10.1016/J.STR.2017.04.014 ",1.79,49.2,"5jii_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",68.3536,"","",""
"5JII","CRYSTAL STRUCTURE OF HUMAN IGG1-FC","10.1016/J.STR.2017.04.014 ",1.79,49.2,"5jii_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",81.111,"","",""
"5JIK","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)","10.1016/J.STR.2017.04.014 ",1.82,0,"5jik_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",132.317,"","",""
"5JIK","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)","10.1016/J.STR.2017.04.014 ",1.82,0,"5jik_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",86.5242,"","",""
"5JLV","RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C","10.1038/NSMB.3245 ",2,0,"5jlv_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(559_D_)",46.5849,"","",""
"5JLV","RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C","10.1038/NSMB.3245 ",2,0,"5jlv_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(559_C_)",46.6668,"","",""
"5JNX","THE 6.6 A CRYO-EM STRUCTURE OF THE FULL-LENGTH HUMAN NPC1 IN COMPLEX WITH THE CLEAVED GLYCOPROTEIN OF EBOLA VIRUS","10.1016/J.CELL.2016.05.022 ",6.56,0,"5jnx_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",288.221,"","",""
"5JPN","STRUCTURE OF HUMAN COMPLEMENT C4 REBUILT USING IMDFF","10.1107/S2059798316012201 ",3.6,130.4,"5jpn_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1391_B_)",196.113,"","",""
"5JPN","STRUCTURE OF HUMAN COMPLEMENT C4 REBUILT USING IMDFF","10.1107/S2059798316012201 ",3.6,130.4,"5jpn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(862_B_)",186.06,"","",""
"5JQ3","CRYSTAL STRUCTURE OF EBOLA GLYCOPROTEIN","10.1038/NATURE18615 ",2.23,72.48,"5jq3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",103.568,"","",""
"5JQ7","CRYSTAL STRUCTURE OF EBOLA GLYCOPROTEIN IN COMPLEX WITH TOREMIFENE","10.1038/NATURE18615 ",2.69,92.64,"5jq7_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",123.094,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(624_D_)",225.705,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_S_)-MAN(10_S_)-[MAN(9_S_)-MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(233_C_)",248.861,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-MAN(8_L_)-[MAN(10_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(330_C_)",297.15,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(300_C_)",305.157,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(261_C_)",303.832,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-[MAN(7_K_)]-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(275_C_)",284.059,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-[MAN(8_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(300_C_)",356.789,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(261_C_)",342.043,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(626_D_)",325.378,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-[MAN(7_J_)]-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(275_C_)",353.387,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(330_C_)",340.696,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_U_)-MAN(10_U_)-[MAN(9_U_)-MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(233_C_)",329.918,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo30","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-MAN(7_d_)-[MAN(6_d_)-MAN(5_d_)]-MAN(4_d_)-[MAN(10_d_)-MAN(9_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(319_D_)",38.3576,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo24","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-MAN(5_X_)-MAN(4_X_)-[MAN(8_X_)-MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(519_C_)",40.2414,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-MAN(8_Q_)-[MAN(10_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(519_B_)",50.6045,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo22","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-MAN(5_V_)-[MAN(7_V_)]-MAN(4_V_)-[MAN(9_V_)-MAN(8_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(319_C_)",40.2642,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(312_C_)",65.1376,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo28","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_b_)-[GLC(7_b_)-MAN(6_b_)-MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(249_D_)",55.0106,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(61_C_)",58.2094,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(319_A_)",39.8963,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo20","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[GLC(7_T_)-MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(249_C_)",45.8285,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(61_D_)",61.4762,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(519_A_)",47.2477,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo16","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[BMA(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(438_B_)",72.6018,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(249_A_)",62.5021,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo15","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_O_)-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)]-MAN(4_O_)-[MAN(10_O_)-MAN(9_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(319_B_)",37.5741,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo32","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-MAN(5_f_)-MAN(4_f_)-[MAN(8_f_)-MAN(7_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(519_D_)",44.981,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(438_A_)",63.3932,"","",""
"5JUV","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-B-GALACTOPYRANOSYL GALACTOSE","10.1111/FEBS.14083 ",2.27,23.5,"5juv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",32.8768,"","",""
"5JUV","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-B-GALACTOPYRANOSYL GALACTOSE","10.1111/FEBS.14083 ",2.27,23.5,"5juv_oligo4","DGalpb1-6DGalpb1-ROH","GAL(2_E_)-GAL(1_E_)",45.2923,"","",""
"5JUV","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-B-GALACTOPYRANOSYL GALACTOSE","10.1111/FEBS.14083 ",2.27,23.5,"5juv_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",45.897,"","",""
"5JYY","STRUCTURE-BASED TETRAVALENT ZANAMIVIR WITH POTENT INHIBITORY ACTIVITY AGAINST DRUG-RESISTANT INFLUENZA VIRUSES","10.1021/ACS.JMEDCHEM.6B00537 ",2.1,0,"5jyy_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(120_A_)",37.978,"","",""
"5K33","CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HER2 IN COMPLEX WITH FCAB STAB19","10.1016/J.STR.2017.04.014 ",3.3,120.4,"5k33_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",132.099,"","",""
"5K64","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)","10.1080/19420862.2017.1364825 ",2.44,100.5,"5k64_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",135.456,"","",""
"5K64","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)","10.1080/19420862.2017.1364825 ",2.44,100.5,"5k64_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",108.831,"","",""
"5K65","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)","10.1080/19420862.2017.1364825 ",2.5,0,"5k65_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",116.089,"","",""
"5K65","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)","10.1080/19420862.2017.1364825 ",2.5,0,"5k65_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",80.7227,"","",""
"5K6W","SIDEKICK-1 IMMUNOGLOBULIN DOMAINS 1-5","10.7554/ELIFE.19058 ",3.5,0,"5k6w_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(203_B_)",83.5932,"","",""
"5K6W","SIDEKICK-1 IMMUNOGLOBULIN DOMAINS 1-5","10.7554/ELIFE.19058 ",3.5,0,"5k6w_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(203_A_)",80.2796,"","",""
"5K6X","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4, CRYSTAL FORM 1","10.7554/ELIFE.19058 ",2.7,0,"5k6x_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(203_B_)",80.007,"","",""
"5K6X","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4, CRYSTAL FORM 1","10.7554/ELIFE.19058 ",2.7,0,"5k6x_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(203_A_)",89.355,"","",""
"5K6Y","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4, CRYSTAL FORM 2","10.7554/ELIFE.19058 ",3.2,0,"5k6y_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(203_B_)",123.07,"","",""
"5K6Y","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4, CRYSTAL FORM 2","10.7554/ELIFE.19058 ",3.2,0,"5k6y_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(203_A_)",92.8745,"","",""
"5K70","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4 H18R/N22S MUTANT","10.7554/ELIFE.19058 ",2.7,0,"5k70_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(203_D_)",90.7064,"","",""
"5K70","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4 H18R/N22S MUTANT","10.7554/ELIFE.19058 ",2.7,0,"5k70_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(203_A_)",70.4994,"","",""
"5K70","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4 H18R/N22S MUTANT","10.7554/ELIFE.19058 ",2.7,0,"5k70_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(203_B_)",71.9623,"","",""
"5K70","SIDEKICK-2 IMMUNOGLOBULIN DOMAINS 1-4 H18R/N22S MUTANT","10.7554/ELIFE.19058 ",2.7,0,"5k70_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(203_C_)",62.0859,"","",""
"5K8D","CRYSTAL STRUCTURE OF RFVIIIFC","10.1111/JTH.13700 ",4.19,205.9,"5k8d_oligo2","DManpa1-2DManpb1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2118_B_)",275.876,"","",""
"5K8D","CRYSTAL STRUCTURE OF RFVIIIFC","10.1111/JTH.13700 ",4.19,205.9,"5k8d_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(239_A_)",228.91,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(483_I_)",127.636,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_I_)",67.616,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(285_F_)",117.498,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo3","DManpa1-4DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(285_I_)",130.142,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo7","DManpa1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(38_F_)",87.607,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(22_F_)",183.404,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo9","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(483_F_)",128.366,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",48.0877,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",49.2868,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",47.4036,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",36.9655,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",55.2509,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",41.4236,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",45.8982,"","",""
"5KAF","RT XFEL STRUCTURE OF PHOTOSYSTEM II IN THE DARK STATE AT 3.0 A RESOLUTION","10.1038/NATURE20161 ",3,47.33,"5kaf_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",55.4518,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",59.2455,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",55.0009,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",61.3,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",60.0777,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",45.0868,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",56.6095,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",46.73,"","",""
"5KAI","NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION","10.1038/NATURE20161 ",2.8,56.52,"5kai_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",53.9032,"","",""
"5KAR","MURINE ACID SPHINGOMYELINASE-LIKE PHOSPHODIESTERASE 3B (SMPDL3B)","10.1074/JBC.M116.755801 ",1.14,0,"5kar_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(223_A_)",31.8942,"","",""
"5KAR","MURINE ACID SPHINGOMYELINASE-LIKE PHOSPHODIESTERASE 3B (SMPDL3B)","10.1074/JBC.M116.755801 ",1.14,0,"5kar_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(34_A_)",34.617,"","",""
"5KAS","MURINE ACID SPHINGOMYELINASE-LIKE PHOSPHODIESTERASE 3B (SMPDL3B) WITH PHOSPHOCHOLINE","10.1074/JBC.M116.755801 ",1.62,0,"5kas_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(34_A_)",61.7967,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(563_B_)",1.38636,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(563_G_)",1.38636,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(563_I_)",1.38636,"","",""
"5KEN","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5ken_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(563_F_)",3.52927,"","",""
"5KEN","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5ken_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",0,"","",""
"5KEN","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5ken_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",0,"","",""
"5KIJ","CRYSTAL STRUCTURE OF THE CLASS I HUMAN ENDOPLASMIC RETICULUM 1,2- ALPHA-MANNOSIDASE AND MAN9GLCNAC2-PA COMPLEX","10.1073/PNAS.1611213113 ",1.65,0,"5kij_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcx1-","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(2_B_)-NAG(1_B_)",13.9538,"","",""
"5KKB","STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA AND MAN9GLCNAC2-PA COMPLEX","10.1073/PNAS.1611213113 ",1.77,0,"5kkb_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(9_D_)-[MAN(8_D_)-MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",35.0126,"","",""
"5KKB","STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA AND MAN9GLCNAC2-PA COMPLEX","10.1073/PNAS.1611213113 ",1.77,0,"5kkb_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(9_C_)-[MAN(8_C_)-MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",34.6234,"","",""
"5KOE","THE STRUCTURE OF ARABIDOPSIS THALIANA FUT1 IN COMPLEX WITH XXLG","10.1111/TPJ.13628 ",1.79,24.59,"5koe_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_E_)-XYS(7_E_)-[XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-BGC(1_E_)",33.5007,"","",""
"5KOR","ARABIDOPSIS THALIANA FUCOSYLTRANSFERASE 1 (FUT1) IN COMPLEX WITH GDP AND A XYLO-OLIGOSSACHARIDE","10.1105/TPC.16.00519 ",2.2,0,"5kor_oligo2","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_F_)-XYS(8_F_)-[GAL(7_F_)-XYS(6_F_)-[XYS(5_F_)-BGC(4_F_)]-BGC(3_F_)]-BGC(2_F_)-BGC(1_F_)",58.4319,"","",""
"5KOR","ARABIDOPSIS THALIANA FUCOSYLTRANSFERASE 1 (FUT1) IN COMPLEX WITH GDP AND A XYLO-OLIGOSSACHARIDE","10.1105/TPC.16.00519 ",2.2,0,"5kor_oligo1","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_E_)-XYS(8_E_)-[GAL(7_E_)-XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-BGC(1_E_)",69.8107,"","",""
"5KQV","INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)","10.1038/NATURE11781 ",4.4,247.6,"5kqv_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(25_F_)",303.678,"","",""
"5KQV","INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)","10.1038/NATURE11781 ",4.4,247.6,"5kqv_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(25_E_)",279.481,"","",""
"5KQV","INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)","10.1038/NATURE11781 ",4.4,247.6,"5kqv_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(514_F_)",289.966,"","",""
"5KVM","EXTRACELLULAR REGION OF MOUSE GPR56/ADGRG1 IN COMPLEX WITH FN3 MONOBODY","10.1016/J.NEURON.2016.08.022 ",2.45,0,"5kvm_oligo3","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(148_A_)",110.34,"","",""
"5KXD","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 6.5","10.1074/JBC.M116.750463 ",1.95,22.83,"5kxd_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)-ASN(146_C_)",50.0965,"","",""
"5KXE","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 4.2","10.1074/JBC.M116.750463 ",2.09,28.47,"5kxe_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)-ASN(146_B_)",57.9507,"","",""
"5KXE","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 4.2","10.1074/JBC.M116.750463 ",2.09,28.47,"5kxe_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-[FUC(5_E_)]-NAG(1_E_)-ASN(146_A_)",72.9836,"","",""
"5KZC","CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01","10.1371/JOURNAL.PPAT.1005815 ",3.25,0,"5kzc_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(79_F_)",118.779,"","",""
"5KZC","CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01","10.1371/JOURNAL.PPAT.1005815 ",3.25,0,"5kzc_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)]-MAN(4_J_)-[MAN(9_J_)-MAN(8_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(79_C_)",92.7856,"","",""
"5KZC","CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01","10.1371/JOURNAL.PPAT.1005815 ",3.25,0,"5kzc_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-[MAN(9_I_)-MAN(8_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(79_A_)",104.71,"","",""
"5KZW","CRYSTAL STRUCTURE OF HUMAN GAA","",2,25.23,"5kzw_oligo6","DFucpa1-6DGlcpNAcb1-ASN","FCA(2_F_)-NAG(1_F_)-ASN(652_A_)",69.1518,"","",""
"5KZW","CRYSTAL STRUCTURE OF HUMAN GAA","",2,25.23,"5kzw_oligo2","DGlcpNAcb1-4[DFucpa1-6]DGlcpNAcb1-ASN","FCA(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(140_A_)",69.2533,"","",""
"5KZX","CRYSTAL STRUCTURE OF HUMAN GAA","",2,25.23,"5kzx_oligo2","DGlcpNAcb1-4[DFucpa1-6]DGlcpNAcb1-ASN","FCA(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(140_A_)",69.2533,"","",""
"5KZX","CRYSTAL STRUCTURE OF HUMAN GAA","",2,25.23,"5kzx_oligo6","DFucpa1-6DGlcpNAcb1-ASN","FCA(2_F_)-NAG(1_F_)-ASN(652_A_)",69.1518,"","",""
"5L0B","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",2.41,44.35,"5l0b_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",68.6571,"","",""
"5L0B","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",2.41,44.35,"5l0b_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_B_)",66.7759,"","",""
"5L0E","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",3.06,50.37,"5l0e_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_B_)",79.0526,"","",""
"5L0E","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",3.06,50.37,"5l0e_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",75.2708,"","",""
"5L14","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",1.9,0,"5l14_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",37.2303,"","",""
"5L15","THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",2.4,0,"5l15_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",52.6181,"","",""
"5L17","THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH ZANAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",2.4,0,"5l17_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",51.6364,"","",""
"5L18","THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH SIALIC ACID FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",1.8,0,"5l18_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",23.938,"","",""
"5L1X","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN IN THE POSTFUSION CONFORMATION","10.1371/JOURNAL.PPAT.1005859 ",3.3,76.86,"5l1x_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(353_H_)",116.87,"","",""
"5L1X","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN IN THE POSTFUSION CONFORMATION","10.1371/JOURNAL.PPAT.1005859 ",3.3,76.86,"5l1x_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(353_L_)",124.084,"","",""
"5L1X","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN IN THE POSTFUSION CONFORMATION","10.1371/JOURNAL.PPAT.1005859 ",3.3,76.86,"5l1x_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(57_C_)",118.151,"","",""
"5L1X","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN IN THE POSTFUSION CONFORMATION","10.1371/JOURNAL.PPAT.1005859 ",3.3,76.86,"5l1x_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(353_B_)",130.295,"","",""
"5L1X","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN IN THE POSTFUSION CONFORMATION","10.1371/JOURNAL.PPAT.1005859 ",3.3,76.86,"5l1x_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(353_F_)",124.6,"","",""
"5L2J","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH C36-GMM","10.1038/NCOMMS13257 ",1.65,24.53,"5l2j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",20.3438,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(670_A_)",240.299,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(658_A_)",225.62,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo9","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1096_A_)",274.611,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(1041_A_)",253.544,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(570_A_)",225.851,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(759_A_)",198.978,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-[MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1096_B_)",365.03,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(658_A_)",271.09,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo15","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(1041_B_)",308.4,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(570_A_)",271.09,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo4","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(1041_A_)",314.45,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(658_B_)",282.96,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(570_B_)",282.96,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1096_A_)",359.83,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(759_A_)",252.79,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(1096_A_)",431.97,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(658_A_)",269.04,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(570_A_)",269.04,"","",""
"5L88","AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSILATED, CRYSTAL FORM I, NON-PARSIMONIOUS MODEL","10.1107/S205979831601723X ",1.88,37.31,"5l88_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(26_L_)",71.2232,"","",""
"5L8R","THE STRUCTURE OF PLANT PHOTOSYSTEM I SUPER-COMPLEX AT 2.6 ANGSTROM RESOLUTION.","10.1038/NPLANTS.2017.14 ",2.6,0,"5l8r_oligo21","DGalpa1-6DGalpb1-C14O5","DGD(801_B_)-DGD(801_B_)",202.084,"","",""
"5L8R","THE STRUCTURE OF PLANT PHOTOSYSTEM I SUPER-COMPLEX AT 2.6 ANGSTROM RESOLUTION.","10.1038/NPLANTS.2017.14 ",2.6,0,"5l8r_oligo20","DGalpa1-6DGalpb1-C31O5","DGD(1106_J_)-DGD(1106_J_)",98.885,"","",""
"5L8R","THE STRUCTURE OF PLANT PHOTOSYSTEM I SUPER-COMPLEX AT 2.6 ANGSTROM RESOLUTION.","10.1038/NPLANTS.2017.14 ",2.6,0,"5l8r_oligo18","DGalpa1-6DGalpb1-C34O5","DGD(854_B_)-DGD(854_B_)",88.725,"","",""
"5L8R","THE STRUCTURE OF PLANT PHOTOSYSTEM I SUPER-COMPLEX AT 2.6 ANGSTROM RESOLUTION.","10.1038/NPLANTS.2017.14 ",2.6,0,"5l8r_oligo19","DGalpa1-6DGalpb1-C20O5","DGD(207_G_)-DGD(207_G_)",207.87,"","",""
"5L8R","THE STRUCTURE OF PLANT PHOTOSYSTEM I SUPER-COMPLEX AT 2.6 ANGSTROM RESOLUTION.","10.1038/NPLANTS.2017.14 ",2.6,0,"5l8r_oligo35","DGalpa1-6DGalpb1-C24O5","DGD(319_4_)-DGD(319_4_)",127.153,"","",""
"5L9Y","CRYSTAL STRUCTURE OF HUMAN HEPARANASE, IN COMPLEX WITH GLUCURONIC ACID CONFIGURED AZIRIDINE PROBE JJB355","10.1038/NCHEMBIO.2395 ",1.88,40.06,"5l9y_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(459_A_)",64.3705,"","",""
"5LA4","CRYSTAL STRUCTURE OF APO HUMAN PROHEPARANASE","10.1038/NCHEMBIO.2395 ",1.9,41.88,"5la4_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(459_A_)",65.6882,"","",""
"5LA7","CRYSTAL STRUCTURE OF HUMAN PROHEPARANASE, IN COMPLEX WITH GLUCURONIC ACID CONFIGURED AZIRIDINE PROBE JJB355","10.1038/NCHEMBIO.2395 ",1.94,46.25,"5la7_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(459_A_)",72.3415,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(207_B_)]-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(59_B_)",30.3717,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo4","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)",66.741,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(206_A_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(207_A_)]-NAG(1_C_)-ASN(59_A_)",31.8898,"","",""
"5LBV","STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION","10.1038/NATURE18938 ",2.2,64.34,"5lbv_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(154_B_)",76.8276,"","",""
"5LCV","STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION","10.1038/NATURE18938 ",2.64,56.51,"5lcv_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(154_B_)",88.0459,"","",""
"5LDS","STRUCTURE OF THE PORCINE AMINOPEPTIDASE N ECTODOMAIN","10.1038/SREP46045 ",2,0,"5lds_oligo1","DIdopa1-3DIdopa1-6[DIdopa1-3]DGlcpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-BMA(4_E_)-[BMA(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(646_A_)",55.8736,"","",""
"5LDU","RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA","",2.3,23.07,"5ldu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(436_A_)",44.378,"","",""
"5LF5","MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) DEGLYCOSYLATED FULL EXTRACELLULAR DOMAIN WITH CO-PURIFIED LIGAND","10.1038/NCOMMS13584 ",3.8,0,"5lf5_oligo4","LFucpa1-6DGlcpNAcx1-","FUC(2_B_)-NAG(1_B_)",183.339,"","",""
"5LFR","CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3","10.1038/NCOMMS13584 ",2.12,0,"5lfr_oligo5","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(99_A_)",98.3893,"","",""
"5LFU","MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN","10.1038/NCOMMS13584 ",4.3,0,"5lfu_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(332_A_)",403.313,"","",""
"5LFU","MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN","10.1038/NCOMMS13584 ",4.3,0,"5lfu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(99_A_)",373.07,"","",""
"5LFV","CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3 WITH SOAKED TRISACCHARIDE LIGAND","10.1038/NCOMMS13584 ",2.3,0,"5lfv_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(99_B_)",122.327,"","",""
"5LFV","CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3 WITH SOAKED TRISACCHARIDE LIGAND","10.1038/NCOMMS13584 ",2.3,0,"5lfv_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(99_A_)",91.4341,"","",""
"5LG1","ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU","10.1016/J.MOLIMM.2016.11.021 ",2.7,0,"5lg1_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",144.153,"","",""
"5LG1","ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU","10.1016/J.MOLIMM.2016.11.021 ",2.7,0,"5lg1_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",86.3385,"","",""
"5LGJ","THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333C","",2.6,57.46,"5lgj_oligo2","DManpa1-3[DManpa1-4]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",86.5186,"","",""
"5LGJ","THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333C","",2.6,57.46,"5lgj_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",121.48,"","",""
"5LGW","GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR D394A MUTANT CO- CRYSTALLISED WITH MALTODEXTRIN","10.1074/JBC.M116.748160 ",1.95,34,"5lgw_oligo6","DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-6DGlcpa1-ROH","GLC(6_F_)-GLC(5_F_)-GLC(4_F_)-GLC(3_F_)-GLC(2_F_)-GLC(1_F_)",68.3348,"","",""
"5LGW","GLGE ISOFORM 1 FROM STREPTOMYCES COELICOLOR D394A MUTANT CO- CRYSTALLISED WITH MALTODEXTRIN","10.1074/JBC.M116.748160 ",1.95,34,"5lgw_oligo4","DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-6[DGlcpa1-4DGlcpa1-4]DGlcpa1-4DGlcpa1-ROH","GLC(7_D_)-GLC(6_D_)-GLC(5_D_)-GLC(4_D_)-GLC(3_D_)-[GLC(9_D_)-GLC(8_D_)]-GLC(2_D_)-GLC(1_D_)",64.4425,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo14","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_L_)-[BMA(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(234_B_)",88.8476,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo23","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_a_)-BMA(4_a_)-[BMA(6_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(234_D_)",93.4405,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo12","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_W_)-BMA(4_W_)-[BMA(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(625_C_)",119.506,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo21","DManpb1-3[DManpb1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(6_Y_)-[BMA(5_Y_)]-BMA(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(735_C_)",137.27,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo13","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(128_B_)",116.407,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(681_A_)",116.223,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo7","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(128_C_)",132.479,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_S_)-[BMA(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_C_)",85.7215,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo2","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(128_A_)",92.6091,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(234_A_)",85.4498,"","",""
"5LIA","CRYSTAL STRUCTURE OF MURINE AUTOTAXIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR","10.1016/J.BMCL.2016.10.036 ",1.92,35.32,"5lia_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",38.85,"","",""
"5LKR","HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES","10.1016/J.BMC.2016.11.032 ",2.52,0,"5lkr_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(241_A_)",122.105,"","",""
"5LM8","CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER","10.1515/BOCA-2017-0001 ",1.7,29.29,"5lm8_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(103_A_)",35.982,"","",""
"5LQQ","STRUCTURE OF AUTOTAXIN (ENPP2) WITH LM350","10.1021/ACS.JMEDCHEM.6B01597 ",2.4,61.5,"5lqq_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",61.6194,"","",""
"5LVX","CRYSTAL STRUCTURE OF GLUCOCEREBROSIDASE WITH AN INHIBITORY QUINAZOLINE MODULATOR","10.1021/JACS.7B13003 ",2.2,39.37,"5lvx_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(19_C_)",50.9502,"","",""
"5LWW","CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC","10.1515/BOCA-2017-0001 ",2.65,41.8,"5lww_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",47.3548,"","",""
"5LY9","STRUCTURE OF MITAT 1.1","10.1038/S41564-017-0013-6 ",1.65,28.86,"5ly9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",38.4173,"","",""
"5M0D","STRUCTURE-BASED EVOLUTION OF A HYBRID STEROID SERIES OF AUTOTAXIN INHIBITORS","10.1021/ACS.JMEDCHEM.6B01743 ",2.4,59.66,"5m0d_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",58.3186,"","",""
"5M0M","STRUCTURE-BASED EVOLUTION OF A HYBRID STEROID SERIES OF AUTOTAXIN INHIBITORS","10.1021/ACS.JMEDCHEM.6B01743 ",2.1,37.02,"5m0m_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",37.4718,"","",""
"5M0S","STRUCTURE-BASED EVOLUTION OF A HYBRID STEROID SERIES OF AUTOTAXIN INHIBITORS","10.1021/ACS.JMEDCHEM.6B01743 ",2.1,47.44,"5m0s_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",47.4522,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",127.389,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.1388,"","",""
"5M5E","CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR","10.1080/2162402X.2016.1277306 ",2.3,54.88,"5m5e_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(17_B_)",45.4885,"","",""
"5M5E","CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR","10.1080/2162402X.2016.1277306 ",2.3,54.88,"5m5e_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(62_C_)",77.3118,"","",""
"5M7I","CRYSTAL STRUCTURE OF GH125 1,6-ALPHA-MANNOSIDASE MUTANT FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH 1,6-ALPHA-MANNOBIOSE","10.1021/JACS.6B11247 ",2.1,27.62,"5m7i_oligo1","DManpa1-6DManpb1-ROH","MAN(2_B_)-BMA(1_B_)",22.9691,"","",""
"5M7M","NOVEL IMIDAZO[1,2-A]PYRIDINE DERIVATIVES WITH POTENT AUTOTAXIN/ENPP2 INHIBITOR ACTIVITY","10.1021/ACS.JMEDCHEM.7B00647 ",2.7,25.37,"5m7m_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(525_A_)",34.1958,"","",""
"5M7Y","CRYSTAL STRUCTURE OF GH125 1,6-ALPHA-MANNOSIDASE MUTANT FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH 1,6-ALPHA-MANNOTRIOSE","10.1021/JACS.6B11247 ",1.55,22.9,"5m7y_oligo1","DManpa1-6DManpa1-6DManpa1-ROH","MAN(3_B_)-MAN(2_B_)-MAN(1_B_)",41.9821,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(96_C_)",61.1618,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo16","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_T_)-[MAN(4_T_)-MAN(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(181_D_)",62.1244,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",62.6109,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(181_B_)",64,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(181_A_)",58.3673,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo12","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_P_)-NAG(1_P_)-ASN(181_C_)",71.3405,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo18","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-MAN(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(350_D_)",46.2573,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(96_D_)",64.2591,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(96_B_)",67.1497,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(350_B_)",49.2818,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo12","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_P_)-[MAN(4_P_)-MAN(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(181_C_)",57.78,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(181_B_)",68.9377,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(181_A_)",66.9209,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo14","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-MAN(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(350_C_)",51.2815,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(96_B_)",66.73,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",50.7055,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(96_D_)",68.3233,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(96_C_)",58.0436,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo17","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_U_)-NAG(1_U_)-ASN(181_D_)",64.375,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(96_B_)",61.1206,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(96_D_)",72.9115,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo15","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-MAN(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(350_C_)",50.0109,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",57.395,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(181_C_)",69.0332,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(96_C_)",54.3906,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(181_C_)",54.8309,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(181_B_)",48.4291,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",40.9042,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo5","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(350_B_)",45.9126,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(181_A_)",60.0705,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(96_C_)",54.9788,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(96_B_)",33.2936,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo20","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(350_D_)",32.0249,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo18","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_V_)-[MAN(4_V_)-MAN(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(181_D_)",35.1375,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo17","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(96_D_)",46.9824,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo17","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(96_D_)",83.7803,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",81.7991,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo5","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(350_B_)",60.5765,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo13","LFucpa1-6DGlcpNAcx1-","FUC(2_Q_)-NAG(1_Q_)",83.5499,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(96_B_)",72.4567,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(96_C_)",84.4382,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(181_B_)",75.6568,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo20","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(350_D_)",71.9153,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(181_A_)",77.0564,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(181_B_)",81.7014,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(181_D_)",73.4995,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",71.0309,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(96_C_)",67.1686,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(350_A_)",59.9506,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo8","DManpa1-3[DManpa1-6]DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(350_C_)",54.5511,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(96_D_)",62.5123,"","",""
"5M8R","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.4,39.01,"5m8r_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(181_C_)",51.7461,"","",""
"5M8R","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.4,39.01,"5m8r_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(96_D_)",66.8332,"","",""
"5M8R","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.4,39.01,"5m8r_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(96_B_)",59.5197,"","",""
"5M8R","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.4,39.01,"5m8r_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(96_C_)",61.5527,"","",""
"5M8R","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.4,39.01,"5m8r_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",61.6655,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo5","DManpa1-6DGlcpNAcb1-ASN","MAN(2_I_)-NAG(1_I_)-ASN(181_B_)",73.5786,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo15","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-MAN(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(350_D_)",58.6664,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(96_D_)",63.7464,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(96_C_)",61.7918,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo7","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-MAN(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(350_B_)",59.1388,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",72.97,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo13","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_Q_)-[MAN(4_Q_)-MAN(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(181_D_)",52.4835,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(96_B_)",57.3121,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(181_B_)",71.7286,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo16","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_T_)-[MAN(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(181_D_)",52.5977,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo18","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[MAN(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(350_D_)",53.8545,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo1","DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(96_B_)",56.9122,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(96_A_)",60.8585,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(96_C_)",76.8982,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(96_D_)",65.9246,"","",""
"5M8T","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.35,43.59,"5m8t_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(181_A_)",73.8141,"","",""
"5MDM","STRUCTURAL INTERMEDIATES IN THE FUSION ASSOCIATED TRANSITION OF VESICULOVIRUS GLYCOPROTEIN","10.15252/EMBJ.201694565 ",3,0,"5mdm_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(323_F_)",190.549,"","",""
"5MFA","CRYSTAL STRUCTURE OF HUMAN PROMYELOPEROXIDASE (PROMPO)","10.1074/JBC.M117.775031 ",1.2,0,"5mfa_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(355_A_)",58.0065,"","",""
"5MGC","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 4-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.3,34.22,"5mgc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",55.3106,"","",""
"5MGC","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 4-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.3,34.22,"5mgc_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",51.1089,"","",""
"5MGD","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.15,28.76,"5mgd_oligo4","DGalpb1-6DGalpb1-4DGlcpa1-ROH","GAL(3_E_)-GAL(2_E_)-GLC(1_E_)",20,"","",""
"5MGD","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.15,28.76,"5mgd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",45.5798,"","",""
"5MGD","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.15,28.76,"5mgd_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",41.5227,"","",""
"5MGR","HUMAN RECEPTOR NKR-P1 IN GLYCOSYLATED FORM, EXTRACELLULAR DOMAIN","10.1038/S41467-022-32577-6 ",1.8,33.5,"5mgr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(169_B_)",49.63,"","",""
"5MGR","HUMAN RECEPTOR NKR-P1 IN GLYCOSYLATED FORM, EXTRACELLULAR DOMAIN","10.1038/S41467-022-32577-6 ",1.8,33.5,"5mgr_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(169_A_)",43.0055,"","",""
"5MHP","NOVEL IMIDAZO[1,2-A]PYRIDINE DERIVATIVES WITH POTENT AUTOTAXIN/ENPP2 INHIBITOR ACTIVITY","10.1021/ACS.JMEDCHEM.7B00032 ",2.43,41.35,"5mhp_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(525_A_)",45.219,"","",""
"5MJ3","INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY, CRYSTAL FORM 1","10.1038/NCOMMS6237 ",1.74,0,"5mj3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",68.294,"","",""
"5MJ4","INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY, CRYSTAL FORM 2","10.1038/NCOMMS6237 ",3.4,0,"5mj4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",132.038,"","",""
"5MJ6","LIGAND-INDUCED CONFORMATIONAL CHANGE OF INSULIN-REGULATED AMINOPEPTIDASE: INSIGHTS ON CATALYTIC MECHANISM AND ACTIVE SITE PLASTICITY.","10.1021/ACS.JMEDCHEM.6B01890 ",2.53,0,"5mj6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(850_A_)",66.9173,"","",""
"5MJ6","LIGAND-INDUCED CONFORMATIONAL CHANGE OF INSULIN-REGULATED AMINOPEPTIDASE: INSIGHTS ON CATALYTIC MECHANISM AND ACTIVE SITE PLASTICITY.","10.1021/ACS.JMEDCHEM.6B01890 ",2.53,0,"5mj6_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(374_A_)",102.143,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo6","DManpa1-3[DManpa1-6]DManpx1-","MAN(3_L_)-[MAN(2_L_)]-BMA(1_L_)",127.646,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo1","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",106.525,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_E_)",90.8911,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(4_G_)-[MAN(3_G_)]-BMA(2_G_)-NAG(1_G_)",101.244,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_D_)",80.7969,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_C_)",88.8571,"","",""
"5MOJ","CRYSTAL STRUCTURE OF IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.26,0,"5moj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",89.3675,"","",""
"5MOJ","CRYSTAL STRUCTURE OF IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.26,0,"5moj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",96.7433,"","",""
"5MOK","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2,0,"5mok_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(4_G_)-[MAN(3_G_)]-BMA(2_G_)-NAG(1_G_)",87.9571,"","",""
"5MOK","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2,0,"5mok_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(394_D_)",63.9979,"","",""
"5MOK","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2,0,"5mok_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",83.1132,"","",""
"5MOK","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2,0,"5mok_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",81.8871,"","",""
"5MOL","HUMAN IGE-FC CRYSTAL STRUCTURE","10.1016/J.BBAPAP.2017.08.005 ",1.75,0,"5mol_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",56.0429,"","",""
"5MOL","HUMAN IGE-FC CRYSTAL STRUCTURE","10.1016/J.BBAPAP.2017.08.005 ",1.75,0,"5mol_oligo1","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",68.1264,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-[MAN(6_E_)]-MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1227_A_)",239.261,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo1","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(638_A_)",279.919,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(56_A_)",221.364,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(894_A_)",250.231,"","",""
"5MWF","HUMAN JAGGED2 C2-EGF2","10.15252/EMBJ.201796632 ",2.8,0,"5mwf_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(153_C_)",82.4786,"","",""
"5MWF","HUMAN JAGGED2 C2-EGF2","10.15252/EMBJ.201796632 ",2.8,0,"5mwf_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(153_B_)",53.5275,"","",""
"5MWF","HUMAN JAGGED2 C2-EGF2","10.15252/EMBJ.201796632 ",2.8,0,"5mwf_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)",93.7386,"","",""
"5MWF","HUMAN JAGGED2 C2-EGF2","10.15252/EMBJ.201796632 ",2.8,0,"5mwf_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(153_F_)",89.8612,"","",""
"5MWF","HUMAN JAGGED2 C2-EGF2","10.15252/EMBJ.201796632 ",2.8,0,"5mwf_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(153_A_)",48.982,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(201_A_)",144.2,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(166_A_)",128.357,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(127_B_)",132.122,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(291_B_)",115.888,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(291_A_)",110.425,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(127_A_)",123.893,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(166_B_)",115.274,"","",""
"5MX0","CRYSTAL STRUCTURE OF HUMAN FIBROMODULIN","10.1016/J.MATBIO.2017.02.002 ",2.21,0,"5mx0_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(201_B_)",144.963,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo26","DGalpa1-6DGalpb1-C28O5","DGD(517_c_)-DGD(517_c_)",34.6195,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo8","DGalpa1-6DGalpb1-C33O5","DGD(103_H_)-DGD(103_H_)",33.5727,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",24.695,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",26.3691,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",31.03,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",36.0014,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo12","DGalpa1-6DGalpb1-C29O5","DGD(518_C_)-DGD(518_C_)",36.1745,"","",""
"5MX2","PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION","10.7554/ELIFE.26933 ",2.2,36.05,"5mx2_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",31.6209,"","",""
"5MZO","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM (OPEN CONFORMATION)","10.1073/PNAS.1703682114 ",3.48,171.1,"5mzo_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(56_A_)",228.438,"","",""
"5MZV","IL-23:IL-23R:NB22E11 COMPLEX","10.1016/J.IMMUNI.2017.12.008 ",2.8,84.47,"5mzv_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(222_A_)",108.285,"","",""
"5N09","CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,0,"5n09_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",95.6753,"","",""
"5N09","CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,0,"5n09_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",113.562,"","",""
"5N0A","CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,145,"5n0a_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",136.831,"","",""
"5N0A","CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,145,"5n0a_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",136.618,"","",""
"5N11","CRYSTAL STRUCTURE OF HUMAN BETA1-CORONAVIRUS OC43 NL/A/2005 HEMAGGLUTININ-ESTERASE","10.1016/J.CHOM.2017.02.008 ",2.45,56.48,"5n11_oligo8","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(315_A_)",88.5347,"","",""
"5N11","CRYSTAL STRUCTURE OF HUMAN BETA1-CORONAVIRUS OC43 NL/A/2005 HEMAGGLUTININ-ESTERASE","10.1016/J.CHOM.2017.02.008 ",2.45,56.48,"5n11_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(89_B_)",64.67,"","",""
"5N2J","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM (CLOSED FORM)","10.1073/PNAS.1703682114 ",4.4,243.3,"5n2j_oligo5","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(56_B_)",280.398,"","",""
"5N2J","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM (CLOSED FORM)","10.1073/PNAS.1703682114 ",4.4,243.3,"5n2j_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(56_A_)",290.552,"","",""
"5N92","CRYSTAL STRUCTURE OF HUMAN IL-17AF","10.1038/S41598-017-08360-9 ",2.3,52.25,"5n92_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(83_F_)",91.8085,"","",""
"5NAN","CRYSTAL STRUCTURE OF HUMAN IL-17AF IN COMPLEX WITH HUMAN IL-17RA","10.1038/S41598-017-08360-9 ",3.3,169.1,"5nan_oligo1","DGlcpNAcb1-4[DGalpb1-6]DGlcpNAcb1-ASN","GAL(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(83_F_)",235.809,"","",""
"5NAP","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON-CHIRAL DONEPEZIL-LIKE INHIBITOR 17","10.1080/14756366.2018.1458030 ",2.17,30.66,"5nap_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",74.5086,"","",""
"5NAU","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON-CHIRAL DONEPEZIL-LIKE COMPOUND 20","10.1080/14756366.2018.1458030 ",2.25,38.09,"5nau_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",82.7627,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(57_B_)",55.3995,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo12","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-MAN(5_N_)-[MAN(7_N_)]-MAN(4_N_)-[MAN(8_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(519_B_)",55.9123,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(318_A_)",28.7231,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo11","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-MAN(5_M_)-[MAN(7_M_)]-MAN(4_M_)-[MAN(8_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(318_B_)",51.3714,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(57_A_)",55.4845,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(248_A_)",44.9074,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(519_A_)",45.7786,"","",""
"5NFF","CRYSTAL STRUCTURE OF GP1 RECEPTOR BINDING DOMAIN FROM MOROGORO VIRUS","10.1371/JOURNAL.PPAT.1006337 ",2.62,55.71,"5nff_oligo3","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-MAN(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(222_H_)",73.0409,"","",""
"5NFG","STRUCTURE OF RECOMBINANT CARDOSIN B FROM CYNARA CARDUNCULUS","10.1007/S00253-017-8445-8 ",2.38,0,"5nfg_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(229_B_)",69.5291,"","",""
"5NFG","STRUCTURE OF RECOMBINANT CARDOSIN B FROM CYNARA CARDUNCULUS","10.1007/S00253-017-8445-8 ",2.38,0,"5nfg_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(229_A_)",72.1709,"","",""
"5NFG","STRUCTURE OF RECOMBINANT CARDOSIN B FROM CYNARA CARDUNCULUS","10.1007/S00253-017-8445-8 ",2.38,0,"5nfg_oligo2","DManpa1-2[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(116_B_)",58.8056,"","",""
"5NFG","STRUCTURE OF RECOMBINANT CARDOSIN B FROM CYNARA CARDUNCULUS","10.1007/S00253-017-8445-8 ",2.38,0,"5nfg_oligo1","DManpa1-2[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(116_A_)",53.365,"","",""
"5NGY","CRYSTAL STRUCTURE OF LEUCONOSTOC CITREUM NRRL B-1299 DEXTRANSUCRASE DSR-M","10.1021/ACSCATAL.7B02182 ",3.7,62.15,"5ngy_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",70.6248,"","",""
"5NIT","GLUCOSE OXIDASE MUTANT A2","10.1021/ACSCATAL.7B01575 ",1.87,20.22,"5nit_oligo21","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(89_A_)",36.3948,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(222_K_)",113.999,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(222_I_)",88.6898,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(222_E_)",106.861,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(222_C_)",77.6809,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(222_A_)",102.636,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(222_G_)",89.5707,"","",""
"5NN0","CRYSTAL STRUCTURE OF HUBCHE WITH N-((1-(2,3-DIHYDRO-1H-INDEN-2-YL) PIPERIDIN-3-YL)METHYL)-N-(2-(DIMETHYLAMINO)ETHYL)-2-NAPHTHAMIDE.","10.1021/ACS.JMEDCHEM.7B01086 ",2.1,0,"5nn0_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(106_A_)",63.5245,"","",""
"5NN0","CRYSTAL STRUCTURE OF HUBCHE WITH N-((1-(2,3-DIHYDRO-1H-INDEN-2-YL) PIPERIDIN-3-YL)METHYL)-N-(2-(DIMETHYLAMINO)ETHYL)-2-NAPHTHAMIDE.","10.1021/ACS.JMEDCHEM.7B01086 ",2.1,0,"5nn0_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",76.4173,"","",""
"5NN0","CRYSTAL STRUCTURE OF HUBCHE WITH N-((1-(2,3-DIHYDRO-1H-INDEN-2-YL) PIPERIDIN-3-YL)METHYL)-N-(2-(DIMETHYLAMINO)ETHYL)-2-NAPHTHAMIDE.","10.1021/ACS.JMEDCHEM.7B01086 ",2.1,0,"5nn0_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",66.0603,"","",""
"5NN3","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA","10.1038/S41467-017-01263-3 ",1.9,33.14,"5nn3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)",64.1325,"","",""
"5NN3","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA","10.1038/S41467-017-01263-3 ",1.9,33.14,"5nn3_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",76.7193,"","",""
"5NN4","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH N-ACETYL-CYSTEINE","10.1038/S41467-017-01263-3 ",1.83,26.42,"5nn4_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(140_A_)",55.9227,"","",""
"5NN4","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH N-ACETYL-CYSTEINE","10.1038/S41467-017-01263-3 ",1.83,26.42,"5nn4_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(652_A_)",79.457,"","",""
"5NN5","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1038/S41467-017-01263-3 ",2,19.49,"5nn5_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)",53.6311,"","",""
"5NN5","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1038/S41467-017-01263-3 ",2,19.49,"5nn5_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",69.5691,"","",""
"5NN6","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH N-HYDROXYETHYL-1-DEOXYNOJIRIMYCIN","10.1038/S41467-017-01263-3 ",2,22.48,"5nn6_oligo5","LFucpa1-6DGlcpNAcx1-","FUC(2_F_)-NAG(1_F_)",58.4882,"","",""
"5NN6","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH N-HYDROXYETHYL-1-DEOXYNOJIRIMYCIN","10.1038/S41467-017-01263-3 ",2,22.48,"5nn6_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)",56.9868,"","",""
"5NN8","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH ACARBOSE","10.1038/S41467-017-01263-3 ",2.45,30.36,"5nn8_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)",77.2682,"","",""
"5NN8","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH ACARBOSE","10.1038/S41467-017-01263-3 ",2.45,30.36,"5nn8_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",89.5983,"","",""
"5NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"5nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.4766,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo2","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-[MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(217_A_)",131.404,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(133_A_)",119.778,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo10","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-[MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(217_B_)",129.336,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(76_A_)",162.004,"","",""
"5NQ7","CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS, IZOFORM I","10.1016/J.IJBIOMAC.2017.10.024 ",2.75,52.63,"5nq7_oligo1","DManpa1-3DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[BMA(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(75_A_)",100.858,"","",""
"5NQ7","CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS, IZOFORM I","10.1016/J.IJBIOMAC.2017.10.024 ",2.75,52.63,"5nq7_oligo2","DManpa1-3[DManpb1-6]DManp[2H]b1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[MAN(5_C_)--BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(398_A_)",134.018,"","",""
"5NQ9","CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS, IZOFORM II, MONOCLINIC","10.1016/J.IJBIOMAC.2017.10.024 ",2.72,53.41,"5nq9_oligo1","DManpa1-6DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(362_A_)",96.294,"","",""
"5NQW","IGE-FC IN COMPLEX WITH SINGLE DOMAIN ANTIBODY 026","10.1038/S41467-017-02312-7 ",3.4,0,"5nqw_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",117.87,"","",""
"5NQW","IGE-FC IN COMPLEX WITH SINGLE DOMAIN ANTIBODY 026","10.1038/S41467-017-02312-7 ",3.4,0,"5nqw_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",125.447,"","",""
"5NSC","FC DEKK HETERODIMER VARIANT","10.1074/JBC.M117.793497 ",2.3,0,"5nsc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",54.7873,"","",""
"5NSC","FC DEKK HETERODIMER VARIANT","10.1074/JBC.M117.793497 ",2.3,0,"5nsc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",41.9274,"","",""
"5NSG","FC DEDE HOMODIMER VARIANT","10.1074/JBC.M117.793497 ",2.22,0,"5nsg_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_B_)-[NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",41.4239,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo21","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",50.3146,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo26","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",46.9283,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo22","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",30.3098,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo27","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-[MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",30.5934,"","",""
"5NUU","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A CHLOROTACRINE-TRYPTOPHAN HYBRID INHIBITOR","10.1016/J.EJMECH.2019.02.021 ",2.5,51.32,"5nuu_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",107.426,"","",""
"5NUZ","JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT","10.1073/PNAS.1702127114 ",1.85,36.18,"5nuz_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(178_C_)",80.1117,"","",""
"5NUZ","JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT","10.1073/PNAS.1702127114 ",1.85,36.18,"5nuz_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(178_D_)",68.4889,"","",""
"5NWE","COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR","10.3390/V10070339 ",2,23.25,"5nwe_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(146_A_)",35.6545,"","",""
"5NZF","COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR","10.3390/V10070339 ",1.75,18.78,"5nzf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(146_C_)",38.5745,"","",""
"5NZN","COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR","10.3390/V10070339 ",1.73,17.61,"5nzn_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(146_C_)",32.6395,"","",""
"5O0N","DEGLYCOSYLATED NOGO RECEPTOR WITH NATIVE DISULFIDE STRUCTURE 4","10.1107/S2059798317013791 ",2.5,0,"5o0n_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(179_A_)",130.898,"","",""
"5O32","THE STRUCTURE OF COMPLEMENT COMPLEX","10.1038/NSMB.3427 ",4.21,108.2,"5o32_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_K_)-[BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(85_A_)",133.796,"","",""
"5O32","THE STRUCTURE OF COMPLEMENT COMPLEX","10.1038/NSMB.3427 ",4.21,108.2,"5o32_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(85_E_)",153.757,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",39.1188,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",38.5508,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo29","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",41.6773,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",44.115,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(297_D_)",117.143,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",88.7826,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",93.0537,"","",""
"5O4G","HER2 IN COMPLEX WITH FAB MF3958","10.1016/J.CCELL.2018.04.003 ",3,0,"5o4g_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(46_C_)",102.603,"","",""
"5O5R","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A UREA BASED INHIBITOR PSMA 1023","",1.65,37,"5o5r_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(140_A_)",62.9376,"","",""
"5O5R","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A UREA BASED INHIBITOR PSMA 1023","",1.65,37,"5o5r_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",51.8129,"","",""
"5O5T","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A UREA BASED INHIBITOR PSMA 1007","",1.43,32.75,"5o5t_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",41.3625,"","",""
"5O5U","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A UREA BASED INHIBITOR PSMA 1027","",1.53,34.1,"5o5u_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",48.4309,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo4","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",89.8691,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo5","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_E_)",93.8865,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",90.0297,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",89.6908,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",87.5253,"","",""
"5OF0","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII), THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR CFBZOG","10.1021/ACSMEDCHEMLETT.8B00318 ",1.48,38.48,"5of0_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",53.6511,"","",""
"5OFX","PLLA LECTIN, TRISACCHARIDE COMPLEX","10.1074/JBC.M117.812792 ",1.75,0,"5ofx_oligo4","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_L_)-GLC(2_L_)-FRU(1_L_)",40.7107,"","",""
"5OFX","PLLA LECTIN, TRISACCHARIDE COMPLEX","10.1074/JBC.M117.812792 ",1.75,0,"5ofx_oligo6","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_N_)-GLC(2_N_)-FRU(1_N_)",14.7736,"","",""
"5OFX","PLLA LECTIN, TRISACCHARIDE COMPLEX","10.1074/JBC.M117.812792 ",1.75,0,"5ofx_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_J_)-GLC(2_J_)-FRU(1_J_)",11.6183,"","",""
"5OFX","PLLA LECTIN, TRISACCHARIDE COMPLEX","10.1074/JBC.M117.812792 ",1.75,0,"5ofx_oligo5","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_M_)-GLC(2_M_)-FRU(1_M_)",13.0723,"","",""
"5OFX","PLLA LECTIN, TRISACCHARIDE COMPLEX","10.1074/JBC.M117.812792 ",1.75,0,"5ofx_oligo3","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_K_)-GLC(2_K_)-FRU(1_K_)",23.3887,"","",""
"5OFX","PLLA LECTIN, TRISACCHARIDE COMPLEX","10.1074/JBC.M117.812792 ",1.75,0,"5ofx_oligo7","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_O_)-GLC(2_O_)-FRU(1_O_)",32.9582,"","",""
"5OFX","PLLA LECTIN, TRISACCHARIDE COMPLEX","10.1074/JBC.M117.812792 ",1.75,0,"5ofx_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_I_)-GLC(2_I_)-FRU(1_I_)",12.8798,"","",""
"5OHI","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH BI-2545","10.1021/ACSMEDCHEMLETT.7B00312 ",1.66,39.56,"5ohi_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_A_)",49.8456,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_E_)",91.9908,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",99.6474,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",88.5176,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",100.341,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",103.983,"","",""
"5OLB","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH PF-8380","10.1021/ACSMEDCHEMLETT.7B00312 ",1.82,25.36,"5olb_oligo4","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_A_)",45.0582,"","",""
"5OLB","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH PF-8380","10.1021/ACSMEDCHEMLETT.7B00312 ",1.82,25.36,"5olb_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-[FUC(5_B_)]-NAG(1_B_)-ASN(53_A_)",39.8809,"","",""
"5OR3","CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE CATECHOL OXIDASE IN MET/DEOXY- FORM","10.1371/JOURNAL.PONE.0196691 ",1.8,0,"5or3_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(104_B_)",41.8452,"","",""
"5OUG","HUMANIZED ALPHA-ACHBP (ACETYLCHOLINE BINDING PROTEIN) IN COMPLEX WITH LOBELINE AND ALLOSTERIC BINDER FRAGMENT 4.","10.1074/JBC.M117.815316 ",2.57,75.54,"5oug_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(108_B_)",82.5771,"","",""
"5OUI","HUMANIZED ALPHA-ACHBP (ACETYLCHOLINE BINDING PROTEIN) IN COMPLEX WITH ALLOSTERIC BINDER FRAGMENT CU2017","10.1074/JBC.M117.815316 ",3.1,81.9,"5oui_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(108_A_)",104.035,"","",""
"5OY0","STRUCTURE OF SYNECHOCYSTIS PHOTOSYSTEM I TRIMER AT 2.5A RESOLUTION","10.1016/J.BBABIO.2018.02.002 ",2.5,0,"5oy0_oligo19","DGalpa1-6DGalpb1-C39O5","DGD(5004_L_)-DGD(5004_L_)",109.197,"","",""
"5OYD","GH5 ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS","10.1186/S13068-018-1039-6 ",2.1,48.03,"5oyd_oligo2","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-C2N1O1","XYS(6_C_)-[XYS(5_C_)-[BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-NBG(1_C_)",43.3227,"","",""
"5OYD","GH5 ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS","10.1186/S13068-018-1039-6 ",2.1,48.03,"5oyd_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-C2N1O1","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-NBG(1_D_)",45.425,"","",""
"5OYE","GH5 ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS","10.1186/S13068-018-1039-6 ",1.9,53.36,"5oye_oligo1","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(6_D_)-[XYS(5_D_)-[BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-BGC(1_D_)",60.6614,"","",""
"5OYE","GH5 ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS","10.1186/S13068-018-1039-6 ",1.9,53.36,"5oye_oligo2","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_C_)-XYS(6_C_)-[XYS(5_C_)-[BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",54.6092,"","",""
"5QJ3","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3- YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE","10.1021/ACSMEDCHEMLETT.8B00308 ",2.76,37.4,"5qj3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",42.4816,"","",""
"5QJ3","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3- YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE","10.1021/ACSMEDCHEMLETT.8B00308 ",2.76,37.4,"5qj3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)",42.7338,"","",""
"5S9L","AUTOTAXIN, 4-[3-OXO-3-(2-OXO-2,3-DIHYDRO-BENZOOXAZOL-6-YL)-PROPYL]- PIPERAZINE-1-CARBOXYLIC ACID 3,5-DICHLORO-BENZYL ESTER, 1.90A, P212121, RFREE=19.1%","",1.9,30.62,"5s9l_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(8_B_)-MAN(7_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",49.5315,"","",""
"5S9M","AUTOTAXIN, (3,5-DICHLOROPHENYL)METHYL (3AS,8AR)-2-(1H-BENZOTRIAZOLE-5- CARBONYL)-1,3,3A,4,5,7,8,8A-OCTAHYDROPYRROLO[3,4-D]AZEPINE-6- CARBOXYLATE, 1.80A, P212121, RFREE=21.1%","",1.8,31.64,"5s9m_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",49.5715,"","",""
"5S9N","AUTOTAXIN, [4-(TRIFLUOROMETHOXY)PHENYL]METHYL (3AS,6AS)-2-(1H- BENZOTRIAZOLE-5-CARBONYL)-1,3,3A,4,6,6A-HEXAHYDROPYRROLO[3,4- C]PYRROLE-5-CARBOXYLATE, 1.80A, P212121, RFREE=23.3%","",1.8,33.72,"5s9n_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",56.893,"","",""
"5SV8","CRYSTAL STRUCTURE OF THE CATALYTIC NUCLEOPHILE AND SURFACE CYSTEINE MUTANT OF VVEG16 IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE","10.1111/TPJ.13421 ",1.59,11.43,"5sv8_oligo1","DXylpa1-6DGlcpb1-4DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",18.5712,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(4_E_)-MAN(3_E_)-[MAN(6_E_)]-BMA(2_E_)-NAG(1_E_)",20.8745,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_H_)-[MAN(4_H_)]-MAN(3_H_)-[MAN(6_H_)]-BMA(2_H_)-NAG(1_H_)",18.5315,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-[MAN(6_F_)]-BMA(2_F_)-NAG(1_F_)",20.5773,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-[MAN(6_B_)]-BMA(2_B_)-NAG(1_B_)",20.1171,"","",""
"5SZL","PROTOCADHERIN GAMMA A1 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.7554/ELIFE.20930 ",4.2,0,"5szl_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(237_D_)",235.59,"","",""
"5SZM","PROTOCADHERIN GAMMA A8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.7554/ELIFE.20930 ",3.6,0,"5szm_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(390_A_)",203.795,"","",""
"5SZO","PROTOCADHERIN GAMMA B7 EXTRACELLULAR CADHERIN DOMAINS 1-4 P41212 CRYSTAL FORM","10.7554/ELIFE.20930 ",3.61,0,"5szo_oligo1","LGulp[6H,3H]a1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(387_B_)",280.859,"","",""
"5SZR","PROTOCADHERIN GAMMA B2 EXTRACELLULAR CADHERIN DOMAINS 3-6","10.7554/ELIFE.20930 ",2.3,0,"5szr_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(389_B_)",107.268,"","",""
"5SZR","PROTOCADHERIN GAMMA B2 EXTRACELLULAR CADHERIN DOMAINS 3-6","10.7554/ELIFE.20930 ",2.3,0,"5szr_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(515_A_)",99.3505,"","",""
"5SZR","PROTOCADHERIN GAMMA B2 EXTRACELLULAR CADHERIN DOMAINS 3-6","10.7554/ELIFE.20930 ",2.3,0,"5szr_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(515_B_)",99.6845,"","",""
"5SZR","PROTOCADHERIN GAMMA B2 EXTRACELLULAR CADHERIN DOMAINS 3-6","10.7554/ELIFE.20930 ",2.3,0,"5szr_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(515_C_)",100.315,"","",""
"5SZR","PROTOCADHERIN GAMMA B2 EXTRACELLULAR CADHERIN DOMAINS 3-6","10.7554/ELIFE.20930 ",2.3,0,"5szr_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(389_A_)",100.763,"","",""
"5SZR","PROTOCADHERIN GAMMA B2 EXTRACELLULAR CADHERIN DOMAINS 3-6","10.7554/ELIFE.20930 ",2.3,0,"5szr_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(389_C_)",94.4897,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo8","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_X_)-[MAN(2_X_)]-MAN(1_X_)",26.4433,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo14","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_d_)-[MAN(2_d_)]-MAN(1_d_)",34.0085,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo16","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_f_)-[MAN(2_f_)]-MAN(1_f_)",30.8664,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo12","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_b_)-[MAN(2_b_)]-MAN(1_b_)",31.7836,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo11","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_a_)-[MAN(2_a_)]-MAN(1_a_)",28.907,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo7","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_W_)-[MAN(2_W_)]-MAN(1_W_)",22.4758,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo6","DManpa1-6DManp[3<R1>]a1-ROH","MAN(2_V_)-MAN(1_V_)",32.7023,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo13","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_c_)-[MAN(2_c_)]-MAN(1_c_)",25.0348,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo5","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_U_)-[MAN(2_U_)]-MAN(1_U_)",22.3715,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo10","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_Z_)-[MAN(2_Z_)]-MAN(1_Z_)",33.8676,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_S_)-[MAN(2_S_)]-MAN(1_S_)",23.2342,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_T_)-[MAN(2_T_)]-MAN(1_T_)",30.8433,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo9","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_Y_)-[MAN(2_Y_)]-MAN(1_Y_)",18.5909,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo15","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_e_)-[MAN(2_e_)]-MAN(1_e_)",18.9345,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo2","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_R_)-[MAN(2_R_)]-MAN(1_R_)",27.6524,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_Q_)-[MAN(2_Q_)]-MAN(1_Q_)",24.5039,"","",""
"5T33","CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1, IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN.","10.1128/JVI.01357-16 ",3.21,116.9,"5t33_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(262_G_)",145.405,"","",""
"5T33","CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1, IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN.","10.1128/JVI.01357-16 ",3.21,116.9,"5t33_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(276_G_)",114.515,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-MAN(8_P_)-[MAN(10_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",168.216,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(88_G_)",203.58,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",198.03,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_R_)-MAN(6_R_)-[NAG(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",336.253,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_W_)-[MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(392_G_)",326.786,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(88_G_)",346.499,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo14","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",291.675,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo10","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_K_)-[GAL(9_K_)-NAG(8_K_)-MAN(7_K_)-[GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(160_G_)",336.057,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo9","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(13_J_)-[GAL(12_J_)-NAG(11_J_)-[GAL(10_J_)-NAG(9_J_)]-MAN(8_J_)-[GAL(6_J_)-NAG(5_J_)-[NAG(7_J_)]-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(156_G_)",325.076,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(363_G_)",373.667,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo15","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(16_P_)-[GAL(14_P_)-NAG(13_P_)-[SIA(12_P_)-GAL(11_P_)-NAG(10_P_)]-MAN(9_P_)-[NAG(15_P_)]-[NAG(8_P_)-[SIA(7_P_)-GAL(6_P_)-NAG(5_P_)]-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(276_G_)",374.56,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(611_B_)",308.88,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_M_)-MAN(8_M_)-[SIA(7_M_)-GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",304.839,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(386_G_)",317.026,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(637_B_)",337.147,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo18","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(448_G_)",322.505,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_G_)",218.953,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[NAG(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",217.53,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo14","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-MAN(5_T_)-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(363_G_)",223.814,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo16","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(392_G_)",243.271,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(611_B_)",260.323,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_G_)",166.778,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(160_G_)",246.507,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_P_)-[MAN(7_P_)-[GAL(6_P_)-NAG(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(276_G_)",265.286,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo1","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(11_J_)-[GAL(10_J_)-NAG(9_J_)-MAN(8_J_)-[GAL(6_J_)-NAG(5_J_)-[NAG(7_J_)]-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(156_G_)",240.369,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo9","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_M_)-MAN(7_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",232.465,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(386_G_)",218.258,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo11","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",208.783,"","",""
"5T6N","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH THE ANTIVIRAL DRUG ARBIDOL","10.1073/PNAS.1617020114 ",2.54,0,"5t6n_oligo8","DRhapa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",103.15,"","",""
"5T6N","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH THE ANTIVIRAL DRUG ARBIDOL","10.1073/PNAS.1617020114 ",2.54,0,"5t6n_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",111.43,"","",""
"5T7N","X-RAY CRYSTAL STRUCTURE OF AA13 LPMO","10.1107/S2059798316019641 ",1.6,13.06,"5t7n_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",28.025,"","",""
"5T9T","PROTOCADHERIN GAMMA B2 EXTRACELLULAR CADHERIN DOMAINS 1-5","10.7554/ELIFE.20930 ",3.5,0,"5t9t_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(389_B_)",107.986,"","",""
"5TCD","HUMAN ALKALINE SPHINGOMYELINASE (ENPP7) IN COMPLEX WITH PHOSPHOCHOLINE","10.1074/JBC.M116.769273 ",2.4,0,"5tcd_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(168_A_)",77.0282,"","",""
"5TGO","CRYSTAL STRUCTURE OF H10 HEMAGGLUTININ MUTANT (K158AA-D193T-Q226L- G228S) FROM JIANGXI-DONGHU (2013) H10N8 INFLUENZA VIRUS","10.1016/J.CELREP.2017.03.054 ",2.35,0,"5tgo_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_G_)-BMA(2_G_)-NAG(1_G_)-NAG(501_C_)-ASN(242_C_)",79.4145,"","",""
"5TGU","CRYSTAL STRUCTURE OF H10 HEMAGGLUTININ MUTANT (K158AA-D193T-Q226L- G228S) FROM JIANGXI-DONGHU (2013) H10N8 INFLUENZA VIRUS IN COMPLEX WITH 6'-SLNLN","10.1016/J.CELREP.2017.03.054 ",2.35,0,"5tgu_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_H_)-BMA(2_H_)-NAG(1_H_)-NAG(405_C_)-ASN(242_C_)",82.8284,"","",""
"5TH0","CRYSTAL STRUCTURE OF H10 HEMAGGLUTININ MUTANT (K158AA-Q226L-G228S) FROM JIANGXI-DONGHU (2013) H10N8 INFLUENZA VIRUS","10.1016/J.CELREP.2017.03.054 ",2.25,0,"5th0_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(242_C_)",76.4155,"","",""
"5TH1","CRYSTAL STRUCTURE OF H10 HEMAGGLUTININ MUTANT (K158AA-Q226L-G228S) FROM JIANGXI-DONGHU (2013) H10N8 INFLUENZA VIRUS IN COMPLEX WITH 6'- SLNLN","10.1016/J.CELREP.2017.03.054 ",2.19,0,"5th1_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(242_C_)",75.7655,"","",""
"5THB","CRYSTAL STRUCTURE OF H10 HEMAGGLUTININ MUTANT (T193D-Q226L-G228S) FROM JIANGXI-DONGHU (2013) H10N8 INFLUENZA VIRUS","10.1016/J.CELREP.2017.03.054 ",2.41,0,"5thb_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(242_C_)",56.4859,"","",""
"5THC","CRYSTAL STRUCTURE OF H10 HEMAGGLUTININ MUTANT (T193D-Q226L-G228S) FROM JIANGXI-DONGHU (2013) H10N8 INFLUENZA VIRUS IN COMPLEX WITH 6'-SLNLN","10.1016/J.CELREP.2017.03.054 ",2.79,0,"5thc_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(242_E_)",70.2334,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(386_E_)",165.906,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(386_D_)",165.906,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(276_E_)",187.068,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(276_D_)",187.068,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(386_F_)",166.412,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(276_F_)",197.329,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",39.2673,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",40.5886,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",48.5064,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",47.4318,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",47.4959,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",34.2077,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",50.0945,"","",""
"5TIS","ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX","10.1038/NATURE20161 ",2.25,47.76,"5tis_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",35.9205,"","",""
"5TKF","NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 HIGH MANNOSYLATION","10.1107/S2053230X16020318 ",2.1,22.12,"5tkf_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(60_A_)",42.3764,"","",""
"5TO3","CRYSTAL STRUCTURE OF THROMBIN MUTANT W215A/E217A FUSED TO EGF456 OF THROMBOMODULIN VIA A 31-RESIDUE LINKER AND BOUND TO PPACK","10.1038/SREP44596 ",2.34,47.7,"5to3_oligo1","DGlcpNAcb1-4DManpb1-4DManpb1-4DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-ASN","BMA(7_C_)-[NAG(6_C_)-BMA(5_C_)-BMA(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)-ASN(364_B_)",75.9236,"","",""
"5TPS","STRUCTURE OF A FC HETERODIMER","",2.7,0,"5tps_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_B_)",95.754,"","",""
"5TPS","STRUCTURE OF A FC HETERODIMER","",2.7,0,"5tps_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",64.6678,"","",""
"5TS5","CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM BOTHROPS ATROX","10.1016/J.TOXICON.2017.01.017 ",2.3,0,"5ts5_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(172_C_)",59.0468,"","",""
"5TS5","CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM BOTHROPS ATROX","10.1016/J.TOXICON.2017.01.017 ",2.3,0,"5ts5_oligo5","LFucpa1-6DGlcpNAcbDGlcpNAcb1-ROH","FUC(2_E_)-NAG(1_E_)-NAG(507_B_)",54.4876,"","",""
"5TW2","STRUCTURE OF MOUSE CD1D WITH BOUND ALPHA-GALACTOSYLSPHINGAMIDE JG168","10.1038/S41598-017-04461-7 ",1.75,32.78,"5tw2_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",48.2142,"","",""
"5TZN","STRUCTURE OF THE VIRAL IMMUNOEVASIN M12 (SMITH) BOUND TO THE NATURAL KILLER CELL RECEPTOR NKR-P1B (B6)","10.1016/J.CELL.2017.03.002 ",2.6,40.65,"5tzn_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(160_G_)",39.033,"","",""
"5TZN","STRUCTURE OF THE VIRAL IMMUNOEVASIN M12 (SMITH) BOUND TO THE NATURAL KILLER CELL RECEPTOR NKR-P1B (B6)","10.1016/J.CELL.2017.03.002 ",2.6,40.65,"5tzn_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(160_F_)",64.4441,"","",""
"5TZN","STRUCTURE OF THE VIRAL IMMUNOEVASIN M12 (SMITH) BOUND TO THE NATURAL KILLER CELL RECEPTOR NKR-P1B (B6)","10.1016/J.CELL.2017.03.002 ",2.6,40.65,"5tzn_oligo5","DManpb1-6DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(97_G_)",78.7393,"","",""
"5TZU","CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2","10.1038/BCJ.2017.7 ",2.1,36.88,"5tzu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(32_C_)",79.5384,"","",""
"5U4Y","IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A","10.1093/PROTEIN/GZX029 ",2.5,53.9,"5u4y_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",76.7339,"","",""
"5U4Y","IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A","10.1093/PROTEIN/GZX029 ",2.5,53.9,"5u4y_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",107.693,"","",""
"5U52","2 HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)","10.1093/PROTEIN/GZX029 ",1.94,0,"5u52_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",47.7893,"","",""
"5U52","2 HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)","10.1093/PROTEIN/GZX029 ",1.94,0,"5u52_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",48.6973,"","",""
"5U66","MODIFIED SINGLE HELIX FROM THE B-DOMAIN OF PROTEIN A BOUND TO IGG1 FC","10.1093/PROTEIN/GZX029 ",1.7,35.31,"5u66_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",68.1113,"","",""
"5U6X","COX-1:P6 COMPLEX STRUCTURE","10.1016/J.EJMECH.2017.06.045 ",2.93,0,"5u6x_oligo7","DManpa1-6DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(144_B_)",114.266,"","",""
"5U6X","COX-1:P6 COMPLEX STRUCTURE","10.1016/J.EJMECH.2017.06.045 ",2.93,0,"5u6x_oligo3","DManpa1-6DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(144_A_)",113.396,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",141.926,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_O_)-[MAN(9_O_)-MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",119.097,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_G_)",145.044,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",137.016,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",113.776,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_P_)-[MAN(9_P_)-MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",104.842,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",102.454,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",113.962,"","",""
"5U81","ACID CERAMIDASE (ASAH1, ACDASE) FROM NAKED MOLE RAT, CYS143ALA, UNCLEAVED","10.1038/S41467-018-03844-2 ",1.4,0,"5u81_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(173_A_)",26.637,"","",""
"5U81","ACID CERAMIDASE (ASAH1, ACDASE) FROM NAKED MOLE RAT, CYS143ALA, UNCLEAVED","10.1038/S41467-018-03844-2 ",1.4,0,"5u81_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(259_A_)",33.5249,"","",""
"5U84","ACID CERAMIDASE (ASAH1, ACDASE) FROM COMMON MINKE WHALE, CYS143ALA, UNCLEAVED","10.1038/S41467-018-03844-2 ",2.34,0,"5u84_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(173_B_)",45.7279,"","",""
"5U84","ACID CERAMIDASE (ASAH1, ACDASE) FROM COMMON MINKE WHALE, CYS143ALA, UNCLEAVED","10.1038/S41467-018-03844-2 ",2.34,0,"5u84_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(173_A_)",54.2618,"","",""
"5UBX","CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C","10.1080/19420862.2017.1375639 ",2.7,0,"5ubx_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcx1-","NAG(6_C_)-MAN(5_C_)-[NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",134.542,"","",""
"5UBX","CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C","10.1080/19420862.2017.1375639 ",2.7,0,"5ubx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",83.5589,"","",""
"5UDC","CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897","10.1126/SCITRANSLMED.AAJ1928 ",3.45,138.6,"5udc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_I_)-MAN(10_I_)-[MAN(9_I_)-MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_F_)",160.552,"","",""
"5UDY","HUMAN ALKALINE SPHINGOMYELINASE (ALK-SMASE, ENPP7, NPP7)","10.1074/JBC.M116.769273 ",2.6,0,"5udy_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(168_A_)",71.1633,"","",""
"5UEM","CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120","10.1126/SCITRANSLMED.AAL2144 ",2.7,0,"5uem_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(289_G_)",52.1044,"","",""
"5UEM","CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120","10.1126/SCITRANSLMED.AAL2144 ",2.7,0,"5uem_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(262_G_)",66.5344,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(156_G_)",175.968,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-MAN(8_P_)-[MAN(10_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",156.809,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(88_G_)",152.526,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo12","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",174.045,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(412_B_)",151.05,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(412_A_)",152.434,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo6","DManp[6P]b1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","M6D(6_E_)-MAN(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(325_A_)",186.153,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(68_B_)",163.936,"","",""
"5UQY","CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78","10.1016/J.CELL.2015.01.041 ",3.6,0,"5uqy_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(564_F_)",127.816,"","",""
"5UQY","CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78","10.1016/J.CELL.2015.01.041 ",3.6,0,"5uqy_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(564_B_)",121.786,"","",""
"5URY","CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH PAM","10.1073/PNAS.1618293114 ",2.1,0,"5ury_oligo1","LFucpa1-3[LFucpa1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[FUC(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(22_A_)",58.9236,"","",""
"5URZ","CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH BOG","10.1073/PNAS.1618293114 ",2.2,0,"5urz_oligo1","LFucpa1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(22_A_)",65.4524,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_G_)",102.535,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_G_)",111.758,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_A_)-MAN(8_A_)-[MAN(10_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",100.148,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",108.888,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_P_)-[MAN(9_P_)-MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",129.245,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",129.201,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",125.816,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",127.942,"","",""
"5UV8","INTERLEUKIN-3 RECEPTOR COMPLEX","10.1038/S41467-017-02633-7 ",2.7,44.01,"5uv8_oligo3","DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(80_G_)",69.9625,"","",""
"5UV8","INTERLEUKIN-3 RECEPTOR COMPLEX","10.1038/S41467-017-02633-7 ",2.7,44.01,"5uv8_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(80_A_)",78.3934,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",28.9164,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",26.5945,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo18","DGalpa1-6DGalpb1-C39O5","DGD(408_d_)-DGD(408_d_)",128.404,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",29.3482,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",24.2677,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo13","DGalpa1-6DGalpb1-C39O5","DGD(408_D_)-DGD(408_D_)",128.103,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(104_h_)-DGD(104_h_)",34.2995,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo11","DGalpa1-6DGalpb1-C29O5","DGD(517_C_)-DGD(517_C_)",25.0477,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",23.605,"","",""
"5V2C","RE-REFINEMENT OF CRYSTAL STRUCTURE OF PHOTOSYSTEM II COMPLEX","10.1007/S11120-017-0425-4 ",1.9,39.48,"5v2c_oligo16","DGalpa1-6DGalpb1-C30O5","DGD(517_c_)-DGD(517_c_)",31.095,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo1","DGlcpNAcb1-2DManpa1-6DManpx1-","NAG(3_K_)-MAN(2_K_)-BMA(1_K_)",109.735,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_L_)-[NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_E_)",105.421,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_M_)-[NAG(7_M_)-MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(297_G_)",77.144,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo6","DGlcpNAcb1-2DManpa1-2[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_N_)-[NAG(7_N_)-MAN(6_N_)-[NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(297_H_)",89.8702,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_A_)",90.4752,"","",""
"5V4M","STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE","10.1038/NATURE22329 ",2.1,0,"5v4m_oligo3","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(78_G_)",65.7761,"","",""
"5V4M","STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE","10.1038/NATURE22329 ",2.1,0,"5v4m_oligo1","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(78_D_)",59.1676,"","",""
"5V5X","PROTOCADHERIN GAMMAB7 EC3-6 CIS-DIMER STRUCTURE","10.1073/PNAS.1713449114 ",3.5,0,"5v5x_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(513_D_)",135.332,"","",""
"5V5X","PROTOCADHERIN GAMMAB7 EC3-6 CIS-DIMER STRUCTURE","10.1073/PNAS.1713449114 ",3.5,0,"5v5x_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(513_B_)",145.125,"","",""
"5V6F","CRYSTAL STRUCTURE OF THE SECOND BETA-PRISM DOMAIN OF RBMC FROM V. CHOLERAE BOUND TO MANNOTRIOSE","10.1371/JOURNAL.PPAT.1006841 ",1.5,9.28,"5v6f_oligo1","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_B_)-[MAN(2_B_)]-BMA(1_B_)",8.24636,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo4","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(301_G_)",201.806,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(295_G_)",142.688,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo10","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",226.815,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-MAN(8_O_)-[MAN(10_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",137.991,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",222.8,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(160_G_)",156.685,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(156_G_)",220.518,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",214.187,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",154.488,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo14","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_C_)",0.851169,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(363_A_)",1.42727,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo31","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_D_)",0.902987,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_A_)",1.07939,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(363_C_)",1.46073,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo29","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_q_)-[MAN(7_q_)]-MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(160_D_)",1.11989,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_g_)-[MAN(7_g_)]-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(276_C_)",0.937159,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo32","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_t_)-[MAN(7_t_)]-MAN(6_t_)-[MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(276_D_)",0.932045,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_x_)-[MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(363_D_)",1.51036,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo17","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_A_)",1.14325,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo15","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-MAN(4_i_)-[MAN(6_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(363_F_)",1.20924,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-MAN(4_v_)-[MAN(6_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(363_G_)",1.20924,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo10","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_d_)-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_F_)",0.997273,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(386_A_)",1.80341,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo37","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(386_G_)",1.80341,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo32","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_r_)-[MAN(7_r_)]-MAN(6_r_)-[MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(276_G_)",0.9475,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo23","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-[MAN(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_A_)",0.9475,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_e_)-[MAN(7_e_)]-MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",0.9475,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",0.997273,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo24","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_j_)-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(386_F_)",1.80341,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo20","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-[MAN(6_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(363_A_)",1.20924,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo31","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_q_)-MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_G_)",0.997273,"","",""
"5VAA","CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT","10.1038/S41598-017-02823-9 ",1.55,28.45,"5vaa_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",49.3079,"","",""
"5VAA","CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT","10.1038/S41598-017-02823-9 ",1.55,28.45,"5vaa_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",29.6555,"","",""
"5VC1","CRYSTAL STRUCTURE OF L-SELECTIN LECTIN/EGF DOMAINS","10.1002/CBIC.201700220 ",1.94,0,"5vc1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(66_A_)",30.3942,"","",""
"5VCJ","STRUCTURE OF ALPHA-GALACTOSYLPHYTOSPHINGOSINE BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1039/C8OB02982B ",3.16,51.62,"5vcj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",90.9648,"","",""
"5VCS","ALPHA-1,6-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE WITH BOUND ACCEPTOR","10.1073/PNAS.1716988115 ",2.8,51.78,"5vcs_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_D_)-[NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",52.8076,"","",""
"5VCS","ALPHA-1,6-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE WITH BOUND ACCEPTOR","10.1073/PNAS.1716988115 ",2.8,51.78,"5vcs_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_C_)-[NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",48.2335,"","",""
"5VEM","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5)","10.1111/FEBS.14266 ",2.6,0,"5vem_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(101_B_)",67.8132,"","",""
"5VEN","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5)","10.1111/FEBS.14266 ",1.69,0,"5ven_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(101_A_)",43.445,"","",""
"5VEN","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5)","10.1111/FEBS.14266 ",1.69,0,"5ven_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(292_A_)",35.4104,"","",""
"5VEN","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5)","10.1111/FEBS.14266 ",1.69,0,"5ven_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(101_B_)",47.1927,"","",""
"5VEN","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5)","10.1111/FEBS.14266 ",1.69,0,"5ven_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(292_B_)",24.4691,"","",""
"5VEO","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5), INACTIVE (T72A), IN COMPLEX WITH AMP","10.1111/FEBS.14266 ",1.53,0,"5veo_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(101_A_)",29.0682,"","",""
"5VEO","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5), INACTIVE (T72A), IN COMPLEX WITH AMP","10.1111/FEBS.14266 ",1.53,0,"5veo_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(292_A_)",28.1275,"","",""
"5VGJ","CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90, BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN","10.1016/J.IMMUNI.2017.04.011 ",3.46,0,"5vgj_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(156_G_)",136.862,"","",""
"5VGJ","CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90, BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN","10.1016/J.IMMUNI.2017.04.011 ",3.46,0,"5vgj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_G_)",185.757,"","",""
"5VGJ","CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90, BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN","10.1016/J.IMMUNI.2017.04.011 ",3.46,0,"5vgj_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(160_G_)",132.112,"","",""
"5VGP","FC FRAGMENT OF HUMAN IGG1 ANTIBODY, FROM NIST MAB","10.1107/S2053230X18009834 ",2.12,56.63,"5vgp_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(300_B_)",82.6261,"","",""
"5VGP","FC FRAGMENT OF HUMAN IGG1 ANTIBODY, FROM NIST MAB","10.1107/S2053230X18009834 ",2.12,56.63,"5vgp_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(300_A_)",54.129,"","",""
"5VH5","CRYSTAL STRUCTURE OF FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB","10.1080/19420862.2017.1320463 ",1.75,39.71,"5vh5_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",57.0187,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo36","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_z_)-MAN(6_z_)-[MAN(5_z_)-MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(262_F_)",440.938,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(637_B_)",253.846,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo33","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_w_)-[MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(160_F_)",313.418,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(637_C_)",238.739,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(637_A_)",271.1,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(276_E_)",541.221,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo5","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_X_)-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_D_)",921.421,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(156_D_)",863.478,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_7_)-[MAN(4_7_)]-BMA(3_7_)-NAG(2_7_)-NAG(1_7_)-ASN(160_D_)",890.392,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo30","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_t_)-MAN(4_t_)-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(448_E_)",327.064,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-[MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(156_F_)",291.606,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(276_D_)",852.185,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(332_D_)",876.104,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_0_)-[MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)-ASN(276_F_)",365.69,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo20","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_m_)-MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_E_)",351.581,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo29","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_s_)-NAG(1_s_)-ASN(392_E_)",259.707,"","",""
"5VK2","STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS","10.1126/SCIENCE.AAM7260 ",3.2,0,"5vk2_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(395_b_)",151.179,"","",""
"5VK2","STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS","10.1126/SCIENCE.AAM7260 ",3.2,0,"5vk2_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_f_)-[NAG(2_f_)]-NAG(1_f_)-ASN(395_c_)",125.631,"","",""
"5VK2","STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS","10.1126/SCIENCE.AAM7260 ",3.2,0,"5vk2_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(395_a_)",118.97,"","",""
"5VKJ","CRYSTAL STRUCTURE OF HUMAN CD22 IG DOMAINS 1-3","10.1038/S41467-017-00836-6 ",2.12,0,"5vkj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(101_A_)",56.0738,"","",""
"5VKM","CRYSTAL STRUCTURE OF HUMAN CD22 IG DOMAINS 1-3 IN COMPLEX WITH ALPHA 2-6 SIALYLLACTOSE","10.1038/S41467-017-00836-6 ",2.2,0,"5vkm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(101_A_)",71.5856,"","",""
"5VL3","CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB","10.1038/S41467-017-00836-6 ",3.1,0,"5vl3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(101_Q_)",90.7811,"","",""
"5VME","CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E, T437R MUTANT","10.1080/19420862.2017.1358838 ",3.1,0,"5vme_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",118.47,"","",""
"5VME","CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E, T437R MUTANT","10.1080/19420862.2017.1358838 ",3.1,0,"5vme_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",159.271,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo26","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_o_)-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(276_J_)",116.187,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_I_)",43.3444,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(276_G_)",127.417,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",31.6909,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(276_I_)",123.538,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo25","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_n_)-[MAN(6_n_)-MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_J_)",45.3979,"","",""
"5VOD","CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 9I6","10.1126/SCIIMMUNOL.AAN1457 ",5.9,75.52,"5vod_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(81_E_)",51.13,"","",""
"5VOD","CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 9I6","10.1126/SCIIMMUNOL.AAN1457 ",5.9,75.52,"5vod_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(67_A_)",51.8136,"","",""
"5VTQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225L/L226S MUTANT IN COMPLEX WITH 3'-SLN","10.1016/J.CHOM.2017.05.011 ",2.95,60.87,"5vtq_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",84.9636,"","",""
"5VTR","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225L/L226S MUTANT IN COMPLEX WITH 6'-SLN","10.1016/J.CHOM.2017.05.011 ",2.5,58.27,"5vtr_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(165_E_)",89.7753,"","",""
"5VTU","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225L/L226S MUTANT APO FORM","10.1016/J.CHOM.2017.05.011 ",2.45,61.35,"5vtu_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_C_)",82.697,"","",""
"5VTY","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT IN COMPLEX WITH 3'-SLN","10.1016/J.CHOM.2017.05.011 ",2.36,53.07,"5vty_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",74.6342,"","",""
"5VTZ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT APO FORM","10.1016/J.CHOM.2017.05.011 ",2.15,52.34,"5vtz_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",71.6235,"","",""
"5VU0","CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS","10.1021/ACSCHEMBIO.8B00342 ",2.26,47.18,"5vu0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",63.5374,"","",""
"5VU0","CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS","10.1021/ACSCHEMBIO.8B00342 ",2.26,47.18,"5vu0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",45.5687,"","",""
"5VU4","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT IN COMPLEX WITH 6'-SLN","10.1016/J.CHOM.2017.05.011 ",2.25,55.45,"5vu4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",77.5462,"","",""
"5VYB","STRUCTURE OF THE CARBOHYDRATE RECOGNITION DOMAIN OF DECTIN-2 COMPLEXED WITH A MAMMALIAN-TYPE HIGH MANNOSE MAN9GLCNAC2 OLIGOSACCHARIDE","10.1074/JBC.M117.799080 ",2.4,45.71,"5vyb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-ROH","MAN(7_B_)-MAN(6_B_)-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",48.04,"","",""
"5W26","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 4-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",1.9,23.83,"5w26_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",30.8531,"","",""
"5W2U","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 7-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",2,25.92,"5w2u_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",32.6517,"","",""
"5W2W","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 8-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",1.85,24.1,"5w2w_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",32.2164,"","",""
"5W2Y","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 9-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",2.39,22.81,"5w2y_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",33.6626,"","",""
"5W42","CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2)","10.1038/S41467-018-04704-9 ",3.57,0,"5w42_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",211.34,"","",""
"5W42","CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2)","10.1038/S41467-018-04704-9 ",3.57,0,"5w42_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",212.532,"","",""
"5W42","CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2)","10.1038/S41467-018-04704-9 ",3.57,0,"5w42_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(63_A_)",245.463,"","",""
"5W5L","CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5l_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",45.4652,"","",""
"5W5L","CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5l_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",69.578,"","",""
"5W5M","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5m_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",57.9635,"","",""
"5W5M","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5m_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.9092,"","",""
"5W5N","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT","10.3390/ANTIB6030012 ",1.85,0,"5w5n_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",85.4825,"","",""
"5W5N","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT","10.3390/ANTIB6030012 ",1.85,0,"5w5n_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",45.7772,"","",""
"5W6D","CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L","10.1084/JEM.20161160 ",3.2,0,"5w6d_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",130.005,"","",""
"5W6D","CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L","10.1084/JEM.20161160 ",3.2,0,"5w6d_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_G_)",148.701,"","",""
"5W6D","CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L","10.1084/JEM.20161160 ",3.2,0,"5w6d_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_A_)-MAN(8_A_)-[MAN(10_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(332_G_)",119.974,"","",""
"5W7B","RABBIT ACYLOXYACYL HYDROLASE (AOAH), PROTEOLYTICALLY PROCESSED, S262A MUTANT, WITH LPS","10.1073/PNAS.1719834115 ",1.9,0,"5w7b_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(206_C_)",55.8979,"","",""
"5W7B","RABBIT ACYLOXYACYL HYDROLASE (AOAH), PROTEOLYTICALLY PROCESSED, S262A MUTANT, WITH LPS","10.1073/PNAS.1719834115 ",1.9,0,"5w7b_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(206_D_)",65.1815,"","",""
"5W7B","RABBIT ACYLOXYACYL HYDROLASE (AOAH), PROTEOLYTICALLY PROCESSED, S262A MUTANT, WITH LPS","10.1073/PNAS.1719834115 ",1.9,0,"5w7b_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(58_A_)",55.0077,"","",""
"5W7B","RABBIT ACYLOXYACYL HYDROLASE (AOAH), PROTEOLYTICALLY PROCESSED, S262A MUTANT, WITH LPS","10.1073/PNAS.1719834115 ",1.9,0,"5w7b_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(58_B_)",56.7077,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.6161,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.6848,"","",""
"5WB7","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION IN COMPLEX WITH EPIREGULIN","10.1016/J.CELL.2017.09.017 ",2.94,92.86,"5wb7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(328_B_)",124.81,"","",""
"5WBE","COX-1:MOFEZOLAC COMPLEX STRUCTURE","10.1016/J.EJMECH.2017.06.045 ",2.75,0,"5wbe_oligo7","DManpa1-6DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(144_B_)",97.4386,"","",""
"5WBE","COX-1:MOFEZOLAC COMPLEX STRUCTURE","10.1016/J.EJMECH.2017.06.045 ",2.75,0,"5wbe_oligo4","DManpa1-6DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(144_A_)",98.6376,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(301_G_)",465.195,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_G_)",492.563,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(88_Q_)",455.553,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo25","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_r_)-[MAN(5_r_)]-MAN(4_r_)-[MAN(7_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(234_Q_)",527.68,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(88_G_)",424.47,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(88_F_)",515.67,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(301_F_)",522.181,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(234_G_)",541.914,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)]-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_F_)",472.915,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(197_G_)",466.767,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_G_)",426.328,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo26","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_Q_)",497.964,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(156_F_)",563.43,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_m_)-[MAN(7_m_)]-MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(332_F_)",446.552,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(301_Q_)",435.296,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo29","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_v_)-[MAN(7_v_)]-MAN(6_v_)-[MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(332_Q_)",453.839,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo17","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_F_)",447.777,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo24","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_q_)-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(197_Q_)",475.206,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-[MAN(7_d_)]-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(332_G_)",449.737,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo15","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(197_F_)",431.202,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(156_Q_)",509.257,"","",""
"5WI8","CRYSTAL STRUCTURE OF MURINE 4-1BB FROM HEK293T CELLS IN P21 SPACE GROUP","10.1074/JBC.M117.814905 ",2.95,71.58,"5wi8_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(138_D_)",100.245,"","",""
"5WI8","CRYSTAL STRUCTURE OF MURINE 4-1BB FROM HEK293T CELLS IN P21 SPACE GROUP","10.1074/JBC.M117.814905 ",2.95,71.58,"5wi8_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(138_A_)",91.1966,"","",""
"5WI8","CRYSTAL STRUCTURE OF MURINE 4-1BB FROM HEK293T CELLS IN P21 SPACE GROUP","10.1074/JBC.M117.814905 ",2.95,71.58,"5wi8_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(138_B_)",75.3916,"","",""
"5WIW","CRYSTAL STRUCTURE OF MURINE 4-1BB N128A MUTANT FROM HEK293T CELLS IN P43 SPACE GROUP","10.1074/JBC.M117.814905 ",2.3,51.94,"5wiw_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(138_B_)",76.5925,"","",""
"5WKE","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PS","10.1126/SCIIMMUNOL.AAO1384 ",1.69,26.27,"5wke_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-[FUC(6_D_)]-NAG(1_D_)-ASN(57_A_)",21.3251,"","",""
"5WKG","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PA","10.1126/SCIIMMUNOL.AAO1384 ",2.06,22.23,"5wkg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",19.8019,"","",""
"5WKI","CRYSTAL STRUCTURE OF PG90 TCR-CD1B-PG COMPLEX","10.1126/SCIIMMUNOL.AAO1384 ",2.75,53.27,"5wki_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(57_A_)",73.8634,"","",""
"5WL1","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG","10.1126/SCIIMMUNOL.AAO1384 ",1.38,22.36,"5wl1_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(20_A_)",47.8432,"","",""
"5WL1","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG","10.1126/SCIIMMUNOL.AAO1384 ",1.38,22.36,"5wl1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(128_A_)",42.8102,"","",""
"5WL1","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG","10.1126/SCIIMMUNOL.AAO1384 ",1.38,22.36,"5wl1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUC(6_E_)]-NAG(1_E_)-ASN(57_A_)",15.8592,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",65.7941,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",62.5927,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",68.7041,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",59.6432,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",73.0823,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",71.3209,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",69.1705,"","",""
"5WS5","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH DARK DATASET)","10.1038/NATURE21400 ",2.35,0,"5ws5_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",66.3336,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",60.4009,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",61.4391,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",53.1918,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",63.1645,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",68.8791,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",51.4182,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",57.7891,"","",""
"5WS6","NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (PREFLASH TWO-FLASH DATASET","10.1038/NATURE21400 ",2.35,0,"5ws6_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",56.3745,"","",""
"5WT9","COMPLEX STRUCTURE OF PD-1 AND NIVOLUMAB-FAB","10.1038/NCOMMS14369 ",2.4,0,"5wt9_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(58_G_)",84.8976,"","",""
"5WYX","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT8M","10.1038/NCHEMBIO.2518 ",2.4,59.58,"5wyx_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",61.9834,"","",""
"5WYX","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT8M","10.1038/NCHEMBIO.2518 ",2.4,59.58,"5wyx_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",62.6507,"","",""
"5WYX","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT8M","10.1038/NCHEMBIO.2518 ",2.4,59.58,"5wyx_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",60.5923,"","",""
"5WYZ","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9B","10.1038/NCHEMBIO.2518 ",2.3,60.22,"5wyz_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",58.905,"","",""
"5WYZ","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9B","10.1038/NCHEMBIO.2518 ",2.3,60.22,"5wyz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",63.3705,"","",""
"5WYZ","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9B","10.1038/NCHEMBIO.2518 ",2.3,60.22,"5wyz_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",65.1025,"","",""
"5WZY","CRYSTAL STRUCTURE OF THE P2X4 RECEPTOR FROM ZEBRAFISH IN THE PRESENCE OF CTP AT 2.8 ANGSTROMS","10.1038/SREP45208 ",2.8,78.59,"5wzy_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(213_A_)",98.0133,"","",""
"5X0M","STRUCTURE OF A EUKARYOTIC VOLTAGE-GATED SODIUM CHANNEL AT NEAR ATOMIC RESOLUTION","10.1126/SCIENCE.AAL4326 ",3.8,0,"5x0m_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",166.845,"","",""
"5X3K","KFLA1895 D451A MUTANT IN COMPLEX WITH ISOMALTOSE","",2.5,0,"5x3k_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_D_)-GLC(1_D_)",27.0045,"","",""
"5X3K","KFLA1895 D451A MUTANT IN COMPLEX WITH ISOMALTOSE","",2.5,0,"5x3k_oligo1","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",23.8445,"","",""
"5X7H","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH CYCLOISOMALTOHEPTAOSE","10.1042/BSR20170253 ",2.6,44.4,"5x7h_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(7_B_)-GLC(6_B_)-GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",55.5706,"","",""
"5X7H","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K CYCLOISOMALTOOLIGOSACCHARIDE GLUCANOTRANSFERASE COMPLEXED WITH CYCLOISOMALTOHEPTAOSE","10.1042/BSR20170253 ",2.6,44.4,"5x7h_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",80.7339,"","",""
"5X7Q","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-1,6- GLUCOSYLTRANSFERASE COMPLEXED WITH MALTOHEXAOSE","10.1042/BCJ20170152 ",1.95,33.38,"5x7q_oligo3","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpb1-ROH","GLC(4_F_)-GLC(3_F_)-GLC(2_F_)-BGC(1_F_)",41.525,"","",""
"5X7Q","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-1,6- GLUCOSYLTRANSFERASE COMPLEXED WITH MALTOHEXAOSE","10.1042/BCJ20170152 ",1.95,33.38,"5x7q_oligo18","DGlcpa1-6DGlcpa1-ROH","GLC(2_H_)-GLC(1_H_)",43.7218,"","",""
"5X7Q","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-1,6- GLUCOSYLTRANSFERASE COMPLEXED WITH MALTOHEXAOSE","10.1042/BCJ20170152 ",1.95,33.38,"5x7q_oligo2","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpb1-ROH","GLC(4_J_)-GLC(3_J_)-GLC(2_J_)-BGC(1_J_)",44.2502,"","",""
"5X7Q","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-1,6- GLUCOSYLTRANSFERASE COMPLEXED WITH MALTOHEXAOSE","10.1042/BCJ20170152 ",1.95,33.38,"5x7q_oligo15","DGlcpa1-6DGlcpa1-ROH","GLC(2_D_)-GLC(1_D_)",52.2041,"","",""
"5X7R","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-1,6- GLUCOSYLTRANSFERASE COMPLEXED WITH ISOMALTOHEXAOSE","10.1042/BCJ20170152 ",1.95,33,"5x7r_oligo20","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",51.7776,"","",""
"5X7R","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-1,6- GLUCOSYLTRANSFERASE COMPLEXED WITH ISOMALTOHEXAOSE","10.1042/BCJ20170152 ",1.95,33,"5x7r_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpb1-ROH","GLC(5_C_)-GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-BGC(1_C_)",41.072,"","",""
"5X7R","CRYSTAL STRUCTURE OF PAENIBACILLUS SP. 598K ALPHA-1,6- GLUCOSYLTRANSFERASE COMPLEXED WITH ISOMALTOHEXAOSE","10.1042/BCJ20170152 ",1.95,33,"5x7r_oligo22","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_F_)-GLC(2_F_)-GLC(1_F_)",50.85,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(325_F_)",122.29,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(412_C_)",103.797,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(325_C_)",114.532,"","",""
"5XFH","CRYSTAL STRUCTURE OF ORYSATA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.9,0,"5xfh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-ROH","NAG(6_C_)-MAN(5_C_)-[GAL(4_C_)-NAG(3_C_)-MAN(2_C_)]-BMA(1_C_)",33.5074,"","",""
"5XFI","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.65,0,"5xfi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",26.4665,"","",""
"5XFI","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.65,0,"5xfi_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",26.2062,"","",""
"5XJE","CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.4,55.11,"5xje_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",66.3192,"","",""
"5XJE","CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.4,55.11,"5xje_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",63.0309,"","",""
"5XJE","CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.4,55.11,"5xje_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(162_C_)",112.688,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",76.3318,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",76.8007,"","",""
"5XJY","CRYO-EM STRUCTURE OF HUMAN ABCA1","10.1016/J.CELL.2017.05.020 ",4.1,0,"5xjy_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1504_A_)",60.3313,"","",""
"5XMH","CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC","10.1074/JBC.M117.814475 ",2.8,52,"5xmh_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",86.2577,"","",""
"5XMH","CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC","10.1074/JBC.M117.814475 ",2.8,52,"5xmh_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",65.8827,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",43.6895,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo13","DGalpa1-6DGalpb1-C28O5","DGD(518_c_)-DGD(518_c_)",22.8564,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",33.2286,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",33.2286,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo22","DGalpa1-6DGalpb1-C28O5","DGD(518_C_)-DGD(518_C_)",22.8564,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo17","DGalpa1-6DGalpb1-C33O5","DGD(520_C_)-DGD(520_C_)",26.5823,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo23","DGalpa1-6DGalpb1-C32O5","DGD(626_B_)-DGD(626_B_)",22.8564,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo26","DGalpa1-6DGalpb1-C33O5","DGD(520_c_)-DGD(520_c_)",26.5823,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",43.6895,"","",""
"5XNL","STRUCTURE OF STACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",2.7,"1.08527e-19","5xnl_oligo29","DGalpa1-6DGalpb1-C32O5","DGD(626_b_)-DGD(626_b_)",22.8564,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo23","DGalpa1-6DGalpb1-C33O5","DGD(520_C_)-DGD(520_C_)",6.97,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo10","DGalpa1-6DGalpb1-C32O5","DGD(626_b_)-DGD(626_b_)",25.4264,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo24","DGalpa1-6DGalpb1-C28O5","DGD(518_c_)-DGD(518_c_)",25.4264,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",46.2595,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",35.7986,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",35.7986,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",46.2595,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo11","DGalpa1-6DGalpb1-C33O5","DGD(520_c_)-DGD(520_c_)",6.97,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo20","DGalpa1-6DGalpb1-C28O5","DGD(518_C_)-DGD(518_C_)",25.4264,"","",""
"5XNM","STRUCTURE OF UNSTACKED C2S2M2-TYPE PSII-LHCII SUPERCOMPLEX FROM PISUM SATIVUM","10.1126/SCIENCE.AAN0327 ",3.2,"1.08527e-19","5xnm_oligo26","DGalpa1-6DGalpb1-C32O5","DGD(626_B_)-DGD(626_B_)",25.4264,"","",""
"5XRF","CRYSTAL STRUCTURE OF DA-36, A THROMBIN-LIKE ENZYME FROM DEINAGKISTRODON ACUTUS","",2.2,0,"5xrf_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(81_A_)",66.2698,"","",""
"5XRF","CRYSTAL STRUCTURE OF DA-36, A THROMBIN-LIKE ENZYME FROM DEINAGKISTRODON ACUTUS","",2.2,0,"5xrf_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(124_A_)",78.0384,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(38_A_)",133.429,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(285_C_)",159.499,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(285_A_)",159.851,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo3","LFucpb1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[FUL(2_I_)]-NAG(1_I_)-ASN(22_A_)",152.366,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(246_E_)",134.334,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo10","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-MAN(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(165_C_)",143.608,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_A_)",145.469,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(38_E_)",175.498,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo19","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_a_)-[MAN(4_a_)-BMA(3_a_)-NAG(2_a_)]-NAG(1_a_)-ASN(38_G_)",190.692,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo22","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(285_G_)",184.601,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-MAN(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",156.687,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(63_G_)",201.197,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-MAN(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(165_E_)",150.77,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo12","LFucpb1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[FUL(2_T_)]-NAG(1_T_)-ASN(22_E_)",172.796,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo21","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-MAN(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(165_G_)",168.133,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_A_)",156.94,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(285_A_)",171.63,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo17","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(126_E_)",183.314,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(285_E_)",175.717,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(5_I_)-[BMA(3_I_)-NAG(2_I_)]-[FUL(4_I_)]-NAG(1_I_)-ASN(22_A_)",178.339,"","",""
"5XSY","STRUCTURE OF THE NAV1.4-BETA1 COMPLEX FROM ELECTRIC EEL","10.1016/J.CELL.2017.06.039 ",4,0,"5xsy_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(317_A_)",185.607,"","",""
"5XWD","CRYSTAL STRUCTURE OF THE COMPLEX OF 059-152-FV AND EGFR-ECD","10.1371/JOURNAL.PONE.0193158 ",2.89,0,"5xwd_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(328_A_)",121.818,"","",""
"5Y2Z","CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP-ADAM22 COMPLEX","10.1038/S41467-018-03947-W ",2.67,0,"5y2z_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(422_F_)",69.4609,"","",""
"5Y2Z","CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP-ADAM22 COMPLEX","10.1038/S41467-018-03947-W ",2.67,0,"5y2z_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(422_H_)",76.3639,"","",""
"5Y2Z","CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP-ADAM22 COMPLEX","10.1038/S41467-018-03947-W ",2.67,0,"5y2z_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)-ASN(422_L_)",59.8191,"","",""
"5Y2Z","CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP-ADAM22 COMPLEX","10.1038/S41467-018-03947-W ",2.67,0,"5y2z_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(422_J_)",75.1945,"","",""
"5Y2Z","CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP-ADAM22 COMPLEX","10.1038/S41467-018-03947-W ",2.67,0,"5y2z_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(422_D_)",77.3591,"","",""
"5Y2Z","CRYSTAL STRUCTURE OF HUMAN LGI1 EPTP-ADAM22 COMPLEX","10.1038/S41467-018-03947-W ",2.67,0,"5y2z_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(422_B_)",84.6459,"","",""
"5Y32","CRYSTAL STRUCTURE OF PTP DELTA IG1-IG2 IN COMPLEX WITH IL1RAPL1","10.1038/NCOMMS7926 ",2.7,0,"5y32_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(264_B_)",93.2127,"","",""
"5Y32","CRYSTAL STRUCTURE OF PTP DELTA IG1-IG2 IN COMPLEX WITH IL1RAPL1","10.1038/NCOMMS7926 ",2.7,0,"5y32_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(122_B_)",81.9661,"","",""
"5Y56","FC MUTANT (K392D/K409D/D399K)","10.1074/JBC.M116.771188 ",2.65,0,"5y56_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",160.569,"","",""
"5Y56","FC MUTANT (K392D/K409D/D399K)","10.1074/JBC.M116.771188 ",2.65,0,"5y56_oligo2","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NDG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",121.516,"","",""
"5YC5","CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA","10.1038/S41598-018-22199-8 ",2.71,54.1,"5yc5_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",59.185,"","",""
"5YC5","CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA","10.1038/S41598-018-22199-8 ",2.71,54.1,"5yc5_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",61.4107,"","",""
"5YDH","CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE CATALYTIC SUBUNITS OF THE MALARIA VECTOR ANOPHELES GAMBIAE, 3.2 A","",3.21,84.29,"5ydh_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(220_B_)",160.423,"","",""
"5YDI","CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE CATALYTIC SUBUNITS OF THE MALARIA VECTOR ANOPHELES GAMBIAE, NEW CRYSTAL PACKING","",3.45,62.64,"5ydi_oligo2","DManpa1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(670_B_)",168.725,"","",""
"5YOW","THE POST-FUSION STRUCTURE OF THE HEARTLAND VIRUS GC GLYCOPROTEIN","10.1128/JVI.01558-17 ",2.1,0,"5yow_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(374_A_)",91.9675,"","",""
"5YQS","ISOPRIMEVEROSE-PRODUCING ENZYME FROM ASPERGILLUS ORYZAE IN COMPLEX WITH ISOPRIMEVEROSE","10.1016/J.JSB.2018.11.005 ",2.4,25.9,"5yqs_oligo3","DXylpa1-6DGlcpb1-ROH","XYS(2_L_)-BGC(1_L_)",24.6858,"","",""
"5YQS","ISOPRIMEVEROSE-PRODUCING ENZYME FROM ASPERGILLUS ORYZAE IN COMPLEX WITH ISOPRIMEVEROSE","10.1016/J.JSB.2018.11.005 ",2.4,25.9,"5yqs_oligo1","DXylpa1-6DGlcpb1-ROH","XYS(2_F_)-BGC(1_F_)",21.76,"","",""
"5YQS","ISOPRIMEVEROSE-PRODUCING ENZYME FROM ASPERGILLUS ORYZAE IN COMPLEX WITH ISOPRIMEVEROSE","10.1016/J.JSB.2018.11.005 ",2.4,25.9,"5yqs_oligo9","DXylpa1-6DGlcpa1-ROH","XYS(2_G_)-GLC(1_G_)",40.1093,"","",""
"5YQS","ISOPRIMEVEROSE-PRODUCING ENZYME FROM ASPERGILLUS ORYZAE IN COMPLEX WITH ISOPRIMEVEROSE","10.1016/J.JSB.2018.11.005 ",2.4,25.9,"5yqs_oligo2","DXylpa1-6DGlcpb1-ROH","XYS(2_H_)-BGC(1_H_)",87.3017,"","",""
"5YQS","ISOPRIMEVEROSE-PRODUCING ENZYME FROM ASPERGILLUS ORYZAE IN COMPLEX WITH ISOPRIMEVEROSE","10.1016/J.JSB.2018.11.005 ",2.4,25.9,"5yqs_oligo4","DXylpa1-6DGlcpb1-ROH","XYS(2_N_)-BGC(1_N_)",82.5211,"","",""
"5YQS","ISOPRIMEVEROSE-PRODUCING ENZYME FROM ASPERGILLUS ORYZAE IN COMPLEX WITH ISOPRIMEVEROSE","10.1016/J.JSB.2018.11.005 ",2.4,25.9,"5yqs_oligo13","DXylpa1-6DGlcpa1-ROH","XYS(2_M_)-GLC(1_M_)",46.6695,"","",""
"5YRG","PPL3A-ISOMALTOSE COMPLEX","10.1002/PROT.25491 ",1.5,0,"5yrg_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_C_)-BGC(1_C_)",23.3286,"","",""
"5YRG","PPL3A-ISOMALTOSE COMPLEX","10.1002/PROT.25491 ",1.5,0,"5yrg_oligo2","DGlcpa1-6DGlcpb1-ROH","GLC(2_D_)-BGC(1_D_)",19.5936,"","",""
"5YRJ","PPL3B-ISOMALTOSE COMPLEX","10.1002/PROT.25491 ",1.8,0,"5yrj_oligo2","DGlcpa1-6DGlcpb1-ROH","GLC(2_D_)-BGC(1_D_)",49.5355,"","",""
"5YRJ","PPL3B-ISOMALTOSE COMPLEX","10.1002/PROT.25491 ",1.8,0,"5yrj_oligo3","DGlcpa1-6DGlcpb1-ROH","GLC(2_C_)-BGC(1_C_)",39.5991,"","",""
"5YRM","PPL3C-ISOMALTOSE COMPLEX","10.1002/PROT.25491 ",1.5,0,"5yrm_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_C_)-BGC(1_C_)",32.9227,"","",""
"5Z14","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9A","",2.8,70.79,"5z14_oligo4","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",77.935,"","",""
"5Z14","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9A","",2.8,70.79,"5z14_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",65.2166,"","",""
"5Z14","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9A","",2.8,70.79,"5z14_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",71.5778,"","",""
"5Z15","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9C","",2.9,82.22,"5z15_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",82.7027,"","",""
"5Z15","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9C","",2.9,82.22,"5z15_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",76.1855,"","",""
"5Z15","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9C","",2.9,82.22,"5z15_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",77.265,"","",""
"5Z8Y","CRYSTAL STRUCTURE OF HUMAN LRRTM2 IN COMPLEX WITH NEUREXIN 1BETA","10.1038/S41467-018-06333-8 ",3.4,0,"5z8y_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(188_D_)",80.3976,"","",""
"5Z8Y","CRYSTAL STRUCTURE OF HUMAN LRRTM2 IN COMPLEX WITH NEUREXIN 1BETA","10.1038/S41467-018-06333-8 ",3.4,0,"5z8y_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(188_F_)",82.8573,"","",""
"5Z8Y","CRYSTAL STRUCTURE OF HUMAN LRRTM2 IN COMPLEX WITH NEUREXIN 1BETA","10.1038/S41467-018-06333-8 ",3.4,0,"5z8y_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(188_H_)",85.7924,"","",""
"5Z8Y","CRYSTAL STRUCTURE OF HUMAN LRRTM2 IN COMPLEX WITH NEUREXIN 1BETA","10.1038/S41467-018-06333-8 ",3.4,0,"5z8y_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(188_B_)",78.6488,"","",""
"5ZGB","CRYO-EM STRUCTURE OF THE RED ALGAL PSI-LHCR","10.1073/PNAS.1722482115 ",3.63,0.00282629,"5zgb_oligo1","DGalpa1-6DGalpb1-C39O5","DGD(851_B_)-DGD(851_B_)",88.26,"","",""
"5ZGH","CRYO-EM STRUCTURE OF THE RED ALGAL PSI-LHCR","10.1073/PNAS.1722482115 ",3.82,0.00282629,"5zgh_oligo1","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",104.34,"","",""
"5ZIC","CRYSTAL STRUCTURE OF HUMAN GNT-V LUMINAL DOMAIN IN COMPLEX WITH ACCEPTOR SUGAR","10.1038/S41467-018-05931-W ",2.1,0,"5zic_oligo1","DGlcpNAcb1-2DLyxpa1-6DManpb1-ROH","NAG(3_C_)-Z4Y(2_C_)-BMA(1_C_)",37.2104,"","",""
"5ZIC","CRYSTAL STRUCTURE OF HUMAN GNT-V LUMINAL DOMAIN IN COMPLEX WITH ACCEPTOR SUGAR","10.1038/S41467-018-05931-W ",2.1,0,"5zic_oligo2","DGlcpNAcb1-2DLyxpa1-6DManpb1-ROH","NAG(3_D_)-Z4Y(2_D_)-BMA(1_D_)",46.3573,"","",""
"5ZJI","STRUCTURE OF PHOTOSYSTEM I SUPERCOMPLEX WITH LIGHT-HARVESTING COMPLEXES I AND II","10.1126/SCIENCE.AAT1156 ",3.3,"1.08527e-19","5zji_oligo1","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",35.73,"","",""
"5ZJI","STRUCTURE OF PHOTOSYSTEM I SUPERCOMPLEX WITH LIGHT-HARVESTING COMPLEXES I AND II","10.1126/SCIENCE.AAT1156 ",3.3,"1.08527e-19","5zji_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(103_J_)-DGD(103_J_)",40.79,"","",""
"5ZO1","CRYSTAL STRUCTURE OF MOUSE NECTIN-LIKE MOLECULE 4 (MNECL-4) FULL ECTODOMAIN (IG1-IG3), 2.2A","10.1073/PNAS.1810969116 ",2.2,48.64,"5zo1_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(67_A_)",165.534,"","",""
"5ZO2","CRYSTAL STRUCTURE OF MOUSE NECTIN-LIKE MOLECULE 4 (MNECL-4) FULL ECTODOMAIN IN COMPLEX WITH MOUSE NECTIN-LIKE MOLECULE 1 (MNECL-1) IG1 DOMAIN, 3.3A","10.1073/PNAS.1810969116 ",3.29,65.7,"5zo2_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(67_C_)",96.1276,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",32.4786,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",37.7673,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(101_h_)-DGD(101_h_)",53.0818,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",37.7123,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",39.1745,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo25","DGalpa1-6DGalpb1-C29O5","DGD(518_c_)-DGD(518_c_)",41.47,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(101_H_)-DGD(101_H_)",47.7059,"","",""
"5ZZN","CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM AN SQDG-DEFICIENT MUTANT OF THERMOSYNECHOCOCCUS ELONGATUS","10.1074/JBC.RA118.004304 ",2.1,47.34,"5zzn_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",34.3205,"","",""
"6A0K","CYCLIC ALPHA-MALTOSYL-(1-->6)-MALTOSE HYDROLASE FROM ARTHROBACTER GLOBIFORMIS, COMPLEX WITH PANOSE","10.1074/JBC.RA118.004472 ",1.94,22.51,"6a0k_oligo3","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",26.1864,"","",""
"6A0K","CYCLIC ALPHA-MALTOSYL-(1-->6)-MALTOSE HYDROLASE FROM ARTHROBACTER GLOBIFORMIS, COMPLEX WITH PANOSE","10.1074/JBC.RA118.004472 ",1.94,22.51,"6a0k_oligo1","DGlcpa1-6DGlcpa1-4DGlcpb1-ROH","GLC(3_D_)-GLC(2_D_)-BGC(1_D_)",33.2015,"","",""
"6A0K","CYCLIC ALPHA-MALTOSYL-(1-->6)-MALTOSE HYDROLASE FROM ARTHROBACTER GLOBIFORMIS, COMPLEX WITH PANOSE","10.1074/JBC.RA118.004472 ",1.94,22.51,"6a0k_oligo4","DGlcpa1-6DGlcpa1-4DGlcpa1-","GLC(3_E_)-GLC(2_E_)-GLC(1_E_)",23.5767,"","",""
"6A0K","CYCLIC ALPHA-MALTOSYL-(1-->6)-MALTOSE HYDROLASE FROM ARTHROBACTER GLOBIFORMIS, COMPLEX WITH PANOSE","10.1074/JBC.RA118.004472 ",1.94,22.51,"6a0k_oligo2","DGlcpa1-6DGlcpa1-4DGlcpb1-ROH","GLC(3_F_)-GLC(2_F_)-BGC(1_F_)",30.2236,"","",""
"6A5D","CRYSTAL STRUCTURE OF PLANT GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEIN LLG1","10.1038/S41586-019-1409-7 ",1.4,15.85,"6a5d_oligo1","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(57_A_)",15.8164,"","",""
"6A5D","CRYSTAL STRUCTURE OF PLANT GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEIN LLG1","10.1038/S41586-019-1409-7 ",1.4,15.85,"6a5d_oligo2","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(57_B_)",15.8164,"","",""
"6A87","PHOLIOTA SQUARROSA LECTIN (PHOSL) IN COMPLEX WITH FUCOSE(ALPHA1-6) GLCNAC","10.1093/GLYCOB/CWZ025 ",2.41,48.38,"6a87_oligo3","LFucpa1-6DGlcpNAcb1-OME","FUC(2_H_)-NAG(1_H_)-MEE(101_E_)",49.8041,"","",""
"6A87","PHOLIOTA SQUARROSA LECTIN (PHOSL) IN COMPLEX WITH FUCOSE(ALPHA1-6) GLCNAC","10.1093/GLYCOB/CWZ025 ",2.41,48.38,"6a87_oligo1","LFucpa1-6DGlcpNAcb1-OME","FUC(2_G_)-NAG(1_G_)-MEE(103_F_)",53.6891,"","",""
"6A87","PHOLIOTA SQUARROSA LECTIN (PHOSL) IN COMPLEX WITH FUCOSE(ALPHA1-6) GLCNAC","10.1093/GLYCOB/CWZ025 ",2.41,48.38,"6a87_oligo2","LFucpa1-6DGlcpNAcb1-OME","FUC(2_I_)-NAG(1_I_)-MEE(104_E_)",78.2977,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(114_A_)",250.437,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",230.159,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_E_)",187.564,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(149_D_)",193.836,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(149_C_)",197.57,"","",""
"6ANA","LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN","10.1016/J.JMB.2017.12.010 ",1.7,0,"6ana_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(18_L_)",64.9312,"","",""
"6AOQ","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ APO FORM","10.1371/JOURNAL.PPAT.1006682 ",2.35,66.44,"6aoq_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",98.1736,"","",""
"6AOR","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ APO FORM","10.1371/JOURNAL.PPAT.1006682 ",1.7,37.18,"6aor_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",51.8565,"","",""
"6AOS","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ L194P MUTANT IN COMPLEX WITH 3'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",2.3,56.47,"6aos_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",96.0571,"","",""
"6AOT","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ L194P MUTANT IN COMPLEX WITH 6'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",1.95,42.62,"6aot_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",75.5545,"","",""
"6AOU","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 3'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",1.75,38.38,"6aou_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",54.0207,"","",""
"6AOV","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 6'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",1.75,40.44,"6aov_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",60.4962,"","",""
"6ARQ","CRYSTAL STRUCTURE OF CD96 (D1) BOUND TO CD155/NECL-5 (D1-3)","10.1016/J.STR.2018.10.023 ",2.88,47.07,"6arq_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(120_D_)",65.6259,"","",""
"6ARQ","CRYSTAL STRUCTURE OF CD96 (D1) BOUND TO CD155/NECL-5 (D1-3)","10.1016/J.STR.2018.10.023 ",2.88,47.07,"6arq_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(188_D_)",98.2491,"","",""
"6ARQ","CRYSTAL STRUCTURE OF CD96 (D1) BOUND TO CD155/NECL-5 (D1-3)","10.1016/J.STR.2018.10.023 ",2.88,47.07,"6arq_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(237_D_)",99.395,"","",""
"6ARU","STRUCTURE OF CETUXIMAB FAB MUTANT IN COMPLEX WITH EGFR EXTRACELLULAR DOMAIN","",3.2,0,"6aru_oligo1","DManpa1-3DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-[MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(328_A_)",63.5727,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(448_G_)",144.044,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_A_)-MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(156_G_)",122.551,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_G_)",120.07,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_G_)",121.475,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(276_G_)",158.373,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(363_G_)",83.9627,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(301_G_)",144.421,"","",""
"6B3D","CRYSTAL STRUCTURE OF ANTI-HIV ANTIBODY PGT128 IN COMPLEX WITH A BACTERIALLY DERIVED SYNTHETIC MIMETIC OF MAN9.","10.1038/S41467-017-01640-Y ",2.27,0,"6b3d_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpa1-ROH","MAN(7_A_)-MAN(6_A_)-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)]-MAN(1_A_)",50.3658,"","",""
"6B3M","THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ","10.1128/JVI.00949-18 ",3.92,60.36,"6b3m_oligo14","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(5_l_)-[MAN(4_l_)]-MAN(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(286_Q_)",72.0587,"","",""
"6B9O","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE","10.1002/ANIE.201801202 ",1.84,0,"6b9o_oligo3","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_E_)-MAN(11_E_)-[MAN(10_E_)-MAN(9_E_)]-MAN(8_E_)-[MAN(7_E_)-MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(446_B_)",31.4421,"","",""
"6B9O","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE","10.1002/ANIE.201801202 ",1.84,0,"6b9o_oligo1","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_C_)-MAN(11_C_)-[MAN(10_C_)-MAN(9_C_)]-MAN(8_C_)-[MAN(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(446_A_)",28.9786,"","",""
"6B9P","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE IN COMPLEX WITH A 36- VALENT IMINOSUGAR CLUSTER INHIBITOR","10.1002/ANIE.201801202 ",2,0,"6b9p_oligo5","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_C_)-MAN(11_C_)-[MAN(10_C_)-MAN(9_C_)]-MAN(8_C_)-[MAN(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(446_A_)",32.879,"","",""
"6B9P","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE IN COMPLEX WITH A 36- VALENT IMINOSUGAR CLUSTER INHIBITOR","10.1002/ANIE.201801202 ",2,0,"6b9p_oligo7","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_E_)-MAN(11_E_)-[MAN(10_E_)-MAN(9_E_)]-MAN(8_E_)-[MAN(7_E_)-MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(446_B_)",33.5281,"","",""
"6BBD","STRUCTURE OF N-GLYCOSYLATED PORCINE SURFACTANT PROTEIN-D COMPLEXED WITH GLYCEROL","10.1074/JBC.RA117.001430 ",1.9,47.29,"6bbd_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(303_A_)",64.9433,"","",""
"6BBE","STRUCTURE OF N-GLYCOSYLATED PORCINE SURFACTANT PROTEIN-D","10.1074/JBC.RA117.001430 ",1.9,47.45,"6bbe_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(303_A_)",63.2997,"","",""
"6BDZ","ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB","10.1016/J.CELL.2017.11.014 ",3.1,0,"6bdz_oligo1","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(79_H_)",75.0157,"","",""
"6BE6","ADAM10 EXTRACELLULAR DOMAIN","10.1016/J.CELL.2017.11.014 ",2.8,0,"6be6_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-[MAN(7_H_)]-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(278_D_)",69.1525,"","",""
"6BE6","ADAM10 EXTRACELLULAR DOMAIN","10.1016/J.CELL.2017.11.014 ",2.8,0,"6be6_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(278_B_)",63.866,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(295_A_)",98.7605,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-MAN(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(448_G_)",68.9015,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)]-MAN(4_D_)-[MAN(10_D_)-MAN(9_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_A_)",77.4074,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo4","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(289_G_)",120.837,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",61.5408,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(448_A_)",88.3234,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(472_A_)",110.471,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(74_C_)",78.9352,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(74_B_)",78.9352,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(241_A_)",109.422,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(472_C_)",110.471,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo29","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(241_C_)",109.422,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(74_A_)",78.9352,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(472_B_)",110.471,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(914_A_)",63.1094,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(914_B_)",63.1094,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo38","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(914_C_)",63.1094,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(241_B_)",109.422,"","",""
"6BGA","2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE","10.1073/PNAS.1802746115 ",2.31,0,"6bga_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(23_C_)",78.8918,"","",""
"6BGA","2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE","10.1073/PNAS.1802746115 ",2.31,0,"6bga_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(19_B_)",74.6923,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",59.9193,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",99.2546,"","",""
"6BKM","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ E190D MUTANT APO FORM","10.1038/S41467-018-03663-5 ",2.2,49.69,"6bkm_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",57.3614,"","",""
"6BKN","CRYSTAL STRUCTURE OF THE A/WYOMING/3/2003 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ APO FORM","10.1038/S41467-018-03663-5 ",1.85,40.17,"6bkn_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",57.0916,"","",""
"6BKQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ E190D MUTANT IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",2.25,49.48,"6bkq_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",82.9898,"","",""
"6BKQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ E190D MUTANT IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",2.25,49.48,"6bkq_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_C_)",72,"","",""
"6BKR","CRYSTAL STRUCTURE OF THE A/WYOMING/3/2003 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",1.76,33.6,"6bkr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",49.0015,"","",""
"6BKS","CRYSTAL STRUCTURE OF THE A/WYOMING/3/2003 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ D190E MUTANT IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",1.8,33.17,"6bks_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",56.9004,"","",""
"6BP2","THERAPEUTIC HUMAN MONOCLONAL ANTIBODY MR191 BOUND TO A MARBURGVIRUS GLYCOPROTEIN","10.1016/J.CHOM.2017.12.003 ",3.17,0,"6bp2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(3_E_)-[MAN(2_E_)]-BMA(1_E_)-NAG(2_F_)-NAG(1_F_)",120.37,"","",""
"6BPL","E. COLI MSBA IN COMPLEX WITH LPS AND INHIBITOR G907","10.1038/S41586-018-0083-5 ",2.91,0,"6bpl_oligo2","DGlcpa1-3[DGlcpa1-6]DGlcpa1-3[GMH1-7]GMH1-","GMH(5_C_)-[GLC(4_C_)-[GLC(3_C_)]-GLC(2_C_)]-GMH(1_C_)",160.065,"","",""
"6BPP","E. COLI MSBA IN COMPLEX WITH LPS AND INHIBITOR G092","10.1038/S41586-018-0083-5 ",2.92,0,"6bpp_oligo1","DGlcpa1-3[DGlcpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(9_C_)-[GLC(8_C_)-[GLC(7_C_)]-GLC(6_C_)]-GMH(5_C_)-GMH(4_C_)-[KDO(10_C_)]-KDO(3_C_)-GCS(2_C_)-PA1(1_C_)",142.913,"","",""
"6BR5","N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND","10.1002/CMDC.201800092 ",2.04,41.91,"6br5_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",60.8159,"","",""
"6BS6","SUSG WITH MIXED LINKAGE AMYLOSACCHARIDE","10.1002/PRO.3410 ",2.17,44.13,"6bs6_oligo3","DGlcpa1-4[DGlcpa1-6]DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(6_E_)-[GLC(5_E_)]-GLC(4_E_)-GLC(3_E_)-GLC(2_E_)-GLC(1_E_)",56.2694,"","",""
"6BS6","SUSG WITH MIXED LINKAGE AMYLOSACCHARIDE","10.1002/PRO.3410 ",2.17,44.13,"6bs6_oligo5","DGlcpa1-4DGlcpa1-6DGlcpa1-4DGlcpa1-4[DGlcpa1-6]DGlcpa1-4DGlcpa1-ROH","GLC(7_G_)-[GLC(6_G_)-GLC(5_G_)-GLC(4_G_)-GLC(3_G_)]-GLC(2_G_)-GLC(1_G_)",51.3909,"","",""
"6BS6","SUSG WITH MIXED LINKAGE AMYLOSACCHARIDE","10.1002/PRO.3410 ",2.17,44.13,"6bs6_oligo2","DGlcpa1-4DGlcpa1-6DGlcpa1-4DGlcpa1-4[DGlcpa1-6]DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(8_D_)-[GLC(7_D_)-GLC(6_D_)-GLC(5_D_)-GLC(4_D_)]-GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",39.682,"","",""
"6BZ4","HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A","10.1042/BCJ20180139 ",2.4,0,"6bz4_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",120.514,"","",""
"6BZ4","HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A","10.1042/BCJ20180139 ",2.4,0,"6bz4_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",105.338,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(290_B_)",87.2064,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(699_A_)",64.0786,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(594_B_)",51.0462,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(789_A_)",81.79,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(426_A_)",81.7961,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(290_A_)",93.3385,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(594_A_)",63.2389,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(699_B_)",69.2694,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(426_B_)",75.5709,"","",""
"6C02","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C), INACTIVE (T205A), N594S, WITH ALPHA,BETA-METHYLENE-ATP (AMPCPP)","10.1111/FEBS.14489 ",1.94,0,"6c02_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(789_A_)",34.65,"","",""
"6C02","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C), INACTIVE (T205A), N594S, WITH ALPHA,BETA-METHYLENE-ATP (AMPCPP)","10.1111/FEBS.14489 ",1.94,0,"6c02_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(699_A_)",47.6336,"","",""
"6C02","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C), INACTIVE (T205A), N594S, WITH ALPHA,BETA-METHYLENE-ATP (AMPCPP)","10.1111/FEBS.14489 ",1.94,0,"6c02_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(290_B_)",47.02,"","",""
"6C02","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C), INACTIVE (T205A), N594S, WITH ALPHA,BETA-METHYLENE-ATP (AMPCPP)","10.1111/FEBS.14489 ",1.94,0,"6c02_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(290_A_)",44.5936,"","",""
"6C02","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C), INACTIVE (T205A), N594S, WITH ALPHA,BETA-METHYLENE-ATP (AMPCPP)","10.1111/FEBS.14489 ",1.94,0,"6c02_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(426_A_)",42.2252,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(1089_A_)",728.227,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1180_A_)",646.185,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(1069_B_)",916.966,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1180_B_)",551.682,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1069_A_)",887.17,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1089_B_)",650.966,"","",""
"6C26","THE CRYO-EM STRUCTURE OF A EUKARYOTIC OLIGOSACCHARYL TRANSFERASE COMPLEX","10.1038/NATURE25755 ",3.5,"1.35632e-19","6c26_oligo1","DManpb1-2DManpb1-2DManpb1-2[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_D_)-[BMA(6_D_)-BMA(5_D_)-BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(539_A_)",52.3196,"","",""
"6C5H","S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN","10.1021/ACS.BIOCHEM.8B00318 ",1.99,30.01,"6c5h_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(85_H_)",38.3832,"","",""
"6C5K","S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2)","10.1021/ACS.BIOCHEM.8B00318 ",1.75,25.91,"6c5k_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(85_H_)",45.4709,"","",""
"6C5K","S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2)","10.1021/ACS.BIOCHEM.8B00318 ",1.75,25.91,"6c5k_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(85_A_)",63.7161,"","",""
"6C5M","STRUCTURE OF GLYCOLIPID AGSA[8,9] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.45,40.77,"6c5m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",49.2726,"","",""
"6C5V","AN ANTI-GH/GL ANTIBODY THAT NEUTRALIZES DUAL-TROPIC INFECTION DEFINES A SITE OF VULNERABILITY ON EPSTEIN-BARR VIRUS","10.1016/J.IMMUNI.2018.03.026 ",4.8,"3.72823e-08","6c5v_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(60_A_)",171.986,"","",""
"6C69","STRUCTURE OF GLYCOLIPID AGSA[12,6P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",1.94,41.04,"6c69_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",55.1021,"","",""
"6C6C","STRUCTURE OF GLYCOLIPID AGSA[20,6P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.08,39.61,"6c6c_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",43.7442,"","",""
"6C6F","STRUCTURE OF GLYCOLIPID AGSA[26,P5P] IN COMPLEX WITH MOUSE CD1D","",1.67,31.77,"6c6f_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",37.2041,"","",""
"6C6H","STRUCTURE OF GLYCOLIPID AGSA[8,P5M] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2,37.91,"6c6h_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",39.86,"","",""
"6C6J","STRUCTURE OF GLYCOLIPID AGSA[8,P5P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",1.79,33.48,"6c6j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",36.807,"","",""
"6CBJ","CRYSTAL STRUCTURE OF DH270.3 FAB IN COMPLEX WITH MAN9","10.1038/S41467-018-03565-6 ",2.85,62.62,"6cbj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_A_)-MAN(10_A_)-[MAN(9_A_)-MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",40.358,"","",""
"6CCB","CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB","10.1128/JVI.02261-17 ",6.5,0,"6ccb_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_C_)",456.253,"","",""
"6CCB","CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB","10.1128/JVI.02261-17 ",6.5,0,"6ccb_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_C_)",486.559,"","",""
"6CCB","CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB","10.1128/JVI.02261-17 ",6.5,0,"6ccb_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-[MAN(7_K_)]-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",469.68,"","",""
"6CCB","CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB","10.1128/JVI.02261-17 ",6.5,0,"6ccb_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",468.368,"","",""
"6CE0","CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM","10.1126/SCIADV.AAU6769 ",4.6,0,"6ce0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",340.259,"","",""
"6CE0","CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM","10.1126/SCIADV.AAU6769 ",4.6,0,"6ce0_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(88_G_)",301.663,"","",""
"6CE0","CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM","10.1126/SCIADV.AAU6769 ",4.6,0,"6ce0_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",267.429,"","",""
"6CE9","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES","10.1038/NATURE26153 ",4.3,0,"6ce9_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(25_B_)",306.187,"","",""
"6CE9","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES","10.1038/NATURE26153 ",4.3,0,"6ce9_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(418_B_)",279.136,"","",""
"6CE9","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES","10.1038/NATURE26153 ",4.3,0,"6ce9_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(418_A_)",276.964,"","",""
"6CE9","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES","10.1038/NATURE26153 ",4.3,0,"6ce9_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(255_B_)",230.225,"","",""
"6CE9","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES","10.1038/NATURE26153 ",4.3,0,"6ce9_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(25_A_)",301.075,"","",""
"6CE9","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES","10.1038/NATURE26153 ",4.3,0,"6ce9_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(255_A_)",234.9,"","",""
"6CEB","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES - C1 SYMMETRY","10.1038/NATURE26153 ",4.7,0,"6ceb_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(255_A_)",318.754,"","",""
"6CEB","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES - C1 SYMMETRY","10.1038/NATURE26153 ",4.7,0,"6ceb_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(25_A_)",383.764,"","",""
"6CEB","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES - C1 SYMMETRY","10.1038/NATURE26153 ",4.7,0,"6ceb_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(418_A_)",347.326,"","",""
"6CEB","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES - C1 SYMMETRY","10.1038/NATURE26153 ",4.7,0,"6ceb_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(255_B_)",297.658,"","",""
"6CEB","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES - C1 SYMMETRY","10.1038/NATURE26153 ",4.7,0,"6ceb_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(25_B_)",348.443,"","",""
"6CEB","INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES - C1 SYMMETRY","10.1038/NATURE26153 ",4.7,0,"6ceb_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(418_B_)",355.762,"","",""
"6CEX","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH SMALL MOLECULE N-CYCLOHEXYLTAURINE","10.1073/PNAS.1801999115 ",2.57,0,"6cex_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",78.9036,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(386_G_)",307.187,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(197_G_)",289.392,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo8","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(276_G_)",301.744,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo5","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_G_)",287.382,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[MAN(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(156_G_)",305.989,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo14","DManpa1-3DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)]-MAN(4_T_)-[MAN(9_T_)-MAN(8_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_G_)",235.459,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo12","DManpa1-6DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(392_G_)",277.518,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo13","DManpa1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(448_G_)",297.833,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_A_)-[MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(637_B_)",290.507,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(88_G_)",260.109,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo1","DManpa1-6DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(88_G_)",248.408,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo13","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(637_B_)",337.601,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(234_G_)",303.198,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo16","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-6DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-MAN(5_V_)-[MAN(7_V_)]-MAN(4_V_)-[MAN(9_V_)-MAN(8_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_G_)",236.741,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo5","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(301_G_)",331.698,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",311.548,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo9","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(160_G_)",313.053,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo3","DManpa1-6DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)]-MAN(4_N_)-[MAN(8_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",318.833,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(133_G_)",309.752,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManp[2<R1>]a1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",279.778,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(448_G_)",311.695,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo8","DManpa1-6DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_G_)",342.365,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",347.05,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo8","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(262_G_)",382.337,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(392_G_)",375.973,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo15","DManpa1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",352.813,"","",""
"6CHF","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 1)","10.1016/J.STR.2020.03.001 ",2.4,0,"6chf_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",77.8394,"","",""
"6CHF","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 1)","10.1016/J.STR.2020.03.001 ",2.4,0,"6chf_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",130.212,"","",""
"6CJC","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3)","10.1016/J.STR.2020.03.001 ",2.58,0,"6cjc_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",96.2532,"","",""
"6CJC","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3)","10.1016/J.STR.2020.03.001 ",2.58,0,"6cjc_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",104.43,"","",""
"6CJX","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 2)","10.1016/J.STR.2020.03.001 ",2.44,0,"6cjx_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",140.362,"","",""
"6CJX","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 2)","10.1016/J.STR.2020.03.001 ",2.44,0,"6cjx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",167.937,"","",""
"6CK9","CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM","10.1016/J.CELREP.2018.03.061 ",2.71,59.06,"6ck9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",84.8133,"","",""
"6CK9","CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM","10.1016/J.CELREP.2018.03.061 ",2.71,59.06,"6ck9_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-MAN(8_N_)-[MAN(10_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_G_)",65.5145,"","",""
"6CK9","CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM","10.1016/J.CELREP.2018.03.061 ",2.71,59.06,"6ck9_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",63.2815,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Y_)-MAN(8_Y_)-[MAN(10_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(234_D_)",56.5979,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(276_F_)",62.9638,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_g_)-MAN(8_g_)-[MAN(10_g_)]-MAN(7_g_)-[MAN(6_g_)-MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(234_F_)",56.7279,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_E_)",64.0936,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(276_D_)",62.4956,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-MAN(8_c_)-[MAN(10_c_)]-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(234_E_)",56.4601,"","",""
"6CMG","CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3","10.1371/JOURNAL.PPAT.1003684 ",2.7,0,"6cmg_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-[FUC(5_G_)]-NAG(1_G_)-ASN(529_A_)",57.5723,"","",""
"6CMI","CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3","10.1371/JOURNAL.PPAT.1003684 ",2.72,0,"6cmi_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-[FUC(5_G_)]-NAG(1_G_)-ASN(529_B_)",72.0376,"","",""
"6CQT","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY (-) STEREOISOMER OF VX","10.1021/ACS.CHEMRESTOX.8B00294 ",2.27,0,"6cqt_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",85.7767,"","",""
"6CQT","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY (-) STEREOISOMER OF VX","10.1021/ACS.CHEMRESTOX.8B00294 ",2.27,0,"6cqt_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",83.5248,"","",""
"6CQU","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE WITH REACTIVATOR HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.31,0,"6cqu_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",86.2649,"","",""
"6CQU","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE WITH REACTIVATOR HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.31,0,"6cqu_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",122.145,"","",""
"6CQU","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE WITH REACTIVATOR HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.31,0,"6cqu_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)",87.4972,"","",""
"6CQV","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH VX(+) AND HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.6,0,"6cqv_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)",79.3464,"","",""
"6CQV","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH VX(+) AND HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.6,0,"6cqv_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)",82.3219,"","",""
"6CQW","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH VX(-) AND HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.28,0,"6cqw_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",106.049,"","",""
"6CQW","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH VX(-) AND HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.28,0,"6cqw_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",107.594,"","",""
"6CQX","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY VX(+)","10.1021/ACS.CHEMRESTOX.8B00294 ",2.4,0,"6cqx_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",105.782,"","",""
"6CQX","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY VX(+)","10.1021/ACS.CHEMRESTOX.8B00294 ",2.4,0,"6cqx_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",106.268,"","",""
"6CQX","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY VX(+)","10.1021/ACS.CHEMRESTOX.8B00294 ",2.4,0,"6cqx_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",138.753,"","",""
"6CQY","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH EMPA AND HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.45,0,"6cqy_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)",90.2655,"","",""
"6CQY","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH EMPA AND HI-6","10.1021/ACS.CHEMRESTOX.8B00294 ",2.45,0,"6cqy_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcp[2<R1>]x1-","FUC(3_D_)-[NAG(2_D_)-",93.5443,"","",""
"6CQZ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY VX","10.1021/ACS.CHEMRESTOX.8B00294 ",2.22,0,"6cqz_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",86.3876,"","",""
"6CQZ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY VX","10.1021/ACS.CHEMRESTOX.8B00294 ",2.22,0,"6cqz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",85.0021,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_A_)",23.9075,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-[MAN(8_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(200_D_)",33.5902,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_W_)-[MAN(8_W_)]-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(200_F_)",30.7528,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_E_)",26.9694,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_C_)",33.4303,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-[MAN(8_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(200_B_)",34.5055,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo21","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-[MAN(8_c_)]-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_H_)",24.9172,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo18","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Z_)-[MAN(8_Z_)]-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(200_G_)",32.5985,"","",""
"6CRQ","GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB","10.1371/JOURNAL.PPAT.1006986 ",4.2,0,"6crq_oligo15","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_A_)",94.8361,"","",""
"6CRQ","GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB","10.1371/JOURNAL.PPAT.1006986 ",4.2,0,"6crq_oligo27","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(276_F_)",95.7818,"","",""
"6CRQ","GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB","10.1371/JOURNAL.PPAT.1006986 ",4.2,0,"6crq_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(276_B_)",94.8802,"","",""
"6CRW","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, SINGLE UPWARDS S1 CTD CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crw_oligo18","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(699_C_)",217.918,"","",""
"6CRZ","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, C3 SYMMETRY","10.1038/S41598-018-34171-7 ",3.3,0,"6crz_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(699_C_)",161.126,"","",""
"6CS0","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, ONE S1 CTD IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",3.8,0,"6cs0_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(699_C_)",161.126,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(699_B_)",267.93,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(269_A_)",283.217,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(783_B_)",283.525,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo17","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(1080_B_)",237.758,"","",""
"6CW6","STRUCTURE OF ALPHA-GC[8,18] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.85,39.95,"6cw6_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",47.6133,"","",""
"6CW9","STRUCTURE OF ALPHA-GC[8,16P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2,38.53,"6cw9_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",54.8042,"","",""
"6CWB","STRUCTURE OF ALPHA-GSA[8,4P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.85,49.71,"6cwb_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",63.9951,"","",""
"6CWE","STRUCTURE OF ALPHA-GSA[8,6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","",2.2,41.42,"6cwe_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",53.0706,"","",""
"6CX5","STRUCTURE OF ALPHA-GSA[8,8P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.4,44.73,"6cx5_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",54.9273,"","",""
"6CX7","STRUCTURE OF ALPHA-GSA[12,6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.6,59.92,"6cx7_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",75.3321,"","",""
"6CX9","STRUCTURE OF ALPHA-GSA[16,6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.36,47.19,"6cx9_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",59.913,"","",""
"6CXA","STRUCTURE OF ALPHA-GSA[20,6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.65,52.62,"6cxa_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",94.3502,"","",""
"6CXE","STRUCTURE OF ALPHA-GSA[26,6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.05,49.47,"6cxe_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",62.8388,"","",""
"6CXF","STRUCTURE OF ALPHA-GSA[26,P5P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.5,42.13,"6cxf_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",85.3584,"","",""
"6CXG","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S","10.1021/ACSCENTSCI.8B00588 ",2.3,0,"6cxg_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpx1-","MAN(4_D_)-MAN(3_D_)-[MAN(5_D_)]-MAN(2_D_)-[MAN(7_D_)-MAN(6_D_)]-BMA(1_D_)",47.9012,"","",""
"6CXG","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S","10.1021/ACSCENTSCI.8B00588 ",2.3,0,"6cxg_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpx1-","MAN(9_B_)-MAN(8_B_)-[MAN(7_B_)-MAN(6_B_)]-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",47.9755,"","",""
"6CXL","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5","10.1021/ACSCENTSCI.8B00588 ",3.59,0,"6cxl_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpx1-","MAN(9_B_)-MAN(8_B_)-[MAN(7_B_)-MAN(6_B_)]-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",94.9361,"","",""
"6CXL","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5","10.1021/ACSCENTSCI.8B00588 ",3.59,0,"6cxl_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpx1-","MAN(9_A_)-MAN(8_A_)-[MAN(7_A_)-MAN(6_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)]-BMA(1_A_)",89.3802,"","",""
"6CZK","CRYSTAL STRUCTURE OF WILD-TYPE HUMAN PRO-CATHEPSIN H","10.1371/JOURNAL.PONE.0200374 ",2,0,"6czk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(208_A_)",41.3411,"","",""
"6CZS","CRYSTAL STRUCTURE OF HUMAN PRO-CATHEPSIN H C26S MUTANT","10.1371/JOURNAL.PONE.0200374 ",1.66,0,"6czs_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(230_A_)",37.7451,"","",""
"6D3B","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) APO FORM","10.1107/S2053230X18017892 ",1.4,16.52,"6d3b_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",21.1986,"","",""
"6D4E","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1.","10.1080/19420862.2019.1589852 ",2.8,0,"6d4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",111.014,"","",""
"6D4E","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1.","10.1080/19420862.2019.1589852 ",2.8,0,"6d4e_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",110.489,"","",""
"6D4I","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2","10.1080/19420862.2019.1589852 ",2.95,0,"6d4i_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",95.5868,"","",""
"6D4I","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2","10.1080/19420862.2019.1589852 ",2.95,0,"6d4i_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",95.3006,"","",""
"6D4M","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3","10.1080/19420862.2019.1589852 ",3.47,0,"6d4m_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",107.192,"","",""
"6D4M","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3","10.1080/19420862.2019.1589852 ",3.47,0,"6d4m_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",99.9066,"","",""
"6D4N","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4","10.1080/19420862.2019.1589852 ",3.25,0,"6d4n_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",150.107,"","",""
"6D4N","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4","10.1080/19420862.2019.1589852 ",3.25,0,"6d4n_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",154.221,"","",""
"6D58","CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3","",2.39,0,"6d58_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",137.351,"","",""
"6D58","CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3","",2.39,0,"6d58_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",148.324,"","",""
"6D64","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH POPC","10.1038/S41467-018-07898-0 ",1.7,27.99,"6d64_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",21.0556,"","",""
"6D64","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH POPC","10.1038/S41467-018-07898-0 ",1.7,27.99,"6d64_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[NAG(3_D_)]-[FUC(2_D_)]-NAG(1_D_)-ASN(20_A_)",63.6391,"","",""
"6D6T","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION B","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6t_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",58.4757,"","",""
"6D6T","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION B","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6t_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(111_D_)",93.8427,"","",""
"6D6U","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION A","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6u_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",52.6052,"","",""
"6D6U","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION A","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6u_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(111_D_)",79.2356,"","",""
"6D96","STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS","",2.15,26.84,"6d96_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(234_E_)",69.9697,"","",""
"6D96","STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS","",2.15,26.84,"6d96_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(234_B_)",69.8009,"","",""
"6D96","STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS","",2.15,26.84,"6d96_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(234_D_)",72.8891,"","",""
"6D96","STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS","",2.15,26.84,"6d96_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(234_G_)",61.3082,"","",""
"6D96","STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS","",2.15,26.84,"6d96_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(234_C_)",64.3491,"","",""
"6D96","STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS","",2.15,26.84,"6d96_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(234_H_)",68.5585,"","",""
"6D96","STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS","",2.15,26.84,"6d96_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(234_F_)",67.8405,"","",""
"6DB6","CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 311-11D IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN","10.1128/JVI.00641-18 ",1.98,0,"6db6_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[DFucpa1-6]DGlcpNAcb1-ASN","FCA(5_A_)-[MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(28_H_)",56.4227,"","",""
"6DBS","FUSION SURFACE STRUCTURE, FUNCTION, AND DYNAMICS OF GAMETE FUSOGEN HAP2","10.7554/ELIFE.39772 ",2.6,0,"6dbs_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(497_C_)",186.402,"","",""
"6DBS","FUSION SURFACE STRUCTURE, FUNCTION, AND DYNAMICS OF GAMETE FUSOGEN HAP2","10.7554/ELIFE.39772 ",2.6,0,"6dbs_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(497_B_)",180.377,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo34","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_k_)-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_E_)",100.304,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo27","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_s_)-[GAL(8_s_)-NAG(7_s_)-[GAL(6_s_)-NAG(5_s_)]-MAN(4_s_)-BMA(3_s_)-NAG(2_s_)]-NAG(1_s_)-ASN(611_F_)",76.7788,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo35","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",117.212,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_C_)",94.8387,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo26","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_r_)-[NAG(8_r_)-MAN(7_r_)-[NAG(6_r_)-[NAG(5_r_)]-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)]-NAG(1_r_)-ASN(637_F_)",97.8233,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo28","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",69.7595,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo19","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(197_A_)",116.2,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo29","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)-ASN(197_C_)",109.509,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo30","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_g_)-[NAG(8_g_)-MAN(7_g_)-[NAG(6_g_)-[NAG(5_g_)]-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(637_D_)",80.832,"","",""
"6DDT","MOUSE BETA-MANNOSIDASE (MANBA)","10.1111/FEBS.14731 ",2.1,0,"6ddt_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(803_A_)",79.6212,"","",""
"6DDT","MOUSE BETA-MANNOSIDASE (MANBA)","10.1111/FEBS.14731 ",2.1,0,"6ddt_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(113_A_)",49.2886,"","",""
"6DDU","MOUSE BETA-MANNOSIDASE BOUND TO BETA-D-MANNOSE (MANBA)","10.1111/FEBS.14731 ",2.67,0,"6ddu_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(113_A_)",75.305,"","",""
"6DDU","MOUSE BETA-MANNOSIDASE BOUND TO BETA-D-MANNOSE (MANBA)","10.1111/FEBS.14731 ",2.67,0,"6ddu_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(803_A_)",161.628,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_U_)-[MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_G_)",95.6592,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",96.4859,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",93.0773,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(156_G_)",105.345,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo27","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_m_)-MAN(8_m_)-[MAN(10_m_)]-MAN(7_m_)-[MAN(6_m_)-MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(332_D_)",158.471,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",178.303,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_D_)",181.364,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_A_)",183.544,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_C_)",198.368,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-MAN(8_c_)-[MAN(10_c_)]-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(332_C_)",173.049,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo23","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(332_D_)",164.422,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_C_)",167.903,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_A_)",162.815,"","",""
"6DG5","STRUCTURE OF A DE NOVO DESIGNED INTERLEUKIN-2/INTERLEUKIN-15 MIMETIC COMPLEX WITH IL-2RB AND IL-2RG","10.1038/S41586-018-0830-7 ",2.52,47.05,"6dg5_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_E_)-[MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(43_B_)",73.2055,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo13","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_F_)",0.997273,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo22","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-[MAN(6_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(363_F_)",1.20924,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_R_)-[MAN(7_R_)]-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(276_A_)",0.9475,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo23","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_i_)-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(386_F_)",1.80341,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo17","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",0.997273,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo34","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_t_)-MAN(4_t_)-[MAN(6_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(363_G_)",1.20924,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo29","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_o_)-MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_G_)",0.997273,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-[MAN(6_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(363_A_)",1.20924,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(386_A_)",1.80341,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo18","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-[MAN(7_d_)]-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(276_F_)",0.9475,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo35","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_u_)-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(386_G_)",1.80341,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo30","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_p_)-[MAN(7_p_)]-MAN(6_p_)-[MAN(5_p_)-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(276_G_)",0.9475,"","",""
"6DJP","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68","10.1038/S41594-018-0093-X ",4.8,"1.49247e-19","6djp_oligo2","DManpa1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",139.687,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(358_A_)",88.0072,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(261_A_)",89.7897,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo3","DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(4_G_)-[BGC(3_G_)]-BGC(2_G_)-BGC(1_G_)",111.645,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo1","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-4DGlcpb1-ROH","GAL(4_F_)-XYS(3_F_)-[BGC(5_F_)]-BGC(2_F_)-BGC(1_F_)",92.0113,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(637_B_)",73.2126,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-[MAN(7_H_)]-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(358_B_)",89.5056,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo6","DGalpb1-2DXylpa1-6[DGlcpb1-4]DGlcpb1-4DGlcpb1-ROH","GAL(4_J_)-XYS(3_J_)-[BGC(5_J_)]-BGC(2_J_)-BGC(1_J_)",93.28,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(637_A_)",75.2987,"","",""
"6DW0","CRYO-EM STRUCTURE OF THE BENZODIAZEPINE-SENSITIVE ALPHA1BETA1GAMMA2S TRI-HETEROMERIC GABAA RECEPTOR IN COMPLEX WITH GABA (WHOLE MAP)","10.7554/ELIFE.39383 ",3.8,"1.08527e-19","6dw0_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(110_A_)",203.011,"","",""
"6DW1","CRYO-EM STRUCTURE OF THE BENZODIAZEPINE-SENSITIVE ALPHA1BETA1GAMMA2S TRI-HETEROMERIC GABAA RECEPTOR IN COMPLEX WITH GABA (ECD MAP)","10.7554/ELIFE.39383 ",3.1,"1.08527e-19","6dw1_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(110_A_)",85.1723,"","",""
"6DXW","HUMAN N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) PRECURSOR (C126A)","10.1073/PNAS.1811759115 ",2.3,0,"6dxw_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(333_C_)",94.0606,"","",""
"6DXW","HUMAN N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) PRECURSOR (C126A)","10.1073/PNAS.1811759115 ",2.3,0,"6dxw_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(333_B_)",67.1159,"","",""
"6DY3","CAENORHABDITIS ELEGANS N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) ORTHOLOG","10.1073/PNAS.1811759115 ",2.7,0,"6dy3_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(150_B_)",106.123,"","",""
"6DY3","CAENORHABDITIS ELEGANS N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) ORTHOLOG","10.1073/PNAS.1811759115 ",2.7,0,"6dy3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(150_F_)",74.9124,"","",""
"6DZL","EBOLA VIRUS MAKONA VARIANT GP (MUCIN-DELETED) IN COMPLEX WITH PAN- EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.14,"2.23709e+11","6dzl_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_D_)",175.647,"","",""
"6DZL","EBOLA VIRUS MAKONA VARIANT GP (MUCIN-DELETED) IN COMPLEX WITH PAN- EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.14,"2.23709e+11","6dzl_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",175.647,"","",""
"6DZL","EBOLA VIRUS MAKONA VARIANT GP (MUCIN-DELETED) IN COMPLEX WITH PAN- EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.14,"2.23709e+11","6dzl_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",175.647,"","",""
"6DZM","BUNDIBUGYO VIRUS GP (MUCIN-DELETED) IN COMPLEX WITH PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.29,0,"6dzm_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",164.015,"","",""
"6DZM","BUNDIBUGYO VIRUS GP (MUCIN-DELETED) IN COMPLEX WITH PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.29,0,"6dzm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_D_)",164.015,"","",""
"6DZM","BUNDIBUGYO VIRUS GP (MUCIN-DELETED) IN COMPLEX WITH PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.29,0,"6dzm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",164.015,"","",""
"6E18","CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII HAP2 ECTODOMAIN PROVIDES STRUCTURAL INSIGHTS OF FUNCTIONAL LOOPS IN GREEN ALGAE.","10.1016/J.STR.2018.09.014 ",2.6,50.89,"6e18_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(578_A_)",92.3693,"","",""
"6E3H","CRYSTAL STRUCTURE OF S9-3-37 BOUND TO H5 INFLUENZA HEMAGGLUTININ","",2.9,75.18,"6e3h_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(169_A_)",113.214,"","",""
"6E3K","INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2","10.1038/S41586-019-0988-7 ",3.25,0,"6e3k_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(110_I_)",216.895,"","",""
"6E3L","INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2","10.1038/S41586-019-0988-7 ",3.8,0,"6e3l_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(137_I_)",228.266,"","",""
"6E4X","HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2)","10.1016/J.CELL.2019.03.048 ",2.25,0,"6e4x_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_A_)-[MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(63_B_)",70.3638,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo16","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)",108.014,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo8","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_b_)-MAN(5_b_)-MAN(4_b_)-[MAN(7_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo1","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_X_)-MAN(5_X_)-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",108.014,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo19","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_m_)-[MAN(5_m_)]-MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)",108.014,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo10","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_d_)-MAN(5_d_)-MAN(4_d_)-[MAN(7_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo20","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_n_)-MAN(5_n_)-MAN(4_n_)-[MAN(7_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo12","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_f_)-MAN(5_f_)-MAN(4_f_)-[MAN(7_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo6","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)",20.1653,"","",""
"6E69","ORTHO-SUBSTITUTED PHENYL SULFONYL FLUORIDE AND FLUOROSULFATE AS POTENT ELASTASE INHIBITORY FRAGMENTS","10.1073/PNAS.1909972116 ",2.33,39.77,"6e69_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(159_D_)",50.9739,"","",""
"6E69","ORTHO-SUBSTITUTED PHENYL SULFONYL FLUORIDE AND FLUOROSULFATE AS POTENT ELASTASE INHIBITORY FRAGMENTS","10.1073/PNAS.1909972116 ",2.33,39.77,"6e69_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(159_A_)",43.2982,"","",""
"6E69","ORTHO-SUBSTITUTED PHENYL SULFONYL FLUORIDE AND FLUOROSULFATE AS POTENT ELASTASE INHIBITORY FRAGMENTS","10.1073/PNAS.1909972116 ",2.33,39.77,"6e69_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(159_C_)",49.7655,"","",""
"6E69","ORTHO-SUBSTITUTED PHENYL SULFONYL FLUORIDE AND FLUOROSULFATE AS POTENT ELASTASE INHIBITORY FRAGMENTS","10.1073/PNAS.1909972116 ",2.33,39.77,"6e69_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(159_B_)",50.1294,"","",""
"6E6B","CRYSTAL STRUCTURE OF THE PROTOCADHERIN GAMMAB4 EXTRACELLULAR DOMAIN","10.1038/S41586-019-1089-3 ",4.52,138.7,"6e6b_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(513_B_)",175.513,"","",""
"6E6B","CRYSTAL STRUCTURE OF THE PROTOCADHERIN GAMMAB4 EXTRACELLULAR DOMAIN","10.1038/S41586-019-1089-3 ",4.52,138.7,"6e6b_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(193_B_)",177.028,"","",""
"6E7K","STRUCTURE OF THE LIPOPROTEIN LIPASE GPIHBP1 COMPLEX THAT MEDIATES PLASMA TRIGLYCERIDE HYDROLYSIS","10.1073/PNAS.1817984116 ",2.8,94.93,"6e7k_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(70_B_)",119.016,"","",""
"6E7K","STRUCTURE OF THE LIPOPROTEIN LIPASE GPIHBP1 COMPLEX THAT MEDIATES PLASMA TRIGLYCERIDE HYDROLYSIS","10.1073/PNAS.1817984116 ",2.8,94.93,"6e7k_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(70_A_)",128.182,"","",""
"6E7R","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-4","",2.1,38.17,"6e7r_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",65.4782,"","",""
"6E7S","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-5","",2.72,73.42,"6e7s_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",92.2711,"","",""
"6E7T","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-6","",2.31,42.34,"6e7t_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",75.8065,"","",""
"6E7U","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-31","",2.27,39.6,"6e7u_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",67.1518,"","",""
"6E7V","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-88","",2.6,51.59,"6e7v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",74.7249,"","",""
"6E7W","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-115","",2.67,49.17,"6e7w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",75.2662,"","",""
"6E7X","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-97","",2.58,48.46,"6e7x_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",78.5495,"","",""
"6EA4","ERAP2 BOUND TO ARYL SULFONAMIDE UNCOMPETITIVE INHIBITOR","",2.45,82.35,"6ea4_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_A_)",102.249,"","",""
"6EA4","ERAP2 BOUND TO ARYL SULFONAMIDE UNCOMPETITIVE INHIBITOR","",2.45,82.35,"6ea4_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(85_B_)",97.8773,"","",""
"6EA4","ERAP2 BOUND TO ARYL SULFONAMIDE UNCOMPETITIVE INHIBITOR","",2.45,82.35,"6ea4_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",102.991,"","",""
"6EA5","STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.75,0,"6ea5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",203.352,"","",""
"6EA5","STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.75,0,"6ea5_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",204.991,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(563_D_)",178.133,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(563_B_)",208.453,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(563_F_)",205.134,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(40_A_)",218.839,"","",""
"6EAH","CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT K394R-S398L STABILIZED IN THE PREFUSION STATE","",3,84.28,"6eah_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(500_C_)",135.634,"","",""
"6EAQ","GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC","10.1074/JBC.RA118.005273 ",2.22,0,"6eaq_oligo1","LArapa1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",42.5249,"","",""
"6EAQ","GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC","10.1074/JBC.RA118.005273 ",2.22,0,"6eaq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",56.5409,"","",""
"6EAY","STRUCTURAL BASIS FOR BROAD NEUTRALIZATION OF EBOLAVIRUSES BY AN ANTIBODY TARGETING THE GLYCOPROTEIN FUSION LOOP","10.1038/S41467-018-06113-4 ",3.72,0,"6eay_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_A_)",102.138,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(276_F_)",71.4769,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(276_D_)",71.4287,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_t_)-[MAN(8_t_)]-MAN(7_t_)-[MAN(6_t_)-MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(234_F_)",70.6465,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo27","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_v_)-[MAN(8_v_)]-MAN(7_v_)-[MAN(6_v_)-MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(234_E_)",71.2083,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_u_)-[MAN(8_u_)]-MAN(7_u_)-[MAN(6_u_)-MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(234_D_)",67.4766,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(276_E_)",71.4638,"","",""
"6EFY","CRYSTAL STRUCTURE OF DIP-ALPHA IG1-3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6efy_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(50_A_)",124.55,"","",""
"6EFZ","CRYSTAL STRUCTURE OF DIP-THETA IG1-3","10.1016/J.NEURON.2018.10.046 ",3.5,0,"6efz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(138_A_)",185.055,"","",""
"6EFZ","CRYSTAL STRUCTURE OF DIP-THETA IG1-3","10.1016/J.NEURON.2018.10.046 ",3.5,0,"6efz_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(250_A_)",217.446,"","",""
"6EG0","CRYSTAL STRUCTURE OF DPR4 IG1-IG2 IN COMPLEX WITH DIP-ETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6eg0_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(224_A_)",135.555,"","",""
"6EG0","CRYSTAL STRUCTURE OF DPR4 IG1-IG2 IN COMPLEX WITH DIP-ETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6eg0_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(51_B_)",113.846,"","",""
"6EG0","CRYSTAL STRUCTURE OF DPR4 IG1-IG2 IN COMPLEX WITH DIP-ETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6eg0_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(291_B_)",98.2293,"","",""
"6EG0","CRYSTAL STRUCTURE OF DPR4 IG1-IG2 IN COMPLEX WITH DIP-ETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6eg0_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(167_A_)",128.452,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(302_A_)",64.5105,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(287_B_)",101.608,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(138_D_)",69.8145,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(115_A_)",118.914,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(344_B_)",130.915,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(302_C_)",71.1331,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(287_D_)",139.531,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(115_C_)",107.113,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(250_B_)",120.729,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(138_B_)",84.3645,"","",""
"6EHO","DIMER OF THE SORTILIN VPS10P DOMAIN AT LOW PH","10.1016/J.STR.2017.09.015 ",3.5,0,"6eho_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",182.888,"","",""
"6ELC","CRYSTAL STRUCTURE OF O-LINKED GLYCOSYLATED VSG3","10.1038/S41564-018-0187-6 ",1.41,23.2,"6elc_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",27.7377,"","",""
"6EN3","CRYSTAL STRUCTURE OF FULL LENGTH ENDOS FROM STREPTOCOCCUS PYOGENES IN COMPLEX WITH G2 OLIGOSACCHARIDE.","10.1038/S41467-018-04300-X ",2.9,0,"6en3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_B_)-NAG(7_B_)-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",87.1648,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(416_B_)",51.3739,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(480_B_)",57.9576,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(416_A_)",52.5568,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(416_D_)",60.1856,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(480_A_)",58.7709,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(480_C_)",60.9894,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(480_D_)",63.9845,"","",""
"6EN6","CRYSTAL STRUCTURE B OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.8,0,"6en6_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(480_B_)",44.7327,"","",""
"6EN6","CRYSTAL STRUCTURE B OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.8,0,"6en6_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(416_B_)",50.8075,"","",""
"6EN6","CRYSTAL STRUCTURE B OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.8,0,"6en6_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(416_A_)",50.6368,"","",""
"6EN6","CRYSTAL STRUCTURE B OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.8,0,"6en6_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(480_A_)",53.4727,"","",""
"6EN6","CRYSTAL STRUCTURE B OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.8,0,"6en6_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(480_D_)",38.3495,"","",""
"6EN6","CRYSTAL STRUCTURE B OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.8,0,"6en6_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(416_D_)",43.5932,"","",""
"6EN6","CRYSTAL STRUCTURE B OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.8,0,"6en6_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(480_C_)",53.4627,"","",""
"6EPK","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS","10.1128/MBIO.00706-23 ",2.7,0,"6epk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(529_E_)",103.334,"","",""
"6EPK","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS","10.1128/MBIO.00706-23 ",2.7,0,"6epk_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(529_B_)",96.4894,"","",""
"6EPY","STRUCTURE OF THE PBP MELB (ATU4661) IN COMPLEX WITH RAFFINOSE FROM A.FABRUM C58","10.1074/JBC.RA118.001856 ",2.04,44.74,"6epy_oligo3","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_G_)-GLC(2_G_)-FRU(1_G_)",38.6521,"","",""
"6EPY","STRUCTURE OF THE PBP MELB (ATU4661) IN COMPLEX WITH RAFFINOSE FROM A.FABRUM C58","10.1074/JBC.RA118.001856 ",2.04,44.74,"6epy_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_F_)-GLC(2_F_)-FRU(1_F_)",42.124,"","",""
"6EPY","STRUCTURE OF THE PBP MELB (ATU4661) IN COMPLEX WITH RAFFINOSE FROM A.FABRUM C58","10.1074/JBC.RA118.001856 ",2.04,44.74,"6epy_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_E_)-GLC(2_E_)-FRU(1_E_)",39.4912,"","",""
"6EPY","STRUCTURE OF THE PBP MELB (ATU4661) IN COMPLEX WITH RAFFINOSE FROM A.FABRUM C58","10.1074/JBC.RA118.001856 ",2.04,44.74,"6epy_oligo4","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_H_)-GLC(2_H_)-FRU(1_H_)",46.7992,"","",""
"6EPZ","STRUCTURE OF THE PERIPLASMIC BINDING PROTEIN MELB (ATU4661) IN COMPLEX WITH MELIBIOSE FROM AGROBACTERIUM FABRUM C58","10.1074/JBC.RA118.001856 ",1.8,33.82,"6epz_oligo4","DGalpa1-6DGlcpa1-ROH","GLA(2_H_)-GLC(1_H_)",32.6641,"","",""
"6EPZ","STRUCTURE OF THE PERIPLASMIC BINDING PROTEIN MELB (ATU4661) IN COMPLEX WITH MELIBIOSE FROM AGROBACTERIUM FABRUM C58","10.1074/JBC.RA118.001856 ",1.8,33.82,"6epz_oligo2","DGalpa1-6DGlcpa1-ROH","GLA(2_F_)-GLC(1_F_)",31.3682,"","",""
"6EPZ","STRUCTURE OF THE PERIPLASMIC BINDING PROTEIN MELB (ATU4661) IN COMPLEX WITH MELIBIOSE FROM AGROBACTERIUM FABRUM C58","10.1074/JBC.RA118.001856 ",1.8,33.82,"6epz_oligo1","DGalpa1-6DGlcpa1-ROH","GLA(2_E_)-GLC(1_E_)",31.585,"","",""
"6EPZ","STRUCTURE OF THE PERIPLASMIC BINDING PROTEIN MELB (ATU4661) IN COMPLEX WITH MELIBIOSE FROM AGROBACTERIUM FABRUM C58","10.1074/JBC.RA118.001856 ",1.8,33.82,"6epz_oligo3","DGalpa1-6DGlcpa1-ROH","GLA(2_G_)-GLC(1_G_)",29.1923,"","",""
"6EQ1","STRUCTURE OF THE PERIPLASMIC BINDING PROTEIN (PBP) MELB (ATU4661) IN COMPLEX WITH STACHYOSE FROM AGROBACTERIUM FABRUM C58","10.1074/JBC.RA118.001856 ",2.1,61.95,"6eq1_oligo1","DGalpa1-6DIdopa1-6DGlcpa2-1DPsifb","GLA(4_C_)-ZCD(3_C_)-GLC(2_C_)-TTV(1_C_)",47.7968,"","",""
"6EQ1","STRUCTURE OF THE PERIPLASMIC BINDING PROTEIN (PBP) MELB (ATU4661) IN COMPLEX WITH STACHYOSE FROM AGROBACTERIUM FABRUM C58","10.1074/JBC.RA118.001856 ",2.1,61.95,"6eq1_oligo2","DGalpa1-6DIdopa1-6DGlcpa2-1DPsifb","GLA(4_D_)-ZCD(3_D_)-GLC(2_D_)-TTV(1_D_)",59.521,"","",""
"6EQP","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ETHOPROPAZINE","10.3390/MOLECULES22122098 ",2.35,57.56,"6eqp_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(106_A_)",100.932,"","",""
"6ETY","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR JHU3371","10.1016/J.BMC.2018.11.022 ",1.68,32.92,"6ety_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",42.86,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo2","[LArafa1-3][LArafa1-4]DGalpb1-6DGalpb1-ROH","RAM(4_F_)-BDP(3_F_)-[AHR(6_F_)]-[AHR(5_F_)]-GAL(2_F_)-GAL(1_F_)",54.6592,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo3","[LArafa1-3][LArafa1-4]DGalpb1-6DGalpb1-ROH","RAM(4_G_)-BDP(3_G_)-[AHR(6_G_)]-[AHR(5_G_)]-GAL(2_G_)-GAL(1_G_)",61.368,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo4","LArafa1-3[LArafa1-4][DGlcpAb1-6]DGalpb1-6DGalpb1-ROH","BDP(5_H_)-[AHR(4_H_)]-[AHR(3_H_)]-GAL(2_H_)-GAL(1_H_)",56.3538,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo1","LArafa1-3[LArafa1-4][DGlcpAb1-6]DGalpb1-6DGalpb1-ROH","BDP(5_E_)-[AHR(4_E_)]-[AHR(3_E_)]-GAL(2_E_)-GAL(1_E_)",53.2694,"","",""
"6EVV","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND NU172, A DUPLEX/QUADRUPLEX 26-MER DNA APTAMER, IN THE PRESENCE OF POTASSIUM IONS.","10.1093/NAR/GKY990 ",2.5,48.2,"6evv_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",71.1303,"","",""
"6EYO","STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS","10.1038/S41598-018-29664-4 ",3.7,0,"6eyo_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",88.1155,"","",""
"6EYO","STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS","10.1038/S41598-018-29664-4 ",3.7,0,"6eyo_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",90.5087,"","",""
"6EZ9","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR JHU3372","10.1016/J.BMC.2018.11.022 ",1.61,29.42,"6ez9_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",41.9151,"","",""
"6EZN","CRYO-EM STRUCTURE OF THE YEAST OLIGOSACCHARYLTRANSFERASE (OST) COMPLEX","10.1038/S41467-022-35067-X ",3.3,"1.35632e-19","6ezn_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(539_F_)",38.7006,"","",""
"6F1C","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.2,226.7,"6f1c_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(204_C_)",278.362,"","",""
"6F1C","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.2,226.7,"6f1c_oligo1","DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[GAL(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(204_A_)",294.022,"","",""
"6F1H","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.5,255.4,"6f1h_oligo1","DGlcpNAcb1-4DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-[NAG(6_E_)-GAL(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(204_A_)",262.001,"","",""
"6F1H","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.5,255.4,"6f1h_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",295.58,"","",""
"6F2Z","STRUCTURE OF A FC MUTANT","",2.3,53.42,"6f2z_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",60.2502,"","",""
"6F2Z","STRUCTURE OF A FC MUTANT","",2.3,53.42,"6f2z_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_B_)",76.6274,"","",""
"6F39","C1R HOMODIMER CUB1-EGF-CUB2","10.1073/PNAS.1718709115 ",5.8,351.4,"6f39_oligo2","DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[GAL(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(204_A_)",410.056,"","",""
"6F39","C1R HOMODIMER CUB1-EGF-CUB2","10.1073/PNAS.1718709115 ",5.8,351.4,"6f39_oligo1","DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[GAL(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(204_B_)",390.7,"","",""
"6F5K","CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA","10.1371/JOURNAL.PONE.0206589 ",1.62,25.44,"6f5k_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",53.1978,"","",""
"6F5L","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR JHU2379","10.1016/J.BMC.2018.11.022 ",1.63,33.72,"6f5l_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",49.336,"","",""
"6F5M","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED HUMAN LEUKOCYTE ELASTASE IN COMPLEX WITH A THIAZOLIDINEDIONE INHIBITOR","10.1107/S2053230X1800537X ",2.7,0,"6f5m_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(159_B_)",124.43,"","",""
"6F5M","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED HUMAN LEUKOCYTE ELASTASE IN COMPLEX WITH A THIAZOLIDINEDIONE INHIBITOR","10.1107/S2053230X1800537X ",2.7,0,"6f5m_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(109_A_)",117.698,"","",""
"6F5M","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED HUMAN LEUKOCYTE ELASTASE IN COMPLEX WITH A THIAZOLIDINEDIONE INHIBITOR","10.1107/S2053230X1800537X ",2.7,0,"6f5m_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(109_B_)",99.7532,"","",""
"6F5M","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED HUMAN LEUKOCYTE ELASTASE IN COMPLEX WITH A THIAZOLIDINEDIONE INHIBITOR","10.1107/S2053230X1800537X ",2.7,0,"6f5m_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(159_A_)",97.2478,"","",""
"6F5U","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH BEPRIDIL","10.1021/ACS.JMEDCHEM.7B01249 ",2.07,0,"6f5u_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",108.02,"","",""
"6F6I","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH PAROXETINE","10.1021/ACS.JMEDCHEM.7B01249 ",2.4,0,"6f6i_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",119.634,"","",""
"6F6N","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH SERTRALINE","10.1021/ACS.JMEDCHEM.7B01249 ",2.15,0,"6f6n_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",105.809,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo5","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_L_)-BMA(5_L_)-RAM(4_L_)-GLA(3_L_)-BMA(2_L_)-RAM(1_L_)",58.0221,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo4","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_K_)-BMA(5_K_)-RAM(4_K_)-GLA(3_K_)-BMA(2_K_)-RAM(1_K_)",69.8502,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo6","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_M_)-BMA(5_M_)-RAM(4_M_)-GLA(3_M_)-BMA(2_M_)-RAM(1_M_)",53.8615,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo3","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_H_)-BMA(5_H_)-RAM(4_H_)-GLA(3_H_)-BMA(2_H_)-RAM(1_H_)",58.9408,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo1","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(4_I_)-BMA(3_I_)-RAM(2_I_)-GLA(1_I_)-BMA(2_J_)-RAM(1_J_)",49.3677,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo2","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_E_)-BMA(5_E_)-RAM(4_E_)-GLA(3_E_)-BMA(2_E_)-RAM(1_E_)",68.8091,"","",""
"6F7Q","HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES","10.1016/J.EJMECH.2018.07.033 ",2.6,0,"6f7q_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(341_B_)",103.274,"","",""
"6F9R","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT-ASP.","10.1111/FEBS.14421 ",1.85,0,"6f9r_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(416_B_)",51.9736,"","",""
"6F9R","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT-ASP.","10.1111/FEBS.14421 ",1.85,0,"6f9r_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",78.3768,"","",""
"6F9R","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT-ASP.","10.1111/FEBS.14421 ",1.85,0,"6f9r_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(480_A_)",58.5086,"","",""
"6F9R","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT-ASP.","10.1111/FEBS.14421 ",1.85,0,"6f9r_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(480_B_)",60.3827,"","",""
"6F9T","CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-1 CONVERTING ENZYME IN COMPLEX WITH SAMPATRILAT.","10.1111/FEBS.14421 ",1.6,0,"6f9t_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",51.383,"","",""
"6F9U","CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-1 CONVERTING ENZYME IN COMPLEX WITH SAMPATRILAT-ASP.","10.1111/FEBS.14421 ",1.9,0,"6f9u_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",62.3176,"","",""
"6F9V","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT.","10.1111/FEBS.14421 ",1.69,0,"6f9v_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(416_A_)",60.1549,"","",""
"6F9V","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT.","10.1111/FEBS.14421 ",1.69,0,"6f9v_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(480_A_)",57.8118,"","",""
"6FAT","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM.","10.1002/1873-3468.13776 ",2.3,34.96,"6fat_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(362_A_)",58.0965,"","",""
"6FAT","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM.","10.1002/1873-3468.13776 ",2.3,34.96,"6fat_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(151_B_)",41.289,"","",""
"6FAT","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM.","10.1002/1873-3468.13776 ",2.3,34.96,"6fat_oligo6","DManpa1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_H_)-MAN(9_H_)-[MAN(11_H_)]-MAN(8_H_)-[MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)]-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(362_B_)",39.1007,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_W_)-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(2365_D_)",106.033,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2365_A_)",161.549,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(2365_B_)",103.711,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Q_)-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(2365_C_)",84.2272,"","",""
"6FE5","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR JHU 2249","10.1016/J.BMC.2018.11.022 ",1.52,32.44,"6fe5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",44.9005,"","",""
"6FG7","CRYSTAL STRUCTURE OF THE BIR2 ECTODOMAIN FROM ARABIDOPSIS THALIANA.","10.1038/S41477-018-0150-9 ",1.9,37.28,"6fg7_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(58_A_)",53.8106,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_J_)-[NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_B_)",86.9288,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_A_)",47.6119,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo2","DGlcpNAcb1-2DManpa1-6[DManp[2<R1>]a1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_C_)",63.1947,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(297_D_)",91.1002,"","",""
"6FHW","STRUCTURE OF HORMOCONIS RESINAE GLUCOAMYLASE","10.1107/S2059798318004989 ",3.6,54.06,"6fhw_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",77.226,"","",""
"6FIF","CRYSTAL STRUCTURE OF THE BRI1 GLY644-ASP (BRI1-6) MUTANT FROM ARABIDOPSIS THALIANA.","10.1073/PNAS.1714972115 ",2.54,87.97,"6fif_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(573_A_)",170.144,"","",""
"6FIG","CRYSTAL STRUCTURE OF THE ANX1 ECTODOMAIN FROM ARABIDOPSIS THALIANA","10.1107/S205979831800774X ",1.48,32.54,"6fig_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(302_A_)",49.9764,"","",""
"6FJ3","HIGH RESOLUTION CRYSTAL STRUCTURE OF PARATHYROID HORMONE 1 RECEPTOR IN COMPLEX WITH A PEPTIDE AGONIST.","10.1038/S41594-018-0151-4 ",2.5,0,"6fj3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",77.5261,"","",""
"6FJ3","HIGH RESOLUTION CRYSTAL STRUCTURE OF PARATHYROID HORMONE 1 RECEPTOR IN COMPLEX WITH A PEPTIDE AGONIST.","10.1038/S41594-018-0151-4 ",2.5,0,"6fj3_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",147.566,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo42","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",52.9495,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo43","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",42.3558,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo37","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",49.23,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo40","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",39.6393,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo28","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",35.2355,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo34","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-[MAN(7_G_)]-MAN(4_G_)-[MAN(9_G_)-MAN(8_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",31.4304,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo29","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",34.69,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",45.1942,"","",""
"6FK6","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS01","10.1073/PNAS.1718084115 ",2.36,86.27,"6fk6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",107.065,"","",""
"6FK7","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS06","10.1073/PNAS.1718084115 ",2.62,0,"6fk7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",95.286,"","",""
"6FK8","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS08","10.1073/PNAS.1718084115 ",2.87,0,"6fk8_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",115.814,"","",""
"6FK9","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS09","10.1073/PNAS.1718084115 ",2.63,0,"6fk9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",113.036,"","",""
"6FKA","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS11","10.1073/PNAS.1718084115 ",2.7,0,"6fka_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",97.8678,"","",""
"6FKC","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS15","10.1073/PNAS.1718084115 ",2.46,0,"6fkc_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",91.3793,"","",""
"6FKD","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS16","10.1073/PNAS.1718084115 ",2.49,0,"6fkd_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",94.9826,"","",""
"6FKK","DROSOPHILA SEMAPHORIN 1B, EXTRACELLULAR DOMAINS 1-2","10.1038/S41467-019-11683-Y ",2.78,0,"6fkk_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(289_A_)",151.985,"","",""
"6FKM","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",2.96,0,"6fkm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(289_B_)",117.348,"","",""
"6FKM","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",2.96,0,"6fkm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(81_B_)",152.145,"","",""
"6FKN","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",4.8,0,"6fkn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(81_D_)",388.334,"","",""
"6FKN","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",4.8,0,"6fkn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(289_D_)",328.191,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(6_R_)-[NAG(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)]-C4W(1_R_)",49.7197,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(4_T_)-[BMA(3_T_)-NAG(2_T_)]-C4W(1_T_)",47.4359,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo6","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(7_S_)-[NAG(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)]-C4W(1_S_)",48.3782,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-C4W(1_V_)",47.9143,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(5_P_)-[MAN(4_P_)-BMA(3_P_)-NAG(2_P_)]-C4W(1_P_)",51.0396,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo8","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(8_U_)-[NAG(7_U_)-MAN(6_U_)-[NAG(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-C4W(1_U_)",45.1991,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(4_W_)-[BMA(3_W_)-NAG(2_W_)]-C4W(1_W_)",58.1216,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo11","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_X_)-[NAG(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)]-C4W(1_X_)",56.2018,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(7_Q_)-[NAG(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-C4W(1_Q_)",44.8705,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo3","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(6_O_)-[NAG(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)]-C4W(1_O_)",45.6217,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo12","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_M_)-[NAG(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-C4W(1_M_)",52.3867,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(8_N_)-[NAG(7_N_)-MAN(6_N_)-[NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-C4W(1_N_)",49.9314,"","",""
"6FX2","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,28.56,"6fx2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-C4W(1_C_)",39.6573,"","",""
"6FX2","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,28.56,"6fx2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-C4W(1_D_)",33.4188,"","",""
"6FX3","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DODECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,26.6,"6fx3_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(10_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)]-C4W(1_C_)",36.0636,"","",""
"6FX3","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DODECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,26.6,"6fx3_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(8_D_)-[SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-C4W(1_D_)",28.679,"","",""
"6FYT","STRUCTURE OF H1 (A/SOLOMON ISLANDS/3/06) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD38","10.1126/SCIENCE.AAQ0620 ",2.8,0,"6fyt_oligo4","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(33_A_)",139.273,"","",""
"6FYT","STRUCTURE OF H1 (A/SOLOMON ISLANDS/3/06) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD38","10.1126/SCIENCE.AAQ0620 ",2.8,0,"6fyt_oligo5","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(154_B_)",145.145,"","",""
"6FYW","STRUCTURE OF B/BRISBANE/60/2008 INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD83","10.1126/SCIENCE.AAQ0620 ",2.2,0,"6fyw_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",71.263,"","",""
"6G0X","TAILSPIKE PROTEIN OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","10.1021/JACS.8B03719 ",1.41,13.87,"6g0x_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAcb1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NAG(1_B_)",13.3591,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",71.6165,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",95.0465,"","",""
"6G95","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH THIORIDAZINE","10.1021/ACS.JMEDCHEM.8B00350 ",2.31,0,"6g95_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",123.262,"","",""
"6G9I","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH CLOMIPRAMINE","10.1021/ACS.JMEDCHEM.8B00350 ",2.19,0,"6g9i_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",154.258,"","",""
"6GCC","CRYSTAL STRUCTURE OF GLUTATHIONE TRANSFERASE XI 3 MUTANT C56S FROM TRAMETES VERSICOLOR IN COMPLEX WITH DEXTRAN-SULFATE","10.1002/1873-3468.13224 ",1.9,0,"6gcc_oligo1","DGlcp[3S,4S]a1-6DAltp[3S,4S]a1-6DAllp[2S,3S,4S]a1-O4S1","5LT(3_C_)-TUG(2_C_)-TUJ(1_C_)",43.4242,"","",""
"6GCC","CRYSTAL STRUCTURE OF GLUTATHIONE TRANSFERASE XI 3 MUTANT C56S FROM TRAMETES VERSICOLOR IN COMPLEX WITH DEXTRAN-SULFATE","10.1002/1873-3468.13224 ",1.9,0,"6gcc_oligo2","DGlcp[3S,4S]a1-6DAltp[3S,4S]a1-6DAllp[2S,3S,4S]a1-O4S1","5LT(3_D_)-TUG(2_D_)-TUJ(1_D_)",39.9333,"","",""
"6GF8","MOLECULAR BASIS OF EGG COAT FILAMENT CROSS-LINKING: STRUCTURE OF THE GLYCOSYLATED ZP1 ZP-N1 DOMAIN HOMODIMER","10.1038/S41467-019-10931-5 ",3.1,0,"6gf8_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(65_A_)",203.14,"","",""
"6GFE","HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY","10.1016/J.BPJ.2019.03.036 ",1.8,35.64,"6gfe_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_B_)-[NAG(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_K_)",42.4825,"","",""
"6GFE","HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY","10.1016/J.BPJ.2019.03.036 ",1.8,35.64,"6gfe_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_A_)-[NAG(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_H_)",33.1592,"","",""
"6GFF","STRUCTURE OF GARP (LRRC32) IN COMPLEX WITH LATENT TGF-BETA1 AND MHG-8 FAB","10.1126/SCIENCE.AAU2909 ",3.1,0,"6gff_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(345_J_)",114.974,"","",""
"6GKE","ALEURIA AURANTIA LECTIN AAL N224Q MUTANT IN COMPLEX WITH FUCALPHA1- 6GLCNAC","",1.08,8.95,"6gke_oligo2","LFucpa1-6DGlcpNAca1-ROH","FUC(2_B_)-NDG(1_B_)",15.6814,"","",""
"6GN7","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND NU172, A DUPLEX/QUADRUPLEX 26-MER DNA APTAMER, IN THE PRESENCE OF SODIUM IONS.","10.1093/NAR/GKY990 ",2.8,52.15,"6gn7_oligo18","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",122.001,"","",""
"6GRT","PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN","10.1074/JBC.RA118.004396 ",4.5,0,"6grt_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(479_B_)",273.173,"","",""
"6GSG","CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE CATECHOL OXIDASE COMPLEXED WITH RESORCINOL","10.1002/CBIC.201800387 ",2.19,0,"6gsg_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(104_A_)",91.3962,"","",""
"6GSZ","CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS","10.1107/S2059798318013049 ",1.38,19.39,"6gsz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(629_A_)",33.2035,"","",""
"6GSZ","CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS","10.1107/S2059798318013049 ",1.38,19.39,"6gsz_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(616_A_)",35.6462,"","",""
"6GSZ","CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS","10.1107/S2059798318013049 ",1.38,19.39,"6gsz_oligo7","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(749_A_)",33.2839,"","",""
"6GTV","CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI F18 WITH BOUND TRIMANNOSE","10.1021/JACS.8B10736 ",2.1,0,"6gtv_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_E_)-[MAN(2_E_)]-MAN(1_E_)",42.2633,"","",""
"6GTW","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI F18 IN COMPLEX WITH TRIMANNOSE","10.1021/JACS.8B10736 ",2.5,0,"6gtw_oligo2","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_F_)-[MAN(2_F_)]-MAN(1_F_)",46.9876,"","",""
"6GTW","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI F18 IN COMPLEX WITH TRIMANNOSE","10.1021/JACS.8B10736 ",2.5,0,"6gtw_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_E_)-[MAN(2_E_)]-MAN(1_E_)",45.3942,"","",""
"6GTY","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI K12 IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN","10.1021/JACS.8B10736 ",1.9,0,"6gty_oligo5","DManpa1-6DManpa1-OME","MAN(2_J_)-MMA(1_J_)",51.3673,"","",""
"6GTY","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI K12 IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN","10.1021/JACS.8B10736 ",1.9,0,"6gty_oligo3","DManpa1-6DManpa1-OME","MAN(2_H_)-MMA(1_H_)",21.55,"","",""
"6GTY","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI K12 IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN","10.1021/JACS.8B10736 ",1.9,0,"6gty_oligo1","DManpa1-6DManpa1-OME","MAN(2_F_)-MMA(1_F_)",22.5345,"","",""
"6GTY","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI K12 IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN","10.1021/JACS.8B10736 ",1.9,0,"6gty_oligo4","DManpa1-6DManpa1-OME","MAN(2_I_)-MMA(1_I_)",22.6427,"","",""
"6GTY","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI K12 IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN","10.1021/JACS.8B10736 ",1.9,0,"6gty_oligo2","DManpa1-6DManpa1-OME","MAN(2_G_)-MMA(1_G_)",22.6373,"","",""
"6GVP","TAILSPIKE PROTEIN MUTANT E372Q (DELTA N471/S472) OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1021/JACS.8B03719 ",1.71,17.14,"6gvp_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",17.9209,"","",""
"6GVR","TAILSPIKE PROTEIN MUTANT E372Q (DELTA N471/S472) OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","10.1021/JACS.8B03719 ",1.85,19.9,"6gvr_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",20.7371,"","",""
"6GYA","AMYLASE IN COMPLEX WITH BRANCHED LIGAND","10.1107/S2059798318014900 ",2.95,56.44,"6gya_oligo9","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_K_)-GLC(2_K_)-GLC(1_K_)",70.1482,"","",""
"6GYA","AMYLASE IN COMPLEX WITH BRANCHED LIGAND","10.1107/S2059798318014900 ",2.95,56.44,"6gya_oligo7","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_I_)-GLC(2_I_)-GLC(1_I_)",67.3106,"","",""
"6GYA","AMYLASE IN COMPLEX WITH BRANCHED LIGAND","10.1107/S2059798318014900 ",2.95,56.44,"6gya_oligo5","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_G_)-GLC(2_G_)-GLC(1_G_)",85.1076,"","",""
"6GYA","AMYLASE IN COMPLEX WITH BRANCHED LIGAND","10.1107/S2059798318014900 ",2.95,56.44,"6gya_oligo3","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_E_)-GLC(2_E_)-GLC(1_E_)",80.9718,"","",""
"6H0H","THE ABC TRANSPORTER ASSOCIATED BINDING PROTEIN FROM B. ANIMALIS SUBSP. LACTIS BL-04 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1074/JBC.RA119.008843 ",1.39,0,"6h0h_oligo1","DGalpb1-6DGalpb1-ROH","GAL(2_C_)-GAL(1_C_)",6.47364,"","",""
"6H0H","THE ABC TRANSPORTER ASSOCIATED BINDING PROTEIN FROM B. ANIMALIS SUBSP. LACTIS BL-04 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1074/JBC.RA119.008843 ",1.39,0,"6h0h_oligo2","DGalpb1-6DGalpb1-ROH","GAL(2_D_)-GAL(1_D_)",7.70182,"","",""
"6H15","STRUCTURE OF LRP6 P3E3P4E4 IN COMPLEX WITH VHH L-P2-B10","10.1038/S41467-018-08172-Z ",2.6,48.27,"6h15_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(859_B_)",98.6675,"","",""
"6H3T","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 1C11","10.1038/S41467-019-08832-8 ",2.84,88.28,"6h3t_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(686_A_)",126.604,"","",""
"6H3T","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 1C11","10.1038/S41467-019-08832-8 ",2.84,88.28,"6h3t_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(493_A_)",104.915,"","",""
"6H3T","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 1C11","10.1038/S41467-019-08832-8 ",2.84,88.28,"6h3t_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(686_B_)",141.473,"","",""
"6H3T","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 1C11","10.1038/S41467-019-08832-8 ",2.84,88.28,"6h3t_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(493_B_)",126.218,"","",""
"6H3U","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6","10.1038/S41467-019-08832-8 ",3.17,113.1,"6h3u_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(686_B_)",224.108,"","",""
"6H3U","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6","10.1038/S41467-019-08832-8 ",3.17,113.1,"6h3u_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(493_A_)",139.41,"","",""
"6H3U","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6","10.1038/S41467-019-08832-8 ",3.17,113.1,"6h3u_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(493_B_)",151.299,"","",""
"6H3U","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6","10.1038/S41467-019-08832-8 ",3.17,113.1,"6h3u_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(686_A_)",198.454,"","",""
"6H3V","BUNYAMWERA VIRUS GLYCOPROTEIN GC HEAD DOMAIN","10.1038/S41467-019-08832-8 ",2.9,103.2,"6h3v_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(624_A_)",138.09,"","",""
"6H3W","LA CROSSE VIRUS GLYCOPROTEIN GC HEAD DOMAIN","10.1038/S41467-019-08832-8 ",2.1,31.72,"6h3w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(490_A_)",48.5913,"","",""
"6H5W","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1021/ACS.JMEDCHEM.8B01309 ",1.37,0,"6h5w_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",47.441,"","",""
"6H5X","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1021/ACS.JMEDCHEM.8B01309 ",1.8,0,"6h5x_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(416_B_)",56.0723,"","",""
"6H5X","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1021/ACS.JMEDCHEM.8B01309 ",1.8,0,"6h5x_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(480_B_)",63.3818,"","",""
"6H5X","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1021/ACS.JMEDCHEM.8B01309 ",1.8,0,"6h5x_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_A_)",58.6568,"","",""
"6H5X","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1021/ACS.JMEDCHEM.8B01309 ",1.8,0,"6h5x_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",69.2558,"","",""
"6H7Y","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 1-79-1","10.1021/ACSMEDCHEMLETT.8B00318 ",1.81,43.92,"6h7y_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",55.506,"","",""
"6H7Z","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 2-65-1","10.1021/ACSMEDCHEMLETT.8B00318 ",2,23.25,"6h7z_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",39.5818,"","",""
"6HA9","STRUCTURE OF AN ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS COMPLEXED WITH XXXG(2F)-BETA-DNP","10.1039/C8OB02250J ",2,39.87,"6ha9_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DManp[2<R1>,2H]b1-C6N2O5","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-NFG(1_D_)",37.3291,"","",""
"6HA9","STRUCTURE OF AN ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS COMPLEXED WITH XXXG(2F)-BETA-DNP","10.1039/C8OB02250J ",2,39.87,"6ha9_oligo1","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DManp[2<R1>,2H]b1-C6N2O5","XYS(6_C_)-[XYS(5_C_)-[BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-NFG(1_C_)",33.1514,"","",""
"6HAA","STRUCTURE OF A COVALENT COMPLEX OF ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS AFTER REACTING WITH XXXG(2F)-BETA-DNP","10.1039/C8OB02250J ",1.7,38.45,"6haa_oligo4","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DManp[2<R1>,2H]a1-GLU","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-G2F(1_D_)-GLU(390_B_)",40.3298,"","",""
"6HAA","STRUCTURE OF A COVALENT COMPLEX OF ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS AFTER REACTING WITH XXXG(2F)-BETA-DNP","10.1039/C8OB02250J ",1.7,38.45,"6haa_oligo3","DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DManp[2<R1>,2H]a1-GLU","XYS(6_C_)-[XYS(5_C_)-[BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-G2F(1_C_)-GLU(390_A_)",31.4448,"","",""
"6HCX","INFLUENZA VIRUS N9 NEURAMINIDASE A COMPLEX WITH ZANAMIVIR MOLECULE (TERN).","",1.3,15.04,"6hcx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",22.1121,"","",""
"6HEB","INFLUENZA A VIRUS N9 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (TERN).","",1.75,14.39,"6heb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(202_A_)",21.7317,"","",""
"6HF4","THE STRUCTURE OF BOMAN26B, A GH26 BETA-MANNANASE FROM BACTEROIDES OVATUS, COMPLEXED WITH G1M4","10.1074/JBC.RA118.007171 ",1.78,0,"6hf4_oligo1","DManpb1-4[DGalpa1-6]DManpb1-4DManpb1-4DManpb1-ROH","GLA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-BMA(2_B_)-BMA(1_B_)",40.872,"","",""
"6HFC","INFLUENZA A VIRUS N9 NEURAMINIDASE NATIVE (TERN).","",1.29,20.27,"6hfc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",32.7769,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(201_B_)",33.7579,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(201_A_)",30.2549,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo5","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(201_C_)",39.6877,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(201_D_)",36.3067,"","",""
"6HG0","INFLUENZA A VIRUS N9 NEURAMINIDASE COMPLEX WITH NANA (TERN/AUSTRALIA).","",1.3,13.5,"6hg0_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",25.1245,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo8","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(201_D_)",29.3961,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(201_A_)",23.21,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(201_C_)",30.4664,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(201_B_)",27.2747,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo8","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(201_C_)",28.4158,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo9","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(201_D_)",28.7035,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(201_A_)",21.962,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(201_B_)",24.5471,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(91_C_)",189.098,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(27_A_)",140.417,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(27_C_)",140.417,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(91_E_)",189.098,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(91_A_)",189.098,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(27_E_)",140.417,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(91_E_)",217.871,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(91_A_)",217.802,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(27_A_)",226.324,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(91_C_)",217.803,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_X_)-[BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(27_E_)",225.781,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(27_C_)",226.028,"","",""
"6HJQ","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",4.1,0,"6hjq_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(27_C_)",175.468,"","",""
"6HJQ","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",4.1,0,"6hjq_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(27_A_)",175.468,"","",""
"6HJQ","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",4.1,0,"6hjq_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(27_E_)",175.468,"","",""
"6HJR","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ WITH TILTED TRANSMEMBRANE (A/DUCK/ALBERTA/35/76[H1N1])","10.1073/PNAS.1810927115 ",4.2,0,"6hjr_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(27_A_)",232.423,"","",""
"6HJR","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ WITH TILTED TRANSMEMBRANE (A/DUCK/ALBERTA/35/76[H1N1])","10.1073/PNAS.1810927115 ",4.2,0,"6hjr_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(27_E_)",238.945,"","",""
"6HJR","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ WITH TILTED TRANSMEMBRANE (A/DUCK/ALBERTA/35/76[H1N1])","10.1073/PNAS.1810927115 ",4.2,0,"6hjr_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(27_C_)",224.681,"","",""
"6HP0","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE","10.1016/J.BMC.2019.05.024 ",1.88,21.87,"6hp0_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(88_A_)",53.84,"","",""
"6HP0","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE","10.1016/J.BMC.2019.05.024 ",1.88,21.87,"6hp0_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(88_B_)",57.643,"","",""
"6HP0","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE","10.1016/J.BMC.2019.05.024 ",1.88,21.87,"6hp0_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(88_C_)",58.4009,"","",""
"6HP0","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE","10.1016/J.BMC.2019.05.024 ",1.88,21.87,"6hp0_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(88_D_)",52.3473,"","",""
"6HP0","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE","10.1016/J.BMC.2019.05.024 ",1.88,21.87,"6hp0_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(146_C_)",37.4679,"","",""
"6HP0","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE","10.1016/J.BMC.2019.05.024 ",1.88,21.87,"6hp0_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(146_A_)",54.6827,"","",""
"6HPF","STRUCTURE OF INACTIVE E165Q MUTANT OF FUNGAL NON-CBM CARRYING GH26 ENDO-B-MANNANASE FROM YUNNANIA PENICILLATA IN COMPLEX WITH ALPHA-62- 61-DI-GALACTOSYL-MANNOTRIOSE","10.1038/S41598-019-38602-X ",1.36,18.04,"6hpf_oligo1","DManpb1-4[DGalpa1-6]DManpb1-4[DGalpa1-6]DManpa1-ROH","GLA(5_B_)-[GLA(4_B_)-[BMA(3_B_)]-BMA(2_B_)]-MAN(1_B_)",24.9418,"","",""
"6HRO","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH INHIBITOR 118A","10.1021/ACS.JMEDCHEM.8B01328 ",2.3,0,"6hro_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",136.312,"","",""
"6HS4","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH INHIBITOR 118","10.1021/ACS.JMEDCHEM.8B01328 ",2.05,0,"6hs4_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",105.534,"","",""
"6HTV","CRYSTAL STRUCTURE OF LEUCONOSTOC CITREUM NRRL B-1299 N-TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-M IN COMPLEX WITH ISOMALTOTETRAOSE","10.1021/ACS.BIOCHEM.9B00373 ",3.9,115.3,"6htv_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",157.597,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-[MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",45.2824,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",48.7914,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",56.0283,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",68.8436,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",73.4616,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",59.4049,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",62.0142,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",58.0084,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",82.4418,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",98.6412,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",108.811,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",90.9571,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",76.1327,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",63.6379,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",60.0994,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",59.5375,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",103.476,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",116.475,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",112.294,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",102.414,"","",""
"6HZN","CRYSTAL STRUCTURE OF HUMAN DERMATAN SULFATE EPIMERASE 1","10.1039/D0SC05971D ",2.41,0,"6hzn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(336_A_)",106.805,"","",""
"6HZZ","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE","10.1073/PNAS.1818333116 ",2.52,54.66,"6hzz_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(225_A_)",109.389,"","",""
"6HZZ","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE","10.1073/PNAS.1818333116 ",2.52,54.66,"6hzz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(393_B_)",111.502,"","",""
"6HZZ","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE","10.1073/PNAS.1818333116 ",2.52,54.66,"6hzz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(393_A_)",105.622,"","",""
"6HZZ","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE","10.1073/PNAS.1818333116 ",2.52,54.66,"6hzz_oligo4","DGlcpNAcb1-4[LGlcp[6H,4H]a1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(303_B_)",99.5612,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(393_B_)",103.91,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo4","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(225_B_)",86.5484,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(393_A_)",93.7493,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(225_A_)",85.052,"","",""
"6I02","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH PRODUCT","10.1073/PNAS.1818333116 ",2.45,54.73,"6i02_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(225_B_)",112.671,"","",""
"6I02","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH PRODUCT","10.1073/PNAS.1818333116 ",2.45,54.73,"6i02_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(225_A_)",98.1355,"","",""
"6I0B","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE S ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR.","10.1016/J.EJMECH.2019.02.021 ",2.38,0,"6i0b_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",110.267,"","",""
"6I0B","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE S ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR.","10.1016/J.EJMECH.2019.02.021 ",2.38,0,"6i0b_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",91.5158,"","",""
"6I0B","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE S ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR.","10.1016/J.EJMECH.2019.02.021 ",2.38,0,"6i0b_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",106.687,"","",""
"6I0C","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE R ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR.","10.1016/J.EJMECH.2019.02.021 ",2.68,0,"6i0c_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",120.344,"","",""
"6I0C","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE R ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR.","10.1016/J.EJMECH.2019.02.021 ",2.68,0,"6i0c_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",104.662,"","",""
"6I0C","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE R ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR.","10.1016/J.EJMECH.2019.02.021 ",2.68,0,"6i0c_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",115.472,"","",""
"6I2K","STRUCTURE OF EV71 COMPLEXED WITH ITS RECEPTOR SCARB2","10.1038/S41564-018-0319-Z ",3.4,0,"6i2k_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(325_E_)",241.234,"","",""
"6I2K","STRUCTURE OF EV71 COMPLEXED WITH ITS RECEPTOR SCARB2","10.1038/S41564-018-0319-Z ",3.4,0,"6i2k_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(412_E_)",324.282,"","",""
"6I3F","CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ANGIOTENSINOGEN AND RENIN AT 2.55 ANGSTROM","10.1074/JBC.RA118.006608 ",2.55,40.39,"6i3f_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(75_B_)",82.3139,"","",""
"6I3J","BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA IN COMPLEX WITH FERRICYANIDE","10.1038/S41598-019-50105-3 ",2.59,36.14,"6i3j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(472_A_)",74.0665,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(111_D_)",171.022,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(111_A_)",156.4,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_B_)",159.316,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_E_)",153.453,"","",""
"6I6X","NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES","10.1002/CHEM.201804662 ",2.39,41.98,"6i6x_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",42.6251,"","",""
"6I6X","NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES","10.1002/CHEM.201804662 ",2.39,41.98,"6i6x_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",65.1871,"","",""
"6IAA","HROBO2 ECTODOMAIN","10.1016/J.CELL.2019.02.004 ",3.6,0,"6iaa_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",147.934,"","",""
"6IAA","HROBO2 ECTODOMAIN","10.1016/J.CELL.2019.02.004 ",3.6,0,"6iaa_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",166.729,"","",""
"6IAA","HROBO2 ECTODOMAIN","10.1016/J.CELL.2019.02.004 ",3.6,0,"6iaa_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",152.02,"","",""
"6IBK","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOSULFAMIDATE ME763","10.1039/C9SC03342D ",1.99,56.99,"6ibk_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(192_B_)",95.8302,"","",""
"6IBM","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOSULFATE ME776","10.1039/C9SC03342D ",2.07,55.24,"6ibm_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",100.193,"","",""
"6IDF","CRYO-EM STRUCTURE OF GAMMA SECRETASE IN COMPLEX WITH A NOTCH FRAGMENT","10.1038/S41586-018-0813-8 ",2.7,"1.35632e-19","6idf_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(55_A_)",70.3275,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",319.482,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",232.727,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(8_P_)-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",225.144,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo4","DManpa1-6DManpx1-","MAN(2_J_)-MAN(1_J_)",317.272,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",297.082,"","",""
"6IFJ","STRUCTURE OF BISPECIFIC FC","",2.4,43.53,"6ifj_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_E_)-[NAG(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",54.7644,"","",""
"6IFJ","STRUCTURE OF BISPECIFIC FC","",2.4,43.53,"6ifj_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",58.2293,"","",""
"6IJJ","PHOTOSYSTEM I OF CHLAMYDOMONAS REINHARDTII","10.1038/S41477-019-0380-5 ",2.89,"1.08527e-19","6ijj_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(850_B_)-DGD(850_B_)",36.86,"","",""
"6IJJ","PHOTOSYSTEM I OF CHLAMYDOMONAS REINHARDTII","10.1038/S41477-019-0380-5 ",2.89,"1.08527e-19","6ijj_oligo12","DGalpa1-6DGalpb1-C31O5","DGD(103_J_)-DGD(103_J_)",71.53,"","",""
"6IJO","PHOTOSYSTEM I OF CHLAMYDOMONAS REINHARDTII","10.1038/S41477-019-0380-5 ",3.3,"1.08527e-19","6ijo_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(850_B_)-DGD(850_B_)",28.37,"","",""
"6IJO","PHOTOSYSTEM I OF CHLAMYDOMONAS REINHARDTII","10.1038/S41477-019-0380-5 ",3.3,"1.08527e-19","6ijo_oligo16","DGalpa1-6DGalpb1-C31O5","DGD(103_J_)-DGD(103_J_)",54.7,"","",""
"6IK8","CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1007/S00425-020-03481-4 ",2.8,52.38,"6ik8_oligo2","DGalpb1-6DGalpb1-ROH","GAL(2_D_)-GAL(1_D_)",95.6668,"","",""
"6IK8","CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1007/S00425-020-03481-4 ",2.8,52.38,"6ik8_oligo4","DGalpb1-6DGalpb1-ROH","GAL(2_F_)-GAL(1_F_)",98.4273,"","",""
"6IOZ","STRUCTURAL INSIGHTS OF IDURSULFASE BETA","",3.1,85.65,"6ioz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(513_A_)",120.866,"","",""
"6IOZ","STRUCTURAL INSIGHTS OF IDURSULFASE BETA","",3.1,85.65,"6ioz_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(115_A_)",116.382,"","",""
"6IQG","X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqg_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",57.5967,"","",""
"6IQG","X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqg_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",60.6374,"","",""
"6IQH","X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqh_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",65.2675,"","",""
"6IQH","X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqh_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",53.7805,"","",""
"6IUJ","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS","10.1074/JBC.RA118.007207 ",2.25,29.48,"6iuj_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_B_)",56.8585,"","",""
"6IUJ","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS","10.1074/JBC.RA118.007207 ",2.25,29.48,"6iuj_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(60_B_)",56.6602,"","",""
"6IUJ","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS","10.1074/JBC.RA118.007207 ",2.25,29.48,"6iuj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(88_A_)",47.7498,"","",""
"6IUT","CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY AVFLUIGG01","10.1074/JBC.RA118.007008 ",2.3,0,"6iut_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(165_A_)",54.5327,"","",""
"6IUV","CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11","10.1074/JBC.RA118.007008 ",2.33,0,"6iuv_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",64.2906,"","",""
"6IUV","CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11","10.1074/JBC.RA118.007008 ",2.33,0,"6iuv_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_B_)",66.5573,"","",""
"6IYC","RECOGNITION OF THE AMYLOID PRECURSOR PROTEIN BY HUMAN GAMMA-SECRETASE","10.1126/SCIENCE.AAW0930 ",2.6,"1.57771e-19","6iyc_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(55_A_)",64.7514,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo5","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(222_B_)",79.7082,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo11","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(222_A_)",62.1653,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo15","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(7_X_)-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(222_C_)",94.8035,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(125_B_)",96.1898,"","",""
"6J15","COMPLEX STRUCTURE OF GY-5 FAB AND PD-1","10.1016/J.ISCI.2019.03.017 ",2.6,0,"6j15_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(58_C_)",39.4861,"","",""
"6J15","COMPLEX STRUCTURE OF GY-5 FAB AND PD-1","10.1016/J.ISCI.2019.03.017 ",2.6,0,"6j15_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(58_D_)",49.9995,"","",""
"6JAD","CRYSTAL STRUCTURE OF ABC TRANSPORTER ALPHA-GLYCOSIDE-BINDING PROTEIN IN COMPLEX WITH PALATINOSE","10.1111/FEBS.15093 ",1.9,22.41,"6jad_oligo1","DGlcpa1-6DFrufa2-ROH","GLC(2_B_)-Z9N(1_B_)",15.7375,"","",""
"6JAO","CRYSTAL STRUCTURE OF ABC TRANSPORTER ALPHA-GLYCOSIDE-BINDING MUTANT PROTEIN R356A IN COMPLEX WITH PALATINOSE","10.1111/FEBS.15093 ",1.77,20.91,"6jao_oligo1","DGlcpa1-6DFrufa2-ROH","GLC(2_B_)-Z9N(1_B_)",12.7159,"","",""
"6JBA","CRYSTAL STRUCTURE OF ABC TRANSPORTER ALPHA-GLYCOSIDE-BINDING MUTANT PROTEIN W287A IN COMPLEX WITH PALATINOSE","10.1111/FEBS.15093 ",2,22.99,"6jba_oligo1","DGlcpa1-6DFrufa2-ROH","GLC(2_B_)-Z9N(1_B_)",21.2694,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo8","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(272_C_)",46.3161,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo1","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(272_A_)",49.6883,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(272_B_)",58.7441,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo11","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(272_D_)",49.6532,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo9","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[BMA(4_M_)]-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(457_C_)",46.8125,"","",""
"6JBT","COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1","10.1080/19420862.2019.1596513 ",2.47,0,"6jbt_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(39_F_)",58.8582,"","",""
"6JBT","COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1","10.1080/19420862.2019.1596513 ",2.47,0,"6jbt_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(30_F_)",68.6655,"","",""
"6JJP","CRYSTAL STRUCTURE OF FAB OF A PD-1 MONOCLONAL ANTIBODY MW11-H317 IN COMPLEX WITH PD-1","10.1038/S42003-019-0642-9 ",2.9,55.25,"6jjp_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(58_F_)",53.6247,"","",""
"6JJP","CRYSTAL STRUCTURE OF FAB OF A PD-1 MONOCLONAL ANTIBODY MW11-H317 IN COMPLEX WITH PD-1","10.1038/S42003-019-0642-9 ",2.9,55.25,"6jjp_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(58_C_)",57.462,"","",""
"6JK3","CRYSTAL STRUCTURE OF A MINI FUNGAL LECTIN, PHOSL IN COMPLEX WITH CORE- FUCOSYLATED CHITOBIOSE","",1.12,17.24,"6jk3_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",23.2197,"","",""
"6JK3","CRYSTAL STRUCTURE OF A MINI FUNGAL LECTIN, PHOSL IN COMPLEX WITH CORE- FUCOSYLATED CHITOBIOSE","",1.12,17.24,"6jk3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",21.3073,"","",""
"6JK3","CRYSTAL STRUCTURE OF A MINI FUNGAL LECTIN, PHOSL IN COMPLEX WITH CORE- FUCOSYLATED CHITOBIOSE","",1.12,17.24,"6jk3_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)",20.9509,"","",""
"6JLA","CRYSTAL STRUCTURE OF A MOUSE EPENDYMIN RELATED PROTEIN","10.1107/S2052252519007668 ",2.4,53.98,"6jla_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(182_B_)",64.2654,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",44.0509,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo50","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",43.6727,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo49","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",48.0536,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(101_e_)-DGD(101_e_)",155.955,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",50.8214,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo48","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",38.8914,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",56.3836,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(521_c_)-DGD(521_c_)",46.9977,"","",""
"6JLJ","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlj_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",59.7455,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",43.8523,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo31","DGalpa1-6DGalpb1-C35O5","DGD(101_e_)-DGD(101_e_)",155.451,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(521_c_)-DGD(521_c_)",50.4977,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",50.4105,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",43.1323,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(522_c_)-DGD(522_c_)",48.2691,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo32","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",58.035,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",55.1959,"","",""
"6JLK","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jlk_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",38.6295,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo52","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",43.9245,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",42.2832,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",54.7873,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo26","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",55.6209,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo51","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",47.085,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(521_c_)-DGD(521_c_)",45.7045,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo50","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",37.8173,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(101_e_)-DGD(101_e_)",147.056,"","",""
"6JLL","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET1)","10.1126/SCIENCE.AAX6998 ",2.15,0,"6jll_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",48.2955,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(918_c_)-DGD(918_c_)",50.6923,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",60.6332,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",68.4136,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo28","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",43.5959,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(101_e_)-DGD(101_e_)",185.33,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(917_c_)-DGD(917_c_)",51.5918,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",53.1086,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(916_c_)-DGD(916_c_)",50.5195,"","",""
"6JLM","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (DARK STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.35,0,"6jlm_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",59.1391,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo39","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",47.8145,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(101_e_)-DGD(101_e_)",171.564,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo41","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",62.6659,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",58.7795,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo43","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",77.2995,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",60.5736,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",71.3118,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(521_c_)-DGD(521_c_)",58.9073,"","",""
"6JLN","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (1F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jln_oligo40","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",67.6741,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",70.1873,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",65.7586,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo35","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",67.5741,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(408_d_)-DGD(408_d_)",163.541,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(521_c_)-DGD(521_c_)",60.1814,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",58.4755,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo34","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",48.1368,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",62.2691,"","",""
"6JLO","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (2F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.4,0,"6jlo_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",77.8986,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",56.4782,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(632_B_)-DGD(632_B_)",75.9759,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(521_c_)-DGD(521_c_)",60.8659,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",48.3273,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(408_d_)-DGD(408_d_)",163.106,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo31","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",70.6141,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",70.0427,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",61.1736,"","",""
"6JLP","XFEL STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II (3F STATE, DATASET2)","10.1126/SCIENCE.AAX6998 ",2.5,0,"6jlp_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",62.8732,"","",""
"6JO5","STRUCTURE OF THE GREEN ALGAL PHOTOSYSTEM I SUPERCOMPLEX WITH LIGHT- HARVESTING COMPLEX I","10.1038/S41477-019-0438-4 ",2.9,512.502,"6jo5_oligo3","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",14.84,"","",""
"6JO6","STRUCTURE OF THE GREEN ALGAL PHOTOSYSTEM I SUPERCOMPLEX WITH LIGHT- HARVESTING COMPLEX I","10.1038/S41477-019-0438-4 ",2.9,512.502,"6jo6_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",26.81,"","",""
"6JR7","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, COMPLEXED WITH GLUCOSE","10.1111/FEBS.15074 ",1.75,23,"6jr7_oligo1","DGlcpa1-6DGlcpa1-ROH","GLC(2_E_)-GLC(1_E_)",30.3995,"","",""
"6JR7","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, COMPLEXED WITH GLUCOSE","10.1111/FEBS.15074 ",1.75,23,"6jr7_oligo4","DGlcpa1-6DGlcpa1-ROH","GLC(2_H_)-GLC(1_H_)",34.9836,"","",""
"6JR7","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, COMPLEXED WITH GLUCOSE","10.1111/FEBS.15074 ",1.75,23,"6jr7_oligo3","DGlcpa1-6DGlcpa1-ROH","GLC(2_G_)-GLC(1_G_)",32.7005,"","",""
"6JR7","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, COMPLEXED WITH GLUCOSE","10.1111/FEBS.15074 ",1.75,23,"6jr7_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_F_)-GLC(1_F_)",33.4145,"","",""
"6JR8","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, MUTANT D412A COMPLEXED WITH ISOMALTOTRIOSE","10.1111/FEBS.15074 ",1.8,20.26,"6jr8_oligo4","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_H_)-GLC(2_H_)-GLC(1_H_)",15.5476,"","",""
"6JR8","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, MUTANT D412A COMPLEXED WITH ISOMALTOTRIOSE","10.1111/FEBS.15074 ",1.8,20.26,"6jr8_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_F_)-GLC(2_F_)-GLC(1_F_)",16.4797,"","",""
"6JR8","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, MUTANT D412A COMPLEXED WITH ISOMALTOTRIOSE","10.1111/FEBS.15074 ",1.8,20.26,"6jr8_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_E_)-GLC(2_E_)-GLC(1_E_)",15.8764,"","",""
"6JR8","FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, MUTANT D412A COMPLEXED WITH ISOMALTOTRIOSE","10.1111/FEBS.15074 ",1.8,20.26,"6jr8_oligo3","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_G_)-GLC(2_G_)-GLC(1_G_)",18.2939,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo51","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_1_)-[BMA(3_1_)-NAG(2_1_)]-NAG(1_1_)-ASN(949_C_)",175.545,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_T_)-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(1218_A_)",128.639,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo33","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_j_)-[BMA(3_j_)-NAG(2_j_)]-NAG(1_j_)-ASN(949_B_)",175.545,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo17","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(482_B_)",110.118,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo49","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_z_)-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(862_C_)",124.457,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo16","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_a_)-MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(357_B_)",96.2194,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo30","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(841_B_)",115.226,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo53","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_3_)-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(1218_C_)",128.639,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo21","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(547_A_)",122.364,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo45","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_v_)-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(547_C_)",122.364,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo43","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_t_)-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(482_C_)",110.118,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo26","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(357_A_)",96.2194,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(1092_B_)",94.2756,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo48","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_y_)-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(841_C_)",115.226,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo19","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(547_B_)",122.364,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_R_)-[BMA(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(949_A_)",175.545,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo31","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(862_B_)",124.457,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo35","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_l_)-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(1218_B_)",128.639,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(862_A_)",124.457,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo24","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(841_A_)",115.226,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo42","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(357_C_)",96.2194,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(1092_A_)",94.2756,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(482_A_)",110.118,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo52","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_2_)-[MAN(4_2_)]-BMA(3_2_)-NAG(2_2_)-NAG(1_2_)-ASN(1092_C_)",94.2756,"","",""
"6KA7","THE COMPLEX STRUCTURE OF HUMAN IGG FC AND ITS BINDING REPEBODY","",3,57.46,"6ka7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_D_)",68.6768,"","",""
"6KA7","THE COMPLEX STRUCTURE OF HUMAN IGG FC AND ITS BINDING REPEBODY","",3,57.46,"6ka7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_C_)",85.4357,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo17","DGalpa1-6DGalpb1-C32O5","DGD(520_c_)-DGD(520_c_)",36.18,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo19","DGalpa1-6DGalpb1-C39O5","DGD(524_c_)-DGD(524_c_)",43.06,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo4","DGalpa1-6DGalpb1-C32O5","DGD(520_C_)-DGD(520_C_)",36.47,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",38.05,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo21","DGalpa1-6DGalpb1-C39O5","DGD(524_C_)-DGD(524_C_)",43.08,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo18","DGalpa1-6DGalpb1-C39O5","DGD(523_c_)-DGD(523_c_)",39.93,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",37.78,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo20","DGalpa1-6DGalpb1-C39O5","DGD(523_C_)-DGD(523_C_)",39.83,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo22","DGalpa1-6DGalpb1-C28O5","DGD(518_c_)-DGD(518_c_)",28.57,"","",""
"6KAC","CRYO-EM STRUCTURE OF THE C2S2-TYPE PSII-LHCII SUPERCOMPLEX FROM CHLAMYDOMONAS REIHARDTII","10.1038/S41477-019-0543-4 ",2.7,"1.35632e-19","6kac_oligo28","DGalpa1-6DGalpb1-C28O5","DGD(518_C_)-DGD(518_C_)",28.79,"","",""
"6KD5","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MSPL/TMPRSS13 IN COMPLEX WITH DEC-RVKR-CMK INHIBITOR","10.26508/LSA.202000849 ",2.6,33.14,"6kd5_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(255_A_)",46.8664,"","",""
"6KFB","HYDROXYNITRILE LYASE FROM THE MILLIPEDE, CHAMBERLINIUS HUALIENENSIS BOUND WITH THIOCYANATE","10.1111/FEBS.15490 ",1.55,19.12,"6kfb_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(123_A_)",41.1823,"","",""
"6KFC","HYDROXYNITRILE LYASE FROM THE MILLIPEDE, CHAMBERLINIUS HUALIENENSIS, COMPLEXED WITH CYANIDE ION","10.1111/FEBS.15490 ",2.1,32.2,"6kfc_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(123_A_)",80.4314,"","",""
"6KHI","SUPERCOMPLEX FOR CYLIC ELECTRON TRANSPORT IN CYANOBACTERIA","10.1038/S41467-020-14456-0 ",3,"1.08527e-19","6khi_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(402_A_)-DGD(402_A_)",65.96,"","",""
"6KHI","SUPERCOMPLEX FOR CYLIC ELECTRON TRANSPORT IN CYANOBACTERIA","10.1038/S41467-020-14456-0 ",3,"1.08527e-19","6khi_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(401_A_)-DGD(401_A_)",61.99,"","",""
"6KHJ","SUPERCOMPLEX FOR ELECTRON TRANSFER","10.1038/S41467-020-14456-0 ",3,"1.08527e-19","6khj_oligo5","DGalpa1-6DGalpb1-C28O5","DGD(401_A_)-DGD(401_A_)",49.95,"","",""
"6KHJ","SUPERCOMPLEX FOR ELECTRON TRANSFER","10.1038/S41467-020-14456-0 ",3,"1.08527e-19","6khj_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(402_A_)-DGD(402_A_)",55.04,"","",""
"6KJ0","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL MUTANT E529Q C2221","10.1038/S42003-019-0744-4 ",2.27,33.8,"6kj0_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(457_A_)",60.9777,"","",""
"6KJ0","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL MUTANT E529Q C2221","10.1038/S42003-019-0744-4 ",2.27,33.8,"6kj0_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(457_B_)",65.5198,"","",""
"6KJ0","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL MUTANT E529Q C2221","10.1038/S42003-019-0744-4 ",2.27,33.8,"6kj0_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(272_A_)",37.9095,"","",""
"6KJ0","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL MUTANT E529Q C2221","10.1038/S42003-019-0744-4 ",2.27,33.8,"6kj0_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(272_B_)",47.8731,"","",""
"6KPN","CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM CORDYCEPS MILITARIS D154N/E156Q MUTANT IN COMPLEX WITH FUCOSYL-N- ACETYLGLUCOSAMINE","10.1074/JBC.RA119.010842 ",2.1,40.47,"6kpn_oligo1","LFucpa1-6DGlcpNAcb1-ROH","FUC(2_B_)-NAG(1_B_)",39.8068,"","",""
"6KPO","CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM CORDYCEPS MILITARIS D154N/E156Q MUTANT IN COMPLEX WITH FUCOSYL-N- ACETYLGLUCOSAMINE-ASN","10.1074/JBC.RA119.010842 ",2.36,60.8,"6kpo_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(406_A_)",90.3696,"","",""
"6KRL","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS EXPRESSED BY PICHIA PASTORIS","10.1002/2211-5463.12873 ",1.6,22.06,"6krl_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(412_A_)",27.8016,"","",""
"6KRL","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS EXPRESSED BY PICHIA PASTORIS","10.1002/2211-5463.12873 ",1.6,22.06,"6krl_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(60_A_)",39.9559,"","",""
"6KRN","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS EXPRESSED BY PICHIA PASTORIS IN COMPLEX WITH ALDOTRIURONIC ACID","10.1002/2211-5463.12873 ",1.65,23.32,"6krn_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(60_A_)",38.6476,"","",""
"6KRN","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS EXPRESSED BY PICHIA PASTORIS IN COMPLEX WITH ALDOTRIURONIC ACID","10.1002/2211-5463.12873 ",1.65,23.32,"6krn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(412_A_)",28.91,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",76.5933,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_C_)",72.5033,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)-[NAG(8_L_)-MAN(7_L_)]-MAN(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_F_)",65.093,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_D_)",66.0174,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-MAN(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",63.1105,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_K_)-NAG(5_K_)-MAN(4_K_)-[NAG(8_K_)-MAN(7_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_E_)",109.683,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",190.445,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcx1-","NAG(6_F_)-MAN(5_F_)-[NAG(4_F_)-MAN(3_F_)]-MAN(2_F_)-NAG(1_F_)",227.744,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",144.018,"","",""
"6KYA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX TH1027","10.1021/ACS.JMEDCHEM.9B02128 ",2.89,100.1,"6kya_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",98.8778,"","",""
"6KYA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX TH1027","10.1021/ACS.JMEDCHEM.9B02128 ",2.89,100.1,"6kya_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",89.3013,"","",""
"6L2J","CRYSTAL STRUCTURE OF YAK LACTOPEROXIDASE AT 1.93 A RESOLUTION.","",1.93,19.7,"6l2j_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(205_A_)",30.9282,"","",""
"6L35","PSI-LHCI SUPERCOMPLEX FROM PHYSCOMETRELLA PATENS","10.1038/S41421-021-00242-9 ",3.23,861509,"6l35_oligo4","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",53.15,"","",""
"6L6R","CRYSTAL STRUCTURE OF LRP6 E1E2-SOST COMPLEX","10.1038/S41467-020-19155-4 ",3.8,100.5,"6l6r_oligo4","LFucpa1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(81_B_)",131.807,"","",""
"6L6R","CRYSTAL STRUCTURE OF LRP6 E1E2-SOST COMPLEX","10.1038/S41467-020-19155-4 ",3.8,100.5,"6l6r_oligo2","LFucpa1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(81_A_)",131.813,"","",""
"6L7O","CRYO-EM STRUCTURE OF CYANOBACTERIA FD-NDH-1L COMPLEX","10.1038/S41467-020-14732-Z ",3.2,131200,"6l7o_oligo28","DGalpa1-6DGalpb1-C39O5","DGD(404_A_)-DGD(404_A_)",77.22,"","",""
"6L7O","CRYO-EM STRUCTURE OF CYANOBACTERIA FD-NDH-1L COMPLEX","10.1038/S41467-020-14732-Z ",3.2,131200,"6l7o_oligo27","DGalpa1-6DGalpb1-C39O5","DGD(403_A_)-DGD(403_A_)",73.43,"","",""
"6L7P","CRYO-EM STRUCTURE OF CYANOBACTERIA NDH-1LDELV COMPLEX","10.1038/S41467-020-14732-Z ",3.6,"1.08527e-19","6l7p_oligo40","DGalpa1-6DGalpb1-C39O5","DGD(404_A_)-DGD(404_A_)",48.41,"","",""
"6L7P","CRYO-EM STRUCTURE OF CYANOBACTERIA NDH-1LDELV COMPLEX","10.1038/S41467-020-14732-Z ",3.6,"1.08527e-19","6l7p_oligo41","DGalpa1-6DGalpb1-C39O5","DGD(405_A_)-DGD(405_A_)",55.83,"","",""
"6LCL","TTGALA, ALPHA-GALACTOSIDASE FROM THERMUS THERMOPHILUS IN COMPLEX WITH STACHYOSE","10.1021/ACS.JAFC.0C00871 ",3.2,53.87,"6lcl_oligo1","DGalpa1-6DGalpx1-","GLA(2_B_)-GLA(1_B_)",57.87,"","",""
"6LCL","TTGALA, ALPHA-GALACTOSIDASE FROM THERMUS THERMOPHILUS IN COMPLEX WITH STACHYOSE","10.1021/ACS.JAFC.0C00871 ",3.2,53.87,"6lcl_oligo3","DGalpa1-6DGalpx1-","GLA(2_F_)-GLA(1_F_)",59.0372,"","",""
"6LCL","TTGALA, ALPHA-GALACTOSIDASE FROM THERMUS THERMOPHILUS IN COMPLEX WITH STACHYOSE","10.1021/ACS.JAFC.0C00871 ",3.2,53.87,"6lcl_oligo2","DGalpa1-6DGalpx1-","GLA(2_D_)-GLA(1_D_)",59.7349,"","",""
"6LEH","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH AN INHIBITOR","10.1021/ACS.JMEDCHEM.9B01967 ",2,41.02,"6leh_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",48.1927,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[NAG(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(54_E_)",78.3845,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[NAG(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(87_G_)",82.4494,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(54_K_)",87.8047,"","",""
"6LQG","HUMAN GAMMA-SECRETASE IN COMPLEX WITH SMALL MOLECULE AVAGACESTAT","10.1016/J.CELL.2020.11.049 ",3.1,"1.08527e-19","6lqg_oligo5","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",73.1962,"","",""
"6LR4","MOLECULAR BASIS FOR INHIBITION OF HUMAN GAMMA-SECRETASE BY SMALL MOLECULE","10.1016/J.CELL.2020.11.049 ",3,"1.08527e-19","6lr4_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",84.3891,"","",""
"6LXI","CRYSTAL STRUCTURE OF Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/BREVIG MISSION/1/1918 (H1N1)","10.1128/MBIO.02315-20 ",2.5,41.22,"6lxi_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(146_A_)",75.6218,"","",""
"6LXI","CRYSTAL STRUCTURE OF Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/BREVIG MISSION/1/1918 (H1N1)","10.1128/MBIO.02315-20 ",2.5,41.22,"6lxi_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(146_B_)",68.7422,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(201_A_)",43.2936,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(201_C_)",43.2447,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(146_A_)",70.578,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(201_D_)",39.8487,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(146_B_)",57.2891,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(146_D_)",50.3602,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(146_C_)",51.515,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(201_B_)",43.283,"","",""
"6LY5","ORGANIZATION AND ENERGY TRANSFER IN A HUGE DIATOM PSI-FCPI SUPERCOMPLEX","10.1038/S41467-020-18867-X ",2.38,12.4576,"6ly5_oligo4","DGalpa1-6DGalpb1-C33O5","DGD(849_b_)-DGD(849_b_)",22.83,"","",""
"6LY5","ORGANIZATION AND ENERGY TRANSFER IN A HUGE DIATOM PSI-FCPI SUPERCOMPLEX","10.1038/S41467-020-18867-X ",2.38,12.4576,"6ly5_oligo28","DGalpa1-6DGalpb1-","DGD(302_L_)-DGD(302_L_)",20,"","",""
"6LY5","ORGANIZATION AND ENERGY TRANSFER IN A HUGE DIATOM PSI-FCPI SUPERCOMPLEX","10.1038/S41467-020-18867-X ",2.38,12.4576,"6ly5_oligo27","DGalpa1-6DGalpb1-C30O5","DGD(215_C_)-DGD(215_C_)",20,"","",""
"6M0R","2.7A YEAST VO STATE3","10.1126/SCIADV.ABB9605 ",2.7,"2.98315e-08","6m0r_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-C40O7P2","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",64.3815,"","",""
"6MAM","CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY, ADI-15946","10.1038/S41594-019-0191-4 ",4.1,0,"6mam_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_L_)",114.129,"","",""
"6MAM","CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY, ADI-15946","10.1038/S41594-019-0191-4 ",4.1,0,"6mam_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_H_)",99.7146,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo30","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_n_)-[GAL(8_n_)-NAG(7_n_)-[GAL(6_n_)-NAG(5_n_)]-MAN(4_n_)-[MAN(9_n_)]-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(611_F_)",146.443,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo2","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_U_)-[NAG(9_U_)-MAN(8_U_)-[NAG(7_U_)-[GAL(6_U_)-NAG(5_U_)]-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(637_B_)",190.606,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo31","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_o_)-[NAG(9_o_)-MAN(8_o_)-[NAG(7_o_)-[GAL(6_o_)-NAG(5_o_)]-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)]-NAG(1_o_)-ASN(637_F_)",172.364,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo17","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(11_T_)-[GAL(8_T_)-NAG(7_T_)-[GAL(6_T_)-NAG(5_T_)]-MAN(4_T_)-[NAG(10_T_)-MAN(9_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(611_B_)",188.354,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",173.997,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo24","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_h_)-MAN(6_h_)-[MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_E_)",214.803,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo7","DManpa1-2[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-3DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(88_G_)",178.016,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(392_G_)",178.329,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",167.636,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_P_)-[MAN(7_P_)]-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",148.121,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(625_B_)",151.202,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(234_G_)",147.586,"","",""
"6MCX","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) RECOMBINANT HEAD DOMAIN","10.1107/S2053230X18017892 ",2.3,51.41,"6mcx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",58.5584,"","",""
"6MDS","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH COMPLEX BIANTENNARY GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,48.7,"6mds_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_C_)-NAG(7_C_)-MAN(6_C_)-[GAL(5_C_)-NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",64.8303,"","",""
"6MDS","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH COMPLEX BIANTENNARY GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,48.7,"6mds_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_D_)-NAG(7_D_)-MAN(6_D_)-[GAL(5_D_)-NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",69.5976,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(392_G_)",118.374,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(234_G_)",78.7298,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",99.9873,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",97.06,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo10","DManpa1-2[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",117.766,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",86.5705,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcp[2<R2>]x1-","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",97.06,"","",""
"6MDV","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH HIGH-MANNOSE GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,52.74,"6mdv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",68.6975,"","",""
"6MDV","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH HIGH-MANNOSE GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,52.74,"6mdv_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",71.0774,"","",""
"6MEJ","CRYSTAL STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN IN COMPLEX WITH HUMAN ANTIBODIES HEPC3 AND HEPC46","10.1016/J.CHOM.2018.10.009 ",2.8,75.1,"6mej_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(556_C_)",111.702,"","",""
"6MEK","CRYSTAL STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE IN COMPLEX WITH HUMAN ANTIBODIES HEPC3 AND HEPC46","10.1016/J.CHOM.2018.10.009 ",3.1,76.85,"6mek_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(556_C_)",109.733,"","",""
"6MET","STRUCTURAL BASIS OF CORECEPTOR RECOGNITION BY HIV-1 ENVELOPE SPIKE","10.1038/S41586-018-0804-9 ",4.5,0,"6met_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_G_)",30.0309,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo5","DGlcpNAcb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_G_)-[NAG(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(1810_B_)",123.211,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(2118_B_)",111.791,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2118_A_)",110.503,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(240_A_)",140.995,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(240_B_)",134.112,"","",""
"6MFP","CRYSTAL STRUCTURE OF THE RV305 C1-C2 SPECIFIC ADCC POTENT ANTIBODY DH677.3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1","10.1128/JVI.01120-19 ",3,93.95,"6mfp_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(72_C_)",141.05,"","",""
"6MFT","CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN","10.7554/ELIFE.37688 ",2.32,0,"6mft_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_C_)",110.031,"","",""
"6MFT","CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN","10.7554/ELIFE.37688 ",2.32,0,"6mft_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_G_)",90.1629,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo2","DGalpb1-2DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(5_E_)-[GAL(4_E_)-XYS(3_E_)-BGC(2_E_)]-BGC(1_E_)",33.9135,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo4","DGalpb1-2DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(5_G_)-[GAL(4_G_)-XYS(3_G_)-BGC(2_G_)]-BGC(1_G_)",37.1047,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo1","DGalpb1-2DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(5_H_)-[GAL(4_H_)-XYS(3_H_)-BGC(2_H_)]-BGC(1_H_)",39.7653,"","",""
"6MGK","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, IN COMPLEX WITH XLX XYLOGLUCAN","10.1042/BCJ20180763 ",2.1,0,"6mgk_oligo3","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-ROH","XYS(7_F_)-[GAL(6_F_)-XYS(5_F_)-[XYS(4_F_)-BGC(3_F_)]-BGC(2_F_)]-BGC(1_F_)",31.8813,"","",""
"6MGL","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, D60A MUTANT IN COMPLEX WITH XXLG AND XGXXLG XYLOGLUCAN","10.1042/BCJ20180763 ",1.5,0,"6mgl_oligo2","DXylpa1-6DGlcpb1-4DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(11_C_)-XYS(10_C_)-[XYS(9_C_)-[XYS(8_C_)-[XYS(7_C_)-BGC(6_C_)-BGC(5_C_)]-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",25.1909,"","",""
"6MGL","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN FROM GH74 ENZYME POGH74 FROM PAENIBACILLUS ODORIFER, D60A MUTANT IN COMPLEX WITH XXLG AND XGXXLG XYLOGLUCAN","10.1042/BCJ20180763 ",1.5,0,"6mgl_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(8_B_)-XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",27.2939,"","",""
"6MGP","STRUCTURE OF HUMAN 4-1BB / 4-1BBL COMPLEX","",2.13,70.98,"6mgp_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[NAG(3_D_)]-[FUC(2_D_)]-NAG(1_D_)-ASN(149_X_)",125.9,"","",""
"6MGP","STRUCTURE OF HUMAN 4-1BB / 4-1BBL COMPLEX","",2.13,70.98,"6mgp_oligo3","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[NAG(3_F_)]-[FUC(2_F_)]-NAG(1_F_)-ASN(149_Z_)",116.215,"","",""
"6MGP","STRUCTURE OF HUMAN 4-1BB / 4-1BBL COMPLEX","",2.13,70.98,"6mgp_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(149_Y_)",119.288,"","",""
"6MHR","STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX","10.1038/S41467-018-07136-7 ",2.8,79.16,"6mhr_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_G_)-[BMA(3_G_)-NAG(2_G_)]-[FUC(4_G_)]-NAG(1_G_)",105.063,"","",""
"6MHR","STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX","10.1038/S41467-018-07136-7 ",2.8,79.16,"6mhr_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[NAG(3_H_)]-[FUC(2_H_)]-NAG(1_H_)-ASN(149_C_)",123.22,"","",""
"6MI2","STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX","10.1038/S41467-018-07136-7 ",2.72,86.69,"6mi2_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(149_F_)",112.446,"","",""
"6MIV","CRYSTAL STRUCTURE OF THE MCD1D/XXQ (JJ300)/INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",2.05,38.54,"6miv_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",49.8685,"","",""
"6MIY","CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",2.75,58.64,"6miy_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(165_E_)",74.0558,"","",""
"6MIY","CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",2.75,58.64,"6miy_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(165_A_)",75.237,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",128.198,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",109.917,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",118.352,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",107.428,"","",""
"6MJ4","CRYSTAL STRUCTURE OF MCD1D/INKTCR TERNARY COMPLEX BOUND TO GLYCOLIPID (XXW)","10.1002/CMDC.201800649 ",2,32.02,"6mj4_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",41.6033,"","",""
"6MJ6","CRYSTAL STRUCTURE OF THE MCD1D/XXX (JJ166) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",2.45,47.33,"6mj6_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",77.8855,"","",""
"6MJA","CRYSTAL STRUCTURE OF THE MCD1D/XXO (JJ294) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",2.35,47.61,"6mja_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",75.0784,"","",""
"6MJI","CRYSTAL STRUCTURE OF THE MCD1D/XXS (JJ304) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",2.3,43.91,"6mji_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",78.9771,"","",""
"6MJJ","CRYSTAL STRUCTURE OF THE MCD1D/XXM (JJ290) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",1.93,30.72,"6mjj_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",38.3755,"","",""
"6MJO","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) FC-GAMMA RECEPTOR III","10.3389/FIMMU.2022.960411 ",1.9,0,"6mjo_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(45_C_)",54.1484,"","",""
"6MJQ","CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",3,52.39,"6mjq_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(165_E_)",80.5658,"","",""
"6MJQ","CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",3,52.39,"6mjq_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(165_A_)",68.682,"","",""
"6MK0","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO ANTAGONIST TDI-4161","10.1021/ACSPTSCI.9B00041 ",3.01,56.99,"6mk0_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-BMA(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(266_A_)",56.2542,"","",""
"6MKB","CRYSTAL STRUCTURE OF MURINE 4-1BB LIGAND","10.1074/JBC.RA118.006297 ",2.5,66.18,"6mkb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(161_D_)",99.5225,"","",""
"6MKB","CRYSTAL STRUCTURE OF MURINE 4-1BB LIGAND","10.1074/JBC.RA118.006297 ",2.5,66.18,"6mkb_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(161_C_)",75.7791,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(295_C_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-[MAN(7_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(301_C_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(295_D_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo35","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo38","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_S_)-[MAN(5_S_)]-MAN(4_S_)-[MAN(7_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo40","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_w_)-MAN(6_w_)-[MAN(5_w_)-MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_T_)-MAN(8_T_)-[MAN(10_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo44","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_0_)-MAN(8_0_)-[MAN(10_0_)]-MAN(7_0_)-[MAN(6_0_)-MAN(5_0_)-MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo43","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_z_)-[MAN(5_z_)]-MAN(4_z_)-[MAN(7_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_k_)-MAN(8_k_)-[MAN(10_k_)]-MAN(7_k_)-[MAN(6_k_)-MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo34","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(295_A_)",0,"","",""
"6MNF","ANTI-HIV-1 FAB 2G12 + MAN8 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.76,0,"6mnf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpx1-","MAN(7_A_)-MAN(6_A_)-[MAN(8_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)]-BMA(1_A_)",44.8795,"","",""
"6MSL","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO EETI-II 2.5D","10.1016/J.STR.2019.06.011 ",3.1,62.24,"6msl_oligo3","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",71.875,"","",""
"6MSU","INTEGRIN ALPHAVBETA3 IN COMPLEX WITH EETI-II 2.5F","10.1016/J.STR.2019.06.011 ",3.11,0,"6msu_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",68.6494,"","",""
"6MTJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM","10.1038/S41467-018-07851-1 ",2.34,39.84,"6mtj_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",46.2439,"","",""
"6MTJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM","10.1038/S41467-018-07851-1 ",2.34,39.84,"6mtj_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",45.5059,"","",""
"6MTN","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR COMPOUND 484 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.0 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,49.33,"6mtn_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-MAN(8_M_)-[MAN(10_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_G_)",54.3368,"","",""
"6MTN","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR COMPOUND 484 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.0 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,49.33,"6mtn_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",58.9171,"","",""
"6MU6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM","10.1038/S41467-018-07851-1 ",2.55,47.31,"6mu6_oligo18","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-MAN(8_M_)-[MAN(10_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_G_)",49.6742,"","",""
"6MU6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM","10.1038/S41467-018-07851-1 ",2.55,47.31,"6mu6_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",58.003,"","",""
"6MU7","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,39.32,"6mu7_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",43.4599,"","",""
"6MU7","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,39.32,"6mu7_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",45.1736,"","",""
"6MU8","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1038/S41467-018-07851-1 ",2.99,55.65,"6mu8_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",56.1078,"","",""
"6MU8","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1038/S41467-018-07851-1 ",2.99,55.65,"6mu8_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",66.193,"","",""
"6MUB","ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.5,0,"6mub_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-ROH","MAN(5_A_)-MAN(4_A_)-[MAN(3_A_)-MAN(2_A_)]-BMA(1_A_)",89.7853,"","",""
"6MUB","ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.5,0,"6mub_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-ROH","MAN(5_B_)-MAN(4_B_)-[MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",90.4504,"","",""
"6MUF","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM","10.1038/S41467-018-07851-1 ",2.91,51.2,"6muf_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",59.9621,"","",""
"6MUF","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM","10.1038/S41467-018-07851-1 ",2.91,51.2,"6muf_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(156_G_)",105.366,"","",""
"6MUF","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM","10.1038/S41467-018-07851-1 ",2.91,51.2,"6muf_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_G_)",69.205,"","",""
"6MUG","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM","10.1038/S41467-018-07851-1 ",2.95,50.04,"6mug_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_G_)",70.4369,"","",""
"6MUG","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM","10.1038/S41467-018-07851-1 ",2.95,50.04,"6mug_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",59.7148,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_A_)",105.712,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo35","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-MAN(4_o_)-[MAN(6_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(197_E_)",105.712,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(156_A_)",116.689,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo19","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-MAN(4_a_)-[MAN(6_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(197_B_)",105.712,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo21","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",111.412,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo37","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_q_)-MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_E_)",111.412,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(156_E_)",116.689,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(156_B_)",116.689,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo23","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_A_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo6","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_a_)-MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_B_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(156_E_)",116.689,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo21","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo36","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_o_)-MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_E_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(6_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(197_B_)",105.712,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(197_A_)",105.712,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_A_)",116.689,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_B_)",116.689,"","",""
"6N2X","ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT","10.1126/SCIENCE.1083182 ",3,0,"6n2x_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_A_)-MAN(10_A_)-[MAN(9_A_)-MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",104.288,"","",""
"6N2X","ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT","10.1126/SCIENCE.1083182 ",3,0,"6n2x_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_B_)-MAN(10_B_)-[MAN(9_B_)-MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",121.327,"","",""
"6N41","CRYSTAL STRUCTURE OF INVBM.18715.A.KN11: INFLUENZA HEMAGGLUTININ FROM STRAIN A/NETHERLANDS/002P1/1951","10.1038/S41598-023-33529-W ",2.5,61.39,"6n41_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_A_)",97.5487,"","",""
"6N41","CRYSTAL STRUCTURE OF INVBM.18715.A.KN11: INFLUENZA HEMAGGLUTININ FROM STRAIN A/NETHERLANDS/002P1/1951","10.1038/S41598-023-33529-W ",2.5,61.39,"6n41_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(162_C_)",103.603,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_C_)",38.3556,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_B_)",39.4536,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(200_D_)",32.7112,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",32.0236,"","",""
"6N4Y","METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43","10.1038/S41586-019-0881-4 ",3.26,79.14,"6n4y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-[FUC(6_J_)]-NAG(1_J_)-ASN(445_B_)",125.693,"","",""
"6N4Y","METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43","10.1038/S41586-019-0881-4 ",3.26,79.14,"6n4y_oligo3","DManpa1-3DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(445_C_)",139.039,"","",""
"6N4Y","METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43","10.1038/S41586-019-0881-4 ",3.26,79.14,"6n4y_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(445_A_)",146.957,"","",""
"6N4Y","METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43","10.1038/S41586-019-0881-4 ",3.26,79.14,"6n4y_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-[FUC(5_L_)]-NAG(1_L_)-ASN(378_D_)",103.711,"","",""
"6N6B","THE COMPLEX CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/MINNESOTA/11/2010 WITH B10 ANTIBODY.","10.1038/S41564-019-0522-6 ",2.3,35.45,"6n6b_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",33.1545,"","",""
"6N9T","STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC","10.1021/ACS.BIOCONJCHEM.8B00809 ",2.58,0,"6n9t_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",56.9825,"","",""
"6N9T","STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC","10.1021/ACS.BIOCONJCHEM.8B00809 ",2.58,0,"6n9t_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.6258,"","",""
"6NAE","CRYSTAL STRUCTURE OF EBOLA ZAIRE GP PROTEIN WITH BOUND ARN0074898","10.1021/ACSMEDCHEMLETT.0C00025 ",2.75,65.3,"6nae_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",100.694,"","",""
"6NAJ","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO HR10 VARIANT OF THE 10TH DOMAIN OF FIBRONECTIN.","10.1038/S41467-019-13928-2 ",3.1,0,"6naj_oligo4","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",68.6142,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(125_B_)",56.8712,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_A_)",66.1199,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(1213_A_)",61.0153,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo33","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(125_C_)",114.318,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(222_B_)",62.1936,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(1213_C_)",64.9509,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(125_A_)",51.1909,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(166_A_)",65.7191,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(236_B_)",84.0842,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(236_A_)",79.2451,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(222_A_)",58.4609,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(1213_B_)",61.632,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo21","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(166_B_)",74.7952,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(125_C_)",73.4373,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(1213_C_)",41.0904,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1213_A_)",44.9311,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(222_A_)",98.2247,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(166_B_)",109.145,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(125_B_)",49.4495,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",75.154,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(783_B_)",80.1244,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1116_A_)",110.488,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo23","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(1080_B_)",89.6668,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(691_A_)",98.4933,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo35","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(783_C_)",81.8096,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(1056_A_)",100.473,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(1080_C_)",95.2198,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(783_A_)",85.9025,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(1080_A_)",103.094,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(1116_B_)",108.226,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo24","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(1116_B_)",112.331,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo23","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(1080_B_)",105.332,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(783_B_)",90.9585,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(691_A_)",111.26,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(783_A_)",90.3866,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(783_C_)",92.852,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(1116_A_)",131.183,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(1056_A_)",118.356,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_D_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(241_A_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_A_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(241_E_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(88_G_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(241_F_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(241_G_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(88_D_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(88_A_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(88_C_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(88_F_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_E_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_C_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-[MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(262_G_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(262_F_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(241_D_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(88_E_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(241_C_)",185.717,"","",""
"6NEA","HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH REACTIVATOR, HLO7","10.1021/ACSMEDCHEMLETT.9B00021 ",2.42,0,"6nea_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",101.246,"","",""
"6NEA","HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH REACTIVATOR, HLO7","10.1021/ACSMEDCHEMLETT.9B00021 ",2.42,0,"6nea_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",95.7194,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_J_)",76.6965,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(332_C_)",76.6965,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_A_)",76.6965,"","",""
"6NHP","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ HA2 I45T MUTANT","10.1126/SCIENCE.AAZ5143 ",2.25,50.92,"6nhp_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",85.7934,"","",""
"6NHQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ HA2 I45M MUTANT","10.1126/SCIENCE.AAZ5143 ",2.5,57.02,"6nhq_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",90.7264,"","",""
"6NHR","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ HA2 I45F MUTANT","10.1126/SCIENCE.AAZ5143 ",2.1,48.81,"6nhr_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",72.8707,"","",""
"6NM6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM","10.1038/S41467-019-08658-4 ",2.74,57.15,"6nm6_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-MAN(8_O_)-[MAN(10_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",52.7055,"","",""
"6NM6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM","10.1038/S41467-019-08658-4 ",2.74,57.15,"6nm6_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",86.8598,"","",""
"6NM6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM","10.1038/S41467-019-08658-4 ",2.74,57.15,"6nm6_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",54.7092,"","",""
"6NM6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM","10.1038/S41467-019-08658-4 ",2.74,57.15,"6nm6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",102.146,"","",""
"6NMY","A CYTOKINE-RECEPTOR COMPLEX","",3.3,95.19,"6nmy_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(80_F_)",122.519,"","",""
"6NMY","A CYTOKINE-RECEPTOR COMPLEX","",3.3,95.19,"6nmy_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(218_F_)",150.434,"","",""
"6NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"6nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.0761,"","",""
"6NNF","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM","10.1038/S41467-019-08658-4 ",2.76,69.41,"6nnf_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",117.383,"","",""
"6NNF","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM","10.1038/S41467-019-08658-4 ",2.76,69.41,"6nnf_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-MAN(8_O_)-[MAN(10_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",64.3647,"","",""
"6NNF","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM","10.1038/S41467-019-08658-4 ",2.76,69.41,"6nnf_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",78.7236,"","",""
"6NNF","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM","10.1038/S41467-019-08658-4 ",2.76,69.41,"6nnf_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",65.9924,"","",""
"6NNJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM","10.1038/S41467-019-08658-4 ",2.6,55.94,"6nnj_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",58.0939,"","",""
"6NNJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM","10.1038/S41467-019-08658-4 ",2.6,55.94,"6nnj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",88.0104,"","",""
"6NNJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM","10.1038/S41467-019-08658-4 ",2.6,55.94,"6nnj_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-MAN(8_N_)-[MAN(10_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_G_)",55.063,"","",""
"6NNJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM","10.1038/S41467-019-08658-4 ",2.6,55.94,"6nnj_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",78.9277,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_A_)",94.3636,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(276_I_)",87.9841,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-MAN(8_i_)-[MAN(10_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_I_)",72.208,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-MAN(8_M_)-[MAN(10_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(234_A_)",73.6707,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(276_E_)",96.7367,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo23","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_X_)-MAN(8_X_)-[MAN(10_X_)]-MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(234_E_)",75.9651,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-[FUC(5_F_)]-NAG(1_F_)-ASN(82_A_)",52.0291,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-[FUC(5_G_)]-NAG(1_G_)-ASN(50_B_)",63.8829,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(62_A_)",57.247,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo4","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[NAG(3_H_)]-[FUC(2_H_)]-NAG(1_H_)-ASN(62_C_)",57.8716,"","",""
"6NRR","CRYSTAL STRUCTURE OF DPR11 IG1 BOUND TO DIP-GAMMA IG+IG2","10.7554/ELIFE.41028 ",2.5,0,"6nrr_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(47_B_)",77.2393,"","",""
"6NRW","CRYSTAL STRUCTURE OF DPR1 IG1 BOUND TO DIP-ETA IG1","10.7554/ELIFE.41028 ",2.4,0,"6nrw_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(51_B_)",80.1266,"","",""
"6NRW","CRYSTAL STRUCTURE OF DPR1 IG1 BOUND TO DIP-ETA IG1","10.7554/ELIFE.41028 ",2.4,0,"6nrw_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(62_C_)",85.8334,"","",""
"6NRW","CRYSTAL STRUCTURE OF DPR1 IG1 BOUND TO DIP-ETA IG1","10.7554/ELIFE.41028 ",2.4,0,"6nrw_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(62_A_)",94.8403,"","",""
"6NS1","CRYSTAL STRUCTURE OF DIP-GAMMA IG1+IG2","10.7554/ELIFE.41028 ",1.85,0,"6ns1_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(47_A_)",60.1109,"","",""
"6NSA","CRYSTAL STRUCTURE OF THE IVR-165 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 3'-SLNLN","10.1016/J.CHOM.2019.04.013 ",1.95,42.32,"6nsa_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",81.8215,"","",""
"6NSC","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT APO FORM","10.1016/J.CHOM.2019.04.013 ",2.25,64.91,"6nsc_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",97.8246,"","",""
"6NSF","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT IN COMPLEX WITH 3'-SLNLN","10.1016/J.CHOM.2019.04.013 ",2.1,51.46,"6nsf_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",85.9365,"","",""
"6NSG","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT IN COMPLEX WITH 6'-SLNLN","10.1016/J.CHOM.2019.04.013 ",2.4,71.07,"6nsg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",115.601,"","",""
"6NT3","CRYO-EM STRUCTURE OF A HUMAN-COCKROACH HYBRID NAV CHANNEL.","",3.4,"1.15243e-41","6nt3_oligo8","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",113.85,"","",""
"6NT4","CRYO-EM STRUCTURE OF A HUMAN-COCKROACH HYBRID NAV CHANNEL BOUND TO ALPHA-SCORPION TOXIN AAH2.","10.1126/SCIENCE.AAV8573 ",3.5,"1.15243e-41","6nt4_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(330_A_)",95.5116,"","",""
"6NTG","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234 IN COMPLEX WITH REACTIVATOR, HI-6","",2.65,0,"6ntg_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",100.041,"","",""
"6NTG","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234 IN COMPLEX WITH REACTIVATOR, HI-6","",2.65,0,"6ntg_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(265_B_)",120.326,"","",""
"6NTG","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234 IN COMPLEX WITH REACTIVATOR, HI-6","",2.65,0,"6ntg_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",99.7479,"","",""
"6NTH","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY (S) STEREOISOMER OF A-232","",2.42,0,"6nth_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",116.706,"","",""
"6NTH","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY (S) STEREOISOMER OF A-232","",2.42,0,"6nth_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",114.209,"","",""
"6NTH","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY (S) STEREOISOMER OF A-232","",2.42,0,"6nth_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",133.555,"","",""
"6NTK","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-232","",2.41,0,"6ntk_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",88.6085,"","",""
"6NTK","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-232","",2.41,0,"6ntk_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",87.2124,"","",""
"6NTL","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234","",2.25,0,"6ntl_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",80.4648,"","",""
"6NTL","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234","",2.25,0,"6ntl_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",77.6533,"","",""
"6NTL","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234","",2.25,0,"6ntl_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",126.287,"","",""
"6NTM","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-232 IN COMPLEX WITH THE REACTIVATOR, HI-6","",2.55,0,"6ntm_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",112.439,"","",""
"6NTM","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-232 IN COMPLEX WITH THE REACTIVATOR, HI-6","",2.55,0,"6ntm_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",114.573,"","",""
"6NTM","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-232 IN COMPLEX WITH THE REACTIVATOR, HI-6","",2.55,0,"6ntm_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",143.692,"","",""
"6NTN","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230 IN COMPLEX WITH THE REACTIVATOR, HI-6","",2.7,0,"6ntn_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",130.432,"","",""
"6NTN","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230 IN COMPLEX WITH THE REACTIVATOR, HI-6","",2.7,0,"6ntn_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",96.6388,"","",""
"6NTN","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230 IN COMPLEX WITH THE REACTIVATOR, HI-6","",2.7,0,"6ntn_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",99.4939,"","",""
"6NTO","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230","",2.05,0,"6nto_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",82.6609,"","",""
"6NTO","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230","",2.05,0,"6nto_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",80.7255,"","",""
"6NTO","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230","",2.05,0,"6nto_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",111.652,"","",""
"6O3O","STRUCTURE OF HUMAN DNAM-1 (CD226) BOUND TO NECTIN-LIKE PROTEIN-5 (NECL-5)","10.1074/JBC.RA119.009261 ",2.8,63.74,"6o3o_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(120_D_)",110.721,"","",""
"6O3O","STRUCTURE OF HUMAN DNAM-1 (CD226) BOUND TO NECTIN-LIKE PROTEIN-5 (NECL-5)","10.1074/JBC.RA119.009261 ",2.8,63.74,"6o3o_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(188_D_)",89.2257,"","",""
"6O3O","STRUCTURE OF HUMAN DNAM-1 (CD226) BOUND TO NECTIN-LIKE PROTEIN-5 (NECL-5)","10.1074/JBC.RA119.009261 ",2.8,63.74,"6o3o_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(120_C_)",105.681,"","",""
"6O69","CRYSTAL STRUCTURE OF DOUBLE MUTANT L380R/F535K OF HUMAN ACETYLCHOLINESTERASE","10.1002/PRO.3625 ",2.08,0,"6o69_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(350_A_)",97.6482,"","",""
"6OEJ","CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY C11 IN COMPLEX WITH HIV-1 CLADE A/E GP120","10.1128/MBIO.00208-20 ",3.45,0,"6oej_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(52_B_)",145.421,"","",""
"6OEJ","CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY C11 IN COMPLEX WITH HIV-1 CLADE A/E GP120","10.1128/MBIO.00208-20 ",3.45,0,"6oej_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(52_H_)",139.712,"","",""
"6OEL","ENGINEERED FAB BOUND TO IL-4 RECEPTOR","10.1074/JBC.RA119.009213 ",3.1,77.12,"6oel_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(28_B_)",121.125,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUC(6_G_)]-NAG(1_G_)-ASN(396_A_)",58.3303,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUC(6_G_)]-NAG(1_G_)-ASN(396_A_)",44.4332,"","",""
"6OHE","ALPHA-L-FUCOSIDASE ALFC D200A IN COMPLEX WITH FUCA(1,6)GLCNAC","10.1038/S41467-020-20044-Z ",3.14,126.6,"6ohe_oligo2","LFucpa1-6DGlcpNAcb1-ROH","FUC(2_F_)-NAG(1_F_)",102.323,"","",""
"6OHE","ALPHA-L-FUCOSIDASE ALFC D200A IN COMPLEX WITH FUCA(1,6)GLCNAC","10.1038/S41467-020-20044-Z ",3.14,126.6,"6ohe_oligo3","LFucpa1-6DGlcpNAcb1-ROH","FUC(2_G_)-NAG(1_G_)",110.983,"","",""
"6OHE","ALPHA-L-FUCOSIDASE ALFC D200A IN COMPLEX WITH FUCA(1,6)GLCNAC","10.1038/S41467-020-20044-Z ",3.14,126.6,"6ohe_oligo4","LFucpa1-6DGlcpNAcb1-ROH","FUC(2_H_)-NAG(1_H_)",127.269,"","",""
"6OHE","ALPHA-L-FUCOSIDASE ALFC D200A IN COMPLEX WITH FUCA(1,6)GLCNAC","10.1038/S41467-020-20044-Z ",3.14,126.6,"6ohe_oligo1","LFucpa1-6DGlcpNAcb1-ROH","FUC(2_E_)-NAG(1_E_)",96.5455,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo29","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_i_)-NAG(1_i_)-ASN(88_D_)",165.295,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_S_)-NAG(1_S_)-ASN(637_B_)",157.49,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo26","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(412_A_)",141.001,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_U_)-NAG(1_U_)-ASN(88_C_)",164.428,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo27","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_g_)-NAG(1_g_)-ASN(637_E_)",153.817,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_T_)-NAG(1_T_)-ASN(616_B_)",159.92,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo28","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_h_)-NAG(1_h_)-ASN(616_E_)",174.246,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)-ASN(197_C_)",114.934,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(88_A_)",164.306,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo14","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-[MAN(6_b_)-[MAN(5_b_)]-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",147.794,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo41","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_u_)-NAG(1_u_)-ASN(637_F_)",154.213,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo36","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_p_)-[MAN(6_p_)-[MAN(5_p_)]-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(262_D_)",147.726,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo15","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_c_)-NAG(1_c_)-ASN(412_C_)",169.421,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo37","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_q_)-NAG(1_q_)-ASN(412_D_)",151.298,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(197_A_)",112.66,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo25","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-[MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",148.601,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo32","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_l_)-[NAG(2_l_)]-NAG(1_l_)-ASN(197_D_)",114.114,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo42","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_v_)-NAG(1_v_)-ASN(616_F_)",170.668,"","",""
"6OJ1","CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3","10.1074/JBC.RA119.009910 ",1.76,31.35,"6oj1_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(92_A_)",52.9317,"","",""
"6OJB","CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3 COMPLEX WITH GALACTOSAMINE","10.1074/JBC.RA119.009910 ",2.09,36.13,"6ojb_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(69_A_)",74.097,"","",""
"6OJB","CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3 COMPLEX WITH GALACTOSAMINE","10.1074/JBC.RA119.009910 ",2.09,36.13,"6ojb_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(92_A_)",59.1192,"","",""
"6OJP","STRUCTURE OF GLYCOLIPID ALPHA-GSA[8,6P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.17,35.5,"6ojp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",52.1115,"","",""
"6OJP","STRUCTURE OF GLYCOLIPID ALPHA-GSA[8,6P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.17,35.5,"6ojp_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(7_A_)",49.0795,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(262_D_)",43.5343,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(448_D_)",53.6832,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo29","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(6_r_)-MAN(5_r_)-[MAN(7_r_)]-MAN(4_r_)-[MAN(9_r_)-MAN(8_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(262_E_)",75.7427,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-[MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(137_E_)",139.732,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo30","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(295_D_)",98.5416,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo31","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(6_s_)-MAN(5_s_)-[MAN(7_s_)]-MAN(4_s_)-[MAN(9_s_)-MAN(8_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_F_)",62.378,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo18","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(332_E_)",70.9753,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo21","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-[MAN(7_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(448_F_)",70.9438,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo20","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)]-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(295_F_)",113.323,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(448_E_)",60.4517,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_X_)-NAG(1_X_)-ASN(625_B_)",159.975,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_c_)-NAG(1_c_)-ASN(197_C_)",166.337,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo20","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_V_)-[MAN(8_V_)-[NAG(7_V_)-[GAL(6_V_)-NAG(5_V_)]-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(637_B_)",122.313,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",193.751,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo22","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",142.411,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo7","DGalpb1-4DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_W_)-[GAL(6_W_)-NAG(5_W_)-MAN(4_W_)-[MAN(7_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(611_B_)",97.6494,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo21","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_e_)-[NAG(8_e_)-MAN(7_e_)-[GAL(6_e_)-NAG(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(637_D_)",126.382,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(44_E_)",113.86,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo14","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(266_C_)",101.519,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo25","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(266_G_)",90.7118,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(266_A_)",104.582,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo19","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(266_E_)",106.8,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo24","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)]-MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(260_G_)",148.146,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(459_E_)",118.827,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(44_A_)",111.477,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo12","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(44_C_)",114.916,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo9","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(459_C_)",118.754,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(266_C_)",103.442,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(260_A_)",90.1001,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-[MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(44_C_)",143.031,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",99.6089,"","",""
"6OMG","STRUCTURE OF MOUSE CD1D- GLC-DAG (SN-1 C18:0, SN-2 C18:1C9)-INKT TCR TERNARY COMPLEX","",2.1,35.83,"6omg_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(165_A_)",53.8339,"","",""
"6OML","HUMAN BMP CHIMERA BV261","10.1126/SCITRANSLMED.AAR4953 ",2.7,48.01,"6oml_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(56_Y_)",88.5579,"","",""
"6ON9","CRYSTAL STRUCTURE OF THE ZIG-8-RIG-5 IG1-IG1 HETERODIMER, TETRAGONAL FORM","10.1073/PNAS.1818631116 ",2,0,"6on9_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(108_B_)",86.6191,"","",""
"6OOL","STRUCTURAL ELUCIDATION OF THE ECTODOMAIN OF MOUSE UNC5H2","",2.8,54.87,"6ool_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(222_A_)",122.202,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(301_G_)",241.954,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_G_)",253.2,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",215.479,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(197_G_)",219.688,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",205.155,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(295_G_)",241.51,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",224.385,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_A_)",107.39,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo28","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_J_)",111.118,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo29","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_o_)-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(276_J_)",190.969,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_D_)",107.896,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo8","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(332_G_)",159.252,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo19","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(332_R_)",147.131,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_K_)",142.888,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo6","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_K_)",208.053,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_G_)",194.573,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_R_)",193.564,"","",""
"6ORO","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB874NHP","10.1038/S41586-019-1250-Z ",3.9,"1.45136e+10","6oro_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_B_)",92.7648,"","",""
"6ORO","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB874NHP","10.1038/S41586-019-1250-Z ",3.9,"1.45136e+10","6oro_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_G_)",89.1418,"","",""
"6ORO","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB874NHP","10.1038/S41586-019-1250-Z ",3.9,"1.45136e+10","6oro_oligo21","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_I_)",87.6252,"","",""
"6ORP","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB897NHP","10.1038/S41586-019-1250-Z ",4.4,"1.45136e+10","6orp_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_I_)",378.461,"","",""
"6ORP","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB897NHP","10.1038/S41586-019-1250-Z ",4.4,"1.45136e+10","6orp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_B_)",356.073,"","",""
"6ORQ","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB275MUR","10.1038/S41586-019-1250-Z ",4.4,12.4576,"6orq_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_I_)",188.509,"","",""
"6ORQ","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB275MUR","10.1038/S41586-019-1250-Z ",4.4,12.4576,"6orq_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_B_)",184.31,"","",""
"6OZ4","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P6 FAB IN COMPLEX WITH HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN.","10.1128/MBIO.01274-21 ",4.05,0,"6oz4_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(197_G_)",298.839,"","",""
"6OZ4","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P6 FAB IN COMPLEX WITH HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN.","10.1128/MBIO.01274-21 ",4.05,0,"6oz4_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",372.288,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(363_F_)",143.178,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_E_)",128.351,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-[MAN(6_s_)-MAN(5_s_)]-MAN(4_s_)-[MAN(9_s_)-MAN(8_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(339_F_)",108.026,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(295_A_)",99.7662,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_q_)-[MAN(6_q_)-MAN(5_q_)]-MAN(4_q_)-[MAN(8_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(332_F_)",86.0985,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-[MAN(6_g_)-MAN(5_g_)]-MAN(4_g_)-[MAN(8_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(332_E_)",86.0985,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(295_E_)",99.7662,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(363_E_)",143.178,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo23","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_o_)-[MAN(8_o_)]-MAN(7_o_)-[MAN(6_o_)-MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(392_F_)",89.0711,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(363_A_)",143.178,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_E_)",110.999,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(295_F_)",99.7662,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_e_)-[MAN(8_e_)]-MAN(7_e_)-[MAN(6_e_)-MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(392_E_)",89.0711,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)]-MAN(4_W_)-[MAN(8_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_A_)",86.0985,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(386_F_)",128.351,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)]-MAN(4_i_)-[MAN(9_i_)-MAN(8_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(339_E_)",108.026,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(386_A_)",128.351,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_U_)-[MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(392_A_)",89.0711,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",110.999,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)]-MAN(4_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(339_A_)",108.026,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo21","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_F_)",110.999,"","",""
"6P2L","CRYSTAL STRUCTURE OF NIASTELLA KOREENSIS GH74 (NKGH74) ENZYME","10.1074/JBC.RA119.009861 ",1.08,0,"6p2l_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpa1-ROH","GAL(8_B_)-XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-GLC(1_B_)",18.6744,"","",""
"6P2L","CRYSTAL STRUCTURE OF NIASTELLA KOREENSIS GH74 (NKGH74) ENZYME","10.1074/JBC.RA119.009861 ",1.08,0,"6p2l_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_C_)-[XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",27.3243,"","",""
"6P2M","CRYSTAL STRUCTURE OF THE CALDICELLULOSIRUPTOR LACTOACETICUS GH74 (CLGH74A) ENZYME IN COMPLEX WITH LLG XYLOGLUCAN","10.1074/JBC.RA119.009861 ",1.98,0,"6p2m_oligo1","DGalpb1-2DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(7_B_)-XYS(6_B_)-[GAL(5_B_)-XYS(4_B_)-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",47.2924,"","",""
"6P2O","CRYSTAL STRUCTURE OF STREPTOMYCES RAPAMYCINICUS GH74 IN COMPLEX WITH XYLOGLUCAN FRAGMENTS XLLG AND XXXG","10.1074/JBC.RA119.009861 ",1.88,0,"6p2o_oligo3","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_E_)-XYS(8_E_)-[GAL(7_E_)-XYS(6_E_)-[XYS(5_E_)-BGC(4_E_)]-BGC(3_E_)]-BGC(2_E_)-BGC(1_E_)",29.6569,"","",""
"6P2O","CRYSTAL STRUCTURE OF STREPTOMYCES RAPAMYCINICUS GH74 IN COMPLEX WITH XYLOGLUCAN FRAGMENTS XLLG AND XXXG","10.1074/JBC.RA119.009861 ",1.88,0,"6p2o_oligo1","DXylpa1-6DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4[DGalpb1-2DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","GAL(9_C_)-XYS(8_C_)-[GAL(7_C_)-XYS(6_C_)-[XYS(5_C_)-BGC(4_C_)]-BGC(3_C_)]-BGC(2_C_)-BGC(1_C_)",32.1234,"","",""
"6P2O","CRYSTAL STRUCTURE OF STREPTOMYCES RAPAMYCINICUS GH74 IN COMPLEX WITH XYLOGLUCAN FRAGMENTS XLLG AND XXXG","10.1074/JBC.RA119.009861 ",1.88,0,"6p2o_oligo4","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_F_)-[XYS(6_F_)-[XYS(5_F_)-BGC(4_F_)]-BGC(3_F_)]-BGC(2_F_)-BGC(1_F_)",23.6618,"","",""
"6P2O","CRYSTAL STRUCTURE OF STREPTOMYCES RAPAMYCINICUS GH74 IN COMPLEX WITH XYLOGLUCAN FRAGMENTS XLLG AND XXXG","10.1074/JBC.RA119.009861 ",1.88,0,"6p2o_oligo2","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_D_)-[XYS(6_D_)-[XYS(5_D_)-BGC(4_D_)]-BGC(3_D_)]-BGC(2_D_)-BGC(1_D_)",39.1398,"","",""
"6P3R","CRYSTAL STRUCTURE OF HUMAN FAB H5.31 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",3,0,"6p3r_oligo4","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAca1-4DGlcpNAcx1-","SIA(7_G_)-GLA(6_G_)-NDG(5_G_)-MAN(4_G_)-[MAN(8_G_)]-MAN(3_G_)-NDG(2_G_)-NAG(1_G_)",150.739,"","",""
"6P3R","CRYSTAL STRUCTURE OF HUMAN FAB H5.31 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",3,0,"6p3r_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_H_)-GAL(6_H_)-NDG(5_H_)-BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(163_L_)",134.35,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo4","DNeup5Aca2-6DGalpa1-4DGlcpNAcb1-2DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_b_)-GLA(6_b_)-NAG(5_b_)-MAN(4_b_)-MAN(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(163_K_)",152.064,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo8","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","SIA(7_f_)-GAL(6_f_)-NDG(5_f_)-MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)",133.384,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo6","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","SIA(7_d_)-GAL(6_d_)-NDG(5_d_)-BMA(4_d_)-MAN(3_d_)-NAG(2_d_)-NAG(1_d_)",127.216,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_Z_)-GAL(6_Z_)-NAG(5_Z_)-BMA(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(163_H_)",134.551,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo7","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpx1-","SIA(5_e_)-GAL(4_e_)-NDG(3_e_)-BMA(2_e_)-MAN(1_e_)",129.585,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo3","DKdnpa2-6DGalpa1-4DGlcpNAca1-2DManpa1-6DManpa1-4DGlcpNAcx1-","SIA(6_a_)-GLA(5_a_)-NDG(4_a_)-MAN(3_a_)-MAN(2_a_)-NAG(1_a_)",128.642,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo5","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpx1-","SIA(5_c_)-GAL(4_c_)-NDG(3_c_)-BMA(2_c_)-BMA(1_c_)",126.251,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_Y_)-GAL(6_Y_)-NDG(5_Y_)-MAN(4_Y_)-MAN(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(163_E_)",147.088,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(234_B_)",49.2008,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(234_A_)",49.2008,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(234_E_)",49.2008,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(88_A_)",97.3982,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_E_)",73.1551,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(88_E_)",97.3982,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo30","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)-ASN(625_A_)",115.53,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo45","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_1_)-[NAG(2_1_)]-NAG(1_1_)-ASN(625_E_)",115.53,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_m_)-[NAG(2_m_)]-NAG(1_m_)-ASN(625_B_)",115.53,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_B_)",73.1551,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(88_B_)",97.3982,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",73.1551,"","",""
"6P6D","HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT","10.3390/PHARMACEUTICS11100546 ",2.31,53.83,"6p6d_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",114.865,"","",""
"6P6D","HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT","10.3390/PHARMACEUTICS11100546 ",2.31,53.83,"6p6d_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",74.0993,"","",""
"6P72","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBAL DOMAIN","10.1073/PNAS.1911773116 ",3.28,62.17,"6p72_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(562_C_)",89.2824,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(562_C_)",105.377,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(403_A_)",104.784,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(502_A_)",81.6887,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(311_C_)",128.904,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(562_A_)",104.05,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(425_A_)",97.1351,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(502_C_)",98.2966,"","",""
"6P8M","CRYSTAL STRUCTURE OF ANTIBODY P-P3B3 A60C HEAVY CHAIN IN COMPLEX WITH 426C HIV-1 GP120 CORE G459C","10.1016/J.CELREP.2019.10.071 ",3.59,0,"6p8m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_C_)",140.773,"","",""
"6P91","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C","10.1016/J.CELL.2019.07.020 ",4,209,"6p91_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(395_a_)",256.901,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(373_a_)",161.811,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)-ASN(395_a_)",161.32,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo19","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_e_)-[NAG(2_e_)]-NAG(1_e_)-ASN(395_c_)",155.303,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(395_b_)",167.435,"","",""
"6PCI","EBOV GPDMUC (MAKONA) IN COMPLEX WITH REBOV-520 AND REBOV-548 FABS","10.1016/J.IMMUNI.2020.01.001 ",4.12,"1.08527e-19","6pci_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(563_F_)",124.551,"","",""
"6PCI","EBOV GPDMUC (MAKONA) IN COMPLEX WITH REBOV-520 AND REBOV-548 FABS","10.1016/J.IMMUNI.2020.01.001 ",4.12,"1.08527e-19","6pci_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(563_E_)",118.981,"","",""
"6PCI","EBOV GPDMUC (MAKONA) IN COMPLEX WITH REBOV-520 AND REBOV-548 FABS","10.1016/J.IMMUNI.2020.01.001 ",4.12,"1.08527e-19","6pci_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(563_D_)",120.192,"","",""
"6PD4","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN","10.1371/JOURNAL.PONE.0048742 ",2.2,32.52,"6pd4_oligo6","DManpb1-6DManpa1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_H_)-[BMA(4_H_)-BMA(3_H_)-NAG(2_H_)]-[FUC(5_H_)]-NAG(1_H_)-ASN(529_B_)",57.8429,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo12","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_T_)-[MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-[FUC(6_T_)]-NAG(1_T_)-ASN(529_G_)",35.3121,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo5","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-[FUC(6_K_)]-NAG(1_K_)-ASN(529_A_)",70.2836,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_N_)-[MAN(5_N_)-[BMA(4_N_)]-MAN(3_N_)-NAG(2_N_)]-[FUC(6_N_)]-NAG(1_N_)-ASN(529_C_)",29.4042,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_Q_)-[BMA(3_Q_)-NAG(2_Q_)]-[FUC(4_Q_)]-NAG(1_Q_)-ASN(529_E_)",51.0882,"","",""
"6PHW","SPAGA D472N STRUCTURE IN COMPLEX WITH MELIBIOSE","10.1074/JBC.RA119.010280 ",2.2,33.47,"6phw_oligo1","DGalpa1-6DGlcpa1-ROH","GLA(2_B_)-GLC(1_B_)",36.9436,"","",""
"6PHX","SPAGA D472N STRUCTURE IN COMPLEX WITH RAFFINOSE","10.1074/JBC.RA119.010280 ",2,29.11,"6phx_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(1_B_)-GLC(2_B_)-FRU(3_B_)",42.9336,"","",""
"6PKG","ZEBRAFISH N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N- ACETYLGLUCOSAMINIDASE (NAGPA) CATALYTIC DOMAIN AUTO-INHIBITED BY PRO- PEPTIDE","10.1016/J.STR.2020.02.001 ",2.8,0,"6pkg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(223_A_)",76.1277,"","",""
"6PKH","ZEBRAFISH N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N- ACETYLGLUCOSAMINIDASE (NAGPA) CATALYTIC DOMAIN AUTO-INHIBITED BY PRO- PEPTIDE","10.1016/J.STR.2020.02.001 ",1.6,0,"6pkh_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(223_A_)",77.0922,"","",""
"6PKY","GUINEA PIG N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N- ACETYLGLUCOSAMINIDASE (NAGPA) CATALYTIC DOMAIN AUTO-INHIBITED BY PRO- PEPTIDE","10.1016/J.STR.2020.02.001 ",3,0,"6pky_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(296_B_)",64.0618,"","",""
"6POG","CRYSTAL STRUCTURE OF THE NELL2 EGF1-6-ROBO3 FN1 COMPLEX","10.1038/S41467-020-15211-1 ",2.76,0,"6pog_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(517_B_)",157.702,"","",""
"6PQL","SBP RAFE IN COMPLEX WITH RAFFINOSE","10.1074/JBC.RA119.010280 ",2.65,39.71,"6pql_oligo1","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_E_)-GLC(1_E_)-FRU(2_E_)",31.2546,"","",""
"6PQL","SBP RAFE IN COMPLEX WITH RAFFINOSE","10.1074/JBC.RA119.010280 ",2.65,39.71,"6pql_oligo3","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_G_)-GLC(1_G_)-FRU(2_G_)",37.2521,"","",""
"6PQL","SBP RAFE IN COMPLEX WITH RAFFINOSE","10.1074/JBC.RA119.010280 ",2.65,39.71,"6pql_oligo2","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_F_)-GLC(1_F_)-FRU(2_F_)",33.6856,"","",""
"6PQL","SBP RAFE IN COMPLEX WITH RAFFINOSE","10.1074/JBC.RA119.010280 ",2.65,39.71,"6pql_oligo4","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_H_)-GLC(1_H_)-FRU(2_H_)",37.3908,"","",""
"6PRE","SBP RAFE IN COMPLEX WITH VERBASCOSE","10.1074/JBC.RA119.010280 ",2.4,36.91,"6pre_oligo4","DGalpa1-6DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(4_H_)-GLA(3_H_)-GLA(2_H_)-GLC(1_H_)-FRU(5_H_)",41.8413,"","",""
"6PRE","SBP RAFE IN COMPLEX WITH VERBASCOSE","10.1074/JBC.RA119.010280 ",2.4,36.91,"6pre_oligo1","DGalpa1-6DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(4_E_)-GLA(3_E_)-GLA(2_E_)-GLC(1_E_)-FRU(5_E_)",33.4064,"","",""
"6PRE","SBP RAFE IN COMPLEX WITH VERBASCOSE","10.1074/JBC.RA119.010280 ",2.4,36.91,"6pre_oligo3","DGalpa1-6DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(4_G_)-GLA(3_G_)-GLA(2_G_)-GLC(1_G_)-FRU(5_G_)",34.6351,"","",""
"6PRE","SBP RAFE IN COMPLEX WITH VERBASCOSE","10.1074/JBC.RA119.010280 ",2.4,36.91,"6pre_oligo2","DGalpa1-6DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(4_F_)-GLA(3_F_)-GLA(2_F_)-GLC(1_F_)-FRU(5_F_)",36.7219,"","",""
"6PRG","SBP RAFE IN COMPLEX WITH STACHYOSE","10.1074/JBC.RA119.010280 ",2.35,28.74,"6prg_oligo2","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(3_D_)-GLA(2_D_)-GLC(1_D_)-FRU(4_D_)",29.9857,"","",""
"6PRG","SBP RAFE IN COMPLEX WITH STACHYOSE","10.1074/JBC.RA119.010280 ",2.35,28.74,"6prg_oligo1","DGalpa1-6DGalpa1-6DGlcpa2-1DFrufb","GLA(3_C_)-GLA(2_C_)-GLC(1_C_)-FRU(4_C_)",25.0425,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(145_E_)",56.5693,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_A_)",53.5422,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(145_B_)",67.9196,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(141_D_)",43.2825,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(145_C_)",72.0353,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(145_E_)",49.0451,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(141_D_)",39.86,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_A_)",37.5302,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(145_C_)",56.7971,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(145_B_)",61.3084,"","",""
"6PW6","THE HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 SOSIP.664 IN COMPLEX WITH THREE COPIES OF THE BOVINE BROADLY NEUTRALIZING ANTIBODY, NC-COW1, FRAGMENT ANTIGEN BINDING DOMAIN","10.1126/SCIADV.ABA0468 ",4.5,"1.42472e+13","6pw6_oligo22","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(262_A_)",83.4296,"","",""
"6PW6","THE HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 SOSIP.664 IN COMPLEX WITH THREE COPIES OF THE BOVINE BROADLY NEUTRALIZING ANTIBODY, NC-COW1, FRAGMENT ANTIGEN BINDING DOMAIN","10.1126/SCIADV.ABA0468 ",4.5,"1.42472e+13","6pw6_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_E_)",83.4296,"","",""
"6PW6","THE HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 SOSIP.664 IN COMPLEX WITH THREE COPIES OF THE BOVINE BROADLY NEUTRALIZING ANTIBODY, NC-COW1, FRAGMENT ANTIGEN BINDING DOMAIN","10.1126/SCIADV.ABA0468 ",4.5,"1.42472e+13","6pw6_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_C_)",83.4296,"","",""
"6PWT","CRYSTAL STRUCTURE OF THE COW C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN OF CD23 IN THE PRESENCE OF GLCNAC2MAN3 OLIGOSACCHARIDE","10.1074/JBC.RA119.010572 ",2.7,85.3,"6pwt_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_B_)-MAN(4_B_)-[NAG(3_B_)-MAN(2_B_)]-MAN(1_B_)",78.1735,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(160_A_)",300.024,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo25","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(160_C_)",300.941,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)]-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(160_E_)",302.096,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo15","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(134_A_)",383.448,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo14","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_j_)-[BMA(3_j_)-NAG(2_j_)]-NAG(1_j_)-ASN(156_A_)",327.316,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",441.867,"","",""
"6PXH","CRYSTAL STRUCTURE OF MERS-COV S1-NTD BOUND WITH G2 FAB","10.1016/J.CELREP.2019.08.052 ",2.3,44.06,"6pxh_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(222_B_)",64.4831,"","",""
"6PXH","CRYSTAL STRUCTURE OF MERS-COV S1-NTD BOUND WITH G2 FAB","10.1016/J.CELREP.2019.08.052 ",2.3,44.06,"6pxh_oligo3","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-[MAN(7_J_)]-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(222_A_)",70.752,"","",""
"6PZ8","MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2","10.1016/J.CELREP.2019.08.052 ",4.19,512.502,"6pz8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(222_B_)",372.533,"","",""
"6PZ8","MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2","10.1016/J.CELREP.2019.08.052 ",4.19,512.502,"6pz8_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(222_F_)",372.533,"","",""
"6PZ8","MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2","10.1016/J.CELREP.2019.08.052 ",4.19,512.502,"6pz8_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(222_J_)",372.533,"","",""
"6PZD","CRYSTAL STRUCTURE OF THE NEURAMINIDASE STABILIZATION MUTANT Y169AH FROM A/SHANGHAI/2/2013 (H7N9)","10.1016/J.CHOM.2019.10.002 ",1.12,0,"6pzd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_B_)-[MAN(9_B_)-MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",19.0801,"","",""
"6PZE","CRYSTAL STRUCTURE OF HUMAN NA-45 FAB IN COMPLEX WITH NEURAMINIDASE Y169AH MUTANT FROM A/SHANGHAI/2/2013 (H7N9)","10.1016/J.CHOM.2019.10.002 ",2.3,0,"6pze_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_B_)-[MAN(9_B_)-MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",37.029,"","",""
"6PZF","CRYSTAL STRUCTURE OF HUMAN NA-63 FAB IN COMPLEX WITH NEURAMINIDASE FROM A/HUNAN/02650/2016(H7N9)","10.1016/J.CHOM.2019.10.002 ",2.8,0,"6pzf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_C_)-MAN(10_C_)-[MAN(9_C_)-MAN(8_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_B_)",71.8412,"","",""
"6PZF","CRYSTAL STRUCTURE OF HUMAN NA-63 FAB IN COMPLEX WITH NEURAMINIDASE FROM A/HUNAN/02650/2016(H7N9)","10.1016/J.CHOM.2019.10.002 ",2.8,0,"6pzf_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_D_)-MAN(10_D_)-[MAN(9_D_)-MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",84.8722,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(200_C_)",28.5102,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-[MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_B_)",28.5102,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_A_)",28.5102,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(200_D_)",28.5102,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-[MAN(8_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(200_E_)",63.3779,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(200_A_)",63.3779,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-[MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(200_B_)",63.3779,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-[MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_F_)",63.3779,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_A_)",75.848,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(200_B_)",75.848,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(200_C_)",75.848,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_D_)",75.848,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",25.6223,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo9","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",18.997,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo17","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_B_)",18.997,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(125_B_)",13.2213,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo23","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(410_C_)",18.997,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)",25.6223,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",13.2213,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",25.6223,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(125_C_)",13.2213,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",12.2331,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(410_B_)",14.7781,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)",23.5246,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(125_C_)",12.2331,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",23.5246,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",14.7781,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(125_B_)",12.2331,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",23.5246,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo25","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(410_C_)",14.7781,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)",26.5844,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",26.5844,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",26.5844,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(125_C_)",14.5058,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",14.5058,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(410_B_)",18.6408,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo25","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(410_C_)",18.6408,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",18.6408,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(125_B_)",14.5058,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_B_)",23.306,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",23.306,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo23","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(410_C_)",23.306,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(125_A_)",19.6578,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(125_C_)",19.6578,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(125_B_)",19.6578,"","",""
"6Q1N","GLUCOCEREBROSIDASE IN COMPLEX WITH PHARMACOLOGICAL CHAPERONE IMX8","",2.53,39.51,"6q1n_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(59_A_)",63.5627,"","",""
"6Q1P","GLUCOCEREBROSIDASE IN COMPLEX WITH PHARMACOLOGICAL CHAPERONE NORIMX8","",2.8,43.81,"6q1p_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(59_A_)",68.4532,"","",""
"6Q1Z","CRYSTAL STRUCTURE OF HUMAN 1G04 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/HUNAN/02650/2016 (H7N9)","10.1126/SCIENCE.AAY0678 ",3.45,0,"6q1z_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_G_)-MAN(10_G_)-[MAN(9_G_)-MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",145.956,"","",""
"6Q1Z","CRYSTAL STRUCTURE OF HUMAN 1G04 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/HUNAN/02650/2016 (H7N9)","10.1126/SCIENCE.AAY0678 ",3.45,0,"6q1z_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",127.785,"","",""
"6Q20","CRYSTAL STRUCTURE OF HUMAN 1E01 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/JAPAN/305/1957 (H2N2)","10.1126/SCIENCE.AAY0678 ",2.45,0,"6q20_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",85.2922,"","",""
"6Q7I","GH3 EXO-BETA-XYLOSIDASE (XLND)","10.1021/ACSCENTSCI.9B00221 ",1.48,21.02,"6q7i_oligo5","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(10_E_)-MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(140_A_)",35.4125,"","",""
"6Q7I","GH3 EXO-BETA-XYLOSIDASE (XLND)","10.1021/ACSCENTSCI.9B00221 ",1.48,21.02,"6q7i_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(140_B_)",31.6495,"","",""
"6Q7J","GH3 EXO-BETA-XYLOSIDASE (XLND) IN COMPLEX WITH XYLOBIOSE AZIRIDINE ACTIVITY BASED PROBE","10.1021/ACSCENTSCI.9B00221 ",2.14,46.1,"6q7j_oligo5","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DRhapa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(140_B_)",67.0677,"","",""
"6Q7J","GH3 EXO-BETA-XYLOSIDASE (XLND) IN COMPLEX WITH XYLOBIOSE AZIRIDINE ACTIVITY BASED PROBE","10.1021/ACSCENTSCI.9B00221 ",2.14,46.1,"6q7j_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(140_A_)",73.5362,"","",""
"6QAA","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-2-(BUTYLAMINO)-N-(2- CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",1.9,0,"6qaa_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",69.2121,"","",""
"6QAA","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-2-(BUTYLAMINO)-N-(2- CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",1.9,0,"6qaa_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",56.4821,"","",""
"6QAA","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-2-(BUTYLAMINO)-N-(2- CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",1.9,0,"6qaa_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",87.3977,"","",""
"6QAB","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N-(1-((2- CYCLOHEPTYLETHYL)AMINO)-3-(1H-INDOL-3-YL)-1-OXOPROPAN-2-YL)-N,N- DIMETHYLBUTAN-1-AMINIUM","10.1039/C9CC01330J ",2.49,0,"6qab_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",97.1046,"","",""
"6QAB","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N-(1-((2- CYCLOHEPTYLETHYL)AMINO)-3-(1H-INDOL-3-YL)-1-OXOPROPAN-2-YL)-N,N- DIMETHYLBUTAN-1-AMINIUM","10.1039/C9CC01330J ",2.49,0,"6qab_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",116.102,"","",""
"6QAB","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N-(1-((2- CYCLOHEPTYLETHYL)AMINO)-3-(1H-INDOL-3-YL)-1-OXOPROPAN-2-YL)-N,N- DIMETHYLBUTAN-1-AMINIUM","10.1039/C9CC01330J ",2.49,0,"6qab_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",87.9464,"","",""
"6QAC","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-2-(BUTYLAMINO)-N-(3- CYCLOHEPTYLPROPYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",2.77,0,"6qac_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",123.057,"","",""
"6QAC","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-2-(BUTYLAMINO)-N-(3- CYCLOHEPTYLPROPYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",2.77,0,"6qac_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",88.9903,"","",""
"6QAD","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((S)-2-(BUTYLAMINO)-N-(2- (4-(DIMETHYLAMINO)CYCLOHEXYL)ETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",2.5,0,"6qad_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",108.439,"","",""
"6QAD","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((S)-2-(BUTYLAMINO)-N-(2- (4-(DIMETHYLAMINO)CYCLOHEXYL)ETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",2.5,0,"6qad_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",75.1964,"","",""
"6QAD","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((S)-2-(BUTYLAMINO)-N-(2- (4-(DIMETHYLAMINO)CYCLOHEXYL)ETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1039/C9CC01330J ",2.5,0,"6qad_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",116.067,"","",""
"6QAE","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N2-BUTYL-N1-(2- CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)-N1,N2-DIMETHYLPROPANE-1,2-DIAMINE","10.1039/C9CC01330J ",2.49,0,"6qae_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",118.492,"","",""
"6QAE","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N2-BUTYL-N1-(2- CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)-N1,N2-DIMETHYLPROPANE-1,2-DIAMINE","10.1039/C9CC01330J ",2.49,0,"6qae_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",93.8085,"","",""
"6QAE","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N2-BUTYL-N1-(2- CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)-N1,N2-DIMETHYLPROPANE-1,2-DIAMINE","10.1039/C9CC01330J ",2.49,0,"6qae_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",101.918,"","",""
"6QD7","EM STRUCTURE OF A EBOV-GP BOUND TO 3T0331 NEUTRALIZING ANTIBODY","10.1038/S41591-019-0602-4 ",3.1,0,"6qd7_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(563_F_)",76.6564,"","",""
"6QD7","EM STRUCTURE OF A EBOV-GP BOUND TO 3T0331 NEUTRALIZING ANTIBODY","10.1038/S41591-019-0602-4 ",3.1,0,"6qd7_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(563_B_)",76.1039,"","",""
"6QD7","EM STRUCTURE OF A EBOV-GP BOUND TO 3T0331 NEUTRALIZING ANTIBODY","10.1038/S41591-019-0602-4 ",3.1,0,"6qd7_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(563_D_)",66.5648,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",40.4742,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_C_)",39.4287,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_A_)",39.9275,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_D_)",40.5464,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_E_)",41.1502,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(190_A_)",77.2607,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(314_A_)",64.9617,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(163_B_)",77.5403,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(314_B_)",74.9674,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(236_A_)",97.5653,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo9","DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(236_B_)",86.1496,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(571_A_)",110.102,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(197_A_)",101.67,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(197_B_)",90.1843,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-MAN(5_L_)-[MAN(7_L_)]-MAN(4_L_)-[MAN(8_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(321_B_)",63.4973,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(321_A_)",68.5622,"","",""
"6QPH","DUNALIELLA MINIMAL PSI COMPLEX","10.1038/S41477-020-0611-9 ",3.4,0,"6qph_oligo10","DGalpa1-6DGalpb1-C11O5","DGD(5002_B_)-DGD(5002_B_)",121.808,"","",""
"6QPH","DUNALIELLA MINIMAL PSI COMPLEX","10.1038/S41477-020-0611-9 ",3.4,0,"6qph_oligo1","DGalpa1-6DGalpb1-C20O5","DGD(811_2_)-DGD(811_2_)",129.43,"","",""
"6QPH","DUNALIELLA MINIMAL PSI COMPLEX","10.1038/S41477-020-0611-9 ",3.4,0,"6qph_oligo3","DGalpa1-6DGalpb1-C3O3","DGD(5001_J_)-DGD(5001_J_)",94.8573,"","",""
"6QPH","DUNALIELLA MINIMAL PSI COMPLEX","10.1038/S41477-020-0611-9 ",3.4,0,"6qph_oligo9","DGalpa1-6DGalpb1-C18O5","DGD(811_4_)-DGD(811_4_)",107.31,"","",""
"6QS1","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH BPPB","10.1042/BCJ20190290 ",1.8,0,"6qs1_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",52.3757,"","",""
"6QS1","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH BPPB","10.1042/BCJ20190290 ",1.8,0,"6qs1_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(416_B_)",65.01,"","",""
"6QS1","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH BPPB","10.1042/BCJ20190290 ",1.8,0,"6qs1_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(480_B_)",61.5673,"","",""
"6QS1","CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH BPPB","10.1042/BCJ20190290 ",1.8,0,"6qs1_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(480_A_)",61.8812,"","",""
"6QXP","PROTEIN PEPTIDE COMPLEX","10.1073/PNAS.2000100117 ",3.2,0,"6qxp_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(73_F_)",109.601,"","",""
"6QXP","PROTEIN PEPTIDE COMPLEX","10.1073/PNAS.2000100117 ",3.2,0,"6qxp_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(73_E_)",136.218,"","",""
"6R6V","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT COUMARIN-BASED PROBE","10.1080/14756366.2019.1710502 ",2.5,62.18,"6r6v_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",89.303,"","",""
"6R6V","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT COUMARIN-BASED PROBE","10.1080/14756366.2019.1710502 ",2.5,62.18,"6r6v_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",121.83,"","",""
"6R6V","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT COUMARIN-BASED PROBE","10.1080/14756366.2019.1710502 ",2.5,62.18,"6r6v_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",106.593,"","",""
"6R6W","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT NBD-BASED PROBE","10.1080/14756366.2019.1710502 ",2.47,66.71,"6r6w_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",120.909,"","",""
"6R6W","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT NBD-BASED PROBE","10.1080/14756366.2019.1710502 ",2.47,66.71,"6r6w_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",113.328,"","",""
"6R6W","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT NBD-BASED PROBE","10.1080/14756366.2019.1710502 ",2.47,66.71,"6r6w_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",90.9949,"","",""
"6RHZ","STRUCTURE OF A MINIMAL PHOTOSYSTEM I FROM A GREEN ALGA","10.1038/S41477-020-0611-9 ",3.2,"1.08527e-19","6rhz_oligo6","DGalpa1-6DGalpb1-C34O5","DGD(5002_B_)-DGD(5002_B_)",70.34,"","",""
"6RPJ","A NON-BLOCKING ANTI-CTLA-4 NANOBODY COMPLEXED WITH CTLA-4","",3.25,89.74,"6rpj_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(78_E_)",90.9491,"","",""
"6RPJ","A NON-BLOCKING ANTI-CTLA-4 NANOBODY COMPLEXED WITH CTLA-4","",3.25,89.74,"6rpj_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(78_G_)",93.7091,"","",""
"6RPJ","A NON-BLOCKING ANTI-CTLA-4 NANOBODY COMPLEXED WITH CTLA-4","",3.25,89.74,"6rpj_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(78_A_)",119.398,"","",""
"6RU5","HUMAN COMPLEMENT C3 IN COMPLEX WITH THE HC3NB1 NANOBODY","10.3389/FIMMU.2019.02007 ",3.9,0,"6ru5_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(939_B_)",189.934,"","",""
"6RUA","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A COUMARIN-BASED FLUORESCENT PROBE LINKED TO SULFONAMIDE TYPE INHIBITOR.","10.1080/14756366.2019.1710502 ",2.75,0,"6rua_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(241_A_)",115.382,"","",""
"6RUA","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A COUMARIN-BASED FLUORESCENT PROBE LINKED TO SULFONAMIDE TYPE INHIBITOR.","10.1080/14756366.2019.1710502 ",2.75,0,"6rua_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(57_A_)",106.127,"","",""
"6RY5","CRYSTAL STRUCTURE OF DFG5 FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH ALPHA-1,6-MANNOBIOSE","10.1073/PNAS.2010661117 ",1.3,0,"6ry5_oligo1","DManpa1-6DManpb1-ROH","MAN(2_B_)-BMA(1_B_)",19.335,"","",""
"6S1X","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII)-E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR KB1160","10.1021/ACS.JMEDCHEM.9B02022 ",1.76,37.29,"6s1x_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",56.8047,"","",""
"6S2G","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND EPIGALLOCATECHIN GALLATE (EGCG)","10.1038/S41598-019-53948-Y ",2.03,33.73,"6s2g_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(107_B_)",50.8245,"","",""
"6S2G","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND EPIGALLOCATECHIN GALLATE (EGCG)","10.1038/S41598-019-53948-Y ",2.03,33.73,"6s2g_oligo13","DManpa1-2DManpa1-2DRhapa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",43.6479,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo33","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",39.6481,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo32","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",45.8798,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",47.3217,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",37.2593,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo28","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",41.3839,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",55.5642,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo27","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",46.4876,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",42.7631,"","",""
"6S5A","CRYSTAL STRUCTURE OF FC P329G LALA WITH ANTI FC P329G FAB","10.1093/PROTEIN/GZZ027 ",1.72,48.94,"6s5a_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_D_)",43.4699,"","",""
"6S5A","CRYSTAL STRUCTURE OF FC P329G LALA WITH ANTI FC P329G FAB","10.1093/PROTEIN/GZZ027 ",1.72,48.94,"6s5a_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",83.0861,"","",""
"6S7O","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-A","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7o_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(548_A_)",48.9795,"","",""
"6S7O","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-A","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7o_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-[MAN(7_K_)]-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(299_E_)",37.9019,"","",""
"6S7T","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-B","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7t_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_L_)-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(627_A_)",61.7127,"","",""
"6S7T","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-B","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7t_oligo10","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-[MAN(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(299_E_)",49.0967,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo25","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",56.3562,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo30","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",58.7464,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",42.2179,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",42.2915,"","",""
"6S9J","CRYSTAL STRUCTURE OF TFR1 MIMICRY IN COMPLEX WITH GP1 FROM MACV","10.1038/S41467-019-13924-6 ",2.7,0,"6s9j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(178_B_)",89.6887,"","",""
"6SAM","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 1-(2,3- DIHYDRO-1H-INDEN2-YL)PIPERIDIN-3-YL N-PHENYL CARBAMATE","10.1016/J.EJMECH.2020.112282 ",2.5,60.96,"6sam_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",99.1988,"","",""
"6SAM","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 1-(2,3- DIHYDRO-1H-INDEN2-YL)PIPERIDIN-3-YL N-PHENYL CARBAMATE","10.1016/J.EJMECH.2020.112282 ",2.5,60.96,"6sam_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(57_A_)",109.802,"","",""
"6SAM","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 1-(2,3- DIHYDRO-1H-INDEN2-YL)PIPERIDIN-3-YL N-PHENYL CARBAMATE","10.1016/J.EJMECH.2020.112282 ",2.5,60.96,"6sam_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(106_A_)",88.8836,"","",""
"6SAM","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 1-(2,3- DIHYDRO-1H-INDEN2-YL)PIPERIDIN-3-YL N-PHENYL CARBAMATE","10.1016/J.EJMECH.2020.112282 ",2.5,60.96,"6sam_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",80.1145,"","",""
"6SAZ","CLEAVED HUMAN FETUIN-B IN COMPLEX WITH CRAYFISH ASTACIN","10.1038/S41598-019-51095-Y ",3,82.4,"6saz_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(37_B_)",135.632,"","",""
"6SAZ","CLEAVED HUMAN FETUIN-B IN COMPLEX WITH CRAYFISH ASTACIN","10.1038/S41598-019-51095-Y ",3,82.4,"6saz_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(37_D_)",113.2,"","",""
"6SFF","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP I41","10.1107/S2059798320013753 ",2.4,66.83,"6sff_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(220_A_)",88.3745,"","",""
"6SGP","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A SULFAMIDE INHIBITOR GLUGLU","",1.58,30.56,"6sgp_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",43.3135,"","",""
"6SHM","AN INACTIVE (D136A AND D137A) VARIANT OF ALPHA-1,6-MANNANASE, GH76A OF SALEGENTIBACTER SP. HEL1_6 IN COMPLEX WITH ALPHA-1,6-MANNOTETROSE","10.1038/S41396-022-01223-W ",1.9,12.8,"6shm_oligo2","DManpa1-6DManpa1-6DManpa1-6DManpa1-ROH","MAN(4_B_)-MAN(3_B_)-MAN(2_B_)-MAN(1_B_)",14.5859,"","",""
"6SKA","TENEURIN 2 IN COMPLEX WITH LATROPHILIN 1 LEC-OLF DOMAINS","10.1016/J.CELL.2019.12.014 ",3.86,0,"6ska_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(2365_A_)",198.766,"","",""
"6SKE","TENEURIN 2 IN COMPLEX WITH LATROPHILIN 2 LEC DOMAIN","10.1016/J.CELL.2019.12.014 ",3.62,99.36,"6ske_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2365_A_)",152.739,"","",""
"6SKE","TENEURIN 2 IN COMPLEX WITH LATROPHILIN 2 LEC DOMAIN","10.1016/J.CELL.2019.12.014 ",3.62,99.36,"6ske_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(2365_C_)",157.151,"","",""
"6SKH","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR SULFAMIDE INHIBITOR GLUASP","",1.58,29.21,"6skh_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",41.954,"","",""
"6SL5","DUNALIELLA PHOTOSYSTEM I SUPERCOMPLEX","10.1016/J.BBABIO.2020.148253 ",2.84,"1.08527e-19","6sl5_oligo1","DGalpa1-6DGalpb1-C34O5","DGD(5002_B_)-DGD(5002_B_)",0,"","",""
"6SL5","DUNALIELLA PHOTOSYSTEM I SUPERCOMPLEX","10.1016/J.BBABIO.2020.148253 ",2.84,"1.08527e-19","6sl5_oligo19","DGalpa1-6DGalpb1-C18O5","DGD(805_3_)-DGD(805_3_)",0,"","",""
"6SL5","DUNALIELLA PHOTOSYSTEM I SUPERCOMPLEX","10.1016/J.BBABIO.2020.148253 ",2.84,"1.08527e-19","6sl5_oligo18","DGalpa1-6DGalpb1-C12O5","DGD(804_3_)-DGD(804_3_)",0,"","",""
"6SL5","DUNALIELLA PHOTOSYSTEM I SUPERCOMPLEX","10.1016/J.BBABIO.2020.148253 ",2.84,"1.08527e-19","6sl5_oligo17","DGalpa1-6DGalpb1-C12O5","DGD(806_2_)-DGD(806_2_)",0,"","",""
"6SMA","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (HNE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC249","10.1021/ACSCHEMBIO.0C00090 ",2.59,41.02,"6sma_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(159_B_)",54.1986,"","",""
"6SMA","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (HNE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC249","10.1021/ACSCHEMBIO.0C00090 ",2.59,41.02,"6sma_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(109_A_)",48.7285,"","",""
"6SMA","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (HNE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC249","10.1021/ACSCHEMBIO.0C00090 ",2.59,41.02,"6sma_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(159_A_)",51.0609,"","",""
"6SMA","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (HNE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC249","10.1021/ACSCHEMBIO.0C00090 ",2.59,41.02,"6sma_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(109_C_)",56.3094,"","",""
"6SMA","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (HNE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC249","10.1021/ACSCHEMBIO.0C00090 ",2.59,41.02,"6sma_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(159_C_)",46.7336,"","",""
"6SMA","CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (HNE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC249","10.1021/ACSCHEMBIO.0C00090 ",2.59,41.02,"6sma_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(109_B_)",61.8194,"","",""
"6SP3","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 1","",3,120.5,"6sp3_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(220_B_)",139.326,"","",""
"6SP3","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 1","",3,120.5,"6sp3_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(220_A_)",156.601,"","",""
"6SYQ","ASR ALTERNANSUCRASE IN COMPLEX WITH ISOMALTOTRIOSE","10.1074/JBC.RA120.013028 ",3,98.51,"6syq_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",112.827,"","",""
"6SYQ","ASR ALTERNANSUCRASE IN COMPLEX WITH ISOMALTOTRIOSE","10.1074/JBC.RA120.013028 ",3,98.51,"6syq_oligo2","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(1505_A_)-GLC(2_D_)-GLC(1_D_)",141.992,"","",""
"6SYQ","ASR ALTERNANSUCRASE IN COMPLEX WITH ISOMALTOTRIOSE","10.1074/JBC.RA120.013028 ",3,98.51,"6syq_oligo3","DGlcpa1-6DGlcpa1-ROH","GLC(2_E_)-GLC(1_E_)",107.696,"","",""
"6SZ6","CHAETOMIUM THERMOPHILUM BETA-GLUCOSIDASE","10.3390/IJMS20235962 ",2.99,51.57,"6sz6_oligo6","DManpa1-2DManpa1-6DManpx1-","MAN(3_F_)-MAN(2_F_)-MAN(1_F_)",54.1342,"","",""
"6SZI","ASR ALTERNANSUCRASE IN COMPLEX WITH ISOMALTOSE","10.1074/JBC.RA120.013028 ",3,81.72,"6szi_oligo1","DGlcpa1-6DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",87.0214,"","",""
"6SZI","ASR ALTERNANSUCRASE IN COMPLEX WITH ISOMALTOSE","10.1074/JBC.RA120.013028 ",3,81.72,"6szi_oligo3","DGlcpa1-6DGlcpa1-ROH","GLC(2_E_)-GLC(1_E_)",111.275,"","",""
"6SZI","ASR ALTERNANSUCRASE IN COMPLEX WITH ISOMALTOSE","10.1074/JBC.RA120.013028 ",3,81.72,"6szi_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_D_)-GLC(1_D_)",117.439,"","",""
"6T16","ASR ALTERNANSUCRASE IN COMPLEX WITH PANOSE","10.1074/JBC.RA120.013028 ",3.1,105.6,"6t16_oligo2","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(1503_A_)-GLC(1504_A_)-GLC(1505_A_)",119.131,"","",""
"6T16","ASR ALTERNANSUCRASE IN COMPLEX WITH PANOSE","10.1074/JBC.RA120.013028 ",3.1,105.6,"6t16_oligo3","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(2_E_)-GLC(1_E_)-GLC(1508_A_)",159.254,"","",""
"6T16","ASR ALTERNANSUCRASE IN COMPLEX WITH PANOSE","10.1074/JBC.RA120.013028 ",3.1,105.6,"6t16_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)-GLC(1501_A_)",139.819,"","",""
"6T16","ASR ALTERNANSUCRASE IN COMPLEX WITH PANOSE","10.1074/JBC.RA120.013028 ",3.1,105.6,"6t16_oligo4","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(1504_B_)-GLC(2_D_)-GLC(1_D_)",163.897,"","",""
"6T18","ASR ALTERNANSUCRASE IN COMPLEX WITH OLIGOALTERNAN","10.1074/JBC.RA120.013028 ",3.15,90.65,"6t18_oligo1","DGlcpa1-6DGlcpa1-3DGlcpa1-6DGlcpa1-3DGlcpa1-6DGlcpa1-ROH","GLC(6_C_)-GLC(5_C_)-GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",111.302,"","",""
"6T18","ASR ALTERNANSUCRASE IN COMPLEX WITH OLIGOALTERNAN","10.1074/JBC.RA120.013028 ",3.15,90.65,"6t18_oligo2","DGlcpa1-3DGlcpa1-6DGlcpa1-ROH","GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",147.912,"","",""
"6T18","ASR ALTERNANSUCRASE IN COMPLEX WITH OLIGOALTERNAN","10.1074/JBC.RA120.013028 ",3.15,90.65,"6t18_oligo3","DGlcpa1-3DGlcpa1-6DGlcpa1-3DGlcpa1-ROH","GLC(4_E_)-GLC(3_E_)-GLC(2_E_)-GLC(1_E_)",117.718,"","",""
"6T1D","PLEUROTUS OSTREATUS LECTIN (POL), COMPELX WITH MELIBIOSE","10.1093/GLYCOB/CWAA006 ",2.2,41.34,"6t1d_oligo12","DGalpa1-6DGlcpa1-ROH","GLA(2_R_)-GLC(1_R_)",72.2091,"","",""
"6T1D","PLEUROTUS OSTREATUS LECTIN (POL), COMPELX WITH MELIBIOSE","10.1093/GLYCOB/CWAA006 ",2.2,41.34,"6t1d_oligo4","DGalpa1-6DGlcpa1-ROH","GLA(2_J_)-GLC(1_J_)",41.2391,"","",""
"6T1D","PLEUROTUS OSTREATUS LECTIN (POL), COMPELX WITH MELIBIOSE","10.1093/GLYCOB/CWAA006 ",2.2,41.34,"6t1d_oligo8","DGalpa1-6DGlcpa1-ROH","GLA(2_N_)-GLC(1_N_)",60.1173,"","",""
"6T1D","PLEUROTUS OSTREATUS LECTIN (POL), COMPELX WITH MELIBIOSE","10.1093/GLYCOB/CWAA006 ",2.2,41.34,"6t1d_oligo6","DGalpa1-6DGlcpa1-ROH","GLA(2_L_)-GLC(1_L_)",62.7264,"","",""
"6T1D","PLEUROTUS OSTREATUS LECTIN (POL), COMPELX WITH MELIBIOSE","10.1093/GLYCOB/CWAA006 ",2.2,41.34,"6t1d_oligo2","DGalpa1-6DGlcpa1-ROH","GLA(2_H_)-GLC(1_H_)",50.88,"","",""
"6T1D","PLEUROTUS OSTREATUS LECTIN (POL), COMPELX WITH MELIBIOSE","10.1093/GLYCOB/CWAA006 ",2.2,41.34,"6t1d_oligo10","DGalpa1-6DGlcpa1-ROH","GLA(2_P_)-GLC(1_P_)",55.7864,"","",""
"6T1P","ASR ALTERNANSUCRASE IN COMPLEX WITH ISOMALTONONAOSE","10.1074/JBC.RA120.013028 ",3.5,108.2,"6t1p_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(4_D_)-GLC(3_D_)-GLC(2_D_)-GLC(1_D_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",146.733,"","",""
"6T8K","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH MAN9GLCNAC PRODUCT IN P1","10.1038/S41467-020-14754-7 ",2,21.34,"6t8k_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(10_C_)-MAN(9_C_)-[MAN(8_C_)-MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",23.4679,"","",""
"6T8K","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH MAN9GLCNAC PRODUCT IN P1","10.1038/S41467-020-14754-7 ",2,21.34,"6t8k_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(10_D_)-MAN(9_D_)-[MAN(8_D_)-MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",23.9043,"","",""
"6T8L","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 WITH MAN9GLCNAC PRODUCT IN P212121","10.1038/S41467-020-14754-7 ",1.7,18.41,"6t8l_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(10_B_)-MAN(9_B_)-[MAN(8_B_)-MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",25.2459,"","",""
"6T9P","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-(N-HYDROXYIMINO)-N- [(1R)-3-{4-[(2-METHYL-1H-IMIDAZOL-1-YL)METHYL]-1H-1,2,3-TRIAZOL-1- YL}-1- PHENYLPROPYL]ACETAMIDE","10.1042/BCJ20200192 ",2.7,71.73,"6t9p_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(241_A_)",133.004,"","",""
"6T9P","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-(N-HYDROXYIMINO)-N- [(1R)-3-{4-[(2-METHYL-1H-IMIDAZOL-1-YL)METHYL]-1H-1,2,3-TRIAZOL-1- YL}-1- PHENYLPROPYL]ACETAMIDE","10.1042/BCJ20200192 ",2.7,71.73,"6t9p_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",141.787,"","",""
"6T9S","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-(N-HYDROXYIMINO)-N- [(1S)-3-{4-[(2-METHYL-1H-IMIDAZOL-1-YL)METHYL]-1H-1,2,3-TRIAZOL-1- YL}-1- PHENYLPROPYL]ACETAMIDE","10.1042/BCJ20200192 ",2.7,72.16,"6t9s_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",117.274,"","",""
"6T9S","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-(N-HYDROXYIMINO)-N- [(1S)-3-{4-[(2-METHYL-1H-IMIDAZOL-1-YL)METHYL]-1H-1,2,3-TRIAZOL-1- YL}-1- PHENYLPROPYL]ACETAMIDE","10.1042/BCJ20200192 ",2.7,72.16,"6t9s_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(241_A_)",111.705,"","",""
"6TAV","CRYSTAL STRUCTURE OF ENDOPEPTIDASE-INDUCED ALPHA2-MACROGLOBULIN","",4.2,256.7,"6tav_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(55_A_)",296.072,"","",""
"6TAV","CRYSTAL STRUCTURE OF ENDOPEPTIDASE-INDUCED ALPHA2-MACROGLOBULIN","",4.2,256.7,"6tav_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(991_B_)",296.429,"","",""
"6TAV","CRYSTAL STRUCTURE OF ENDOPEPTIDASE-INDUCED ALPHA2-MACROGLOBULIN","",4.2,256.7,"6tav_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(396_A_)",293.192,"","",""
"6TAV","CRYSTAL STRUCTURE OF ENDOPEPTIDASE-INDUCED ALPHA2-MACROGLOBULIN","",4.2,256.7,"6tav_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(55_B_)",300,"","",""
"6TAV","CRYSTAL STRUCTURE OF ENDOPEPTIDASE-INDUCED ALPHA2-MACROGLOBULIN","",4.2,256.7,"6tav_oligo18","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(991_D_)",295.995,"","",""
"6TCV","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH MAN9GLCNAC2ASN SUBSTRATE","10.1038/S41467-020-14754-7 ",1.31,22.45,"6tcv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_A_)-MAN(10_A_)-[MAN(9_A_)-MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(501_B_)",20.6623,"","",""
"6TCW","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 WITH MAN5GLCNAC PRODUCT","10.1038/S41467-020-14754-7 ",1.6,23.13,"6tcw_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-[MAN(6_B_)]-BMA(2_B_)-NAG(1_B_)",22.4539,"","",""
"6TJV","STRUCTURE OF THE NDH-1MS COMPLEX FROM THERMOSYNECHOCOCCUS ELONGATUS","10.1038/S41467-020-14347-4 ",3.2,3220.21,"6tjv_oligo6","DGalpa1-6DGalpb1-C39O5","DGD(501_A_)-DGD(501_A_)",67.47,"","",""
"6TJV","STRUCTURE OF THE NDH-1MS COMPLEX FROM THERMOSYNECHOCOCCUS ELONGATUS","10.1038/S41467-020-14347-4 ",3.2,3220.21,"6tjv_oligo7","DGalpa1-6DGalpb1-C39O5","DGD(401_L_)-DGD(401_L_)",71.42,"","",""
"6TKV","CRYSTAL STRUCTURE OF THE HUMAN FUT8 IN COMPLEX WITH GDP AND A BIANTENNARY COMPLEX N-GLYCAN","10.1038/S41467-020-14794-Z ",1.95,36.11,"6tkv_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",48.896,"","",""
"6TKV","CRYSTAL STRUCTURE OF THE HUMAN FUT8 IN COMPLEX WITH GDP AND A BIANTENNARY COMPLEX N-GLYCAN","10.1038/S41467-020-14794-Z ",1.95,36.11,"6tkv_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",39.4397,"","",""
"6TP5","CRYSTAL STRUCTURE OF HUMAN TRANSMEMBRANE PROLYL 4-HYDROXYLASE","10.1074/JBC.RA120.016542 ",2.25,87.78,"6tp5_oligo4","DManpb1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[BMA(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(382_B_)",119.763,"","",""
"6TP5","CRYSTAL STRUCTURE OF HUMAN TRANSMEMBRANE PROLYL 4-HYDROXYLASE","10.1074/JBC.RA120.016542 ",2.25,87.78,"6tp5_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(382_A_)",124.942,"","",""
"6TQK","CRYO-EM OF NATIVE HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT.","10.15252/EMBJ.2020106807 ",3.35,0,"6tqk_oligo2","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[NAG(7_G_)-[GAL(6_G_)-NAG(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(396_C_)",161.743,"","",""
"6TQK","CRYO-EM OF NATIVE HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT.","10.15252/EMBJ.2020106807 ",3.35,0,"6tqk_oligo4","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-[NAG(7_E_)-[GAL(6_E_)-NAG(5_E_)]-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(396_A_)",174.455,"","",""
"6TQL","CRYO-EM OF ELASTASE-TREATED HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.15252/EMBJ.2020106807 ",3.96,"1.15243e-41","6tql_oligo3","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-6[DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-[GAL(6_E_)-NAG(5_E_)]-MAN(4_E_)-[NAG(10_E_)-[NAG(9_E_)]-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(396_A_)",233.983,"","",""
"6TQL","CRYO-EM OF ELASTASE-TREATED HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.15252/EMBJ.2020106807 ",3.96,"1.15243e-41","6tql_oligo4","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_G_)-MAN(7_G_)-[NAG(6_G_)-[NAG(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(396_C_)",177.91,"","",""
"6TRF","CHAETOMIUM THERMOPHILUM UDP-GLUCOSE GLUCOSYL TRANSFERASE (UGGT) PURIFIED FROM CELLS TREATED WITH KIFUNENSINE.","10.1016/J.STR.2020.11.017 ",4.11,270.2,"6trf_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(56_A_)",296.427,"","",""
"6TRT","CHAETOMIUM THERMOPHILUM UDP-GLUCOSE GLUCOSYL TRANSFERASE (UGGT) DOUBLE CYSTEINE MUTANT S180C/T742C.","10.1016/J.STR.2020.11.017 ",4.58,142.9,"6trt_oligo2","DManpa1-2DManpa1-2DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(56_A_)",273.278,"","",""
"6TS2","TRUNCATED VERSION OF CHAETOMIUM THERMOPHILUM UDP-GLUCOSE GLUCOSYL TRANSFERASE (UGGT) LACKING DOMAIN TRXL2 (417-650).","10.1016/J.STR.2020.11.017 ",5.74,133.7,"6ts2_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(56_C_)",234.713,"","",""
"6TS2","TRUNCATED VERSION OF CHAETOMIUM THERMOPHILUM UDP-GLUCOSE GLUCOSYL TRANSFERASE (UGGT) LACKING DOMAIN TRXL2 (417-650).","10.1016/J.STR.2020.11.017 ",5.74,133.7,"6ts2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(56_A_)",163.813,"","",""
"6TT1","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH 33RE.","10.1042/BCJ20200060 ",1.8,42.62,"6tt1_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(416_A_)",51.0886,"","",""
"6TT1","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH 33RE.","10.1042/BCJ20200060 ",1.8,42.62,"6tt1_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(480_A_)",47.8259,"","",""
"6TT1","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH 33RE.","10.1042/BCJ20200060 ",1.8,42.62,"6tt1_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_B_)",54.2027,"","",""
"6TT3","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SG6.","10.1042/BCJ20200060 ",1.7,38.72,"6tt3_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",52.5752,"","",""
"6TT3","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SG6.","10.1042/BCJ20200060 ",1.7,38.72,"6tt3_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_B_)",61.1473,"","",""
"6TT3","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SG6.","10.1042/BCJ20200060 ",1.7,38.72,"6tt3_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_A_)",58.0768,"","",""
"6TT4","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1042/BCJ20200060 ",1.8,40.4,"6tt4_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(416_B_)",65.6716,"","",""
"6TT4","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1042/BCJ20200060 ",1.8,40.4,"6tt4_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(480_A_)",65.6936,"","",""
"6TT4","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1042/BCJ20200060 ",1.8,40.4,"6tt4_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_B_)",56.7236,"","",""
"6TVA","CRYSTAL STRUCTURE OF THE HAEMAGGLUTININ FROM A TRANSMISSIBLE H10N7 SEAL INFLUENZA VIRUS ISOLATED IN NETHERLAND IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE, 3'-SLN","10.1016/J.CHOM.2020.08.011 ",1.74,32.81,"6tva_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(154_D_)",34.9431,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",90.1858,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",89.4071,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",81.1384,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",78.2778,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(356_G_)",116.689,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(359_G_)",82.5555,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_G_)",86.0508,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(268_G_)",98.7998,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(280_G_)",88.5601,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(467_G_)",98.4087,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",95.2927,"","",""
"6TYS","A POTENT CROSS-NEUTRALIZING ANTIBODY TARGETING THE FUSION GLYCOPROTEIN INHIBITS NIPAH VIRUS AND HENDRA VIRUS INFECTION","10.1038/S41594-019-0308-9 ",3.5,0,"6tys_oligo8","DManpa1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_T_)-[MAN(2_T_)]-BMA(1_T_)-NAG(2_S_)-NAG(1_S_)-ASN(414_E_)",166.819,"","",""
"6TYS","A POTENT CROSS-NEUTRALIZING ANTIBODY TARGETING THE FUSION GLYCOPROTEIN INHIBITS NIPAH VIRUS AND HENDRA VIRUS INFECTION","10.1038/S41594-019-0308-9 ",3.5,0,"6tys_oligo5","DManpa1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_P_)-[MAN(2_P_)]-BMA(1_P_)-NAG(2_O_)-NAG(1_O_)-ASN(414_B_)",166.819,"","",""
"6TYS","A POTENT CROSS-NEUTRALIZING ANTIBODY TARGETING THE FUSION GLYCOPROTEIN INHIBITS NIPAH VIRUS AND HENDRA VIRUS INFECTION","10.1038/S41594-019-0308-9 ",3.5,0,"6tys_oligo2","DManpa1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_K_)-[MAN(2_K_)]-BMA(1_K_)-NAG(2_J_)-NAG(1_J_)-ASN(414_A_)",166.819,"","",""
"6TZB","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 6'-SLNLN","10.1038/S41467-020-15102-5 ",2.24,49.07,"6tzb_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_C_)",92.4486,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(200_A_)",29.4068,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-[MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(200_E_)",29.4068,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_B_)",29.4068,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(200_J_)",29.4068,"","",""
"6U0L","ASYMMETRICALLY OPEN CONFORMATIONAL STATE (CLASS I) OF HIV-1 ENV TRIMER BG505 SOSIP.664 IN COMPLEX WITH SCD4 AND E51 FAB","10.1038/S41594-019-0344-5 ",3.3,"2.23709e+11","6u0l_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_B_)",78.0496,"","",""
"6U11","XENOPUS LAEVIS N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N- ACETYLGLUCOSAMINIDASE (NAGPA) (C46S C219S C453S C480S C486S) WITH CTD MOSTLY FLEXIBLE","10.1016/J.STR.2020.02.001 ",2.7,54.2,"6u11_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(53_A_)",131.035,"","",""
"6U6T","NEURONAL GROWTH REGULATOR 1 (NEGR1)","10.1016/J.JMB.2020.07.014 ",3.01,62.68,"6u6t_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(155_A_)",64.4454,"","",""
"6U7H","CRYO-EM STRUCTURE OF THE HCOV-229E SPIKE GLYCOPROTEIN","10.7554/ELIFE.51230 ",3.1,0,"6u7h_oligo10","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(62_C_)",126.427,"","",""
"6U7H","CRYO-EM STRUCTURE OF THE HCOV-229E SPIKE GLYCOPROTEIN","10.7554/ELIFE.51230 ",3.1,0,"6u7h_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(62_B_)",127.312,"","",""
"6U7H","CRYO-EM STRUCTURE OF THE HCOV-229E SPIKE GLYCOPROTEIN","10.7554/ELIFE.51230 ",3.1,0,"6u7h_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(62_A_)",126.313,"","",""
"6U7K","PREFUSION STRUCTURE OF PEDV SPIKE","10.1128/JVI.00923-19 ",3.14,0,"6u7k_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",30,"","",""
"6U7K","PREFUSION STRUCTURE OF PEDV SPIKE","10.1128/JVI.00923-19 ",3.14,0,"6u7k_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(261_C_)",30.5556,"","",""
"6U7K","PREFUSION STRUCTURE OF PEDV SPIKE","10.1128/JVI.00923-19 ",3.14,0,"6u7k_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNx1-","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",30,"","",""
"6U7N","CRYSTAL STRUCTURE OF NEUROTRIMIN (NTM)","10.1016/J.JMB.2020.07.014 ",3.32,79.78,"6u7n_oligo1","LFucpa1-6DGlcpNAcx1-","FUC(2_C_)-NAG(1_C_)",125.124,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_a_)-[MAN(7_a_)]-MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_K_)",56.8225,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_R_)",53.4418,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_V_)-[MAN(7_V_)]-MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_G_)",46.2403,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_G_)",55.8962,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo13","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(332_R_)",43.7697,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Y_)-MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_K_)",64.4775,"","",""
"6UGW","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A C-CENTERED ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2,42.26,"6ugw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",57.1612,"","",""
"6UGX","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2.1,39.91,"6ugx_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(300_B_)",51.9827,"","",""
"6UGX","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2.1,39.91,"6ugx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(300_A_)",48.6664,"","",""
"6UGY","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB (REMICADE) IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT C","10.1007/S40259-019-00390-1 ",2.1,44.15,"6ugy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",68.9984,"","",""
"6UJA","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH PRO-TGF-BETA1","10.1016/J.CELL.2019.12.030 ",3.3,"5.17114e+07","6uja_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",30.7015,"","",""
"6UJB","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS C6D4 AND 11D12V2","10.1016/J.CELL.2019.12.030 ",3.51,869877,"6ujb_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",50.378,"","",""
"6UJC","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS C6-RGD3 AND 11D12V2","10.1016/J.CELL.2019.12.030 ",3.56,869877,"6ujc_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",76.7564,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)]-MAN(4_a_)-[MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(160_E_)",132.807,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo16","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(134_A_)",190.141,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo25","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(160_C_)",146.034,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(197_A_)",195.821,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(160_A_)",124.793,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo14","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_m_)-[BMA(3_m_)-NAG(2_m_)]-NAG(1_m_)-ASN(156_A_)",147.09,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo9","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-BMA(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_A_)",29.6255,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo5","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-BMA(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_E_)",29.6255,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo16","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-BMA(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(332_I_)",29.6255,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_I_)",29.3445,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_A_)",29.3445,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_E_)",29.3445,"","",""
"6UM7","CRYO-EM STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY DH270.MU1 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",3.5,"5.37397e+08","6um7_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(332_I_)",72.3844,"","",""
"6UM7","CRYO-EM STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY DH270.MU1 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",3.5,"5.37397e+08","6um7_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_E_)",71.68,"","",""
"6UM7","CRYO-EM STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY DH270.MU1 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",3.5,"5.37397e+08","6um7_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_A_)",79.9017,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(297_F_)",46.501,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_C_)-MAN(6_A_)-[NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(297_C_)",71.2319,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(297_E_)",46.0612,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_D_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_D_)",75.8019,"","",""
"6UQR","COMPLEX OF IGE AND LIGELIZUMAB","10.1038/S41467-019-13815-W ",3.65,113.1,"6uqr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_B_)",123.397,"","",""
"6UR5","RESURFACED INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY","10.1021/ACSINFECDIS.0C00008 ",4,97.3,"6ur5_oligo1","DManpb1-4[LFucpa1-6]DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[FUC(4_E_)-[BMA(3_E_)]-NAG(2_E_)]-NAG(1_E_)-ASN(165_C_)",127.058,"","",""
"6UR5","RESURFACED INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY","10.1021/ACSINFECDIS.0C00008 ",4,97.3,"6ur5_oligo2","DManpa1-3DManpb1-4[LFucpa1-6]DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)]-NAG(2_F_)]-NAG(1_F_)-ASN(165_D_)",130.714,"","",""
"6URH","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY AR3X IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.7554/ELIFE.53169 ",2.2,58.47,"6urh_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(423_C_)",125.295,"","",""
"6URH","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY AR3X IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.7554/ELIFE.53169 ",2.2,58.47,"6urh_oligo4","DManpa1-6DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(556_C_)",116.15,"","",""
"6URH","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY AR3X IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.7554/ELIFE.53169 ",2.2,58.47,"6urh_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(532_C_)",78.6156,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-[MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(88_G_)",200.201,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(10_B_)-MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(301_G_)",161.204,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(392_G_)",188.34,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",146.548,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_G_)",146.964,"","",""
"6UUD","CRYSTAL STRUCTURE OF ANTIBODY 5D5 IN COMPLEX WITH PFCSP N-TERMINAL PEPTIDE","10.1084/JEM.20200061 ",1.85,33.1,"6uud_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(98_H_)",80.977,"","",""
"6UUH","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY 438- B11","10.1126/SCIADV.ABB1328 ",2.7,60.13,"6uuh_oligo1","DManpa1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(27_B_)",109.495,"","",""
"6UUL","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY 438- D5","10.1126/SCIADV.ABB1328 ",2.06,54.58,"6uul_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(27_B_)",133.905,"","",""
"6UWZ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ALPHA-BUNGAROTOXIN","10.1016/J.NEURON.2020.03.012 ",2.69,0,"6uwz_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",65.2135,"","",""
"6UWZ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ALPHA-BUNGAROTOXIN","10.1016/J.NEURON.2020.03.012 ",2.69,0,"6uwz_oligo5","DManpa1-6DManpa1-6DGlcpNAcb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-MAN(4_L_)-NAG(3_L_)-NAG(2_L_)-NAG(1_L_)",59.548,"","",""
"6UWZ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ALPHA-BUNGAROTOXIN","10.1016/J.NEURON.2020.03.012 ",2.69,0,"6uwz_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(141_A_)",54.6852,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(257_C_)",133.96,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(257_A_)",131.936,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(257_B_)",139.192,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo5","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_E_)-BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(164_A_)",199.785,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo2","DManpa1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_B_)-MAN(7_B_)-[MAN(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(143_A_)",207.568,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(234_A_)",172.33,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo3","DManpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(8_C_)-MAN(7_C_)-[BMA(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",170.736,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo4","DManpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_C_)-MAN(7_C_)-[BMA(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(174_A_)",172.124,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo3","DManpa1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_B_)-MAN(7_B_)-[MAN(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(143_A_)",204.617,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo2","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[BMA(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(234_A_)",171.996,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_X_)-NAG(1_X_)-ASN(611_E_)",64.47,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_A_)",76.0659,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_D_)",76.0659,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo25","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_e_)-[NAG(2_e_)]-NAG(1_e_)-ASN(137_D_)",67.3479,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(611_B_)",64.47,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo27","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_g_)-NAG(1_g_)-ASN(611_F_)",64.47,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_C_)",76.0659,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(137_A_)",67.3479,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)-ASN(137_C_)",67.3479,"","",""
"6V44","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM SWINE INFLUENZA VIRUS A/SWINE/MISSOURI/A01727926/2015","10.1016/J.HELIYON.2020.E04068 ",2.2,50.79,"6v44_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(162_A_)",66.2038,"","",""
"6V44","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM SWINE INFLUENZA VIRUS A/SWINE/MISSOURI/A01727926/2015","10.1016/J.HELIYON.2020.E04068 ",2.2,50.79,"6v44_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(162_C_)",65.9658,"","",""
"6V44","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM SWINE INFLUENZA VIRUS A/SWINE/MISSOURI/A01727926/2015","10.1016/J.HELIYON.2020.E04068 ",2.2,50.79,"6v44_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(162_E_)",67.8699,"","",""
"6V46","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/TURKEY/ONTARIO/6118/1968 (H8N4)","10.1016/J.HELIYON.2020.E04068 ",2.25,47.7,"6v46_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(134_E_)",98.5342,"","",""
"6V46","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/TURKEY/ONTARIO/6118/1968 (H8N4)","10.1016/J.HELIYON.2020.E04068 ",2.25,47.7,"6v46_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(134_A_)",96.2706,"","",""
"6V46","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/TURKEY/ONTARIO/6118/1968 (H8N4)","10.1016/J.HELIYON.2020.E04068 ",2.25,47.7,"6v46_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(134_C_)",92.7121,"","",""
"6V6W","CRYSTAL STRUCTURE OF ANTIBODY 438-B11 DSS MUTANT (CYS98A-100AA) IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22","10.1126/SCIADV.ABB1328 ",6.5,279.1,"6v6w_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(88_C_)",292.76,"","",""
"6V6W","CRYSTAL STRUCTURE OF ANTIBODY 438-B11 DSS MUTANT (CYS98A-100AA) IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22","10.1126/SCIADV.ABB1328 ",6.5,279.1,"6v6w_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(332_G_)",238.617,"","",""
"6V6W","CRYSTAL STRUCTURE OF ANTIBODY 438-B11 DSS MUTANT (CYS98A-100AA) IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22","10.1126/SCIADV.ABB1328 ",6.5,279.1,"6v6w_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(88_G_)",289.727,"","",""
"6V6W","CRYSTAL STRUCTURE OF ANTIBODY 438-B11 DSS MUTANT (CYS98A-100AA) IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22","10.1126/SCIADV.ABB1328 ",6.5,279.1,"6v6w_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_C_)",241.589,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Z_)-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(332_A_)",35.7523,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo20","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_l_)-MAN(7_l_)-[MAN(6_l_)-MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(332_G_)",35.7523,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_x_)-MAN(7_x_)-[MAN(6_x_)-MAN(5_x_)-MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(332_M_)",35.7523,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",88.7104,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo6","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",67.9209,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",77.9424,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",72.0745,"","",""
"6VC9","TB19 COMPLEX","10.1074/JBC.RA120.012395 ",2.25,60.83,"6vc9_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(311_A_)",106.128,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_d_)-[MAN(4_d_)-BMA(3_d_)-NAG(2_d_)]-NAG(1_d_)-ASN(255_K_)",133.022,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Z_)-[BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(25_E_)",170.556,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_g_)-[BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(25_W_)",172.451,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_f_)-[BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(255_Q_)",124.037,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_c_)-[NAG(2_c_)]-NAG(1_c_)-ASN(25_K_)",174.138,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(16_E_)",156.716,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_j_)-[BMA(3_j_)-NAG(2_j_)]-NAG(1_j_)-ASN(16_W_)",161.933,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_i_)-[MAN(4_i_)-BMA(3_i_)-NAG(2_i_)]-NAG(1_i_)-ASN(255_W_)",141.117,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_a_)-[BMA(3_a_)-NAG(2_a_)]-NAG(1_a_)-ASN(255_E_)",122.173,"","",""
"6VEQ","CON-INS G1 IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",3.25,0,"6veq_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(255_E_)",157.738,"","",""
"6VEQ","CON-INS G1 IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",3.25,0,"6veq_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(255_K_)",143.034,"","",""
"6VFL","BG505-SOSIP MODEL RECONSTRUCTED BY SUBPARTICLE EXTRACTION AND REFINEMENT FROM A TETRAHEDRAL NANOPARTICLE T33_DN10","10.1371/JOURNAL.PPAT.1008665 ",4.14,"1.08527e-19","6vfl_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_C_)",76.786,"","",""
"6VFL","BG505-SOSIP MODEL RECONSTRUCTED BY SUBPARTICLE EXTRACTION AND REFINEMENT FROM A TETRAHEDRAL NANOPARTICLE T33_DN10","10.1371/JOURNAL.PPAT.1008665 ",4.14,"1.08527e-19","6vfl_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",76.786,"","",""
"6VFL","BG505-SOSIP MODEL RECONSTRUCTED BY SUBPARTICLE EXTRACTION AND REFINEMENT FROM A TETRAHEDRAL NANOPARTICLE T33_DN10","10.1371/JOURNAL.PPAT.1008665 ",4.14,"1.08527e-19","6vfl_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_E_)",76.786,"","",""
"6VFQ","CRYSTAL STRUCTURE OF MONOMERIC HUMAN PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",2.3,64.07,"6vfq_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(256_A_)",117.178,"","",""
"6VFR","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 18 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",2.79,121.2,"6vfr_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(242_A_)",141.469,"","",""
"6VFR","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 18 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",2.79,121.2,"6vfr_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(242_B_)",163.227,"","",""
"6VFR","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 18 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",2.79,121.2,"6vfr_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(76_A_)",167.496,"","",""
"6VFT","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 17 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.71,128,"6vft_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(249_B_)",163.421,"","",""
"6VFT","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 17 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.71,128,"6vft_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(249_D_)",160.872,"","",""
"6VFT","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 17 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.71,128,"6vft_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(249_A_)",142.891,"","",""
"6VFT","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 17 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.71,128,"6vft_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_J_)-[MAN(4_J_)-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(249_C_)",155.42,"","",""
"6VFT","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 17 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.71,128,"6vft_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(422_A_)",184.678,"","",""
"6VFU","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 19 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.5,193.4,"6vfu_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(399_A_)",206.777,"","",""
"6VFU","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 19 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.5,193.4,"6vfu_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(399_C_)",217.009,"","",""
"6VFV","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 8 EC5-EC6","10.1016/J.CELREP.2020.02.003 ",2.9,52.68,"6vfv_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(587_A_)",70.4913,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(256_B_)",341.328,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(256_E_)",345.257,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(256_C_)",406.916,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(256_A_)",343.284,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(256_D_)",373.745,"","",""
"6VG1","XENOPUS PROTOCADHERIN 8.1 EC1-6","10.1016/J.CELREP.2020.02.003 ",2,68.64,"6vg1_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(398_B_)",74.1859,"","",""
"6VG1","XENOPUS PROTOCADHERIN 8.1 EC1-6","10.1016/J.CELREP.2020.02.003 ",2,68.64,"6vg1_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(398_A_)",72.66,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(197_G_)",115.099,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(197_C_)",114.441,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo18","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(197_I_)",117.312,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_f_)-[MAN(7_f_)]-MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(276_I_)",126.832,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",127.378,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_P_)-[MAN(7_P_)]-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(276_G_)",129.137,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_C_)",127.327,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo8","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[MAN(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_C_)",129.032,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_I_)",123.697,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo22","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-[MAN(6_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(363_I_)",121.831,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-[MAN(6_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(363_C_)",121.845,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo14","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(363_G_)",116.208,"","",""
"6VJM","HUMAN METABOTROPIC GABA(B) RECEPTOR IN ITS APO STATE","10.1038/S41586-020-2408-4 ",3.97,0,"6vjm_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(440_A_)",204.963,"","",""
"6VKC","CRYSTAL STRUCTURE OF INHIBITOR JNJ-36811054 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN","10.1021/ACS.JMEDCHEM.0C00226 ",2.6,61.11,"6vkc_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(500_F_)",109.01,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",78.3368,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo21","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_D_)",78.3368,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo23","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_i_)-[NAG(2_i_)]-NAG(1_i_)-ASN(611_F_)",80.1191,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_a_)-[NAG(2_a_)]-NAG(1_a_)-ASN(611_E_)",80.1191,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(611_B_)",80.1191,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_C_)",78.3368,"","",""
"6VL5","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED TETRAHEDRAL NANOPARTICLE, BG505 SOSIP-T33_DN2","10.1038/S41541-020-00223-1 ",4.5,8.00784,"6vl5_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",125.554,"","",""
"6VL5","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED TETRAHEDRAL NANOPARTICLE, BG505 SOSIP-T33_DN2","10.1038/S41541-020-00223-1 ",4.5,8.00784,"6vl5_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_E_)",125.554,"","",""
"6VL5","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED TETRAHEDRAL NANOPARTICLE, BG505 SOSIP-T33_DN2","10.1038/S41541-020-00223-1 ",4.5,8.00784,"6vl5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",125.554,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(601_G_)",74.1023,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(601_B_)",70.2448,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo6","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(601_H_)",48.2195,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(601_A_)",56.7987,"","",""
"6VLK","A VARICELLA-ZOSTER VIRUS GLYCOPROTEIN","10.1038/S41467-020-17911-0 ",2.45,0,"6vlk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(686_A_)",123.938,"","",""
"6VLK","A VARICELLA-ZOSTER VIRUS GLYCOPROTEIN","10.1038/S41467-020-17911-0 ",2.45,0,"6vlk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(257_A_)",75.2051,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_A_)",120.672,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)",134.999,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",134.74,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_H_)",140.801,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_G_)",117.813,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_H_)",125.332,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_A_)",100.416,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(88_C_)",100.416,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(88_D_)",100.416,"","",""
"6VO1","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J","10.1371/JOURNAL.PPAT.1008753 ",3.88,"2.14959e+09","6vo1_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_C_)",129.182,"","",""
"6VO1","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J","10.1371/JOURNAL.PPAT.1008753 ",3.88,"2.14959e+09","6vo1_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",129.182,"","",""
"6VO1","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J","10.1371/JOURNAL.PPAT.1008753 ",3.88,"2.14959e+09","6vo1_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(262_D_)",129.182,"","",""
"6VO3","AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01214-20 ",4.25,512.502,"6vo3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_A_)",121.751,"","",""
"6VO3","AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01214-20 ",4.25,512.502,"6vo3_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(276_D_)",121.751,"","",""
"6VO3","AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01214-20 ",4.25,512.502,"6vo3_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_C_)",121.751,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo23","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_n_)-NAG(1_n_)-ASN(625_B_)",159.975,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_k_)-[NAG(2_k_)]-NAG(1_k_)-ASN(611_D_)",124.264,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_h_)-NAG(1_h_)-ASN(197_C_)",166.337,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",193.751,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_j_)-[NAG(2_j_)]-NAG(1_j_)-ASN(637_D_)",112.746,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo21","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_l_)-[MAN(8_l_)-[NAG(7_l_)-[GAL(6_l_)-NAG(5_l_)]-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)]-NAG(1_l_)-ASN(637_B_)",122.313,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo22","DGalpb1-4DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_m_)-[GAL(6_m_)-NAG(5_m_)-MAN(4_m_)-[MAN(7_m_)]-BMA(3_m_)-NAG(2_m_)]-NAG(1_m_)-ASN(611_B_)",97.6494,"","",""
"6VRW","CRYO-EM STRUCTURE OF STABILIZED HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.71,0,"6vrw_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_D_)",158.5,"","",""
"6VRW","CRYO-EM STRUCTURE OF STABILIZED HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.71,0,"6vrw_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_A_)",145.556,"","",""
"6VRW","CRYO-EM STRUCTURE OF STABILIZED HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.71,0,"6vrw_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",145.69,"","",""
"6VRY","STRUCTURE OF NCI09 FAB IN COMPLEX WITH SIV V2 PEPTIDE","",1.4,0,"6vry_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_A_)-[BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(30_L_)",39.2407,"","",""
"6VSL","CRYSTAL STRUCTURE OF A HUMAN FUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.1,0,"6vsl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.7328,"","",""
"6VSL","CRYSTAL STRUCTURE OF A HUMAN FUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.1,0,"6vsl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.7808,"","",""
"6VSZ","CRYSTAL STRUCTURE OF A HUMAN AFUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.6,0,"6vsz_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",111.767,"","",""
"6VSZ","CRYSTAL STRUCTURE OF A HUMAN AFUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.6,0,"6vsz_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",94.3261,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_G_)",151.641,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo20","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_G_)",99.7773,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_F_)",96.8107,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-[MAN(6_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(130_G_)",164.664,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo18","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[NAG(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(264_C_)",46.2131,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo8","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-[NAG(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_A_)",46.2131,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo7","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-[NAG(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(264_B_)",46.2131,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo17","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(197_C_)",167.201,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo9","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Y_)-MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(386_A_)",196.204,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo45","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_4_)-MAN(6_4_)-[MAN(5_4_)-MAN(4_4_)]-BMA(3_4_)-NAG(2_4_)-NAG(1_4_)-ASN(386_E_)",199.47,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo37","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_w_)-MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)",171.229,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo25","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(197_A_)",164.415,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo40","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_z_)-[MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(262_E_)",218.989,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_A_)",228.155,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo29","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_o_)-MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(386_C_)",191.833,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_C_)",217.516,"","",""
"6VZI","CRYSTAL STRUCTURE OF HIV-1 CAP256 RNS-3MUT-2G-SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1128/JVI.00074-20 ",2.72,49.32,"6vzi_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-[MAN(10_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_G_)",54.6252,"","",""
"6VZI","CRYSTAL STRUCTURE OF HIV-1 CAP256 RNS-3MUT-2G-SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1128/JVI.00074-20 ",2.72,49.32,"6vzi_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",72.6259,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(156_G_)",111.643,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo15","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-[MAN(6_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(88_G_)",51.3689,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo16","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-MAN(8_P_)-[MAN(10_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",50.1545,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",71.0289,"","",""
"6W16","CRYSTAL STRUCTURE OF A HUMAN METAPNEUMOVIRUS MONOMERIC FUSION PROTEIN COMPLEXED WITH 458 FAB","10.1371/JOURNAL.PPAT.1008942 ",3.1,0,"6w16_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(57_F_)",143.755,"","",""
"6W35","A NEW AUTOTAXIN INHIBITOR FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS: A CLINICAL CANDIDATE DISCOVERED USING DNA-ENCODED CHEMISTRY","10.1021/ACS.JMEDCHEM.0C00688 ",1.98,39.14,"6w35_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(525_A_)",36.2714,"","",""
"6W3H","BRAIN DELIVERY OF THERAPEUTIC PROTEINS USING AN FC FRAGMENT BLOOD- BRAIN BARRIER TRANSPORT VEHICLE IN MICE AND MONKEYS","10.1126/SCITRANSLMED.AAY1359 ",3.38,72.05,"6w3h_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",86.4807,"","",""
"6W5Y","INFERRED RECEPTOR BINDING DOMAIN OF HUMAN ENDOGENOUS RETROVIRUS ENVELOPE ENVP(B)1","10.1128/MBIO.02772-20 ",2.5,56.17,"6w5y_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(57_B_)",108.508,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_h_)-[BMA(3_h_)-NAG(2_h_)]-[FUC(4_h_)]-NAG(1_h_)-ASN(54_D_)",118.733,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo18","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_r_)-NAG(1_r_)-ASN(172_S_)",110.648,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_d_)-NAG(1_d_)-ASN(54_5_)",101.695,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo16","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_p_)-NAG(1_p_)-ASN(172_P_)",111.593,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo14","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_n_)-[BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(172_M_)",101.431,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_m_)-[NAG(2_m_)]-NAG(1_m_)-ASN(54_L_)",100.394,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(54_2_)",113.494,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo23","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_w_)-[FUC(2_w_)]-NAG(1_w_)-ASN(54_Z_)",112.174,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_a_)-[BMA(3_a_)-NAG(2_a_)]-NAG(1_a_)-ASN(172_1_)",94.8084,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_e_)-[NAG(2_e_)]-NAG(1_e_)-ASN(172_7_)",109.663,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo22","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_v_)-NAG(1_v_)-ASN(172_Y_)",91.8,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_k_)-[BMA(3_k_)-NAG(2_k_)]-[FUC(4_k_)]-NAG(1_k_)-ASN(172_I_)",101.319,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_j_)-[NAG(2_j_)]-NAG(1_j_)-ASN(54_G_)",111.527,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo15","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_o_)-NAG(1_o_)-ASN(54_N_)",95.2336,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_l_)-[NAG(2_l_)]-NAG(1_l_)-ASN(54_J_)",109.254,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_c_)-[BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(172_4_)",92.9184,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo21","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_u_)-NAG(1_u_)-ASN(54_W_)",103.179,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_i_)-[NAG(2_i_)]-NAG(1_i_)-ASN(172_F_)",95.0503,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo20","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_t_)-NAG(1_t_)-ASN(172_V_)",101.655,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo19","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_s_)-[NAG(2_s_)]-NAG(1_s_)-ASN(54_T_)",102.992,"","",""
"6WIB","NEXT GENERATION MONOMERIC IGG4 FC","10.1038/S42003-021-02565-5 ",2.55,35.64,"6wib_oligo1","NAG1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",56.8193,"","",""
"6WIX","CRYSTAL STRUCTURE OF HIV-1 MI369 RNS-DS.SOSIP PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1016/J.CELREP.2020.108432 ",2.67,47.5,"6wix_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",55.8452,"","",""
"6WIX","CRYSTAL STRUCTURE OF HIV-1 MI369 RNS-DS.SOSIP PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1016/J.CELREP.2020.108432 ",2.67,47.5,"6wix_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",59.4076,"","",""
"6WJ1","CRYSTAL STRUCTURE OF FAB 54-4H03 BOUND TO H1 INFLUENZA HEMAGGLUTININ","10.1016/J.CHOM.2020.06.003 ",3.5,124.6,"6wj1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(94_A_)",184.437,"","",""
"6WJ1","CRYSTAL STRUCTURE OF FAB 54-4H03 BOUND TO H1 INFLUENZA HEMAGGLUTININ","10.1016/J.CHOM.2020.06.003 ",3.5,124.6,"6wj1_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(94_C_)",140.116,"","",""
"6WJ1","CRYSTAL STRUCTURE OF FAB 54-4H03 BOUND TO H1 INFLUENZA HEMAGGLUTININ","10.1016/J.CHOM.2020.06.003 ",3.5,124.6,"6wj1_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(33_C_)",180.736,"","",""
"6WJ6","CRYO-EM STRUCTURE OF APO-PHOTOSYSTEM II FROM SYNECHOCYSTIS SP. PCC 6803","10.1016/J.JOULE.2020.07.016 ",2.58,"1.08527e-19","6wj6_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(101_H_)-DGD(101_H_)",27.03,"","",""
"6WJ6","CRYO-EM STRUCTURE OF APO-PHOTOSYSTEM II FROM SYNECHOCYSTIS SP. PCC 6803","10.1016/J.JOULE.2020.07.016 ",2.58,"1.08527e-19","6wj6_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",33.74,"","",""
"6WLW","THE VO REGION OF HUMAN V-ATPASE IN STATE 1 (FOCUSED REFINEMENT)","10.1016/J.MOLCEL.2020.09.029 ",3,"1.08527e-19","6wlw_oligo1","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C25O7P2","MAN(11_r_)-MAN(10_r_)-[GLC(9_r_)-GLC(8_r_)-GLC(7_r_)-MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-WJP(905_R_)",65.1511,"","",""
"6WM2","HUMAN V-ATPASE IN STATE 1 WITH SIDK AND ADP","10.1016/J.MOLCEL.2020.09.029 ",3.1,"1.08527e-19","6wm2_oligo9","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C25O7P2","MAN(11_r_)-MAN(10_r_)-[GLC(9_r_)-GLC(8_r_)-GLC(7_r_)-MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-WJP(907_R_)",83.4146,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(913_C_)-[MAN(914_C_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",80.8812,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(914_D_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(590_D_)",67.5638,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(1005_B_)-[MAN(1004_B_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",62.661,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-[MAN(1005_A_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",54.9311,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(1013_B_)-[MAN(1014_B_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",65.741,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(905_C_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",63.3341,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(293_D_)",70.8689,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(1013_A_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",56.7677,"","",""
"6WMN","HUMAN POLY-N-ACETYL-LACTOSAMINE SYNTHASE STRUCTURE DEMONSTRATES A MODULAR ASSEMBLY OF CATALYTIC SUBSITES FOR GT-A GLYCOSYLTRANSFERASES","10.1074/JBC.RA120.015305 ",2.04,58.87,"6wmn_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(219_B_)",56.9932,"","",""
"6WNA","NEXT GENERATION MONOMERIC IGG4 FC","10.1038/S42003-021-02565-5 ",2.4,45.39,"6wna_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4NAG1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_H_)",83.6889,"","",""
"6WO5","STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 1A BOUND TO NEUTRALIZING ANTIBODY 212.1.1 AND NON NEUTRALIZING ANTIBODY E1","10.1126/SCIADV.ABB5642 ",2.62,0,"6wo5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(430_F_)",75.8195,"","",""
"6WOL","NEXT GENERATION MONOMERIC IGG4 FC BOUND TO NEONATAL FC RECEPTOR","10.1038/S42003-021-02565-5 ",2.49,45.35,"6wol_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_H_)",79.3048,"","",""
"6WPS","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1038/S41586-020-2349-Y ",3.1,0,"6wps_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(343_A_)",69.3132,"","",""
"6WPS","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1038/S41586-020-2349-Y ",3.1,0,"6wps_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_X_)-[MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(343_E_)",69.3132,"","",""
"6WPS","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1038/S41586-020-2349-Y ",3.1,0,"6wps_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_B_)",69.3132,"","",""
"6WPT","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT (OPEN STATE)","10.1038/S41586-020-2349-Y ",3.7,0,"6wpt_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_C_)",117.21,"","",""
"6WPT","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT (OPEN STATE)","10.1038/S41586-020-2349-Y ",3.7,0,"6wpt_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(343_A_)",122.057,"","",""
"6WRW","CRYSTAL STRUCTURE OF COMPUTATIONALLY DESIGNED PROTEIN 2DS25.5 IN COMPLEX WITH THE HUMAN TRANSFERRIN RECEPTOR ECTODOMAIN","10.1073/PNAS.2021569118 ",2.84,88.92,"6wrw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(317_B_)",129.277,"","",""
"6WUV","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GA","10.1021/ACS.CHEMRESTOX.0C00406 ",2.63,66.68,"6wuv_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",109.223,"","",""
"6WUV","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GA","10.1021/ACS.CHEMRESTOX.0C00406 ",2.63,66.68,"6wuv_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(265_B_)",130.258,"","",""
"6WUV","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GA","10.1021/ACS.CHEMRESTOX.0C00406 ",2.63,66.68,"6wuv_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",116.336,"","",""
"6WUY","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH GA AND HI-6","10.1021/ACS.CHEMRESTOX.0C00406 ",2.46,66.17,"6wuy_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",126.45,"","",""
"6WUY","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH GA AND HI-6","10.1021/ACS.CHEMRESTOX.0C00406 ",2.46,66.17,"6wuy_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)",119.153,"","",""
"6WUZ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GB","10.1021/ACS.CHEMRESTOX.0C00406 ",2.25,38.82,"6wuz_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(265_B_)",105.129,"","",""
"6WUZ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GB","10.1021/ACS.CHEMRESTOX.0C00406 ",2.25,38.82,"6wuz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",86.1346,"","",""
"6WUZ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GB","10.1021/ACS.CHEMRESTOX.0C00406 ",2.25,38.82,"6wuz_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",92.5539,"","",""
"6WV1","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH GB AND HI-6","10.1021/ACS.CHEMRESTOX.0C00406 ",2.37,51.03,"6wv1_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",102.739,"","",""
"6WV1","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH GB AND HI-6","10.1021/ACS.CHEMRESTOX.0C00406 ",2.37,51.03,"6wv1_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",95.2046,"","",""
"6WVC","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GD","10.1021/ACS.CHEMRESTOX.0C00406 ",2.6,50.33,"6wvc_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",89.49,"","",""
"6WVC","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GD","10.1021/ACS.CHEMRESTOX.0C00406 ",2.6,50.33,"6wvc_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",86.2491,"","",""
"6WVO","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH GD AND HI-6","10.1021/ACS.CHEMRESTOX.0C00406 ",2.19,46.88,"6wvo_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",91.7339,"","",""
"6WVO","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH GD AND HI-6","10.1021/ACS.CHEMRESTOX.0C00406 ",2.19,46.88,"6wvo_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",84.7673,"","",""
"6WVP","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GF","10.1021/ACS.CHEMRESTOX.0C00406 ",2.31,40.58,"6wvp_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(2_C_)-[NAG(601_A_)]-NAG(1_C_)",108.631,"","",""
"6WVP","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GF","10.1021/ACS.CHEMRESTOX.0C00406 ",2.31,40.58,"6wvp_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",111.33,"","",""
"6WVQ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GP","10.1021/ACS.CHEMRESTOX.0C00406 ",2.29,43.9,"6wvq_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)",82.7005,"","",""
"6WVQ","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY GP","10.1021/ACS.CHEMRESTOX.0C00406 ",2.29,43.9,"6wvq_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",80.0284,"","",""
"6WVZ","CRYSTAL STRUCTURE OF ANTI-MET FAB ARM OF AMIVANTAMAB IN COMPLEX WITH HUMAN MET","10.1016/J.JBC.2021.100641 ",3.1,0,"6wvz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(106_M_)",174.516,"","",""
"6WVZ","CRYSTAL STRUCTURE OF ANTI-MET FAB ARM OF AMIVANTAMAB IN COMPLEX WITH HUMAN MET","10.1016/J.JBC.2021.100641 ",3.1,0,"6wvz_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(405_M_)",171.839,"","",""
"6WXR","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE ABSENCE OF NADPH","10.1038/S41594-020-0501-X ",3.2,"1.08527e-19","6wxr_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(109_B_)",33.6549,"","",""
"6WXU","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE DIMER-OF-DIMER STATE","10.1038/S41594-020-0501-X ",2.7,"1.08527e-19","6wxu_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_D_)",51.6896,"","",""
"6WXU","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE DIMER-OF-DIMER STATE","10.1038/S41594-020-0501-X ",2.7,"1.08527e-19","6wxu_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(109_B_)",51.6896,"","",""
"6WXV","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE PRESENCE OF NADPH","10.1038/S41594-020-0501-X ",3.3,"1.08527e-19","6wxv_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(109_B_)",0,"","",""
"6WXZ","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-29 A.K.A 7-(1,2-DIPHENYLETHYL)-1H-[1,2,3]TRIAZOLO[4,5- B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.23,58.81,"6wxz_oligo2","DManpa1-6DManpx1-","MAN(2_F_)-BMA(1_F_)",62.6282,"","",""
"6WXZ","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-29 A.K.A 7-(1,2-DIPHENYLETHYL)-1H-[1,2,3]TRIAZOLO[4,5- B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.23,58.81,"6wxz_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(317_B_)",54.9223,"","",""
"6WXZ","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-29 A.K.A 7-(1,2-DIPHENYLETHYL)-1H-[1,2,3]TRIAZOLO[4,5- B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.23,58.81,"6wxz_oligo1","DManpa1-6DManpx1-","MAN(2_G_)-BMA(1_G_)",55.919,"","",""
"6WXZ","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-29 A.K.A 7-(1,2-DIPHENYLETHYL)-1H-[1,2,3]TRIAZOLO[4,5- B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.23,58.81,"6wxz_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(317_E_)",50.4995,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(317_I_)",51.8645,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(317_G_)",50.1985,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(317_B_)",52.4202,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(317_E_)",49.8829,"","",""
"6WY5","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-37 A.K.A 7-(1-PHENYL-3-(((1S,3S)-3-PHENYL-2,3-DIHYDRO-1H- INDEN-1-YL)AMINO)PROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.9,97.75,"6wy5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_B_)",87.4176,"","",""
"6WY5","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-37 A.K.A 7-(1-PHENYL-3-(((1S,3S)-3-PHENYL-2,3-DIHYDRO-1H- INDEN-1-YL)AMINO)PROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.9,97.75,"6wy5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(317_E_)",77.4373,"","",""
"6WY7","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-41 A.K.A 7-[1-PHENYL-3-({4-PHENYLBICYCLO[2.2.2]OCTAN-1- YL}AMINO)PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.09,24.38,"6wy7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(317_B_)",25.79,"","",""
"6WY7","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-41 A.K.A 7-[1-PHENYL-3-({4-PHENYLBICYCLO[2.2.2]OCTAN-1- YL}AMINO)PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.09,24.38,"6wy7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_E_)",26.7079,"","",""
"6X1T","STRUCTURE OF PHIS FAB (SC50-3) IN COMPLEX WITH PHIS MIMETIC PEPTIDE","10.1073/PNAS.2010644118 ",2.34,49.33,"6x1t_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(97_A_)",85.3376,"","",""
"6X3S","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH BICUCULLINE METHBROMIDE","10.1038/S41586-020-2654-5 ",3.12,"1.42472e+13","6x3s_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",50.4167,"","",""
"6X3T","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PROPOFOL","10.1038/S41586-020-2654-5 ",2.55,"1.42472e+13","6x3t_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",37.1476,"","",""
"6X3U","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS FLUMAZENIL","10.1038/S41586-020-2654-5 ",3.49,"1.42472e+13","6x3u_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",31.0121,"","",""
"6X3V","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS ETOMIDATE","10.1038/S41586-020-2654-5 ",3.5,"1.42472e+13","6x3v_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",39.123,"","",""
"6X3W","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PHENOBARBITAL","10.1038/S41586-020-2654-5 ",3.3,"1.42472e+13","6x3w_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",41.7306,"","",""
"6X3X","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS DIAZEPAM","10.1038/S41586-020-2654-5 ",2.92,"1.42472e+13","6x3x_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",43.7112,"","",""
"6X3Z","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA","10.1038/S41586-020-2654-5 ",3.23,"5.93244e+11","6x3z_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",61.4891,"","",""
"6X40","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PICROTOXIN","10.1038/S41586-020-2654-5 ",2.86,"1.42472e+13","6x40_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",54.1976,"","",""
"6X48","SORTILIN-PROGRANULIN INTERACTION WITH COMPOUND 17","10.1016/J.BMCL.2020.127403 ",2.9,89.9,"6x48_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",112.76,"","",""
"6X4G","CRYSTAL STRUCTURE OF ICOS IN COMPLEX WITH ICOS-L AND AN ANTI ICOS-L VNAR DOMAIN","10.1038/S41467-020-18828-4 ",3.5,85.77,"6x4g_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(173_C_)",124.116,"","",""
"6X4G","CRYSTAL STRUCTURE OF ICOS IN COMPLEX WITH ICOS-L AND AN ANTI ICOS-L VNAR DOMAIN","10.1038/S41467-020-18828-4 ",3.5,85.77,"6x4g_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(110_A_)",113.192,"","",""
"6X5R","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A2-ASN","10.1074/JBC.RA120.014625 ",2.4,0,"6x5r_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(700_C_)",47.8686,"","",""
"6X5R","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A2-ASN","10.1074/JBC.RA120.014625 ",2.4,0,"6x5r_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(700_D_)",45.2336,"","",""
"6X5S","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3'-ASN","10.1074/JBC.RA120.014625 ",3.3,0,"6x5s_oligo4","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_F_)-MAN(7_F_)-[NAG(6_F_)-[NAG(5_F_)]-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(700_D_)",67.5676,"","",""
"6X5S","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3'-ASN","10.1074/JBC.RA120.014625 ",3.3,0,"6x5s_oligo3","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_E_)-MAN(7_E_)-[NAG(6_E_)-[NAG(5_E_)]-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(700_C_)",67.874,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo14","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_N_)-[NAG(4_N_)-MAN(3_N_)]-BMA(2_N_)-NAG(1_N_)",72.5517,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo9","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(700_A_)",67.9324,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo11","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(700_C_)",62.2491,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo12","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_L_)-[NAG(4_L_)-MAN(3_L_)]-BMA(2_L_)-NAG(1_L_)",72.644,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_J_)-[NAG(4_J_)-MAN(3_J_)]-BMA(2_J_)-NAG(1_J_)",71.7953,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo16","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_P_)-[NAG(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",73.6539,"","",""
"6XC9","IMMUNE RECEPTOR COMPLEX","10.1038/S41467-021-25404-X ",2.4,50.36,"6xc9_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(33_H_)",138.545,"","",""
"6XCM","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2020.06.025 ",3.42,12.4576,"6xcm_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(1134_C_)",157.576,"","",""
"6XCM","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2020.06.025 ",3.42,12.4576,"6xcm_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(1134_B_)",171.899,"","",""
"6XCM","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2020.06.025 ",3.42,12.4576,"6xcm_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(801_A_)",124.547,"","",""
"6XCN","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2020.06.025 ",3.66,914629,"6xcn_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)-ASN(1134_E_)",117.942,"","",""
"6XCN","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2020.06.025 ",3.66,914629,"6xcn_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(1134_A_)",111.526,"","",""
"6XCN","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2020.06.025 ",3.66,914629,"6xcn_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1134_C_)",118.799,"","",""
"6XDG","COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES","10.1126/SCIENCE.ABD0827 ",3.9,"2.15283e+08","6xdg_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(343_E_)",285.741,"","",""
"6XP6","3C11-DQ2-GLIA-A2 COMPLEX","10.1126/SCIIMMUNOL.ABG4925 ",2.4,0,"6xp6_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_L_)-[BMA(5_L_)-[BMA(4_L_)]-BMA(3_L_)-NAG(2_L_)]-[FUC(6_L_)]-NAG(1_L_)-ASN(19_B_)",85.7192,"","",""
"6XP6","3C11-DQ2-GLIA-A2 COMPLEX","10.1126/SCIIMMUNOL.ABG4925 ",2.4,0,"6xp6_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(19_E_)",84.5577,"","",""
"6XPO","INFLUENZA HEMAGGLUTININ A/BANGKOK/01/1979(H3N2)","10.1128/MBIO.01144-21 ",3,93,"6xpo_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(126_A_)",157.064,"","",""
"6XQ0","HUMAN ANTIBODY S8V2-18 IN COMPLEX WITH THE INFLUENZA HEMAGGLUTININ HEAD DOMAIN OF A/CALIFORNIA/7/2009(NYMC-X181)(H1N1)","10.1128/MBIO.01144-21 ",2.3,43.35,"6xq0_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_G_)-[BMA(3_G_)-NAG(2_G_)]-[FUC(4_G_)]-NAG(1_G_)-ASN(94_D_)",51.0662,"","",""
"6XQ0","HUMAN ANTIBODY S8V2-18 IN COMPLEX WITH THE INFLUENZA HEMAGGLUTININ HEAD DOMAIN OF A/CALIFORNIA/7/2009(NYMC-X181)(H1N1)","10.1128/MBIO.01144-21 ",2.3,43.35,"6xq0_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_H_)-[BMA(3_H_)-NAG(2_H_)]-[FUC(4_H_)]-NAG(1_H_)-ASN(94_A_)",51.8884,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(156_F_)",253.703,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_E_)",212.176,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_V_)-[MAN(7_V_)]-MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(160_F_)",220.016,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(160_G_)",244.744,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_G_)",210.363,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_G_)",253.157,"","",""
"6XST","RECOMBINANT BETA-2-GLYCOPROTEIN I WITH PUTATIVE MEMBRANE INSERTION LOOP","",2.92,88.66,"6xst_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(234_A_)",142.195,"","",""
"6XST","RECOMBINANT BETA-2-GLYCOPROTEIN I WITH PUTATIVE MEMBRANE INSERTION LOOP","",2.92,88.66,"6xst_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(174_A_)",128.672,"","",""
"6XTA","RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (2S)-N-[2-(1- BENZYLAZEPAN-4-YL)ETHYL]-2-(BUTYLAMINO)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1016/J.EJMECH.2020.112766 ",2.5,74.81,"6xta_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(241_A_)",117.893,"","",""
"6XTA","RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (2S)-N-[2-(1- BENZYLAZEPAN-4-YL)ETHYL]-2-(BUTYLAMINO)-3-(1H-INDOL-3-YL)PROPANAMIDE","10.1016/J.EJMECH.2020.112766 ",2.5,74.81,"6xta_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",133.537,"","",""
"6XUT","CRYSTALLOGRAPHIC STRUCTURE OF OLIGOSACCHARIDE DEHYDROGENASE FROM PYCNOPORUS CINNABARINUS, LIGAND-FREE FORM","10.1186/S13068-021-02003-Y ",1.6,39.76,"6xut_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(439_A_)",100.282,"","",""
"6XWE","CRYSTAL STRUCTURE OF LYK3 ECTODOMAIN","10.1126/SCIENCE.ABB3377 ",1.49,21.26,"6xwe_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(199_A_)",96.6732,"","",""
"6Y0F","STRUCTURE OF HUMAN FAPALPHA IN COMPLEX WITH LINAGLIPTIN","",2.92,52.73,"6y0f_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(314_D_)",74.4109,"","",""
"6Y0F","STRUCTURE OF HUMAN FAPALPHA IN COMPLEX WITH LINAGLIPTIN","",2.92,52.73,"6y0f_oligo12","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(227_D_)",65.2864,"","",""
"6Y0F","STRUCTURE OF HUMAN FAPALPHA IN COMPLEX WITH LINAGLIPTIN","",2.92,52.73,"6y0f_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(92_D_)",90.065,"","",""
"6Y3C","HUMAN COX-1 CRYSTAL STRUCTURE","10.1038/S41598-021-83438-Z ",3.36,90.9,"6y3c_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(144_A_)",121.356,"","",""
"6Y3Y","HUMAN CORONAVIRUS HKU1 HAEMAGGLUTININ-ESTERASE","10.1038/S41467-020-18440-6 ",3.39,0,"6y3y_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(286_A_)",129.34,"","",""
"6Y3Y","HUMAN CORONAVIRUS HKU1 HAEMAGGLUTININ-ESTERASE","10.1038/S41467-020-18440-6 ",3.39,0,"6y3y_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(286_B_)",128.683,"","",""
"6Y5G","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 8","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5g_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",60.102,"","",""
"6Y5G","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 8","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5g_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",60.102,"","",""
"6Y5G","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 8","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5g_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",60.102,"","",""
"6Y5H","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 5 (STATE I)","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5h_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",51.8598,"","",""
"6Y5H","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 5 (STATE I)","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5h_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",51.8598,"","",""
"6Y5H","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 5 (STATE I)","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5h_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",51.8598,"","",""
"6Y5M","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH COMPOUND 1A","10.1016/J.BMCL.2020.127663 ",2.01,35.27,"6y5m_oligo3","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",42.6865,"","",""
"6Y5W","CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN COMPLEX OF ANDES VIRUS IN A NEAR POSTFUSION CONFORMATION","10.1016/J.CELL.2020.08.023 ",2.55,70.26,"6y5w_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(930_B_)",73.3371,"","",""
"6Y5W","CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN COMPLEX OF ANDES VIRUS IN A NEAR POSTFUSION CONFORMATION","10.1016/J.CELL.2020.08.023 ",2.55,70.26,"6y5w_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(350_A_)",100.352,"","",""
"6Y6Q","STRUCTURE OF ANDES VIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION","10.1016/J.CELL.2020.08.023 ",2.7,98.14,"6y6q_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(930_A_)",110.123,"","",""
"6Y8F","AN INACTIVE (D136N AND D137N) VARIANT OF ALPHA-1,6-MANNANASE, GH76A OF SALEGENTIBACTER SP. HEL1_6 IN COMPLEX WITH ALPHA-1,6-MANNOTRIOSE","10.1038/S41396-022-01223-W ",1.47,19.99,"6y8f_oligo1","DManpa1-6DManpa1-6DManpa1-ROH","MAN(3_B_)-MAN(2_B_)-MAN(1_B_)",16.2345,"","",""
"6Y9M","CRYSTAL STRUCTURE OF TSWV GLYCOPROTEIN N ECTODOMAIN (SGN)","10.1073/PNAS.2004657117 ",3.4,159.3,"6y9m_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(116_B_)",285.209,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo33","DGalpa1-6DGalpb1-C24O5","DGD(803_3_)-DGD(803_3_)",74.52,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo26","DGalpa1-6DGalpb1-C34O5","DGD(5005_B_)-DGD(5005_B_)",35.14,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo28","DGalpa1-6DGalpb1-C14O5","DGD(803_1_)-DGD(803_1_)",68.76,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo14","DGalpa1-6DGalpb1-C24O5","DGD(802_4_)-DGD(802_4_)",62.5,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo21","DGalpa1-6DGalpb1-C20O5","DGD(5003_G_)-DGD(5003_G_)",62.24,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo27","DGalpa1-6DGalpb1-C30O5","DGD(5005_F_)-DGD(5005_F_)",65.05,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo13","DGalpa1-6DGalpb1-C24O5","DGD(801_4_)-DGD(801_4_)",66.36,"","",""
"6YAC","PLANT PSI-FERREDOXIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.5,"1.08527e-19","6yac_oligo22","DGalpa1-6DGalpb1-C31O5","DGD(5001_J_)-DGD(5001_J_)",44.72,"","",""
"6YCF","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS IN COMPLEX WITH THE E64 INHIBITOR","10.1038/S41598-020-76172-5 ",1.85,29.03,"6ycf_oligo1","DXylpb1-2[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(117_A_)",38.3723,"","",""
"6YCG","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS IN COMPLEX WITH THE TLCK INHIBITOR","10.1038/S41598-020-76172-5 ",1.45,17.38,"6ycg_oligo1","DXylpb1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(117_A_)",24.7054,"","",""
"6YEZ","PLANT PSI-FERREDOXIN-PLASTOCYANIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.7,"1.35632e-19","6yez_oligo18","DGalpa1-6DGalpb1-C24O5","DGD(803_3_)-DGD(803_3_)",117.99,"","",""
"6YEZ","PLANT PSI-FERREDOXIN-PLASTOCYANIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.7,"1.35632e-19","6yez_oligo5","DGalpa1-6DGalpb1-C14O5","DGD(803_1_)-DGD(803_1_)",110.92,"","",""
"6YEZ","PLANT PSI-FERREDOXIN-PLASTOCYANIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.7,"1.35632e-19","6yez_oligo3","DGalpa1-6DGalpb1-C34O5","DGD(5005_B_)-DGD(5005_B_)",70.31,"","",""
"6YEZ","PLANT PSI-FERREDOXIN-PLASTOCYANIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.7,"1.35632e-19","6yez_oligo20","DGalpa1-6DGalpb1-C20O5","DGD(5003_G_)-DGD(5003_G_)",110.9,"","",""
"6YEZ","PLANT PSI-FERREDOXIN-PLASTOCYANIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.7,"1.35632e-19","6yez_oligo13","DGalpa1-6DGalpb1-C24O5","DGD(802_4_)-DGD(802_4_)",99.21,"","",""
"6YEZ","PLANT PSI-FERREDOXIN-PLASTOCYANIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.7,"1.35632e-19","6yez_oligo21","DGalpa1-6DGalpb1-C31O5","DGD(5001_J_)-DGD(5001_J_)",82.24,"","",""
"6YEZ","PLANT PSI-FERREDOXIN-PLASTOCYANIN SUPERCOMPLEX","10.1038/S41477-020-00779-9 ",2.7,"1.35632e-19","6yez_oligo4","DGalpa1-6DGalpb1-C30O5","DGD(5005_F_)-DGD(5005_F_)",102.56,"","",""
"6YGE","NADASE FROM ASPERGILLUS FUMIGATUS","10.1038/S41467-021-21307-Z ",1.6,39.81,"6yge_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(95_A_)",55.3714,"","",""
"6YGE","NADASE FROM ASPERGILLUS FUMIGATUS","10.1038/S41467-021-21307-Z ",1.6,39.81,"6yge_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(118_B_)",58.6821,"","",""
"6YGE","NADASE FROM ASPERGILLUS FUMIGATUS","10.1038/S41467-021-21307-Z ",1.6,39.81,"6yge_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(118_A_)",61.6,"","",""
"6YGF","NADASE FROM ASPERGILLUS FUMIGATUS WITH TRAPPED REACTION PRODUCTS","10.1038/S41467-021-21307-Z ",1.7,35.24,"6ygf_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(95_A_)",53.2959,"","",""
"6YGF","NADASE FROM ASPERGILLUS FUMIGATUS WITH TRAPPED REACTION PRODUCTS","10.1038/S41467-021-21307-Z ",1.7,35.24,"6ygf_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(95_B_)",92.6495,"","",""
"6YGF","NADASE FROM ASPERGILLUS FUMIGATUS WITH TRAPPED REACTION PRODUCTS","10.1038/S41467-021-21307-Z ",1.7,35.24,"6ygf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(118_B_)",57.558,"","",""
"6YGF","NADASE FROM ASPERGILLUS FUMIGATUS WITH TRAPPED REACTION PRODUCTS","10.1038/S41467-021-21307-Z ",1.7,35.24,"6ygf_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(118_A_)",86.9539,"","",""
"6YGG","NADASE FROM ASPERGILLUS FUMIGATUS COMPLEXED WITH A SUBSTRATE ANOLOGUE","10.1038/S41467-021-21307-Z ",1.85,32.7,"6ygg_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(45_B_)",47.4636,"","",""
"6YGG","NADASE FROM ASPERGILLUS FUMIGATUS COMPLEXED WITH A SUBSTRATE ANOLOGUE","10.1038/S41467-021-21307-Z ",1.85,32.7,"6ygg_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(45_A_)",55.3903,"","",""
"6YGG","NADASE FROM ASPERGILLUS FUMIGATUS COMPLEXED WITH A SUBSTRATE ANOLOGUE","10.1038/S41467-021-21307-Z ",1.85,32.7,"6ygg_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(95_B_)",65.8033,"","",""
"6YGG","NADASE FROM ASPERGILLUS FUMIGATUS COMPLEXED WITH A SUBSTRATE ANOLOGUE","10.1038/S41467-021-21307-Z ",1.85,32.7,"6ygg_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(118_B_)",59.37,"","",""
"6YGG","NADASE FROM ASPERGILLUS FUMIGATUS COMPLEXED WITH A SUBSTRATE ANOLOGUE","10.1038/S41467-021-21307-Z ",1.85,32.7,"6ygg_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(95_A_)",52.7886,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo27","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",132.06,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo31","DGalpa1-6DGalpb1-C32O5","DGD(413_a_)-DGD(413_a_)",160.65,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",166.98,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",166.67,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo32","DGalpa1-6DGalpb1-C28O5","DGD(517_c_)-DGD(517_c_)",133.18,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo18","DGalpa1-6DGalpb1-C28O5","DGD(518_C_)-DGD(518_C_)",132.66,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo6","DGalpa1-6DGalpb1-C33O5","DGD(101_J_)-DGD(101_J_)",169.34,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",133.01,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo17","DGalpa1-6DGalpb1-C33O5","DGD(519_c_)-DGD(519_c_)",167.17,"","",""
"6YP7","PSII-LHCII C2S2 SUPERCOMPLEX FROM PISUM SATIVUM GROWN IN HIGH LIGHT CONDITIONS","10.3390/IJMS21228643 ",3.8,"1.35632e-19","6yp7_oligo25","DGalpa1-6DGalpb1-C32O5","DGD(401_A_)-DGD(401_A_)",167.4,"","",""
"6YRB","CRYSTAL STRUCTURE OF THE TETRAMERIZATION DOMAIN OF THE GLYCOPROTEIN GN (ANDES VIRUS) AT PH 7.5","10.1016/J.CELL.2020.08.023 ",2.35,47.79,"6yrb_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(402_A_)",72.0709,"","",""
"6YSC","GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",2.05,47.89,"6ysc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",79.578,"","",""
"6YSC","GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",2.05,47.89,"6ysc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",47.605,"","",""
"6YT7","GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.55,36.54,"6yt7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",54.2184,"","",""
"6YT7","GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.55,36.54,"6yt7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",43.4009,"","",""
"6YTB","GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.65,38.23,"6ytb_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",61.2668,"","",""
"6YTB","GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.65,38.23,"6ytb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",42.0985,"","",""
"6YXR","DUNALIELLA MINIMAL PHOTOSYSTEM I","10.1016/J.BBABIO.2020.148253 ",3.4,"1.08527e-19","6yxr_oligo5","DGalpa1-6DGalpb1-C34O5","DGD(5002_B_)-DGD(5002_B_)",36.46,"","",""
"6Z30","HUMAN CATION-INDEPENDENT MANNOSE 6-PHOSPHATE/ IGF2 RECEPTOR DOMAINS 9- 10","10.1016/J.STR.2020.08.002 ",1.5,0,"6z30_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1312_A_)",21.9442,"","",""
"6Z79","VARIANT SURFACE GLYCOPROTEIN VSGSUR, I3C (""MAGIC TRIANGLE"") DERIVATIVE USED FOR PHASING OF THE STRUCTURE AND SUBSEQUENTLY AS A MODEL FOR MOLECULAR REPLACEMENT OF NATIVE, MUTANTS, AND DRUG SOAKS.","10.1038/S41564-020-00844-1 ",1.92,46.05,"6z79_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",36.84,"","",""
"6Z7A","VARIANT SURFACE GLYCOPROTEIN VSGSUR","10.1038/S41564-020-00844-1 ",1.21,29.66,"6z7a_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",26.0968,"","",""
"6Z7B","VARIANT SURFACE GLYCOPROTEIN VSGSUR BOUND TO SURAMIN","10.1038/S41564-020-00844-1 ",1.86,21.54,"6z7b_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(130_A_)",32.0158,"","",""
"6Z7B","VARIANT SURFACE GLYCOPROTEIN VSGSUR BOUND TO SURAMIN","10.1038/S41564-020-00844-1 ",1.86,21.54,"6z7b_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(130_B_)",27.0412,"","",""
"6Z7C","VARIANT SURFACE GLYCOPROTEIN VSGSUR MUTANT H122A","10.1038/S41564-020-00844-1 ",1.64,37.76,"6z7c_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",39.3804,"","",""
"6Z7D","VARIANT SURFACE GLYCOPROTEIN VSGSUR MUTANT H122A SOAKED IN 0.77 MM SURAMIN.","10.1038/S41564-020-00844-1 ",1.75,39.37,"6z7d_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",37.2715,"","",""
"6Z7E","VARIANT SURFACE GLYCOPROTEIN VSGSUR MUTANT H122A SOAKED IN 7.7 MM SURAMIN","10.1038/S41564-020-00844-1 ",1.66,39.02,"6z7e_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",29.786,"","",""
"6Z8G","CRYSTAL STRUCTURE OF VSG13 SOAKED IN 0.5 M USED TO PHASE VSG13 TO SOLVE THE STRUCTURE.","10.1038/S41564-020-00844-1 ",1.56,32.92,"6z8g_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(260_A_)",35.6548,"","",""
"6Z8G","CRYSTAL STRUCTURE OF VSG13 SOAKED IN 0.5 M USED TO PHASE VSG13 TO SOLVE THE STRUCTURE.","10.1038/S41564-020-00844-1 ",1.56,32.92,"6z8g_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(260_B_)",31.8205,"","",""
"6Z8H","CRYSTAL STRUCTURE OF VARIANT SURFACE GLYCOPROTEIN VSG13","10.1038/S41564-020-00844-1 ",1.38,31.18,"6z8h_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(2_C_)-BMA(1_C_)-NAG(502_A_)-NAG(504_B_)",32.8636,"","",""
"6Z8H","CRYSTAL STRUCTURE OF VARIANT SURFACE GLYCOPROTEIN VSG13","10.1038/S41564-020-00844-1 ",1.38,31.18,"6z8h_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(2_D_)-BMA(1_D_)-NAG(501_B_)-NAG(501_A_)-ASN(260_A_)",32.0925,"","",""
"6ZBW","STRUCTURE OF THE D125N MUTANT OF THE CATALYTIC DOMAIN OF THE BACILLUS CIRCULANS ALPHA-1,6 MANNANASE IN COMPLEX WITH AN ALPHA-1,6-ALPHA- MANNO-CYCLOPHELLITOL TRISACCHARIDE INHIBITOR","10.1002/CHEM.202101255 ",1.4,19.22,"6zbw_oligo1","DManpa1-6DManpa1-C7O5","MAN(2_D_)-MAN(1_D_)-PBW(403_B_)",17.3123,"","",""
"6ZBW","STRUCTURE OF THE D125N MUTANT OF THE CATALYTIC DOMAIN OF THE BACILLUS CIRCULANS ALPHA-1,6 MANNANASE IN COMPLEX WITH AN ALPHA-1,6-ALPHA- MANNO-CYCLOPHELLITOL TRISACCHARIDE INHIBITOR","10.1002/CHEM.202101255 ",1.4,19.22,"6zbw_oligo2","DManpa1-6DManpa1-C7O5","MAN(2_C_)-MAN(1_C_)-PBW(401_A_)",17.0205,"","",""
"6ZEP","FLAVOURZYME LEUCINE AMINOPEPTIDASE A PROENZYME","10.1016/J.JSB.2021.107741 ",1.61,0,"6zep_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(87_A_)",58.0933,"","",""
"6ZGF","SPIKE PROTEIN OF RATG13 BAT CORONAVIRUS IN CLOSED CONFORMATION","10.1038/S41594-020-0468-7 ",3.1,0,"6zgf_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(331_B_)",45.6827,"","",""
"6ZGF","SPIKE PROTEIN OF RATG13 BAT CORONAVIRUS IN CLOSED CONFORMATION","10.1038/S41594-020-0468-7 ",3.1,0,"6zgf_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(331_A_)",45.6827,"","",""
"6ZGF","SPIKE PROTEIN OF RATG13 BAT CORONAVIRUS IN CLOSED CONFORMATION","10.1038/S41594-020-0468-7 ",3.1,0,"6zgf_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(370_A_)",30.38,"","",""
"6ZGF","SPIKE PROTEIN OF RATG13 BAT CORONAVIRUS IN CLOSED CONFORMATION","10.1038/S41594-020-0468-7 ",3.1,0,"6zgf_oligo30","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_g_)-NAG(1_g_)-ASN(370_C_)",30.38,"","",""
"6ZGF","SPIKE PROTEIN OF RATG13 BAT CORONAVIRUS IN CLOSED CONFORMATION","10.1038/S41594-020-0468-7 ",3.1,0,"6zgf_oligo25","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(331_C_)",45.6827,"","",""
"6ZGF","SPIKE PROTEIN OF RATG13 BAT CORONAVIRUS IN CLOSED CONFORMATION","10.1038/S41594-020-0468-7 ",3.1,0,"6zgf_oligo20","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_W_)-NAG(1_W_)-ASN(370_B_)",30.38,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",91.2233,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",104.921,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",96.6548,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",98.5729,"","",""
"6ZOO","PHOTOSYSTEM I REDUCED PLASTOCYANIN COMPLEX","10.1042/BCJ20210267 ",2.74,"1.35632e-19","6zoo_oligo12","DGalpa1-6DGalpb1-C30O5","DGD(5005_F_)-DGD(5005_F_)",78.64,"","",""
"6ZOO","PHOTOSYSTEM I REDUCED PLASTOCYANIN COMPLEX","10.1042/BCJ20210267 ",2.74,"1.35632e-19","6zoo_oligo13","DGalpa1-6DGalpb1-C20O5","DGD(5003_G_)-DGD(5003_G_)",79.75,"","",""
"6ZOO","PHOTOSYSTEM I REDUCED PLASTOCYANIN COMPLEX","10.1042/BCJ20210267 ",2.74,"1.35632e-19","6zoo_oligo16","DGalpa1-6DGalpb1-C24O5","DGD(803_3_)-DGD(803_3_)",79.28,"","",""
"6ZOO","PHOTOSYSTEM I REDUCED PLASTOCYANIN COMPLEX","10.1042/BCJ20210267 ",2.74,"1.35632e-19","6zoo_oligo32","DGalpa1-6DGalpb1-C34O5","DGD(5005_B_)-DGD(5005_B_)",35.2,"","",""
"6ZOO","PHOTOSYSTEM I REDUCED PLASTOCYANIN COMPLEX","10.1042/BCJ20210267 ",2.74,"1.35632e-19","6zoo_oligo14","DGalpa1-6DGalpb1-C31O5","DGD(5001_J_)-DGD(5001_J_)",59.38,"","",""
"6ZOO","PHOTOSYSTEM I REDUCED PLASTOCYANIN COMPLEX","10.1042/BCJ20210267 ",2.74,"1.35632e-19","6zoo_oligo11","DGalpa1-6DGalpb1-C23O5","DGD(802_4_)-DGD(802_4_)",75.93,"","",""
"6ZOO","PHOTOSYSTEM I REDUCED PLASTOCYANIN COMPLEX","10.1042/BCJ20210267 ",2.74,"1.35632e-19","6zoo_oligo15","DGalpa1-6DGalpb1-C14O5","DGD(803_1_)-DGD(803_1_)",85.86,"","",""
"6ZPQ","CRYSTAL STRUCTURE OF THE OPEN CONFORMATION OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN.","10.1111/FEBS.15601 ",1.85,43.45,"6zpq_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(480_B_)",61.0218,"","",""
"6ZPQ","CRYSTAL STRUCTURE OF THE OPEN CONFORMATION OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN.","10.1111/FEBS.15601 ",1.85,43.45,"6zpq_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(480_A_)",60.5233,"","",""
"6ZPQ","CRYSTAL STRUCTURE OF THE OPEN CONFORMATION OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN.","10.1111/FEBS.15601 ",1.85,43.45,"6zpq_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(480_C_)",56.8952,"","",""
"6ZPQ","CRYSTAL STRUCTURE OF THE OPEN CONFORMATION OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN.","10.1111/FEBS.15601 ",1.85,43.45,"6zpq_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(480_D_)",68.1433,"","",""
"6ZPT","CRYSTAL STRUCTURE OF THE OPEN CONFORMATION OF S2_S'-MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN.","10.1111/FEBS.15601 ",2.8,70.83,"6zpt_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_A_)",72.5132,"","",""
"6ZPT","CRYSTAL STRUCTURE OF THE OPEN CONFORMATION OF S2_S'-MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN.","10.1111/FEBS.15601 ",2.8,70.83,"6zpt_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_C_)",81.9923,"","",""
"6ZPT","CRYSTAL STRUCTURE OF THE OPEN CONFORMATION OF S2_S'-MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN.","10.1111/FEBS.15601 ",2.8,70.83,"6zpt_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(480_D_)",74.1091,"","",""
"6ZPU","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN WITH INSERTED SYMMETRY MOLECULE C-TERMINUS.","10.1111/FEBS.15601 ",2,39.6,"6zpu_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(109_A_)",57.8309,"","",""
"6ZQR","CRYSTAL STRUCTURE OF TETRAMERIC FIBRINOGEN-LIKE RECOGNITION DOMAIN OF FIBCD1 WITH GLCNAC LIGAND BOUND","",1.93,18.31,"6zqr_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(340_A_)",47.6102,"","",""
"6ZQV","CRYO-EM STRUCTURE OF MATURE SPONDWENI VIRUS","10.1038/S41467-021-21505-9 ",2.6,"1.15243e-41","6zqv_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(154_E_)",95.5494,"","",""
"6ZQV","CRYO-EM STRUCTURE OF MATURE SPONDWENI VIRUS","10.1038/S41467-021-21505-9 ",2.6,"1.15243e-41","6zqv_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(154_A_)",94.9427,"","",""
"6ZQV","CRYO-EM STRUCTURE OF MATURE SPONDWENI VIRUS","10.1038/S41467-021-21505-9 ",2.6,"1.15243e-41","6zqv_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(154_C_)",90.1939,"","",""
"6ZRK","CRYSTAL STRUCTURE OF H8 HAEMAGGLUTININ","10.1101/CSHPERSPECT.A038638 ",2,44.24,"6zrk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(134_C_)",52.8888,"","",""
"6ZS5","3.5 A CRYO-EM STRUCTURE OF HUMAN UROMODULIN FILAMENT CORE","10.7554/ELIFE.60265 ",3.5,0,"6zs5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(396_A_)",132.979,"","",""
"6ZWE","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH ((6- ((2E,4E)-5-(BENZO[D][1,3]DIOXOL-5-YL)PENTA-2,4-DIENAMIDO)HEXYL) TRIPHENYLPHOSPHONIUM BROMIDE)","10.3390/ANTIOX10020329 ",3,97.42,"6zwe_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",137.725,"","",""
"6ZWE","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH ((6- ((2E,4E)-5-(BENZO[D][1,3]DIOXOL-5-YL)PENTA-2,4-DIENAMIDO)HEXYL) TRIPHENYLPHOSPHONIUM BROMIDE)","10.3390/ANTIOX10020329 ",3,97.42,"6zwe_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",148.331,"","",""
"6ZWI","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((6-((2E,4E)-5- (BENZO[D][1,3]DIOXOL-5-YL)PENTA-2,4-DIENAMIDO)HEXYL) TRIPHENYLPHOSPHONIUM BROMIDE)","10.3390/ANTIOX10020329 ",1.85,56.31,"6zwi_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(57_A_)",122.694,"","",""
"6ZWI","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((6-((2E,4E)-5- (BENZO[D][1,3]DIOXOL-5-YL)PENTA-2,4-DIENAMIDO)HEXYL) TRIPHENYLPHOSPHONIUM BROMIDE)","10.3390/ANTIOX10020329 ",1.85,56.31,"6zwi_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(106_A_)",98.4009,"","",""
"6ZWI","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((6-((2E,4E)-5- (BENZO[D][1,3]DIOXOL-5-YL)PENTA-2,4-DIENAMIDO)HEXYL) TRIPHENYLPHOSPHONIUM BROMIDE)","10.3390/ANTIOX10020329 ",1.85,56.31,"6zwi_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(341_A_)",75.3385,"","",""
"6ZWI","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((6-((2E,4E)-5- (BENZO[D][1,3]DIOXOL-5-YL)PENTA-2,4-DIENAMIDO)HEXYL) TRIPHENYLPHOSPHONIUM BROMIDE)","10.3390/ANTIOX10020329 ",1.85,56.31,"6zwi_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(241_A_)",102.463,"","",""
"6ZXS","COLD GROWN PEA PHOTOSYSTEM I","",3,123.9,"6zxs_oligo2","DGalpa1-6DGalpb1-C34O5","DGD(855_B_)-DGD(855_B_)",113.266,"","",""
"6ZXS","COLD GROWN PEA PHOTOSYSTEM I","",3,123.9,"6zxs_oligo3","DGalpa1-6DGalpb1-C30O5","DGD(309_F_)-DGD(309_F_)",172.389,"","",""
"6ZXS","COLD GROWN PEA PHOTOSYSTEM I","",3,123.9,"6zxs_oligo6","DGalpa1-6DGalpb1-C24O5","DGD(327_2_)-DGD(327_2_)",145.229,"","",""
"6ZXS","COLD GROWN PEA PHOTOSYSTEM I","",3,123.9,"6zxs_oligo4","DGalpa1-6DGalpb1-C31O5","DGD(1106_J_)-DGD(1106_J_)",152.173,"","",""
"6ZYA","EXTENDED HUMAN UROMODULIN FILAMENT CORE AT 3.5 A RESOLUTION","10.7554/ELIFE.60265 ",3.5,0,"6zya_oligo2","DManpa1-6DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(396_A_)",159.163,"","",""
"6ZZX","STRUCTURE OF LOW-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",2.7,"1.08527e-19","6zzx_oligo2","DGalpa1-6DGalpb1-C19O5","DGD(803_8_)-DGD(803_8_)",31.08,"","",""
"6ZZX","STRUCTURE OF LOW-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",2.7,"1.08527e-19","6zzx_oligo11","DGalpa1-6DGalpb1-C39O5","DGD(5003_B_)-DGD(5003_B_)",20.11,"","",""
"6ZZX","STRUCTURE OF LOW-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",2.7,"1.08527e-19","6zzx_oligo12","DGalpa1-6DGalpb1-C32O5","DGD(802_8_)-DGD(802_8_)",33.42,"","",""
"6ZZX","STRUCTURE OF LOW-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",2.7,"1.08527e-19","6zzx_oligo5","DGalpa1-6DGalpb1-C23O5","DGD(806_7_)-DGD(806_7_)",31.66,"","",""
"6ZZY","STRUCTURE OF HIGH-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",3.16,"1.08527e-19","6zzy_oligo2","DGalpa1-6DGalpb1-C24O5","DGD(5005_A_)-DGD(5005_A_)",24.74,"","",""
"6ZZY","STRUCTURE OF HIGH-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",3.16,"1.08527e-19","6zzy_oligo3","DGalpa1-6DGalpb1-C39O5","DGD(5003_B_)-DGD(5003_B_)",19.81,"","",""
"6ZZY","STRUCTURE OF HIGH-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",3.16,"1.08527e-19","6zzy_oligo1","DGalpa1-6DGalpb1-C39O5","DGD(802_8_)-DGD(802_8_)",34.27,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo13","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_U_)-NAG(1_U_)-ASN(150_H_)",93.9405,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(150_C_)",92.8555,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(150_A_)",83.6227,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(150_B_)",78.0523,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo12","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_T_)-NAG(1_T_)-ASN(150_G_)",92.9309,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(150_D_)",85.29,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(150_E_)",92.7614,"","",""
"7A0K","CRYSTAL STRUCTURE OF THE ENTIRE ECTODOMAIN FROM THE PHYSCOMITRELLA PATENS RECEPTOR KINASE CR4","",2.7,0,"7a0k_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_S_)-NAG(1_S_)-ASN(150_F_)",98.4386,"","",""
"7A0Q","CRYSTAL STRUCTURE OF KIEVITONE HYDRATASE FROM NECTRIA HAEMATOCOCCA (C2 SG)","",1.5,23.91,"7a0q_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(218_A_)",27.2045,"","",""
"7A0T","CRYSTAL STRUCTURE OF KIEVITONE HYDRATASE FROM NECTRIA HAEMATOCOCCA (P21 SG)","",2,34.95,"7a0t_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(218_B_)",37.3676,"","",""
"7A0T","CRYSTAL STRUCTURE OF KIEVITONE HYDRATASE FROM NECTRIA HAEMATOCOCCA (P21 SG)","",2,34.95,"7a0t_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(218_A_)",44.1531,"","",""
"7A3O","CRYSTAL STRUCTURE OF DENGUE 1 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10","10.1016/J.CELL.2021.11.010 ",2.8,105.4,"7a3o_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(67_A_)",171.057,"","",""
"7A3R","CRYSTAL STRUCTURE OF DENGUE 1 VIRUS ENVELOPE GLYCOPROTEIN","10.1016/J.CELL.2021.11.010 ",3.6,72.58,"7a3r_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(153_A_)",71.4077,"","",""
"7A3T","CRYSTAL STRUCTURE OF DENGUE 3 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8","10.1016/J.CELL.2021.11.010 ",2.65,70.82,"7a3t_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(67_A_)",117.583,"","",""
"7A4P","STRUCTURE OF SMALL HIGH-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",4.2,"1.08527e-19","7a4p_oligo4","DGalpa1-6DGalpb1-C39O5","DGD(5003_B_)-DGD(5003_B_)",63.6,"","",""
"7A4P","STRUCTURE OF SMALL HIGH-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",4.2,"1.08527e-19","7a4p_oligo3","DGalpa1-6DGalpb1-C24O5","DGD(5005_A_)-DGD(5005_A_)",44.57,"","",""
"7A4P","STRUCTURE OF SMALL HIGH-LIGHT GROWN CHLORELLA OHADII PHOTOSYSTEM I","10.1038/S41477-021-00983-1 ",4.2,"1.08527e-19","7a4p_oligo5","DGalpa1-6DGalpb1-C39O5","DGD(802_8_)-DGD(802_8_)",79.64,"","",""
"7A57","LA CROSSE VIRUS ENVELOPE GLYCOPROTEIN GC W1066H MUTANT FUSION DOMAINS IN POSTFUSION CONFORMATION","10.1016/J.CELREP.2023.112142 ",3.16,109.5,"7a57_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(1177_C_)",157.195,"","",""
"7A57","LA CROSSE VIRUS ENVELOPE GLYCOPROTEIN GC W1066H MUTANT FUSION DOMAINS IN POSTFUSION CONFORMATION","10.1016/J.CELREP.2023.112142 ",3.16,109.5,"7a57_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(1177_A_)",142.065,"","",""
"7A57","LA CROSSE VIRUS ENVELOPE GLYCOPROTEIN GC W1066H MUTANT FUSION DOMAINS IN POSTFUSION CONFORMATION","10.1016/J.CELREP.2023.112142 ",3.16,109.5,"7a57_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(1177_B_)",149.755,"","",""
"7A59","CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ENVELOPE GLYCOPROTEIN GC W1191H/W1197A/W1199A MUTANT IN POSTFUSION CONFORMATION (ORTHORHOMBIC CRYSTAL FORM)","10.1126/SCIENCE.ABL6502 ",2.2,72.77,"7a59_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(1345_C_)",133.882,"","",""
"7A5V","CRYOEM STRUCTURE OF A HUMAN GAMMA-AMINOBUTYRIC ACID RECEPTOR, THE GABA(A)R-BETA3 HOMOPENTAMER, IN COMPLEX WITH HISTAMINE AND MEGABODY MB25 IN LIPID NANODISC","10.1038/S41586-020-2829-0 ",1.7,0,"7a5v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(149_A_)",58.1069,"","",""
"7AKD","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",4,"1.35632e-19","7akd_oligo13","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_T_)-[MAN(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(343_C_)",90.1902,"","",""
"7AKD","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",4,"1.35632e-19","7akd_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(282_C_)",98.3084,"","",""
"7AKD","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",4,"1.35632e-19","7akd_oligo14","DManpa1-6DManpx1-","MAN(2_U_)-MAN(1_U_)",98.3036,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(119_B_)",83.0739,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo6","DManpa1-3DManpa1-3[DManpa1-2[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_N_)-[MAN(8_N_)-[MAN(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(330_C_)",114.126,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo11","DManpa1-3DManpa1-3[DManpa1-2[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_T_)-[MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(330_B_)",116.815,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(119_C_)",82.023,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(119_A_)",79.1039,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo17","DManpa1-3DManpa1-3[DManpa1-2[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_Z_)-[MAN(8_Z_)-[MAN(7_Z_)]-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(330_A_)",111.712,"","",""
"7AKK","STRUCTURE OF A COMPLEMENT FACTOR-RECEPTOR COMPLEX","10.1038/S41467-022-29580-2 ",3.4,112.4,"7akk_oligo2","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_J_)-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(63_C_)",126.509,"","",""
"7ALK","STRUCTURE OF DROSOPHILA C2-DSL-EGF1","10.15252/EMBR.202152729 ",3,35.61,"7alk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(137_A_)",41.3356,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo5","DManpa1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(137_A_)",85.8083,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(378_B_)",77.8957,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(461_B_)",51.9495,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo6","DGlcpNAcb1-4[LGalpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(461_A_)",81.6691,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(378_A_)",78.4155,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(137_B_)",69.0495,"","",""
"7AMZ","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((2S,3R)-4-((2,2-DIMETHYLPROPYL)AMINO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)- 2,2-DIPHENYLACETAMIDE","10.1016/J.EJMECH.2021.113397 ",2.25,54.47,"7amz_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(341_A_)",74.6097,"","",""
"7AMZ","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((2S,3R)-4-((2,2-DIMETHYLPROPYL)AMINO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)- 2,2-DIPHENYLACETAMIDE","10.1016/J.EJMECH.2021.113397 ",2.25,54.47,"7amz_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",102.743,"","",""
"7AMZ","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((2S,3R)-4-((2,2-DIMETHYLPROPYL)AMINO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)- 2,2-DIPHENYLACETAMIDE","10.1016/J.EJMECH.2021.113397 ",2.25,54.47,"7amz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(106_A_)",91.51,"","",""
"7AMZ","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((2S,3R)-4-((2,2-DIMETHYLPROPYL)AMINO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)- 2,2-DIPHENYLACETAMIDE","10.1016/J.EJMECH.2021.113397 ",2.25,54.47,"7amz_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",104.118,"","",""
"7ANQ","COMPLETE PCSK9 C-TER DOMAIN IN COMPLEX WITH VHH P1.40","10.1016/J.MOLMET.2022.101662 ",2.2,52.02,"7anq_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(533_A_)",110.982,"","",""
"7API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3,0,"7api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",53.2947,"","",""
"7AQ1","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA IN COMPLEX WITH THE SPECIFIC INHIBITOR MWT-S-270","10.3390/IJMS22115651 ",2.41,55.52,"7aq1_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-[MAN(7_I_)]-MAN(4_I_)-[MAN(9_I_)-MAN(8_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(547_A_)",66.9821,"","",""
"7AQ1","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA IN COMPLEX WITH THE SPECIFIC INHIBITOR MWT-S-270","10.3390/IJMS22115651 ",2.41,55.52,"7aq1_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-MAN(5_L_)-[MAN(7_L_)]-MAN(4_L_)-[MAN(8_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(547_B_)",76.3333,"","",""
"7ARN","CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A GLYCOSYLATED LYMPHOMA ANTIBODY","",1.57,0,"7arn_oligo2","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(91_L_)",66.8796,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(445_A_)",153.578,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo7","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(592_A_)",161.788,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUC(6_E_)]-NAG(1_E_)-ASN(218_A_)",141.635,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo14","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_R_)-MAN(11_R_)-[MAN(10_R_)-MAN(9_R_)]-MAN(8_R_)-[GLC(7_R_)-MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(547_C_)",124.457,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo15","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[FUC(2_S_)]-NAG(1_S_)-ASN(592_C_)",155.036,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-[FUC(5_H_)]-NAG(1_H_)-ASN(436_A_)",147.234,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_P_)-[MAN(4_P_)-BMA(3_P_)-NAG(2_P_)]-[FUC(5_P_)]-NAG(1_P_)-ASN(436_C_)",151.712,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-[FUC(6_O_)]-NAG(1_O_)-ASN(370_C_)",156.815,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo5","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_J_)-MAN(11_J_)-[MAN(10_J_)-MAN(9_J_)]-MAN(8_J_)-[GLC(7_J_)-MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(547_A_)",121.215,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(445_C_)",154.172,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(370_A_)",156.512,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-[FUC(6_M_)]-NAG(1_M_)-ASN(218_C_)",137.172,"","",""
"7AWG","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (2- ((1-(BENZENESULFONYL)-1H-INDOL-4-YL)OXY)ETHYL)(BENZYL)AMINE","10.1016/J.EJMECH.2021.113792 ",2,43.63,"7awg_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",88.5418,"","",""
"7AWG","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (2- ((1-(BENZENESULFONYL)-1H-INDOL-4-YL)OXY)ETHYL)(BENZYL)AMINE","10.1016/J.EJMECH.2021.113792 ",2,43.63,"7awg_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",77.3085,"","",""
"7AWG","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (2- ((1-(BENZENESULFONYL)-1H-INDOL-4-YL)OXY)ETHYL)(BENZYL)AMINE","10.1016/J.EJMECH.2021.113792 ",2,43.63,"7awg_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",63.6227,"","",""
"7AWH","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TERT- BUTYL 3-(((2-((1-(BENZENESULFONYL)-1H-INDOL-4-YL)OXY)ETHYL)AMINO) METHYL)PIPERIDINE-1-CARBOXYLATE","10.1016/J.EJMECH.2021.113792 ",2.3,68.99,"7awh_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",103.825,"","",""
"7AWH","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TERT- BUTYL 3-(((2-((1-(BENZENESULFONYL)-1H-INDOL-4-YL)OXY)ETHYL)AMINO) METHYL)PIPERIDINE-1-CARBOXYLATE","10.1016/J.EJMECH.2021.113792 ",2.3,68.99,"7awh_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",118.902,"","",""
"7AWH","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TERT- BUTYL 3-(((2-((1-(BENZENESULFONYL)-1H-INDOL-4-YL)OXY)ETHYL)AMINO) METHYL)PIPERIDINE-1-CARBOXYLATE","10.1016/J.EJMECH.2021.113792 ",2.3,68.99,"7awh_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",90.6221,"","",""
"7AWI","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TERT- BUTYL 3-(((2-((1-BENZYL-1H-INDOL-4-YL)OXY)ETHYL)AMINO) METHYL]PIPERIDINE-1-CARBOXYLATE","10.1016/J.EJMECH.2021.113792 ",2.3,66.5,"7awi_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",118.024,"","",""
"7AWI","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TERT- BUTYL 3-(((2-((1-BENZYL-1H-INDOL-4-YL)OXY)ETHYL)AMINO) METHYL]PIPERIDINE-1-CARBOXYLATE","10.1016/J.EJMECH.2021.113792 ",2.3,66.5,"7awi_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",87.7788,"","",""
"7AWI","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TERT- BUTYL 3-(((2-((1-BENZYL-1H-INDOL-4-YL)OXY)ETHYL)AMINO) METHYL]PIPERIDINE-1-CARBOXYLATE","10.1016/J.EJMECH.2021.113792 ",2.3,66.5,"7awi_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",100.78,"","",""
"7B38","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH MG+2","10.1002/PRO.4061 ",1.85,36.12,"7b38_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(59_A_)",65.6282,"","",""
"7B75","CRYO-EM STRUCTURE OF HUMAN THYROGLOBULIN","10.1038/S41467-021-27693-8 ",3.2,0,"7b75_oligo6","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(2582_A_)",147.695,"","",""
"7B75","CRYO-EM STRUCTURE OF HUMAN THYROGLOBULIN","10.1038/S41467-021-27693-8 ",3.2,0,"7b75_oligo12","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(2582_B_)",150.89,"","",""
"7B8E","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH CA+2","10.1002/PRO.4061 ",2.23,43.68,"7b8e_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(59_A_)",80.685,"","",""
"7BEH","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB","10.1016/J.CELL.2021.02.032 ",2.3,59.31,"7beh_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",81.6064,"","",""
"7BEH","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB","10.1016/J.CELL.2021.02.032 ",2.3,59.31,"7beh_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(59_H_)",59.4091,"","",""
"7BEI","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB","10.1016/J.CELL.2021.02.032 ",2.3,51.13,"7bei_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",90.8164,"","",""
"7BEJ","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 1)","10.1016/J.CELL.2021.02.032 ",2.42,57.5,"7bej_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",98.3255,"","",""
"7BEK","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 2)","10.1016/J.CELL.2021.02.032 ",2.04,62.73,"7bek_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",113.958,"","",""
"7BEL","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS","10.1016/J.CELL.2021.02.032 ",2.53,69.91,"7bel_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(35_E_)",91.1424,"","",""
"7BEL","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS","10.1016/J.CELL.2021.02.032 ",2.53,69.91,"7bel_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(35_H_)",88.1701,"","",""
"7BEM","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 SCFV","10.1016/J.CELL.2021.02.032 ",2.52,93.8,"7bem_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",150.922,"","",""
"7BEN","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS","10.1016/J.CELL.2021.02.032 ",2.5,72.1,"7ben_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(102_H_)",105.7,"","",""
"7BEN","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS","10.1016/J.CELL.2021.02.032 ",2.5,72.1,"7ben_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(102_D_)",108.428,"","",""
"7BEO","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS","10.1016/J.CELL.2021.02.032 ",3.19,90.21,"7beo_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(102_C_)",115.382,"","",""
"7BEO","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS","10.1016/J.CELL.2021.02.032 ",3.19,90.21,"7beo_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(102_H_)",113.046,"","",""
"7BEO","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS","10.1016/J.CELL.2021.02.032 ",3.19,90.21,"7beo_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(343_X_)",136.481,"","",""
"7BEP","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS","10.1016/J.CELL.2021.02.032 ",2.61,99.07,"7bep_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(343_E_)",144.507,"","",""
"7BEP","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS","10.1016/J.CELL.2021.02.032 ",2.61,99.07,"7bep_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_C_)",135.208,"","",""
"7BFZ","X-RAY STRUCTURE OF HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) IN COMPLEX WITH A INHIBITOR GLU-490","10.1038/S41467-021-25746-6 ",1.73,36.47,"7bfz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(638_A_)",51.5416,"","",""
"7BFZ","X-RAY STRUCTURE OF HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) IN COMPLEX WITH A INHIBITOR GLU-490","10.1038/S41467-021-25746-6 ",1.73,36.47,"7bfz_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(140_A_)",80.2127,"","",""
"7BGC","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-METHYLANACARDATE HYBRID INHIBITOR","10.1021/ACS.JMEDCHEM.1C00048 ",2.4,89.48,"7bgc_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(57_A_)",155.328,"","",""
"7BGC","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-METHYLANACARDATE HYBRID INHIBITOR","10.1021/ACS.JMEDCHEM.1C00048 ",2.4,89.48,"7bgc_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",151.424,"","",""
"7BGC","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-METHYLANACARDATE HYBRID INHIBITOR","10.1021/ACS.JMEDCHEM.1C00048 ",2.4,89.48,"7bgc_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(341_A_)",134.746,"","",""
"7BGI","PHOTOSYSTEM I OF A TEMPERATURE SENSITIVE MUTANT CHLAMYDOMONAS REINHARDTII","10.1038/S42003-021-02911-7 ",2.54,"1.49247e-19","7bgi_oligo6","DGalpa1-6DGalpb1-C39O5","DGD(5003_B_)-DGD(5003_B_)",24.2,"","",""
"7BHD","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.4,35.25,"7bhd_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",47.56,"","",""
"7BHD","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.4,35.25,"7bhd_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",58.9397,"","",""
"7BLX","PHOTOSYSTEM I OF A TEMPERATURE SENSITIVE MUTANT CHLAMYDOMONAS REINHARDTII","10.1038/S42003-021-02911-7 ",3.15,"1.35632e-19","7blx_oligo10","DGalpa1-6DGalpb1-C39O5","DGD(5003_B_)-DGD(5003_B_)",13.94,"","",""
"7BLZ","RED ALGA C.MEROLAE PHOTOSYSTEM I","",3.1,"1.35632e-19","7blz_oligo3","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",48.07,"","",""
"7BLZ","RED ALGA C.MEROLAE PHOTOSYSTEM I","",3.1,"1.35632e-19","7blz_oligo5","DGalpa1-6DGalpb1-C39O5","DGD(849_B_)-DGD(849_B_)",37.93,"","",""
"7BLZ","RED ALGA C.MEROLAE PHOTOSYSTEM I","",3.1,"1.35632e-19","7blz_oligo4","DGalpa1-6DGalpb1-C39O5","DGD(846_B_)-DGD(846_B_)",30.86,"","",""
"7BNN","OPEN CONFORMATION OF D614G SARS-COV-2 SPIKE WITH 1 ERECT RBD","10.1073/PNAS.2022586118 ",3.5,0,"7bnn_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(1074_A_)",97.1379,"","",""
"7BO3","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-(2-(1H-INDOL-3-YL) ETHYL)-2-CYCLOHEPTYL-N-METHYLETHAN-1-AMINE","10.1016/J.EJMECH.2022.114248 ",2.2,58.55,"7bo3_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(241_A_)",97.7764,"","",""
"7BO3","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-(2-(1H-INDOL-3-YL) ETHYL)-2-CYCLOHEPTYL-N-METHYLETHAN-1-AMINE","10.1016/J.EJMECH.2022.114248 ",2.2,58.55,"7bo3_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",79.8973,"","",""
"7BO3","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-(2-(1H-INDOL-3-YL) ETHYL)-2-CYCLOHEPTYL-N-METHYLETHAN-1-AMINE","10.1016/J.EJMECH.2022.114248 ",2.2,58.55,"7bo3_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",113.31,"","",""
"7BO4","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 3-(2-(BUTYL(2- CYCLOHEPTYLETHYL)AMINO)ETHYL)-1H-INDOL-6-OL","10.1016/J.EJMECH.2022.114248 ",2.4,65.25,"7bo4_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",111.03,"","",""
"7BO4","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 3-(2-(BUTYL(2- CYCLOHEPTYLETHYL)AMINO)ETHYL)-1H-INDOL-6-OL","10.1016/J.EJMECH.2022.114248 ",2.4,65.25,"7bo4_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(485_A_)",116.745,"","",""
"7BO4","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 3-(2-(BUTYL(2- CYCLOHEPTYLETHYL)AMINO)ETHYL)-1H-INDOL-6-OL","10.1016/J.EJMECH.2022.114248 ",2.4,65.25,"7bo4_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(106_A_)",104.186,"","",""
"7BO4","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 3-(2-(BUTYL(2- CYCLOHEPTYLETHYL)AMINO)ETHYL)-1H-INDOL-6-OL","10.1016/J.EJMECH.2022.114248 ",2.4,65.25,"7bo4_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",108.72,"","",""
"7BO4","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 3-(2-(BUTYL(2- CYCLOHEPTYLETHYL)AMINO)ETHYL)-1H-INDOL-6-OL","10.1016/J.EJMECH.2022.114248 ",2.4,65.25,"7bo4_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(341_A_)",86.4718,"","",""
"7BPS","CRYSTAL STRUCTURE OF MOUSE TEX101","10.1002/1873-3468.13875 ",2.35,46.01,"7bps_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(45_B_)",65.4503,"","",""
"7BPS","CRYSTAL STRUCTURE OF MOUSE TEX101","10.1002/1873-3468.13875 ",2.35,46.01,"7bps_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(45_A_)",92.6082,"","",""
"7BPS","CRYSTAL STRUCTURE OF MOUSE TEX101","10.1002/1873-3468.13875 ",2.35,46.01,"7bps_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(110_B_)",57.9145,"","",""
"7BPS","CRYSTAL STRUCTURE OF MOUSE TEX101","10.1002/1873-3468.13875 ",2.35,46.01,"7bps_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(110_A_)",62.4839,"","",""
"7BT8","MEVO LECTIN COMPLEX WITH MANNOTRIOSE","10.1093/GLYCOB/CWAA063 ",2.7,37.97,"7bt8_oligo2","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_I_)-[MAN(2_I_)]-BMA(1_I_)",38.3333,"","",""
"7BT8","MEVO LECTIN COMPLEX WITH MANNOTRIOSE","10.1093/GLYCOB/CWAA063 ",2.7,37.97,"7bt8_oligo1","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_H_)-[MAN(2_H_)]-BMA(1_H_)",52.9936,"","",""
"7BT8","MEVO LECTIN COMPLEX WITH MANNOTRIOSE","10.1093/GLYCOB/CWAA063 ",2.7,37.97,"7bt8_oligo3","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_J_)-[MAN(2_J_)]-BMA(1_J_)",56.0206,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo4","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(305_D_)-MAN(3_J_)-[MAN(2_J_)]-MAN(1_J_)",58.4286,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(3_H_)-MAN(2_H_)-[MAN(4_H_)]-MAN(1_H_)",55.1868,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo2","DManpa1-6DManpa1-C6O6","MAN(3_I_)-MAN(2_I_)",50.8932,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(3_M_)-MAN(2_M_)-[MAN(4_M_)]-MAN(1_M_)",53.8757,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo6","DManpa1-6DManpa1-ROH","MAN(2_L_)-MAN(1_L_)",56.9582,"","",""
"7BVT","CRYSTAL STRUCTURE OF CYCLIC ALPHA-MALTOSYL-1,6-MALTOSE BINDING PROTEIN FROM ARTHROBACTER GLOBIFORMIS","10.1371/JOURNAL.PONE.0241912 ",1.47,22.72,"7bvt_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",30.6982,"","",""
"7C8W","STRUCTURE OF SYBODY MR17 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR- BINDING DOMAIN (RBD)","10.1038/S41467-021-24905-Z ",2.77,73.5,"7c8w_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(343_B_)",126.875,"","",""
"7C9I","HUMAN GAMMA-SECRETASE IN COMPLEX WITH SMALL MOLECULE L-685,458","10.1016/J.CELL.2020.11.049 ",3.1,"1.08527e-19","7c9i_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",66.3371,"","",""
"7CAN","STRUCTURE OF SYBODY MR17-K99Y IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD)","10.1038/S41467-021-24905-Z ",2.94,79.38,"7can_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_B_)",135.581,"","",""
"7CBK","STRUCTURE OF HUMAN NEUTROPHIL ELASTASE ECOTIN COMPLEX","10.1021/ACS.BIOCHEM.0C00493 ",2.7,39.95,"7cbk_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)",73.4273,"","",""
"7CBK","STRUCTURE OF HUMAN NEUTROPHIL ELASTASE ECOTIN COMPLEX","10.1021/ACS.BIOCHEM.0C00493 ",2.7,39.95,"7cbk_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",53.1885,"","",""
"7CBK","STRUCTURE OF HUMAN NEUTROPHIL ELASTASE ECOTIN COMPLEX","10.1021/ACS.BIOCHEM.0C00493 ",2.7,39.95,"7cbk_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(109_D_)",66.9752,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo53","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",64.5436,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",60.6105,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",65.6386,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo49","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",60.0155,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo51","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",64.9491,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo50","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",55.4505,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo48","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",50.8405,"","",""
"7CJI","PHOTOSYSTEM II STRUCTURE IN THE S1 STATE","10.1107/S2052252521002177 ",2.35,67.02,"7cji_oligo52","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",55.3895,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo45","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",66.8268,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",62.1673,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",56.1259,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(520_C_)-DGD(520_C_)",52.0855,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",50.9991,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",55.315,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",58.6745,"","",""
"7CJJ","PHOTOSYSTEM II STRUCTURE IN THE S2 STATE","10.1107/S2052252521002177 ",2.4,63.11,"7cjj_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",46.0214,"","",""
"7CM4","CRYSTAL STRUCTURE OF COVID-19 VIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH A NEUTRALIZING ANTIBODY CT-P59","10.1038/S41467-020-20602-5 ",2.71,65.14,"7cm4_oligo1","DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",126.383,"","",""
"7CN9","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE ECTODOMAIN","10.1016/J.CELREP.2020.108016 ",4.7,0,"7cn9_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_k_)-[NAG(2_k_)]-NAG(1_k_)-ASN(165_C_)",150.327,"","",""
"7CN9","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE ECTODOMAIN","10.1016/J.CELREP.2020.108016 ",4.7,0,"7cn9_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(282_B_)",179.466,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo31","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",51.3627,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo32","DGalpa1-6DGalpb1-C35O5","DGD(520_C_)-DGD(520_C_)",47.2236,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",59.6332,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",43.5214,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo34","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",49.4332,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",53.6995,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo35","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",58.0177,"","",""
"7COU","STRUCTURE OF CYANOBACTERIAL PHOTOSYSTEM II IN THE DARK S1 STATE","10.1107/S2052252521002177 ",2.25,61.37,"7cou_oligo33","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",56.5909,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",79.6069,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",99.0707,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",93.1876,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",93.1497,"","",""
"7CU5","N-GLYCOSYLATION OF PD-1 AND GLYCOSYLATION DEPENDENT BINDING OF PD-1 SPECIFIC MONOCLONAL ANTIBODY CAMRELIZUMAB","10.15252/EMBR.202051444 ",2.81,50.7,"7cu5_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(49_E_)",89.19,"","",""
"7CU5","N-GLYCOSYLATION OF PD-1 AND GLYCOSYLATION DEPENDENT BINDING OF PD-1 SPECIFIC MONOCLONAL ANTIBODY CAMRELIZUMAB","10.15252/EMBR.202051444 ",2.81,50.7,"7cu5_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(58_E_)",64.1893,"","",""
"7CU5","N-GLYCOSYLATION OF PD-1 AND GLYCOSYLATION DEPENDENT BINDING OF PD-1 SPECIFIC MONOCLONAL ANTIBODY CAMRELIZUMAB","10.15252/EMBR.202051444 ",2.81,50.7,"7cu5_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)",89.8528,"","",""
"7CU5","N-GLYCOSYLATION OF PD-1 AND GLYCOSYLATION DEPENDENT BINDING OF PD-1 SPECIFIC MONOCLONAL ANTIBODY CAMRELIZUMAB","10.15252/EMBR.202051444 ",2.81,50.7,"7cu5_oligo3","DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(58_Q_)",63.316,"","",""
"7CYC","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.21,0,"7cyc_oligo9","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(62_C_)",294.269,"","",""
"7CYC","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.21,0,"7cyc_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(62_B_)",294.269,"","",""
"7CYC","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.21,0,"7cyc_oligo8","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(62_A_)",294.269,"","",""
"7CYD","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.55,0,"7cyd_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(62_A_)",318.988,"","",""
"7CYD","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.55,0,"7cyd_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(62_C_)",318.988,"","",""
"7CYD","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.55,0,"7cyd_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(62_B_)",318.988,"","",""
"7CYM","CRYSTAL STRUCTURE OF LI-CADHERIN EC1-4","10.1016/J.JBC.2021.101054 ",2.7,75.28,"7cym_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(250_B_)",90.7609,"","",""
"7CYM","CRYSTAL STRUCTURE OF LI-CADHERIN EC1-4","10.1016/J.JBC.2021.101054 ",2.7,75.28,"7cym_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(250_A_)",111.392,"","",""
"7CYV","CRYSTAL STRUCTURE OF FD20, A NEUTRALIZING SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD)","10.15252/EMMM.202114544 ",3.13,61.91,"7cyv_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_A_)-[BMA(3_A_)-NAG(2_A_)]-[FUC(4_A_)]-NAG(1_A_)",84.2282,"","",""
"7CZF","CRYSTAL STRUCTURE OF KAPOSI SARCOMA ASSOCIATED HERPESVIRUS (KSHV ) GHGL IN COMPLEX WITH THE LIGAND BINDING DOMIAN (LBD) OF EPHA2","10.1038/S41467-020-19617-9 ",3.2,64.67,"7czf_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(54_B_)",124.685,"","",""
"7CZF","CRYSTAL STRUCTURE OF KAPOSI SARCOMA ASSOCIATED HERPESVIRUS (KSHV ) GHGL IN COMPLEX WITH THE LIGAND BINDING DOMIAN (LBD) OF EPHA2","10.1038/S41467-020-19617-9 ",3.2,64.67,"7czf_oligo2","DManpa1-4DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(4_S_)-MAN(3_S_)-NAG(2_S_)]-[FUC(5_S_)]-NAG(1_S_)-ASN(54_E_)",131.373,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo11","DGalpa1-6DGalpb1-C30O5","DGD(5411_a_)-DGD(5411_a_)",71.5764,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo30","DGalpa1-6DGalpb1-C20O5","DGD(518_C_)-DGD(518_C_)",76.225,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo5","DGalpa1-6DGalpb1-C27O5","DGD(5102_h_)-DGD(5102_h_)",69.8109,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo13","DGalpa1-6DGalpb1-C26O5","DGD(5515_c_)-DGD(5515_c_)",85.01,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo31","DGalpa1-6DGalpb1-C30O5","DGD(519_C_)-DGD(519_C_)",56.6191,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo14","DGalpa1-6DGalpb1-C20O5","DGD(5516_c_)-DGD(5516_c_)",76.7418,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo10","DGalpa1-6DGalpb1-C27O5","DGD(102_H_)-DGD(102_H_)",73.8509,"","",""
"7CZL","STRUCTURAL INSIGHTS INTO A DIMERIC PSB27-PHOTOSYSTEM II COMPLEX FROM A CYANOBACTERIUM THERMOSYNECHOCOCCUS VULCANUS","10.1073/PNAS.2018053118 ",3.78,3220.21,"7czl_oligo26","DGalpa1-6DGalpb1-C26O5","DGD(517_C_)-DGD(517_C_)",77.7309,"","",""
"7D0J","PHOTOSYSTEM I-LHCI-LHCII OF CHLAMYDOMONAS REINHARDTII","10.1038/S41467-021-21362-6 ",3.42,"1.08527e-19","7d0j_oligo7","DGalpa1-6DGalpb1-C30O5","DGD(848_B_)-DGD(848_B_)",63.96,"","",""
"7D0J","PHOTOSYSTEM I-LHCI-LHCII OF CHLAMYDOMONAS REINHARDTII","10.1038/S41467-021-21362-6 ",3.42,"1.08527e-19","7d0j_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(846_B_)-DGD(846_B_)",67.25,"","",""
"7D0V","CRYSTAL STRUCTURE OF TAIWAN COBRA 5'-NUCLEOTIDASE","",2.18,35.08,"7d0v_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(333_A_)",61.2295,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",23.0291,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(101_h_)-DGD(101_h_)",20.94,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo18","DGalpa1-6DGalpb1-C35O5","DGD(101_H_)-DGD(101_H_)",20.94,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",19.145,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",17.9286,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",19.145,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",23.0291,"","",""
"7D1T","CRYO-EM STRUCTURE OF PSII AT 1.95 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",1.95,"1.08527e-19","7d1t_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",17.9286,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo34","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",23.4582,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo31","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",18.9027,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo33","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",18.5327,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",18.45,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",23.5364,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",18.6014,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo32","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",19.7936,"","",""
"7D1U","CRYO-EM STRUCTURE OF PSII AT 2.08 ANGSTROM RESOLUTION","10.1038/S42003-021-01919-3 ",2.08,"1.08527e-19","7d1u_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",19.7373,"","",""
"7D2Z","STRUCTURE OF SYBODY SR31 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD)","10.1371/JOURNAL.PPAT.1009328 ",1.97,49.49,"7d2z_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(343_B_)",85.1643,"","",""
"7D30","STRUCTURE OF SYBODY MR17-SR31 FUSION IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD)","10.1371/JOURNAL.PPAT.1009328 ",2.1,50.52,"7d30_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-[FUC(5_C_)]-NAG(1_C_)-ASN(343_B_)",80.7715,"","",""
"7D3E","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN LOW-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.8,"1.08527e-19","7d3e_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_D_)",92.4529,"","",""
"7D3E","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN LOW-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.8,"1.08527e-19","7d3e_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(109_B_)",92.0688,"","",""
"7D3F","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN HIGH-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.3,"1.08527e-19","7d3f_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(109_B_)",53.1484,"","",""
"7D3F","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN HIGH-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.3,"1.08527e-19","7d3f_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_D_)",54.0505,"","",""
"7D4B","CRYSTAL STRUCTURE OF 4-1BB IN COMPLEX WITH A VHH","10.1136/JITC-2020-002131 ",3.14,90.05,"7d4b_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(138_A_)",159.745,"","",""
"7D4B","CRYSTAL STRUCTURE OF 4-1BB IN COMPLEX WITH A VHH","10.1136/JITC-2020-002131 ",3.14,90.05,"7d4b_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(149_A_)",161.866,"","",""
"7D8X","CRYOEM STRUCTURE OF HUMAN GAMMA-SECRETASE IN COMPLEX WITH E2012 AND L685458","10.1016/J.CELL.2020.11.049 ",2.6,"1.08527e-19","7d8x_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",51.2158,"","",""
"7D9O","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH COMPOUND 2","10.1021/ACS.JMEDCHEM.0C01863 ",2.45,38.55,"7d9o_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",51.0312,"","",""
"7D9O","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH COMPOUND 2","10.1021/ACS.JMEDCHEM.0C01863 ",2.45,38.55,"7d9o_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",45.4088,"","",""
"7D9P","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH COMPOUND 12","10.1021/ACS.JMEDCHEM.0C01863 ",2.85,46.6,"7d9p_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",62.9106,"","",""
"7D9P","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH COMPOUND 12","10.1021/ACS.JMEDCHEM.0C01863 ",2.85,46.6,"7d9p_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",67.247,"","",""
"7D9Q","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH COMPOUND 7","10.1021/ACS.JMEDCHEM.0C01863 ",2.66,42.68,"7d9q_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",52.5203,"","",""
"7D9Q","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH COMPOUND 7","10.1021/ACS.JMEDCHEM.0C01863 ",2.66,42.68,"7d9q_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",56.8727,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_E_)-[MAN(3_E_)]-MAN(2_E_)-[MAN(5_E_)]-BMA(1_E_)",10.3211,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_F_)-[MAN(3_F_)]-MAN(2_F_)-[MAN(5_F_)]-BMA(1_F_)",20.0651,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-[MAN(5_C_)]-BMA(1_C_)",12.1253,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-[MAN(5_D_)]-BMA(1_D_)",11.9224,"","",""
"7DE5","CRYSTAL STRUCTURE OF YAK LACTOPEROXIDASE AT 1.55 A RESOLUTION.","10.1007/S10930-020-09957-2 ",1.55,19.58,"7de5_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(205_A_)",26.693,"","",""
"7DED","MEVO LECTIN COMPLEX WITH MANNOHEPTOSE (MAN7)","10.1093/GLYCOB/CWAB022 ",2.23,19.84,"7ded_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-ROH","MAN(6_I_)-MAN(5_I_)-[MAN(4_I_)-MAN(3_I_)-MAN(2_I_)]-MAN(1_I_)",37.3214,"","",""
"7DED","MEVO LECTIN COMPLEX WITH MANNOHEPTOSE (MAN7)","10.1093/GLYCOB/CWAB022 ",2.23,19.84,"7ded_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-ROH","MAN(6_J_)-MAN(5_J_)-[MAN(4_J_)-MAN(3_J_)-MAN(2_J_)]-MAN(1_J_)",34.8562,"","",""
"7DED","MEVO LECTIN COMPLEX WITH MANNOHEPTOSE (MAN7)","10.1093/GLYCOB/CWAB022 ",2.23,19.84,"7ded_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-ROH","MAN(6_H_)-MAN(5_H_)-[MAN(4_H_)-MAN(3_H_)-MAN(2_H_)]-MAN(1_H_)",31.0248,"","",""
"7DKZ","STRUCTURE OF PLANT PHOTOSYSTEM I-LIGHT HARVESTING COMPLEX I SUPERCOMPLEX","10.1111/JIPB.13095 ",2.39,101.2,"7dkz_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",98.4623,"","",""
"7DKZ","STRUCTURE OF PLANT PHOTOSYSTEM I-LIGHT HARVESTING COMPLEX I SUPERCOMPLEX","10.1111/JIPB.13095 ",2.39,101.2,"7dkz_oligo5","DGalpa1-6DGalpb1-C33O5","DGD(323_4_)-DGD(323_4_)",113.299,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(546_A_)",230.447,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(546_C_)",221.167,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo5","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(53_A_)",227.541,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(53_C_)",225.217,"","",""
"7DPM","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB","10.1080/19420862.2021.1953683 ",3.3,95.11,"7dpm_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(343_C_)",102.202,"","",""
"7DRC","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1 IN COMPLEX WITH XYLOGLUCANASE XEG1 AND BAK1","10.1038/S41586-022-05214-X ",2.92,865621,"7drc_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(562_C_)",85.8325,"","",""
"7DRC","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1 IN COMPLEX WITH XYLOGLUCANASE XEG1 AND BAK1","10.1038/S41586-022-05214-X ",2.92,865621,"7drc_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(143_C_)",75.0117,"","",""
"7DXA","PSII INTERMEDIATE PSB28-RC47","10.1038/S41477-021-00961-7 ",3.14,"1.08527e-19","7dxa_oligo6","DGalpa1-6DGalpb1-C27O5","DGD(412_d_)-DGD(412_d_)",24.53,"","",""
"7DXH","CRYO-EM STRUCTURE OF PSII INTERMEDIATE PSB28-PSII COMPLEX","10.1038/S41477-021-00961-7 ",3.14,"1.08527e-19","7dxh_oligo11","DGalpa1-6DGalpb1-C30O5","DGD(406_a_)-DGD(406_a_)",59.78,"","",""
"7DXH","CRYO-EM STRUCTURE OF PSII INTERMEDIATE PSB28-PSII COMPLEX","10.1038/S41477-021-00961-7 ",3.14,"1.08527e-19","7dxh_oligo8","DGalpa1-6DGalpb1-C20O5","DGD(517_c_)-DGD(517_c_)",59.47,"","",""
"7DXH","CRYO-EM STRUCTURE OF PSII INTERMEDIATE PSB28-PSII COMPLEX","10.1038/S41477-021-00961-7 ",3.14,"1.08527e-19","7dxh_oligo13","DGalpa1-6DGalpb1-C27O5","DGD(104_h_)-DGD(104_h_)",14.49,"","",""
"7DXH","CRYO-EM STRUCTURE OF PSII INTERMEDIATE PSB28-PSII COMPLEX","10.1038/S41477-021-00961-7 ",3.14,"1.08527e-19","7dxh_oligo10","DGalpa1-6DGalpb1-C26O5","DGD(516_c_)-DGD(516_c_)",29.76,"","",""
"7DZ7","STATE TRANSITION SUPERCOMPLEX PSI-LHCI-LHCII FROM DOUBLE PHOSPHATASE MUTANT PPH1;PBCP OF GREEN ALGA CHLAMYDOMONAS REINHARDTII","10.1038/S41477-021-00960-8 ",2.84,"1.35632e-19","7dz7_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(850_B_)-DGD(850_B_)",29.08,"","",""
"7DZ8","STATE TRANSITION SUPERCOMPLEX PSI-LHCI-LHCII FROM THE LHCBM1 LACKING MUTANT OF CHLAMYDOMONAS REINHARDTII","10.1038/S41477-021-00960-8 ",3.16,"1.35632e-19","7dz8_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(850_B_)-DGD(850_B_)",24.54,"","",""
"7E3D","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE","10.1016/J.IJBIOMAC.2022.05.009 ",2.5,36.74,"7e3d_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",87.3558,"","",""
"7E3D","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE","10.1016/J.IJBIOMAC.2022.05.009 ",2.5,36.74,"7e3d_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",83.2112,"","",""
"7E3H","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DONEPEZIL","10.1016/J.IJBIOMAC.2022.05.009 ",2.45,41.22,"7e3h_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(350_B_)",87.1721,"","",""
"7E3H","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DONEPEZIL","10.1016/J.IJBIOMAC.2022.05.009 ",2.45,41.22,"7e3h_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",81.2324,"","",""
"7E57","CRYSTAL STRUCTURE OF MURINE GITR-GITRL COMPLEX","10.1016/J.CELREP.2021.109734 ",3.3,0,"7e57_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(134_C_)",82.0452,"","",""
"7E57","CRYSTAL STRUCTURE OF MURINE GITR-GITRL COMPLEX","10.1016/J.CELREP.2021.109734 ",3.3,0,"7e57_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(134_D_)",90.2014,"","",""
"7E7I","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN THE APO STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7i_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1529_A_)",51.898,"","",""
"7E7I","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN THE APO STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7i_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(415_A_)",78.2338,"","",""
"7E7O","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN NRPE-BOUND STATE","10.1038/S41467-021-24194-6 ",3.4,"1.15243e-41","7e7o_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(415_A_)",86.0476,"","",""
"7E7O","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN NRPE-BOUND STATE","10.1038/S41467-021-24194-6 ",3.4,"1.15243e-41","7e7o_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_N_)-[BMA(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1529_A_)",66.4942,"","",""
"7E7Q","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN ATP-BOUND STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7q_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1529_A_)",83.9967,"","",""
"7E7Q","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN ATP-BOUND STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7q_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(415_A_)",100.188,"","",""
"7EAP","CRYSTAL STRUCTURE OF IPEA-XXXG COMPLEX","10.1002/1873-3468.14427 ",1.42,20.21,"7eap_oligo1","DXylpa1-6DGlcpb1-4[DXylpa1-6]DGlcpb1-4[DXylpa1-6]DGlcpb1-4DGlcpb1-ROH","XYS(7_B_)-[XYS(6_B_)-[XYS(5_B_)-BGC(4_B_)]-BGC(3_B_)]-BGC(2_B_)-BGC(1_B_)",48.4775,"","",""
"7EAP","CRYSTAL STRUCTURE OF IPEA-XXXG COMPLEX","10.1002/1873-3468.14427 ",1.42,20.21,"7eap_oligo2","DXylpa1-6DGlcpb1-ROH","XYS(2_C_)-BGC(1_C_)",34.7582,"","",""
"7EDA","STRUCTURE OF MONOMERIC PHOTOSYSTEM II","10.1016/J.BBABIO.2021.148471 ",2.78,"1.35632e-19","7eda_oligo7","DGalpa1-6DGalpb1-C23O5","DGD(518_C_)-DGD(518_C_)",18.87,"","",""
"7EDA","STRUCTURE OF MONOMERIC PHOTOSYSTEM II","10.1016/J.BBABIO.2021.148471 ",2.78,"1.35632e-19","7eda_oligo3","DGalpa1-6DGalpb1-C22O5","DGD(517_C_)-DGD(517_C_)",18.42,"","",""
"7EDA","STRUCTURE OF MONOMERIC PHOTOSYSTEM II","10.1016/J.BBABIO.2021.148471 ",2.78,"1.35632e-19","7eda_oligo2","DGalpa1-6DGalpb1-C14O5","DGD(516_C_)-DGD(516_C_)",17.83,"","",""
"7EDA","STRUCTURE OF MONOMERIC PHOTOSYSTEM II","10.1016/J.BBABIO.2021.148471 ",2.78,"1.35632e-19","7eda_oligo8","DGalpa1-6DGalpb1-C23O5","DGD(102_H_)-DGD(102_H_)",17.46,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo15","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_c_)-[BMA(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)",123.991,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo11","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_Y_)-[BMA(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(502_H_)",101.864,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo12","DManpb1-3[DManpb1-6]DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(6_Z_)-[BMA(5_Z_)]-BMA(4_Z_)-[BMA(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)",71.1831,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo1","DManpb1-2DManpb1-3[DManpb1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_O_)-BMA(6_O_)-[BMA(5_O_)-BMA(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(90_E_)",79.3492,"","",""
"7EEE","COMPLEX STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 12 BETA-1,3-1,4- GLUCANASE WITH GENTIOBIOSE","10.1016/J.JSB.2021.107774 ",1.66,24.89,"7eee_oligo1","DManpb1-6DManpb1-ROH","BMA(2_B_)-BMA(1_B_)",34.4332,"","",""
"7EOX","PROTEASE STRUCTURE FROM EUPHORBIA RESINIFERA","10.1002/BAB.2307 ",1.7,26.67,"7eox_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(121_B_)",34.8843,"","",""
"7EW6","BARLEY PHOTOSYSTEM I-LHCI-LHCA5 SUPERCOMPLEX","10.1038/S41586-021-04277-6 ",3.4,"2.23631e+08","7ew6_oligo5","DGalpa1-6DGalpb1-C39O5","DGD(103_J_)-DGD(103_J_)",97.81,"","",""
"7EW6","BARLEY PHOTOSYSTEM I-LHCI-LHCA5 SUPERCOMPLEX","10.1038/S41586-021-04277-6 ",3.4,"2.23631e+08","7ew6_oligo4","DGalpa1-6DGalpb1-C32O5","DGD(850_B_)-DGD(850_B_)",73.05,"","",""
"7EWK","BARLEY PHOTOSYSTEM I-LHCI-LHCA6 SUPERCOMPLEX","10.1038/S41586-021-04277-6 ",3.88,"1.35632e-19","7ewk_oligo1","DGalpa1-6DGalpb1-C39O5","DGD(104_J_)-DGD(104_J_)",140.99,"","",""
"7EWK","BARLEY PHOTOSYSTEM I-LHCI-LHCA6 SUPERCOMPLEX","10.1038/S41586-021-04277-6 ",3.88,"1.35632e-19","7ewk_oligo2","DGalpa1-6DGalpb1-C25O5","DGD(851_B_)-DGD(851_B_)",96.06,"","",""
"7EXR","CRYSTAL STRUCTURE OF ALKALINE ALPHA-GALACTOSIDASE D383A MUTANT FROM ARABIDOPSIS THALIANA COMPLEXED WITH STACHYOSE.","10.1107/S2059798323000037 ",2,42.68,"7exr_oligo1","DGalpa1-6DGalpa1-6DGlcpa1-C6O6","GLA(4_C_)-ZCD(3_C_)-GLC(2_C_)-TTV(1_C_)",55.8167,"","",""
"7EXR","CRYSTAL STRUCTURE OF ALKALINE ALPHA-GALACTOSIDASE D383A MUTANT FROM ARABIDOPSIS THALIANA COMPLEXED WITH STACHYOSE.","10.1107/S2059798323000037 ",2,42.68,"7exr_oligo2","DGalpa1-6DGalpa1-6DGlcpa1-C6O6","GLA(4_D_)-ZCD(3_D_)-GLC(2_D_)-TTV(1_D_)",38.5642,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo4","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_G_)-BMA(4_G_)-[MAN(6_G_)]-MAN(3_G_)-[MAN(8_G_)-MAN(7_G_)]-BMA(2_G_)-NAG(1_G_)",43.8794,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo1","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(2_E_)-NAG(1_E_)",50.9472,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo6","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-ROH","MAN(4_J_)-MAN(3_J_)-BMA(2_J_)-NAG(1_J_)",57.9889,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo31","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_W_)-MAN(6_W_)-[MAN(5_W_)-BMA(4_W_)]-BMA(3_W_)-NAG(2_W_)",41.5661,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo17","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_N_)-MAN(6_N_)-[MAN(5_N_)-BMA(4_N_)]-BMA(3_N_)-NAG(2_N_)",46.8612,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo26","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_T_)-MAN(6_T_)-[MAN(5_T_)-BMA(4_T_)]-BMA(3_T_)-NAG(2_T_)",42.4547,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo21","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(6_Q_)-MAN(5_Q_)-[MAN(4_Q_)-BMA(3_Q_)]-BMA(2_Q_)-NAG(1_Q_)",46.1589,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo5","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)",46.2948,"","",""
"7F5G","THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL4 (SA4)","10.1016/J.IJBIOMAC.2022.04.096 ",1.75,29.19,"7f5g_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[NAG(3_F_)]-[FUC(2_F_)]-NAG(1_F_)-ASN(343_C_)",69.0868,"","",""
"7F5G","THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL4 (SA4)","10.1016/J.IJBIOMAC.2022.04.096 ",1.75,29.19,"7f5g_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(343_A_)",74.7264,"","",""
"7F5H","THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL28 (SC4)","10.3389/FMICB.2022.875840 ",3,90.63,"7f5h_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(343_B_)",184.534,"","",""
"7F5H","THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL28 (SC4)","10.3389/FMICB.2022.875840 ",3,90.63,"7f5h_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(343_A_)",188.026,"","",""
"7F5J","A MUTANT OF AN ENZYME FROM VIOLA YEDOENSIS","10.1093/PLCELL/KOAC281 ",1.59,37.91,"7f5j_oligo1","LFucpa1-6DGlcpNAcx1-","FUC(2_C_)-NAG(1_C_)",54.5915,"","",""
"7F5P","A MUTANT OF AN ENZYME FROM VIOLA YEDOENSIS","10.1093/PLCELL/KOAC281 ",1.9,72.89,"7f5p_oligo5","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)",163.025,"","",""
"7F5R","CRYSTAL STRUCTURE OF SARS-COV-2 Y453F-RBD BOUND TO MINK ACE2","",3.01,65.55,"7f5r_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(216_A_)",92.7705,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpb1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_I_)-[MAN(7_I_)]-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(272_C_)",67.6513,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo9","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(2_E_)-NAG(1_E_)",55.8041,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo12","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-ROH","MAN(6_G_)-BMA(5_G_)-[MAN(7_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)",52.6286,"","",""
"7FA0","AN ENZYME MUTANT FROM VIOLA YEDOENSIS","10.1093/PLCELL/KOAC281 ",1.8,33.24,"7fa0_oligo1","LFucpa1-6DGlcpNAcx1-","FUC(2_C_)-NAG(1_C_)",51.2721,"","",""
"7FBK","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN N501Y MUTANT IN COMPLEX WITH NEUTRALIZING NANOBODY 20G6","10.1002/SMTD.202200387 ",1.9,50.55,"7fbk_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(343_B_)",78.3351,"","",""
"7FBK","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN N501Y MUTANT IN COMPLEX WITH NEUTRALIZING NANOBODY 20G6","10.1002/SMTD.202200387 ",1.9,50.55,"7fbk_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(343_A_)",91.9452,"","",""
"7FC3","STRUCTURE OF NL63 RECEPTOR-BINDING DOMAIN COMPLEXED WITH HORSE ACE2","10.1016/J.STR.2022.07.005 ",3.19,62.32,"7fc3_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(322_A_)",89.6014,"","",""
"7FD2","CRYO-EM STRUCTURE OF AN ALPHAVIRUS, GETAH VIRUS","10.1038/S41421-022-00374-6 ",2.81,0,"7fd2_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_B_)",35.8305,"","",""
"7FD2","CRYO-EM STRUCTURE OF AN ALPHAVIRUS, GETAH VIRUS","10.1038/S41421-022-00374-6 ",2.81,0,"7fd2_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_N_)",29.1816,"","",""
"7FD2","CRYO-EM STRUCTURE OF AN ALPHAVIRUS, GETAH VIRUS","10.1038/S41421-022-00374-6 ",2.81,0,"7fd2_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_J_)",31.7093,"","",""
"7FD2","CRYO-EM STRUCTURE OF AN ALPHAVIRUS, GETAH VIRUS","10.1038/S41421-022-00374-6 ",2.81,0,"7fd2_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_F_)",31.8409,"","",""
"7FH1","STRUCTURE OF THE HUMAN MECKELIN","10.1126/SCIADV.ABJ9748 ",3.34,0,"7fh1_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",56.7076,"","",""
"7FH1","STRUCTURE OF THE HUMAN MECKELIN","10.1126/SCIADV.ABJ9748 ",3.34,0,"7fh1_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",56.7076,"","",""
"7FJC","CRYSTAL STRUCTURE OF SARS-COV-2 BETA RBD COMPLEXED WITH P36-5D2 FAB","",2.96,86.79,"7fjc_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(343_E_)",91.2145,"","",""
"7JG2","SECRETORY IMMUNOGLOBIN A (SIGA)","10.7554/ELIFE.56098 ",3.3,"1.35632e-19","7jg2_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(72_E_)",75.5529,"","",""
"7JGZ","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE","10.7554/ELIFE.72416 ",3.51,101.2,"7jgz_oligo1","DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(236_A_)",118.444,"","",""
"7JGZ","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE","10.7554/ELIFE.72416 ",3.51,101.2,"7jgz_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(247_A_)",128.249,"","",""
"7JHI","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 IODIDE- DERIVATIVE","10.1074/JBC.RA120.015306 ",2.5,30.66,"7jhi_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(219_C_)",47.2907,"","",""
"7JHK","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 IN UNLIGANDED FORM","10.1074/JBC.RA120.015306 ",2.34,37.64,"7jhk_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(219_B_)",55.6307,"","",""
"7JHK","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 IN UNLIGANDED FORM","10.1074/JBC.RA120.015306 ",2.34,37.64,"7jhk_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(219_D_)",60.5251,"","",""
"7JHL","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP-N-ACETYLGLUCOSAMINE","10.1074/JBC.RA120.015306 ",2.26,39.08,"7jhl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_B_)",63.2807,"","",""
"7JHL","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP-N-ACETYLGLUCOSAMINE","10.1074/JBC.RA120.015306 ",2.26,39.08,"7jhl_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(219_A_)",56.3267,"","",""
"7JHM","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH N- ACETYL-LACTOSAMINE","10.1074/JBC.RA120.015306 ",2.19,42.35,"7jhm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(219_A_)",58.2536,"","",""
"7JHM","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH N- ACETYL-LACTOSAMINE","10.1074/JBC.RA120.015306 ",2.19,42.35,"7jhm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_B_)",68.9073,"","",""
"7JHN","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP AND TRISACCHARIDE GLCNAC-BETA1-3GAL-BETA1-4GLCNAC","10.1074/JBC.RA120.015306 ",2.2,38.95,"7jhn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(219_A_)",66.5064,"","",""
"7JHO","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP","10.1074/JBC.RA120.015306 ",1.85,25.48,"7jho_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_A_)",40.2611,"","",""
"7JHO","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP","10.1074/JBC.RA120.015306 ",1.85,25.48,"7jho_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(219_B_)",41.1384,"","",""
"7JHO","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP","10.1074/JBC.RA120.015306 ",1.85,25.48,"7jho_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(173_A_)",53.9314,"","",""
"7JIK","HUMAN RECOMBINANT BETA-2-GLYCOPROTEIN 1","",2.69,89.69,"7jik_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(174_A_)",129.21,"","",""
"7JIK","HUMAN RECOMBINANT BETA-2-GLYCOPROTEIN 1","",2.69,89.69,"7jik_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(234_A_)",137.92,"","",""
"7JM7","STRUCTURE OF HUMAN CLC-7/OSTM1 COMPLEX","10.7554/ELIFE.59555 ",2.82,"1.08527e-19","7jm7_oligo4","DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",57.4536,"","",""
"7JM7","STRUCTURE OF HUMAN CLC-7/OSTM1 COMPLEX","10.7554/ELIFE.59555 ",2.82,"1.08527e-19","7jm7_oligo9","DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",58.4259,"","",""
"7JPH","CRYSTAL STRUCTURE OF EBOV GLYCOPROTEIN WITH MODIFIED HR1C AND HR2 STALK AT 3.2 A RESOLUTION","10.1038/S41467-021-22867-W ",3.2,93.62,"7jph_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",103.019,"","",""
"7JPI","CRYSTAL STRUCTURE OF EBOV GLYCOPROTEIN WITH MODIFIED HR2 STALK AT 2.3A RESOLUTION","10.1038/S41467-021-22867-W ",2.28,58.37,"7jpi_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",86.335,"","",""
"7JZM","SARS-COV-2 SPIKE IN COMPLEX WITH LCB3 (LOCAL REFINEMENT OF THE RBD AND LCB3)","10.1126/SCIENCE.ABD9909 ",3.5,524802,"7jzm_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_B_)",42.5658,"","",""
"7JZU","SARS-COV-2 SPIKE IN COMPLEX WITH LCB1 (LOCAL REFINEMENT OF THE RBD AND LCB1)","10.1126/SCIENCE.ABD9909 ",3.1,"1.08527e-19","7jzu_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_B_)",24.3712,"","",""
"7K1S","THE N-TERMINUS OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN B HAS A FUNCTIONAL ROLE IN FUSION.","10.1371/JOURNAL.PPAT.1008961 ",3.9,0,"7k1s_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(257_C_)",78.0009,"","",""
"7K1S","THE N-TERMINUS OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN B HAS A FUNCTIONAL ROLE IN FUSION.","10.1371/JOURNAL.PPAT.1008961 ",3.9,0,"7k1s_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(257_A_)",71.7453,"","",""
"7K1S","THE N-TERMINUS OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN B HAS A FUNCTIONAL ROLE IN FUSION.","10.1371/JOURNAL.PPAT.1008961 ",3.9,0,"7k1s_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(257_B_)",77.6248,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K43","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIENCE.ABE3354 ",2.6,"1.08527e-19","7k43_oligo17","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Z_)-[BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(343_E_)",7.35182,"","",""
"7K43","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIENCE.ABE3354 ",2.6,"1.08527e-19","7k43_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_A_)",7.35182,"","",""
"7K43","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIENCE.ABE3354 ",2.6,"1.08527e-19","7k43_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_B_)",7.35182,"","",""
"7K4O","TANNIN ACYL HYDROLASE FROM ASPERGILLUS NIGER","10.1107/S2059798320016484 ",1.65,30.72,"7k4o_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(79_A_)",58.5002,"","",""
"7K4O","TANNIN ACYL HYDROLASE FROM ASPERGILLUS NIGER","10.1107/S2059798320016484 ",1.65,30.72,"7k4o_oligo1","DManpa1-2DManpa1-6[DRhapa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(519_A_)",55.4916,"","",""
"7K66","STRUCTURE OF BLOOD COAGULATION FACTOR VIII IN COMPLEX WITH AN ANTI-C1 DOMAIN PATHOGENIC ANTIBODY INHIBITOR","10.1182/BLOOD.2020008940 ",3.92,148.5,"7k66_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(2118_A_)",178.032,"","",""
"7K8Z","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135","10.1038/S41586-020-2852-1 ",3.5,2050.01,"7k8z_oligo15","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(343_C_)",161.493,"","",""
"7K8Z","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135","10.1038/S41586-020-2852-1 ",3.5,2050.01,"7k8z_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_A_)",174.233,"","",""
"7K9H","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3.2,2050.01,"7k9h_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(717_B_)",102.114,"","",""
"7K9H","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3.2,2050.01,"7k9h_oligo33","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_n_)-NAG(1_n_)-ASN(603_C_)",110.689,"","",""
"7K9H","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3.2,2050.01,"7k9h_oligo37","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(717_C_)",104.475,"","",""
"7K9H","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3.2,2050.01,"7k9h_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(717_A_)",105.056,"","",""
"7K9H","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3.2,2050.01,"7k9h_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(603_A_)",110.02,"","",""
"7K9H","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2B04 (ONE UP, TWO DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3.2,2050.01,"7k9h_oligo21","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_b_)-NAG(1_b_)-ASN(603_B_)",109.937,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo24","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(717_B_)",118.052,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(717_A_)",117.633,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo20","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_c_)-NAG(1_c_)-ASN(603_B_)",154.98,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo38","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_u_)-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(717_C_)",117.315,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo33","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_p_)-[BMA(3_p_)-NAG(2_p_)]-NAG(1_p_)-ASN(343_C_)",156.365,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo34","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_q_)-NAG(1_q_)-ASN(603_C_)",154.141,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo16","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_A_)",160.888,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo19","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_b_)-[BMA(3_b_)-NAG(2_b_)]-NAG(1_b_)-ASN(343_B_)",151.595,"","",""
"7K9J","SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING FAB 2H04 (THREE DOWN CONFORMATION)","10.1016/J.CELREP.2021.109881 ",3,2050.01,"7k9j_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(603_A_)",152.401,"","",""
"7K9K","SARS-COV-2 SPIKE RBD IN COMPLEX WITH NEUTRALIZING FAB 2H04 (LOCAL REFINEMENT)","10.1016/J.CELREP.2021.109881 ",3.14,"5.50295e+11","7k9k_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",75.6423,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(165_G_)",102.047,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(38_C_)",123.048,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(246_A_)",114.094,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(246_G_)",114.99,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(38_G_)",125.914,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(165_C_)",99.792,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(38_A_)",121.149,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(246_C_)",116.46,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",102.764,"","",""
"7KC4","HUMAN WLS IN COMPLEX WITH WNT8A","10.1016/J.CELL.2020.11.038 ",3.19,"1.35632e-19","7kc4_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(103_D_)",62.9036,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_K_)-[NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(297_E_)",82.9721,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",78.367,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_D_)",80.854,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(45_F_)",93.0668,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",66.2085,"","",""
"7KD6","INSULIN RECEPTOR L1-CR PLUS ALPHACT FRAGMENT IN CO-COMPLEX WITH FV 83- 7 AND SINGLE-CHAIN INSULIN SCI-B","10.1016/J.BPJ.2022.09.038 ",2.6,87.37,"7kd6_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_1_)-[BMA(3_1_)-NAG(2_1_)]-NAG(1_1_)-ASN(16_E_)",126.88,"","",""
"7KD6","INSULIN RECEPTOR L1-CR PLUS ALPHACT FRAGMENT IN CO-COMPLEX WITH FV 83- 7 AND SINGLE-CHAIN INSULIN SCI-B","10.1016/J.BPJ.2022.09.038 ",2.6,87.37,"7kd6_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Z_)-[BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(255_W_)",129.383,"","",""
"7KD6","INSULIN RECEPTOR L1-CR PLUS ALPHACT FRAGMENT IN CO-COMPLEX WITH FV 83- 7 AND SINGLE-CHAIN INSULIN SCI-B","10.1016/J.BPJ.2022.09.038 ",2.6,87.37,"7kd6_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(255_K_)",108.676,"","",""
"7KD6","INSULIN RECEPTOR L1-CR PLUS ALPHACT FRAGMENT IN CO-COMPLEX WITH FV 83- 7 AND SINGLE-CHAIN INSULIN SCI-B","10.1016/J.BPJ.2022.09.038 ",2.6,87.37,"7kd6_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(25_E_)",132.917,"","",""
"7KD6","INSULIN RECEPTOR L1-CR PLUS ALPHACT FRAGMENT IN CO-COMPLEX WITH FV 83- 7 AND SINGLE-CHAIN INSULIN SCI-B","10.1016/J.BPJ.2022.09.038 ",2.6,87.37,"7kd6_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(255_E_)",101.133,"","",""
"7KD6","INSULIN RECEPTOR L1-CR PLUS ALPHACT FRAGMENT IN CO-COMPLEX WITH FV 83- 7 AND SINGLE-CHAIN INSULIN SCI-B","10.1016/J.BPJ.2022.09.038 ",2.6,87.37,"7kd6_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Y_)-[BMA(3_Y_)-NAG(2_Y_)]-NAG(1_Y_)-ASN(255_Q_)",114.739,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_W_)-[MAN(8_W_)]-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(234_E_)",62.951,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(276_G_)",77.2333,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(637_B_)",35.9661,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo18","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_j_)-[MAN(7_j_)]-MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(234_G_)",53.2753,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",83.0309,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(332_G_)",60.4424,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(156_G_)",88.7475,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(637_A_)",52.5475,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(332_E_)",71.531,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-[MAN(6_f_)-MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_F_)",70.2755,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo8","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(234_F_)",62.1509,"","",""
"7KEI","DQA1*01:02/DQB1*06:02 IN COMPLEX WITH A HEMAGGLUTININ PEPTIDE FROM THE H1N1 PANDEMIC FLU VIRUS.","",1.75,21.89,"7kei_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",64.6567,"","",""
"7KEJ","BDBV-289 BOUND TO EBOV GPDMUC MAKONA","10.1016/J.CELREP.2021.108984 ",3.8,"1.08527e-19","7kej_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_E_)",72.2302,"","",""
"7KEJ","BDBV-289 BOUND TO EBOV GPDMUC MAKONA","10.1016/J.CELREP.2021.108984 ",3.8,"1.08527e-19","7kej_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_F_)",72.2302,"","",""
"7KEJ","BDBV-289 BOUND TO EBOV GPDMUC MAKONA","10.1016/J.CELREP.2021.108984 ",3.8,"1.08527e-19","7kej_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_D_)",72.2302,"","",""
"7KEW","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-43","10.1016/J.CELREP.2021.108984 ",4.16,"3.35873e+07","7kew_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",122.909,"","",""
"7KEW","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-43","10.1016/J.CELREP.2021.108984 ",4.16,"3.35873e+07","7kew_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",122.909,"","",""
"7KEW","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-43","10.1016/J.CELREP.2021.108984 ",4.16,"3.35873e+07","7kew_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_D_)",122.909,"","",""
"7KEX","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-293","10.1016/J.CELREP.2021.108984 ",4.25,"5.37397e+08","7kex_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_D_)",219.932,"","",""
"7KEX","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-293","10.1016/J.CELREP.2021.108984 ",4.25,"5.37397e+08","7kex_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",219.932,"","",""
"7KEX","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-293","10.1016/J.CELREP.2021.108984 ",4.25,"5.37397e+08","7kex_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",219.932,"","",""
"7KF9","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-296 AND EBOV-515","10.1016/J.CELREP.2021.108984 ",4.4,"5.37397e+08","7kf9_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_E_)",246.137,"","",""
"7KF9","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-296 AND EBOV-515","10.1016/J.CELREP.2021.108984 ",4.4,"5.37397e+08","7kf9_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_D_)",246.137,"","",""
"7KF9","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-296 AND EBOV-515","10.1016/J.CELREP.2021.108984 ",4.4,"5.37397e+08","7kf9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_F_)",246.137,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(257_C_)",179.001,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(257_B_)",179.001,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_E_)",90.586,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_D_)",90.586,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(257_A_)",179.001,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(563_F_)",90.586,"","",""
"7KFE","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-329","10.1016/J.CELREP.2021.108984 ",6.6,"3.35873e+07","7kfe_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(563_D_)",208.957,"","",""
"7KFE","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-329","10.1016/J.CELREP.2021.108984 ",6.6,"3.35873e+07","7kfe_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_F_)",173.646,"","",""
"7KFE","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-329","10.1016/J.CELREP.2021.108984 ",6.6,"3.35873e+07","7kfe_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_E_)",187.963,"","",""
"7KFH","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-437","10.1016/J.CELREP.2021.108984 ",3.8,"5.37397e+08","7kfh_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",98.392,"","",""
"7KFH","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-437","10.1016/J.CELREP.2021.108984 ",3.8,"5.37397e+08","7kfh_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_D_)",98.392,"","",""
"7KFH","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-437","10.1016/J.CELREP.2021.108984 ",3.8,"5.37397e+08","7kfh_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",98.392,"","",""
"7KG4","RECOMBINANT BETA-2-GLYCOPROTEIN I ANTIBODY RECOGNITION LOOP MUTANT","",3.3,91.34,"7kg4_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(174_B_)",129.651,"","",""
"7KG4","RECOMBINANT BETA-2-GLYCOPROTEIN I ANTIBODY RECOGNITION LOOP MUTANT","",3.3,91.34,"7kg4_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(234_A_)",138.793,"","",""
"7KG4","RECOMBINANT BETA-2-GLYCOPROTEIN I ANTIBODY RECOGNITION LOOP MUTANT","",3.3,91.34,"7kg4_oligo3","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(174_A_)",124.189,"","",""
"7KHR","CRYO-EM STRUCTURE OF BAFILOMYCIN A1-BOUND INTACT V-ATPASE FROM BOVINE BRAIN","10.1038/S41467-021-22111-5 ",3.62,"1.35632e-19","7khr_oligo14","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(2_Q_)-MAN(1_Q_)-[GLC(9_t_)-GLC(8_t_)-GLC(7_t_)-MAN(6_t_)-MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)",99.5183,"","",""
"7KI4","STRUCTURE OF THE NIV F GLYCOPROTEIN IN COMPLEX WITH THE 12B2 NEUTRALIZING ANTIBODY","10.1038/S41594-021-00584-8 ",2.9,524802,"7ki4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(67_A_)",23.4574,"","",""
"7KI4","STRUCTURE OF THE NIV F GLYCOPROTEIN IN COMPLEX WITH THE 12B2 NEUTRALIZING ANTIBODY","10.1038/S41594-021-00584-8 ",2.9,524802,"7ki4_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_U_)-[MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(67_E_)",23.4574,"","",""
"7KI4","STRUCTURE OF THE NIV F GLYCOPROTEIN IN COMPLEX WITH THE 12B2 NEUTRALIZING ANTIBODY","10.1038/S41594-021-00584-8 ",2.9,524802,"7ki4_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Q_)-[MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(67_B_)",23.4574,"","",""
"7KLC","CRYSTAL STRUCTURE OF M4H2K1 FAB BOUND TO HIV-1 BG505 GP120 CORE AND TO 17B FAB","10.1128/MBIO.00429-21 ",4.3,169,"7klc_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_A_)",134.133,"","",""
"7KMD","CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22","10.1128/MBIO.00429-21 ",3.39,113.1,"7kmd_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_G_)",161.402,"","",""
"7KMD","CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22","10.1128/MBIO.00429-21 ",3.39,113.1,"7kmd_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(88_G_)",87.3944,"","",""
"7KMD","CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22","10.1128/MBIO.00429-21 ",3.39,113.1,"7kmd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_G_)",115.747,"","",""
"7KN8","CRYSTAL STRUCTURE OF THE GH74 XYLOGLUCANASE FROM XANTHOMONAS CAMPESTRIS (XCC1752)","10.1038/S41467-021-24277-4 ",1.95,19.42,"7kn8_oligo1","DXylpa1-6DGlcpb1-4DGlcpb1-ROH","XYS(3_C_)-BGC(2_C_)-BGC(1_C_)",21.0748,"","",""
"7KN8","CRYSTAL STRUCTURE OF THE GH74 XYLOGLUCANASE FROM XANTHOMONAS CAMPESTRIS (XCC1752)","10.1038/S41467-021-24277-4 ",1.95,19.42,"7kn8_oligo2","DXylpa1-6DGlcpb1-4DGlcpb1-ROH","XYS(3_D_)-BGC(2_D_)-BGC(1_D_)",20.8563,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_F_)",17.8727,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_I_)",29.4727,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_C_)",1,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_M_)",11.5455,"","",""
"7KQH","ANTIBODIES THAT ENGAGE THE HEMAGGLUTININ RECEPTOR-BINDING SITE OF INFLUENZA B VIRUSES","10.1021/ACSINFECDIS.0C00726 ",3.5,180.4,"7kqh_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(145_B_)",247.291,"","",""
"7KRQ","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.44,0,"7krq_oligo31","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_h_)-[NAG(2_h_)]-NAG(1_h_)",97.7893,"","",""
"7KRQ","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.44,0,"7krq_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)",96.8994,"","",""
"7KRQ","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.44,0,"7krq_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)",95.5436,"","",""
"7KRR","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.5,0,"7krr_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)",85.4547,"","",""
"7KRR","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.5,0,"7krr_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)",94.9264,"","",""
"7KRR","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.5,0,"7krr_oligo19","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)",97.184,"","",""
"7KRS","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.2,0,"7krs_oligo22","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)",72.1772,"","",""
"7KRS","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.2,0,"7krs_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)",73.0003,"","",""
"7KRS","STRUCTURAL IMPACT ON SARS-COV-2 SPIKE PROTEIN BY D614G SUBSTITUTION","10.1126/SCIENCE.ABF2303 ",3.2,0,"7krs_oligo34","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_k_)-[NAG(2_k_)]-NAG(1_k_)",68.2306,"","",""
"7KSQ","THE STRUCTURE OF THE MOSS PSI-LHCI REVEALS THE EVOLUTION OF THE LHCI ANTENNA","10.1038/S41477-022-01099-W ",2.8,"1.08527e-19","7ksq_oligo9","DGalpa1-6DGalpb1-C34O5","DGD(5002_B_)-DGD(5002_B_)",29.65,"","",""
"7KUX","THE STRUCTURE OF THE MOSS PSI-LHCI REVEALS THE EVOLUTION OF THE LHCI ANTENNA","10.1038/S41477-022-01099-W ",2.8,"1.08527e-19","7kux_oligo9","DGalpa1-6DGalpb1-C34O5","DGD(5002_B_)-DGD(5002_B_)",29.65,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(63_B_)",186.975,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(63_C_)",190.439,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(63_A_)",174.858,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(170_C_)",228.023,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(170_B_)",219.048,"","",""
"7KZB","POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES","10.1080/19420862.2021.1922134 ",2.83,80.74,"7kzb_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(343_C_)",105.87,"","",""
"7L02","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.2,"1.08527e-19","7l02_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(801_A_)",122.799,"","",""
"7L02","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.2,"1.08527e-19","7l02_oligo13","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(709_C_)",138.591,"","",""
"7L02","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.2,"1.08527e-19","7l02_oligo3","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[BMA(7_F_)]-MAN(4_F_)-[BMA(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(717_A_)",119.197,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",96.9767,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo3","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_N_)-MAN(5_N_)-[BMA(7_N_)]-MAN(4_N_)-[BMA(8_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",91.8477,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",96.9767,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo13","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_X_)-MAN(5_X_)-[BMA(7_X_)]-MAN(4_X_)-[BMA(8_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",91.8477,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",37.0887,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo10","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",120.857,"","",""
"7L09","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT","10.1016/J.CELL.2021.04.042 ",3.1,2050.01,"7l09_oligo13","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(709_C_)",120.37,"","",""
"7L09","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT","10.1016/J.CELL.2021.04.042 ",3.1,2050.01,"7l09_oligo1","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[BMA(7_F_)]-MAN(4_F_)-[BMA(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(717_A_)",91.7264,"","",""
"7L09","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT","10.1016/J.CELL.2021.04.042 ",3.1,2050.01,"7l09_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(801_A_)",96.6767,"","",""
"7L0N","CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY","10.1016/J.CELL.2021.01.037 ",2.78,86.1,"7l0n_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(343_S_)",104.939,"","",""
"7L0N","CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY","10.1016/J.CELL.2021.01.037 ",2.78,86.1,"7l0n_oligo1","DManpb1-6DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_R_)",111.652,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-6DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_P_)-NAG(5_P_)-MAN(4_P_)-[MAN(8_P_)-MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(343_C_)",89.2622,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(343_B_)",97.9957,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_I_)-MAN(7_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(343_A_)",98.394,"","",""
"7L6O","CRYO-EM STRUCTURE OF HIV-1 ENV CH848.3.D0949.10.17CHIM.6R.DS.SOSIP.664","10.1016/J.CELL.2021.04.042 ",3.9,"1.15243e-41","7l6o_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_c_)",100.401,"","",""
"7L6O","CRYO-EM STRUCTURE OF HIV-1 ENV CH848.3.D0949.10.17CHIM.6R.DS.SOSIP.664","10.1016/J.CELL.2021.04.042 ",3.9,"1.15243e-41","7l6o_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_a_)",103.748,"","",""
"7L6O","CRYO-EM STRUCTURE OF HIV-1 ENV CH848.3.D0949.10.17CHIM.6R.DS.SOSIP.664","10.1016/J.CELL.2021.04.042 ",3.9,"1.15243e-41","7l6o_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_e_)",99.2009,"","",""
"7L7T","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT A)","10.1038/S41467-021-25087-4 ",3.7,"1.08527e-19","7l7t_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_C_)",93.0489,"","",""
"7L7T","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT A)","10.1038/S41467-021-25087-4 ",3.7,"1.08527e-19","7l7t_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",93.0489,"","",""
"7L7T","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT A)","10.1038/S41467-021-25087-4 ",3.7,"1.08527e-19","7l7t_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_E_)",93.0489,"","",""
"7L7U","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT B)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l7u_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_E_)",69.7782,"","",""
"7L7U","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT B)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l7u_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",69.7782,"","",""
"7L7U","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT B)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l7u_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_C_)",69.7782,"","",""
"7L86","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,"1.35632e-19","7l86_oligo57","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_C_)",65.9855,"","",""
"7L86","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,"1.35632e-19","7l86_oligo48","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",58.628,"","",""
"7L86","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,"1.35632e-19","7l86_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_A_)",62.3382,"","",""
"7L87","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"1.35632e-19","7l87_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_D_)",79.3236,"","",""
"7L87","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"1.35632e-19","7l87_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_A_)",52.6146,"","",""
"7L88","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"2.21517e+08","7l88_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",81.5304,"","",""
"7L88","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"2.21517e+08","7l88_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_D_)",76.7613,"","",""
"7L89","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.35632e-19","7l89_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_B_)",83.8931,"","",""
"7L89","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.35632e-19","7l89_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_A_)",76.7878,"","",""
"7L89","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.35632e-19","7l89_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",92.5907,"","",""
"7L8A","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.3,8.00784,"7l8a_oligo56","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",65.4229,"","",""
"7L8A","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.3,8.00784,"7l8a_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_C_)",68.4969,"","",""
"7L8B","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,8.00784,"7l8b_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_C_)",112.981,"","",""
"7L8B","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,8.00784,"7l8b_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_E_)",84.6193,"","",""
"7L8B","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,8.00784,"7l8b_oligo56","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_A_)",76.3409,"","",""
"7L8C","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,8.00784,"7l8c_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_D_)",59.8907,"","",""
"7L8C","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,8.00784,"7l8c_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",58.2362,"","",""
"7L8D","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.6,"1.08527e-19","7l8d_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_C_)",156.731,"","",""
"7L8D","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.6,"1.08527e-19","7l8d_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_D_)",152.182,"","",""
"7L8D","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.6,"1.08527e-19","7l8d_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",154.26,"","",""
"7L8E","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8e_oligo45","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_A_)",121.138,"","",""
"7L8E","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8e_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_E_)",137.301,"","",""
"7L8E","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8e_oligo65","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",140.324,"","",""
"7L8G","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"1.08527e-19","7l8g_oligo49","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_A_)",142.502,"","",""
"7L8G","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"1.08527e-19","7l8g_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_E_)",150.407,"","",""
"7L8G","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"1.08527e-19","7l8g_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",153.263,"","",""
"7L8P","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH SIBRAFIBAN","10.1016/J.CELL.2022.08.008 ",2.35,78.3,"7l8p_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",70.8667,"","",""
"7L8S","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"5.50295e+11","7l8s_oligo54","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_A_)",110.769,"","",""
"7L8S","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"5.50295e+11","7l8s_oligo46","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_E_)",133.432,"","",""
"7L8S","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"5.50295e+11","7l8s_oligo40","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",133.515,"","",""
"7L8T","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,"5.50295e+11","7l8t_oligo65","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_E_)",111.852,"","",""
"7L8T","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,"5.50295e+11","7l8t_oligo62","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_C_)",65.1265,"","",""
"7L8T","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,"5.50295e+11","7l8t_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",93.3292,"","",""
"7L8U","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"5.50295e+11","7l8u_oligo55","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(611_B_)",78.3561,"","",""
"7L8U","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"5.50295e+11","7l8u_oligo58","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_E_)",132.204,"","",""
"7L8W","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.1,"5.50295e+11","7l8w_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_C_)",88.046,"","",""
"7L8W","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.1,"5.50295e+11","7l8w_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-[MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",70.2435,"","",""
"7L8W","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.1,"5.50295e+11","7l8w_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_E_)",106.78,"","",""
"7L8X","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3,"5.50295e+11","7l8x_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_E_)",78.443,"","",""
"7L8X","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3,"5.50295e+11","7l8x_oligo64","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_C_)",73.2394,"","",""
"7L8X","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3,"5.50295e+11","7l8x_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpb1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-[BMA(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",83.734,"","",""
"7L8Y","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-5 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8y_oligo49","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_C_)",116.843,"","",""
"7L8Y","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-5 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8y_oligo53","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",90.3104,"","",""
"7L8Y","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-5 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8y_oligo57","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_E_)",101.778,"","",""
"7L8Z","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-7 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l8z_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",95.9453,"","",""
"7L8Z","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-7 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l8z_oligo57","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_C_)",78.9891,"","",""
"7L8Z","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-7 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l8z_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_D_)",89.1802,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)",41.135,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(317_E_)",43.6035,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)",41.9037,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)",40.7027,"","",""
"7LAL","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-18 AKA 7-(3-(2,3-DIHYDRO-1H-INDEN-1-YLAMINO)-1- PHENYLPROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.75,70,"7lal_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_G_)-[MAN(602_B_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)",81.4618,"","",""
"7LAL","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-18 AKA 7-(3-(2,3-DIHYDRO-1H-INDEN-1-YLAMINO)-1- PHENYLPROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.75,70,"7lal_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",81.4407,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(317_B_)",41.1064,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(317_G_)",40.6742,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(317_E_)",43.5361,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(317_I_)",41.9139,"","",""
"7LBE","CRYOEM STRUCTURE OF THE HCMV TRIMER GHGLGO IN COMPLEX WITH NEUTRALIZING FABS 13H11 AND MSL-109","10.1016/J.CELL.2021.01.036 ",2.9,"1.08527e-19","7lbe_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(160_C_)",78.105,"","",""
"7LBF","CRYOEM STRUCTURE OF THE HCMV TRIMER GHGLGO IN COMPLEX WITH HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA AND NEUTRALIZING FABS 13H11 AND MSL-109","10.1016/J.CELL.2021.01.036 ",2.8,524802,"7lbf_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(160_C_)",63.401,"","",""
"7LBG","CRYOEM STRUCTURE OF THE HCMV TRIMER GHGLGO IN COMPLEX WITH HUMAN TRANSFORMING GROWTH FACTOR BETA RECEPTOR TYPE 3 AND NEUTRALIZING FABS 13H11 AND MSL-109","10.1016/J.CELL.2021.01.036 ",2.6,524802,"7lbg_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(160_C_)",42.8138,"","",""
"7LBL","STRUCTURE OF HUMAN IGG1 FC","",2.13,59.11,"7lbl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_B_)",89.7303,"","",""
"7LBL","STRUCTURE OF HUMAN IGG1 FC","",2.13,59.11,"7lbl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",63.4261,"","",""
"7LDJ","SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH WNB-2","10.1073/PNAS.210191811 ",2.36,59.28,"7ldj_oligo2","DGlcpNAcb1-4DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_J_)-[NAG(5_J_)-MAN(4_J_)-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(343_A_)",96.8809,"","",""
"7LEN","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH R84K MUTATION IN COMPLEX WITH EPIREGULIN CRYSTALLIZED WITH TREHALOSE","10.1038/S41586-021-04393-3 ",2.9,86.62,"7len_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(328_B_)",117.079,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(97_A_)",297.151,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(97_G_)",280.543,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(97_H_)",333.261,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(97_E_)",282.177,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(97_C_)",314.354,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(97_F_)",267.484,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(97_D_)",306.152,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(97_B_)",277.751,"","",""
"7LF5","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267)","",2.6,92.97,"7lf5_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",114.462,"","",""
"7LF9","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC329)","",2.2,64.68,"7lf9_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",117.126,"","",""
"7LF9","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC329)","",2.2,64.68,"7lf9_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",70.1762,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",68.1181,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",113.798,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(267_A_)",95.1127,"","",""
"7LFS","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH A265V MUTATION IN COMPLEX WITH EPIREGULIN","10.1038/S41586-021-04393-3 ",3.5,99,"7lfs_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(328_B_)",141.21,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_f_)-NAG(1_f_)-ASN(611_B_)",60.9827,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo34","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_z_)-[MAN(7_z_)]-MAN(6_z_)-[MAN(5_z_)-MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(276_F_)",55.5635,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo33","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-[MAN(5_y_)-MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(262_F_)",66.8188,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo28","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_t_)-NAG(1_t_)-ASN(611_G_)",60.9827,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_E_)",66.8188,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo42","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_7_)-NAG(1_7_)-ASN(611_I_)",60.9827,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_l_)-[MAN(7_l_)]-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(276_E_)",55.5635,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[MAN(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_A_)",55.5635,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",66.8188,"","",""
"7LIR","STRUCTURE OF THE INVERTEBRATE ALK GRD","10.1038/S41586-021-04141-7 ",2.6,82.1,"7lir_oligo5","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(6_C_)-[MAN(4_C_)-MAN(3_C_)-NAG(2_C_)]-[FUC(5_C_)]-NAG(1_C_)",108.659,"","",""
"7LIR","STRUCTURE OF THE INVERTEBRATE ALK GRD","10.1038/S41586-021-04141-7 ",2.6,82.1,"7lir_oligo4","DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_G_)-[MAN(3_G_)-NAG(2_G_)]-[FUC(4_G_)]-NAG(1_G_)",102.404,"","",""
"7LKP","STRUCTURE OF ATP-FREE HUMAN ABCA4","10.7554/ELIFE.63524 ",3.27,"1.08527e-19","7lkp_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",111.255,"","",""
"7LKZ","STRUCTURE OF ATP-BOUND HUMAN ABCA4","10.7554/ELIFE.63524 ",3.27,"1.15243e-41","7lkz_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",90.4164,"","",""
"7LL1","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC40.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll1_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(276_G_)",97.9476,"","",""
"7LL1","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC40.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll1_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(276_C_)",99.9556,"","",""
"7LL1","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC40.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll1_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(276_A_)",98.8192,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_C_)",155.741,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(363_A_)",135.45,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(363_E_)",140.303,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",156.027,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(363_C_)",141.784,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_E_)",160.708,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(276_A_)",149.355,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo19","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_C_)",137.558,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo30","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_p_)-[MAN(5_p_)]-MAN(4_p_)-[MAN(7_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(276_E_)",164.192,"","",""
"7LLK","CRYO-EM STRUCTURE OF Q23.17_DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY 179NC75 FAB","10.1016/J.CELREP.2021.109922 ",4.8,"5.37397e+08","7llk_oligo17","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_A_)",153.244,"","",""
"7LLK","CRYO-EM STRUCTURE OF Q23.17_DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY 179NC75 FAB","10.1016/J.CELREP.2021.109922 ",4.8,"5.37397e+08","7llk_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_E_)",153.244,"","",""
"7LLK","CRYO-EM STRUCTURE OF Q23.17_DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY 179NC75 FAB","10.1016/J.CELREP.2021.109922 ",4.8,"5.37397e+08","7llk_oligo27","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_I_)",153.244,"","",""
"7LLK","CRYO-EM STRUCTURE OF Q23.17_DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY 179NC75 FAB","10.1016/J.CELREP.2021.109922 ",4.8,"5.37397e+08","7llk_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",117.854,"","",""
"7LLK","CRYO-EM STRUCTURE OF Q23.17_DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY 179NC75 FAB","10.1016/J.CELREP.2021.109922 ",4.8,"5.37397e+08","7llk_oligo32","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)",117.854,"","",""
"7LLK","CRYO-EM STRUCTURE OF Q23.17_DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY 179NC75 FAB","10.1016/J.CELREP.2021.109922 ",4.8,"5.37397e+08","7llk_oligo22","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)",117.854,"","",""
"7LM8","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS","10.1016/J.CHOM.2021.04.005 ",1.94,22.88,"7lm8_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",32.2339,"","",""
"7LM9","CRYSTAL STRUCTURE OF SARS-COV SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING ANTIBODY CV38-142 FAB ISOLATED FROM COVID-19 PATIENT","10.1016/J.CHOM.2021.04.005 ",1.53,26.92,"7lm9_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(330_A_)",31.8493,"","",""
"7LO4","SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN WITH A G485R MUTATION IN COMPLEX WITH HUMAN ACE2","10.1101/2021.03.16.434488 ",2.47,38.11,"7lo4_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(103_A_)",67.9264,"","",""
"7LO6","STRUCTURE OF CD4 MIMETIC BNM-III-170 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lo6_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_C_)",111.598,"","",""
"7LO6","STRUCTURE OF CD4 MIMETIC BNM-III-170 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lo6_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_E_)",96.4803,"","",""
"7LO6","STRUCTURE OF CD4 MIMETIC BNM-III-170 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lo6_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",141.492,"","",""
"7LOK","STRUCTURE OF CD4 MIMETIC M48U1 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lok_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-SER","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-SER(447_A_)",72.266,"","",""
"7LOK","STRUCTURE OF CD4 MIMETIC M48U1 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lok_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_C_)",29.922,"","",""
"7LPN","CRYO-EM STRUCTURE OF LLAMA J3 VHH ANTIBODY IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1016/J.STR.2022.03.012 ",3.61,"1.08527e-19","7lpn_oligo23","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(301_F_)",186.475,"","",""
"7LPN","CRYO-EM STRUCTURE OF LLAMA J3 VHH ANTIBODY IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1016/J.STR.2022.03.012 ",3.61,"1.08527e-19","7lpn_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(301_C_)",193.692,"","",""
"7LPN","CRYO-EM STRUCTURE OF LLAMA J3 VHH ANTIBODY IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1016/J.STR.2022.03.012 ",3.61,"1.08527e-19","7lpn_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(301_G_)",172.865,"","",""
"7LRS","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.89,"1.08527e-19","7lrs_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(343_C_)",110.993,"","",""
"7LRT","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.54,"5.50295e+11","7lrt_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(343_B_)",343.695,"","",""
"7LRT","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.54,"5.50295e+11","7lrt_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(343_A_)",340.766,"","",""
"7LRT","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.54,"5.50295e+11","7lrt_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(343_C_)",286.798,"","",""
"7LSU","RUMINOCOCCUS BROMII AMY12-D392A WITH 63-A-D-GLUCOSYL-MALTOTRIOSE","10.1016/J.JSB.2021.107765 ",1.95,15.23,"7lsu_oligo1","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpb1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-BGC(1_C_)",17.7423,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_e_)",215.077,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo10","DManpa1-6DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(241_e_)",50.6023,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_f_)",230.489,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(289_f_)",80.2638,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(289_d_)",83.2305,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo1","DManpa1-6DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(241_d_)",43.6847,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_d_)",242.518,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(289_e_)",71.9329,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo17","DManpa1-6DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(241_f_)",84.9814,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",30,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_e_)",31.1251,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(262_c_)",30.4791,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_a_)",30.4827,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_e_)",30.4918,"","",""
"7LUS","IGG2 FC CHARGE PAIR MUTATION VERSION 1 (CPMV1)","10.1016/J.ISCI.2021.103447 ",2.45,39,"7lus_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_B_)",37.042,"","",""
"7LUS","IGG2 FC CHARGE PAIR MUTATION VERSION 1 (CPMV1)","10.1016/J.ISCI.2021.103447 ",2.45,39,"7lus_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",38.1909,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo25","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_h_)-[MAN(8_h_)]-MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_B_)",41.5229,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(138_A_)",63.5006,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_A_)",59.1032,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_v_)-[MAN(8_v_)]-MAN(7_v_)-[MAN(6_v_)-MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(332_C_)",43.113,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_A_)",41.5036,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo13","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",59.6742,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo42","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-[MAN(5_y_)-MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(138_C_)",63.4604,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo34","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_C_)",59.6732,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo28","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(138_B_)",62.3423,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo25","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_h_)-[MAN(8_h_)]-MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_B_)",68.1506,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo13","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",89.7189,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_A_)",67.7974,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo28","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(138_B_)",89.408,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(138_A_)",89.1991,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_A_)",89.8459,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo42","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-[MAN(5_y_)-MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(138_C_)",89.082,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo34","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_C_)",89.7277,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_v_)-[MAN(8_v_)]-MAN(7_v_)-[MAN(6_v_)-MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(332_C_)",66.3606,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo35","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_u_)-MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_E_)",131.317,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo28","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(138_A_)",64.6208,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo38","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_x_)-[MAN(8_x_)]-MAN(7_x_)-[MAN(6_x_)-MAN(5_x_)-MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(332_E_)",53.0979,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_j_)-[MAN(8_j_)]-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_C_)",51.7729,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_i_)-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(301_C_)",146.009,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo17","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",132.362,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo6","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",132.231,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo14","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-MAN(5_o_)-MAN(4_o_)-[MAN(8_o_)-MAN(7_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(138_E_)",63.5044,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo19","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_A_)",145.02,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo37","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(301_E_)",144.809,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo20","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_A_)",52.3971,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo25","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-MAN(4_a_)-[MAN(8_a_)-MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(138_C_)",63.257,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo20","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_A_)",76.9976,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_j_)-[MAN(8_j_)]-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_C_)",77.4678,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo6","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",191.053,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo37","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(301_E_)",244.246,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo35","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_u_)-MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_E_)",185.128,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo14","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-MAN(5_o_)-MAN(4_o_)-[MAN(8_o_)-MAN(7_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(138_E_)",113.48,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_i_)-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(301_C_)",211.06,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo19","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_A_)",240.697,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo28","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(138_A_)",111.995,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo17","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",191.216,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo38","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_x_)-[MAN(8_x_)]-MAN(7_x_)-[MAN(6_x_)-MAN(5_x_)-MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(332_E_)",77.0157,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo25","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-MAN(4_a_)-[MAN(8_a_)-MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(138_C_)",111.368,"","",""
"7LXW","SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.8,512.502,"7lxw_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(17_A_)",31.0042,"","",""
"7LXW","SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.8,512.502,"7lxw_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(149_A_)",33.37,"","",""
"7LXX","SARS-COV-2 S/S2M11/S2L28 LOCAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",3,512.502,"7lxx_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(17_A_)",27.8409,"","",""
"7LXY","SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.2,2050.01,"7lxy_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(343_A_)",34.6407,"","",""
"7LXY","SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.2,2050.01,"7lxy_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(343_J_)",34.6407,"","",""
"7LXY","SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.2,2050.01,"7lxy_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_B_)",34.6407,"","",""
"7LXZ","SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.6,2050.01,"7lxz_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_U_)-[BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(343_B_)",29.5325,"","",""
"7LXZ","SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.6,2050.01,"7lxz_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(17_K_)",40.3203,"","",""
"7LXZ","SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.6,2050.01,"7lxz_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(343_A_)",29.5325,"","",""
"7LXZ","SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.6,2050.01,"7lxz_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(17_A_)",40.3203,"","",""
"7LXZ","SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.6,2050.01,"7lxz_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(17_B_)",40.3203,"","",""
"7LXZ","SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.6,2050.01,"7lxz_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Z_)-[BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(343_K_)",29.5325,"","",""
"7LY0","SARS-COV-2 S/S2M11/S2M28 LOCAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.6,"5.50295e+11","7ly0_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(17_A_)",61.428,"","",""
"7LY2","SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.5,2050.01,"7ly2_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(343_A_)",11.5489,"","",""
"7LY2","SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.5,2050.01,"7ly2_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_B_)",11.5489,"","",""
"7LY2","SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT","10.1016/J.CELL.2021.03.028 ",2.5,2050.01,"7ly2_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(343_J_)",11.5489,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(122_B_)",124.558,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(282_A_)",181.936,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(61_B_)",157.11,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(165_A_)",151.405,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(149_B_)",159.056,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(122_A_)",127.741,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(61_A_)",160.892,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(17_A_)",150.788,"","",""
"7LY3","CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB","10.1016/J.CELL.2021.03.028 ",3,93.86,"7ly3_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(17_B_)",160.359,"","",""
"7LY9","CRYO-EM STRUCTURE OF 2909 FAB IN COMPLEX WITH 3BNC117 FAB AND CAP256.WK34.C80 SOSIP.RNS2 N160K HIV-1 ENV TRIMER","10.1038/S41467-021-26579-Z ",3.91,"5.37397e+08","7ly9_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_D_)",103.916,"","",""
"7LY9","CRYO-EM STRUCTURE OF 2909 FAB IN COMPLEX WITH 3BNC117 FAB AND CAP256.WK34.C80 SOSIP.RNS2 N160K HIV-1 ENV TRIMER","10.1038/S41467-021-26579-Z ",3.91,"5.37397e+08","7ly9_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(276_K_)",94.9948,"","",""
"7LY9","CRYO-EM STRUCTURE OF 2909 FAB IN COMPLEX WITH 3BNC117 FAB AND CAP256.WK34.C80 SOSIP.RNS2 N160K HIV-1 ENV TRIMER","10.1038/S41467-021-26579-Z ",3.91,"5.37397e+08","7ly9_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(276_G_)",97.3608,"","",""
"7LYD","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0075146","",2.35,65.07,"7lyd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",94.7145,"","",""
"7LYU","REELIN REPEAT 8","10.1016/J.BPJ.2022.06.002 ",3,64.81,"7lyu_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(3412_A_)",73.4618,"","",""
"7LYU","REELIN REPEAT 8","10.1016/J.BPJ.2022.06.002 ",3,64.81,"7lyu_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(3185_A_)",73.8541,"","",""
"7LYY","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0075164","",2.75,79.7,"7lyy_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",106.546,"","",""
"7M1P","HUMAN ABCA4 STRUCTURE IN THE UNBOUND STATE","10.1038/S41467-021-26161-7 ",3.6,0,"7m1p_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",65.4933,"","",""
"7M1Q","HUMAN ABCA4 STRUCTURE IN COMPLEX WITH N-RET-PE","10.1038/S41467-021-26161-7 ",2.92,0,"7m1q_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1529_A_)",90.8404,"","",""
"7M2D","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0074953","",2.7,74.29,"7m2d_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",101.105,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",13.2035,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(125_C_)",13.2035,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(125_E_)",13.2035,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(166_C_)",25.2645,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(166_A_)",25.2645,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(166_E_)",25.2645,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",16.816,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo17","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_C_)",16.816,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo23","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(410_E_)",16.816,"","",""
"7M6D","STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022","10.1016/J.CELL.2021.04.032 ",3.1,83.66,"7m6d_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(343_C_)",113.952,"","",""
"7M6E","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19","10.1016/J.CELL.2021.04.032 ",3.3,"5.50295e+11","7m6e_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(343_B_)",81.2645,"","",""
"7M75","ROOM TEMPERATURE XFEL CRYSTALLOGRAPHY REVEALS ASYMMETRY IN THE VICINITY OF THE TWO PHYLLOQUINONES IN PHOTOSYSTEM I","10.1038/S41598-021-00236-3 ",2.75,77.3,"7m75_oligo6","DGalpa1-6DGalpb1-C39O5","DGD(206_L_)-DGD(206_L_)",127.081,"","",""
"7M76","ROOM TEMPERATURE XFEL CRYSTALLOGRAPHY REVEALS ASYMMETRY IN THE VICINITY OF THE TWO PHYLLOQUINONES IN PHOTOSYSTEM I","10.1038/S41598-021-00236-3 ",3,67.26,"7m76_oligo5","DGalpa1-6DGalpb1-C39O5","DGD(207_L_)-DGD(207_L_)",116.931,"","",""
"7M78","ROOM TEMPERATURE XFEL CRYSTALLOGRAPHY REVEALS ASYMMETRY IN THE VICINITY OF THE TWO PHYLLOQUINONES IN PHOTOSYSTEM I","10.1038/S41598-021-00236-3 ",3,42.1,"7m78_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(207_L_)-DGD(207_L_)",90.7809,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(257_C_)",179.001,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(257_A_)",179.001,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(563_E_)",90.586,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(563_D_)",90.586,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(563_F_)",90.586,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(257_B_)",179.001,"","",""
"7MD5","INSULIN RECEPTOR ECTODOMAIN DIMER COMPLEXED WITH TWO IRPA-9 PARTIAL AGONISTS","10.1038/S41467-022-28561-9 ",5.2,512.502,"7md5_oligo10","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(418_B_)",355.762,"","",""
"7MD5","INSULIN RECEPTOR ECTODOMAIN DIMER COMPLEXED WITH TWO IRPA-9 PARTIAL AGONISTS","10.1038/S41467-022-28561-9 ",5.2,512.502,"7md5_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(255_A_)",318.754,"","",""
"7MD5","INSULIN RECEPTOR ECTODOMAIN DIMER COMPLEXED WITH TWO IRPA-9 PARTIAL AGONISTS","10.1038/S41467-022-28561-9 ",5.2,512.502,"7md5_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(418_A_)",347.326,"","",""
"7MD5","INSULIN RECEPTOR ECTODOMAIN DIMER COMPLEXED WITH TWO IRPA-9 PARTIAL AGONISTS","10.1038/S41467-022-28561-9 ",5.2,512.502,"7md5_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(25_B_)",348.443,"","",""
"7MD5","INSULIN RECEPTOR ECTODOMAIN DIMER COMPLEXED WITH TWO IRPA-9 PARTIAL AGONISTS","10.1038/S41467-022-28561-9 ",5.2,512.502,"7md5_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(255_B_)",297.658,"","",""
"7MD5","INSULIN RECEPTOR ECTODOMAIN DIMER COMPLEXED WITH TWO IRPA-9 PARTIAL AGONISTS","10.1038/S41467-022-28561-9 ",5.2,512.502,"7md5_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)-ASN(25_A_)",383.764,"","",""
"7MDU","BG505 SOSIP MD39 IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33104 MAB.1 AND RM20A3","10.1126/SCIADV.ABK2039 ",3.3,"1.35632e-19","7mdu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",74.8515,"","",""
"7MEM","CRYOEM STRUCTURE OF MONOCLONAL FAB 045-09 2B05 BINDING THE LATERAL PATCH OF INFLUENZA VIRUS H1 HA","10.1126/SCITRANSLMED.ABG4535 ",3.2,"1.08527e-19","7mem_oligo1","LFucpa1-6DGlcpNAcx1-","FUC(2_M_)-NAG(1_M_)",169.443,"","",""
"7MEM","CRYOEM STRUCTURE OF MONOCLONAL FAB 045-09 2B05 BINDING THE LATERAL PATCH OF INFLUENZA VIRUS H1 HA","10.1126/SCITRANSLMED.ABG4535 ",3.2,"1.08527e-19","7mem_oligo5","LFucpa1-6DGlcpNAcx1-","FUC(2_Q_)-NAG(1_Q_)",169.443,"","",""
"7MEM","CRYOEM STRUCTURE OF MONOCLONAL FAB 045-09 2B05 BINDING THE LATERAL PATCH OF INFLUENZA VIRUS H1 HA","10.1126/SCITRANSLMED.ABG4535 ",3.2,"1.08527e-19","7mem_oligo3","LFucpa1-6DGlcpNAcx1-","FUC(2_O_)-NAG(1_O_)",169.443,"","",""
"7MEP","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33172 MAB.1 AND RM19R","10.1126/SCIADV.ABK2039 ",3.5,"1.35632e-19","7mep_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_D_)",73.6902,"","",""
"7MEP","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33172 MAB.1 AND RM19R","10.1126/SCIADV.ABK2039 ",3.5,"1.35632e-19","7mep_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_C_)",75.8071,"","",""
"7MEP","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33172 MAB.1 AND RM19R","10.1126/SCIADV.ABK2039 ",3.5,"1.35632e-19","7mep_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_A_)",70.5684,"","",""
"7MF1","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 47D1","10.1016/J.CELREP.2021.109109 ",2.09,62.94,"7mf1_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(93_L_)",93.04,"","",""
"7MFH","CRYSTAL STRUCTURE OF BIO-32546 BOUND MOUSE AUTOTAXIN","10.1021/ACSMEDCHEMLETT.1C00211 ",2.3,60.22,"7mfh_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",67.2115,"","",""
"7MLV","CRYO-EM REVEALS PARTIALLY AND FULLY ASSEMBLED NATIVE GLYCINE RECEPTORS,HOMOMERIC TETRAMER","10.1038/S41586-021-04022-Z ",4.1,"1.08527e-19","7mlv_oligo1","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(504_D_)-MAN(507_D_)-[MAN(502_D_)-MAN(501_D_)]-BMA(503_D_)-NAG(506_D_)-NAG(505_D_)",190.534,"","",""
"7MLV","CRYO-EM REVEALS PARTIALLY AND FULLY ASSEMBLED NATIVE GLYCINE RECEPTORS,HOMOMERIC TETRAMER","10.1038/S41586-021-04022-Z ",4.1,"1.08527e-19","7mlv_oligo4","DManpa1-2DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",182.91,"","",""
"7MLV","CRYO-EM REVEALS PARTIALLY AND FULLY ASSEMBLED NATIVE GLYCINE RECEPTORS,HOMOMERIC TETRAMER","10.1038/S41586-021-04022-Z ",4.1,"1.08527e-19","7mlv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(38_A_)",168.312,"","",""
"7MLZ","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY B1-182.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.71,"1.08527e-19","7mlz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(343_A_)",125.762,"","",""
"7MSQ","COMPLEX BETWEEN THE FAB ARM OF AB-3467 AND THE SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD)","10.1016/J.IMMUNI.2021.10.019 ",2.29,50.26,"7msq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(343_A_)",84.4324,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo14","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",60.9167,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",57.73,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo25","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)]-MAN(4_m_)-[MAN(7_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(160_F_)",67.1953,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_A_)",64.9677,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_G_)",61.8186,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo28","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_p_)-[MAN(5_p_)]-MAN(4_p_)-[MAN(7_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(276_G_)",70.6173,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_F_)",56.5956,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(276_P_)",88.3447,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_Y_)-MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(234_G_)",58.8008,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-MAN(8_i_)-[MAN(10_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_J_)",41.6534,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(276_J_)",62.362,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_r_)-MAN(8_r_)-[MAN(10_r_)]-MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(234_P_)",69.7401,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_G_)",79.6289,"","",""
"7MXI","IGE-FC IN COMPLEX WITH DARPINS E2_79 AND E3_53","10.1016/J.JACI.2021.03.050 ",2.8,61.19,"7mxi_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(371_B_)",91.5561,"","",""
"7MXP","CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE","10.1002/AIC.17440 ",4.46,"5.50295e+11","7mxp_oligo6","[DGlcpNAcb1-2][DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_N_)-[BMA(7_N_)-[NAG(5_N_)-MAN(4_N_)]-[NAG(6_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(17_C_)",498.957,"","",""
"7MXP","CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE","10.1002/AIC.17440 ",4.46,"5.50295e+11","7mxp_oligo3","[DGlcpNAcb1-2][DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[BMA(7_F_)-[NAG(5_F_)-MAN(4_F_)]-[NAG(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(17_A_)",560.011,"","",""
"7MZF","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 37","10.1016/J.CELREP.2021.109822 ",2.49,54.73,"7mzf_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",98.5836,"","",""
"7MZG","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 42","10.1016/J.CELREP.2021.109822 ",2,43.94,"7mzg_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",92.3161,"","",""
"7MZH","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 119","10.1016/J.CELREP.2021.109822 ",2.1,49.46,"7mzh_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(343_A_)",74.7404,"","",""
"7MZK","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129 AND FAB PDI 96","10.1016/J.CELREP.2021.109822 ",2.25,50.44,"7mzk_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(343_A_)",85.6306,"","",""
"7MZK","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 129 AND FAB PDI 96","10.1016/J.CELREP.2021.109822 ",2.25,50.44,"7mzk_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(343_B_)",91.6873,"","",""
"7MZL","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 210","10.1016/J.CELREP.2021.109822 ",3.7,102.1,"7mzl_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",168.283,"","",""
"7MZM","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 215","10.1016/J.CELREP.2021.109822 ",2.3,52.92,"7mzm_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(343_A_)",113.768,"","",""
"7MZN","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB PDI 231","10.1016/J.CELREP.2021.109822 ",3.1,64.63,"7mzn_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",143.517,"","",""
"7N1Q","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.44,"1.15243e-41","7n1q_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(1074_B_)",113.302,"","",""
"7N1Q","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.44,"1.15243e-41","7n1q_oligo26","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_c_)-[NAG(2_c_)]-NAG(1_c_)-ASN(1074_C_)",108.327,"","",""
"7N1Q","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.44,"1.15243e-41","7n1q_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",106.609,"","",""
"7N1T","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.44,"1.15243e-41","7n1t_oligo31","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_h_)-[NAG(2_h_)]-NAG(1_h_)-ASN(1074_C_)",128.649,"","",""
"7N1T","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.44,"1.15243e-41","7n1t_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(1074_A_)",130.347,"","",""
"7N1T","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.44,"1.15243e-41","7n1t_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(1074_B_)",114.005,"","",""
"7N1U","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.14,"1.15243e-41","7n1u_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(1074_B_)",115.146,"","",""
"7N1U","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.14,"1.15243e-41","7n1u_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(1074_A_)",120.126,"","",""
"7N1U","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.14,"1.15243e-41","7n1u_oligo31","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_h_)-[NAG(2_h_)]-NAG(1_h_)-ASN(1074_C_)",116.381,"","",""
"7N1V","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.5,"1.15243e-41","7n1v_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1074_B_)",125.345,"","",""
"7N1V","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.5,"1.15243e-41","7n1v_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",123.817,"","",""
"7N1V","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.5,"1.15243e-41","7n1v_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",116.084,"","",""
"7N1W","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.33,"1.15243e-41","7n1w_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",127.122,"","",""
"7N1W","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.33,"1.15243e-41","7n1w_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1074_B_)",131.125,"","",""
"7N1W","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",3.33,"1.15243e-41","7n1w_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",118.769,"","",""
"7N1X","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",4,"1.15243e-41","7n1x_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",147.621,"","",""
"7N1X","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",4,"1.15243e-41","7n1x_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1074_B_)",139.619,"","",""
"7N1X","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",4,"1.15243e-41","7n1x_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",134.084,"","",""
"7N1Y","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",4.3,"1.15243e-41","7n1y_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",172.148,"","",""
"7N1Y","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",4.3,"1.15243e-41","7n1y_oligo23","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Z_)-[NAG(2_Z_)]-NAG(1_Z_)-ASN(1074_C_)",180.902,"","",""
"7N1Y","STRUCTURAL BASIS FOR ENHANCED INFECTIVITY AND IMMUNE EVASION OF SARS- COV-2 VARIANTS","10.1126/SCIENCE.ABI9745 ",4.3,"1.15243e-41","7n1y_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(1074_B_)",221.354,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_A_)",91.8283,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_G_)",124.711,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_F_)",135.092,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo23","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-MAN(4_k_)-[MAN(6_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(160_F_)",118.432,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_L_)-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(262_A_)",146.379,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",85.6505,"","",""
"7N4Y","THE STRUCTURE OF BOVINE THYROGLOBULIN WITH IODINATED TYROSINES","10.1107/S2059798321010056 ",2.61,0,"7n4y_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)",44.0564,"","",""
"7N4Y","THE STRUCTURE OF BOVINE THYROGLOBULIN WITH IODINATED TYROSINES","10.1107/S2059798321010056 ",2.61,0,"7n4y_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)",44.0564,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo32","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_f_)-[NAG(2_f_)]-NAG(1_f_)-ASN(611_B_)",88.4242,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo13","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_B_)",2.57273,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo49","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_w_)-[NAG(2_w_)]-NAG(1_w_)-ASN(611_C_)",7.38697,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo48","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_v_)-MAN(6_v_)-[MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(448_C_)",2.49247,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo38","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_l_)-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_C_)",2.63623,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo28","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",2.26545,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo16","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",2.51571,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo35","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_C_)",3.64891,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo13","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_B_)",2.61831,"","",""
"7N8H","SARS-COV-2 S (B.1.429 / EPSILON VARIANT) + S2M11 + S2L20 GLOBAL REFINEMENT","10.1126/SCIENCE.ABI7994 ",2.3,2050.01,"7n8h_oligo6","DGlcpNAcb1-4[LFucpa1-6]DManp[2H]b1-ASN","FUC(3_S_)-[NAG(2_S_)--ASN(343_F_)",3.20645,"","",""
"7N8H","SARS-COV-2 S (B.1.429 / EPSILON VARIANT) + S2M11 + S2L20 GLOBAL REFINEMENT","10.1126/SCIENCE.ABI7994 ",2.3,2050.01,"7n8h_oligo11","DGlcpNAcb1-4[LFucpa1-6]DManp[2H]b1-ASN","FUC(3_V_)-[NAG(2_V_)--ASN(343_K_)",3.20645,"","",""
"7N8H","SARS-COV-2 S (B.1.429 / EPSILON VARIANT) + S2M11 + S2L20 GLOBAL REFINEMENT","10.1126/SCIENCE.ABI7994 ",2.3,2050.01,"7n8h_oligo3","DGlcpNAcb1-4[LFucpa1-6]DManp[2H]b1-ASN","FUC(3_P_)-[NAG(2_P_)--ASN(343_A_)",3.20645,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo50","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",0.77,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo48","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",7.86,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo51","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",4.48,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo52","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",7.86,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo54","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",0.77,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo49","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",5.12,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo53","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",5.12,"","",""
"7N8O","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",1.93,"1.35632e-19","7n8o_oligo47","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",4.48,"","",""
"7NAM","LRP6_E1 IN COMPLEX WITH LR-EET-3.5","10.1073/PNAS.2207327119 ",1.6,40.69,"7nam_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_E_)-[MAN(3_E_)-NAG(2_E_)]-[FUC(4_E_)]-NAG(1_E_)",62.6361,"","",""
"7NAM","LRP6_E1 IN COMPLEX WITH LR-EET-3.5","10.1073/PNAS.2207327119 ",1.6,40.69,"7nam_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_D_)-[MAN(3_D_)-NAG(2_D_)]-[FUC(4_D_)]-NAG(1_D_)",65.2446,"","",""
"7ND4","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB","10.1016/J.CELL.2021.02.032 ",3.6,0,"7nd4_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(35_H_)",148.033,"","",""
"7ND7","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB","10.1016/J.CELL.2021.02.032 ",3.6,0,"7nd7_oligo17","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Z_)-[NAG(2_Z_)]-NAG(1_Z_)-ASN(59_F_)",145.61,"","",""
"7ND7","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB","10.1016/J.CELL.2021.02.032 ",3.6,0,"7nd7_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(59_H_)",151.605,"","",""
"7ND7","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB","10.1016/J.CELL.2021.02.032 ",3.6,0,"7nd7_oligo18","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_a_)-[NAG(2_a_)]-NAG(1_a_)-ASN(59_J_)",148.722,"","",""
"7ND9","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-253H55L FAB","10.1016/J.CELL.2021.02.032 ",2.8,0,"7nd9_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(102_H_)",200.03,"","",""
"7NDA","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-253H55L FAB","10.1016/J.CELL.2021.02.032 ",3.3,0,"7nda_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(102_H_)",205.508,"","",""
"7NDB","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 253H165L FAB","10.1016/J.CELL.2021.02.032 ",4.6,0,"7ndb_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(102_H_)",464.432,"","",""
"7NEG","CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB","10.1016/J.CELL.2021.02.033 ",2.19,68.27,"7neg_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",123.593,"","",""
"7NEH","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB","10.1016/J.CELL.2021.02.033 ",1.77,49.8,"7neh_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",96.7188,"","",""
"7NI1","CRYSTAL STRUCTURE OF NATIVE HUMAN MYELOPEROXIDASE IN COMPLEX WITH CPD 9","10.1021/ACS.JMEDCHEM.1C02141 ",2.11,24.09,"7ni1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",42.8436,"","",""
"7NI1","CRYSTAL STRUCTURE OF NATIVE HUMAN MYELOPEROXIDASE IN COMPLEX WITH CPD 9","10.1021/ACS.JMEDCHEM.1C02141 ",2.11,24.09,"7ni1_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",37.0813,"","",""
"7NI3","CRYSTAL STRUCTURE OF NATIVE HUMAN MYELOPEROXIDASE IN COMPLEX WITH CPD 3","10.1021/ACS.JMEDCHEM.1C02141 ",2.1,16.89,"7ni3_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",26.5189,"","",""
"7NI3","CRYSTAL STRUCTURE OF NATIVE HUMAN MYELOPEROXIDASE IN COMPLEX WITH CPD 3","10.1021/ACS.JMEDCHEM.1C02141 ",2.1,16.89,"7ni3_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",20.6132,"","",""
"7NKS","STRUCTURE OF THE HANTAAN VIRUS GN GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH FAB HTN-GN1","10.1128/MBIO.02531-20 ",3.5,124.9,"7nks_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(134_B_)",159.594,"","",""
"7NKS","STRUCTURE OF THE HANTAAN VIRUS GN GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH FAB HTN-GN1","10.1128/MBIO.02531-20 ",3.5,124.9,"7nks_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(134_A_)",157.152,"","",""
"7NL5","STRUCTURE OF THE CATALYTIC DOMAIN OF THE BACILLUS CIRCULANS ALPHA-1,6 MANNANASE IN COMPLEX WITH AN ALPHA-1,6-ALPHA-MANNO-CYCLOPHELLITOL TRISACCHARIDE INHIBITOR","10.1002/CHEM.202101255 ",1.4,16.59,"7nl5_oligo1","DManpa1-6DManpa1-C7O6","MAN(2_B_)-MAN(1_B_)-UKQ(401_A_)",17.6705,"","",""
"7NN9","NATIVE INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN)","",2,0,"7nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",29.5796,"","",""
"7NP1","CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODY ION-360","10.3389/FIMMU.2021.678570 ",2.8,64.92,"7np1_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(343_A_)",139.312,"","",""
"7NP1","CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODY ION-360","10.3389/FIMMU.2021.678570 ",2.8,64.92,"7np1_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(343_C_)",102.553,"","",""
"7NRH","HANTAAN VIRUS GLYCOPROTEIN (GN) IN COMPLEX WITH FAB FRAGMENT HTN-GN1.","10.1128/MBIO.02531-20 ",19,"1.08527e-19","7nrh_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(134_A_)",157.152,"","",""
"7NSK","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A HYDROXAMIC LIGAND","",3.1,77.33,"7nsk_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",89.9555,"","",""
"7NSK","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A HYDROXAMIC LIGAND","",3.1,77.33,"7nsk_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(85_B_)",71.6855,"","",""
"7NUP","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A MIXED HYDROXAMIC AND SULFONYL LIGAND","",3.1,56.51,"7nup_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(85_C_)",65.0998,"","",""
"7NWF","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH HYBRID-TYPE GLYCAN (GALGLCNACMAN5GLCNAC) PRODUCT","10.1016/J.JBC.2021.101011 ",2,25.67,"7nwf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",32.2842,"","",""
"7NWL","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 (OPEN FORM) IN COMPLEX WITH FIBRONECTIN AND TS2/16 FV-CLASP","10.1126/SCIADV.ABE9716 ",3.1,"1.35632e-19","7nwl_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(386_B_)",248.41,"","",""
"7NWL","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 (OPEN FORM) IN COMPLEX WITH FIBRONECTIN AND TS2/16 FV-CLASP","10.1126/SCIADV.ABE9716 ",3.1,"1.35632e-19","7nwl_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",183.158,"","",""
"7NWL","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 (OPEN FORM) IN COMPLEX WITH FIBRONECTIN AND TS2/16 FV-CLASP","10.1126/SCIADV.ABE9716 ",3.1,"1.35632e-19","7nwl_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(275_A_)",109.242,"","",""
"7NXD","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 IN THE HALF-BENT CONFORMATION","10.1126/SCIADV.ABE9716 ",4.6,0,"7nxd_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(275_A_)",141.757,"","",""
"7O7L","(H-ALPHA2M)4 NATIVE I","10.1073/PNAS.2200102119 ",4.5,"1.15243e-41","7o7l_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",390.911,"","",""
"7O7L","(H-ALPHA2M)4 NATIVE I","10.1073/PNAS.2200102119 ",4.5,"1.15243e-41","7o7l_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",390.911,"","",""
"7O7M","(H-ALPHA2M)4 NATIVE II","10.1073/PNAS.2200102119 ",6.6,"1.15243e-41","7o7m_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",390.911,"","",""
"7O7M","(H-ALPHA2M)4 NATIVE II","10.1073/PNAS.2200102119 ",6.6,"1.15243e-41","7o7m_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",390.911,"","",""
"7O7O","(H-ALPHA2M)4 SEMIACTIVATED II STATE","10.1073/PNAS.2200102119 ",4.8,"1.15243e-41","7o7o_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(396_C_)",436.061,"","",""
"7O7O","(H-ALPHA2M)4 SEMIACTIVATED II STATE","10.1073/PNAS.2200102119 ",4.8,"1.15243e-41","7o7o_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(396_D_)",390.827,"","",""
"7O7O","(H-ALPHA2M)4 SEMIACTIVATED II STATE","10.1073/PNAS.2200102119 ",4.8,"1.15243e-41","7o7o_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(396_A_)",436.061,"","",""
"7O7O","(H-ALPHA2M)4 SEMIACTIVATED II STATE","10.1073/PNAS.2200102119 ",4.8,"1.15243e-41","7o7o_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(396_B_)",390.827,"","",""
"7O7S","(H-ALPHA2M)4 PLASMIN-ACTIVATED II STATE","10.1073/PNAS.2200102119 ",4.3,"1.15243e-41","7o7s_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(396_D_)",389.651,"","",""
"7OCI","CRYO-EM STRUCTURE OF YEAST OST6P CONTAINING OLIGOSACCHARYLTRANSFERASE COMPLEX","10.1093/GLYCOB/CWAB084 ",3.46,0.000748774,"7oci_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(539_F_)",59.5461,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo18","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(355_E_)",99.9177,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_c_)-[NAG(5_c_)-MAN(4_c_)-[MAN(6_c_)]-BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(483_G_)",63.8999,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(355_G_)",94.7053,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_Z_)-[MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)",61.5899,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_L_)-[NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(483_A_)",66.0927,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo16","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(355_D_)",105.852,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(355_A_)",92.1143,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Q_)-[MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(483_C_)",62.6464,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_W_)-[MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(483_E_)",61.2448,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(483_B_)",58.6994,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_g_)-[NAG(5_g_)-MAN(4_g_)-[MAN(6_g_)]-BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(483_H_)",61.3553,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo21","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(355_F_)",126.392,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_T_)-[MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(483_D_)",62.2005,"","",""
"7OIX","STRUCTURE OF THERMOSTABLE HUMAN MFSD2A IN COMPLEX WITH THERMOSTABLE HUMAN SYNC2","10.1038/S41594-022-00786-8 ",3.6,"1.08527e-19","7oix_oligo2","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(312_A_)",109.786,"","",""
"7OIX","STRUCTURE OF THERMOSTABLE HUMAN MFSD2A IN COMPLEX WITH THERMOSTABLE HUMAN SYNC2","10.1038/S41594-022-00786-8 ",3.6,"1.08527e-19","7oix_oligo1","DManpa1-3[DManpa1-6]DManpb1-6DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(177_A_)",118.868,"","",""
"7OK5","CRYSTAL STRUCTURE OF MOUSE NEUROFASCIN 155 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",2.97,113.2,"7ok5_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(420_B_)",164.496,"","",""
"7OK5","CRYSTAL STRUCTURE OF MOUSE NEUROFASCIN 155 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",2.97,113.2,"7ok5_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(420_A_)",147.934,"","",""
"7OK5","CRYSTAL STRUCTURE OF MOUSE NEUROFASCIN 155 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",2.97,113.2,"7ok5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(457_A_)",147.837,"","",""
"7OKS","X-RAY STRUCTURE OF SOLUBLE EPCR IN P212121 SPACE GROUP","10.1038/S41598-022-18844-Y ",1.95,45.89,"7oks_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(47_B_)",39.9764,"","",""
"7OKS","X-RAY STRUCTURE OF SOLUBLE EPCR IN P212121 SPACE GROUP","10.1038/S41598-022-18844-Y ",1.95,45.89,"7oks_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(47_D_)",44.4136,"","",""
"7OKS","X-RAY STRUCTURE OF SOLUBLE EPCR IN P212121 SPACE GROUP","10.1038/S41598-022-18844-Y ",1.95,45.89,"7oks_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(47_C_)",44.7782,"","",""
"7OKS","X-RAY STRUCTURE OF SOLUBLE EPCR IN P212121 SPACE GROUP","10.1038/S41598-022-18844-Y ",1.95,45.89,"7oks_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(47_A_)",52.5264,"","",""
"7OKT","X-RAY STRUCTURE OF SOLUBLE EPCR IN C2221 SPACE GROUP","10.1038/S41598-022-18844-Y ",1.95,63.34,"7okt_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(47_B_)",55.1723,"","",""
"7OL2","CRYSTAL STRUCTURE OF MOUSE CONTACTIN 1 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",3.89,105.2,"7ol2_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(258_A_)",165.994,"","",""
"7OL2","CRYSTAL STRUCTURE OF MOUSE CONTACTIN 1 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",3.89,105.2,"7ol2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(457_A_)",153.601,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(420_C_)",308.787,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(494_D_)",281.205,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(494_C_)",348.805,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo9","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(316_C_)",444.739,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(457_D_)",370.395,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(457_C_)",359.789,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo4","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(457_B_)",291.537,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo13","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Q_)-[MAN(7_Q_)]-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(420_D_)",299.097,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo7","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(494_B_)",248.678,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo14","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(316_D_)",387.751,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(457_A_)",240.892,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(258_B_)",257.316,"","",""
"7OLY","STRUCTURE OF ACTIVIN A IN COMPLEX WITH AN ACTRIIB-ALK4 FUSION REVEAL INSIGHT INTO ACTIVIN RECEPTOR INTERACTIONS","10.1016/J.ISCI.2021.103590 ",3.27,112.9,"7oly_oligo2","DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(65_C_)",175.163,"","",""
"7OR9","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND COVOX-278 FABS","10.1016/J.CELL.2021.06.020 ",2.34,61.39,"7or9_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_E_)",125.298,"","",""
"7ORA","CRYSTAL STRUCTURE OF THE T478K MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.6,66.02,"7ora_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(343_C_)",92.9767,"","",""
"7ORA","CRYSTAL STRUCTURE OF THE T478K MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.6,66.02,"7ora_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(102_F_)",83.6806,"","",""
"7ORA","CRYSTAL STRUCTURE OF THE T478K MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.6,66.02,"7ora_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(102_H_)",87.413,"","",""
"7ORA","CRYSTAL STRUCTURE OF THE T478K MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.6,66.02,"7ora_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(343_R_)",97.3023,"","",""
"7ORB","CRYSTAL STRUCTURE OF THE L452R MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-75 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.5,65.47,"7orb_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_J_)-[MAN(4_J_)-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(343_X_)",121.837,"","",""
"7ORB","CRYSTAL STRUCTURE OF THE L452R MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-75 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.5,65.47,"7orb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_R_)",128.645,"","",""
"7ORB","CRYSTAL STRUCTURE OF THE L452R MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-75 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.5,65.47,"7orb_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(102_C_)",101.994,"","",""
"7ORB","CRYSTAL STRUCTURE OF THE L452R MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-75 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.5,65.47,"7orb_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(102_H_)",94.3297,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo5","DGalpa1-6DGalpb1-C32O5","DGD(415_A_)-DGD(415_A_)",34.59,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo7","DGalpa1-6DGalpb1-C28O5","DGD(515_C_)-DGD(515_C_)",19.37,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo39","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",62.85,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo9","DGalpa1-6DGalpb1-C32O5","DGD(401_a_)-DGD(401_a_)",34.22,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo37","DGalpa1-6DGalpb1-C35O5","DGD(626_b_)-DGD(626_b_)",24.3,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",61.58,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(626_B_)-DGD(626_B_)",24.57,"","",""
"7OUI","STRUCTURE OF C2S2M2-TYPE PHOTOSYSTEM SUPERCOMPLEX FROM ARABIDOPSIS THALIANA (DIGITONIN-EXTRACTED)","10.1038/S41598-021-94914-X ",2.79,"1.08527e-19","7oui_oligo38","DGalpa1-6DGalpb1-C28O5","DGD(515_c_)-DGD(515_c_)",20.86,"","",""
"7P2P","HUMAN SIGNAL PEPTIDASE COMPLEX PARALOG A (SPC-A)","10.1016/J.MOLCEL.2021.07.031 ",4.9,"1.35632e-19","7p2p_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",276.243,"","",""
"7P2Q","HUMAN SIGNAL PEPTIDASE COMPLEX PARALOG C (SPC-C)","10.1016/J.MOLCEL.2021.07.031 ",4.9,"1.35632e-19","7p2q_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",337.497,"","",""
"7P56","VARIANT SURFACE GLYCOPROTEIN 2 (VSG2, MITAT1.2, VSG221) BOUND TO CALCIUM","10.1016/J.CELREP.2023.112262 ",1.74,34.79,"7p56_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(289_B_)",46.3448,"","",""
"7P59","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) WITH TWO O- LINKED POST-TRANSLATIONAL MODIFICATIONS","10.1016/J.CELREP.2023.112262 ",1.27,24.21,"7p59_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",23.8674,"","",""
"7P5A","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) MUTANT (SERINE 317 TO ALANINE), SINGLE O-LINKED GLYCOSYLATED AT SER319","10.1016/J.CELREP.2023.112262 ",1.95,24.34,"7p5a_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",36.3997,"","",""
"7P5B","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) MUTANT (SERINE 319 TO ALANINE), SINGLE O-LINKED GLYCOSYLATED AT SER317","10.1016/J.CELREP.2023.112262 ",1.13,25.63,"7p5b_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",28.4682,"","",""
"7P5D","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) MUTANT (SERINE 317 AND 319 TO ALANINE)","10.1016/J.CELREP.2023.112262 ",1.42,24.97,"7p5d_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",28.7906,"","",""
"7P7P","CRYSTAL STRUCTURE OF ERAP2 AMINOPEPTIDASE IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE((1R)-1-AMINO-3-PHENYLPROPYL){(2S)-3-[((2S)-1-AMINO- 1-OXO-3-PHENYLPROPAN-2-YL)AMINO]-2-{[3-(2-HYDROXYPHENYL)-ISOXAZOL-5- YL]METHYL}-3-OXOPROPYL}PHOSPHINIC ACID","10.1021/ACSMEDCHEMLETT.1C00582 ",3,92.48,"7p7p_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_A_)",132.664,"","",""
"7P7P","CRYSTAL STRUCTURE OF ERAP2 AMINOPEPTIDASE IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE((1R)-1-AMINO-3-PHENYLPROPYL){(2S)-3-[((2S)-1-AMINO- 1-OXO-3-PHENYLPROPAN-2-YL)AMINO]-2-{[3-(2-HYDROXYPHENYL)-ISOXAZOL-5- YL]METHYL}-3-OXOPROPYL}PHOSPHINIC ACID","10.1021/ACSMEDCHEMLETT.1C00582 ",3,92.48,"7p7p_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(85_B_)",108.302,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_r_)-MAN(10_r_)-[MAN(9_r_)-MAN(8_r_)]-MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(332_B_)",111.551,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo41","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_6_)-MAN(10_6_)-[MAN(9_6_)-MAN(8_6_)]-MAN(7_6_)-[MAN(6_6_)-MAN(5_6_)-MAN(4_6_)]-BMA(3_6_)-NAG(2_6_)-NAG(1_6_)-ASN(332_C_)",110.422,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo27","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-MAN(5_s_)-[MAN(7_s_)]-MAN(4_s_)-[MAN(9_s_)-MAN(8_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_B_)",127.77,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo13","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_l_)-[MAN(7_l_)]-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(276_B_)",143.989,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo34","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_z_)-[MAN(7_z_)]-MAN(6_z_)-[MAN(5_z_)-MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(276_C_)",142.312,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo25","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-MAN(5_q_)-MAN(4_q_)-[MAN(8_q_)-MAN(7_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(295_B_)",119.176,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_1_)-[MAN(4_1_)]-BMA(3_1_)-NAG(2_1_)-NAG(1_1_)-ASN(363_C_)",122.525,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo33","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-MAN(5_y_)-[MAN(7_y_)]-MAN(4_y_)-[MAN(9_y_)-MAN(8_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(262_C_)",124.072,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-MAN(5_W_)-[MAN(7_W_)]-MAN(4_W_)-[MAN(9_W_)-MAN(8_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",124.626,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo40","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_5_)-MAN(5_5_)-MAN(4_5_)-[MAN(8_5_)-MAN(7_5_)]-BMA(3_5_)-NAG(2_5_)-NAG(1_5_)-ASN(295_C_)",119.502,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(363_A_)",127.009,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(363_B_)",122.351,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[MAN(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_A_)",140.173,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-MAN(5_b_)-MAN(4_b_)-[MAN(7_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(295_A_)",114.857,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_a_)-MAN(10_a_)-[MAN(9_a_)-MAN(8_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_A_)",112.563,"","",""
"7PEE","CRYSTAL STRUCTURE OF EXTRACELLULAR PART OF HUMAN TROP2","10.3390/IJMS221910640 ",2.81,75.8,"7pee_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(168_B_)",123.034,"","",""
"7PEE","CRYSTAL STRUCTURE OF EXTRACELLULAR PART OF HUMAN TROP2","10.3390/IJMS221910640 ",2.81,75.8,"7pee_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(168_A_)",133.91,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_F_)-NAG(8_F_)-MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(232_A_)",354.721,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(322_A_)",350.723,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_O_)-[MAN(7_O_)]-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(275_C_)",364.812,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo12","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_I_)-MAN(8_I_)-[NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(396_A_)",318.28,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(76_C_)",669.42,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(513_B_)",346.408,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(513_A_)",413.492,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_N_)-NAG(8_N_)-MAN(7_N_)-[GAL(6_N_)-NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(232_C_)",323.928,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo13","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(322_C_)",363.58,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(275_A_)",497.925,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo14","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_Q_)-MAN(8_Q_)-[NAG(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)]-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(396_C_)",303.191,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(76_A_)",669.42,"","",""
"7PFS","CRYSTAL STRUCTURE OF ERAP2 AMINOPEPTIDASE IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE ((1R)-1-AMINO-3-PHENYLPROPYL){2-([1,1:3,1- TERPHENYL]-5-YLMETHYL)-3-[((2S)-1-AMINO-1-OXO-3-PHENYLPROPAN-2-YL)- AMINO]-3-OXOPROPYL}PHOSPHINIC ACID","10.1021/ACSMEDCHEMLETT.1C00582 ",2.7,0,"7pfs_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(85_B_)",83.2036,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo2","DGalpa1-6DGalpb1-C16O5","DGD(623_B_)-DGD(623_B_)",43.83,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",33.39,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo13","DGalpa1-6DGalpb1-C28O5","DGD(518_c_)-DGD(518_c_)",36.65,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo12","DGalpa1-6DGalpb1-C16O5","DGD(623_b_)-DGD(623_b_)",40.57,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo8","DGalpa1-6DGalpb1-C32O5","DGD(520_c_)-DGD(520_c_)",33.03,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo10","DGalpa1-6DGalpb1-C26O5","DGD(519_C_)-DGD(519_C_)",43.01,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo9","DGalpa1-6DGalpb1-C24O5","DGD(518_C_)-DGD(518_C_)",36.68,"","",""
"7PI0","UNSTACKED COMPACT DUNALIELLA PSII","10.7554/ELIFE.81150 ",2.43,"1.35632e-19","7pi0_oligo11","DGalpa1-6DGalpb1-C26O5","DGD(520_C_)-DGD(520_C_)",41.7,"","",""
"7PQY","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH FI-3A FAB","10.7150/THNO.65563 ",3,175.2,"7pqy_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(343_E_)",218.567,"","",""
"7PR7","CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH COVALENT INHIBITOR VL166","10.1073/PNAS.2203167119 ",1.52,33.37,"7pr7_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(459_A_)",56.1995,"","",""
"7PR8","CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH COVALENT INHIBITOR GR109","10.1073/PNAS.2203167119 ",1.66,36.5,"7pr8_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(459_A_)",65.62,"","",""
"7PRT","CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH COVALENT INHIBITOR CB678","10.1073/PNAS.2203167119 ",1.7,38.66,"7prt_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(459_A_)",77.0518,"","",""
"7PRY","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND BETA-6 FABS","10.1016/J.CHOM.2021.11.013 ",3.1,106.8,"7pry_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(343_I_)",145.205,"","",""
"7PRY","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-45 AND BETA-6 FABS","10.1016/J.CHOM.2021.11.013 ",3.1,106.8,"7pry_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(343_E_)",144.908,"","",""
"7PRZ","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-22 FABS","10.1016/J.CHOM.2021.11.013 ",3.2,131.3,"7prz_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(35_L_)",198.283,"","",""
"7PRZ","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-22 FABS","10.1016/J.CHOM.2021.11.013 ",3.2,131.3,"7prz_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",190.848,"","",""
"7PS2","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-29 AND BETA-53 FABS","10.1016/J.CHOM.2021.11.013 ",2.99,147,"7ps2_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(343_G_)",153.273,"","",""
"7PS5","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-47 FAB","10.1016/J.CHOM.2021.11.013 ",3.14,129.6,"7ps5_oligo2","DManpa1-6DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_E_)",205.859,"","",""
"7PS5","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-47 FAB","10.1016/J.CHOM.2021.11.013 ",3.14,129.6,"7ps5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(102_H_)",191.042,"","",""
"7PS6","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-44 AND BETA-54 FABS","10.1016/J.CHOM.2021.11.013 ",2.26,79.59,"7ps6_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(343_E_)",125.705,"","",""
"7PUK","CRYSTAL STRUCTURE OF ENDOGLYCOSIDASE E GH18 DOMAIN FROM ENTEROCOCCUS FAECALIS IN COMPLEX WITH MAN5 PRODUCT","10.1038/S41467-022-28722-W ",2.69,0,"7puk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-[MAN(6_B_)]-BMA(2_B_)-NAG(1_B_)",61.0827,"","",""
"7PUK","CRYSTAL STRUCTURE OF ENDOGLYCOSIDASE E GH18 DOMAIN FROM ENTEROCOCCUS FAECALIS IN COMPLEX WITH MAN5 PRODUCT","10.1038/S41467-022-28722-W ",2.69,0,"7puk_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-[MAN(6_D_)]-BMA(2_D_)-NAG(1_D_)",66.0082,"","",""
"7PUR","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 2","",3.9,137.3,"7pur_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(220_A_)",146.876,"","",""
"7PUR","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 2","",3.9,137.3,"7pur_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(220_B_)",178.129,"","",""
"7Q0G","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-49 AND FI-3A FABS","10.1016/J.CHOM.2021.11.013 ",1.82,46.63,"7q0g_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(343_E_)",73.6862,"","",""
"7Q0H","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-50 AND BETA-54","10.1016/J.CHOM.2021.11.013 ",3.65,125.6,"7q0h_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(343_E_)",115.631,"","",""
"7Q0I","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-43","10.1016/J.CHOM.2021.11.013 ",2.39,52.97,"7q0i_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(17_D_)",87.0255,"","",""
"7Q0I","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-43","10.1016/J.CHOM.2021.11.013 ",2.39,52.97,"7q0i_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(165_D_)",71.8245,"","",""
"7Q0I","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-43","10.1016/J.CHOM.2021.11.013 ",2.39,52.97,"7q0i_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(122_D_)",78.7752,"","",""
"7Q15","CRYSTAL STRUCTURE OF FCRN AND BETA-2-MICROGLOBULIN IN COMPLEX WITH IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",3.3,63.19,"7q15_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_E_)",123.087,"","",""
"7Q15","CRYSTAL STRUCTURE OF FCRN AND BETA-2-MICROGLOBULIN IN COMPLEX WITH IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",3.3,63.19,"7q15_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[MAN(7_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_F_)",129.195,"","",""
"7Q1M","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2S)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-2,2- DIPHENYLACETAMIDE","10.1016/J.EJMECH.2023.115135 ",2.79,76.48,"7q1m_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",140.634,"","",""
"7Q1M","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2S)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-2,2- DIPHENYLACETAMIDE","10.1016/J.EJMECH.2023.115135 ",2.79,76.48,"7q1m_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",116.638,"","",""
"7Q1M","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2S)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-2,2- DIPHENYLACETAMIDE","10.1016/J.EJMECH.2023.115135 ",2.79,76.48,"7q1m_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",164.032,"","",""
"7Q1N","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2R)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-2,2- DIPHENYLACETAMIDE","10.1016/J.EJMECH.2023.115135 ",2.35,73.77,"7q1n_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",145.647,"","",""
"7Q1N","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2R)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-2,2- DIPHENYLACETAMIDE","10.1016/J.EJMECH.2023.115135 ",2.35,73.77,"7q1n_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(106_A_)",131.107,"","",""
"7Q1N","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2R)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-2,2- DIPHENYLACETAMIDE","10.1016/J.EJMECH.2023.115135 ",2.35,73.77,"7q1n_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(341_A_)",103.635,"","",""
"7Q1N","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2R)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-2,2- DIPHENYLACETAMIDE","10.1016/J.EJMECH.2023.115135 ",2.35,73.77,"7q1n_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",141.017,"","",""
"7Q1O","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2S)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-3,3- DIPHENYLPROPANAMIDE","10.1016/J.EJMECH.2023.115135 ",2.65,71.13,"7q1o_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",123.278,"","",""
"7Q1O","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2S)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-3,3- DIPHENYLPROPANAMIDE","10.1016/J.EJMECH.2023.115135 ",2.65,71.13,"7q1o_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(106_A_)",118.708,"","",""
"7Q1O","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2S)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-3,3- DIPHENYLPROPANAMIDE","10.1016/J.EJMECH.2023.115135 ",2.65,71.13,"7q1o_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",101.749,"","",""
"7Q1P","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2R)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-3,3- DIPHENYLPROPANAMIDE","10.1016/J.EJMECH.2023.115135 ",2.35,66.66,"7q1p_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",117.628,"","",""
"7Q1P","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2R)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-3,3- DIPHENYLPROPANAMIDE","10.1016/J.EJMECH.2023.115135 ",2.35,66.66,"7q1p_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(106_A_)",95.3173,"","",""
"7Q1P","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- [(2R)-3-[(CYCLOHEXYLMETHYL)AMINO]-2-HYDROXYPROPYL]-3,3- DIPHENYLPROPANAMIDE","10.1016/J.EJMECH.2023.115135 ",2.35,66.66,"7q1p_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",92.7788,"","",""
"7Q24","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD011","10.1021/ACS.JMEDCHEM.1C01924 ",2,42.95,"7q24_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_A_)",62.1005,"","",""
"7Q24","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD011","10.1021/ACS.JMEDCHEM.1C01924 ",2,42.95,"7q24_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_B_)",67.5154,"","",""
"7Q24","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD011","10.1021/ACS.JMEDCHEM.1C01924 ",2,42.95,"7q24_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(416_B_)",90.7914,"","",""
"7Q24","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD011","10.1021/ACS.JMEDCHEM.1C01924 ",2,42.95,"7q24_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",66.5266,"","",""
"7Q25","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD012","10.1021/ACS.JMEDCHEM.1C01924 ",1.6,42.74,"7q25_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(416_A_)",58.3634,"","",""
"7Q25","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD012","10.1021/ACS.JMEDCHEM.1C01924 ",1.6,42.74,"7q25_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(416_B_)",90.0473,"","",""
"7Q25","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD012","10.1021/ACS.JMEDCHEM.1C01924 ",1.6,42.74,"7q25_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(480_B_)",68.5964,"","",""
"7Q25","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD012","10.1021/ACS.JMEDCHEM.1C01924 ",1.6,42.74,"7q25_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(480_A_)",67.1973,"","",""
"7Q26","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD013","10.1021/ACS.JMEDCHEM.1C01924 ",1.7,39.02,"7q26_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_B_)",58.7109,"","",""
"7Q26","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD013","10.1021/ACS.JMEDCHEM.1C01924 ",1.7,39.02,"7q26_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(416_B_)",84.1875,"","",""
"7Q26","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD013","10.1021/ACS.JMEDCHEM.1C01924 ",1.7,39.02,"7q26_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_A_)",57.6523,"","",""
"7Q26","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD013","10.1021/ACS.JMEDCHEM.1C01924 ",1.7,39.02,"7q26_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",57.8236,"","",""
"7Q27","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD011","10.1021/ACS.JMEDCHEM.1C01924 ",1.5,19.68,"7q27_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",42.5089,"","",""
"7Q28","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD012","10.1021/ACS.JMEDCHEM.1C01924 ",1.65,28.93,"7q28_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",55.8865,"","",""
"7Q29","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD013","10.1021/ACS.JMEDCHEM.1C01924 ",1.6,21.33,"7q29_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",52.7927,"","",""
"7Q3N","CRYO-EM OF THE COMPLEX BETWEEN HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) AND THE FIMH LECTIN DOMAIN FROM UROPATHOGENIC E. COLI","10.1038/S41594-022-00729-3 ",7.4,13.2733,"7q3n_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(76_U_)",500.4,"","",""
"7Q3N","CRYO-EM OF THE COMPLEX BETWEEN HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) AND THE FIMH LECTIN DOMAIN FROM UROPATHOGENIC E. COLI","10.1038/S41594-022-00729-3 ",7.4,13.2733,"7q3n_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(275_U_)",156.824,"","",""
"7Q3N","CRYO-EM OF THE COMPLEX BETWEEN HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) AND THE FIMH LECTIN DOMAIN FROM UROPATHOGENIC E. COLI","10.1038/S41594-022-00729-3 ",7.4,13.2733,"7q3n_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(232_U_)",237.809,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(297_A_)",71.0918,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(297_C_)",61.8418,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcx1-","NAG(4_E_)-MAN(3_E_)-BMA(2_E_)-NAG(1_E_)",60.3587,"","",""
"7Q3Y","STRUCTURE OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I- CONVERTING ENZYME SHOWING THE N- AND C-TERMINAL ELLIPSOID DOMAINS","10.15252/EMBJ.2021110550 ",4.34,"1.15243e-41","7q3y_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(648_A_)",191.184,"","",""
"7Q3Y","STRUCTURE OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I- CONVERTING ENZYME SHOWING THE N- AND C-TERMINAL ELLIPSOID DOMAINS","10.15252/EMBJ.2021110550 ",4.34,"1.15243e-41","7q3y_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(289_A_)",186.202,"","",""
"7Q3Y","STRUCTURE OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I- CONVERTING ENZYME SHOWING THE N- AND C-TERMINAL ELLIPSOID DOMAINS","10.15252/EMBJ.2021110550 ",4.34,"1.15243e-41","7q3y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(25_A_)",190.003,"","",""
"7Q49","LOCAL REFINEMENT STRUCTURE OF THE N-DOMAIN OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.72,"1.15243e-41","7q49_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",185.567,"","",""
"7Q49","LOCAL REFINEMENT STRUCTURE OF THE N-DOMAIN OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.72,"1.15243e-41","7q49_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(25_A_)",193.674,"","",""
"7Q4C","LOCAL REFINEMENT STRUCTURE OF THE C-DOMAIN OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",4.08,"1.15243e-41","7q4c_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(648_A_)",83.8132,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(25_A_)",100.57,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo10","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(25_B_)",101.383,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",120.422,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo11","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_M_)-[NAG(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(289_B_)",115.79,"","",""
"7Q4E","LOCAL REFINEMENT STRUCTURE OF A SINGLE N-DOMAIN OF FULL-LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.63,"1.15243e-41","7q4e_oligo5","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(25_A_)",109.553,"","",""
"7Q4E","LOCAL REFINEMENT STRUCTURE OF A SINGLE N-DOMAIN OF FULL-LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.63,"1.15243e-41","7q4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",124.826,"","",""
"7Q6E","BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS- COV-2 VARIANTS","10.1016/J.CHOM.2021.11.013 ",2.7,512.502,"7q6e_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_V_)-[MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(340_C_)",85.4979,"","",""
"7Q6E","BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS- COV-2 VARIANTS","10.1016/J.CHOM.2021.11.013 ",2.7,512.502,"7q6e_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(340_A_)",69.0604,"","",""
"7Q6E","BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS- COV-2 VARIANTS","10.1016/J.CHOM.2021.11.013 ",2.7,512.502,"7q6e_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_P_)-[MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(340_B_)",99.2105,"","",""
"7Q9F","BETA-50 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN","10.1016/J.CHOM.2021.11.013 ",3.6,2050.01,"7q9f_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(340_B_)",189.976,"","",""
"7Q9F","BETA-50 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN","10.1016/J.CHOM.2021.11.013 ",3.6,2050.01,"7q9f_oligo13","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(340_C_)",173.848,"","",""
"7Q9F","BETA-50 FAB IN COMPLEX WITH SARS-COV-2 BETA-SPIKE GLYCOPROTEIN","10.1016/J.CHOM.2021.11.013 ",3.6,2050.01,"7q9f_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(340_A_)",186.143,"","",""
"7QA4","CRYSTAL STRUCTURE OF STABILIZED H3N2 A/HONG KONG/1/1968 HEMAGGLUTININ AT 2.2 ANGSTROM","10.1073/PNAS.2115379119 ",2.19,66.57,"7qa4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",108.735,"","",""
"7QBQ","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-BENZYL-1-(8- HYDROXYQUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.49,68.53,"7qbq_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",129.026,"","",""
"7QBQ","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-BENZYL-1-(8- HYDROXYQUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.49,68.53,"7qbq_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",95.9955,"","",""
"7QBQ","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-BENZYL-1-(8- HYDROXYQUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.49,68.53,"7qbq_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(241_A_)",122.65,"","",""
"7QBQ","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-BENZYL-1-(8- HYDROXYQUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.49,68.53,"7qbq_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(106_A_)",110.414,"","",""
"7QBR","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-TERT-BUTYL-1-(8-(3- (4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.13,60.78,"7qbr_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",91.4612,"","",""
"7QBR","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-TERT-BUTYL-1-(8-(3- (4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.13,60.78,"7qbr_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(106_A_)",111.992,"","",""
"7QBR","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-TERT-BUTYL-1-(8-(3- (4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.13,60.78,"7qbr_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(57_A_)",118.757,"","",""
"7QBR","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (Z)-N-TERT-BUTYL-1-(8-(3- (4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLIN-2-YL)METHANIMINE OXIDE","10.1016/J.APSB.2023.01.013 ",2.13,60.78,"7qbr_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(241_A_)",108.775,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(4738_B_)",32.9545,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_H_)-NAG(8_H_)-MAN(7_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(4578_B_)",30.101,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo4","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(14_D_)-[GAL(13_D_)-NAG(12_D_)-[GAL(11_D_)-NAG(10_D_)]-MAN(9_D_)-[GAL(8_D_)-NAG(7_D_)-[GAL(6_D_)-NAG(5_D_)]-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(4567_A_)",30.0649,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(4832_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_G_)-[GAL(9_G_)-NAG(8_G_)-MAN(7_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(4703_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_F_)-[GAL(9_F_)-NAG(8_F_)-MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(4839_B_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo13","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(12_O_)-[GAL(11_O_)-NAG(10_O_)-MAN(9_O_)-[GAL(8_O_)-NAG(7_O_)-[GAL(6_O_)-NAG(5_O_)]-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(4567_B_)",36.6591,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(4906_A_)",30.2273,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo1","DManpa1-3[DManpb1-4]DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[BMA(4_I_)-[MAN(3_I_)]-NAG(2_I_)]-NAG(1_I_)-ASN(4738_A_)",30.1818,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo9","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_J_)-[GAL(9_J_)-NAG(8_J_)-MAN(7_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(4839_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo14","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_Q_)-[GAL(9_Q_)-NAG(8_Q_)-MAN(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(4832_B_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_K_)-NAG(8_K_)-MAN(7_K_)-[GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(4578_A_)",30.101,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(4906_B_)",30.2273,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo10","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_L_)-[GAL(9_L_)-NAG(8_L_)-MAN(7_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(4703_B_)",30.0909,"","",""
"7QCN","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS: VWCN TO TIL DOMAINS WITH A C2 SYMMETRY","",3.4,0,"7qcn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4578_A_)",30.1818,"","",""
"7QCN","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS: VWCN TO TIL DOMAINS WITH A C2 SYMMETRY","",3.4,0,"7qcn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(4578_B_)",30.1818,"","",""
"7QCU","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS PARTIALLY DEGLYCOSYLATED.","",3.25,0,"7qcu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4578_A_)",41.8182,"","",""
"7QCU","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS PARTIALLY DEGLYCOSYLATED.","",3.25,0,"7qcu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(4578_B_)",38.1818,"","",""
"7QHD","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-1-(4-((2-(1H-INDOL-3- YL)ETHYL)CARBAMOYL)BENZYL)-N-(3-((1,2,3,4-TETRAHYDROACRIDIN-9-YL) AMINO)PROPYL)PIPERIDINE-3-CARBOXAMIDE","10.1016/J.BIOORG.2023.106465 ",2.04,45.92,"7qhd_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",66.0455,"","",""
"7QHD","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-1-(4-((2-(1H-INDOL-3- YL)ETHYL)CARBAMOYL)BENZYL)-N-(3-((1,2,3,4-TETRAHYDROACRIDIN-9-YL) AMINO)PROPYL)PIPERIDINE-3-CARBOXAMIDE","10.1016/J.BIOORG.2023.106465 ",2.04,45.92,"7qhd_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(106_A_)",90.3794,"","",""
"7QHD","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-1-(4-((2-(1H-INDOL-3- YL)ETHYL)CARBAMOYL)BENZYL)-N-(3-((1,2,3,4-TETRAHYDROACRIDIN-9-YL) AMINO)PROPYL)PIPERIDINE-3-CARBOXAMIDE","10.1016/J.BIOORG.2023.106465 ",2.04,45.92,"7qhd_oligo8","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",94.9796,"","",""
"7QHE","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-1-(4-((NAPHTHALEN-1- YL)CARBAMOYL)BENZYL)-N-(3-((1,2,3,4-TETRAHYDROACRIDIN-9-YL)AMINO) PROPYL)PIPERIDINE-3-CARBOXAMIDE","10.1016/J.BIOORG.2023.106465 ",2.47,56.79,"7qhe_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",81.7046,"","",""
"7QHE","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-1-(4-((NAPHTHALEN-1- YL)CARBAMOYL)BENZYL)-N-(3-((1,2,3,4-TETRAHYDROACRIDIN-9-YL)AMINO) PROPYL)PIPERIDINE-3-CARBOXAMIDE","10.1016/J.BIOORG.2023.106465 ",2.47,56.79,"7qhe_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",121.31,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_C_)",188.371,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(141_B_)",120.714,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-[MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(141_E_)",120.907,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",103.199,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(143_C_)",125.936,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",99.4149,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(141_E_)",75.2905,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_C_)",122.229,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",69.9748,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(141_B_)",86.1187,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(143_C_)",82.0325,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",65.3742,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(143_C_)",123.075,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(141_E_)",105.341,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_C_)",167.488,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(141_B_)",128.369,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",93.2959,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",96.9753,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",84.3865,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",138.598,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_D_)",78.4831,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_C_)",77.8322,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",105.804,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",77.4236,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",69.9598,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",95.0315,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",106.8,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_C_)",98.9287,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_D_)",100.545,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",159.157,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",100.687,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",123.403,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",92.7305,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",93.398,"","",""
"7QN9","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25 IN A PRE- OPEN/CLOSED STATE","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qn9_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_C_)",98.6518,"","",""
"7QN9","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25 IN A PRE- OPEN/CLOSED STATE","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qn9_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_D_)",107.843,"","",""
"7QN9","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25 IN A PRE- OPEN/CLOSED STATE","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qn9_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",111.025,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_E_)",126.206,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_D_)",154.745,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",136.393,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",192.224,"","",""
"7QNB","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qnb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_E_)",113.428,"","",""
"7QNB","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qnb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_D_)",155.846,"","",""
"7QNB","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qnb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",154.516,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_D_)",98.0682,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_C_)",95.5549,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",154.41,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",107.594,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",161.598,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",98.2911,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",104.781,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",96.7836,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_E_)",78.2491,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_a_)-[MAN(8_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(111_A_)",65.8454,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(111_D_)",93.0927,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",75.7353,"","",""
"7QO7","SARS-COV-2 S OMICRON SPIKE B.1.1.529","10.1101/2021.12.27.474250 ",3.02,0,"7qo7_oligo22","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(1071_C_)",86.5485,"","",""
"7QQF","CRYSTAL STRUCTURE OF UNLIGANDED MYORG","10.1371/JOURNAL.PBIO.3001764 ",2.43,58.35,"7qqf_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(511_A_)",95.7209,"","",""
"7QQF","CRYSTAL STRUCTURE OF UNLIGANDED MYORG","10.1371/JOURNAL.PBIO.3001764 ",2.43,58.35,"7qqf_oligo6","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[NAG(3_J_)]-[FUC(2_J_)]-NAG(1_J_)-ASN(372_C_)",106.247,"","",""
"7QQG","CRYSTAL STRUCTURE OF MYORG BOUND TO 1-DEOXYGALACTONOJIRIMYCIN","10.1371/JOURNAL.PBIO.3001764 ",2.43,56.61,"7qqg_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(346_A_)",67.4485,"","",""
"7QU1","MACHUPO VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH FAB FRAGMENT OF ANTIBODY MAC1","10.1128/MBIO.02650-21 ",1.91,44.95,"7qu1_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(178_C_)",74.2584,"","",""
"7QUO","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3,44.82,"7quo_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_E_)-[MAN(7_E_)]-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",68.9084,"","",""
"7QUO","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3,44.82,"7quo_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",63.8168,"","",""
"7QUR","SARS-COV-2 SPIKE WITH ETHYLBENZAMIDE-TRI-IODO SIALLYLLACTOSE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.27,"1.15243e-41","7qur_oligo12","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[NAG(3_O_)]-[FUC(2_O_)]-NAG(1_O_)-ASN(165_C_)",73.8577,"","",""
"7QUR","SARS-COV-2 SPIKE WITH ETHYLBENZAMIDE-TRI-IODO SIALLYLLACTOSE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.27,"1.15243e-41","7qur_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(165_A_)",73.8577,"","",""
"7QUR","SARS-COV-2 SPIKE WITH ETHYLBENZAMIDE-TRI-IODO SIALLYLLACTOSE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.27,"1.15243e-41","7qur_oligo8","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(165_B_)",73.8577,"","",""
"7QUS","SARS-COV-2 SPIKE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.39,"1.15243e-41","7qus_oligo12","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[NAG(3_O_)]-[FUC(2_O_)]-NAG(1_O_)-ASN(165_C_)",58.3302,"","",""
"7QUS","SARS-COV-2 SPIKE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.39,"1.15243e-41","7qus_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(165_A_)",58.3302,"","",""
"7QUS","SARS-COV-2 SPIKE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.39,"1.15243e-41","7qus_oligo5","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(165_B_)",58.3302,"","",""
"7QZR","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.18,32.35,"7qzr_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(483_D_)",35.353,"","",""
"7QZR","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.18,32.35,"7qzr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(483_B_)",35.4898,"","",""
"7R14","ALPHA VARIANT SARS-COV-2 SPIKE WITH 1 ERECT RBD","10.1038/S41467-022-28768-W ",3.4,0,"7r14_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(1074_A_)",94.7524,"","",""
"7R18","MINK VARIANT SARS-COV-2 SPIKE IN CLOSED CONFORMATION","10.1038/S41467-022-28768-W ",3,0,"7r18_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(1098_A_)",35.89,"","",""
"7R18","MINK VARIANT SARS-COV-2 SPIKE IN CLOSED CONFORMATION","10.1038/S41467-022-28768-W ",3,0,"7r18_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(1098_B_)",35.89,"","",""
"7R18","MINK VARIANT SARS-COV-2 SPIKE IN CLOSED CONFORMATION","10.1038/S41467-022-28768-W ",3,0,"7r18_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(1098_C_)",35.89,"","",""
"7R3K","CHLAMYDOMONAS REINHARDTII TSP9 MUTANT SMALL PHOTOSYSTEM I COMPLEX","10.3390/BIOM13030537 ",2.52,"1.08527e-19","7r3k_oligo12","DGalpa1-6DGalpb1-C39O5","DGD(848_B_)-DGD(848_B_)",20.69,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",89.1007,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",92.6009,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",94.6846,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",92.5293,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",111.123,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",102.033,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",91.0413,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",99.7284,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",97.7238,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",100.23,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",111.082,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",79.4584,"","",""
"7R7N","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2D106 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND S2D106)","10.1038/S41586-021-03807-6 ",3.95,"5.37397e+08","7r7n_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",79.0206,"","",""
"7R8L","STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODY C099 AND CR3022","10.1016/J.IMMUNI.2021.07.008 ",2.6,59.94,"7r8l_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_A_)-[BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",111.756,"","",""
"7R8M","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C032","10.1016/J.IMMUNI.2021.07.008 ",3.4,2050.01,"7r8m_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(343_B_)",122.442,"","",""
"7R8O","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C548","10.1016/J.IMMUNI.2021.07.008 ",3.5,"5.50295e+11","7r8o_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(343_B_)",162.773,"","",""
"7R8O","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C548","10.1016/J.IMMUNI.2021.07.008 ",3.5,"5.50295e+11","7r8o_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_Q_)-[MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(343_E_)",163.053,"","",""
"7R8O","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY C548","10.1016/J.IMMUNI.2021.07.008 ",3.5,"5.50295e+11","7r8o_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(343_A_)",162.306,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-[MAN(6_b_)-MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",89.9704,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",89.9704,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo28","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_n_)-[MAN(6_n_)-MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_E_)",89.9704,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(156_A_)",103.891,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(156_E_)",103.891,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(156_C_)",103.891,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo23","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(137_C_)",325.86,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(282_A_)",189.057,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo24","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(234_C_)",372.732,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo22","DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(122_C_)",410.808,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo13","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(137_B_)",232.911,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo25","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(282_C_)",309.93,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo2","DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(122_A_)",179.761,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_B_)",227.773,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo15","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(282_B_)",275.562,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo12","DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(122_B_)",287.413,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(234_A_)",220.51,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo11","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(137_A_)",242.775,"","",""
"7RC9","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 21","10.1021/ACSMEDCHEMLETT.2C00049 ",2.76,90.81,"7rc9_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",97.5545,"","",""
"7RC9","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 21","10.1021/ACSMEDCHEMLETT.2C00049 ",2.76,90.81,"7rc9_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",109.128,"","",""
"7RC9","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 21","10.1021/ACSMEDCHEMLETT.2C00049 ",2.76,90.81,"7rc9_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",81.0415,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo53","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",6.37,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo52","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",11.04,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo48","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",11.04,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo46","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",8.34,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo51","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",12.42,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo47","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",12.42,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo49","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",6.37,"","",""
"7RCV","HIGH-RESOLUTION STRUCTURE OF PHOTOSYSTEM II FROM THE MESOPHILIC CYANOBACTERIUM, SYNECHOCYSTIS SP. PCC 6803","10.1073/PNAS.2116765118 ",2.01,"1.35632e-19","7rcv_oligo50","DGalpa1-6DGalpb1-C35O5","DGD(515_c_)-DGD(515_c_)",8.34,"","",""
"7RDM","CRYSTAL STRUCTURE OF PCDN-38B, A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY","10.1016/J.JMB.2021.167303 ",2.08,42.61,"7rdm_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(26_B_)",78.0156,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(556_C_)",109.962,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(540_C_)",116.093,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(540_D_)",133.039,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(623_D_)",127.645,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(556_D_)",127.018,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(623_C_)",119.201,"","",""
"7RFC","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1382 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",3.24,72.59,"7rfc_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(556_D_)",111.64,"","",""
"7RGF","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE DISRUPTED TRANS INTERFACE","10.7554/ELIFE.72416 ",2.4,73.39,"7rgf_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(236_B_)",93.0596,"","",""
"7RGF","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE DISRUPTED TRANS INTERFACE","10.7554/ELIFE.72416 ",2.4,73.39,"7rgf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(236_A_)",88.4368,"","",""
"7RKS","STRUCTURE OF THE SARS-COV RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C118","10.1016/J.CELREP.2021.109760 ",2.7,62.79,"7rks_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(330_S_)",98.2342,"","",""
"7ROQ","ALTERNATIVE STRUCTURE OF HUMAN ABCA1","",4.1,0,"7roq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1504_A_)",77.7536,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(197_G_)",68.1662,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(276_A_)",63.6827,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(197_A_)",68.1662,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(276_C_)",63.6827,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(276_G_)",63.6827,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo17","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-MAN(4_c_)-[MAN(6_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_G_)",78.4573,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(197_C_)",68.1662,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_C_)",78.4573,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",78.4573,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(276_C_)",120.377,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(276_D_)",120.377,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",96.2758,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(276_A_)",120.377,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",96.2758,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_D_)",96.2758,"","",""
"7RU3","CC6.33 IGG IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (NON-UNIFORM REFINEMENT)","10.1016/J.ISCI.2022.104914 ",3.3,"1.08527e-19","7ru3_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(343_B_)",183.341,"","",""
"7RU4","CC6.33 IGG IN COMPLEX WITH SARS-COV-2-6P-MUT7 S PROTEIN (RBD/FV LOCAL REFINEMENT)","10.1016/J.ISCI.2022.104914 ",3.3,"1.08527e-19","7ru4_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",74.7354,"","",""
"7S2S","NANOBODY BOUND TO INTERLEUKIN-2RBETA","10.1016/J.CELL.2022.02.025 ",1.93,54.65,"7s2s_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",60.7085,"","",""
"7S2S","NANOBODY BOUND TO INTERLEUKIN-2RBETA","10.1016/J.CELL.2022.02.025 ",1.93,54.65,"7s2s_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)",38.6787,"","",""
"7S2S","NANOBODY BOUND TO INTERLEUKIN-2RBETA","10.1016/J.CELL.2022.02.025 ",1.93,54.65,"7s2s_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)",67.6511,"","",""
"7S2S","NANOBODY BOUND TO INTERLEUKIN-2RBETA","10.1016/J.CELL.2022.02.025 ",1.93,54.65,"7s2s_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)",40.894,"","",""
"7S69","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) GAMMA SUBUNIT (GNPTG), FROM CLAWED FROG","10.1073/PNAS.2203518119 ",3.04,56.35,"7s69_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(87_A_)",76.8762,"","",""
"7S69","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) GAMMA SUBUNIT (GNPTG), FROM CLAWED FROG","10.1073/PNAS.2203518119 ",3.04,56.35,"7s69_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(87_B_)",72.0631,"","",""
"7S6N","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH","10.1073/PNAS.2203518119 ",2.7,46.95,"7s6n_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(187_A_)",68.9882,"","",""
"7S6N","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH","10.1073/PNAS.2203518119 ",2.7,46.95,"7s6n_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(187_B_)",95.9224,"","",""
"7S8H","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C AND FAB 36.1F","10.1016/J.CELREP.2022.110841 ",2.7,79.91,"7s8h_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(99_A_)",126.267,"","",""
"7S8H","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C AND FAB 36.1F","10.1016/J.CELREP.2022.110841 ",2.7,79.91,"7s8h_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(395_a_)",120.156,"","",""
"7S8H","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C AND FAB 36.1F","10.1016/J.CELREP.2022.110841 ",2.7,79.91,"7s8h_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(119_A_)",128.201,"","",""
"7S8H","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C AND FAB 36.1F","10.1016/J.CELREP.2022.110841 ",2.7,79.91,"7s8h_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(79_A_)",117.035,"","",""
"7SA3","STRUCTURE OF A MONOMERIC PHOTOSYSTEM II CORE COMPLEX FROM A CYANOBACTERIUM ACCLIMATED TO FAR-RED LIGHT","10.1016/J.JBC.2021.101424 ",2.25,"1.08527e-19","7sa3_oligo9","DGalpa1-6DGalpb1-C20O5","DGD(515_C_)-DGD(515_C_)",26.57,"","",""
"7SBD","MURINE FAB/IGE IN COMPLEX WITH PROFILIN FROM HEVEA BRASIELIENSIS (HEV B 8)","10.1038/S42003-022-03718-W ",3.04,63.99,"7sbd_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(189_H_)",81.3969,"","",""
"7SBG","MURINE FAB/IGE IN COMPLEX WITH PROFILIN FROM HEVEA BRASIELIENSIS (HEV B 8)","10.1038/S42003-022-03718-W ",3.34,73.1,"7sbg_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(189_H_)",92.4527,"","",""
"7SBK","CLOSED STATE OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbk_oligo18","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(1074_A_)",108.642,"","",""
"7SBK","CLOSED STATE OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbk_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(1074_B_)",108.642,"","",""
"7SBK","CLOSED STATE OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbk_oligo29","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_f_)-[NAG(2_f_)]-NAG(1_f_)-ASN(1074_C_)",108.642,"","",""
"7SBL","ONE RBD-UP 1 OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbl_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",85.1564,"","",""
"7SBL","ONE RBD-UP 1 OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbl_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(1074_B_)",108.277,"","",""
"7SBL","ONE RBD-UP 1 OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbl_oligo25","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(1074_C_)",96.8561,"","",""
"7SBO","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbo_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1074_B_)",94.4761,"","",""
"7SBO","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbo_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",96.8561,"","",""
"7SBO","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 DELTA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbo_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",85.1564,"","",""
"7SBP","CLOSED STATE OF PRE-FUSION SARS-COV-2 KAPPA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbp_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(1074_A_)",116.182,"","",""
"7SBP","CLOSED STATE OF PRE-FUSION SARS-COV-2 KAPPA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbp_oligo32","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_i_)-[NAG(2_i_)]-NAG(1_i_)-ASN(1074_C_)",124.386,"","",""
"7SBP","CLOSED STATE OF PRE-FUSION SARS-COV-2 KAPPA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.44,"1.15243e-41","7sbp_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(1074_B_)",123.195,"","",""
"7SBR","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 KAPPA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbr_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",85.1142,"","",""
"7SBR","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 KAPPA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbr_oligo18","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(1074_B_)",94.4761,"","",""
"7SBR","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 KAPPA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbr_oligo29","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_f_)-[NAG(2_f_)]-NAG(1_f_)-ASN(1074_C_)",96.8561,"","",""
"7SBS","ONE RBD-UP 1 OF PRE-FUSION SARS-COV-2 GAMMA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbs_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(1074_A_)",85.1564,"","",""
"7SBS","ONE RBD-UP 1 OF PRE-FUSION SARS-COV-2 GAMMA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbs_oligo25","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(1074_C_)",96.8561,"","",""
"7SBS","ONE RBD-UP 1 OF PRE-FUSION SARS-COV-2 GAMMA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbs_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(1074_B_)",94.4761,"","",""
"7SBT","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 GAMMA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbt_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(1074_B_)",94.4761,"","",""
"7SBT","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 GAMMA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbt_oligo26","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_c_)-[NAG(2_c_)]-NAG(1_c_)-ASN(1074_C_)",96.8561,"","",""
"7SBT","ONE RBD-UP 2 OF PRE-FUSION SARS-COV-2 GAMMA VARIANT SPIKE PROTEIN","10.1126/SCIENCE.ABL9463 ",3.5,"1.15243e-41","7sbt_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(1074_A_)",85.1564,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(365_c_)",100.971,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo18","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(395_b_)",124.419,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(365_b_)",100.971,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_g_)-[NAG(2_g_)]-NAG(1_g_)-ASN(395_c_)",124.419,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(365_a_)",100.971,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(395_a_)",124.419,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(395_a_)",203.06,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo14","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(390_a_)",146.777,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo26","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_l_)-[NAG(2_l_)]-NAG(1_l_)-ASN(395_c_)",203.06,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_A_)",142.597,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo17","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Z_)-[NAG(2_Z_)]-NAG(1_Z_)-ASN(395_b_)",203.06,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(109_C_)",142.597,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Y_)-[BMA(3_Y_)-NAG(2_Y_)]-NAG(1_Y_)-ASN(390_b_)",146.777,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo25","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_k_)-[BMA(3_k_)-NAG(2_k_)]-NAG(1_k_)-ASN(390_c_)",146.777,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(109_B_)",142.597,"","",""
"7SHT","STRUCTURE OF A PARTIALLY DISRUPTED IGE HIGH AFFINITY RECEPTOR COMPLEX BOUND TO AN OMALIZUMAB VARIANT","10.1038/S41467-021-27397-Z ",7.29,"2.06915e+08","7sht_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",320.077,"","",""
"7SHT","STRUCTURE OF A PARTIALLY DISRUPTED IGE HIGH AFFINITY RECEPTOR COMPLEX BOUND TO AN OMALIZUMAB VARIANT","10.1038/S41467-021-27397-Z ",7.29,"2.06915e+08","7sht_oligo7","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_D_)",343.719,"","",""
"7SHU","IGE-FC IN COMPLEX WITH OMALIZUMAB VARIANT C02","10.1038/S41467-021-27397-Z ",2.75,98.91,"7shu_oligo2","DManpb1-4[DManpa1-6]DGlcpNAcb1-ASN","MAN(3_H_)-[BMA(2_H_)]-NAG(1_H_)-ASN(28_C_)",115.362,"","",""
"7SHY","IGE-FC IN COMPLEX WITH OMALIZUMAB SCFV","10.1038/S41467-021-27397-Z ",3,99.2,"7shy_oligo2","DManpb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(394_G_)",131.48,"","",""
"7SHY","IGE-FC IN COMPLEX WITH OMALIZUMAB SCFV","10.1038/S41467-021-27397-Z ",3,99.2,"7shy_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(394_B_)",142.045,"","",""
"7SHY","IGE-FC IN COMPLEX WITH OMALIZUMAB SCFV","10.1038/S41467-021-27397-Z ",3,99.2,"7shy_oligo1","DManpa1-3DGlcp[2<R1>]x[LFucpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","FUC(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(394_A_)",138.014,"","",""
"7SHY","IGE-FC IN COMPLEX WITH OMALIZUMAB SCFV","10.1038/S41467-021-27397-Z ",3,99.2,"7shy_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-THR","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-THR(396_H_)",147.985,"","",""
"7SHZ","IGE-FC IN COMPLEX WITH HAE","10.1038/S41467-021-27397-Z ",3,112.4,"7shz_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(394_A_)",158.27,"","",""
"7SHZ","IGE-FC IN COMPLEX WITH HAE","10.1038/S41467-021-27397-Z ",3,112.4,"7shz_oligo1","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(394_B_)",154.672,"","",""
"7SHZ","IGE-FC IN COMPLEX WITH HAE","10.1038/S41467-021-27397-Z ",3,112.4,"7shz_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-[MAN(6_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(394_H_)",171.196,"","",""
"7SI0","IGE-FC IN COMPLEX WITH 813","10.1038/S41467-021-27397-Z ",3,65.07,"7si0_oligo5","DManpa1-6DManpx1-","MAN(2_Q_)-MAN(1_Q_)",67.0227,"","",""
"7SI0","IGE-FC IN COMPLEX WITH 813","10.1038/S41467-021-27397-Z ",3,65.07,"7si0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(394_A_)",89.0682,"","",""
"7SI0","IGE-FC IN COMPLEX WITH 813","10.1038/S41467-021-27397-Z ",3,65.07,"7si0_oligo2","DManpa1-6DManpx1-","MAN(2_N_)-MAN(1_N_)",48.4273,"","",""
"7SJ2","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH, IN COMPLEX WITH URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE (UDP-GLCNAC) AND MAGNESIUM","10.1073/PNAS.2203518119 ",2.3,50.76,"7sj2_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(376_A_)",101.891,"","",""
"7SJ2","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH, IN COMPLEX WITH URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE (UDP-GLCNAC) AND MAGNESIUM","10.1073/PNAS.2203518119 ",2.3,50.76,"7sj2_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",67.0871,"","",""
"7SJ2","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH, IN COMPLEX WITH URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE (UDP-GLCNAC) AND MAGNESIUM","10.1073/PNAS.2203518119 ",2.3,50.76,"7sj2_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(187_B_)",97.3694,"","",""
"7SJ2","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH, IN COMPLEX WITH URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE (UDP-GLCNAC) AND MAGNESIUM","10.1073/PNAS.2203518119 ",2.3,50.76,"7sj2_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(187_A_)",82.8494,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo34","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_m_)-MAN(4_m_)-[MAN(6_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)",166.894,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo6","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_d_)-MAN(5_d_)-MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)",130.419,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo19","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_i_)-MAN(4_i_)-[MAN(6_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)",166.894,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",130.419,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo21","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_k_)-MAN(5_k_)-MAN(4_k_)-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)",130.419,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo32","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",166.894,"","",""
"7SLV","VANIN-1 COMPLEXED WITH COMPOUND 3","10.1021/ACS.JMEDCHEM.1C01849 ",2.13,53.28,"7slv_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(294_A_)",92.1431,"","",""
"7SLV","VANIN-1 COMPLEXED WITH COMPOUND 3","10.1021/ACS.JMEDCHEM.1C01849 ",2.13,53.28,"7slv_oligo1","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(179_A_)",53.1135,"","",""
"7SLX","VANIN-1 COMPLEXED WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.1C01849 ",2.35,59.19,"7slx_oligo5","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",57.5398,"","",""
"7SLY","VANIN-1 COMPLEXED WITH COMPOUND 27","10.1021/ACS.JMEDCHEM.1C01849 ",2.17,65.13,"7sly_oligo6","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(179_A_)",62.0695,"","",""
"7SMM","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM","10.1038/S41594-022-00737-3 ",2.5,"1.08527e-19","7smm_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",71.6678,"","",""
"7SMM","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM","10.1038/S41594-022-00737-3 ",2.5,"1.08527e-19","7smm_oligo4","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",78.1909,"","",""
"7SMM","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM","10.1038/S41594-022-00737-3 ",2.5,"1.08527e-19","7smm_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",75.4939,"","",""
"7SMQ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM WITH ADDED CHOLESTEROL","10.1038/S41594-022-00737-3 ",2.7,"1.08527e-19","7smq_oligo6","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",76.6926,"","",""
"7SMQ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM WITH ADDED CHOLESTEROL","10.1038/S41594-022-00737-3 ",2.7,"1.08527e-19","7smq_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",74.6358,"","",""
"7SMQ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM WITH ADDED CHOLESTEROL","10.1038/S41594-022-00737-3 ",2.7,"1.08527e-19","7smq_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",73.2971,"","",""
"7SMR","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH CARBACHOL, DESENSITIZED STATE","10.1038/S41594-022-00737-3 ",2.77,"1.08527e-19","7smr_oligo5","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",72.2858,"","",""
"7SMR","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH CARBACHOL, DESENSITIZED STATE","10.1038/S41594-022-00737-3 ",2.77,"1.08527e-19","7smr_oligo4","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",63.4205,"","",""
"7SMR","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH CARBACHOL, DESENSITIZED STATE","10.1038/S41594-022-00737-3 ",2.77,"1.08527e-19","7smr_oligo3","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",64.6922,"","",""
"7SMS","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH D- TUBOCURARINE","10.1038/S41594-022-00737-3 ",3.18,"1.08527e-19","7sms_oligo5","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",78.4351,"","",""
"7SMS","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH D- TUBOCURARINE","10.1038/S41594-022-00737-3 ",3.18,"1.08527e-19","7sms_oligo2","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",71.1554,"","",""
"7SMS","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH D- TUBOCURARINE","10.1038/S41594-022-00737-3 ",3.18,"1.08527e-19","7sms_oligo4","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",82.3962,"","",""
"7SMT","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH D- TUBOCURARINE AND CARBACHOL","10.1038/S41594-022-00737-3 ",2.56,"1.08527e-19","7smt_oligo5","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",78.4473,"","",""
"7SMT","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH D- TUBOCURARINE AND CARBACHOL","10.1038/S41594-022-00737-3 ",2.56,"1.08527e-19","7smt_oligo4","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",74.112,"","",""
"7SMT","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH D- TUBOCURARINE AND CARBACHOL","10.1038/S41594-022-00737-3 ",2.56,"1.08527e-19","7smt_oligo2","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",68.7544,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(103_A_)",137.377,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo11","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_O_)-MAN(8_O_)-[GAL(6_O_)-NAG(5_O_)-[NAG(7_O_)]-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(90_B_)",154.758,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo3","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(10_I_)-MAN(9_I_)-[GAL(8_I_)-NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(90_A_)",153.312,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(103_B_)",146.426,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo9","DGlcpNAcb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(546_B_)",157.943,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(322_B_)",150.049,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo2","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(10_H_)-NAG(9_H_)-MAN(8_H_)-[GAL(6_H_)-NAG(5_H_)-[NAG(7_H_)]-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(53_A_)",163.886,"","",""
"7SN2","STRUCTURE OF HUMAN SARS-COV-2 NEUTRALIZING ANTIBODY C1C-A3 FAB","10.1126/SCIENCE.ABL6251 ",4.3,"1.08527e-19","7sn2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(343_A_)",112.631,"","",""
"7SO9","SARS-COV-2 S B.1.617.2 DELTA VARIANT + S2M11 + S2L20 GLOBAL REFINEMENT","10.1126/SCIENCE.ABL8506 ",2.4,524802,"7so9_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(343_F_)",1.64545,"","",""
"7SO9","SARS-COV-2 S B.1.617.2 DELTA VARIANT + S2M11 + S2L20 GLOBAL REFINEMENT","10.1126/SCIENCE.ABL8506 ",2.4,524802,"7so9_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_P_)-NAG(1_P_)-ASN(343_A_)",1.64545,"","",""
"7SO9","SARS-COV-2 S B.1.617.2 DELTA VARIANT + S2M11 + S2L20 GLOBAL REFINEMENT","10.1126/SCIENCE.ABL8506 ",2.4,524802,"7so9_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(343_K_)",1.64545,"","",""
"7SOC","SARS-COV-2 S RBD B.1.617.1 KAPPA VARIANT S309 LOCAL REFINEMENT","10.1126/SCIENCE.ABL8506 ",3.3,"5.50295e+11","7soc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",23.2536,"","",""
"7SPO","CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH VNAR 3B4","10.1038/S41467-021-27611-Y ",1.92,62.22,"7spo_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(343_B_)",123.464,"","",""
"7SPO","CRYSTAL STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH VNAR 3B4","10.1038/S41467-021-27611-Y ",1.92,62.22,"7spo_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(343_A_)",102.261,"","",""
"7SSQ","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0075231","",2.25,67.34,"7ssq_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",87.7576,"","",""
"7SSR","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0075093","",2.5,72.9,"7ssr_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",80.9807,"","",""
"7SYY","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.74,73.91,"7syy_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(481_A_)",112.409,"","",""
"7SYY","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.74,73.91,"7syy_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-[FUC(5_B_)]-NAG(1_B_)-ASN(529_A_)",92.6753,"","",""
"7SYY","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.74,73.91,"7syy_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(378_A_)",123.802,"","",""
"7SYZ","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.86,67.92,"7syz_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_D_)-[BMA(3_D_)-NAG(2_D_)]-[FUC(4_D_)]-NAG(1_D_)-ASN(378_A_)",86.1089,"","",""
"7SYZ","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.86,67.92,"7syz_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(481_A_)",79.3259,"","",""
"7SYZ","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.86,67.92,"7syz_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-[FUC(5_E_)]-NAG(1_E_)-ASN(529_A_)",80.2823,"","",""
"7SYZ","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.86,67.92,"7syz_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(306_A_)",86.4827,"","",""
"7T2D","CRYSTAL STRUCTURE OF THE B1 TCR IN COMPLEX WITH HLA-DP4-PLY","10.1016/J.IMMUNI.2023.03.020 ",3.4,103.2,"7t2d_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(118_F_)",156.091,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(146_A_)",92.7042,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(156_A_)",98.2264,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(284_A_)",97.2355,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(37_A_)",59.4957,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(278_A_)",66.1891,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(212_A_)",59.7667,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo36","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_v_)-[NAG(2_v_)]-NAG(1_v_)-ASN(371_E_)",134.221,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo22","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)-ASN(371_A_)",133.389,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_m_)-[MAN(6_m_)-MAN(5_m_)]-MAN(4_m_)-[MAN(8_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(37_E_)",75.832,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(8_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(37_A_)",78.6119,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)]-MAN(4_Z_)-[MAN(8_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(37_C_)",81.2136,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_e_)-[MAN(6_e_)-MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(278_C_)",88.9912,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(156_A_)",120.958,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(146_C_)",125.368,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo33","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(284_E_)",110.444,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_i_)-[NAG(2_i_)]-NAG(1_i_)-ASN(371_C_)",132.256,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo30","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_p_)-[NAG(2_p_)]-NAG(1_p_)-ASN(156_E_)",126.472,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(284_C_)",122.412,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(284_A_)",111.44,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(212_C_)",80.1579,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo29","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_o_)-[NAG(2_o_)]-NAG(1_o_)-ASN(146_E_)",120.901,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(278_A_)",94.0865,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(146_A_)",120.549,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(212_A_)",83.1836,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(278_E_)",86.6279,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo31","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_q_)-[NAG(2_q_)]-NAG(1_q_)-ASN(212_E_)",80.4761,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_c_)-[NAG(2_c_)]-NAG(1_c_)-ASN(156_C_)",118.285,"","",""
"7T6X","CRYO-EM STRUCTURE OF FULL-LENGTH HEPATITIS C VIRUS E1E2 GLYCOPROTEIN IN COMPLEX WITH AR4A, AT12009, AND IGH505 FABS","10.1126/SCIENCE.ABN9884 ",3.83,0.00048876,"7t6x_oligo3","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(623_U_)",211.021,"","",""
"7T6X","CRYO-EM STRUCTURE OF FULL-LENGTH HEPATITIS C VIRUS E1E2 GLYCOPROTEIN IN COMPLEX WITH AR4A, AT12009, AND IGH505 FABS","10.1126/SCIENCE.ABN9884 ",3.83,0.00048876,"7t6x_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(305_E_)",147.276,"","",""
"7T6X","CRYO-EM STRUCTURE OF FULL-LENGTH HEPATITIS C VIRUS E1E2 GLYCOPROTEIN IN COMPLEX WITH AR4A, AT12009, AND IGH505 FABS","10.1126/SCIENCE.ABN9884 ",3.83,0.00048876,"7t6x_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(196_E_)",141.618,"","",""
"7T7B","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING ANTIBODY ADI-62113 FAB","10.1038/S42003-022-03700-6 ",2.59,42.08,"7t7b_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",76.3112,"","",""
"7TAS","SARS-COV-2 SPIKE IN COMPLEX WITH THE S2K146 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND S2K146)","10.1126/SCIENCE.ABM8143 ",3.2,2050.01,"7tas_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",41.4527,"","",""
"7TBW","THE STRUCTURE OF ATP-BOUND ABCA1","10.1038/S44161-022-00022-Y ",3.1,"1.15243e-41","7tbw_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",91.1685,"","",""
"7TBY","THE STRUCTURE OF HUMAN ABCA1 IN NANODISC","10.1038/S44161-022-00022-Y ",4,"1.15243e-41","7tby_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",116.744,"","",""
"7TBZ","THE STRUCTURE OF ABCA1 Y482C","10.1038/S44161-022-00022-Y ",4.3,"1.15243e-41","7tbz_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",177.528,"","",""
"7TC0","THE STRUCTURE OF HUMAN ABCA1 IN DIGITONIN","10.1038/S44161-022-00022-Y ",3.1,"1.15243e-41","7tc0_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",73.1611,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo11","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-[MAN(6_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(197_M_)",185.422,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(197_E_)",189.823,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo5","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(197_A_)",190.258,"","",""
"7TCT","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922","10.1016/J.CELL.2022.08.008 ",2.5,62.64,"7tct_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",89.3584,"","",""
"7TD8","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH TIROFIBAN","10.1016/J.CELL.2022.08.008 ",2.6,82.07,"7td8_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",108.479,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(717_B_)",123.361,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(801_A_)",128.919,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(61_B_)",140.377,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(234_B_)",157.146,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(717_C_)",119.737,"","",""
"7TFN","CRYO-EM STRUCTURE OF CD4BS ANTIBODY AB1303 IN COMPLEX WITH HIV-1 ENV TRIMER BG505 SOSIP.664","10.1038/S41467-022-28424-3 ",4,"5.37397e+08","7tfn_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(363_A_)",82.9851,"","",""
"7TFN","CRYO-EM STRUCTURE OF CD4BS ANTIBODY AB1303 IN COMPLEX WITH HIV-1 ENV TRIMER BG505 SOSIP.664","10.1038/S41467-022-28424-3 ",4,"5.37397e+08","7tfn_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",131.834,"","",""
"7TLY","SARS-COV-2 S B.1.1.529 OMICRON VARIANT (RBD + S309 LOCAL REFINEMENT)","10.1126/SCIENCE.ABN8652 ",3,2050.01,"7tly_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(343_I_)",22.7466,"","",""
"7TMZ","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS COMPOUND 4","10.1016/J.CELL.2022.08.008 ",2.2,66.87,"7tmz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",84.4705,"","",""
"7TN9","STRUCTURE OF THE INMAZEB COCKTAIL AND RESISTANCE TO ESCAPE AGAINST EBOLA VIRUS","10.1016/J.CHOM.2023.01.002 ",3.1,512.502,"7tn9_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(6_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(563_X_)",119.979,"","",""
"7TN9","STRUCTURE OF THE INMAZEB COCKTAIL AND RESISTANCE TO ESCAPE AGAINST EBOLA VIRUS","10.1016/J.CHOM.2023.01.002 ",3.1,512.502,"7tn9_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(563_W_)",119.139,"","",""
"7TN9","STRUCTURE OF THE INMAZEB COCKTAIL AND RESISTANCE TO ESCAPE AGAINST EBOLA VIRUS","10.1016/J.CHOM.2023.01.002 ",3.1,512.502,"7tn9_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(563_V_)",100.592,"","",""
"7TNW","STRUCTURAL AND FUNCTIONAL IMPACT BY SARS-COV-2 OMICRON SPIKE MUTATIONS","10.1016/J.CELREP.2022.110729 ",3.1,"1.15243e-41","7tnw_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(1074_C_)",137.116,"","",""
"7TNW","STRUCTURAL AND FUNCTIONAL IMPACT BY SARS-COV-2 OMICRON SPIKE MUTATIONS","10.1016/J.CELREP.2022.110729 ",3.1,"1.15243e-41","7tnw_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(1074_A_)",137.116,"","",""
"7TNW","STRUCTURAL AND FUNCTIONAL IMPACT BY SARS-COV-2 OMICRON SPIKE MUTATIONS","10.1016/J.CELREP.2022.110729 ",3.1,"1.15243e-41","7tnw_oligo31","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_h_)-[NAG(2_h_)]-NAG(1_h_)-ASN(1074_B_)",137.116,"","",""
"7TO4","STRUCTURAL AND FUNCTIONAL IMPACT BY SARS-COV-2 OMICRON SPIKE MUTATIONS","10.1016/J.CELREP.2022.110729 ",3.4,"1.15243e-41","7to4_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1074_B_)",182.597,"","",""
"7TO4","STRUCTURAL AND FUNCTIONAL IMPACT BY SARS-COV-2 OMICRON SPIKE MUTATIONS","10.1016/J.CELREP.2022.110729 ",3.4,"1.15243e-41","7to4_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",148.854,"","",""
"7TO4","STRUCTURAL AND FUNCTIONAL IMPACT BY SARS-COV-2 OMICRON SPIKE MUTATIONS","10.1016/J.CELREP.2022.110729 ",3.4,"1.15243e-41","7to4_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",171.446,"","",""
"7TP4","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY K398.22","10.1126/SCITRANSLMED.ABL9605 ",1.95,53.28,"7tp4_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_Z_)",31.5427,"","",""
"7TPD","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH EF5154","10.1016/J.CELL.2022.08.008 ",2.6,63.63,"7tpd_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",88.5156,"","",""
"7TPS","CRYSTAL STRUCTURE OF ALPN-202 (ENGINEERED CD80 VIGD) IN COMPLEX WITH PD-L1","10.1038/S41467-022-29286-5 ",3.15,110.9,"7tps_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(35_D_)",140.688,"","",""
"7TPS","CRYSTAL STRUCTURE OF ALPN-202 (ENGINEERED CD80 VIGD) IN COMPLEX WITH PD-L1","10.1038/S41467-022-29286-5 ",3.15,110.9,"7tps_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(89_A_)",107.772,"","",""
"7TPS","CRYSTAL STRUCTURE OF ALPN-202 (ENGINEERED CD80 VIGD) IN COMPLEX WITH PD-L1","10.1038/S41467-022-29286-5 ",3.15,110.9,"7tps_oligo4","DGlcpNAcb1-3[LFucpa1-6]DGlcpNAcx1-","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",131.611,"","",""
"7TPS","CRYSTAL STRUCTURE OF ALPN-202 (ENGINEERED CD80 VIGD) IN COMPLEX WITH PD-L1","10.1038/S41467-022-29286-5 ",3.15,110.9,"7tps_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(89_C_)",156.125,"","",""
"7TXD","CRYO-EM STRUCTURE OF BG505 SOSIP HIV-1 ENV TRIMER IN COMPLEX WITH CD4 RECEPTOR (D1D2) AND BROADLY NEUTRALIZING DARPIN BND.9","10.1038/S41594-023-01062-Z ",3.87,512.502,"7txd_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-[MAN(6_b_)-MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_E_)",64.9825,"","",""
"7TXD","CRYO-EM STRUCTURE OF BG505 SOSIP HIV-1 ENV TRIMER IN COMPLEX WITH CD4 RECEPTOR (D1D2) AND BROADLY NEUTRALIZING DARPIN BND.9","10.1038/S41594-023-01062-Z ",3.87,512.502,"7txd_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",87.3618,"","",""
"7TXD","CRYO-EM STRUCTURE OF BG505 SOSIP HIV-1 ENV TRIMER IN COMPLEX WITH CD4 RECEPTOR (D1D2) AND BROADLY NEUTRALIZING DARPIN BND.9","10.1038/S41594-023-01062-Z ",3.87,512.502,"7txd_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_C_)",131.939,"","",""
"7TXZ","NIPAH VIRUS ATTACHMENT (G) GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH NAH1.3 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE DISTAL REGION)","10.1126/SCIENCE.ABM5561 ",3.2,0,"7txz_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(529_A_)",35.3342,"","",""
"7TXZ","NIPAH VIRUS ATTACHMENT (G) GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH NAH1.3 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE DISTAL REGION)","10.1126/SCIENCE.ABM5561 ",3.2,0,"7txz_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(529_B_)",30.7227,"","",""
"7TY0","NIPAH VIRUS ATTACHMENT (G) GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH NAH1.3 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE STALK REGION)","10.1126/SCIENCE.ABM5561 ",3.5,0,"7ty0_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(529_D_)",41.8591,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(79_C_)",57.6689,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(79_A_)",56.5965,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(79_B_)",58.8022,"","",""
"7U4F","NEURAMINIDASE FROM INFLUENZA VIRUS A/MOSCOW/10/1999(H3N2)","10.1038/S41467-022-34060-8 ",1.4,16.75,"7u4f_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",25.0175,"","",""
"7U4G","NEURAMINIDASE FROM INFLUENZA VIRUS A/SHANDONG/9/1993(H3N2)","10.1038/S41467-022-34060-8 ",1.65,19.37,"7u4g_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",30.76,"","",""
"7U7N","IL-27 QUATERNARY RECEPTOR SIGNALING COMPLEX","10.7554/ELIFE.78463 ",3.47,"2.14959e+09","7u7n_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(83_B_)",134.506,"","",""
"7U9F","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS COMPOUND 4 IN MN2+","10.1016/J.CELL.2022.08.008 ",2.7,80.48,"7u9f_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",68.0471,"","",""
"7U9V","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4-1","10.1016/J.CELL.2022.08.008 ",2.25,77.51,"7u9v_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",81.2971,"","",""
"7UAB","HUMAN PRO-MEPRIN ALPHA (ZYMOGEN STATE)","10.1038/S41467-022-33893-7 ",3.7,0,"7uab_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(414_A_)",110.529,"","",""
"7UAB","HUMAN PRO-MEPRIN ALPHA (ZYMOGEN STATE)","10.1038/S41467-022-33893-7 ",3.7,0,"7uab_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(414_E_)",98.2257,"","",""
"7UAB","HUMAN PRO-MEPRIN ALPHA (ZYMOGEN STATE)","10.1038/S41467-022-33893-7 ",3.7,0,"7uab_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(414_H_)",102.302,"","",""
"7UAB","HUMAN PRO-MEPRIN ALPHA (ZYMOGEN STATE)","10.1038/S41467-022-33893-7 ",3.7,0,"7uab_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(414_D_)",113.643,"","",""
"7UAC","HUMAN PRO-MEPRIN ALPHA (ZYMOGEN STATE)","10.1038/S41467-022-33893-7 ",2.7,0,"7uac_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(414_H_)",108.543,"","",""
"7UAE","HUMAN MEPRIN ALPHA (ACTIVE STATE)","10.1038/S41467-022-33893-7 ",2.6,0,"7uae_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(414_A_)",95.7891,"","",""
"7UAF","HUMAN MEPRIN ALPHA INHIBITORY COMPLEX WITH COMPOUND 10D (N~3~,N~3~- BIS[(2H-1,3-BENZODIOXOL-5-YL)METHYL]-N-HYDROXY-BETA-ALANINAMIDE)","10.1038/S41467-022-33893-7 ",2.4,0,"7uaf_oligo14","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_R_)-[BMA(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(414_D_)",65.935,"","",""
"7UAF","HUMAN MEPRIN ALPHA INHIBITORY COMPLEX WITH COMPOUND 10D (N~3~,N~3~- BIS[(2H-1,3-BENZODIOXOL-5-YL)METHYL]-N-HYDROXY-BETA-ALANINAMIDE)","10.1038/S41467-022-33893-7 ",2.4,0,"7uaf_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(414_A_)",57.5591,"","",""
"7UAF","HUMAN MEPRIN ALPHA INHIBITORY COMPLEX WITH COMPOUND 10D (N~3~,N~3~- BIS[(2H-1,3-BENZODIOXOL-5-YL)METHYL]-N-HYDROXY-BETA-ALANINAMIDE)","10.1038/S41467-022-33893-7 ",2.4,0,"7uaf_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(414_B_)",58.9341,"","",""
"7UAF","HUMAN MEPRIN ALPHA INHIBITORY COMPLEX WITH COMPOUND 10D (N~3~,N~3~- BIS[(2H-1,3-BENZODIOXOL-5-YL)METHYL]-N-HYDROXY-BETA-ALANINAMIDE)","10.1038/S41467-022-33893-7 ",2.4,0,"7uaf_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(414_C_)",67.3968,"","",""
"7UAI","MEPRIN ALPHA HELIX IN COMPLEX WITH FETUIN-B","10.1038/S41467-022-33893-7 ",2.8,"5.17114e+07","7uai_oligo14","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_T_)-[BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(414_D_)",115.178,"","",""
"7UAI","MEPRIN ALPHA HELIX IN COMPLEX WITH FETUIN-B","10.1038/S41467-022-33893-7 ",2.8,"5.17114e+07","7uai_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(414_E_)",133.71,"","",""
"7UAI","MEPRIN ALPHA HELIX IN COMPLEX WITH FETUIN-B","10.1038/S41467-022-33893-7 ",2.8,"5.17114e+07","7uai_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Q_)-[BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(414_C_)",115.526,"","",""
"7UAI","MEPRIN ALPHA HELIX IN COMPLEX WITH FETUIN-B","10.1038/S41467-022-33893-7 ",2.8,"5.17114e+07","7uai_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(414_B_)",115.185,"","",""
"7UAR","STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE NEUTRALIZING ANTIBODY FAB FRAGMENT, C1717","10.1016/J.IMMUNI.2022.04.003 ",3.5,"1.08527e-19","7uar_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(282_B_)",95.1105,"","",""
"7UBR","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH GR144053","10.1016/J.CELL.2022.08.008 ",2.05,72.94,"7ubr_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",78.0127,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(160_G_)",332.543,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(392_G_)",291.114,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo18","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Y_)-[BMA(3_Y_)-NAG(2_Y_)]-NAG(1_Y_)-ASN(88_G_)",317.192,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo7","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)]-MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_G_)",286.96,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(276_G_)",300.557,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(301_G_)",293.716,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo17","DManpb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_X_)-MAN(4_X_)-[MAN(6_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_G_)",311.131,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo12","DManpa1-6DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_G_)",235.489,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(611_B_)",319.908,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo6","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(332_G_)",45.9453,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_P_)",43.1522,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_G_)",41.9787,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo18","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_j_)-MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_I_)",40.8734,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_r_)-MAN(6_r_)-[MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(332_P_)",44.571,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_I_)",40.5847,"","",""
"7UCY","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH GANTOFIBAN","10.1016/J.CELL.2022.08.008 ",2.35,74.46,"7ucy_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",72.1291,"","",""
"7UDG","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LOTRAFIBAN","10.1016/J.CELL.2022.08.008 ",2.8,103.3,"7udg_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",102.156,"","",""
"7UDH","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4-3","10.1016/J.CELL.2022.08.008 ",2,80.57,"7udh_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",124.361,"","",""
"7UDH","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4-3","10.1016/J.CELL.2022.08.008 ",2,80.57,"7udh_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(501_C_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",109.582,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(78_C_)",47.3998,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(78_B_)",51.4784,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(78_A_)",53.156,"","",""
"7UE0","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH FRADAFIBAN","10.1016/J.CELL.2022.08.008 ",2.74,93.48,"7ue0_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",93.4467,"","",""
"7UFH","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH FRADAFIBAN (MN/CA)","10.1016/J.CELL.2022.08.008 ",3,104.2,"7ufh_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",99.0776,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo23","DManpa1-3DManpa1-3[DManp[3<R1>]b1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(332_C_)",71.367,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",69.0705,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo15","DManpa1-3[DManp[3<R1>]a1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_f_)-[MAN(6_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_B_)",65.4373,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_C_)",75.7151,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo7","DManpa1-3DManpa1-3[DManp[3<R1>]a1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(332_A_)",66.9489,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_A_)",69.1395,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo17","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-MAN(5_h_)-[MAN(7_h_)]-MAN(4_h_)-[MAN(9_h_)-MAN(8_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_C_)",98.9344,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo16","DManpb1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(606_C_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",77.2122,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo10","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-[MAN(7_a_)]-MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_B_)",100.406,"","",""
"7UGP","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE LIGHT CHAIN AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 CONTAINING THE N276 GP120 GLYCAN- CLASS 1","10.1038/S41467-022-33860-2 ",4.2,210.333,"7ugp_oligo2","DManpa1-2DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_B_)",44.7242,"","",""
"7UGP","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE LIGHT CHAIN AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 CONTAINING THE N276 GP120 GLYCAN- CLASS 1","10.1038/S41467-022-33860-2 ",4.2,210.333,"7ugp_oligo3","DManpa1-2DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_A_)",43.7194,"","",""
"7UGP","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE LIGHT CHAIN AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 CONTAINING THE N276 GP120 GLYCAN- CLASS 1","10.1038/S41467-022-33860-2 ",4.2,210.333,"7ugp_oligo9","DManpa1-2DManpa1-4[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(332_C_)",47.0565,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_p_)-MAN(7_p_)-[MAN(6_p_)-MAN(5_p_)-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(332_B_)",27.5606,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo36","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_1_)-[MAN(8_1_)]-MAN(7_1_)-[MAN(6_1_)-MAN(5_1_)-MAN(4_1_)]-BMA(3_1_)-NAG(2_1_)-NAG(1_1_)-ASN(332_C_)",28.7037,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",29.5504,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(262_B_)",29.9547,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_d_)-[MAN(8_d_)]-MAN(7_d_)-[MAN(6_d_)-MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(332_A_)",33.6194,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_C_)",30.6655,"","",""
"7UH8","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH ROXIFIBAN (MN/CA)","10.1016/J.CELL.2022.08.008 ",2.75,92.04,"7uh8_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",81.9382,"","",""
"7UHB","SARS-COV-2 SPIKE IN COMPLEX WITH AHB2-2GS-SB175 (LOCAL REFINEMENT OF THE RBD AND AHB2)","10.1126/SCITRANSLMED.ABN1252 ",3,"1.15243e-41","7uhb_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_C_)",18.0591,"","",""
"7UJE","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922 IN MN2+","10.1016/J.CELL.2022.08.008 ",2.5,86.9,"7uje_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",106.106,"","",""
"7UJE","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922 IN MN2+","10.1016/J.CELL.2022.08.008 ",2.5,86.9,"7uje_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",112.538,"","",""
"7UJK","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LAMIFIBAN","10.1016/J.CELL.2022.08.008 ",2.43,68.02,"7ujk_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",64.2862,"","",""
"7UK9","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LAMIFIBAN (MN)","10.1016/J.CELL.2022.08.008 ",2.6,93.59,"7uk9_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",87.8336,"","",""
"7UKO","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH SIBRAFIBAN (MN)","10.1016/J.CELL.2022.08.008 ",2.6,67.23,"7uko_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",62.084,"","",""
"7UKP","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH A GANTOFIBAN ANALOG","10.1016/J.CELL.2022.08.008 ",2.8,111.4,"7ukp_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",100.168,"","",""
"7UKT","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4.2","10.1016/J.CELL.2022.08.008 ",2.37,103.9,"7ukt_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",123.444,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(74_A_)",306.725,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_D_)",229.013,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(74_D_)",307.562,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(88_A_)",225.288,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_w_)-[MAN(8_w_)]-MAN(7_w_)-[MAN(6_w_)-MAN(5_w_)-MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(332_I_)",41.6446,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(386_I_)",29.9762,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_G_)",39.4849,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_A_)",36.3307,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_U_)-[MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_G_)",38.2005,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-[MAN(8_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(332_A_)",26.9699,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(119_A_)",68.5214,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo33","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_u_)-[MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)]-NAG(1_u_)-ASN(395_c_)",83.363,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(365_b_)",56.0532,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo32","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_t_)-[NAG(2_t_)]-NAG(1_t_)-ASN(390_c_)",85.3206,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_q_)-[MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)]-NAG(1_q_)-ASN(119_C_)",71.1451,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(109_A_)",81.5382,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_i_)-[NAG(2_i_)]-NAG(1_i_)-ASN(390_b_)",87.2912,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_j_)-[MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)]-NAG(1_j_)-ASN(395_b_)",85.0394,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_X_)-[BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(109_B_)",78.5066,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(365_a_)",55.337,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(390_a_)",82.2764,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo30","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_r_)-[MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(365_c_)",57.1744,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_V_)-[MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(395_a_)",83.5571,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo23","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_k_)-[BMA(3_k_)-NAG(2_k_)]-NAG(1_k_)-ASN(109_C_)",81.8798,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(79_B_)",68.1725,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_m_)-[MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)]-NAG(1_m_)-ASN(395_b_)",90.2483,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(365_a_)",56.4217,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(89_A_)",64.1244,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(119_A_)",104.041,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_x_)-[MAN(5_x_)-[MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)]-NAG(1_x_)-ASN(395_c_)",91.1989,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Y_)-[MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)]-NAG(1_Y_)-ASN(395_a_)",86.6397,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_e_)-[BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(119_B_)",108.214,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(365_b_)",59.795,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo15","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_X_)-[BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(390_a_)",97.4098,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(89_B_)",58.4092,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo26","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_r_)-[BMA(3_r_)-NAG(2_r_)]-NAG(1_r_)-ASN(119_C_)",87.0623,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo22","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_n_)-[MAN(4_n_)-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(109_C_)",86.61,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo29","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(365_c_)",57.9815,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo20","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_l_)-[BMA(3_l_)-NAG(2_l_)]-NAG(1_l_)-ASN(390_b_)",106.158,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(109_A_)",91.7025,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_p_)-[MAN(5_p_)-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(89_C_)",61.8833,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo31","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_w_)-[BMA(3_w_)-NAG(2_w_)]-NAG(1_w_)-ASN(390_c_)",101.137,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_d_)-[BMA(3_d_)-NAG(2_d_)]-NAG(1_d_)-ASN(109_B_)",75.047,"","",""
"7UPW","THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIIMMUNOL.ADD5446 ",2.7,"5.37397e+08","7upw_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(343_A_)",56.3076,"","",""
"7UPW","THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIIMMUNOL.ADD5446 ",2.7,"5.37397e+08","7upw_oligo35","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_r_)-[NAG(2_r_)]-NAG(1_r_)-ASN(343_C_)",55.7645,"","",""
"7UPW","THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIIMMUNOL.ADD5446 ",2.7,"5.37397e+08","7upw_oligo32","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_o_)-[NAG(2_o_)]-NAG(1_o_)-ASN(1074_C_)",52.7612,"","",""
"7UPW","THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIIMMUNOL.ADD5446 ",2.7,"5.37397e+08","7upw_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(1074_A_)",52.8797,"","",""
"7UPW","THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIIMMUNOL.ADD5446 ",2.7,"5.37397e+08","7upw_oligo23","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_f_)-[NAG(2_f_)]-NAG(1_f_)-ASN(343_B_)",55.8579,"","",""
"7UPW","THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIIMMUNOL.ADD5446 ",2.7,"5.37397e+08","7upw_oligo20","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_c_)-[NAG(2_c_)]-NAG(1_c_)-ASN(1074_B_)",52.9215,"","",""
"7UPX","THREE RBD-DOWN STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS)","10.1126/SCIIMMUNOL.ADD5446 ",3.2,"5.37397e+08","7upx_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",85.0515,"","",""
"7UPY","ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","",3.1,"5.37397e+08","7upy_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(343_A_)",105.867,"","",""
"7UPY","ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","",3.1,"5.37397e+08","7upy_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(1074_A_)",77.9576,"","",""
"7UPY","ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","",3.1,"5.37397e+08","7upy_oligo33","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_p_)-[NAG(2_p_)]-NAG(1_p_)-ASN(343_C_)",100.021,"","",""
"7UPY","ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","",3.1,"5.37397e+08","7upy_oligo18","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_a_)-[NAG(2_a_)]-NAG(1_a_)-ASN(1074_B_)",89.9339,"","",""
"7UPY","ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","",3.1,"5.37397e+08","7upy_oligo30","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_m_)-[NAG(2_m_)]-NAG(1_m_)-ASN(1074_C_)",76.987,"","",""
"7UPY","ONE RBD-UP STATE OF SARS-COV-2 D614G SPIKE IN COMPLEX WITH THE SP1-77 NEUTRALIZING ANTIBODY FAB FRAGMENT","",3.1,"5.37397e+08","7upy_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(343_B_)",92.9312,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo35","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_F_)",113.537,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(88_G_)",116.437,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo41","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_A_)",110.825,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo36","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(88_A_)",114.387,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-MAN(5_d_)-[MAN(7_d_)]-MAN(4_d_)-[MAN(9_d_)-MAN(8_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(241_A_)",104.198,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(339_G_)",155.873,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(88_F_)",115.885,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo17","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_r_)-MAN(5_r_)-[MAN(7_r_)]-MAN(4_r_)-[MAN(9_r_)-MAN(8_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(241_F_)",105.298,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_0_)-[MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)-ASN(339_F_)",154.559,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",112.49,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo16","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-[MAN(7_P_)]-MAN(4_P_)-[MAN(9_P_)-MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(241_G_)",105.298,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(339_A_)",157.015,"","",""
"7URU","CRYSTAL STRUCTURE OF THE LOW AFFINITY FC GAMMA RECEPTOR IIIA VARIANT IN COMPLEX WITH THE FC OF IGG1.","",2.4,0,"7uru_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",92.0661,"","",""
"7URU","CRYSTAL STRUCTURE OF THE LOW AFFINITY FC GAMMA RECEPTOR IIIA VARIANT IN COMPLEX WITH THE FC OF IGG1.","",2.4,0,"7uru_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",89.1557,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_Y_)-[MAN(2_Y_)]-BMA(1_Y_)-NAG(2_X_)-NAG(1_X_)-ASN(284_C_)",34.1865,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_Q_)-[MAN(2_Q_)]-BMA(1_Q_)-NAG(2_P_)-NAG(1_P_)-ASN(284_B_)",34.1865,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1199_B_)",29.7329,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_H_)-[MAN(2_H_)]-BMA(1_H_)-NAG(2_G_)-NAG(1_G_)-ASN(284_A_)",34.1865,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(1199_C_)",29.7329,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1199_A_)",29.7329,"","",""
"7USL","INTEGRIN ALPHAM/BETA2 ECTODOMAIN IN COMPLEX WITH ADENYLATE CYCLASE TOXIN RTX751 AND M1F5 FAB","10.1016/J.CELREP.2022.111196 ",2.7,"2.14959e+09","7usl_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(1059_A_)",64.9424,"","",""
"7USR","PLASMODIUM FALCIPARUM PROTEIN PFS230 D1D2 - STRUCTURE OF THE FIRST TWO 6-CYSTEINE DOMAINS","10.1042/BCJ20220554 ",1.93,40.21,"7usr_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(829_A_)",109.568,"","",""
"7USS","PLASMODIUM FALCIPARUM PROTEIN PFS230 PRO-D1D2 - STRUCTURE OF THE FIRST TWO 6-CYSTEINE DOMAINS WITH N-TERMINAL EXTENSION","10.1042/BCJ20220554 ",1.9,41.14,"7uss_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(585_A_)",77.6597,"","",""
"7UX0","HUMAN SPERM TMEM95 ECTODOMAIN","10.1073/PNAS.2207805119 ",1.49,30.3,"7ux0_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(117_A_)",41.2159,"","",""
"7UYI","CRYSTAL STRUCTURE OF THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3,80.54,"7uyi_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(87_E_)",101.357,"","",""
"7UYI","CRYSTAL STRUCTURE OF THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3,80.54,"7uyi_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(87_D_)",103.581,"","",""
"7UZ3","BAND 3-GLYCOPHORIN A COMPLEX, OUTWARD FACING","10.1038/S41594-022-00792-W ",2.35,0,"7uz3_oligo2","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(642_E_)",43.1927,"","",""
"7UZ3","BAND 3-GLYCOPHORIN A COMPLEX, OUTWARD FACING","10.1038/S41594-022-00792-W ",2.35,0,"7uz3_oligo1","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(642_C_)",43.1927,"","",""
"7UZC","STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE MOUSE ANTIBODY FAB FRAGMENT, M8A-34","10.1016/J.IMMUNI.2022.10.019 ",2.2,47.02,"7uzc_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(343_A_)",84.5227,"","",""
"7V07","BAND 3-I-TM LOCAL REFINEMENT FROM ERYTHROCYTE ANKYRIN-1 COMPLEX CONSENSUS RECONSTRUCTION","10.1038/S41594-022-00792-W ",2.8,0,"7v07_oligo1","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(642_C_)",43.0485,"","",""
"7V07","BAND 3-I-TM LOCAL REFINEMENT FROM ERYTHROCYTE ANKYRIN-1 COMPLEX CONSENSUS RECONSTRUCTION","10.1038/S41594-022-00792-W ",2.8,0,"7v07_oligo2","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(642_E_)",62.4177,"","",""
"7VGH","CRYO-EM STRUCTURE OF THE HUMAN P4-TYPE FLIPPASE ATP8B1-CDC50B IN THE AUTO-INHIBITED E2P STATE","10.1073/PNAS.2118656119 ",3.39,"1.08527e-19","7vgh_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(171_A_)",95.0941,"","",""
"7VLC","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 78% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.2,49.41,"7vlc_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(58_H_)",76.5782,"","",""
"7VLC","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 78% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.2,49.41,"7vlc_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(58_D_)",75.34,"","",""
"7VLD","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 69% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.1,39.4,"7vld_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(58_H_)",64.7086,"","",""
"7VLD","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 69% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.1,39.4,"7vld_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(58_D_)",74.2123,"","",""
"7VLE","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 55% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.3,44.83,"7vle_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(58_D_)",77.8159,"","",""
"7VLE","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 55% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.3,44.83,"7vle_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(58_H_)",69.7082,"","",""
"7VLF","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 26% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.4,52.97,"7vlf_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(58_D_)",82.5668,"","",""
"7VLF","OXY-DEOXY INTERMEDIATE OF V2 HEMOGLOBIN AT 26% OXYGEN SATURATION","10.2142/BIOPHYSICO.BPPB-V19.0019 ",2.4,52.97,"7vlf_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(58_H_)",76.4532,"","",""
"7VQ0","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN (2-UP RBD) BOUND TO NEUTRALIZING NANOBODIES P86","10.1038/S42003-022-03630-3 ",3.03,"1.08527e-19","7vq0_oligo24","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",66.5842,"","",""
"7VQ0","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN (2-UP RBD) BOUND TO NEUTRALIZING NANOBODIES P86","10.1038/S42003-022-03630-3 ",3.03,"1.08527e-19","7vq0_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(1074_A_)",81.3064,"","",""
"7VQ0","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN (2-UP RBD) BOUND TO NEUTRALIZING NANOBODIES P86","10.1038/S42003-022-03630-3 ",3.03,"1.08527e-19","7vq0_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)-ASN(1074_B_)",71.8803,"","",""
"7VS7","CRYSTAL STRUCTURE OF THE ECTODOMAIN OF OSCERK1 IN COMPLEX WITH CHITIN HEXAMER","10.1111/JIPB.13279 ",2.02,42.88,"7vs7_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(3_C_)-NAG(2_C_)]-[FUC(4_C_)]-NAG(1_C_)-ASN(48_A_)",56.2365,"","",""
"7W3V","PLANT RECEPTOR LIKE PROTEIN RXEG1 IN COMPLEX WITH XYLOGLUCANASE XEG1","10.1038/S41586-022-05214-X ",3.11,0,"7w3v_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(143_C_)",67.7395,"","",""
"7W3X","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1","10.1038/S41586-022-05214-X ",3.21,0,"7w3x_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-MAN(5_A_)-[MAN(7_A_)]-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(143_C_)",80.743,"","",""
"7W3X","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1","10.1038/S41586-022-05214-X ",3.21,0,"7w3x_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(562_C_)",82.9325,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(726_A_)",322.928,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo45","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_v_)-[NAG(2_v_)]-NAG(1_v_)-ASN(743_C_)",245.275,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(216_B_)",323.122,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(514_C_)",298.627,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(1232_B_)",306.36,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(726_B_)",300.987,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(514_B_)",314.099,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(787_B_)",363.683,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(688_B_)",279.114,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(514_A_)",313.122,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(781_A_)",343.14,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(688_C_)",265.089,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(264_A_)",200.741,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo19","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(216_A_)",319.628,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo40","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(726_C_)",284.692,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_Z_)-[MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(556_B_)",303.125,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(300_A_)",308.713,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(743_A_)",242.966,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(264_C_)",205.319,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(264_B_)",194.815,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo33","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_j_)-[BMA(3_j_)-NAG(2_j_)]-NAG(1_j_)-ASN(300_C_)",322.676,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo20","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(556_A_)",307.728,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo38","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_o_)-[MAN(4_o_)-BMA(3_o_)-NAG(2_o_)]-NAG(1_o_)-ASN(556_C_)",290.678,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(787_A_)",359.688,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(1232_C_)",330.493,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(781_B_)",350.559,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(1232_A_)",329.966,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo41","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(781_C_)",355.567,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_U_)-[BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(300_B_)",307.823,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo31","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_h_)-[BMA(3_h_)-NAG(2_h_)]-NAG(1_h_)-ASN(216_C_)",347.77,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(688_A_)",257.872,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(787_C_)",363.318,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo30","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_g_)-[NAG(2_g_)]-NAG(1_g_)-ASN(743_B_)",244.212,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(787_C_)",399.475,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(688_B_)",306.494,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(787_A_)",392.784,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(556_B_)",332.096,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(556_C_)",388.181,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(264_C_)",267.961,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(264_B_)",190.37,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo43","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_t_)-[BMA(3_t_)-NAG(2_t_)]-NAG(1_t_)-ASN(743_C_)",343.081,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(344_A_)",379.379,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(216_B_)",422.306,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_i_)-[MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)]-NAG(1_i_)-ASN(300_C_)",414.769,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_e_)-[MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(300_B_)",387.366,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_A_)",199.843,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(216_A_)",436.92,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(1232_A_)",349.269,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(781_A_)",391.52,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Z_)-[BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(743_B_)",315.553,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(726_B_)",399.214,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(556_A_)",367.393,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(787_B_)",413.761,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(781_B_)",386.924,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(688_C_)",319.281,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(324_A_)",364.513,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(344_B_)",372.977,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo24","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(743_A_)",427.853,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo17","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(300_A_)",373.626,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(324_B_)",354.213,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo42","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_s_)-NAG(1_s_)-ASN(667_C_)",245.082,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(344_C_)",396.997,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(781_C_)",389.956,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(688_A_)",273.78,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(726_A_)",393.201,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(726_C_)",393.771,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo33","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(324_C_)",344.091,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(216_C_)",398.031,"","",""
"7WA3","STRUCTURE OF AMERICAN MINK ACE2","",2.28,40,"7wa3_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(216_B_)",74.1976,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(141_G_)",30.712,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(200_E_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(262_K_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(200_H_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_B_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(141_J_)",30.712,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_E_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_B_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_H_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(200_K_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(141_A_)",30.712,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(141_D_)",30.712,"","",""
"7WD1","CRYSTAL STRUCTURE OF R14 BOUND TO SARS-COV-2 RBD","10.1016/J.XCRM.2023.100918 ",2.5,48.14,"7wd1_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(343_B_)",94.2841,"","",""
"7WD1","CRYSTAL STRUCTURE OF R14 BOUND TO SARS-COV-2 RBD","10.1016/J.XCRM.2023.100918 ",2.5,48.14,"7wd1_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(343_A_)",108.966,"","",""
"7WD2","CRYSTAL STRUCTURE OF S43 BOUND TO SARS-COV-2 RBD","10.1016/J.XCRM.2023.100918 ",2.69,46.58,"7wd2_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(343_A_)",57.6412,"","",""
"7WD2","CRYSTAL STRUCTURE OF S43 BOUND TO SARS-COV-2 RBD","10.1016/J.XCRM.2023.100918 ",2.69,46.58,"7wd2_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(55_D_)",102.437,"","",""
"7WG3","STRUCTURAL BASIS OF INTERLEUKIN-17B RECEPTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY D9 FOR GUIDING HUMANIZATION AND AFFINITY MATURATION FOR CANCER THERAPY","10.1016/J.CELREP.2022.111555 ",2.19,46.47,"7wg3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(50_J_)",88.0342,"","",""
"7WG3","STRUCTURAL BASIS OF INTERLEUKIN-17B RECEPTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY D9 FOR GUIDING HUMANIZATION AND AFFINITY MATURATION FOR CANCER THERAPY","10.1016/J.CELREP.2022.111555 ",2.19,46.47,"7wg3_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(50_I_)",84.3209,"","",""
"7WH6","THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAF1_N179S)","",1.58,14.93,"7wh6_oligo1","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(105_A_)",25.0805,"","",""
"7WH7","THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAF1_N179S) WITH XYLOTETRAOSE","",1.44,13.84,"7wh7_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-[MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(105_A_)",22.5778,"","",""
"7WH7","THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAF1_N179S) WITH XYLOTETRAOSE","",1.44,13.84,"7wh7_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(105_B_)",21.726,"","",""
"7WHU","HUMAN NEUTROPHIL ELASTASE IN-COMPLEX WITH ECOTIN PEPTIDE","10.1002/PRO.4274 ",2.89,0,"7whu_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(105_C_)",39.8942,"","",""
"7WHU","HUMAN NEUTROPHIL ELASTASE IN-COMPLEX WITH ECOTIN PEPTIDE","10.1002/PRO.4274 ",2.89,0,"7whu_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(105_D_)",44.2009,"","",""
"7WHU","HUMAN NEUTROPHIL ELASTASE IN-COMPLEX WITH ECOTIN PEPTIDE","10.1002/PRO.4274 ",2.89,0,"7whu_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(154_D_)",50.7468,"","",""
"7WHU","HUMAN NEUTROPHIL ELASTASE IN-COMPLEX WITH ECOTIN PEPTIDE","10.1002/PRO.4274 ",2.89,0,"7whu_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)",41.6823,"","",""
"7WHU","HUMAN NEUTROPHIL ELASTASE IN-COMPLEX WITH ECOTIN PEPTIDE","10.1002/PRO.4274 ",2.89,0,"7whu_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(105_A_)",39.7758,"","",""
"7WHU","HUMAN NEUTROPHIL ELASTASE IN-COMPLEX WITH ECOTIN PEPTIDE","10.1002/PRO.4274 ",2.89,0,"7whu_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(154_C_)",42.683,"","",""
"7WPO","STRUCTURE OF NEOCOV RBD BINDING TO BAT37 ACE2","10.1038/S41586-022-05513-3 ",3.5,0,"7wpo_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",43.3104,"","",""
"7WPO","STRUCTURE OF NEOCOV RBD BINDING TO BAT37 ACE2","10.1038/S41586-022-05513-3 ",3.5,0,"7wpo_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(329_A_)",43.0521,"","",""
"7WPZ","STRUCTURE OF PDF-2180-COV RBD BINDING TO BAT37 ACE2","10.1038/S41586-022-05513-3 ",3.8,0,"7wpz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",66.8255,"","",""
"7WQV","CRYSTAL STRUCTURE OF A NEUTRALIZING MONOCLONAL ANTIBODY (AB08) IN COMPLEX WITH SARS-COV-2 RECEPTOR-BINDING DOMAIN (RBD)","10.1371/JOURNAL.PPAT.1011085 ",2.8,56.4,"7wqv_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(343_A_)",115.796,"","",""
"7WQV","CRYSTAL STRUCTURE OF A NEUTRALIZING MONOCLONAL ANTIBODY (AB08) IN COMPLEX WITH SARS-COV-2 RECEPTOR-BINDING DOMAIN (RBD)","10.1371/JOURNAL.PPAT.1011085 ",2.8,56.4,"7wqv_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_S_)-NAG(1_S_)-ASN(343_G_)",127.976,"","",""
"7WR8","LOCAL CRYOEM STRUCTURE OF THE SARS-COV-2 S6P(B.1.1.529) IN COMPLEX WITH BD55-3152 FAB","10.1038/S41586-022-04980-Y ",3.5,"1.08527e-19","7wr8_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_R_)",30.5518,"","",""
"7WR9","LOCAL CRYOEM STRUCTURE OF THE SARS-COV S2P IN COMPLEX WITH BD55-3152 FAB","",3.24,"1.08527e-19","7wr9_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(330_F_)",50.8659,"","",""
"7WUE","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE MONOCLONAL ANTIBODY M31A7","10.1126/SCITRANSLMED.ABM0899 ",3.2,64.79,"7wue_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(343_A_)",95.4203,"","",""
"7WUE","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE MONOCLONAL ANTIBODY M31A7","10.1126/SCITRANSLMED.ABM0899 ",3.2,64.79,"7wue_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(102_C_)",116.923,"","",""
"7WUE","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE MONOCLONAL ANTIBODY M31A7","10.1126/SCITRANSLMED.ABM0899 ",3.2,64.79,"7wue_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(102_E_)",112.758,"","",""
"7WUE","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE MONOCLONAL ANTIBODY M31A7","10.1126/SCITRANSLMED.ABM0899 ",3.2,64.79,"7wue_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(343_B_)",107.371,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo4","DGlcpNAcb1-4[LGalpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(165_A_)",161.383,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(717_C_)",193.014,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(282_C_)",32.1516,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo23","DManpa1-3[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)]-MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(1074_E_)",158.84,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo20","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_c_)-NAG(1_c_)-ASN(603_E_)",148.839,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(282_A_)",164.135,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(331_C_)",170.389,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo19","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(149_E_)",169.702,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo24","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_g_)-[BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(102_H_)",236.457,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo21","DGlcpNAcb1-2[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[NAG(5_d_)]-MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(331_E_)",185.229,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo18","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_a_)-[BMA(3_a_)-NAG(2_a_)]-NAG(1_a_)-ASN(717_E_)",149.558,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo12","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(165_C_)",170.202,"","",""
"7WV5","ECTOTLR3-POLY(I:C)","10.1038/S41467-022-34602-0 ",3.1,"3.35873e+07","7wv5_oligo147","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(413_B_)",102.163,"","",""
"7WV5","ECTOTLR3-POLY(I:C)","10.1038/S41467-022-34602-0 ",3.1,"3.35873e+07","7wv5_oligo142","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(413_A_)",102.16,"","",""
"7WVG","CRYSTAL STRUCTURE OF H18 COMPLEXED WITH SIA28","10.1038/S41467-022-35236-Y ",2.6,49.66,"7wvg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(268_A_)",74.2066,"","",""
"7WVG","CRYSTAL STRUCTURE OF H18 COMPLEXED WITH SIA28","10.1038/S41467-022-35236-Y ",2.6,49.66,"7wvg_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(21_A_)",87.4827,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",134.525,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",132.398,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",134.072,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",143.179,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",135.398,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",139.536,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",123.032,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",99.815,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",100.985,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",129.912,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",130.728,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",122.626,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",126.666,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",151.224,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",149.673,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",126.569,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",137.543,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",138.996,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",149.642,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",139.569,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",130.65,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",139.333,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",151.553,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",129.71,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",124.978,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",116.278,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",125.568,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",123.725,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",123.146,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",115.116,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",139.962,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",120.427,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",160.914,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",140.642,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo9","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",161.85,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",119.45,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",102.1,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",121.977,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",128.61,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",102.692,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",128.258,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",120.917,"","",""
"7X1M","THE COMPLEX STRUCTURE OF OMICRON BA.1 RBD WITH BD604, S309,AND S304","10.1016/J.IMMUNI.2022.06.005 ",2.74,"1.08527e-19","7x1m_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(343_M_)",38.4306,"","",""
"7X2L","CRYSTAL STRUCTURE OF NANOBODY 3-2A2-4 WITH SARS-COV-2 RBD","10.1038/S41467-022-35642-2 ",2.4,69.34,"7x2l_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_A_)-[BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",69.6905,"","",""
"7X2M","CRYSTAL STRUCTURE OF NANOBODY 1-2C7 WITH SARS-COV-2 RBD","10.1038/S41467-022-35642-2 ",1.8,44.69,"7x2m_oligo1","DGlcpNAcb1-4[DManpa1-6]DGlcpNAcb1-ASN","MAN(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_E_)",67.2091,"","",""
"7X2N","CRYSTAL STRUCTURE OF DIELS-ALDERASE PYCR1","",1.72,33.45,"7x2n_oligo1","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(211_A_)",51.2327,"","",""
"7X2N","CRYSTAL STRUCTURE OF DIELS-ALDERASE PYCR1","",1.72,33.45,"7x2n_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(43_A_)",75.0538,"","",""
"7X2S","CRYSTAL STRUCTURE OF HETERO-DIELS-ALDERASE PYCR1 IN COMPLEX WITH NEOSETOPHOMONE B AND TROPOLONE O-QUINONE METHIDE","",1.92,36.33,"7x2s_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(211_A_)",43.1609,"","",""
"7X2X","CRYSTAL STRUCTURE OF HETERO-DIELS-ALDERASE PYCR1 IN COMPLEX WITH 10- HYDROXY-8E-HUMULENE","",1.58,29.45,"7x2x_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(43_A_)",63.5571,"","",""
"7X2X","CRYSTAL STRUCTURE OF HETERO-DIELS-ALDERASE PYCR1 IN COMPLEX WITH 10- HYDROXY-8E-HUMULENE","",1.58,29.45,"7x2x_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpb]DManp[3<R1>]b1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[BMA(8_B_)--NAG(2_B_)-NAG(1_B_)-ASN(211_A_)",38.07,"","",""
"7X36","CRYSTAL STRUCTURE OF HETERO-DIELS-ALDERASE EUPFF","",1.92,31.09,"7x36_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(213_C_)",50.3257,"","",""
"7X8W","THE SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND WITH THE FAB FRAGMENT OF A HUMAN NEUTRALIZING ANTIBODY AB354","10.1016/J.ISCI.2022.105596 ",3.1,"1.08527e-19","7x8w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(59_H_)",127.288,"","",""
"7X93","THE SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND WITH THE FAB FRAGMENT OF A HUMAN NEUTRALIZING ANTIBODY AB765","10.1016/J.ISCI.2023.106955 ",3.3,"1.08527e-19","7x93_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(343_D_)",177.602,"","",""
"7X96","THE SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND WITH THE FAB FRAGMENT OF A HUMAN NEUTRALIZING ANTIBODY AB847","10.1016/J.ISCI.2023.106955 ",3.4,"1.08527e-19","7x96_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(343_G_)",173.07,"","",""
"7XB1","CRYSTAL STRUCTURE OF OMICRON BA.3 RBD COMPLEXED WITH HACE2","10.1016/J.CELL.2022.06.023 ",2.7,50.39,"7xb1_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(103_A_)",122.489,"","",""
"7XCK","CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON RBD IN COMPLEX WITH S309 FAB (LOCAL REFINEMENT)","10.1038/S41467-022-32665-7 ",2.5,"3.35873e+07","7xck_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_M_)",22.1106,"","",""
"7XJF","CRYSTAL STRUCTURE OF 6MW3211 FAB IN COMPLEX WITH CD47","10.7150/THNO.79367 ",2.6,35.86,"7xjf_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(32_C_)",90.3418,"","",""
"7XJF","CRYSTAL STRUCTURE OF 6MW3211 FAB IN COMPLEX WITH CD47","10.7150/THNO.79367 ",2.6,35.86,"7xjf_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(55_C_)",86.7168,"","",""
"7XJF","CRYSTAL STRUCTURE OF 6MW3211 FAB IN COMPLEX WITH CD47","10.7150/THNO.79367 ",2.6,35.86,"7xjf_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(16_C_)",61.3648,"","",""
"7XN1","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH TACRINE","10.1016/J.IJBIOMAC.2022.05.009 ",2.85,0,"7xn1_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(350_B_)",53.1791,"","",""
"7XN1","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH TACRINE","10.1016/J.IJBIOMAC.2022.05.009 ",2.85,0,"7xn1_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",76.8194,"","",""
"7XQP","PSI-LHCI-LHCII-LHCB9 SUPERCOMPLEX OF PHYSCOMITRELLA PATENS","10.1038/S41477-023-01401-4 ",2.68,"7.70976e-33","7xqp_oligo6","DGalpa1-6DGalpb1-C39O5","DGD(847_B_)-DGD(847_B_)",45.8,"","",""
"7XSW","STRUCTURE OF SARS-COV-2 ANTIBODY S309 WITH GX/P2V/2017 RBD","10.1016/J.CELREP.2022.111831 ",3.3,75.49,"7xsw_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(343_R_)",75.8567,"","",""
"7XTJ","CRYSTAL STRUCTURE OF E88A MUTANT OF GH3 BETA-XYLOSIDASE FROM ASPERGILLUS NIGER (ANBX)","10.1007/S00253-023-12445-Z ",2.5,60.85,"7xtj_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(121_A_)",71.1197,"","",""
"7XTJ","CRYSTAL STRUCTURE OF E88A MUTANT OF GH3 BETA-XYLOSIDASE FROM ASPERGILLUS NIGER (ANBX)","10.1007/S00253-023-12445-Z ",2.5,60.85,"7xtj_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(121_B_)",76.5102,"","",""
"7XWA","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 OMICRON BA.4/5 VARIANT SPIKE PROTEIN IN COMPLEX WITH ITS RECEPTOR ACE2","10.1016/J.CELL.2022.09.018 ",3.36,130.2,"7xwa_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(90_C_)",144.157,"","",""
"7Y0C","CRYSTAL STRUCTURE OF BD55-1403 AND SARS-COV-2 OMICRON RBD","10.1016/J.CELREP.2022.111845 ",2.94,62.94,"7y0c_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(343_R_)",67.4839,"","",""
"7Y0C","CRYSTAL STRUCTURE OF BD55-1403 AND SARS-COV-2 OMICRON RBD","10.1016/J.CELREP.2022.111845 ",2.94,62.94,"7y0c_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(343_E_)",63.9366,"","",""
"7Y0V","THE CO-CRYSTAL STRUCTURE OF BA.1-RBD WITH FAB-5549","10.1016/J.CELREP.2022.111845 ",2.48,83.61,"7y0v_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_A_)-[BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(343_R_)",82.8111,"","",""
"7Y0W","LOCAL STRUCTURE OF BD55-5514 AND BD55-5840 FAB AND OMICRON BA.1 RBD COMPLEX","10.1016/J.CELREP.2022.111845 ",3.42,"2.14959e+09","7y0w_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)",42.4064,"","",""
"7Y1T","COMPLEX OF INTEGRIN ALPHAV/BETA8 AND L-TGF-BETA1 AT A RATIO OF 1:2","10.1038/S41467-022-32655-9 ",3.24,"1.35632e-19","7y1t_oligo4","DManpa1-6DManpa1-4[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(266_A_)",96.4047,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_B_)",148.773,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_B_)",111.239,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_D_)",114.903,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",178.716,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_D_)",158.421,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",183.215,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",474.941,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_D_)",464.855,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",478.944,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_B_)",475.308,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_D_)",525.33,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_B_)",500.705,"","",""
"7Y5T","CRYOEM STRUCTURE OF PS1-CONTAINING GAMMA-SECRETASE IN COMPLEX WITH MRK-560","10.1038/S41467-022-33817-5 ",2.9,"1.35632e-19","7y5t_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",82.5651,"","",""
"7Y5X","CRYOEM STRUCTURE OF PS2-CONTAINING GAMMA-SECRETASE TREATED WITH MRK- 560","10.1038/S41467-022-33817-5 ",3,3397.21,"7y5x_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",62.7262,"","",""
"7Y5Z","CRYOEM STRUCTURE OF HUMAN PS2-CONTAINING GAMMA-SECRETASE","10.1038/S41467-022-33817-5 ",3.4,"2.15283e+08","7y5z_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",97.0602,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo34","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_k_)-[BMA(3_k_)-NAG(2_k_)]-NAG(1_k_)-ASN(1232_B_)",924.735,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(264_C_)",725.682,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(216_A_)",789.203,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo23","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Z_)-[NAG(2_Z_)]-NAG(1_Z_)-ASN(1232_C_)",844.113,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo26","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_c_)-NAG(1_c_)-ASN(300_B_)",816.839,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo29","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_f_)-NAG(1_f_)-ASN(351_B_)",783.215,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_P_)-NAG(1_P_)-ASN(300_C_)",768.186,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_A_)",827.514,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo24","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_a_)-[BMA(3_a_)-NAG(2_a_)]-NAG(1_a_)-ASN(216_B_)",745.596,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(264_B_)",724.089,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo14","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_S_)-NAG(1_S_)-ASN(351_C_)",767.474,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_N_)-[BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(216_C_)",746.316,"","",""
"7Y6U","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-CLOSE CONFORMATION","10.1038/S41467-022-32588-3 ",3.2,"1.15243e-41","7y6u_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(300_A_)",162.824,"","",""
"7Y6U","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-CLOSE CONFORMATION","10.1038/S41467-022-32588-3 ",3.2,"1.15243e-41","7y6u_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(264_A_)",156.813,"","",""
"7Y6U","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-CLOSE CONFORMATION","10.1038/S41467-022-32588-3 ",3.2,"1.15243e-41","7y6u_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(351_A_)",173.32,"","",""
"7Y6U","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-CLOSE CONFORMATION","10.1038/S41467-022-32588-3 ",3.2,"1.15243e-41","7y6u_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(216_A_)",235.795,"","",""
"7Y6U","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-CLOSE CONFORMATION","10.1038/S41467-022-32588-3 ",3.2,"1.15243e-41","7y6u_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(1232_A_)",195.213,"","",""
"7Y6V","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-OPEN CONFORMATION","10.1038/S41467-022-32588-3 ",3.3,"1.15243e-41","7y6v_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(351_A_)",174.213,"","",""
"7Y6V","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-OPEN CONFORMATION","10.1038/S41467-022-32588-3 ",3.3,"1.15243e-41","7y6v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(264_A_)",159.096,"","",""
"7Y6V","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-OPEN CONFORMATION","10.1038/S41467-022-32588-3 ",3.3,"1.15243e-41","7y6v_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(216_A_)",283.537,"","",""
"7Y6V","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-OPEN CONFORMATION","10.1038/S41467-022-32588-3 ",3.3,"1.15243e-41","7y6v_oligo14","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_O_)-[NAG(2_O_)]-NAG(1_O_)-ASN(1232_A_)",191.362,"","",""
"7Y6V","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-OPEN CONFORMATION","10.1038/S41467-022-32588-3 ",3.3,"1.15243e-41","7y6v_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(300_A_)",176.498,"","",""
"7Y7B","CRYO-EM STRUCTURE OF CRYPTOPHYTE PHOTOSYSTEM I","10.1093/PLCELL/KOAD087 ",2.66,"1.35632e-19","7y7b_oligo15","DGalpa1-6DGalpb1-C32O5","DGD(848_B_)-DGD(848_B_)",29.1277,"","",""
"7Y7B","CRYO-EM STRUCTURE OF CRYPTOPHYTE PHOTOSYSTEM I","10.1093/PLCELL/KOAD087 ",2.66,"1.35632e-19","7y7b_oligo16","DGalpa1-6DGalpb1-C33O5","DGD(303_Z_)-DGD(303_Z_)",61.1309,"","",""
"7Y8A","CRYO-EM STRUCTURE OF CRYPTOPHYTE PHOTOSYSTEM I","10.1093/PLCELL/KOAD087 ",2.71,"1.35632e-19","7y8a_oligo10","DGalpa1-6DGalpb1-C33O5","DGD(303_Z_)-DGD(303_Z_)",90.63,"","",""
"7Y8A","CRYO-EM STRUCTURE OF CRYPTOPHYTE PHOTOSYSTEM I","10.1093/PLCELL/KOAD087 ",2.71,"1.35632e-19","7y8a_oligo12","DGalpa1-6DGalpb1-C32O5","DGD(848_B_)-DGD(848_B_)",53.1173,"","",""
"7YAD","CRYO-EM STRUCTURE OF S309-RBD-RBD-S309 IN THE S309-BOUND OMICRON SPIKE PROTEIN (LOCAL REFINEMENT)","10.1038/S41467-022-32665-7 ",2.66,"1.08527e-19","7yad_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(343_M_)",59.0015,"","",""
"7YAD","CRYO-EM STRUCTURE OF S309-RBD-RBD-S309 IN THE S309-BOUND OMICRON SPIKE PROTEIN (LOCAL REFINEMENT)","10.1038/S41467-022-32665-7 ",2.66,"1.08527e-19","7yad_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(343_E_)",63.0542,"","",""
"7YBI","SARS-COV-2 MU VARIANT SPIKE (OPEN STATE)","",4.1,0,"7ybi_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",128.244,"","",""
"7YBI","SARS-COV-2 MU VARIANT SPIKE (OPEN STATE)","",4.1,0,"7ybi_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1074_B_)",133.714,"","",""
"7YBI","SARS-COV-2 MU VARIANT SPIKE (OPEN STATE)","",4.1,0,"7ybi_oligo27","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",121.597,"","",""
"7YBK","SARS-COV-2 B.1.620 VARIANT SPIKE (OPEN STATE)","",3.9,0,"7ybk_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(1074_B_)",84.5754,"","",""
"7YBK","SARS-COV-2 B.1.620 VARIANT SPIKE (OPEN STATE)","",3.9,0,"7ybk_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(1074_A_)",94.6942,"","",""
"7YBK","SARS-COV-2 B.1.620 VARIANT SPIKE (OPEN STATE)","",3.9,0,"7ybk_oligo26","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(1074_C_)",98.6024,"","",""
"7YBL","SARS-COV-2 B.1.620 VARIANT SPIKE (CLOSE STATE)","",3.6,0,"7ybl_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(1074_B_)",96.613,"","",""
"7YBL","SARS-COV-2 B.1.620 VARIANT SPIKE (CLOSE STATE)","",3.6,0,"7ybl_oligo22","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(1074_A_)",109.556,"","",""
"7YBL","SARS-COV-2 B.1.620 VARIANT SPIKE (CLOSE STATE)","",3.6,0,"7ybl_oligo31","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_h_)-[NAG(2_h_)]-NAG(1_h_)-ASN(1074_C_)",99.91,"","",""
"7YCA","CRYO-EM STRUCTURE OF THE PSI-LHCI-LHCP SUPERCOMPLEX FROM OSTREOCOCCUS TAURI","10.7554/ELIFE.84488 ",2.94,"1.35632e-19","7yca_oligo13","DGalpa1-6DGalpb1-C32O5","DGD(850_B_)-DGD(850_B_)",34.2805,"","",""
"7YCA","CRYO-EM STRUCTURE OF THE PSI-LHCI-LHCP SUPERCOMPLEX FROM OSTREOCOCCUS TAURI","10.7554/ELIFE.84488 ",2.94,"1.35632e-19","7yca_oligo7","DGalpa1-6DGalpb1-C24O5","DGD(854_A_)-DGD(854_A_)",55.8427,"","",""
"7YCK","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH FP-12A FAB","10.1038/S41467-023-35949-8 ",2.6,71.8,"7yck_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_A_)",97.8568,"","",""
"7YCK","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH FP-12A FAB","10.1038/S41467-023-35949-8 ",2.6,71.8,"7yck_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(343_B_)",93.3224,"","",""
"7YCL","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH IS-9A FAB","10.1038/S41467-023-35949-8 ",2.13,27.63,"7ycl_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_D_)",61.6615,"","",""
"7YHW","CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON BA.2.12.1 RBD IN COMPLEX WITH HUMAN ACE2 (LOCAL REFINEMENT)","10.1038/S41467-023-39942-Z ",3.09,"1.08527e-19","7yhw_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(546_A_)",71.5958,"","",""
"7YMI","PSII-PCB DIMER OF ACARYOCHLORIS MARINA","",3.3,"1.08527e-19","7ymi_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(625_b_)-DGD(625_b_)",54.81,"","",""
"7YMI","PSII-PCB DIMER OF ACARYOCHLORIS MARINA","",3.3,"1.08527e-19","7ymi_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",62.22,"","",""
"7YMI","PSII-PCB DIMER OF ACARYOCHLORIS MARINA","",3.3,"1.08527e-19","7ymi_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(624_B_)-DGD(624_B_)",54.81,"","",""
"7YMI","PSII-PCB DIMER OF ACARYOCHLORIS MARINA","",3.3,"1.08527e-19","7ymi_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",62.22,"","",""
"7YMT","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 2","",6.55,"1.15243e-41","7ymt_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(125_C_)",281.571,"","",""
"7YMT","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 2","",6.55,"1.15243e-41","7ymt_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_B_)",253.458,"","",""
"7YMT","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 2","",6.55,"1.15243e-41","7ymt_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(619_C_)",293.844,"","",""
"7YMT","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 2","",6.55,"1.15243e-41","7ymt_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",255.422,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(719_B_)",714.962,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo22","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_Y_)-NAG(1_Y_)-ASN(619_C_)",672.302,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",622.727,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo11","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(719_A_)",610.924,"","",""
"7YMW","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 4","",6.05,"1.15243e-41","7ymw_oligo2","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(66_C_)",232.582,"","",""
"7YMX","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 2","",4.44,"1.15243e-41","7ymx_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(125_C_)",232.728,"","",""
"7YMX","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 2","",4.44,"1.15243e-41","7ymx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",192.833,"","",""
"7YMX","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 2","",4.44,"1.15243e-41","7ymx_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(125_B_)",218.301,"","",""
"7YMY","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 1","",4.96,"1.15243e-41","7ymy_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(125_B_)",241.422,"","",""
"7YMY","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 1","",4.96,"1.15243e-41","7ymy_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(125_C_)",267.567,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo9","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(719_A_)",196,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo12","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(619_B_)",200.902,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(719_B_)",189.648,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo17","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_T_)-NAG(1_T_)-ASN(719_C_)",180.52,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",198.233,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(125_B_)",206.637,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(125_C_)",203.405,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo2","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(619_A_)",212.657,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo16","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_S_)-NAG(1_S_)-ASN(619_C_)",206.424,"","",""
"7YN0","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ALL RBD-DOWN CONFORMATION","",4.1,"1.15243e-41","7yn0_oligo15","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(719_C_)",128.049,"","",""
"7YN0","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ALL RBD-DOWN CONFORMATION","",4.1,"1.15243e-41","7yn0_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(719_B_)",131.659,"","",""
"7YN0","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ALL RBD-DOWN CONFORMATION","",4.1,"1.15243e-41","7yn0_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(719_A_)",129.778,"","",""
"7YN0","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ALL RBD-DOWN CONFORMATION","",4.1,"1.15243e-41","7yn0_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(222_C_)",183.841,"","",""
"7YN0","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ALL RBD-DOWN CONFORMATION","",4.1,"1.15243e-41","7yn0_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(222_A_)",179.867,"","",""
"7YN0","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ALL RBD-DOWN CONFORMATION","",4.1,"1.15243e-41","7yn0_oligo10","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(222_B_)",173.424,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo70","DGalpa1-6DGalpb1-C35O5","DGD(918_c_)-DGD(918_c_)",40.4545,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo65","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",36.2318,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo71","DGalpa1-6DGalpb1-C35O5","DGD(919_c_)-DGD(919_c_)",37.0518,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo66","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",32.3145,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo64","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",31.6636,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo69","DGalpa1-6DGalpb1-C35O5","DGD(917_c_)-DGD(917_c_)",35.1255,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo68","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",39.7718,"","",""
"7YQ2","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA2 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,46.22,"7yq2_oligo73","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",42.525,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",42.7055,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",38.8036,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",29.9582,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(520_C_)-DGD(520_C_)",30.0682,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(104_H_)-DGD(104_H_)",39.0991,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",35.6423,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",33.8627,"","",""
"7YQ7","CRYSTAL STRUCTURE OF PHOTOSYSTEM II EXPRESSING PSBA3 GENE ONLY","10.1016/J.JBC.2022.102668 ",1.9,43.95,"7yq7_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",32.7655,"","",""
"7YQS","NEUTRON STRUCTURE OF A L-RHAMNOSE-ALPHA-1,4-D-GLUCURONATE LYASE FROM FUSARIUM OXYSPORUM 12S, L-RHA COMPLEX","",1.25,0,"7yqs_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(247_A_)",59.5691,"","",""
"7YQX","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE1)","10.1016/J.CHOM.2022.09.018 ",3.72,512.502,"7yqx_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(343_B_)",197.553,"","",""
"7YQX","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE1)","10.1016/J.CHOM.2022.09.018 ",3.72,512.502,"7yqx_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_A_)",343.541,"","",""
"7YQY","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE2)","10.1016/J.CHOM.2022.09.018 ",3.74,"1.08527e-19","7yqy_oligo8","DManpb1-4DGlcpNAcb1-4[DArapb1-6]DGlcpNAcx1-","FUC(4_Q_)-[BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)",196.724,"","",""
"7YQY","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE2)","10.1016/J.CHOM.2022.09.018 ",3.74,"1.08527e-19","7yqy_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAc[3<R1>]x1-","FUC(4_U_)-[BMA(3_U_)-NAG(2_U_)-",235.628,"","",""
"7YQY","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE2)","10.1016/J.CHOM.2022.09.018 ",3.74,"1.08527e-19","7yqy_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)",246.97,"","",""
"7YQZ","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE3)","10.1016/J.CHOM.2022.09.018 ",3.84,512.502,"7yqz_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(343_A_)",200.853,"","",""
"7YQZ","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE3)","10.1016/J.CHOM.2022.09.018 ",3.84,512.502,"7yqz_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(343_C_)",136.2,"","",""
"7YR0","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (INTERFACE)","10.1016/J.CHOM.2022.09.018 ",3.98,512.502,"7yr0_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(343_A_)",54.5068,"","",""
"7Z0X","THSC20.HVTR26 FAB BOUND TO SARS-COV-2 RECEPTOR BINDING DOMAIN","10.1371/JOURNAL.PPAT.1010465 ",1.8,51.49,"7z0x_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_R_)",60.623,"","",""
"7Z0Y","THSC20.HVTR04 FAB BOUND TO SARS-COV-2 RECEPTOR BINDING DOMAIN","10.1371/JOURNAL.PPAT.1010465 ",2.95,66,"7z0y_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_R_)",103.179,"","",""
"7Z14","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH A SHORT-CHAIN NEUROTOXIN.","10.1038/S41467-022-32174-7 ",3.15,"1.35632e-19","7z14_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(141_D_)",102.763,"","",""
"7Z14","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH A SHORT-CHAIN NEUROTOXIN.","10.1038/S41467-022-32174-7 ",3.15,"1.35632e-19","7z14_oligo5","DManpa1-6DManpa1-6DGlcpNAcb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-NAG(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(141_E_)",107.069,"","",""
"7Z14","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH A SHORT-CHAIN NEUROTOXIN.","10.1038/S41467-022-32174-7 ",3.15,"1.35632e-19","7z14_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-[MAN(7_K_)]-MAN(4_K_)-[MAN(9_K_)-MAN(8_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_A_)",106.075,"","",""
"7Z51","TICK-BORNE ENCEPHALITIS VIRUS KUUTSALO-14","10.3390/V14040792 ",3.3,0,"7z51_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(154_B_)",98.5885,"","",""
"7Z51","TICK-BORNE ENCEPHALITIS VIRUS KUUTSALO-14","10.3390/V14040792 ",3.3,0,"7z51_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(154_C_)",85.1518,"","",""
"7Z51","TICK-BORNE ENCEPHALITIS VIRUS KUUTSALO-14","10.3390/V14040792 ",3.3,0,"7z51_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(154_A_)",89.427,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_q_)-[MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)]-NAG(1_q_)-ASN(483_T_)",37.0665,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_c_)-[MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(483_D_)",33.2317,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(391_N_)",63.1913,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_k_)-[MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)]-NAG(1_k_)-ASN(483_N_)",38.2741,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(391_B_)",56.2507,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_e_)-[MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(483_H_)",42.6933,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_a_)-[MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)]-NAG(1_a_)-ASN(483_B_)",36.1155,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_h_)-[MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)]-NAG(1_h_)-ASN(483_J_)",39.5667,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_n_)-[MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(483_P_)",35.288,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_t_)-[MAN(5_t_)-[MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)]-NAG(1_t_)-ASN(483_V_)",39.0839,"","",""
"7Z6Z","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH FOSINOPRILAT","10.1111/FEBS.16543 ",1.75,34.97,"7z6z_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(416_B_)",68.1458,"","",""
"7Z6Z","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH FOSINOPRILAT","10.1111/FEBS.16543 ",1.75,34.97,"7z6z_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(480_A_)",54.2755,"","",""
"7Z6Z","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH FOSINOPRILAT","10.1111/FEBS.16543 ",1.75,34.97,"7z6z_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(416_A_)",61.0195,"","",""
"7Z6Z","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH FOSINOPRILAT","10.1111/FEBS.16543 ",1.75,34.97,"7z6z_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(480_B_)",54.7805,"","",""
"7Z70","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH FOSINOPRILAT","10.1111/FEBS.16543 ",1.85,26.35,"7z70_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)",53.3118,"","",""
"7ZFC","SARS-COV-2 BETA RBD IN COMPLEX WITH NANOBODY C1, OMI-18 AND OMI-31 FABS","10.1016/J.CELL.2022.05.014 ",3.24,146,"7zfc_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(343_E_)",222.451,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_B_)",152.449,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",151.5,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(81_A_)",236.839,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(81_B_)",233.774,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",152.01,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(81_C_)",234.641,"","",""
"7ZJ7","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 4.8","10.1073/PNAS.2208011119 ",3.95,0,"7zj7_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(81_A_)",424.34,"","",""
"7ZJ7","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 4.8","10.1073/PNAS.2208011119 ",3.95,0,"7zj7_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(81_B_)",423.057,"","",""
"7ZJ7","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 4.8","10.1073/PNAS.2208011119 ",3.95,0,"7zj7_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(81_C_)",424.198,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",230.717,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(81_A_)",349.031,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_M_)-[BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(81_C_)",344.435,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(81_B_)",347.453,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",222.121,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_B_)",223.486,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)]-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(295_C_)",112.964,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_D_)",124.973,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",131.367,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_A_)",145.946,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(301_C_)",125.959,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(301_A_)",144.38,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_C_)",117.527,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)]-MAN(4_c_)-[MAN(7_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(295_D_)",147.389,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_A_)",136.065,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(332_C_)",105.493,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(301_D_)",154.196,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-[MAN(7_d_)]-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(332_D_)",180.322,"","",""
"7ZPB","STRUCTURE OF HEMIACETYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 8-(3-(4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLINE-2- CARBALDEHYDE","10.1016/J.APSB.2023.01.013 ",2.31,58.16,"7zpb_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(57_A_)",108.22,"","",""
"7ZPB","STRUCTURE OF HEMIACETYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 8-(3-(4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLINE-2- CARBALDEHYDE","10.1016/J.APSB.2023.01.013 ",2.31,58.16,"7zpb_oligo3","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(241_A_)",95.2695,"","",""
"7ZPB","STRUCTURE OF HEMIACETYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 8-(3-(4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLINE-2- CARBALDEHYDE","10.1016/J.APSB.2023.01.013 ",2.31,58.16,"7zpb_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(341_A_)",78.7239,"","",""
"7ZPB","STRUCTURE OF HEMIACETYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 8-(3-(4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLINE-2- CARBALDEHYDE","10.1016/J.APSB.2023.01.013 ",2.31,58.16,"7zpb_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(485_A_)",99.9345,"","",""
"7ZPB","STRUCTURE OF HEMIACETYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 8-(3-(4-(PROP-2-YN-1-YL)PIPERAZIN-1-YL)PROPOXY)QUINOLINE-2- CARBALDEHYDE","10.1016/J.APSB.2023.01.013 ",2.31,58.16,"7zpb_oligo7","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(106_A_)",85.1573,"","",""
"7ZU8","CRYSTAL STRUCTURE OF THE ZYMOGEN FORM OF THE GLUTAMIC-CLASS PROLYL- ENDOPEPTIDASE NEPROSIN AT 2.05 A RESOLUTION IN PRESENCE OF THE CRYSTALLOPHORE LU-XO4.","10.1038/S41467-022-32215-1 ",2.05,48.48,"7zu8_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(145_A_)",71.1612,"","",""
"7ZVA","CRYSTAL STRUCTURE OF THE NATIVE ZYMOGEN FORM OF THE GLUTAMIC-CLASS PROLYL-ENDOPEPTIDASE NEPROSIN AT 1.80 A RESOLUTION.","10.1038/S41467-022-32215-1 ",1.8,35.76,"7zva_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(145_A_)",51.2886,"","",""
"7ZVB","CRYSTAL STRUCTURE OF THE MATURE FORM OF THE GLUTAMIC-CLASS PROLYL- ENDOPEPTIDASE NEPROSIN AT 2.35 A RESOLUTION.","10.1038/S41467-022-32215-1 ",2.35,39.57,"7zvb_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(152_A_)",52.4817,"","",""
"7ZWF","PFS48/45 BOUND TO SCFV FRAGMENT OF MONOCLONAL ANTIBODY 32F3","10.1038/S41467-022-33379-6 ",2.13,98.74,"7zwf_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(303_A_)",117,"","",""
"7ZWI","PFS48/45 C-TERMINAL DOMAIN BOUND TO FAB FRAGMENT OF MONOCLONAL ANTIBODY 32F3","10.1038/S41467-022-33379-6 ",1.9,42.85,"7zwi_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(303_D_)",52.2312,"","",""
"7ZWM","PFS48/45 CENTRAL AND C-TERMINAL DOMAINS BOUND TO FAB FRAGMENTS OF MONOCLONAL ANTIBODY 10D8 AND 32F3","10.1038/S41467-022-33379-6 ",3.69,161.4,"7zwm_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(204_F_)",191.715,"","",""
"7ZXG","PFS48/45 BOUND TO FAB FRAGMENT OF MONOCLONAL ANTIBODY 10D8","10.1038/S41467-022-33379-6 ",4.2,212.1,"7zxg_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(204_A_)",264.986,"","",""
"7ZYF","INSULIN REGULATED AMINOPEPTIDASE (IRAP) IN COMPLEX WITH A NANOMOLAR ALPHA HYDROXY BETA AMINO ACID BASED INHIBITOR.","10.1021/ACS.JMEDCHEM.2C00904 ",2.81,39.16,"7zyf_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(184_A_)",67.8904,"","",""
"7ZYF","INSULIN REGULATED AMINOPEPTIDASE (IRAP) IN COMPLEX WITH A NANOMOLAR ALPHA HYDROXY BETA AMINO ACID BASED INHIBITOR.","10.1021/ACS.JMEDCHEM.2C00904 ",2.81,39.16,"7zyf_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(760_B_)",96.8527,"","",""
"7ZYF","INSULIN REGULATED AMINOPEPTIDASE (IRAP) IN COMPLEX WITH A NANOMOLAR ALPHA HYDROXY BETA AMINO ACID BASED INHIBITOR.","10.1021/ACS.JMEDCHEM.2C00904 ",2.81,39.16,"7zyf_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(184_B_)",71.9616,"","",""
"8A16","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P212121","10.1016/J.JBC.2022.102750 ",2.89,75.76,"8a16_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(544_A_)",95.1707,"","",""
"8A16","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P212121","10.1016/J.JBC.2022.102750 ",2.89,75.76,"8a16_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(598_B_)",95.8573,"","",""
"8A16","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P212121","10.1016/J.JBC.2022.102750 ",2.89,75.76,"8a16_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(544_B_)",97.7555,"","",""
"8A17","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P3221","10.1016/J.JBC.2022.102750 ",3.09,113.4,"8a17_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(598_C_)",159.658,"","",""
"8A17","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P3221","10.1016/J.JBC.2022.102750 ",3.09,113.4,"8a17_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(544_C_)",132.112,"","",""
"8A17","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P3221","10.1016/J.JBC.2022.102750 ",3.09,113.4,"8a17_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(544_D_)",129.891,"","",""
"8A17","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P3221","10.1016/J.JBC.2022.102750 ",3.09,113.4,"8a17_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(544_B_)",124.085,"","",""
"8A17","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P3221","10.1016/J.JBC.2022.102750 ",3.09,113.4,"8a17_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(598_D_)",144.329,"","",""
"8A17","HUMAN PTPRM DOMAINS FN3-4, IN SPACEGROUP P3221","10.1016/J.JBC.2022.102750 ",3.09,113.4,"8a17_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(544_A_)",138.96,"","",""
"8A1F","HUMAN PTPRK N-TERMINAL DOMAINS MAM-IG-FN1","10.1016/J.JBC.2022.102750 ",3,116.9,"8a1f_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(101_A_)",163.03,"","",""
"8A48","LESS CRYSTALLISABLE"" IGG1 FC FRAGMENT (E382S VARIANT)","10.1038/S41467-022-35340-Z ",3.04,136.2,"8a48_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",154.664,"","",""
"8A48","LESS CRYSTALLISABLE"" IGG1 FC FRAGMENT (E382S VARIANT)","10.1038/S41467-022-35340-Z ",3.04,136.2,"8a48_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",201.009,"","",""
"8A49","ENDOGLYCOSIDASE S IN COMPLEX WITH IGG1 FC","10.1038/S41467-022-35340-Z ",3.45,146.6,"8a49_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",155.645,"","",""
"8AEN","HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH ZINC AND N,N,N-TRIMETHYL-2- OXO-2-(2-(PYRIDIN-2-YLMETHYLENE)HYDRAZINEYL)ETHAN-1-AMINIUM","10.1002/CBIC.202200456 ",3.01,87.43,"8aen_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(350_B_)",153.732,"","",""
"8AEN","HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH ZINC AND N,N,N-TRIMETHYL-2- OXO-2-(2-(PYRIDIN-2-YLMETHYLENE)HYDRAZINEYL)ETHAN-1-AMINIUM","10.1002/CBIC.202200456 ",3.01,87.43,"8aen_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",137.466,"","",""
"8AEV","HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH N,N,N-TRIMETHYL-2-OXO-2-(2- (PYRIDIN-2-YLMETHYLENE)HYDRAZINEYL)ETHAN-1-AMINIUM","10.1002/CBIC.202200456 ",2.89,88.45,"8aev_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",128.782,"","",""
"8AEV","HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH N,N,N-TRIMETHYL-2-OXO-2-(2- (PYRIDIN-2-YLMETHYLENE)HYDRAZINEYL)ETHAN-1-AMINIUM","10.1002/CBIC.202200456 ",2.89,88.45,"8aev_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(350_B_)",155.433,"","",""
"8AEZ","X-RAY STRUCTURE OF THE DEGLYCOSYLATED RECEPTOR BINDING DOMAIN OF ENV GLYCOPROTEIN OF SIMIAN FOAMY VIRUS","10.1038/S41467-023-36923-0 ",2.57,75.14,"8aez_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(390_A_)",85.7584,"","",""
"8AGC","STRUCTURE OF YEAST OLIGOSACCHARYLRANSFERASE COMPLEX WITH LIPID-LINKED OLIGOSACCHARIDE AND NON-ACCEPTOR PEPTIDE BOUND","10.1038/S41467-022-35067-X ",3.1,"1.35632e-19","8agc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(539_A_)",53.7575,"","",""
"8AGC","STRUCTURE OF YEAST OLIGOSACCHARYLRANSFERASE COMPLEX WITH LIPID-LINKED OLIGOSACCHARIDE AND NON-ACCEPTOR PEPTIDE BOUND","10.1038/S41467-022-35067-X ",3.1,"1.35632e-19","8agc_oligo3","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C20O7P2","MAN(11_L_)-MAN(10_L_)-[GLC(9_L_)-GLC(8_L_)-GLC(7_L_)-MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NDG(1_L_)-ELU(1001_A_)",76.5284,"","",""
"8AGE","STRUCTURE OF YEAST OLIGOSACCHARYLRANSFERASE COMPLEX WITH ACCEPTOR PEPTIDE BOUND","10.1038/S41467-022-35067-X ",2.8,"1.35632e-19","8age_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(303_F_)-[MAN(302_F_)-MAN(301_F_)-MAN(503_G_)]-BMA(502_G_)-NAG(501_G_)-NAG(801_A_)-ASN(539_A_)",51.0703,"","",""
"8AI7","STRUCTURE OF CARBAMOYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 3-(((2-CYCLOHEPTYLETHYL)(METHYL)AMINO)METHYL)-1H-INDOL-7-YL N,N- DIMETHYLCARBAMATE","10.1016/J.EJMECH.2022.115048 ",2.13,65.82,"8ai7_oligo4","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(485_F_)",131.124,"","",""
"8AI7","STRUCTURE OF CARBAMOYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 3-(((2-CYCLOHEPTYLETHYL)(METHYL)AMINO)METHYL)-1H-INDOL-7-YL N,N- DIMETHYLCARBAMATE","10.1016/J.EJMECH.2022.115048 ",2.13,65.82,"8ai7_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_F_)",92.443,"","",""
"8AI7","STRUCTURE OF CARBAMOYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 3-(((2-CYCLOHEPTYLETHYL)(METHYL)AMINO)METHYL)-1H-INDOL-7-YL N,N- DIMETHYLCARBAMATE","10.1016/J.EJMECH.2022.115048 ",2.13,65.82,"8ai7_oligo2","LFucpa1-6DGlcpNAcx1-","FUC(2_B_)-NAG(1_B_)",129.459,"","",""
"8AI7","STRUCTURE OF CARBAMOYLATED HUMAN BUTYRYLCHOLINESTERASE UPON REACTION WITH 3-(((2-CYCLOHEPTYLETHYL)(METHYL)AMINO)METHYL)-1H-INDOL-7-YL N,N- DIMETHYLCARBAMATE","10.1016/J.EJMECH.2022.115048 ",2.13,65.82,"8ai7_oligo3","LFucpa1-6DGlcpNAcx1-","FUC(2_C_)-NAG(1_C_)",99.2319,"","",""
"8AIC","X-RAY STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF ENV GLYCOPROTEIN OF SIMIAN FOAMY VIRUS","10.1038/S41467-023-36923-0 ",2.8,69.54,"8aic_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-[MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(390_B_)",101.843,"","",""
"8AIC","X-RAY STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF ENV GLYCOPROTEIN OF SIMIAN FOAMY VIRUS","10.1038/S41467-023-36923-0 ",2.8,69.54,"8aic_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(390_A_)",103.245,"","",""
"8AKP","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF G7048 FROM PENICILLIUM SUMATRAENSE","10.1186/S13068-022-02233-8 ",1.9,0,"8akp_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(166_A_)",54.0327,"","",""
"8AM1","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ZINC AND N,N,N-TRIMETHYL- 2-OXO-2-(2-(PYRIDIN-2-YLMETHYLENE)HYDRAZINEYL)ETHAN-1-AMINIUM","10.1002/CBIC.202200456 ",2.53,70.6,"8am1_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",116.924,"","",""
"8AM1","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ZINC AND N,N,N-TRIMETHYL- 2-OXO-2-(2-(PYRIDIN-2-YLMETHYLENE)HYDRAZINEYL)ETHAN-1-AMINIUM","10.1002/CBIC.202200456 ",2.53,70.6,"8am1_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",94.5458,"","",""
"8AM2","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2,2'-(((1E,1'E)-(2- PHENYLPYRIMIDINE-4,6-DIYL)BIS(METHANEYLYLIDENE))BIS(HYDRAZIN-1-YL-2- YLIDENE))BIS(N,N,N-TRIMETHYL-2-OXOETHAN-1-AMINIUM)","10.1002/CBIC.202200456 ",2.5,53.41,"8am2_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",99.3291,"","",""
"8AM2","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2,2'-(((1E,1'E)-(2- PHENYLPYRIMIDINE-4,6-DIYL)BIS(METHANEYLYLIDENE))BIS(HYDRAZIN-1-YL-2- YLIDENE))BIS(N,N,N-TRIMETHYL-2-OXOETHAN-1-AMINIUM)","10.1002/CBIC.202200456 ",2.5,53.41,"8am2_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",78.0806,"","",""
"8API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3.1,0,"8api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",25.9524,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_h_)-[BMA(3_h_)-NAG(2_h_)]-NAG(1_h_)-ASN(58_R_)",94.8361,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Z_)-[BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(49_A_)",104.435,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_a_)-[NAG(2_a_)]-NAG(1_a_)-ASN(58_A_)",104.502,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_j_)-[NAG(2_j_)]-NAG(1_j_)-ASN(58_X_)",116.952,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo7","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_e_)-[NAG(2_e_)]-NAG(1_e_)-ASN(58_I_)",116.85,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo13","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_k_)-[BMA(3_k_)-NAG(2_k_)]-NAG(1_k_)-ASN(58_Y_)",118.676,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo5","DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_c_)-[BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(58_F_)",88.8161,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo6","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_d_)-NAG(1_d_)-ASN(49_I_)",127.27,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_g_)-[BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(58_O_)",98.7766,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo11","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_i_)-NAG(1_i_)-ASN(49_X_)",127.19,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo8","DManpa1-3[DManpa1-6]DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_f_)-[MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(58_L_)",108.284,"","",""
"8AV5","GLYCOSYLATED PADA-I MUTANT OF UNSPECIFIC PEROXYGENASE FROM AGROCYBE AEGERITA","",1.62,30.39,"8av5_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(286_A_)",43.5868,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(506_H_)-[MAN(505_H_)-MAN(504_H_)]-BMA(503_H_)-NAG(502_H_)-NAG(501_H_)",35.9318,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(405_F_)-[MAN(404_F_)]-BMA(403_F_)-NAG(402_F_)-NAG(401_F_)",30,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(406_E_)-[MAN(405_E_)-MAN(404_E_)]-MAN(403_E_)-NAG(402_E_)-NAG(401_E_)-ASN(295_E_)",30.6309,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",31.0804,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_G_)",30.5764,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(506_D_)-[MAN(505_D_)-MAN(504_D_)]-BMA(503_D_)-NAG(502_D_)-NAG(501_D_)-ASN(295_D_)",30.4518,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(406_C_)-[MAN(405_C_)-MAN(404_C_)-MAN(403_C_)]-BMA(402_C_)-NAG(401_C_)-NAG(400_C_)-ASN(295_C_)",30.1875,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(405_B_)-[MAN(406_B_)-MAN(404_B_)]-BMA(403_B_)-NAG(402_B_)-NAG(401_B_)-ASN(295_B_)",30.4167,"","",""
"8B48","STRUCTURE OF LENTITHECIUM FLUVIATILE CARBOHYDRATE ESTERASE FROM THE CE15 FAMILY (LFCE15C)","10.1107/S205979832300325X ",2.65,59.1,"8b48_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(241_D_)",117.055,"","",""
"8B48","STRUCTURE OF LENTITHECIUM FLUVIATILE CARBOHYDRATE ESTERASE FROM THE CE15 FAMILY (LFCE15C)","10.1107/S205979832300325X ",2.65,59.1,"8b48_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(241_C_)",121.98,"","",""
"8B48","STRUCTURE OF LENTITHECIUM FLUVIATILE CARBOHYDRATE ESTERASE FROM THE CE15 FAMILY (LFCE15C)","10.1107/S205979832300325X ",2.65,59.1,"8b48_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(241_B_)",134.829,"","",""
"8BES","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH FRUCTOSE","10.3390/IJMS232314981 ",1.86,26.5,"8bes_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(350_C_)",62.4867,"","",""
"8BET","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENESIS IN COMPLEX WITH SUCROSE","10.3390/IJMS232314981 ",2.38,37.08,"8bet_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(350_C_)",68.9794,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo9","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_N_)-GLC(2_N_)-FRU(1_N_)",76.1692,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo5","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_J_)-GLC(2_J_)-FRU(1_J_)",57.3332,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo3","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_G_)-GLC(2_G_)-FRU(1_G_)",43.2655,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo7","DGalpa1-6DGlcpa2-1DFrufb","GLA(3_L_)-GLC(2_L_)-FRU(1_L_)",52.0331,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(350_B_)",82.7954,"","",""
"8BGG","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE (OMICRON BA.1 VARIANT) IN COMPLEX WITH NANOBODY W25 (MAP 5, FOCUS REFINEMENT ON RBD, W25 AND ADJACENT NTD)","",6.04,"1.08527e-19","8bgg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(122_B_)",185.493,"","",""
"8BH5","SARS-COV-2 BA.2.12.1 RBD IN COMPLEX WITH BETA-27 FAB AND C1 NANOBODY","10.1038/S41421-022-00482-3 ",2.38,57.92,"8bh5_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_A_)-NAG(1_A_)-ASN(343_E_)",97.2641,"","",""
"8BHH","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM IN COMPLEX WITH P-COUMARIC ACID","10.1107/S2059798323004175 ",1.69,28.71,"8bhh_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(151_B_)",30.6568,"","",""
"8BHH","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM IN COMPLEX WITH P-COUMARIC ACID","10.1107/S2059798323004175 ",1.69,28.71,"8bhh_oligo4","DManpa1-2DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(151_A_)",47.7164,"","",""
"8BHH","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM IN COMPLEX WITH P-COUMARIC ACID","10.1107/S2059798323004175 ",1.69,28.71,"8bhh_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(362_B_)",26.596,"","",""
"8BHH","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM IN COMPLEX WITH P-COUMARIC ACID","10.1107/S2059798323004175 ",1.69,28.71,"8bhh_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(362_A_)",31.3338,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-[FUC(6_J_)]-NAG(1_J_)-ASN(81_B_)",43.6947,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo13","DManpa1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(81_A_)",45.6718,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-[FUC(6_H_)]-NAG(1_H_)-ASN(396_A_)",31.453,"","",""
"8BW5","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND THE DUPLEX/QUADRUPLEX APTAMER M08S-1_41MER","10.1093/NAR/GKAD634 ",2.8,77.14,"8bw5_oligo19","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",104.268,"","",""
"8BXY","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.45,32.69,"8bxy_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",61.4667,"","",""
"8BXY","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.45,32.69,"8bxy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DManp[2H]b1-ROH","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-",73.5086,"","",""
"8BY3","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3.19,61.21,"8by3_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",90.5867,"","",""
"8BY3","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3.19,61.21,"8by3_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_E_)-[MAN(7_E_)]-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",83.1976,"","",""
"8C1B","FOCUSED MAP FOR STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",3.8,0,"8c1b_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(391_H_)",134.259,"","",""
"8C1B","FOCUSED MAP FOR STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",3.8,0,"8c1b_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(391_X_)",141.325,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(391_H_)",145.552,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(166_R_)",187.437,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_R_)",157.426,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(391_X_)",168.317,"","",""
"8C29","CRYO-EM STRUCTURE OF PHOTOSYSTEM II C2S2 SUPERCOMPLEX FROM NORWAY SPRUCE (PICEA ABIES) AT 2.8 ANGSTROM RESOLUTION","10.1038/S41477-023-01483-0 ",2.79,"1.08527e-19","8c29_oligo14","DGalpa1-6DGalpb1-C39O5","DGD(515_C_)-DGD(515_C_)",36.9891,"","",""
"8C29","CRYO-EM STRUCTURE OF PHOTOSYSTEM II C2S2 SUPERCOMPLEX FROM NORWAY SPRUCE (PICEA ABIES) AT 2.8 ANGSTROM RESOLUTION","10.1038/S41477-023-01483-0 ",2.79,"1.08527e-19","8c29_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(502_H_)-DGD(502_H_)",37.0759,"","",""
"8C29","CRYO-EM STRUCTURE OF PHOTOSYSTEM II C2S2 SUPERCOMPLEX FROM NORWAY SPRUCE (PICEA ABIES) AT 2.8 ANGSTROM RESOLUTION","10.1038/S41477-023-01483-0 ",2.79,"1.08527e-19","8c29_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(411_d_)-DGD(411_d_)",36.7805,"","",""
"8C29","CRYO-EM STRUCTURE OF PHOTOSYSTEM II C2S2 SUPERCOMPLEX FROM NORWAY SPRUCE (PICEA ABIES) AT 2.8 ANGSTROM RESOLUTION","10.1038/S41477-023-01483-0 ",2.79,"1.08527e-19","8c29_oligo2","DGalpa1-6DGalpb1-C28O5","DGD(515_c_)-DGD(515_c_)",36.8614,"","",""
"8C3V","SARS-COV-2 DELTA-RBD COMPLEXED WITH BA.2-13 FAB AND C1 NANOBODY","10.1016/J.CELREP.2023.112271 ",2.74,93.88,"8c3v_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(343_X_)",116.648,"","",""
"8C3V","SARS-COV-2 DELTA-RBD COMPLEXED WITH BA.2-13 FAB AND C1 NANOBODY","10.1016/J.CELREP.2023.112271 ",2.74,93.88,"8c3v_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_Y_)",116.535,"","",""
"8C3V","SARS-COV-2 DELTA-RBD COMPLEXED WITH BA.2-13 FAB AND C1 NANOBODY","10.1016/J.CELREP.2023.112271 ",2.74,93.88,"8c3v_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(343_R_)",124.911,"","",""
"8C6I","TMEM2 ECTODOMAIN","10.12688/WELLCOMEOPENRES.18937.2 ",3.5,0,"8c6i_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(1078_A_)",130.935,"","",""
"8C6I","TMEM2 ECTODOMAIN","10.12688/WELLCOMEOPENRES.18937.2 ",3.5,0,"8c6i_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(1092_A_)",128.311,"","",""
"8C6I","TMEM2 ECTODOMAIN","10.12688/WELLCOMEOPENRES.18937.2 ",3.5,0,"8c6i_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1234_A_)",126.02,"","",""
"8CB1","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH N-PNT-DNM 15","10.1039/D3SC01021J ",1.75,40.59,"8cb1_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)",97.6038,"","",""
"8CB1","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH N-PNT-DNM 15","10.1039/D3SC01021J ",1.75,40.59,"8cb1_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(140_G_)",80.305,"","",""
"8CB6","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COVALENT COMPLEX WITH TAMRA TAGGED 1,6-EPI-CYLCOPHELLITOL AZIRIDINE ACTIVITY BASED PROBE","10.1039/D3SC01021J ",1.9,41.15,"8cb6_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(140_F_)",72.5412,"","",""
"8CGO","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-{[2- (BENZYLOXY)-3-METHOXYPHENYL]METHYL}-N-[3-(2-FLUOROPHENYL) PROPYL]CYCLOBUTANAMINE","10.1016/J.EJMECH.2023.115301 ",2.65,69.9,"8cgo_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(57_A_)",114.494,"","",""
"8CGO","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-{[2- (BENZYLOXY)-3-METHOXYPHENYL]METHYL}-N-[3-(2-FLUOROPHENYL) PROPYL]CYCLOBUTANAMINE","10.1016/J.EJMECH.2023.115301 ",2.65,69.9,"8cgo_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",104.019,"","",""
"8CGO","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-{[2- (BENZYLOXY)-3-METHOXYPHENYL]METHYL}-N-[3-(2-FLUOROPHENYL) PROPYL]CYCLOBUTANAMINE","10.1016/J.EJMECH.2023.115301 ",2.65,69.9,"8cgo_oligo5","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(106_A_)",87.9405,"","",""
"8CGO","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-{[2- (BENZYLOXY)-3-METHOXYPHENYL]METHYL}-N-[3-(2-FLUOROPHENYL) PROPYL]CYCLOBUTANAMINE","10.1016/J.EJMECH.2023.115301 ",2.65,69.9,"8cgo_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(341_A_)",92.3885,"","",""
"8CWI","FAB ARM OF ANTIBODY 10G4 BOUND TO COV-2 RECEPTOR BINDING DOMAIN (RBD)","",1.87,35.18,"8cwi_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",70.3282,"","",""
"8CWI","FAB ARM OF ANTIBODY 10G4 BOUND TO COV-2 RECEPTOR BINDING DOMAIN (RBD)","",1.87,35.18,"8cwi_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(107_L_)",64.4727,"","",""
"8CWJ","FAB ARMS OF ANTIBODIES 4C12-B12 AND CR3022 BOUND TO PANGOLIN RECEPTOR BINDING DOMAIN (PRBD)","",2.45,70.33,"8cwj_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_G_)",118.734,"","",""
"8CWJ","FAB ARMS OF ANTIBODIES 4C12-B12 AND CR3022 BOUND TO PANGOLIN RECEPTOR BINDING DOMAIN (PRBD)","",2.45,70.33,"8cwj_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(370_I_)",160.179,"","",""
"8CWJ","FAB ARMS OF ANTIBODIES 4C12-B12 AND CR3022 BOUND TO PANGOLIN RECEPTOR BINDING DOMAIN (PRBD)","",2.45,70.33,"8cwj_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(343_I_)",119.205,"","",""
"8CWU","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING NANOBODY 1-21","10.1016/J.CELREP.2022.111004 ",1.71,24.21,"8cwu_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_A_)",65.8633,"","",""
"8CWV","CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH A CROSS-NEUTRALIZING NANOBODY 2-31 AND A HUMAN ANTIBODY CC12.1 FAB","10.1016/J.CELREP.2022.111004 ",2.51,46.09,"8cwv_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_A_)",95.8524,"","",""
"8CXI","STRUCTURES OF ZIKA VIRUS IN COMPLEX WITH ANTIBODIES TARGETING E DIMER EPITOPES AND BASIS FOR NEUTRALIZATION EFFICACY","",3.4,"1.08527e-19","8cxi_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)",87.7757,"","",""
"8CXI","STRUCTURES OF ZIKA VIRUS IN COMPLEX WITH ANTIBODIES TARGETING E DIMER EPITOPES AND BASIS FOR NEUTRALIZATION EFFICACY","",3.4,"1.08527e-19","8cxi_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(154_A_)",85.9891,"","",""
"8CYA","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-67","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cya_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)",146.43,"","",""
"8CYA","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 2-67","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cya_oligo18","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)-ASN(1074_C_)",140.135,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(801_A_)",144.248,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1098_A_)",167.511,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo10","LFucpa1-2DGalpb1-4LFucpa1-6[DManpb1-4DGlcpNAcb1-4]DGlcpNAcb1-ASN","FUC(4_I_)-GAL(3_I_)-FUC(2_I_)-[BMA(6_I_)-NAG(5_I_)]-NAG(1_I_)-ASN(1074_A_)",153.722,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(717_A_)",141.855,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(709_A_)",158.823,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1098_B_)",150.921,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(801_B_)",155.129,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(717_C_)",142.779,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(276_E_)",79.6994,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(276_A_)",78.7414,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(276_I_)",84.9538,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_a_)-MAN(8_a_)-[MAN(10_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(234_E_)",89.2785,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_A_)",60.0807,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_j_)-MAN(8_j_)-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(234_I_)",56.3614,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo5","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(241_G_)",487.322,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(363_G_)",479.639,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",425.457,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(301_G_)",481.207,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",395.041,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_G_)",489.664,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",404.094,"","",""
"8D3A","CRYSTAL STRUCTURE OF DH475 FAB IN COMPLEX WITH MAN9","10.3389/FIMMU.2022.962939 ",2.9,82.4,"8d3a_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_G_)-MAN(10_G_)-[MAN(9_G_)-MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",81.0283,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(107_D_)",65.1504,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(107_B_)",53.616,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(107_A_)",61.7229,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(107_C_)",66.1091,"","",""
"8D3Z","CRYSTAL STRUCTURE OF GALS1 IN COMPLEX WITH MANGANESE FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.56,107.4,"8d3z_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",81.8578,"","",""
"8D3Z","CRYSTAL STRUCTURE OF GALS1 IN COMPLEX WITH MANGANESE FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.56,107.4,"8d3z_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(107_B_)",171.509,"","",""
"8D4Q","CRYSTAL STRUCTURE OF NEUTROPHIL ELASTASE INHIBITED BY EAP1 FROM S. AUREUS","10.1016/J.JBC.2023.102969 ",2.2,48.53,"8d4q_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(123_A_)",63.75,"","",""
"8D4Q","CRYSTAL STRUCTURE OF NEUTROPHIL ELASTASE INHIBITED BY EAP1 FROM S. AUREUS","10.1016/J.JBC.2023.102969 ",2.2,48.53,"8d4q_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(172_A_)",83.5661,"","",""
"8D4Q","CRYSTAL STRUCTURE OF NEUTROPHIL ELASTASE INHIBITED BY EAP1 FROM S. AUREUS","10.1016/J.JBC.2023.102969 ",2.2,48.53,"8d4q_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(123_B_)",71.9058,"","",""
"8D4Q","CRYSTAL STRUCTURE OF NEUTROPHIL ELASTASE INHIBITED BY EAP1 FROM S. AUREUS","10.1016/J.JBC.2023.102969 ",2.2,48.53,"8d4q_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(172_B_)",61.5176,"","",""
"8D4U","CRYSTAL STRUCTURE OF NEUTROPHIL ELASTASE INHIBITED BY EAP2 FROM S. AUREUS","10.1016/J.JBC.2023.102969 ",1.9,46.75,"8d4u_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(172_A_)",60.4982,"","",""
"8D4U","CRYSTAL STRUCTURE OF NEUTROPHIL ELASTASE INHIBITED BY EAP2 FROM S. AUREUS","10.1016/J.JBC.2023.102969 ",1.9,46.75,"8d4u_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(123_A_)",43.5161,"","",""
"8D56","ONE RBD-UP STATE OF SARS-COV-2 BA.2 VARIANT SPIKE PROTEIN","10.1038/S41594-023-01023-6 ",3,"1.15243e-41","8d56_oligo28","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_e_)-[NAG(2_e_)]-NAG(1_e_)-ASN(1074_C_)",116.432,"","",""
"8D56","ONE RBD-UP STATE OF SARS-COV-2 BA.2 VARIANT SPIKE PROTEIN","10.1038/S41594-023-01023-6 ",3,"1.15243e-41","8d56_oligo13","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(1074_B_)",100.302,"","",""
"8D56","ONE RBD-UP STATE OF SARS-COV-2 BA.2 VARIANT SPIKE PROTEIN","10.1038/S41594-023-01023-6 ",3,"1.15243e-41","8d56_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(1074_A_)",118.281,"","",""
"8D87","FITTED CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SFV INTO SUBTOMOGRAM AVERAGED CHIKV E1 GLYCOPROTEIN DENSITY","10.1038/S41467-022-32431-9 ",27.2,"1.15243e-41","8d87_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NDG(1_E_)-ASN(141_B_)",134.96,"","",""
"8DD2","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS ZOLPIDEM","10.1038/S41467-022-32212-4 ",2.9,"2.14959e+09","8dd2_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",37.1905,"","",""
"8DF1","CHI3L1 BOUND BY ANTIBODY C59","10.1093/ABT/TBAC027 ",3.3,71.17,"8df1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(65_C_)",129.236,"","",""
"8DF1","CHI3L1 BOUND BY ANTIBODY C59","10.1093/ABT/TBAC027 ",3.3,71.17,"8df1_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(65_A_)",94.3314,"","",""
"8DF1","CHI3L1 BOUND BY ANTIBODY C59","10.1093/ABT/TBAC027 ",3.3,71.17,"8df1_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(65_E_)",113.074,"","",""
"8DFW","CRYSTAL STRUCTURE OF HUMAN BTN2A1 IN COMPLEX WITH VGAMMA9-VDELTA2 T CELL RECEPTOR","",2.1,58.2,"8dfw_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(92_A_)",66.8825,"","",""
"8DIN","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.5,68.26,"8din_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",59.0284,"","",""
"8DIN","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.5,68.26,"8din_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",97.4553,"","",""
"8DIR","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.3,61.7,"8dir_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",53.7698,"","",""
"8DIR","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.3,61.7,"8dir_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",90.7651,"","",""
"8DJ7","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.39,69.66,"8dj7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",62.1081,"","",""
"8DJ7","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.39,69.66,"8dj7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.2131,"","",""
"8DL1","BOGH13ASUS-E523Q FROM BACTEROIDES OVATUS BOUND TO MALTOHEPTAOSE","",2.09,26.13,"8dl1_oligo12","DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(5_R_)-GLC(4_R_)-GLC(3_R_)-GLC(2_R_)-GLC(1_R_)",34.6362,"","",""
"8DL1","BOGH13ASUS-E523Q FROM BACTEROIDES OVATUS BOUND TO MALTOHEPTAOSE","",2.09,26.13,"8dl1_oligo10","DGlcpa1-4DGlcpa1-6[DGlcpa1-4]DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(6_P_)-GLC(5_P_)-[GLC(7_P_)]-GLC(4_P_)-GLC(3_P_)-GLC(2_P_)-GLC(1_P_)",37.0823,"","",""
"8DL1","BOGH13ASUS-E523Q FROM BACTEROIDES OVATUS BOUND TO MALTOHEPTAOSE","",2.09,26.13,"8dl1_oligo11","DGlcpa1-4DGlcpa1-6DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(6_Q_)-GLC(5_Q_)-GLC(4_Q_)-GLC(3_Q_)-GLC(2_Q_)-GLC(1_Q_)",37.2617,"","",""
"8DL1","BOGH13ASUS-E523Q FROM BACTEROIDES OVATUS BOUND TO MALTOHEPTAOSE","",2.09,26.13,"8dl1_oligo9","DGlcpa1-4[DGlcpa1-6]DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-ROH","GLC(7_O_)-[GLC(6_O_)]-GLC(5_O_)-GLC(4_O_)-GLC(3_O_)-GLC(2_O_)-GLC(1_O_)",32.7105,"","",""
"8DLW","CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH FAB S2M11","10.1038/S41467-022-32262-8 ",2.16,"7.45788e-09","8dlw_oligo17","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_Z_)-[BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(343_E_)",110.85,"","",""
"8DLW","CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH FAB S2M11","10.1038/S41467-022-32262-8 ",2.16,"7.45788e-09","8dlw_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_B_)",108.321,"","",""
"8DLW","CRYO-EM STRUCTURE OF SARS-COV-2 EPSILON (B.1.429) SPIKE PROTEIN IN COMPLEX WITH FAB S2M11","10.1038/S41467-022-32262-8 ",2.16,"7.45788e-09","8dlw_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_A_)",110.323,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-MAN(8_i_)-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_I_)",55.284,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(276_E_)",95.7844,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_A_)",65.5456,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(276_I_)",80.9815,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Y_)-MAN(8_Y_)-[MAN(10_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(234_E_)",63.8452,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo15","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_I_)",105.618,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_E_)",105.391,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_E_)",82.8048,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo11","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_I_)",79.6404,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_A_)",109.629,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_A_)",81.97,"","",""
"8DPL","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 2.1.1D5 SCFV AND 6D6 SCFV BOUND","",2.53,"1.08527e-19","8dpl_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_N_)",52.3908,"","",""
"8DPL","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 2.1.1D5 SCFV AND 6D6 SCFV BOUND","",2.53,"1.08527e-19","8dpl_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(563_E_)",52.0005,"","",""
"8DPL","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 2.1.1D5 SCFV AND 6D6 SCFV BOUND","",2.53,"1.08527e-19","8dpl_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_J_)",52.0312,"","",""
"8DPM","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 9.20.1A2 FAB AND 6D6 SCFV BOUND","",3,"1.08527e-19","8dpm_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_L_)",17.6167,"","",""
"8DPM","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 9.20.1A2 FAB AND 6D6 SCFV BOUND","",3,"1.08527e-19","8dpm_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(563_B_)",18.3777,"","",""
"8DPM","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 9.20.1A2 FAB AND 6D6 SCFV BOUND","",3,"1.08527e-19","8dpm_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_G_)",17.7744,"","",""
"8DT3","CRYO-EM STRUCTURE OF SPIKE BINDING TO FAB OF NEUTRALIZING ANTIBODY (LOCALLY REFINED)","10.1126/SCIIMMUNOL.ABP9962 ",3.3,"3.4444e+09","8dt3_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(343_C_)",97.8394,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(154_E_)",132.83,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_t_)-[MAN(6_t_)-MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(332_I_)",91.3969,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-[MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(262_I_)",89.128,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(441_E_)",139.246,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo28","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(441_I_)",135.219,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(154_I_)",120.453,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_E_)",90.4809,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(441_A_)",132.74,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(154_A_)",129.73,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",90.5089,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-[MAN(6_f_)-MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_A_)",88.2883,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_A_)",82.8638,"","",""
"8DU5","MURINE SIALIDASE-1 (NEU1)","10.1126/SCIADV.ADF8169 ",3.5,93.91,"8du5_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(346_A_)",164.971,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(612_F_)",117.614,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(47_C_)",86.6251,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(47_G_)",94.5591,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(612_B_)",107.709,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(612_A_)",119.03,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(47_I_)",90.1546,"","",""
"8DV3","CRYSTAL STRUCTURE OF HUMAN CD1B PRESENTING PHOSPHATIDYLINOSITOL C34:1","10.1016/J.JBC.2022.102849 ",1.9,0,"8dv3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",28.1208,"","",""
"8DV3","CRYSTAL STRUCTURE OF HUMAN CD1B PRESENTING PHOSPHATIDYLINOSITOL C34:1","10.1016/J.JBC.2022.102849 ",1.9,0,"8dv3_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(20_A_)",77.4824,"","",""
"8DVL","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.18","10.1021/ACSCHEMBIO.2C00753 ",2.5,63.03,"8dvl_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",82.5737,"","",""
"8DVL","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.18","10.1021/ACSCHEMBIO.2C00753 ",2.5,63.03,"8dvl_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",87.4885,"","",""
"8DVM","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.6","10.1021/ACSCHEMBIO.2C00753 ",2,49.36,"8dvm_oligo2","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(7_F_)-[FUC(5_F_)-[FUC(4_F_)]-NAG(3_F_)-NAG(2_F_)]-[FUC(6_F_)]-NAG(1_F_)",69.9421,"","",""
"8DVN","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.10","10.1021/ACSCHEMBIO.2C00753 ",2.53,86.88,"8dvn_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)",124.942,"","",""
"8DXT","FAB ARM OF ANTIBODY GAR12 BOUND TO THE RECEPTOR BINDING DOMAIN OF SARS-COV-2.","10.1038/S41467-023-36295-5 ",2.25,71.71,"8dxt_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(343_R_)",108.471,"","",""
"8E7M","STRUCTURE OF THE HUMAN ACE2 RECEPTOR IN COMPLEX WITH ANTIBODY FAB FRAGMENT, 05B04","10.1101/2022.08.24.505169 ",3.3,"3.05475e-05","8e7m_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(90_A_)",45.6497,"","",""
"8E7M","STRUCTURE OF THE HUMAN ACE2 RECEPTOR IN COMPLEX WITH ANTIBODY FAB FRAGMENT, 05B04","10.1101/2022.08.24.505169 ",3.3,"3.05475e-05","8e7m_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(103_A_)",81.9388,"","",""
"8EDC","STRUCTURE OF C. ELEGANS UNC-5 IG 1+2 DOMAINS","",2.89,73.01,"8edc_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(178_A_)",108.672,"","",""
"8EDI","STRUCTURE OF C. ELEGANS UNC-5 IG 1+2 DOMAINS BOUND TO HEPARIN DP4","",2.11,68.13,"8edi_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(178_A_)",107.663,"","",""
"8EDI","STRUCTURE OF C. ELEGANS UNC-5 IG 1+2 DOMAINS BOUND TO HEPARIN DP4","",2.11,68.13,"8edi_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(178_B_)",103.343,"","",""
"8EGW","COMPLEX OF FAT4(EC1-4) BOUND TO DCHS1(EC1-3)","10.1038/S41467-023-36435-X ",2.3,0,"8egw_oligo4","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(237_B_)",107.289,"","",""
"8EGW","COMPLEX OF FAT4(EC1-4) BOUND TO DCHS1(EC1-3)","10.1038/S41467-023-36435-X ",2.3,0,"8egw_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-[FUC(5_E_)]-NAG(1_E_)-ASN(435_B_)",112.057,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(109_C_)",90.2061,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(365_c_)",90.0535,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(365_a_)",90.0535,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo9","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(373_c_)",115.328,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo15","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(373_a_)",115.328,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo22","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(109_B_)",90.2061,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo10","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(109_A_)",90.2061,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(365_b_)",90.0535,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo27","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(373_b_)",115.328,"","",""
"8EJE","STRUCTURE OF LINEAGE II LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN NIG08-A41)","10.1016/J.CELREP.2023.112524 ",3.69,"5.50295e+11","8eje_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(364_c_)",58.364,"","",""
"8EJE","STRUCTURE OF LINEAGE II LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN NIG08-A41)","10.1016/J.CELREP.2023.112524 ",3.69,"5.50295e+11","8eje_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(364_a_)",58.364,"","",""
"8EJE","STRUCTURE OF LINEAGE II LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN NIG08-A41)","10.1016/J.CELREP.2023.112524 ",3.69,"5.50295e+11","8eje_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(364_b_)",58.364,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(365_a_)",95.5775,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(79_C_)",99.6153,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(365_c_)",95.5775,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)-ASN(167_C_)",124.426,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(365_b_)",95.5775,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(79_A_)",99.6153,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(79_B_)",99.6153,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo9","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(167_B_)",124.426,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(167_A_)",124.426,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(119_A_)",188.233,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(119_B_)",188.233,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(119_C_)",188.233,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(78_A_)",74.4213,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(78_B_)",74.4213,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(78_C_)",74.4213,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(364_a_)",51.9904,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo24","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_d_)-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(364_b_)",51.9904,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(364_c_)",51.9904,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_k_)-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(365_a_)",77.387,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(201_J_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(89_C_)",67.412,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo15","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_V_)-MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(365_c_)",77.387,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo18","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(201_H_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(89_A_)",67.412,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo24","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_i_)-MAN(6_i_)-[MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(365_b_)",77.387,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo11","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(201_h_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(89_B_)",67.412,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(365_c_)",115.703,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(365_a_)",113.156,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(365_b_)",115.703,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo3","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(89_A_)",137.833,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(109_A_)",187.534,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(365_a_)",47.8673,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(79_C_)",60.9587,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-[MAN(201_l_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(79_A_)",60.9587,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo16","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(119_B_)",57.6394,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(79_B_)",60.9587,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_W_)-[NAG(2_W_)]-NAG(1_W_)-ASN(119_C_)",57.6394,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo6","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(119_A_)",57.6394,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(365_b_)",47.8673,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(365_c_)",47.8673,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(343_A_)",257.559,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(717_A_)",186.987,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(1134_A_)",226.735,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(1134_C_)",225.975,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(282_B_)",229.525,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(801_C_)",179.632,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(282_A_)",225.8,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(343_B_)",254.683,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(801_A_)",178.291,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(1134_B_)",229.907,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(717_C_)",181.629,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(717_B_)",190.597,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(801_B_)",183.011,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(282_C_)",229.337,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(343_C_)",250.81,"","",""
"8EPP","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 WITH TWO RBDS IN THE OPEN CONFORMATION","10.1126/SCIADV.ADG0330 ",3.1,"1.15243e-41","8epp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(282_A_)",325.633,"","",""
"8EPP","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 WITH TWO RBDS IN THE OPEN CONFORMATION","10.1126/SCIADV.ADG0330 ",3.1,"1.15243e-41","8epp_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(801_B_)",187.069,"","",""
"8EPP","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 WITH TWO RBDS IN THE OPEN CONFORMATION","10.1126/SCIADV.ADG0330 ",3.1,"1.15243e-41","8epp_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(801_C_)",190.59,"","",""
"8EQM","STRUCTURE OF A DIMERIC PHOTOSYSTEM II COMPLEX ACCLIMATED TO FAR-RED LIGHT","10.1016/J.JBC.2022.102815 ",2.6,"9.5524e-06","8eqm_oligo8","DGalpa1-6DGalpb1-C22O5","DGD(516_c_)-DGD(516_c_)",37.13,"","",""
"8EQM","STRUCTURE OF A DIMERIC PHOTOSYSTEM II COMPLEX ACCLIMATED TO FAR-RED LIGHT","10.1016/J.JBC.2022.102815 ",2.6,"9.5524e-06","8eqm_oligo12","DGalpa1-6DGalpb1-C22O5","DGD(516_C_)-DGD(516_C_)",37.13,"","",""
"8ESK","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, RESTING-LIKE STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8esk_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",85.5935,"","",""
"8ESK","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, RESTING-LIKE STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8esk_oligo4","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",96.1796,"","",""
"8ESK","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, RESTING-LIKE STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8esk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",88.0286,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo2","DGalpa1-6DGalpb1-C39O5","DGD(617_A_)-DGD(617_A_)",55.7705,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",37.885,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",32.8723,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(101_h_)-DGD(101_h_)",46.9786,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo18","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",42.63,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",43.7718,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",38.4877,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",33.3245,"","",""
"8EZ5","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.19,"8ez5_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",45.1868,"","",""
"8F0H","STRUCTURE OF SARS-COV-2 SPIKE WITH ANTIBODY FABS 2A10 AND 1H2 (LOCAL REFINEMENT OF THE RBD AND FABS 1H2 AND 2A10)","10.1016/J.CELREP.2023.112421 ",3.18,"5.37397e+08","8f0h_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(343_C_)",115.927,"","",""
"8F0P","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE HYBRID INHIBITOR GNE-1305","10.7554/ELIFE.84151 ",2.2,"1.15243e-41","8f0p_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",15.7485,"","",""
"8F0R","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE ARYLSULFONAMIDE INHIBITOR GNE-3565","10.7554/ELIFE.84151 ",2.9,"1.15243e-41","8f0r_oligo2","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcx1-","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",38.1534,"","",""
"8F0S","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE HYBRID INHIBITOR GNE-9296","10.7554/ELIFE.84151 ",3.1,"1.15243e-41","8f0s_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcx1-","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",35.3938,"","",""
"8F2S","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, PORE-BLOCKED STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8f2s_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",104.401,"","",""
"8F2S","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, PORE-BLOCKED STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8f2s_oligo10","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",84.7904,"","",""
"8F2S","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, PORE-BLOCKED STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8f2s_oligo6","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",105.547,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",41.0041,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",38.7005,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo6","DGalpa1-6DGalpb1-C39O5","DGD(616_A_)-DGD(616_A_)",53.1291,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(515_c_)-DGD(515_c_)",27.0386,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",34.5182,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",36.405,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",28.2859,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(101_h_)-DGD(101_h_)",46.8595,"","",""
"8F4C","RT XFEL STRUCTURE OF THE TWO-FLASH STATE OF PHOTOSYSTEM II (2F, S3- RICH) AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.61,"8f4c_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",33.3991,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo4","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",42.8655,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",39.0905,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",47.1405,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",32.1564,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",44.3473,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",36.5773,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo9","DGalpa1-6DGalpb1-C39O5","DGD(615_A_)-DGD(615_A_)",58.0836,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",47.2814,"","",""
"8F4D","RT XFEL STRUCTURE OF PHOTOSYSTEM II 50 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.15 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.15,44.78,"8f4d_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",33.5718,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",36.0364,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",43.9345,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",32.6891,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",44.2805,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo24","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",37.8655,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo23","DGalpa1-6DGalpb1-C39O5","DGD(616_A_)-DGD(616_A_)",56.9777,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",33.5,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo7","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",42.0295,"","",""
"8F4E","RT XFEL STRUCTURE OF PHOTOSYSTEM II 250 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.09 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.09,44.02,"8f4e_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",47.2091,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",42.0859,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",44.0759,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",28.1336,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(515_c_)-DGD(515_c_)",29.3286,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo16","DGalpa1-6DGalpb1-C39O5","DGD(616_A_)-DGD(616_A_)",54.3336,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",36.9236,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(101_J_)-DGD(101_J_)",32.8473,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",47.2655,"","",""
"8F4F","RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.85,"8f4f_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",39.4541,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",50.9064,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",37.0236,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",28.4177,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo22","DGalpa1-6DGalpb1-C39O5","DGD(617_A_)-DGD(617_A_)",57.005,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo18","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",28.525,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",41.2045,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",35.1386,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",47.9173,"","",""
"8F4G","RT XFEL STRUCTURE OF PHOTOSYSTEM II 730 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.03 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.03,41.16,"8f4g_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",42.0045,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",30.9577,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",33.8023,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo23","DGalpa1-6DGalpb1-C39O5","DGD(619_A_)-DGD(619_A_)",59.5018,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",38.3445,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(101_H_)-DGD(101_H_)",51.3677,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",53.2145,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",48.9123,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo22","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",45.6241,"","",""
"8F4H","RT XFEL STRUCTURE OF PHOTOSYSTEM II 1200 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.10 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.1,45.17,"8f4h_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",39.1895,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",35.6709,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo3","DGalpa1-6DGalpb1-C35O5","DGD(515_c_)-DGD(515_c_)",27.3564,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(101_h_)-DGD(101_h_)",43.7377,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo18","DGalpa1-6DGalpb1-C39O5","DGD(616_A_)-DGD(616_A_)",54.1786,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo2","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",26.5927,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",42.63,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",33.0755,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",38.7741,"","",""
"8F4I","RT XFEL STRUCTURE OF PHOTOSYSTEM II 2000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,39.84,"8f4i_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",31.9336,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo23","DGalpa1-6DGalpb1-C35O5","DGD(515_C_)-DGD(515_C_)",27.925,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo20","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",39.8973,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo22","DGalpa1-6DGalpb1-C39O5","DGD(617_A_)-DGD(617_A_)",54.7841,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo18","DGalpa1-6DGalpb1-C35O5","DGD(103_h_)-DGD(103_h_)",47.1855,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo25","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",37.3232,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo6","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",32.4164,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo19","DGalpa1-6DGalpb1-C35O5","DGD(516_c_)-DGD(516_c_)",28.8014,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo5","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",43.0605,"","",""
"8F4J","RT XFEL STRUCTURE OF PHOTOSYSTEM II 4000 MICROSECONDS AFTER THE THIRD ILLUMINATION AT 2.00 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2,40.71,"8f4j_oligo21","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",34.225,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",39.8109,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo17","DGalpa1-6DGalpb1-C35O5","DGD(517_c_)-DGD(517_c_)",35.3055,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo14","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",47.3923,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo13","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",46.5059,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo1","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",40.585,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo15","DGalpa1-6DGalpb1-C35O5","DGD(516_C_)-DGD(516_C_)",33.8105,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo16","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",49.8241,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",46.9968,"","",""
"8F4K","RT XFEL STRUCTURE OF THE THREE-FLASH STATE OF PHOTOSYSTEM II (3F, S0- RICH) AT 2.16 ANGSTROM RESOLUTION","10.1038/S41586-023-06038-Z ",2.16,46.67,"8f4k_oligo25","DGalpa1-6DGalpb1-C39O5","DGD(614_A_)-DGD(614_A_)",58.3286,"","",""
"8F60","ANTI-BTLA MONOCLONAL ANTIBODY R23C8 IN COMPLEX WITH BTLA","10.1016/J.STR.2023.05.011 ",1.64,28.63,"8f60_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(110_C_)",36.6764,"","",""
"8F6Y","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ETOMIDATE, DESENSITIZED-LIKE STATE","10.1038/S41467-023-38827-5 ",2.79,"1.08527e-19","8f6y_oligo5","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",88.2376,"","",""
"8F6Y","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ETOMIDATE, DESENSITIZED-LIKE STATE","10.1038/S41467-023-38827-5 ",2.79,"1.08527e-19","8f6y_oligo2","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",105.333,"","",""
"8F6Y","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ETOMIDATE, DESENSITIZED-LIKE STATE","10.1038/S41467-023-38827-5 ",2.79,"1.08527e-19","8f6y_oligo6","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_E_)",96.5482,"","",""
"8F6Z","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH SUCCINYLCHOLINE, DESENSITIZED-LIKE STATE","10.1038/S41467-023-38827-5 ",2.7,"1.08527e-19","8f6z_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(143_B_)",62.117,"","",""
"8F6Z","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH SUCCINYLCHOLINE, DESENSITIZED-LIKE STATE","10.1038/S41467-023-38827-5 ",2.7,"1.08527e-19","8f6z_oligo8","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_D_)",47.9262,"","",""
"8F6Z","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH SUCCINYLCHOLINE, DESENSITIZED-LIKE STATE","10.1038/S41467-023-38827-5 ",2.7,"1.08527e-19","8f6z_oligo1","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",89.1671,"","",""
"8F6Z","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH SUCCINYLCHOLINE, DESENSITIZED-LIKE STATE","10.1038/S41467-023-38827-5 ",2.7,"1.08527e-19","8f6z_oligo3","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_E_)",62.2136,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_L_)-MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(297_F_)",82.2497,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(297_A_)",77.1554,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_E_)",73.2138,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(297_B_)",89.7328,"","",""
"8F8X","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM II","",2.6,79.15,"8f8x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",85.9644,"","",""
"8F8X","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM II","",2.6,79.15,"8f8x_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",84.3382,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo41","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-MAN(4_r_)-[MAN(6_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(262_A_)",84.1124,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_E_)",127.66,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_C_)",83.9999,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo9","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(339_C_)",234.375,"","",""
"8FBW","CRYSTAL STRUCTURE OF SIV-1 V2 ANTIBODY NCI05 IN COMPLEX WITH A V2 PEPTIDE","10.1128/JVI.01864-22 ",2.35,0,"8fbw_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(113_C_)",64.7166,"","",""
"8FCZ","CRYSTAL STRUCTURE OF GROUND-STATE RHODOPSIN IN COMPLEX WITH A NANOBODY","",3.7,211.1,"8fcz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(15_B_)",222.166,"","",""
"8FCZ","CRYSTAL STRUCTURE OF GROUND-STATE RHODOPSIN IN COMPLEX WITH A NANOBODY","",3.7,211.1,"8fcz_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",228.688,"","",""
"8FD0","CRYSTAL STRUCTURE OF BOVINE ROD OPSIN IN COMPLEX WITH A NANOBODY","",3.71,230.9,"8fd0_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",248.428,"","",""
"8FD0","CRYSTAL STRUCTURE OF BOVINE ROD OPSIN IN COMPLEX WITH A NANOBODY","",3.71,230.9,"8fd0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(15_B_)",234.581,"","",""
"8FD1","CRYSTAL STRUCTURE OF PHOTOACTIVATED RHODOPSIN IN COMPLEX WITH A NANOBODY","",4.25,291.8,"8fd1_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",319.058,"","",""
"8FD1","CRYSTAL STRUCTURE OF PHOTOACTIVATED RHODOPSIN IN COMPLEX WITH A NANOBODY","",4.25,291.8,"8fd1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(15_B_)",304.517,"","",""
"8FFE","CRYSTAL STRUCTURE OF LRP6 E1E2 DOMAINS BOUND TO YW210.09 FAB AND ENGINEERED XWNT8 PEPTIDE","10.1073/PNAS.2218238120 ",1.72,38.7,"8ffe_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(486_A_)",87.4034,"","",""
"8FFE","CRYSTAL STRUCTURE OF LRP6 E1E2 DOMAINS BOUND TO YW210.09 FAB AND ENGINEERED XWNT8 PEPTIDE","10.1073/PNAS.2218238120 ",1.72,38.7,"8ffe_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(3_C_)-NAG(2_C_)]-[FUC(4_C_)]-NAG(1_C_)-ASN(433_A_)",55.5996,"","",""
"8FHD","CRYO-EM STRUCTURE OF HUMAN VOLTAGE-GATED SODIUM CHANNEL NAV1.6","10.1073/PNAS.2220578120 ",3.1,"1.08527e-19","8fhd_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(326_A_)",174.537,"","",""
"8FIA","THE STRUCTURE OF FLY TENEURIN SELF ASSEMBLY","10.15252/EMBR.202256728 ",2.4,68.53,"8fia_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(2091_A_)",94.9194,"","",""
"8FIA","THE STRUCTURE OF FLY TENEURIN SELF ASSEMBLY","10.15252/EMBR.202256728 ",2.4,68.53,"8fia_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(857_A_)",77.322,"","",""
"8FIA","THE STRUCTURE OF FLY TENEURIN SELF ASSEMBLY","10.15252/EMBR.202256728 ",2.4,68.53,"8fia_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(1211_A_)",109.721,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(363_C_)",90.0496,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo13","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(301_C_)",116.61,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_C_)",100.376,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo16","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(301_F_)",107.625,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_w_)-[MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(160_G_)",72.2878,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo41","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(156_G_)",98.3051,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(448_C_)",113.123,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo34","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(301_G_)",111.951,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_I_)",60.0806,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(160_C_)",60.7071,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_G_)",60.7438,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-SER","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-SER(447_C_)",52.9086,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(156_G_)",146.459,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(386_G_)",153.773,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_C_)",146.459,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo33","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_I_)",119.866,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_G_)",119.866,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(386_C_)",153.773,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(156_I_)",146.459,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_C_)",119.866,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(386_I_)",153.773,"","",""
"8G18","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-108","10.1021/ACSCHEMNEURO.2C00779 ",2.85,51.91,"8g18_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",20,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_O_)",151.008,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_N_)",150.754,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(146_O_)",303.887,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_M_)",149.749,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(146_M_)",310.675,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo21","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_P_)",150.737,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo20","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(146_L_)",246.096,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(146_G_)",234.22,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo14","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(146_K_)",248.144,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo21","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_U_)-[MAN(7_U_)]-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(200_L_)",109.522,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo22","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_X_)-[BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(234_L_)",298.491,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_K_)",112.937,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_V_)-[BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(234_J_)",269.428,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_t_)-[BMA(3_t_)-NAG(2_t_)]-NAG(1_t_)-ASN(234_G_)",285.526,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo5","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(146_J_)",240.857,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",116.749,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo16","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_W_)-[BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(234_K_)",280.451,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_J_)",103.872,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",97.4353,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_X_)-[NAG(2_X_)]-NAG(1_X_)-ASN(234_L_)",214.851,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_U_)-[MAN(7_U_)]-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(200_L_)",97.4265,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_J_)",97.4011,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_V_)-[NAG(2_V_)]-NAG(1_V_)-ASN(234_J_)",215.398,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_K_)",97.4069,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_5_)-[NAG(2_5_)]-NAG(1_5_)-ASN(245_J_)",416.789,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_H_)",128.259,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo23","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_m_)-[NAG(2_m_)]-NAG(1_m_)-ASN(245_H_)",242.512,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_J_)",146.598,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo8","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_e_)-[NAG(2_e_)]-NAG(1_e_)-ASN(245_G_)",221.768,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_B_)",127.726,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo24","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_u_)-[NAG(2_u_)]-NAG(1_u_)-ASN(245_B_)",235.472,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_G_)",129.074,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_u_)-[NAG(2_u_)]-NAG(1_u_)-ASN(245_B_)",166.35,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_B_)",88.3875,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo19","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_U_)-[MAN(7_U_)]-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(200_E_)",88.3216,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo24","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_a_)-[NAG(2_a_)]-NAG(1_a_)-ASN(245_E_)",165.587,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo18","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Z_)-[NAG(2_Z_)]-NAG(1_Z_)-ASN(245_D_)",166.433,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_A_)",88.3861,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo12","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_Y_)-[NAG(2_Y_)]-NAG(1_Y_)-ASN(245_A_)",164.084,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo13","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_D_)",88.3419,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_E_)",69.6674,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo21","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_H_)",73.4307,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",72.3917,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_F_)",71.9847,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo22","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",78.1568,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo16","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_F_)",77.9231,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_d_)-[NAG(2_d_)]-NAG(1_d_)-ASN(234_E_)",138.423,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_E_)",75.3932,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo10","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_H_)",77.7738,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_G_)",72.0359,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_W_)-[MAN(7_W_)]-MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(200_J_)",72.01,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo3","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_I_)",72.0668,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Q_)-[MAN(7_Q_)]-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(200_H_)",71.993,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_J_)",102.554,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo24","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_u_)-[NAG(2_u_)]-NAG(1_u_)-ASN(245_I_)",192.221,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo20","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_4_)-[BMA(3_4_)-NAG(2_4_)]-NAG(1_4_)-ASN(234_J_)",244.238,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_G_)",77.8418,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo10","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_I_)",72.1523,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo23","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_m_)-[NAG(2_m_)]-NAG(1_m_)-ASN(245_H_)",156.548,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo8","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_j_)-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(146_H_)",232.722,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_l_)-[BMA(3_l_)-NAG(2_l_)]-NAG(1_l_)-ASN(234_H_)",238.566,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_H_)",87.4539,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_d_)-[BMA(3_d_)-NAG(2_d_)]-NAG(1_d_)-ASN(234_G_)",230.034,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo5","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_e_)-[NAG(2_e_)]-NAG(1_e_)-ASN(245_G_)",188.005,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo21","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_5_)-[NAG(2_5_)]-NAG(1_5_)-ASN(245_J_)",366.202,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo16","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_t_)-[BMA(3_t_)-NAG(2_t_)]-NAG(1_t_)-ASN(234_I_)",236.628,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(88_G_)",138.542,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(88_I_)",145.314,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo20","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_t_)-[MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(262_I_)",160.55,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_C_)",146.259,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_C_)",148.856,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(88_G_)",136.735,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(88_I_)",137.029,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_C_)",136.883,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo30","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_G_)",148.411,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_v_)-[MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(262_I_)",149.143,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_C_)",149.552,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo21","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",137.729,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_J_)",82.2551,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo24","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_D_)",109.415,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(88_G_)",193.126,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_E_)",530.275,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(386_P_)",508.357,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_G_)",494.234,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(386_P_)",375.861,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_G_)",445.952,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_E_)",365.397,"","",""
"8GB5","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 25F9","10.1126/SCITRANSLMED.ADG7404 ",3.35,0,"8gb5_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_P_)-[BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(343_J_)",94.4793,"","",""
"8GB5","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 25F9","10.1126/SCITRANSLMED.ADG7404 ",3.35,0,"8gb5_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(343_G_)",89.6414,"","",""
"8GB5","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 25F9","10.1126/SCITRANSLMED.ADG7404 ",3.35,0,"8gb5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(343_D_)",87.8078,"","",""
"8GB6","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 21B6","10.1126/SCITRANSLMED.ADG7404 ",1.75,0,"8gb6_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",69.7364,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo40","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",49.9655,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo41","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",58.7473,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo30","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",54.4441,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo43","DGalpa1-6DGalpb1-C35O5","DGD(102_h_)-DGD(102_h_)",98.8396,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo42","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",52.73,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo29","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",48.1627,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo31","DGalpa1-6DGalpb1-C31O5","DGD(519_C_)-DGD(519_C_)",49.3782,"","",""
"8GN0","CRYSTAL STRUCTURE OF DCBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.15,64.78,"8gn0_oligo39","DGalpa1-6DGalpb1-C35O5","DGD(103_H_)-DGD(103_H_)",84.3514,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo59","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",47.4705,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo56","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",43.7036,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo60","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",52.81,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo58","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",56.1686,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo62","DGalpa1-6DGalpb1-C35O5","DGD(703_h_)-DGD(703_h_)",64.0455,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo61","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",50.7895,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo55","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",48.9386,"","",""
"8GN1","CRYSTAL STRUCTURE OF DBBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",2.1,59.3,"8gn1_oligo54","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",44.2118,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo12","DGalpa1-6DGalpb1-C35O5","DGD(1205_h_)-DGD(1205_h_)",52.815,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo9","DGalpa1-6DGalpb1-C35O5","DGD(518_c_)-DGD(518_c_)",42.1736,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo10","DGalpa1-6DGalpb1-C35O5","DGD(519_c_)-DGD(519_c_)",47.7632,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo8","DGalpa1-6DGalpb1-C35O5","DGD(102_H_)-DGD(102_H_)",48.3686,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo61","DGalpa1-6DGalpb1-C35O5","DGD(518_C_)-DGD(518_C_)",42.3368,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo60","DGalpa1-6DGalpb1-C35O5","DGD(517_C_)-DGD(517_C_)",39.7709,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo11","DGalpa1-6DGalpb1-C35O5","DGD(520_c_)-DGD(520_c_)",44.5964,"","",""
"8GN2","CRYSTAL STRUCTURE OF PPBQ-BOUND PHOTOSYSTEM II COMPLEX","10.1016/J.JBC.2023.104839 ",1.95,53.07,"8gn2_oligo62","DGalpa1-6DGalpb1-C35O5","DGD(519_C_)-DGD(519_C_)",38.9345,"","",""
"8GP5","STRUCTURE OF X18 UFO PROTOMER IN COMPLEX WITH F6 FAB VHVL DOMAIN","10.1038/S41467-023-40321-X ",4.05,0,"8gp5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(262_X_)",131.432,"","",""
"8GP5","STRUCTURE OF X18 UFO PROTOMER IN COMPLEX WITH F6 FAB VHVL DOMAIN","10.1038/S41467-023-40321-X ",4.05,0,"8gp5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(88_X_)",111.288,"","",""
"8GPG","HIV-1 ENV X18 UFO IN COMPLEX WITH F6 FAB","10.1038/S41467-023-40321-X ",4.1,0,"8gpg_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_Z_)",100.193,"","",""
"8GPG","HIV-1 ENV X18 UFO IN COMPLEX WITH F6 FAB","10.1038/S41467-023-40321-X ",4.1,0,"8gpg_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_Y_)",101.563,"","",""
"8GPG","HIV-1 ENV X18 UFO IN COMPLEX WITH F6 FAB","10.1038/S41467-023-40321-X ",4.1,0,"8gpg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(88_X_)",98.4871,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_Z_)",83.28,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_a_)-MAN(8_a_)-[MAN(10_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(234_Y_)",82.2711,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_X_)",79.1638,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(234_X_)",83.1753,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_j_)-MAN(10_j_)-[MAN(9_j_)-MAN(8_j_)]-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(234_Z_)",84.668,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_Y_)",87.0662,"","",""
"8GV7","CRYSTAL STRUCTURE OF PN-SIA28 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H18 A/FLAT-FACED BAT/PERU/033/2010","10.1038/S41467-022-35236-Y ",2.6,49.41,"8gv7_oligo1","LFucpa1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(21_A_)",78.8114,"","",""
"8GV7","CRYSTAL STRUCTURE OF PN-SIA28 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H18 A/FLAT-FACED BAT/PERU/033/2010","10.1038/S41467-022-35236-Y ",2.6,49.41,"8gv7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(268_A_)",74.552,"","",""
"8GZ5","CRYSTAL STRUCTURE OF NEUTRALIZING VHH P17 IN COMPLEX WITH SARS-COV-2 ALPHA VARIANT SPIKE RECEPTOR-BINDING DOMAIN","10.1093/JB/MVAC096 ",1.7,39.71,"8gz5_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_A_)",83.1397,"","",""
"8H06","CRYO-EM STRUCTURE OF SARS-COV-2 OMICRON BA.4/5 RBD IN COMPLEX WITH HUMAN ACE2 (LOCAL REFINEMENT)","10.1038/S41467-023-39942-Z ",2.66,"1.08527e-19","8h06_oligo3","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(546_A_)",75.0785,"","",""
"8H2U","X-RAY STRUCTURE OF PHOTOSYSTEM I-LHCI SUPER COMPLEX FROM CHLAMYDOMONAS REINHARDTII.","10.1016/J.BBABIO.2023.148986 ",3.4,0,"8h2u_oligo2","DGalpa1-6DGalpb1-C34O5","DGD(848_B_)-DGD(848_B_)",182.695,"","",""
"8H2U","X-RAY STRUCTURE OF PHOTOSYSTEM I-LHCI SUPER COMPLEX FROM CHLAMYDOMONAS REINHARDTII.","10.1016/J.BBABIO.2023.148986 ",3.4,0,"8h2u_oligo3","DGalpa1-6DGalpb1-C24O5","DGD(319_5_)-DGD(319_5_)",161.122,"","",""
"8H5C","STRUCTURE OF SARS-COV-2 OMICRON BA.2.75 RBD IN COMPLEX WITH HUMAN ACE2","10.1038/S41467-023-39942-Z ",2.9,55.75,"8h5c_oligo2","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(103_A_)",143.405,"","",""
"8HC0","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAINS OF GPR110","10.1016/J.JMB.2023.167979 ",2.9,0,"8hc0_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(389_A_)",74.6032,"","",""
"8HTU","CRYO-EM STRUCTURE OF PPPSI-L","10.1038/S41477-023-01463-4 ",2.87,"1.08527e-19","8htu_oligo14","DGalpa1-6DGalpb1-C39O5","DGD(850_B_)-DGD(850_B_)",19.31,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(433_B_)",36.6682,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo7","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(393_C_)",33.0036,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(433_C_)",39.5875,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(433_D_)",35.7476,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(393_A_)",32.7889,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(433_A_)",37.0061,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(393_B_)",31.9383,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo10","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)]-MAN(4_N_)-[MAN(9_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(393_D_)",28.2597,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(433_A_)",30.7447,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_N_)-MAN(10_N_)-[MAN(9_N_)-MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(393_D_)",26.9676,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo12","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(433_D_)",29.9224,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)]-MAN(4_H_)-[MAN(10_H_)-MAN(9_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(393_B_)",25.3125,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(393_A_)",23.915,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(433_C_)",30.9458,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(433_B_)",31.6368,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo7","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-[MAN(7_K_)]-MAN(4_K_)-[MAN(9_K_)-MAN(8_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(393_C_)",27.2081,"","",""
"8IF2","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 OMICRON BQ.1.1 VARIANT SPIKE PROTEIN IN COMPLEX WITH ITS RECEPTOR ACE2","10.1038/S41467-023-38188-Z ",2.78,83.2,"8if2_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(90_A_)",137.253,"","",""
"8IOU","STRUCTURE OF SARS-COV-2 XBB.1 SPIKE GLYCOPROTEIN IN COMPLEX WITH ACE2 (1-UP STATE)","10.1038/S41467-023-38435-3 ",3.18,"1.08527e-19","8iou_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(103_D_)",155.583,"","",""
"8IOV","STRUCTURE OF SARS-COV-2 XBB.1 SPIKE RBD IN COMPLEX WITH ACE2","10.1038/S41467-023-38435-3 ",3.29,"1.08527e-19","8iov_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(103_A_)",194.021,"","",""
"8IUA","CRYSTAL STRUCTURE OF GH66 ENDODEXTRANASE FROM FLAVOBACTERIUM JOHNSONIAE IN COMPLEX WITH ISOMALTOSE","10.1016/J.JBC.2023.104885 ",1.8,28.62,"8iua_oligo2","DGlcpa1-6DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",29.0595,"","",""
"8IUB","CRYSTAL STRUCTURE OF GH66 ENDODEXTRANASE FROM FLAVOBACTERIUM JOHNSONIAE IN COMPLEX WITH ISOMALTOTRIOSE","10.1016/J.JBC.2023.104885 ",1.18,14.53,"8iub_oligo1","DGlcpa1-6DGlcpa1-6DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",14.3018,"","",""
"8IUC","CRYSTAL STRUCTURE OF GH65 ALPHA-1,2-GLUCOSIDASE FROM FLAVOBACTERIUM JOHNSONIAE IN COMPLEX WITH ISOMALTOSE","10.1016/J.JBC.2023.104885 ",1.56,26.71,"8iuc_oligo3","DGlcpa1-6DGlcpb1-ROH","GLC(2_F_)-BGC(1_F_)",34.1114,"","",""
"8IUC","CRYSTAL STRUCTURE OF GH65 ALPHA-1,2-GLUCOSIDASE FROM FLAVOBACTERIUM JOHNSONIAE IN COMPLEX WITH ISOMALTOSE","10.1016/J.JBC.2023.104885 ",1.56,26.71,"8iuc_oligo1","DGlcpa1-6DGlcpb1-ROH","GLC(2_D_)-BGC(1_D_)",27.3736,"","",""
"8IUC","CRYSTAL STRUCTURE OF GH65 ALPHA-1,2-GLUCOSIDASE FROM FLAVOBACTERIUM JOHNSONIAE IN COMPLEX WITH ISOMALTOSE","10.1016/J.JBC.2023.104885 ",1.56,26.71,"8iuc_oligo2","DGlcpa1-6DGlcpb1-ROH","GLC(2_E_)-BGC(1_E_)",26.9195,"","",""
"8JBK","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.3NA+ STATE","10.1002/1873-3468.14689 ",2.8,83.89,"8jbk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(265_B_)",147.973,"","",""
"8JBK","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.3NA+ STATE","10.1002/1873-3468.14689 ",2.8,83.89,"8jbk_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(158_B_)",126.566,"","",""
"8JBL","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE","10.1002/1873-3468.14689 ",3,90.02,"8jbl_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(265_B_)",173.5,"","",""
"8JBL","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE","10.1002/1873-3468.14689 ",3,90.02,"8jbl_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(158_B_)",145.961,"","",""
"8JBM","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MN2+ STATE","10.1002/1873-3468.14689 ",2.9,88.06,"8jbm_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(158_B_)",137.849,"","",""
"8JBM","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MN2+ STATE","10.1002/1873-3468.14689 ",2.9,88.06,"8jbm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(265_B_)",189.62,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_B_)",125.396,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",153.56,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_D_)",128.621,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",151.463,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_B_)",132.833,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_D_)",124.943,"","",""
"8JJ5","PORCINE UROPLAKIN COMPLEX","",3.5,"1.08527e-19","8jj5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(139_C_)",31.068,"","",""
"8OG1","EXOSTOSIN-LIKE 3 APO ENZYME","",1.58,36.17,"8og1_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(790_A_)",64.0968,"","",""
"8OG4","EXOSTOSIN-LIKE 3 UDP COMPLEX","",2.1,65.78,"8og4_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(790_B_)",76.0851,"","",""
"8OG4","EXOSTOSIN-LIKE 3 UDP COMPLEX","",2.1,65.78,"8og4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(790_A_)",90.2511,"","",""
"8OK4","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",1.23,22.25,"8ok4_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",24.9371,"","",""
"8OK5","VARIANT SURFACE GLYCOPROTEIN VSG11 MONOMER WITH IODINE","10.1371/JOURNAL.PNTD.0011621 ",1.27,20.7,"8ok5_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",18.6879,"","",""
"8OK6","VARIANT SURFACE GLYCOPROTEIN VSG11 TWO MONOMERS","10.1371/JOURNAL.PNTD.0011621 ",1.75,42.68,"8ok6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(68_C_)",43.5873,"","",""
"8OK6","VARIANT SURFACE GLYCOPROTEIN VSG11 TWO MONOMERS","10.1371/JOURNAL.PNTD.0011621 ",1.75,42.68,"8ok6_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",49.7111,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(198_A_)",57.1453,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(145_B_)",45.6173,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(198_B_)",51.5929,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(198_C_)",53.7345,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(145_D_)",48.4826,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(145_C_)",44.833,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(198_D_)",59.8656,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(68_A_)",88.8741,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(68_B_)",115.42,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo11","DManpa1-3[DManpa1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(68_N_)",142.533,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(68_K_)",123.651,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo5","DManpa1-3[DManpa1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(68_G_)",97.3885,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(68_J_)",88.2132,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(68_L_)",132.101,"","",""
"8PE9","COMPLEX BETWEEN DDR1 DS-LIKE DOMAIN AND PRTH-101 FAB","10.1136/JITC-2023-006720 ",3.15,68.75,"8pe9_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(260_A_)",78.8306,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",81.4487,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",68.9822,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",81.6622,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",78.2827,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_A_)",144.203,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(276_E_)",140.317,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_E_)",134.785,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",134.943,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo9","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_I_)",149.743,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_I_)",136.549,"","",""
"8SAQ","CRYOEM STRUCTURE OF DH270.6-CH848.0526.25","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8saq_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_E_)",47.7093,"","",""
"8SAQ","CRYOEM STRUCTURE OF DH270.6-CH848.0526.25","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8saq_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",40.0284,"","",""
"8SAQ","CRYOEM STRUCTURE OF DH270.6-CH848.0526.25","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8saq_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(334_K_)",41.9823,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-MAN(8_T_)-[MAN(10_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_F_)",81.0319,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_O_)-MAN(10_O_)-[MAN(9_O_)-MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_A_)",91.0326,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_Y_)-MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(332_K_)",89.1712,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_K_)",144.62,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",93.5735,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",104.093,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",120.787,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",115.657,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo11","DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_K_)",143.891,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",108.144,"","",""
"8SAV","CRYOEM STRUCTURE OF VRC01-CH848.0526.25","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sav_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_E_)",125.879,"","",""
"8SAV","CRYOEM STRUCTURE OF VRC01-CH848.0526.25","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sav_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_I_)",121.531,"","",""
"8SAV","CRYOEM STRUCTURE OF VRC01-CH848.0526.25","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sav_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",119.121,"","",""
"8SAW","CRYOEM STRUCTURE OF DH270.UCA.G57R-CH848.10.17DT","10.1038/S41467-023-38108-1 ",3.3,"1.08527e-19","8saw_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-[MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",44.5952,"","",""
"8SAW","CRYOEM STRUCTURE OF DH270.UCA.G57R-CH848.10.17DT","10.1038/S41467-023-38108-1 ",3.3,"1.08527e-19","8saw_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(292_K_)",45.9862,"","",""
"8SAW","CRYOEM STRUCTURE OF DH270.UCA.G57R-CH848.10.17DT","10.1038/S41467-023-38108-1 ",3.3,"1.08527e-19","8saw_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_E_)",45.408,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",117.623,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",120.791,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",119.892,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_V_)-MAN(10_V_)-[MAN(9_V_)-MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",32.9092,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(442_F_)",91.5831,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",32.843,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",26.1882,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-[MAN(10_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",23.711,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",39.2394,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-MAN(8_R_)-[MAN(10_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",25.9853,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-MAN(8_V_)-[MAN(10_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",25.1853,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_A_)",40.0345,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(156_F_)",46.1342,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_K_)",49.9155,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",41.6835,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",34.1154,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",41.5063,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo7","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(156_A_)",57.8124,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo9","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(156_F_)",50.9635,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_Y_)-MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(332_K_)",27.3535,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_O_)-MAN(10_O_)-[MAN(9_O_)-MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_A_)",31.4939,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_T_)-MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_F_)",33.9937,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo15","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(442_K_)",44.1584,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo14","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(156_K_)",52.0526,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",89.3938,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_K_)",88.5625,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_A_)",106.819,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_V_)-MAN(10_V_)-[MAN(9_V_)-MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",71.0108,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(156_F_)",99.2912,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",62.7731,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",87.9335,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",64.7202,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(442_F_)",99.5085,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_K_)",101.45,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",24.0663,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",24.8931,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_V_)-MAN(10_V_)-[MAN(9_V_)-MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",14.7497,"","",""
"8SGO","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PREGNENOLONE SULFATE","10.1038/S41467-023-40800-1 ",2.65,"1.35632e-19","8sgo_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",52.2102,"","",""
"8SI9","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS ALLOPREGNANOLONE","10.1038/S41467-023-40800-1 ",2.98,"1.35632e-19","8si9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",75.5249,"","",""
"8SID","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS DEHYDROEPIANDROSTERONE SULFATE","10.1038/S41467-023-40800-1 ",2.71,"1.35632e-19","8sid_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",81.0507,"","",""
"8SK5","CRYSTAL STRUCTURE OF THE SARS-COV-2 NEUTRALIZING VHH 7A9 BOUND TO THE SPIKE RECEPTOR BINDING DOMAIN","10.1038/S41598-023-40919-7 ",2.01,47.94,"8sk5_oligo1","DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(343_A_)",88.5885,"","",""
"8T2U","CRYO-EM STRUCTURES OF FULL-LENGTH INTEGRIN ALPHAIIBBETA3 IN NATIVE LIPIDS COMPLEXED WITH EPTIFIBATIDE","10.1038/S41467-023-39763-0 ",3.1,"1.15243e-41","8t2u_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(320_B_)",315.041,"","",""
"8T2V","CRYO-EM STRUCTURES OF FULL-LENGTH INTEGRIN ALPHAIIBBETA3 IN NATIVE LIPIDS","10.1038/S41467-023-39763-0 ",3.4,"1.15243e-41","8t2v_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(452_B_)",315.724,"","",""
"8T2V","CRYO-EM STRUCTURES OF FULL-LENGTH INTEGRIN ALPHAIIBBETA3 IN NATIVE LIPIDS","10.1038/S41467-023-39763-0 ",3.4,"1.15243e-41","8t2v_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(371_B_)",293.528,"","",""
"9API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3,0,"9api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",57.3958,"","",""
